PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Alder, A; Wilcke, L; Pietsch, E; von Thien, H; Pazicky, S; Low, C; Mesen-Ramirez, P; Bachmann, A; Burda, PC; Kunick, C; Sondermann, H; Wilson, D; Gilberger, TW				Alder, Arne; Wilcke, Louisa; Pietsch, Emma; von Thien, Heidrun; Pazicky, Samuel; Low, Christian; Mesen-Ramirez, Paolo; Bachmann, Anna; Burda, Paul-Christian; Kunick, Conrad; Sondermann, Holger; Wilson, Danny; Gilberger, Tim-Wolf			Functional inactivation of Plasmodium falciparum glycogen synthase kinase GSK3 modulates erythrocyte invasion and blocks maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALARIA PARASITES; PROTEIN-KINASES; EXPRESSION; TRANSCRIPTOME; GAMETOCYTES; PHOSPHORYLATION; INHIBITORS	Malaria is responsible for hundreds of thousands of deaths every year. The lack of an effective vaccine and the global spread of multidrug resistant parasites hampers the fight against the disease and underlines the need for new antimalarial drugs. Central to the pathogenesis of malaria is the proliferation of Plasmodium parasites within human erythrocytes. Parasites invade erythrocytes via a coordinated sequence of receptor-ligand interactions between the parasite and the host cell. Posttranslational modifications such as protein phosphorylation are known to be key regulators in this process and are mediated by protein kinases. For several parasite kinases, including the Plasmodium falciparum glycogen synthase kinase 3 (PfGSK3), inhibitors have been shown to block erythrocyte invasion. Here, we provide an assessment of PfGSK3 function by reverse genetics. Using targeted gene disruption, we show the active gene copy, PfGSK3 beta, is not essential for asexual blood stage proliferation, although it modulates efficient erythrocyte invasion. We found functional inactivation leads to a 69% decreased growth rate and confirmed this growth defect by rescue experiments with wildtype and catalytically inactive mutants. Functional knockout of PfGSK3 beta does not lead to transcriptional upregulation of the second copy of PfGSK3. We further analyze expression, localization, and function of PfGSK3 beta during gametocytogenesis using a parasite line allowing conditional induction of sexual commitment. We demonstrate PfGSK3 beta-deficient gametocytes show a strikingly malformed morphology leading to the death of parasites in later stages of gametocyte development. Taken together, these findings are important for our understanding and the development of PfGSK3 as an antimalarial target.	[Alder, Arne; Wilcke, Louisa; Pietsch, Emma; von Thien, Heidrun; Pazicky, Samuel; Low, Christian; Mesen-Ramirez, Paolo; Bachmann, Anna; Burda, Paul-Christian; Sondermann, Holger; Wilson, Danny; Gilberger, Tim-Wolf] CSSB Ctr Struct Syst Biol, Hamburg, Germany; [Alder, Arne; Wilcke, Louisa; Pietsch, Emma; von Thien, Heidrun; Mesen-Ramirez, Paolo; Bachmann, Anna; Burda, Paul-Christian; Wilson, Danny; Gilberger, Tim-Wolf] Bernhard Nocht Inst Trop Med, Dept Cellular Parasitol, Hamburg, Germany; [Alder, Arne; Wilcke, Louisa; Pietsch, Emma; von Thien, Heidrun; Mesen-Ramirez, Paolo; Bachmann, Anna; Burda, Paul-Christian; Gilberger, Tim-Wolf] Univ Hamburg, Dept Biol, Hamburg, Germany; [Pazicky, Samuel; Low, Christian] European Mol Biol Lab, Hamburg Unit, Hamburg, Germany; [Kunick, Conrad] Tech Univ Carolo Wilhelmina Braunschweig, Inst Med & Pharmazeut Chem, Braunschweig, Germany; [Sondermann, Holger] DESY, Hamburg, Germany; [Sondermann, Holger] Christian Albrechts Univ Kiel, Kiel, Germany; [Wilson, Danny] Univ Adelaide, Sch Biol Sci, Res Ctr Infect Dis, Adelaide, SA, Australia; [Wilson, Danny] Burnet Inst, Melbourne, Vic, Australia; [Wilson, Danny] Univ Adelaide, Inst Photon & Adv Sensing IPAS, Adelaide, SA, Australia	Bernhard Nocht Institut fur Tropenmedizin; University of Hamburg; European Molecular Biology Laboratory (EMBL); Braunschweig University of Technology; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Kiel; University of Adelaide; Burnet Institute; University of Adelaide	Gilberger, TW (corresponding author), CSSB Ctr Struct Syst Biol, Hamburg, Germany.; Gilberger, TW (corresponding author), Bernhard Nocht Inst Trop Med, Dept Cellular Parasitol, Hamburg, Germany.; Gilberger, TW (corresponding author), Univ Hamburg, Dept Biol, Hamburg, Germany.	gilberger@bnitm.de	Bachmann, Anna/GRO-1087-2022	Alder, Arne/0000-0003-4918-4640; Pietsch, Emma/0000-0003-4744-1666; Pazicky, Samuel/0000-0002-4674-9784; Bachmann, Anna/0000-0001-8397-7308; Loew, Christian/0000-0003-0764-7483	German Research Foundation [SPP2225]; HamburgX project grant; Jurgen Manchot-Stiftung fellowship; Humboldt foundation	German Research Foundation(German Research Foundation (DFG)); HamburgX project grant; Jurgen Manchot-Stiftung fellowship; Humboldt foundation(Alexander von Humboldt Foundation)	This work was supported by the German Research Foundation (SPP2225) and the HamburgX project grant. A. A. gratefully acknowledges support by a Jurgen Manchot-Stiftung fellowship. D. W. is supported by the Humboldt foundation.	Adderley J, 2021, TRENDS PARASITOL, V37, P508, DOI 10.1016/j.pt.2021.01.002; Aher RB, 2015, SAR QSAR ENVIRON RES, V26, P959, DOI 10.1080/1062936X.2015.1104518; Alam MM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8285; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Bachmann A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005538; Bansal A, 2016, MBIO, V7, DOI [10.1128/mBio.02011-16, 10.1128/mbio.02011-16]; Bansal A, 2013, J BIOL CHEM, V288, P1590, DOI 10.1074/jbc.M112.411934; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Birnbaum J, 2017, NAT METHODS, V14, P450, DOI 10.1038/nmeth.4223; Boltryk SD, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24954-4; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Burda PC, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107817; Burns AL, 2019, FEMS MICROBIOL REV, V43, P223, DOI 10.1093/femsre/fuz005; Buskes MJ, 2016, ORG BIOMOL CHEM, V14, P4617, DOI [10.1039/c5ob02517f, 10.1039/C5OB02517F]; Cassiano GC, 2021, ADV PROTEIN CHEM STR, V124, P225, DOI 10.1016/bs.apcsb.2020.10.004; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Collins CR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003344; Dastidar EG, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-5; Droucheau E, 2004, BBA-PROTEINS PROTEOM, V1697, P181, DOI 10.1016/j.bbapap.2003.11.023; Dzikowski R, 2006, PLOS PATHOG, V2, P184, DOI 10.1371/journal.ppat.0020022; Engelberg K, 2013, BIOCHEM J, V452, P457, DOI 10.1042/BJ20121694; Filarsky M, 2018, SCIENCE, V359, P1259, DOI 10.1126/science.aan6042; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Fugel W, 2013, J MED CHEM, V56, P264, DOI 10.1021/jm301575n; Gomes AR, 2015, CELL HOST MICROBE, V17, P404, DOI 10.1016/j.chom.2015.01.014; HAWKING F, 1971, T ROY SOC TROP MED H, V65, P549, DOI 10.1016/0035-9203(71)90036-8; Hitz E, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001483; Hitz E, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-01873-0; Hitz E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68717-5; Holland Z, 2009, EUKARYOT CELL, V8, P388, DOI 10.1128/EC.00334-08; Janse CJ, 2011, TRENDS PARASITOL, V27, P31, DOI 10.1016/j.pt.2010.06.016; Josling GA, 2018, ANNU REV MICROBIOL, V72, P501, DOI 10.1146/annurev-micro-090817-062712; Khan SM, 2005, CELL, V121, P675, DOI 10.1016/j.cell.2005.03.027; Kumar S, 2021, MBIO, V12, DOI 10.1128/mBio.02575-21; Kumar S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00053-1; Lande DH, 2021, MOLECULES, V26, DOI 10.3390/molecules26164739; Lasonder E, 2016, NUCLEIC ACIDS RES, V44, P6087, DOI 10.1093/nar/gkw536; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Leykauf K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000941; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Lopez-Barragan MJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-587; Malleret B, 2011, SCI REP-UK, V1, DOI 10.1038/srep00118; Masch A, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2725-y; McCarthy JS, 2020, CLIN INFECT DIS, V71, pE657, DOI 10.1093/cid/ciaa368; Moolman C, 2021, BIOORG CHEM, V112, DOI 10.1016/j.bioorg.2021.104839; Moon RW, 2013, P NATL ACAD SCI USA, V110, P531, DOI 10.1073/pnas.1216457110; More KR, 2020, MBIO, V11, DOI 10.1128/mBio.01287-20; Patel A, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000264; Pazicky S, 2022, BIOCHEM J, V479, P337, DOI 10.1042/BCJ20210829; Pease BN, 2013, J PROTEOME RES, V12, P4028, DOI 10.1021/pr400394g; Pelle KG, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0133-7; Prinz B, 2016, SCI REP-UK, V6, DOI 10.1038/srep34479; Sinxadi P, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.01896-19; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Struck NS, 2005, J CELL SCI, V118, P5603, DOI 10.1242/jcs.02673; Tewari R, 2010, CELL HOST MICROBE, V8, P377, DOI 10.1016/j.chom.2010.09.006; Tham WH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005343; Thomas JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157873; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Treeck M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000322; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Wadhwa P, 2020, CURR TOP MED CHEM, V20, P1522, DOI 10.2174/1568026620666200516153136; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; Wang L, 2022, MED RES REV, V42, P946, DOI 10.1002/med.21867; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wichers JS, 2019, MBIO, V10, DOI 10.1128/mBio.01500-19; Wichers JS, 2022, MBIO, V13, DOI 10.1128/mbio.00623-22; Wichers JS, 2021, MSPHERE, V6, DOI 10.1128/mSphere.00743-21; Wilde ML, 2019, MBIO, V10, DOI 10.1128/mBio.01972-19; Young JA, 2005, MOL BIOCHEM PARASIT, V143, P67, DOI 10.1016/j.molbiopara.2005.05.007; Zhang M, 2018, SCIENCE, V360, P506, DOI 10.1126/science.aap7847	73	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102360	10.1016/j.jbc.2022.102360	http://dx.doi.org/10.1016/j.jbc.2022.102360			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4V3XX	35961464	gold, Green Published			2022-12-26	WOS:000859414300014
J	Fujisawa, T; Kinoue, K; Seike, R; Kikukawa, T; Unno, M				Fujisawa, Tomotsumi; Kinoue, Kouta; Seike, Ryouhei; Kikukawa, Takashi; Unno, Masashi			Reisomerization of retinal represents a molecular switch mediating Na+ uptake and release by a bacterial sodium-pumping rhodopsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE RAMAN-SPECTROSCOPY; CHROMOPHORE STRUCTURE; VIBRATIONAL ANALYSIS; ALL-TRANS; ION-PUMP; BACTERIORHODOPSIN; INTERMEDIATE; TEMPERATURE; BINDING; SPECTRA	Sodium-pumping rhodopsins (NaRs) are membrane transporters that utilize light energy to pump Na+ across the cellular membrane. Within the NaRs, the retinal Schiff base chromophore absorbs light, and a photochemically induced transient state, referred to as the "O intermediate", performs both the uptake and release of Na+. However, the structure of the O intermediate remains unclear. Here, we used time-resolved cryo-Raman spectroscopy under preresonance conditions to study the structure of the retinal chromophore in the O intermediate of an NaR from the bacterium Indibacter alkaliphilus. We observed two O intermediates, termed O1 and O2, having distinct chromophore structures. We show O1 displays a distorted 13-cis chromophore, while O2 contains a distorted all-trans structure. This finding indicated that the uptake and release of Na+ are achieved not by a single O intermediate but by two sequential O intermediates that are toggled via isomerization of the retinal chromophore. These results provide crucial structural insight into the unidirectional Na+ transport mediated by the chromophore-binding pocket of NaRs.	[Fujisawa, Tomotsumi; Kinoue, Kouta; Seike, Ryouhei; Unno, Masashi] Saga Univ, Fac Sci & Engn, Dept Chem & Appl Chem, Saga, Japan; [Kikukawa, Takashi] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido, Japan; Hokkaido Univ, Global Inst Collaborat Res & Educ, Global Stn Soft Matter, Sapporo, Hokkaido, Japan	Saga University; Hokkaido University; Hokkaido University	Fujisawa, T; Unno, M (corresponding author), Saga Univ, Fac Sci & Engn, Dept Chem & Appl Chem, Saga, Japan.	tfuji@cc.saga-u.ac.jp; unno@cc.saga-u.ac.jp	Kikukawa, Takashi/F-5266-2011	Kikukawa, Takashi/0000-0002-6185-7281	JSPS KAKENHI, Japan [21K04997, 22K05037]; Sumitomo Foundation, Japan	JSPS KAKENHI, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Sumitomo Foundation, Japan	This research was conducted with support from grant-in-aid JSPS KAKENHI, Japan Grant Number 21K04997 to T. F. and 22K05037 to M. U. This work was also supported in part by Grant for Environmental Research Projects from The Sumitomo Foundation, Japan to T. K.	ATON B, 1977, BIOCHEMISTRY-US, V16, P2995, DOI 10.1021/bi00632a029; Balashov SP, 2014, BIOCHEMISTRY-US, V53, P7549, DOI 10.1021/bi501064n; BRAIMAN M, 1980, BIOCHEMISTRY-US, V19, P5421, DOI 10.1021/bi00564a042; Chen HF, 2018, PHYS CHEM CHEM PHYS, V20, P17694, DOI 10.1039/c8cp02599a; CHIZHOV I, 1992, BIOPHYS J, V61, P1001, DOI 10.1016/S0006-3495(92)81907-0; EYRING G, 1980, BIOCHEMISTRY-US, V19, P2410, DOI 10.1021/bi00552a020; Gellini C, 2000, FEBS LETT, V472, P263, DOI 10.1016/S0014-5793(00)01472-1; Haraguchi S, 2018, P NATL ACAD SCI USA, V115, P8671, DOI 10.1073/pnas.1806491115; HEYDE ME, 1971, J AM CHEM SOC, V93, P6776, DOI 10.1021/ja00754a012; Iizuka A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47178-5; Inoue K, 2015, TRENDS MICROBIOL, V23, P91, DOI 10.1016/j.tim.2014.10.009; Inoue K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2689; Jakdetchai O, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf4213; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kajimoto K, 2017, J PHYS CHEM B, V121, P4431, DOI 10.1021/acs.jpcb.7b02421; Kato HE, 2016, BIOESSAYS, V38, P1274, DOI 10.1002/bies.201600065; Kato T, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100792; Kochendoerfer GG, 1997, BIOCHEMISTRY-US, V36, P6577, DOI 10.1021/bi970322o; Kovalev K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16032-y; Matsuo J, 2020, J PHYS CHEM LETT, V11, P8579, DOI 10.1021/acs.jpclett.0c02448; Murabe K, 2020, J AM CHEM SOC, V142, P16023, DOI 10.1021/jacs.0c07264; Nakamizo Y, 2021, PHYS CHEM CHEM PHYS, V23, P2072, DOI 10.1039/d0cp05652a; Nishimura N, 2019, J PHYS CHEM B, V123, P3430, DOI 10.1021/acs.jpcb.9b00928; Otomo A, 2018, J PHYS CHEM LETT, V9, P6431, DOI 10.1021/acs.jpclett.8b02741; Skopintsev P, 2020, NATURE, V583, P314, DOI 10.1038/s41586-020-2307-8; SMITH SO, 1987, J PHYS CHEM-US, V91, P804, DOI 10.1021/j100288a011; SMITH SO, 1984, P NATL ACAD SCI-BIOL, V81, P2055, DOI 10.1073/pnas.81.7.2055; SMITH SO, 1985, J MEMBRANE BIOL, V85, P95, DOI 10.1007/BF01871263; SMITH SO, 1987, J AM CHEM SOC, V109, P3108, DOI 10.1021/ja00244a038; SMITH SO, 1984, J BIOL CHEM, V259, P2326; SMITH SO, 1983, BIOCHEMISTRY-US, V22, P6141, DOI 10.1021/bi00295a016; Suomivuori CM, 2017, P NATL ACAD SCI USA, V114, P7043, DOI 10.1073/pnas.1703625114; Tateishi Y, 2011, BIOCHEMISTRY-US, V50, P2135, DOI 10.1021/bi1019572; Tsujimura M, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100459; Unno M, 2004, J BIOL CHEM, V279, P23855, DOI 10.1074/jbc.C400137200; VANDENBERG R, 1990, BIOPHYS J, V58, P135, DOI 10.1016/S0006-3495(90)82359-6; Yanagisawa S, 2017, J RAMAN SPECTROSC, V48, P680, DOI 10.1002/jrs.5100	37	0	0	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102366	10.1016/j.jbc.2022.102366	http://dx.doi.org/10.1016/j.jbc.2022.102366			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5B1GH	35963435	gold, Green Published			2022-12-26	WOS:000863323200012
J	Osada, N; Nagae, M; Nakano, M; Hirata, T; Kizuka, Y				Osada, Naoko; Nagae, Masamichi; Nakano, Miyako; Hirata, Tetsuya; Kizuka, Yasuhiko			Examination of differential glycoprotein preferences of N-acetylglucosaminyltransferase-IV isozymes a and b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE SPECIFICITIES; CDNA CLONING; GLYCOSYLATION; PROTEIN; EXPRESSION; GLYCANS; OLIGOSACCHARIDES; BIOSYNTHESIS; LECTINS; PATHWAY	The N-glycans attached to proteins contain various GlcNAc branches, the aberrant formation of which correlates with various diseases. N-Acetylglucosaminyltransferase-IVa (GnT-IVa or MGAT4A) and Gnt-IVb (or MGAT4B) are isoenzymes that catalyze the formation of the beta 1,4-GlcNAc branch in N-glycans. However, the functional differences between these isozymes remain unresolved. Here, using cellular and UDP-Glo enzyme assays, we discovered that GnT-IVa and GnT-IVb have distinct glycoprotein preferences both in cells and in vitro. Notably, we show that GnT-IVb acted efficiently on glycopro-teins bearing an N-glycan premodified by GnT-IV. To further understand the mechanism of this reaction, we focused on the noncatalytic C-terminal lectin domain, which selectively rec-ognizes the product glycans. Replacement of a nonconserved amino acid in the GnT-IVb lectin domain with the corre-sponding residue in GnT-IVa altered the glycoprotein prefer-ence of GnT-IVb to resemble that of GnT-IVa. Our findings demonstrate that the C-terminal lectin domain regulates dif-ferential substrate selectivity of GnT-IVa and GnT-IVb, high-lighting a new mechanism by which N-glycan branches are formed on glycoproteins.	[Osada, Naoko; Kizuka, Yasuhiko] Gifu Univ, Fac Appl Biol Sci, Gifu, Japan; [Nagae, Masamichi] Res Inst Microbial Dis, Dept Mol Immunol, Suita, Japan; [Nagae, Masamichi] Osaka Univ, Immunol Frontier Res Ctr iFReC, Lab Mol Immunol, Suita, Japan; [Nakano, Miyako] Hiroshima Univ, Grad Sch Integrated Sci Life, Higashihiroshima, Japan; [Hirata, Tetsuya; Kizuka, Yasuhiko] Gifu Univ, Inst Glyco Core Res iGCORE, Gifu, Japan	Gifu University; Osaka University; Hiroshima University; Gifu University	Kizuka, Y (corresponding author), Gifu Univ, Fac Appl Biol Sci, Gifu, Japan.; Kizuka, Y (corresponding author), Gifu Univ, Inst Glyco Core Res iGCORE, Gifu, Japan.	kizuka@gifu-u.ac.jp		Nagae, Masamichi/0000-0002-5470-3807	Leading Initiative for Excellent Young Researchers project [20H03207]; Japan Society for the Pro-motion of Science, a CREST grant [18070267]; Leading Initiative for Excellent Young Researchers project [20H03207]; Japan Society for the Promotion of Science, a CREST [18070267]; FOREST (Fusion Oriented REsearch for disruptive Science and Technology) [20H03207]; Japan Science and Technology Agency; Takeda Science Foundation;  [JPMJFR215Z]	Leading Initiative for Excellent Young Researchers project; Japan Society for the Pro-motion of Science, a CREST grant; Leading Initiative for Excellent Young Researchers project; Japan Society for the Promotion of Science, a CREST; FOREST (Fusion Oriented REsearch for disruptive Science and Technology); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); 	This work was partially supported by a Grant-in-Aid for Scientific Research (B) to Y. K. (grant no.: 20H03207) , a Leading Initiative for Excellent Young Researchers project (to Y. K.) from the Japan Society for the Promotion of Science, a CREST grant (grant no.: 18070267; to Y. K.) and a FOREST (Fusion Oriented REsearch for disruptive Science and Technology) grant (grant no.: JPMJFR215Z; to Y. K.) from Japan Science and Technology Agency, and a grant from the Takeda Science Foundation to Y. K.	BHATTACHARYYA L, 1988, BIOCHEMISTRY-US, V27, P1034, DOI 10.1021/bi00403a028; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; BROCKHAUSEN I, 1988, BIOCHIMIE, V70, P1521, DOI 10.1016/0300-9084(88)90289-1; Cherepanova N, 2016, CURR OPIN CELL BIOL, V41, P57, DOI 10.1016/j.ceb.2016.03.021; Clerc F, 2016, GLYCOCONJUGATE J, V33, P309, DOI 10.1007/s10719-015-9626-2; CROWLEY JF, 1984, ARCH BIOCHEM BIOPHYS, V231, P524, DOI 10.1016/0003-9861(84)90417-X; Fritz TA, 2004, P NATL ACAD SCI USA, V101, P15307, DOI 10.1073/pnas.0405657101; GREEN ED, 1988, J BIOL CHEM, V263, P18253; Hirata T, 2020, BBA-GEN SUBJECTS, V1864, DOI 10.1016/j.bbagen.2020.129726; Hobohm L, 2022, CELL MOL LIFE SCI, V79, DOI 10.1007/s00018-022-04163-y; Holdener BC, 2019, CURR OPIN STRUC BIOL, V56, P78, DOI 10.1016/j.sbi.2018.12.005; Huang HH, 2015, ELIFE, V4, DOI 10.7554/eLife.08916; Huang YF, 2021, DEV CELL, V56, P1195, DOI 10.1016/j.devcel.2021.02.023; Khoder-Agha F, 2019, CELL MOL LIFE SCI, V76, P1821, DOI 10.1007/s00018-019-03032-5; Kizuka Y, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6020025; Kizuka Y, 2016, BIOCHEM J, V473, P21, DOI 10.1042/BJ20150607; Kizuka Y, 2015, EMBO MOL MED, V7, P175, DOI 10.15252/emmm.201404438; Kong Y, 2015, GLYCOBIOLOGY, V25, P55, DOI 10.1093/glycob/cwu089; Kubota T, 2006, J MOL BIOL, V359, P708, DOI 10.1016/j.jmb.2006.03.061; Kuwabara N, 2016, P NATL ACAD SCI USA, V113, P9280, DOI 10.1073/pnas.1525545113; Mereiter S, 2019, CANCER CELL, V36, P6, DOI 10.1016/j.ccell.2019.06.006; Minowa MT, 1998, J BIOL CHEM, V273, P11556, DOI 10.1074/jbc.273.19.11556; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Nagae M, 2022, COMMUN BIOL, V5, DOI 10.1038/s42003-022-03661-w; Nagae M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020437; Nakano M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009001; Oguri S, 2006, GLYCOCONJUGATE J, V23, P473, DOI 10.1007/s10719-006-6216-3; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Ohtsubo K, 2011, NAT MED, V17, P1067, DOI 10.1038/nm.2414; Osuka RF, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2022.101666; Pabst M, 2007, ANAL CHEM, V79, P5051, DOI 10.1021/ac070363i; Sakamoto Y, 2000, J BIOL CHEM, V275, P36029, DOI 10.1074/jbc.M005860200; SHIBUYA N, 1989, J BIOCHEM-TOKYO, V106, P1098, DOI 10.1093/oxfordjournals.jbchem.a122972; Shrimal S, 2015, SEMIN CELL DEV BIOL, V41, P71, DOI 10.1016/j.semcdb.2014.11.005; Stanley P., 2015, ESSENTIALS GLYCOBIOL; Taguchi T, 2000, J BIOL CHEM, V275, P32598, DOI 10.1074/jbc.M004673200; Takamatsu Shinji, 2013, Methods Mol Biol, V1022, P283, DOI 10.1007/978-1-62703-465-4_21; Takamatsu S, 2010, GLYCOBIOLOGY, V20, P485, DOI 10.1093/glycob/cwp200; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Vibhute AM, 2022, BBA-GEN SUBJECTS, V1866, DOI 10.1016/j.bbagen.2022.130118; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Yoshida A, 1998, GLYCOCONJUGATE J, V15, P1115, DOI 10.1023/A:1006951519522; Zhao YY, 2008, CANCER SCI, V99, P1304, DOI 10.1111/j.1349-7006.2008.00839.x; Zhou LJ, 2011, J BIOL CHEM, V286, P8677, DOI 10.1074/jbc.M110.194860	45	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102400	10.1016/j.jbc.2022.102400	http://dx.doi.org/10.1016/j.jbc.2022.102400			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4V3XX	35988645	gold, Green Published			2022-12-26	WOS:000859414300015
J	Peil, K; Varv, S; Ilves, I; Kristjuhan, K; Jurgens, H; Kristjuhan, A				Peil, Kadri; Varv, Signe; Ilves, Ivar; Kristjuhan, Kersti; Jurgens, Henel; Kristjuhan, Arnold			Transcriptional regulator Taf14 binds DNA and is required for the function of transcription factor TFIID in the absence of histone H2A.Z	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEATS DOMAIN; SACCHAROMYCES-CEREVISIAE; VARIANT; IDENTIFICATION; GENES; ASSOCIATION; INITIATION; PROTEOMICS; SUBUNIT; COMPLEX	The transcriptional regulator Taf14 is a component of multiple protein complexes involved in transcription initiation and chromatin remodeling in yeast cells. Although Taf14 is not required for cell viability, it becomes essential in conditions where the formation of the transcription preinitiation complex is hampered. The specific role of Taf14 in mediating transcription initiation and preinitiation complex formation is unclear. Here, we explored its role in the general transcription factor IID by mapping Taf14 genetic and proteomic interactions and found that it was needed for the function of the complex if Htz1, the yeast homolog of histone H2A.Z, was absent from chromatin. Dissecting the functional domains of Taf14 revealed that the linker region between the YEATS and ET domains was required for cell viability in the absence of Htz1 protein. We further show that the linker region of Taf14 interacts with DNA. We propose that providing additional DNA binding capacity might be a general role of Taf14 in the recruitment of protein complexes to DNA and chromatin.	[Peil, Kadri; Varv, Signe; Kristjuhan, Kersti; Jurgens, Henel; Kristjuhan, Arnold] Univ Tartu, Inst Mol & Cell Biol, Tartu, Estonia; [Ilves, Ivar] Univ Tartu, Inst Technol, Tartu, Estonia	University of Tartu; University of Tartu	Kristjuhan, A (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Tartu, Estonia.	arnoldk@ut.ee	Ilves, Ivar/H-2472-2012	Ilves, Ivar/0000-0002-1747-9973; Peil, Kadri/0000-0002-2158-9622				Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Andrews FH, 2016, NAT CHEM BIOL, V12, P396, DOI 10.1038/nchembio.2065; Bennett CB, 2001, NAT GENET, V29, P426, DOI 10.1038/ng778; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Cairns BR, 1996, MOL CELL BIOL, V16, P3308; Chen GC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18021-7; Chen SH, 2010, J BIOL CHEM, V285, P12803, DOI 10.1074/jbc.M110.106989; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Erlich RL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003717; Faure G, 2013, BIOINFORMATICS, V29, P1726, DOI 10.1093/bioinformatics/btt271; Feigerle JT, 2016, J BIOL CHEM, V291, P22721, DOI 10.1074/jbc.M116.751107; Freeman MD, 2014, BIOL-TARGETS THER, V8, P269, DOI 10.2147/BTT.S67046; Gowans GJ, 2019, MOL CELL, V76, P909, DOI 10.1016/j.molcel.2019.09.029; Green MR, 2000, TRENDS BIOCHEM SCI, V25, P59, DOI 10.1016/S0968-0004(99)01527-3; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Kimura M, 2004, NUCLEIC ACIDS RES, V32, P6706, DOI 10.1093/nar/gkh1000; Klein BJ, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-30937-w; Klein BJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07072-6; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Kubik S, 2015, MOL CELL, V60, P422, DOI 10.1016/j.molcel.2015.10.002; Lundblad RL, 2018, HANDBOOK OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, 5TH EDITION, P1, DOI 10.1201/b21846; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Peil K, 2020, EPIGENET CHROMATIN, V13, DOI 10.1186/s13072-020-00347-7; Perez-Riverol Y, 2022, NUCLEIC ACIDS RES, V50, pD543, DOI 10.1093/nar/gkab1038; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Rossi MJ, 2021, NATURE, V592, P309, DOI 10.1038/s41586-021-03314-8; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; Santisteban MS, 2000, CELL, V103, P411, DOI 10.1016/S0092-8674(00)00133-1; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schulze JM, 2010, MOL GENET GENOMICS, V283, P365, DOI 10.1007/s00438-010-0523-x; Shah AD, 2020, J PROTEOME RES, V19, P204, DOI 10.1021/acs.jproteome.9b00496; Shanle EK, 2015, GENE DEV, V29, P1795, DOI 10.1101/gad.269977.115; Tamberg N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30562-y; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Tramantano M, 2016, ELIFE, V5, DOI 10.7554/eLife.14243; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zhang W, 2011, BIOCHEM J, V436, P83, DOI 10.1042/BJ20110004	44	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102369	10.1016/j.jbc.2022.102369	http://dx.doi.org/10.1016/j.jbc.2022.102369			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4V3XX	35970389	gold, Green Published			2022-12-26	WOS:000859414300005
J	Given, J; Casson, K; Dolk, H; Loane, M				Given, Joanne; Casson, Karen; Dolk, Helen; Loane, Maria			Sociodemographic variation in prescriptions dispensed in early pregnancy in Northern Ireland 2010-2016	PLOS ONE			English	Article							MEDICATION USE; PREVALENCE; HEALTH; WOMEN; CARE; DETERMINANTS; PATTERNS; EPILEPSY; AGE	Aim To establish the prevalence of prescriptions dispensed in early pregnancy by maternal age and area deprivation, for women who gave birth in Northern Ireland (NI) 2011-2016. Study design Population-based linked cohort study. Methods The NI Maternity System (NIMATS) database was used to identify all births to resident mothers in NI between 2011 and 2016. Prescriptions dispensed between the last menstrual period (LMP) and the first antenatal care visit (mean 10.7 weeks) (2010-2016) were extracted from the Enhanced Prescribing Database (EPD) which records all prescriptions dispensed by pharmacists in NI. EPD data were linked to NIMATS using the mother's Health and Care Number. Maternal deprivation based on the NI Multiple Deprivation Measure 2017 was linked using the mother's postcode. Results The cohort included 139,687 pregnancies resulting in live or stillbirths to 106,206 women. A medication was dispensed in 63.5% of pregnancies, and in 48.7% of pregnancies excluding supplements (vitamins, iron, and folic acid). Folic acid was the most commonly dispensed medication (33.1%). Excluding supplements, the mean number of medications was 1.1, with 4.2% having >= 5 medications. The most common non-supplement medications were antibiotics (13.1%), antiemetics (8.7%), analgesics (6.9%), hormonal medications (6.9%) and antidepressants (6.1%). Younger women (<20 years) had more antibiotics while older women (40+ years) had more antidepressants, cardiovascular, antihypertensives, anticoagulant medications and thyroxine. The proportion of women living in the most deprived areas with prescriptions for antidepressants, sedatives, tranquilisers, analgesics, and anti-epileptic medications was double the proportion of women with these medications in the least deprived areas. Conclusion Half of all pregnant women in NI were dispensed a non-supplement medication between LMP and the first antenatal care visit. Younger and older mothers and those living in the most deprived areas were more likely to have medications dispensed. More antidepressants were dispensed in areas of social deprivation.	[Given, Joanne; Casson, Karen; Dolk, Helen; Loane, Maria] Univ Ulster, Fac Life Hlth Sci, Belfast, North Ireland	Ulster University	Loane, M (corresponding author), Univ Ulster, Fac Life Hlth Sci, Belfast, North Ireland.	ma.loane@ulster.ac.uk	Given, Joanne/J-3484-2017	Given, Joanne/0000-0003-4921-1944; Loane, Maria/0000-0002-1206-3637	Economic and Social Research Council [ESL/L007509/1]	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	HD and ML received funding for this study from the Economic and Social Research Council (https://esrc.ukri.org/) grant number ESL/L007509/1 (Administrative Data Research Centre -Northern Ireland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MP, 2011, AM J MED GENET C, V157C, P175, DOI 10.1002/ajmg.c.30313; Agresti A., 2019, INTRO CATEGORICAL AN, V3rd; Bakker MK, 2006, BJOG-INT J OBSTET GY, V113, P559, DOI 10.1111/j.1471-0528.2006.00927.x; Berry J, 2005, GUIDE STAT METHODS I; Bjorn Anne-Mette Bay, 2011, Clin Epidemiol, V3, P149, DOI 10.2147/CLEP.S17747; Brough L, 2009, J HUM NUTR DIET, V22, P100, DOI 10.1111/j.1365-277X.2008.00936.x; Bunting BP, 2012, PSYCHOL MED, V42, P1727, DOI 10.1017/S0033291711002510; Campbell E, 2013, EPILEPSY BEHAV, V28, P354, DOI 10.1016/j.yebeh.2013.05.019; Cleary BJ, 2010, PHARMACOEPIDEM DR S, V19, P408, DOI 10.1002/pds.1906; Daw JR, 2011, PHARMACOEPIDEM DR S, V20, P895, DOI 10.1002/pds.2184; de Jonge L, 2015, DRUG SAFETY, V38, P737, DOI 10.1007/s40264-015-0302-z; Demailly R, 2017, PHARMACOEPIDEM DR S, V26, P1126, DOI 10.1002/pds.4265; Dolk H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227908; Joseph KS, 2009, J OBSTET GYNAECOL CA, V31, P422, DOI 10.1016/S1701-2163(16)34173-1; Kendler KS, 2014, PSYCHOL MED, V44, P2537, DOI 10.1017/S0033291713003048; Lupattelli A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004365; Mazer-Amirshahi M, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.06.013; McDonald H, 2020, J PUBLIC HEALTH-UK, V42, P801, DOI 10.1093/pubmed/fdz184; Mitchell AA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.029; Modder J., 2010, MANAGEMENT WOMEN OBE; Mohammed SH, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028238; Molenaar NM, 2020, J AFFECT DISORDERS, V264, P82, DOI 10.1016/j.jad.2019.12.014; National Institute for Health and Care Excellence, 2021, ANTENATAL CARE NG201; National Institute for Health and Care Excellence, 2013, MATERN CHILD NUTR; Neural tube defects (prevention in pregnancy), 2018, BNF BRIT NATL FORMUL; NICE, 2015, DIAB PREGN MAN PREC; Northern Ireland Statistics and Research Agency, 2017, NO IRELAND MULTIPLE; Northern Ireland Statistics and Research Agency, 2017, REGISTRAR GEN NO IRE; Olesen C, 2006, EUR J CLIN PHARMACOL, V62, P547, DOI 10.1007/s00228-006-0119-x; Relton CL, 2005, PUBLIC HEALTH NUTR, V8, P338, DOI 10.1079/PHN2004690; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Sharrar RG, 2013, THER ADV DRUG SAF, V4, P211, DOI 10.1177/2042098613490780; Sillanpaa M, 2004, EPILEPSIA, V45, P971, DOI 10.1111/j.0013-9580.2004.44203.x; Smolina K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128312; Stephansson Olof, 2011, Clin Epidemiol, V3, P43, DOI 10.2147/CLEP.S16305; Tamblyn R, 2014, ANN INTERN MED, V160, P441, DOI 10.7326/M13-1705; Thorpe PG, 2013, PHARMACOEPIDEM DR S, V22, P1013, DOI 10.1002/pds.3495; Tinker SC, 2015, MATERN CHILD HLTH J, V19, P1097, DOI 10.1007/s10995-014-1611-z; Wemakor A, 2014, J AFFECT DISORDERS, V167, P299, DOI 10.1016/j.jad.2014.06.015	39	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0267710	10.1371/journal.pone.0267710	http://dx.doi.org/10.1371/journal.pone.0267710			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994459	Green Published, gold			2022-12-26	WOS:000877093400001
J	Thibault, E; Mahoney, SM; Briskie, JV; Shaikh, M; Reudink, MW				Thibault, Emma; Mahoney, Sean M.; Briskie, James V.; Shaikh, Mateen; Reudink, Matthew W.			Extra-pair paternity drivers plumage colour elaboration in male passerines	PLOS ONE			English	Article							SEXUAL SELECTION; BIRDS; EVOLUTION; DICHROMATISM	The elaborate ornamental plumage displayed by birds has largely been attributed to sexual selection, whereby the greater success of ornamented males in attaining mates drives a rapid elaboration of those ornaments. Indeed, plumage elaboration tends to be greatest in species with a high variance in reproductive success such as polygynous mating systems. Even among socially monogamous species, many males are extremely colourful. In their now-classic study, Moller and Birkhead (1994) suggested that increased variance in reproductive success afforded by extra-pair paternity should intensify sexual selection pressure and thus an elaboration of male plumage and sexual dichromatism, but the relatively few measures of extra-pair paternity at the time prevented a rigorous test of this hypothesis. In the nearly three decades since that paper's publication, hundreds of studies have been published on rates of extra-pair paternity and more objective measures of plumage colouration have been developed, allowing for a large-scale comparative test of Moller and Birkhead's (1994) hypothesis. Using an analysis of 186 socially monogamous passerine species with estimates of extra-pair paternity, our phylogenetically controlled analysis confirms Moller and Birkhead's (1994) early work, demonstrating that rates of extra-pair paternity are positively associated with male, but not female, colouration and with the extent of sexual dichromatism. Plumage evolution is complex and multifaceted, driven by phylogenetic, ecological, and social factors, but our analysis confirms a key role of extra-pair mate choice in driving the evolution of ornamental traits.	[Thibault, Emma; Mahoney, Sean M.; Reudink, Matthew W.] Thompson Rivers Univ, Dept Biol Sci, Kamloops, BC, Canada; [Briskie, James V.] Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand; [Shaikh, Mateen] Thompson Rivers Univ, Dept Math & Stat, Kamloops, BC, Canada	University of Canterbury	Reudink, MW (corresponding author), Thompson Rivers Univ, Dept Biol Sci, Kamloops, BC, Canada.	mreudink@tru.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [4603-2018]; Thompson Rivers University CUEF UREAP award	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Thompson Rivers University CUEF UREAP award	Funding for this research was provided by an Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant #4603-2018 to MWR and a Thompson Rivers University CUEF UREAP award to ET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundsen T, 2000, TRENDS ECOL EVOL, V15, P149, DOI 10.1016/S0169-5347(99)01800-5; Andersson M, 1996, TRENDS ECOL EVOL, V11, P53, DOI 10.1016/0169-5347(96)81042-1; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Badyaev AV, 2003, ANNU REV ECOL EVOL S, V34, P27, DOI 10.1146/annurev.ecolsys.34.011802.132441; Billerman S.M., 2020, BIRDS OF THE WORLD, DOI DOI 10.2173/BOW; Brouwer L, 2019, MOL ECOL, V28, P4864, DOI 10.1111/mec.15259; Dale J, 2015, NATURE, V527, P367, DOI 10.1038/nature15509; Darwin C., 1871, P423; Dunn PO, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400155; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Friedman NR, 2009, EVOLUTION, V63, P3269, DOI 10.1111/j.1558-5646.2009.00792.x; Fuller RC, 2005, AM NAT, V166, P437, DOI 10.1086/444443; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; HILL GE, 1991, NATURE, V350, P337, DOI 10.1038/350337a0; Johnson AE, 2013, ECOL EVOL, V3, P3030, DOI 10.1002/ece3.686; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; McGraw K. J., 2006, BIRD COLORATION, VI; MOLLER AP, 1994, EVOLUTION, V48, P1089, DOI 10.1111/j.1558-5646.1994.tb05296.x; Omland KE, 1997, EVOLUTION, V51, P1636, DOI 10.1111/j.1558-5646.1997.tb01486.x; Petrie M, 1998, TRENDS ECOL EVOL, V13, P52, DOI 10.1016/S0169-5347(97)01232-9; Petrie M, 1998, P NATL ACAD SCI USA, V95, P9390, DOI 10.1073/pnas.95.16.9390; Pinheiro J, 2020, R PACKAGE VERSION 31; Poesel A, 2011, AUK, V128, P770, DOI 10.1525/auk.2011.11127; Prum RO, 2010, EVOLUTION, V64, P3085, DOI 10.1111/j.1558-5646.2010.01054.x; R Core Team, 2021, R LANG ENV STAT; Reudink MW, 2021, WILSON J ORNITHOL, V133, P1, DOI 10.1676/19-00084; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Wiens JJ, 2001, TRENDS ECOL EVOL, V16, P517, DOI 10.1016/S0169-5347(01)02217-0	31	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0273347	10.1371/journal.pone.0273347	http://dx.doi.org/10.1371/journal.pone.0273347			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994495	gold, Green Published			2022-12-26	WOS:000877093400046
J	Petrucciani, A; Yu, G; Ventresca, M				Petrucciani, Alexa; Yu, Geonsik; Ventresca, Mario			Multi-season transmission model of Eastern Equine Encephalitis	PLOS ONE			English	Article							WEST-NILE-VIRUS; HOST-FEEDING PATTERNS; CULISETA-MELANURA; DIPTERA-CULICIDAE; MOSQUITOS DIPTERA; CULEX; BIRDS; EXTINCTION; ARBOVIRUS; INFECTION	Eastern Equine Encephalitis (EEE) is an arbovirus that, while it has been known to exist since the 1930's, recently had a spike in cases. This increased prevalence is particularly concerning due to the severity of the disease with 1 in 3 symptomatic patients dying. The cause of this peak is currently unknown but could be due to changes in climate, the virus itself, or host behavior. In this paper we propose a novel multi-season deterministic model of EEE spread and its stochastic counterpart. Models were parameterized using a dataset from the Florida Department of Health with sixteen years of sentinel chicken seroconversion rates. The different roles of the enzootic and bridge mosquito vectors were explored. As expected, enzootic mosquitoes like Culiseta melanura were more important for EEE persistence, while bridge vectors were implicated in the disease burden in humans. These models were used to explore hypothetical viral mutations and host behavior changes, including increased infectivity, vertical transmission, and host feeding preferences. Results showed that changes in the enzootic vector transmission increased cases among birds more drastically than equivalent changes in the bridge vector. Additionally, a 5% difference in the bridge vector's bird feeding preference can increase cumulative dead-end host infections more than 20-fold. Taken together, this suggests changes in many parts of the transmission cycle can augment cases in birds, but the bridge vectors feeding preference acts as a valve limiting the enzootic circulation from its impact on dead-end hosts, such as humans. Our what-if scenario analysis reveals and measures possible threats regarding EEE and relevant environmental changes and hypothetically suggests how to prevent potential damage to public health and the equine economy.	[Petrucciani, Alexa] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Yu, Geonsik; Ventresca, Mario] Purdue Univ, Sch Ind Engn, W Lafayette, IN 47907 USA; [Ventresca, Mario] Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ventresca, M (corresponding author), Purdue Univ, Sch Ind Engn, W Lafayette, IN 47907 USA.; Ventresca, M (corresponding author), Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.	mventresca@purdue.edu		Ventresca, Mario/0000-0002-1246-297X; Yu, Geonsik/0000-0002-4394-0022				Agarwal A, 2016, VIROLOGY, V497, P59, DOI 10.1016/j.virol.2016.06.025; Aguilar PV, 2008, J VIROL, V82, P6972, DOI 10.1128/JVI.01283-07; Aguilar PV, 2008, J VIROL, V82, P4920, DOI 10.1128/JVI.02514-07; Allen LJS, 2013, MATH BIOSCI, V243, P99, DOI 10.1016/j.mbs.2013.02.006; Allen LJS, 2012, J BIOL DYNAM, V6, P590, DOI 10.1080/17513758.2012.665502; Armstrong PM, 2013, NEW ENGL J MED, V368, P1670, DOI 10.1056/NEJMp1213696; Bartlett MS., 1956, DETERMINISTIC STOCHA; Berman JJ, 2019, TAXONOMIC GUIDE TO INFECTIOUS DISEASES: UNDERSTANDING THE BIOLOGIC CLASSES OF PATHOGENIC ORGANISMS, 2ND EDITION, P1, DOI 10.1016/C2018-0-00339-4; Beveroth TA, 2006, AM J TROP MED HYG, V74, P174, DOI 10.4269/ajtmh.2006.74.174; Blosser EM, 2017, J MED ENTOMOL, V54, P1365, DOI 10.1093/jme/tjx140; Bonney PJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204262; Bosak PJ, 2001, J VECTOR ECOL, V26, P103; BREMERMANN HJ, 1983, J THEOR BIOL, V100, P411, DOI 10.1016/0022-5193(83)90438-1; Burkett-Cadena ND, 2015, J MED ENTOMOL, V52, P1074, DOI 10.1093/jme/tjv087; Bustamante DM, 2010, AM J TROP MED HYG, V82, P1172, DOI 10.4269/ajtmh.2010.09-0323; Chen JH, 2021, CHEM SCI, V12, P6929, DOI 10.1039/d1sc01203g; Chowell Gerardo, 2017, Infect Dis Model, V2, P379, DOI 10.1016/j.idm.2017.08.001; Darbro JM, 2007, BEHAV ECOL, V18, P750, DOI 10.1093/beheco/arm043; EDMAN JD, 1972, J MED ENTOMOL, V9, P429, DOI 10.1093/jmedent/9.5.429; for Disease Control C Prevention., 2020, E EQ ENCH; for Disease Control C Prevention., 2021, E EQ ENCH STAT MAPS; Gardner CL, 2013, J VIROL, V87, P8582, DOI 10.1128/JVI.00937-13; Ghosh N, 2022, INT IMMUNOPHARMACOL, V105, DOI 10.1016/j.intimp.2022.108565; Giordano BV, 2020, J MED ENTOMOL, V57, P1501, DOI 10.1093/jme/tjaa053; GOLDFIELD M, 1968, AM J EPIDEMIOL, V87, P32, DOI 10.1093/oxfordjournals.aje.a120807; Grassly NC, 2006, P ROY SOC B-BIOL SCI, V273, P2541, DOI 10.1098/rspb.2006.3604; Gray KM, 2011, J MED ENTOMOL, V48, P167, DOI 10.1603/ME10176; Grewar JD, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252117; Hamer GL, 2009, AM J TROP MED HYG, V80, P268, DOI 10.4269/ajtmh.2009.80.268; Hartemink NA, 2007, VECTOR-BORNE ZOONOT, V7, P575, DOI 10.1089/vbz.2006.0613; HAYES RO, 1962, AM J HYG, V75, P183, DOI 10.1093/oxfordjournals.aje.a120242; Heberlein-Larson LA, 2019, AM J TROP MED HYG, V100, P1266, DOI 10.4269/ajtmh.18-0783; Hribar LJ, 2019, DATA BRIEF, V26, DOI 10.1016/j.dib.2019.104516; Kain MP, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1684; Keeling MJ, 2002, P ROY SOC B-BIOL SCI, V269, P335, DOI 10.1098/rspb.2001.1898; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Ketkar H, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020150; Kraft D., 1988, SOFTWARE PACKAGE SEQ; Lahodny GE, 2015, J BIOL DYNAM, V9, P128, DOI 10.1080/17513758.2014.954763; Levine RS, 2016, AM J TROP MED HYG, V95, P1174, DOI 10.4269/ajtmh.15-0809; Maquart M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147589; Mbogo RW, 2018, J APPL MATH, V2018, P1, DOI [10.1155/2018/2439520, DOI 10.1155/2018/2439520]; Meshram CD, 2020, J VIROL, V94, DOI 10.1128/JVI.00617-20; Molaei G, 2006, EMERG INFECT DIS, V12, P468, DOI 10.3201/eid1203.051004; Molaei G, 2008, J MED ENTOMOL, V45, P1143, DOI 10.1603/0022-2585(2008)45[1143:HPOPMV]2.0.CO;2; Molaei G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004347; Morens DM, 2019, NEW ENGL J MED, V381, P1989, DOI 10.1056/NEJMp1914328; Morrison A., 2019, FLORIDA ARBOVIRUS SU; Olson B., 2012, ADV ARTIF INTELL, DOI [10.1155/2012/674832, DOI 10.1155/2012/674832]; Pandya J, 2012, VACCINE, V30, P1276, DOI 10.1016/j.vaccine.2011.12.121; Peck KM, 2018, J VIROL, V92, DOI 10.1128/JVI.01031-17; Porco TC, 2005, J THEOR BIOL, V233, P91, DOI 10.1016/j.jtbi.2004.09.009; Richards SL, 2006, J MED ENTOMOL, V43, P543, DOI 10.1603/0022-2585(2006)43[543:HPOAAD]2.0.CO;2; Sardelis MR, 2002, J MED ENTOMOL, V39, P480, DOI 10.1603/0022-2585-39.3.480; Trobaugh DW, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007584; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; TURELL MJ, 1994, J MED ENTOMOL, V31, P287, DOI 10.1093/jmedent/31.2.287; Unnasch RS, 2006, ECOL MODEL, V192, P425, DOI 10.1016/j.ecolmodel.2005.07.011; van den Driessche Pauline, 2017, Infect Dis Model, V2, P288, DOI 10.1016/j.idm.2017.06.002; Wales DJ, 1999, SCIENCE, V285, P1368, DOI 10.1126/science.285.5432.1368; Wang R, 2021, GENOMICS, V113, P2158, DOI 10.1016/j.ygeno.2021.05.006; Weaver SC, 1999, J VIROL, V73, P4316, DOI 10.1128/JVI.73.5.4316-4326.1999; WEAVER SC, 1993, VIROLOGY, V195, P700, DOI 10.1006/viro.1993.1421; Whitehorn J, 2019, CLIN MED, V19, P149, DOI 10.7861/clinmedicine.19-2-149; Wilke ABB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45337-2; WILLIAMS JE, 1974, J MED ENTOMOL, V11, P352, DOI 10.1093/jmedent/11.3.352; Wonham MJ, 2008, LECT NOTES MATH, V1945, P365; Wonham MJ, 2004, P ROY SOC B-BIOL SCI, V271, P501, DOI 10.1098/rspb.2003.2608	68	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0272130	10.1371/journal.pone.0272130	http://dx.doi.org/10.1371/journal.pone.0272130			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976903	gold, Green Published			2022-12-26	WOS:000847227000023
J	Gupta, A; Balakrishnan, B; Karki, S; Slayton, M; Jash, S; Banerjee, S; Grahn, THM; Jambunathan, S; Disney, S; Hussein, H; Kong, D; Lowell, BB; Natarajan, P; Reddy, UK; Gokce, N; Sharma, VM; Puri, V				Gupta, Abhishek; Balakrishnan, Bijinu; Karki, Shakun; Slayton, Mark; Jash, Sukanta; Banerjee, Sayani; Grahn, Tan Hooi Min; Jambunathan, Srikarthika; Disney, Sarah; Hussein, Hebaallaha; Kong, Dong; Lowell, Bradford B.; Natarajan, Purushothaman; Reddy, Umesh K.; Gokce, Noyan; Sharma, Vishva M.; Puri, Vishwajeet			Human CIDEC transgene improves lipid metabolism and protects against high-fat diet-induced glucose intolerance in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; ADIPOSE-TISSUE; GENE V115F; LIPOLYSIS; PROTEIN-27; OBESITY; LIPASE; FSP27; GROWTH; ALPHA	Cell death-inducing DNA fragmentation factor-like effector C (CIDEC) expression in adipose tissue positively correlates with insulin sensitivity in obese humans. Further, E186X, a single-nucleotide CIDEC variant is associated with lipodystrophy, hypertriglyceridemia, and insulin resistance. To establish the unknown mechanistic link between CIDEC and maintenance of systemic glucose homeostasis, we generated transgenic mouse models expressing CIDEC (Ad-CIDECtg) and CIDEC E186X variant (Ad-CIDECmut) transgene specifically in the adipose tissue. We found that Ad-CIDECtg but not Ad-CIDECmut mice were protected against high-fat diet-induced glucose intolerance. Furthermore, we revealed the role of CIDEC in lipid metabolism using transcriptomics and lipidomics. Serum triglycerides, cholesterol, and low-density lipoproteins were lower in high-fat diet-fed Ad-CIDECtg mice compared to their littermate controls. Mechanistically, we demonstrated that CIDEC regulates the enzymatic activity of adipose triglyceride lipase via interacting with its activator, CGI-58, to reduce free fatty acid release and lipotoxicity. In addition, we confirmed that CIDEC is indeed a vital regulator of lipolysis in adipose tissue of obese humans, and treatment with recombinant CIDEC decreased triglyceride breakdown in visceral human adipose tissue. Our study unravels a central pathway whereby adipocyte-specific CIDEC plays a pivotal role in regulating adipose lipid metabolism and whole-body glucose homeostasis. In summary, our findings identify human CIDEC as a potential 'drug' or a 'druggable' target to reverse obesity-induced lipotoxicity and glucose intolerance.	[Gupta, Abhishek; Balakrishnan, Bijinu; Slayton, Mark; Disney, Sarah; Hussein, Hebaallaha; Sharma, Vishva M.; Puri, Vishwajeet] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci & Diabet Inst, Athens, OH 45701 USA; [Karki, Shakun; Gokce, Noyan] Boston Univ, Sch Med, Evans Dept Med, Boston, MA 02118 USA; [Karki, Shakun; Gokce, Noyan] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Jash, Sukanta; Banerjee, Sayani] Brown Univ, Alpert Med Sch, Providence, RI USA; [Grahn, Tan Hooi Min] Lund Univ Hosp, Lund Stem Cell Ctr, Div Mol Med & Gene Therapy, Lund, Sweden; [Jambunathan, Srikarthika] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Kong, Dong] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Dept Pediat, Div Endocrinol, Boston, MA USA; [Kong, Dong] Harvard Med Sch, Boston, MA 02115 USA; [Lowell, Bradford B.] Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA USA; [Lowell, Bradford B.] Harvard Med Sch, Program Neurosci, Boston, MA USA; [Natarajan, Purushothaman; Reddy, Umesh K.] West Virginia State Univ, Dept Biol, Institute, WV USA	University System of Ohio; Ohio University; Boston University; Boston University; Brown University; Lund University; Skane University Hospital; Boston University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; West Virginia State University	Sharma, VM; Puri, V (corresponding author), Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci & Diabet Inst, Athens, OH 45701 USA.	sharmav@ohio.edu; puri@ohio.edu		Slayton, Mark/0000-0002-7321-032X	NIH/NIDDK [R01DK101711, R01HL140836, RO1DK124126]; Osteopathic Heritage Foundation's Vision 2020 to Heritage College of Osteopathic Medicine at Ohio University;  [R01 NS107315];  [R01 DK108797];  [R21 HD098056];  [P30 DK046200]	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Osteopathic Heritage Foundation's Vision 2020 to Heritage College of Osteopathic Medicine at Ohio University; ; ; ; 	This work was supported by NIH/NIDDK grant R01DK101711 (V. P.), R01HL140836 (N. G. and V. P.), RO1DK124126 (V. P.), funds from Osteopathic Heritage Foundation's Vision 2020 to Heritage College of Osteopathic Medicine at Ohio University (V. P.), R01 NS107315 (D. K.), R01 DK108797 (D. K.), R21 HD098056 (D. K.), P30 DK046200 (D. K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abreu-Vieira G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8433; ARNER P, 1995, ANN MED, V27, P435, DOI 10.3109/07853899709002451; Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007; Dahlman I, 2005, DIABETES, V54, P3032, DOI 10.2337/diabetes.54.10.3032; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Grahn THM, 2014, J BIOL CHEM, V289, P12029, DOI 10.1074/jbc.M113.539890; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Hjelholt AJ, 2019, MOL METAB, V29, P65, DOI 10.1016/j.molmet.2019.08.013; Hoyer KL, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14373; Hruby A, 2015, PHARMACOECONOMICS, V33, P673, DOI 10.1007/s40273-014-0243-x; Jambunathan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028614; Jash S, 2019, ISCIENCE, V20, P73, DOI 10.1016/j.isci.2019.09.011; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jocken JWE, 2008, DIABETES, V57, P1834, DOI 10.2337/db07-0857; Karki S, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011431; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Kim JY, 2008, AM J PHYSIOL-ENDOC M, V294, pE654, DOI 10.1152/ajpendo.00104.2007; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Liao BY, 2008, P NATL ACAD SCI USA, V105, P6987, DOI [10.1073/pnas.0800387105, 10.1073/pnas.0806419105]; Liu K, 2009, AM J PHYSIOL-ENDOC M, V297, pE1395, DOI 10.1152/ajpendo.00188.2009; Lopez-Jaramillo P, 2014, HORM MOL BIOL CLIN I, V18, P37, DOI 10.1515/hmbci-2013-0053; McLaugblin T, 2007, DIABETOLOGIA, V50, P1707, DOI 10.1007/s00125-007-0708-y; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Miyoshi H, 2008, J CELL BIOCHEM, V105, P1430, DOI 10.1002/jcb.21964; Moreno-Navarrete JM, 2014, INT J OBESITY, V38, P865, DOI 10.1038/ijo.2013.171; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Pasarica M, 2009, DIABETES CARE, V32, P900, DOI 10.2337/dc08-2240; Puri V, 2008, ACTA PHYSIOL, V192, P103, DOI 10.1111/j.1748-1716.2007.01786.x; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Rubio-Cabezas O, 2009, EMBO MOL MED, V1, P280, DOI 10.1002/emmm.200900037; Sharma R, 2020, MOL CELL ENDOCRINOL, V518, DOI 10.1016/j.mce.2020.111038; Sharma VM, 2019, AM J PHYSIOL-ENDOC M, V316, pE34, DOI 10.1152/ajpendo.00129.2018; Singh M, 2014, J BIOL CHEM, V289, P14481, DOI 10.1074/jbc.C114.563080; Slayton M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030238; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Tan XR, 2016, OBESITY, V24, P1070, DOI 10.1002/oby.21436; Tanaka N, 2015, J BIOL CHEM, V290, P3092, DOI 10.1074/jbc.M114.605980; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wu JJ, 2013, MOL BIOL REP, V40, P5691, DOI 10.1007/s11033-013-2671-7; Yang J, 2012, OBESITY, V20, P932, DOI 10.1038/oby.2011.371; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zhang L, 2008, METABOLISM, V57, P502, DOI 10.1016/j.metabol.2007.11.011; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	50	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102347	10.1016/j.jbc.2022.102347	http://dx.doi.org/10.1016/j.jbc.2022.102347			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5B1GH	35963433	gold, Green Published			2022-12-26	WOS:000863323200001
J	Jing, DJ; Liu, HW; Zhang, T; Ge, SC; Ren, SS; Ma, MX				Jing, Deji; Liu, Hongwei; Zhang, Tian; Ge, Shaocheng; Ren, Shuaishuai; Ma, Mingxing			Study on coal dust diffusion law and new pneumatic spiral spray dedusting technology at transfer point of mine cross roadway	PLOS ONE			English	Article							NUMERICAL-SIMULATION; POLLUTION CHARACTERISTICS; RESPIRABLE DUST; AIR-FLOW; VENTILATION; FACE	In order to solve the problem of coal dust pollution at the transfer point, a three-dimensional numerical model of wind flow-coal dust at the loading point of underground rubber run was established by computational fluid dynamics (CFD) discrete particle model and finite element method and k-epsilon turbulence model, and the coal dust diffusion pollution phenomenon caused by the coal flow transfer under the intersection of wind flow in the cross tunnel was studied. Based on the simulation results of wind flow velocity contour, pressure contour and isochronous flow vector distribution, the influence mechanism of wind flow and coal dust characteristics on the distribution of wind flow and coal dust diffusion in the roadway is analysed, and a dust control and reduction system and treatment scheme with new pneumatic screw spray technology as the core is proposed to suppress coal dust pollution at the reloading point. The results of the study show that the wind flow distribution is mainly influenced by the intersection of tape traction and cross-roadway wind flow, showing a complex multi-layer distribution along the roadway and in the normal direction; the diffusion of coal dust of different particle sizes is influenced by the roadway wind flow, and coal dust with particle sizes in the range of 10 mu m-20 mu m is more easily diffused, and the dust with particle sizes in the range of 20 mu m-45 mu m is mainly collected and suspended near the vortex wind flow at the cross-roadway. The coal dust in the range of 20 mu m-45 mu m is more likely to gather in the vortex; the treatment system effectively controls the coal dust inside the dust cover, and the spiral-shaped transported droplet particle group formed by the pneumatic spiral spray combines with it efficiently, which verifies the dust control and reduction effect of the pneumatic spiral spray system at the transfer point, and the dust removal efficiency reaches 89.35% similar to 93.06%, which provides relevant theoretical support for the treatment of dust pollution at the coal transfer point in underground coal mines It provides the theoretical support and means to control dust pollution at underground coal transfer points.	[Jing, Deji; Liu, Hongwei; Zhang, Tian; Ren, Shuaishuai; Ma, Mingxing] Liaoning Tech Univ, Coll Safety Sci & Engn, Fuxing, Peoples R China; [Jing, Deji; Liu, Hongwei; Zhang, Tian; Ren, Shuaishuai; Ma, Mingxing] Liaoning Tech Univ, Res Inst Safety Sci & Engn, Fuxing, Peoples R China; [Jing, Deji; Liu, Hongwei; Zhang, Tian; Ren, Shuaishuai; Ma, Mingxing] Liaoning Tech Univ, Thermodynam Disasters & Control Minist Educ, Fuxing, Peoples R China; [Ge, Shaocheng] Taiyuan Univ Technol, Safety & Emergency Management Engn Coll, Taiyuan, Peoples R China	Liaoning Technical University; Liaoning Technical University; Liaoning Technical University; Taiyuan University of Technology	Zhang, T (corresponding author), Liaoning Tech Univ, Coll Safety Sci & Engn, Fuxing, Peoples R China.; Zhang, T (corresponding author), Liaoning Tech Univ, Res Inst Safety Sci & Engn, Fuxing, Peoples R China.; Zhang, T (corresponding author), Liaoning Tech Univ, Thermodynam Disasters & Control Minist Educ, Fuxing, Peoples R China.	zhangtian@lntu.edu.cn			National Natural Science Foundation of China [51704146]; Natural science fund project in Liaoning Province [2020-MS-304]; Liaoning provincial funding for scientific research projects [LJK0323]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural science fund project in Liaoning Province; Liaoning provincial funding for scientific research projects	The National Natural Science Foundation of China (51704146) JDJ Natural science fund project in Liaoning Province (2020-MS-304) JDJ Liaoning provincial funding for scientific research projects (LJK0323) JDJ Funders play a supporting role in research design, data collection and analysis, publication decisions or manuscript preparation.	Du T, 2020, ENERGY, V212, DOI 10.1016/j.energy.2020.118616; Faeth GM, 1995, INT J MULTIPHAS FLOW, V21, P99, DOI 10.1016/0301-9322(95)00059-7; Guo C, 2020, J CLEAN PROD, V276, DOI 10.1016/j.jclepro.2020.123632; Hpa B., 2020, J CLEAN PROD, V275; Jing DJ, 2021, POWDER TECHNOL, V388, P554, DOI 10.1016/j.powtec.2021.04.067; Qin Y., 2014, J LIAONING TU NATURA; Ronghua Liu., 2000, JHUNAN UNIVSCITECHNO, V15, P17; Torano J, 2011, TUNN UNDERGR SP TECH, V26, P201, DOI 10.1016/j.tust.2010.07.005; Wang HQ, 2021, BIOMED ENVIRON SCI, V34, P83, DOI 10.3967/bes2021.011; Wang PF, 2019, TUNN UNDERGR SP TECH, V90, P194, DOI 10.1016/j.tust.2019.04.026; Xu CW, 2020, POWDER TECHNOL, V371, P217, DOI 10.1016/j.powtec.2020.05.047; Yin WJ, 2019, ADV POWDER TECHNOL, V30, P2600, DOI 10.1016/j.apt.2019.08.007; Zhang GB, 2021, PROCESS SAF ENVIRON, V146, P515, DOI 10.1016/j.psep.2020.11.044; Zhang PF, 2017, ENRGY PROCED, V142, P1367, DOI 10.1016/j.egypro.2017.12.521; Zhang Q, 2018, J CLEAN PROD, V184, P239, DOI 10.1016/j.jclepro.2018.02.230; Zhang T, 2020, ADV MECH ENG, V12, DOI 10.1177/1687814020977689; Zhang T, 2020, INT J COAL SCI TECHN, V7, P597, DOI 10.1007/s40789-020-00314-3; Zhang T, 2020, J BRAZ SOC MECH SCI, V42, DOI 10.1007/s40430-020-02411-5; Zhao P, 2021, J LOSS PREVENT PROC, V71, DOI 10.1016/j.jlp.2021.104490; Zhong'an Jiang., 2013, SHENZHEN U SCI ENG, V30, P313, DOI DOI 10.3724/SP.J.1249.2013.03313; Zhou G, 2018, POWDER TECHNOL, V339, P354, DOI 10.1016/j.powtec.2018.07.078; Zhou G, 2017, PROCESS SAF ENVIRON, V106, P117, DOI 10.1016/j.psep.2016.12.005	22	0	0	11	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0272304	10.1371/journal.pone.0272304	http://dx.doi.org/10.1371/journal.pone.0272304			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994466	gold, Green Published			2022-12-26	WOS:000877093400019
J	Pinkham, R; Koon, KK; To, J; Chan, J; Vial, F; Gomm, M; Eckery, DC; Massei, G				Pinkham, Rebecca; Koon, Ka-Kei; To, Jason; Chan, Jason; Vial, Flavie; Gomm, Matt; Eckery, Douglas C.; Massei, Giovanna			Long-term effect of a GnRH-based immunocontraceptive on feral cattle in Hong Kong	PLOS ONE			English	Article							WHITE-TAILED DEER; VACCINE; BEHAVIOR; FERTILITY; CONTRACEPTION; GONACON(TM); PHYSIOLOGY; CONFLICT	Increasing human-wildlife conflicts worldwide are driving the need for multiple solutions to reducing "problem" wildlife and their impacts. Fertility control is advocated as a non-lethal tool to manage free-living wildlife and in particular to control iconic species. Injectable immunocontraceptives, such as GonaCon, stimulate the immune system to produce anti-bodies against the gonadotrophin-releasing hormone (GnRH), which in turn affects the release of reproductive hormones in mammals. Feral cattle (Bos indicus or Bos taurus) in Hong Kong are an iconic species whose numbers and impacts on human activities have increased over the last decade. Previous studies have proven that a primer vaccination and booster dose of GonaCon in female cattle are safe and effective in reducing pregnancy levels one year post-treatment. The aims of this project were 1. to evaluate the longevity of the effect of GonaCon in feral cattle up to four years post-vaccination; and 2. to assess if a second booster dose of GonaCon, administered at either two or four years post-vaccination, extends the contraceptive effect in this species. Vaccination with GonaCon, administered as a primer and booster dose, was effective in causing significant infertility in free-living cattle for at least three years post-vaccination, with the percentage of pregnant animals in the vaccinated group decreasing from 76% at vaccination to 35%, 19% and 7% in years 2, 3 and 4 post-vaccination, compared with 67% at vaccination to 50%, 57% and 14% respectively in the control group. A second booster dose of GonaCon administered either 2 or 4 years after vaccination rendered 100% of the Treated cattle infertile for at least another year. These results suggested that vaccination with GonaCon can reduce feral cattle population growth and that a second booster dose can extend the longevity of the contraceptive effect.	[Pinkham, Rebecca; Vial, Flavie; Gomm, Matt; Massei, Giovanna] Anim & Plant Hlth Agcy, Natl Wildlife Management Ctr, York, N Yorkshire, England; [Koon, Ka-Kei; To, Jason; Chan, Jason] Agr Fisheries & Conservat Dept, Anim Management Operat Div, Hong Kong, Peoples R China; [Eckery, Douglas C.] USDA, APHIS, Natl Wildlife Res Ctr, Ft Collins, CO USA	Animal & Plant Health Agency UK; United States Department of Agriculture (USDA)	Pinkham, R (corresponding author), Anim & Plant Hlth Agcy, Natl Wildlife Management Ctr, York, N Yorkshire, England.	Rebecca.pinkham@apha.gov.uk			Agriculture, Fisheries and Conservation Department in Hong Kong	Agriculture, Fisheries and Conservation Department in Hong Kong	This study was funded by the Agriculture, Fisheries and Conservation Department in Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker DL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201570; Barbato M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231162; BERTEAUX D, 1992, J ZOOL, V228, P265, DOI 10.1111/j.1469-7998.1992.tb04607.x; Commun L, 2016, J VET DIAGN INVEST, V28, P207, DOI 10.1177/1040638716632815; Delsink A, 2012, FREERANGING AFRICAN; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Druce HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027952; Duka Toni, 2005, Ecological Management & Restoration, V6, P172, DOI 10.1111/j.1442-8903.2005.00234.x; Fagerstone KA, 2010, INTEGR ZOOL, V5, P15, DOI 10.1111/j.1749-4877.2010.00185.x; Fernando P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050917; Gionfriddo JP, 2011, WILDLIFE SOC B, V35, P142, DOI 10.1002/wsb.32; Gionfriddo JP, 2009, WILDLIFE RES, V36, P177, DOI 10.1071/WR08061; Gray ME, 2010, WILDLIFE RES, V37, P475, DOI 10.1071/WR09175; Habibzadeh F, 2016, BIOCHEM MEDICA, V26, P297, DOI 10.11613/BM.2016.034; HART BL, 1975, HORM BEHAV, V6, P247, DOI 10.1016/0018-506X(75)90012-4; Heydon MJ, 2010, WILDLIFE RES, V37, P731, DOI 10.1071/WR10006; Killian G, 2008, WILDLIFE RES, V35, P531, DOI 10.1071/WR07134; Killian G, 2009, J WILDLIFE DIS, V45, P184, DOI 10.7589/0090-3558-45.1.184; Kirkpatrick JF, 2011, AM J REPROD IMMUNOL, V66, P40, DOI 10.1111/j.1600-0897.2011.01003.x; Lute ML, 2016, CONSERV BIOL, V30, P1200, DOI 10.1111/cobi.12731; Mannen H, 2017, ANIM SCI J, V88, P739, DOI 10.1111/asj.12716; Massei G, 2008, WILDLIFE RES, V35, P540, DOI 10.1071/WR07132; Massei G, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03781; Massei G, 2018, VACCINE, V36, P7393, DOI 10.1016/j.vaccine.2018.09.071; Massei G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121598; Massei G, 2014, WILDLIFE RES, V41, P1, DOI 10.1071/WR13141; Massei G, 2012, WILDLIFE RES, V39, P378, DOI 10.1071/WR11196; Massei G, 2010, WILDLIFE RES, V37, P428, DOI 10.1071/WR08179; Miller LA, 2004, J WILDLIFE DIS, V40, P725, DOI 10.7589/0090-3558-40.4.725; Miller LA, 2000, AM J REPROD IMMUNOL, V44, P266, DOI 10.1111/j.8755-8920.2000.440503.x; Miller LA, 2008, AM J REPROD IMMUNOL, V60, P214, DOI 10.1111/j.1600-0897.2008.00616.x; Powers JG, 2014, WILDLIFE SOC B, V38, P650, DOI 10.1002/wsb.434; Powers JG, 2011, BIOL REPROD, V85, P1152, DOI 10.1095/biolreprod.110.088237; Price EO, 2003, J ANIM SCI, V81, P411; R Core Team, 2021, R LANG ENV STAT; Rutberg AT, 2008, WILDLIFE RES, V35, P494, DOI 10.1071/WR07128; Sharp T., 2011, MODEL ASSESSING RELA, VSecond; Therneau T., 2021, PACKAGE SURVIVAL ANA, DOI DOI 10.1198/TECH.2004.S740; Tizard I., 1982, An introduction to veterinary immunology.	39	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0272604	10.1371/journal.pone.0272604	http://dx.doi.org/10.1371/journal.pone.0272604			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976896	Green Published, gold			2022-12-26	WOS:000847227000050
J	Ridgway, S; Dibble, DS; Baird, M				Ridgway, Sam; Dibble, Dianna Samuelson; Baird, Mark			Sights and sounds dolphins, Tursiops truncatus preying on native fish of San Diego Bay and offshore in the Pacific Ocean	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; SUCTION; WHALES; ODONTOCETI; KINEMATICS; APPARATUS; BELUGAS; KOGIA	For the first time, dolphins wearing video cameras were observed capturing and eating live native fish. While freely swimming in San Diego Bay, one dolphin caught 69 resident fish, 64 demersal, 5 near surface, while the other caught 40, 36 demersal and 4 near the surface. Two other dolphins were observed capturing 135 live native fish in a sea water pool. Two additional dolphins were observed feeding opportunistically during open water sessions in the Pacific Ocean. Notably, one of these dolphins was observed to consume 8 yellow-bellied sea snakes (Hydrophis platurus). Searching dolphins clicked at intervals of 20 to 50 ms. On approaching prey, click intervals shorten into a terminal buzz and then a squeal. Squeals were bursts of clicks that varied in duration, peak frequency, and amplitude. Squeals continued as the dolphin seized, manipulated and swallowed the prey. If fish escaped, the dolphin continued the chase and sonar clicks were heard less often than the continuous terminal buzz and squeal. During captures, the dolphins' lips flared to reveal nearly all of the teeth. The throat expanded outward. Fish continued escape swimming even as they entered the dolphins' mouth, yet the dolphin appeared to suck the fish right down.	[Ridgway, Sam; Dibble, Dianna Samuelson; Baird, Mark] Natl Marine Mammal Fdn, San Diego, CA 92106 USA; [Ridgway, Sam] Univ Calif San Diego, Dept Pathol, Sch Med, San Diego, CA 92093 USA	University of California System; University of California San Diego	Ridgway, S (corresponding author), Natl Marine Mammal Fdn, San Diego, CA 92106 USA.; Ridgway, S (corresponding author), Univ Calif San Diego, Dept Pathol, Sch Med, San Diego, CA 92093 USA.	sam.ridgway@nmmf.org		Ridgway, Sam/0000-0001-7474-9880	Office of Naval Research [12604848]; National Marine Mammal Foundation	Office of Naval Research(Office of Naval Research); National Marine Mammal Foundation	The authors (SR, DD) received funding from the Office of Naval Research (https://www.onr.navy.mil/).The associated grant number is 12604848. In addition, authors received funding from the National Marine Mammal Foundation (nmmf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelis G., 2008, ANIMAL BORNE IMAGING, P15; Au W. W., 1993, SONAR DOLPHINS; Barros N.B., 1990, P309; Blanco C, 2001, J MAR BIOL ASSOC UK, V81, P1053, DOI 10.1017/S0025315401005057; Bloodworth B, 2005, J EXP BIOL, V208, P3721, DOI 10.1242/jeb.01807; Bloodworth BE, 2007, J ANAT, V211, P78, DOI 10.1111/j.1469-7580.2007.00755.x; Davis RW, 2003, MAR ECOL PROG SER, V264, P109, DOI 10.3354/meps264109; Dibble D. S., 2016, INT J COMP PSYCHOL, V29, P32031; Gannon DP, 2005, ANIM BEHAV, V69, P709, DOI 10.1016/j.anbehav.2004.06.020; GRAHAM JB, 1987, J EXP BIOL, V127, P27; Harper CJ, 2008, J MORPHOL, V269, P820, DOI 10.1002/jmor.10628; Heyning J.E., 1989, NATURAL HIST MUSEUM, V405, P1; Ineich I., 1998, B SOCI T ETUDES OC A, P86; Ineich Ivan, 2017, Bulletin de la Societe Herpetologique de France, P95; Ito H, 2002, FISHERIES SCI, V68, P268, DOI 10.2331/fishsci.68.sup1_268; Jensen FH, 2009, J EXP BIOL, V212, P1078, DOI 10.1242/jeb.025619; Johnson M, 2006, J EXP BIOL, V209, P5038, DOI 10.1242/jeb.02596; Kane EA, 2009, J EXP BIOL, V212, P3939, DOI 10.1242/jeb.034686; Kastelein R.A., 1997, P279; Ladegaard M, 2017, J EXP BIOL, V220, P2654, DOI 10.1242/jeb.159913; LAWRENCE BARBARA, 1965, BULL MUS COMP ZOOL HARVARD UNIV, V133, P1; LEATHERWOOD S, 1975, MAR FISH REV, V37, P10; Marshall CD, 2016, CRC MAR BIOL SER, P95; REIDENBERG JS, 1994, ANAT RECORD, V240, P598, DOI 10.1002/ar.1092400417; Ridgway SH, 2014, J EXP BIOL, V217, P2910, DOI 10.1242/jeb.100511; Ridgway S, 2006, J EXP BIOL, V209, P2902, DOI 10.1242/jeb.02348; Ridgway S, 2015, J EXP BIOL, V218, P3987, DOI 10.1242/jeb.130559; Ridgway SH, 2018, BIOL OPEN, V7, DOI 10.1242/bio.031625; Ridgway SH, 1999, MAR MAMMAL SCI, V15, P926, DOI 10.1111/j.1748-7692.1999.tb00861.x; RIDGWAY SH, 1993, IEEE ENG MED BIOL, V12, P83, DOI 10.1109/51.232347; Rossbach KA, 1997, MAR MAMMAL SCI, V13, P498, DOI 10.1111/j.1748-7692.1997.tb00658.x; Vick J.A., 1978, AD AO56 1 92, P17; Wainwright PC, 2015, INTEGR COMP BIOL, V55, P134, DOI 10.1093/icb/icv026; Wells R., 1999, HDB MARINE MAMMALS, V6, P137; Werth AJ, 2006, J MAMMAL, V87, P579, DOI 10.1644/05-MAMM-A-279R1.1; Werth AJ, 2007, ANAT REC, V290, P546, DOI 10.1002/ar.20538; Werth AJ, 2006, J MORPHOL, V267, P1415, DOI 10.1002/jmor.10486; Wisniewska DM, 2015, ELIFE, V4, DOI 10.7554/eLife.05651; Wisniewska DM, 2014, J EXP BIOL, V217, P4279, DOI 10.1242/jeb.113415; Wisniewska DM, 2016, CURR BIOL, V26, P1441, DOI 10.1016/j.cub.2016.03.069; Wood F.G., 1980, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, V28, P381	41	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0265382	10.1371/journal.pone.0265382	http://dx.doi.org/10.1371/journal.pone.0265382			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976877	gold, Green Submitted, Green Published			2022-12-26	WOS:000847227000002
J	Segawa, HK; Uematsu, H; Dorji, N; Wangdi, U; Dorjee, C; Yangchen, P; Kunisawa, S; Sakamoto, R; Imanaka, Y				Segawa, Hiromi Kohori; Uematsu, Hironori; Dorji, Nidup; Wangdi, Ugyen; Dorjee, Chencho; Yangchen, Pemba; Kunisawa, Susumu; Sakamoto, Ryota; Imanaka, Yuichi			Social and behavioral factors related to blood pressure measurement: A cross-sectional study in Bhutan	PLOS ONE			English	Article							HEALTH-SEEKING BEHAVIOR; HYPERTENSION; PREVALENCE; MIDDLE; TESTS; CARE	Cardiovascular disease is a leading cause of death in the Kingdom of Bhutan, and early detection of hypertension is critical for preventing cardiovascular disease. However, health-seeking behavior, including blood pressure measurement, is infrequently investigated in Bhutan. Therefore, this study investigated factors related to blood pressure measurement in Bhutan. We performed a secondary data analysis of a target population of 1,962 individuals using data from the "2014 Bhutan STEPS survey data"as a cross-sectional study. Approximately 26% of those with hypertension who were detected during the STEPS survey had never had their blood pressure measured. Previous blood pressure measurement was significantly associated with age and working status in men (self-employed [odds ratio (OR): 0.219, 95% CI: 0.133-0.361], non-working [OR: 0.114, 95% CI: 0.050-0.263], employee [OR: 1.000]). Previous blood pressure measurement was significantly associated with higher income in women (Quartile-2 [OR: 1.984, 95% CI: 1.209-3.255], Quartile-1 [OR: 2.161, 95% CI: 1.415-3.299], Quartile-4 [OR: 1.000]). A family history of hypertension (OR: 2.019, 95% CI: 1.549-2.243) increased the likelihood of having experienced a blood pressure measurement in both men and women. Multivariate logistic regression showed that people with unhealthy lifestyles (high salt intake [adjusted odds ratio (AOR): 0.247, 95% confidence interval (CI): 0.068-0.893], tobacco use [AOR: 0.538, 95% CI: 0.380-0.761]) had a decreased likelihood of previous blood pressure measurement. To promote the early detection of hypertension in Bhutan, we suggest that more attention be paid to low-income women, non-working, self-employed, and low-income men, and a reduction of barriers to blood pressure measurement. Before the STEPS survey, a substantial number of hypertensive people had never had their blood pressure measured or were unconcerned about their health. As a result, we propose that early blood pressure monitoring and treatment for people with hypertension or at higher risk of hypertension be given increased emphasis.	[Segawa, Hiromi Kohori; Uematsu, Hironori; Kunisawa, Susumu; Imanaka, Yuichi] Kyoto Univ, Grad Sch Med, Dept Healthcare Econ & Qual Management, Kyoto, Japan; [Segawa, Hiromi Kohori] Kyoto Univ, Kokoro Res Ctr, Kyoto, Japan; [Dorji, Nidup; Wangdi, Ugyen; Dorjee, Chencho] Khesar Gyalpo Univ Med Sci Bhutan, Fac Nursing & Publ Hlth, Thimphu, Bhutan; [Yangchen, Pemba] Minist Hlth Bhutan, Noncommunicable Dis Div, Thimphu, Bhutan; [Sakamoto, Ryota] Kyoto Univ, Ctr Southeast Asian Studies, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University	Imanaka, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Healthcare Econ & Qual Management, Kyoto, Japan.	imanaka-y@umin.net	KUNISAWA, Susumu/HCH-1094-2022	Segawa, Hiromi/0000-0003-4038-1189; Dorji, Nidup/0000-0001-6243-0020	K. Matsushita Foundation [19-048]; Kyoto University; Program of Collaborative Research at the Centre for Southeast Asian Studies (IPCR-CSEAS); Japan Society for the Promotion of Science (JSPS Kakenhi) [JP19H01075]	K. Matsushita Foundation; Kyoto University; Program of Collaborative Research at the Centre for Southeast Asian Studies (IPCR-CSEAS); Japan Society for the Promotion of Science (JSPS Kakenhi)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by K. Matsushita Foundation (http://matsushitakonosuke-zaidan.or.jp/en/) in the form of a grant (19-048) to HKS. This study was also supported by Kyoto University (https://ipcr.cseas.kyoto-u.ac.jp/), Program of Collaborative Research at the Centre for Southeast Asian Studies (IPCR-CSEAS) with funding (type 4) for YI and funding (type 7) for HKS. Kyoto University also supported this study with funding (Ishizue 2022) for YI. There are no grant numbers associate with the support from Kyoto University. This study was also supported by Japan Society for the Promotion of Science (JSPS Kakenhi) in the form of a grant (JP19H01075) to YI. The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; Ahmed SM, 2000, SOC SCI MED, V51, P361, DOI 10.1016/S0277-9536(99)00461-X; Akseer N, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1608; [Anonymous], 2008, CONSTITUTION BHUTAN; Asia Pacific Observatory on Health System and Policies, KINGD BHUT HLTH SYST; Barton H, 2006, J R SOC PROMO HEALTH, V126, P252, DOI 10.1177/1466424006070466; Basu S, 2013, HYPERTENSION, V62, P18, DOI 10.1161/HYPERTENSIONAHA.113.01374; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Bull FC, 2020, BRIT J SPORT MED, V54, P1451, DOI 10.1136/bjsports-2020-102955; Centre for Bhutan Studies & GNH Research, 2016, 2015 GNH SURV REP CO; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Damrongplasit K, 2017, INT J HEALTH ECON MA, V17, P51, DOI 10.1007/s10754-016-9194-4; Department of Labour and WHO Bhutan Office., 2012, PROF OCC HLTH SAF BH; Elliott WI, 2007, CURR PROB CARDIOLOGY, V32, P201, DOI 10.1016/j.cpcardiol.2007.01.002; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Holmes MV, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4164; Huang YL, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5953; Khatri RB, 2018, REPROD HEALTH MATTER, V26, P32, DOI 10.1080/09688080.2018.1535686; Kjeldsen SE, 2018, PHARMACOL RES, V129, P95, DOI 10.1016/j.phrs.2017.11.003; Kohori-Segawa H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234257; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Leonard TC, 2008, CONST POLITICAL ECON, V19, P356, DOI 10.1007/s10602-008-9056-2; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; Ministry of Health Bhutan, 2020, ANN HLTH B; Ministry of Health Bhutan, 1990, ANN HLTH B; National Statistics Bureau in Bhutan, 2005, POPULATION HOUSING C; National Statistics Bureau in Bhutan, STAT YB 2021; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Pelzom D, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4989-x; Perreault L, 2012, LANCET, V379, P2243, DOI 10.1016/S0140-6736(12)60525-X; Pruckner GJ, 2020, EUR J HEALTH ECON, V21, P251, DOI 10.1007/s10198-019-01124-4; RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391; RAO JNK, 1987, ANN STAT, V15, P385, DOI 10.1214/aos/1176350273; ROSENSTOCK IM, 1966, MILBANK FUND Q, V44, P94, DOI 10.2307/3348967; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Shaikh BT, 2005, J PUBLIC HEALTH-UK, V27, P49, DOI 10.1093/pubmed/fdh207; Tanaka T, 2002, J HUM HYPERTENS, V16, P97, DOI 10.1038/sj.jhh.1001307; Tobgay T, 2011, TROP MED INT HEALTH, V16, P731, DOI 10.1111/j.1365-3156.2011.02760.x; Venkataramani AS, 2016, LANCET PUBLIC HEALTH, V1, pE18, DOI 10.1016/S2468-2667(16)30005-6; Wang X, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4490; WHO, 2017, WHO STEPS SURV MAN; WHO, 2011, NCD COUNTR PROF; World Health Organization, 2017, MAJ NCDS THEIR RISK; World Health Organization, 2010, PACK ESS NONC PEN DI; World Health Organization, 2018, NCD COUNTR PROF; [World Health Organization 2013], 2013, WHODCOWHD20132; World Health Organization, 2013, GLOB ACT PLAN PREV C; World Health Organization and Ministry of Health in Bhutan,, NAT SURV NONC DIS RI; Zhang XF, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0538-9; Zhang Y, 2019, J HYPERTENS, V37, P99, DOI 10.1097/HJH.0000000000001879	50	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0271914	10.1371/journal.pone.0271914	http://dx.doi.org/10.1371/journal.pone.0271914			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976922	Green Published, gold			2022-12-26	WOS:000847227000018
J	Pose, M; Dillon, KM; Denicola, A; Alvarez, B; Matson, JB; Moeller, MN; Cuevasanta, E				Pose, Manuela; Dillon, Kearsley M.; Denicola, Ana; Alvarez, Beatriz; Matson, John B.; Moeller, Matias N.; Cuevasanta, Ernesto			Fluorescent detection of hydrogen sulfide (H2S) through the formation of pyrene excimers enhances H2S quantification in biochemical systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL-CHANGE; N-ETHYLMALEIMIDE; PROBE; BINDING; CHEMISTRY; TOOLS; ASSAY; FORM	Hydrogen sulfide (H2S) is produced endogenously by several enzymatic pathways and modulates physiological functions in mammals. Quantification of H2S in biochemical systems re-mains challenging because of the presence of interferents with similar reactivity, particularly thiols. Herein, we present a new quantification method based on the formation of pyrene exci-mers in solution. We synthesized the probe 2-(maleimido)ethyl 4-pyrenylbutanoate (MEPB) and determined that MEPB reacted with H2S in a two-step reaction to yield the thioether-linked dimer (MEPB)2S, which formed excimers upon excita-tion, with a broad peak of fluorescence emission centered at 480 nm. In contrast, we found that the products formed with thiols showed peaks at 378 and 398 nm. The difference in emission between the products prevented the interference. Furthermore, we showed that the excimer fluorescence signal yielded a linear response to H2S, with a limit of detection of 54 nM in a fluorometer. Our quantification method with MEPB was successfully applied to follow the reaction of H2S with glutathione disulfide and to quantify the production of H2S from cysteine by Escherichia coli. In conclusion, this method represents an addition to the toolkit of biochemists to quantify H2S specifically and sensitively in biochemical systems.	[Pose, Manuela; Alvarez, Beatriz; Cuevasanta, Ernesto] Univ Republica, Lab Enzimol, Montevideo, Uruguay; [Pose, Manuela; Denicola, Ana; Moeller, Matias N.] Univ Republica, Fac Ciencias, Lab Fisicoquim Biol, Inst Quim Biol, Montevideo, Uruguay; [Pose, Manuela; Denicola, Ana; Alvarez, Beatriz; Moeller, Matias N.; Cuevasanta, Ernesto] Univ Republica, Ctr Invest Biomed CEINBIO, Montevideo, Uruguay; [Dillon, Kearsley M.; Matson, John B.] Virginia Tech, Dept Chem, Blacksburg, VA USA; [Cuevasanta, Ernesto] Univ Republica, Unidad Bioquim Analit, Ctr Invest Nucl, Fac Ciencias, Montevideo, Uruguay	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Virginia Polytechnic Institute & State University; Universidad de la Republica, Uruguay	Cuevasanta, E (corresponding author), Univ Republica, Lab Enzimol, Montevideo, Uruguay.; Moeller, MN (corresponding author), Univ Republica, Fac Ciencias, Lab Fisicoquim Biol, Inst Quim Biol, Montevideo, Uruguay.; Moeller, MN; Cuevasanta, E (corresponding author), Univ Republica, Ctr Invest Biomed CEINBIO, Montevideo, Uruguay.; Cuevasanta, E (corresponding author), Univ Republica, Unidad Bioquim Analit, Ctr Invest Nucl, Fac Ciencias, Montevideo, Uruguay.	mmoller@fcien.edu.uy; ecuevasanta@fcien.edu.uy		Moller, Matias N./0000-0002-3486-8217	Fondo Vaz Ferreira (Ministerio de Educacion y Cultura, Uruguay) [I/FVF2017/069]; Fondo Clemente Estable (ANII) [FCE_1_2017_1_136043]; Comision Sectorial de Investigacion Cientifica (Universidad de la Republica, Uruguay); CSIC I+D [2018]; US National Institutes of Health [R01GM123508]; Comision Academica de Posgrado (CAP, Universidad de la Republica); Programa de Desarrollo de las Ciencias Basicas (PEDECIBA, Uruguay); PEDECIBA	Fondo Vaz Ferreira (Ministerio de Educacion y Cultura, Uruguay); Fondo Clemente Estable (ANII); Comision Sectorial de Investigacion Cientifica (Universidad de la Republica, Uruguay); CSIC I+D; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Comision Academica de Posgrado (CAP, Universidad de la Republica); Programa de Desarrollo de las Ciencias Basicas (PEDECIBA, Uruguay); PEDECIBA	This work was supported by grants from Fondo Vaz Ferreira (Ministerio de Educacion y Cultura, Uruguay; grant no.: I/FVF2017/069; to E. C.), Fondo Clemente Estable (ANII, grant no.: FCE_1_2017_1_136043; to M. N. M.), Comision Sectorial de Investigacion Cientifica (Universidad de la Republica, Uruguay) (grant no.: CSIC I+D 2017; to B. A., CSIC I+D 2020; to M. N. M., CSIC Grupos 2014 and 2018; to A. D.), and US National Institutes of Health (grant no.: R01GM123508; to J. B. M.). The authors acknowledge fellowships from Comision Academica de Posgrado (CAP, Universidad de la Republica; to E. C.) and Programa de Desarrollo de las Ciencias Basicas (PEDECIBA, Uruguay; to E. C.). Additional funding was obtained from PEDECIBA. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe K, 1996, J NEUROSCI, V16, P1066; Ahn T, 2002, ANAL BIOCHEM, V306, P247, DOI 10.1006/abio.2002.5717; Bains G, 2011, MOLECULES, V16, P7909, DOI 10.3390/molecules16097909; Bains GK, 2012, BIOCHEMISTRY-US, V51, P6207, DOI 10.1021/bi3005285; Baird R., 2017, STANDARD METHODS EXA; BEAUCHAMP RO, 1984, CRC CR REV TOXICOL, V13, P25, DOI 10.3109/10408448409029321; BEDNAR RA, 1990, BIOCHEMISTRY-US, V29, P3684, DOI 10.1021/bi00467a014; Benchoam D, 2020, J BIOL CHEM, V295, P15466, DOI 10.1074/jbc.RA120.014728; Carballal S, 2016, J BIOL CHEM, V291, P8004, DOI 10.1074/jbc.M116.718734; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Cuevasanta E, 2017, ARCH BIOCHEM BIOPHYS, V617, P9, DOI 10.1016/j.abb.2016.09.018; Cuevasanta E, 2015, J BIOL CHEM, V290, P26866, DOI 10.1074/jbc.M115.672816; DANENKOV IA I, 1951, Sov Med, V8, P20; Dillon KM, 2021, ACS CHEM BIOL, V16, P1128, DOI 10.1021/acschembio.1c00255; Doeller JE, 2005, ANAL BIOCHEM, V341, P40, DOI 10.1016/j.ab.2005.03.024; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Filipovic MR, 2018, CHEM REV, V118, P377, DOI 10.1021/acs.chemrev.7b00205; FORSTER T, 1969, ANGEW CHEM INT EDIT, V8, P333, DOI 10.1002/anie.196903331; Furne J, 2008, AM J PHYSIOL-REG I, V295, pR1479, DOI 10.1152/ajpregu.90566.2008; GREGORY JD, 1955, J AM CHEM SOC, V77, P3922, DOI 10.1021/ja01619a073; Grice K, 2005, SCIENCE, V307, P706, DOI 10.1126/science.1104323; Han MK, 2002, BIOCHEMISTRY-US, V41, P3468, DOI 10.1021/bi015901e; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; Huyser E. S., 1978, ORGANIC FREE RADICAL, V69, P258; Jameson D. M., 2014, INTRO FLUORESCENCE, V1st, DOI [10.1201/b16502, DOI 10.1201/B16502]; Jung JM, 2017, SPECTROCHIM ACTA A, V178, P203, DOI 10.1016/j.saa.2017.02.006; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lehrer S S, 1995, Subcell Biochem, V24, P115; Leschelle X, 2005, BBA-GEN SUBJECTS, V1725, P201, DOI 10.1016/j.bbagen.2005.06.002; Levitt MD, 2011, ANTIOXID REDOX SIGN, V15, P373, DOI 10.1089/ars.2010.3525; Linares IAP, 2017, DYES PIGMENTS, V145, P518, DOI 10.1016/j.dyepig.2017.06.011; Lippert AR, 2011, J AM CHEM SOC, V133, P10078, DOI 10.1021/ja203661j; Liu CR, 2011, ANGEW CHEM INT EDIT, V50, P10327, DOI 10.1002/anie.201104305; McCluskey A, 2003, BIOORG CHEM, V31, P68, DOI 10.1016/S0045-2068(02)00524-2; Miyamoto R, 2011, NEUROSCI LETT, V499, P137, DOI 10.1016/j.neulet.2011.05.057; Mizuguchi C, 2012, BIOCHEMISTRY-US, V51, P5580, DOI 10.1021/bi300672s; Moller MN, 2018, FREE RADICAL BIO MED, V128, P137, DOI 10.1016/j.freeradbiomed.2018.04.553; MOYLE M, 1958, AUST J CHEM, V11, P211, DOI 10.1071/CH9580211; Myszkowska J, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10071065; NEWTON GL, 1981, ANAL BIOCHEM, V114, P383, DOI 10.1016/0003-2697(81)90498-X; Niwayama S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026691; Olson KR, 2016, PHYSIOLOGY, V31, P60, DOI 10.1152/physiol.00024.2015; Patel AB, 2010, BIOCHEMISTRY-US, V49, P1766, DOI 10.1021/bi901902e; Peng HJ, 2011, ANGEW CHEM INT EDIT, V50, P9672, DOI 10.1002/anie.201104236; Powell CR, 2018, BIOCHEM PHARMACOL, V149, P110, DOI 10.1016/j.bcp.2017.11.014; Qian Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1506; REIFFENSTEIN RJ, 1992, ANNU REV PHARMACOL, V32, P109, DOI 10.1146/annurev.pa.32.040192.000545; Rubright SLM, 2017, NITRIC OXIDE-BIOL CH, V71, P1, DOI 10.1016/j.niox.2017.09.011; Sasakura K, 2011, J AM CHEM SOC, V133, P18003, DOI 10.1021/ja207851s; Searcy DG, 2003, CELL RES, V13, P229, DOI 10.1038/sj.cr.7290168; Somerharju P, 2002, CHEM PHYS LIPIDS, V116, P57, DOI 10.1016/S0009-3084(02)00020-8; Ubuka T, 2002, J CHROMATOGR B, V781, P227, DOI 10.1016/S1570-0232(02)00623-2; Vitvitsky V, 2012, ANTIOXID REDOX SIGN, V17, P22, DOI 10.1089/ars.2011.4310; WELTMAN JK, 1973, J BIOL CHEM, V248, P3173; West JM, 2004, J BIOL CHEM, V279, P945, DOI 10.1074/jbc.M304018200; Yoshida H, 2009, ANAL SCI, V25, P829, DOI 10.2116/analsci.25.829; Zhang YF, 2014, BIOTECHNIQUES, V57, P208, DOI 10.2144/000114218	59	0	0	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	298	10							102402	10.1016/j.jbc.2022.102402	http://dx.doi.org/10.1016/j.jbc.2022.102402			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5K6GU	35988644	gold, Green Published			2022-12-26	WOS:000869823800001
J	Assis, AD; Chiarotto, GB; da Silva, NS; Simoes, GF; Oliveira, ALR				Assis, Alex Dias; Chiarotto, Gabriela Bortolanca; da Silva, Natalia Scanavachia; Simoes, Gustavo Ferreira; Rodrigues Oliveira, Alexandre Leite			Pregabalin synchronizes the regeneration of nerve and muscle fibers optimizing the gait recovery of MDX dystrophic mice	FASEB JOURNAL			English	Article						DMD; MDX; nervous injury; nervous system; pregabalin therapy	DUCHENNE MUSCULAR-DYSTROPHY; SPINAL-CORD-INJURY; AXONAL REGENERATION; NEUROPATHIC PAIN; PURKINJE-CELLS; MESSENGER-RNA; EXPRESSION; GABAPENTIN; SUBUNIT; BINDING	Duchenne muscular dystrophy (DMD) is an X-linked genetic disorder induced by mutations in the dystrophin gene, leading to a degeneration of muscle fibers, triggering retrograde immunomodulatory, and degenerative events in the central nervous system. Thus, neuroprotective drugs such as pregabalin (PGB) can improve motor function by modulating plasticity, together with anti-inflammatory effects. The present work aimed to study the effects of PGB on axonal regeneration after axotomy in dystrophic and non-dystrophic mice. For that, MDX and C57BL/10 mouse strains were subjected to peripheral nerve damage and were treated with PGB (30 mg/kg/day, i.p.) for 28 consecutive days. The treatment was carried out in mice as soon as they completed 5 weeks of life, 1 week before the lesion, corresponding to the peak period of muscle degeneration in the MDX strain. Six-week-old mice were submitted to unilateral sciatic nerve crush and were sacrificed in the 9th week of age. The ipsi and contralateral sciatic nerves were processed for immunohistochemistry and qRT-PCR, evaluating the expression of proteins and gene transcripts related to neuronal and Schwann cell activity. Cranial tibial muscles were dissected for evaluation of neuromuscular junctions using alpha-bungarotoxin, and the myelinated axons of the sciatic nerve were analyzed by morphometry. The recovery of motor function was monitored throughout the treatment through tests of forced locomotion (rotarod) and spontaneous walking track test (Catwalk system). The results show that treatment with PGB reduced the retrograde cyclic effects of muscle degeneration/regeneration on the nervous system. This fact was confirmed after peripheral nerve injury, showing better adaptation and response of neurons and glia for rapid axonal regeneration, with efficient muscle targeting and regain of function. No side effects of PGB treatment were observed, and the expression of pro-regenerative proteins in neurons and Schwann cells was upregulated. Morphometry of the axons was in line with the preservation of motor endplates, resulting in enhanced performance of dystrophic animals. Overall, the present data indicate that pregabalin is protective and enhances regeneration of the SNP during the development of DMD, improving motor function, which can, in turn, be translated to the clinic.	[Assis, Alex Dias; Chiarotto, Gabriela Bortolanca; da Silva, Natalia Scanavachia; Simoes, Gustavo Ferreira; Rodrigues Oliveira, Alexandre Leite] Univ Campinas UNICAMP, Lab Nerve Regenerat, Cidade Univ Zeferino Vaz,Rua Monteiro Lobato 255, BR-13083970 Campinas, SP, Brazil	Universidade Estadual de Campinas	Oliveira, ALR (corresponding author), Univ Campinas UNICAMP, Lab Nerve Regenerat, Cidade Univ Zeferino Vaz,Rua Monteiro Lobato 255, BR-13083970 Campinas, SP, Brazil.	alroliv@unicamp.br			Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2018/05006-0, 2015/14385-7]; MCTI | Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [303085/20170-7, 446609/2014-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); MCTI | Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Grant/Award Number: 2018/05006-0 and 2015/14385-7; MCTI | Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Grant/Award Number: 303085/20170-7 and 446609/2014-5	Assis AD, 2021, MOL CELL NEUROSCI, V114, DOI 10.1016/j.mcn.2021.103632; Banks GB, 2008, CURR TOP DEV BIOL, V84, P431, DOI 10.1016/S0070-2153(08)00609-1; Bian F, 2006, BRAIN RES, V1075, P68, DOI 10.1016/j.brainres.2005.12.084; BIXBY JL, 1981, J NEUROCYTOL, V10, P81, DOI 10.1007/BF01181746; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Burns DP, 2019, J PHYSIOL-LONDON, V597, P831, DOI 10.1113/JP277443; Caudal D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230083; Celik M, 2015, INT J NEUROSCI, V125, P845, DOI 10.3109/00207454.2014.978976; Court FA, 2006, CURR OPIN NEUROBIOL, V16, P501, DOI 10.1016/j.conb.2006.08.005; Cullheim S, 2002, BRAIN RES REV, V40, P309, DOI 10.1016/S0165-0173(02)00213-8; Cunningham MO, 2004, EUR J NEUROSCI, V20, P1566, DOI 10.1111/j.1460-9568.2004.03625.x; Daneshdoust D, 2017, NEUROSCIENCE, V344, P148, DOI 10.1016/j.neuroscience.2016.12.037; DIMARIO JX, 1991, DEV BIOL, V148, P314, DOI 10.1016/0012-1606(91)90340-9; Dooley DJ, 2000, J PHARMACOL EXP THER, V295, P1086; Fink K, 2002, NEUROPHARMACOLOGY, V42, P229, DOI 10.1016/S0028-3908(01)00172-1; Ha KY, 2008, EUR SPINE J, V17, P864, DOI 10.1007/s00586-008-0653-6; Ha KY, 2011, J KOREAN MED SCI, V26, P404, DOI 10.3346/jkms.2011.26.3.404; Haastert-Talini K., 2017, MODERN CONCEPTS PERI, P127; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Inserra MM, 1998, MICROSURG, V18, P119, DOI 10.1002/(SICI)1098-2752(1998)18:2<119::AID-MICR10>3.3.CO;2-Z; Joshi I, 2006, EUR J PHARMACOL, V553, P82, DOI 10.1016/j.ejphar.2006.09.019; Krishnan VS, 2020, MOL CELL NEUROSCI, V105, DOI 10.1016/j.mcn.2020.103484; Kueh SLL, 2008, CLIN EXP PHARMACOL P, V35, P207, DOI 10.1111/j.1440-1681.2007.04816.x; Kueh SLL, 2011, NEUROBIOL DIS, V43, P558, DOI 10.1016/j.nbd.2011.05.002; KUNKEL LM, 1985, P NATL ACAD SCI USA, V82, P4778, DOI 10.1073/pnas.82.14.4778; Kwak D., 2020, INT J ENV RES PUBLIC, V17, P1; Li JY, 2012, NEUROSCI LETT, V531, P52, DOI 10.1016/j.neulet.2012.10.014; Li M, 2005, ACTA PHARMACOL SIN, V26, P192, DOI 10.1111/j.1745-7254.2005.00522.x; LINDA H, 1992, EXP BRAIN RES, V91, P284; LU X, 1994, BRAIN RES, V652, P174, DOI 10.1016/0006-8993(94)90335-2; MAYHEW TM, 1984, J ANAT, V139, P45; MCDOUALL RM, 1990, J NEUROL SCI, V99, P199, DOI 10.1016/0022-510X(90)90156-H; Meymandi MS, 2017, INFLAMMOPHARMACOLOGY, V25, P237, DOI 10.1007/s10787-017-0325-4; MIRA JC, 1979, J ANAT, V129, P77; NAGEL A, 1990, MUSCLE NERVE, V13, P742, DOI 10.1002/mus.880130813; Pane M, 2013, NEUROMUSCULAR DISORD, V23, P313, DOI 10.1016/j.nmd.2013.01.011; Patel AM, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0535-1; Pearce JMS, 2005, EUR NEUROL, V54, P46, DOI 10.1159/000087386; Personius KE, 2005, MUSCLE NERVE, V32, P656, DOI 10.1002/mus.20405; Piehl F, 1998, EXP BRAIN RES, V119, P191, DOI 10.1007/s002210050333; RASMINSKY M, 1978, BRAIN RES, V143, P71, DOI 10.1016/0006-8993(78)90753-9; RAY PN, 1985, NATURE, V318, P672, DOI 10.1038/318672a0; Razzoli M, 2020, EBIOMEDICINE, V55, DOI 10.1016/j.ebiom.2020.102700; Krishnan VS, 2020, MOL CELL NEUROSCI, V108, DOI 10.1016/j.mcn.2020.103549; Schopf CL., 2021, P NATL ACAD SCI USA, V118, P1; SHORER Z, 1995, J CHILD NEUROL, V10, P472, DOI 10.1177/088307389501000610; Silva GAA, 2014, BRAIN BEHAV, V4, P925, DOI 10.1002/brb3.276; Simoes GF, 2010, NEUROPATH APPL NEURO, V36, P55, DOI 10.1111/j.1365-2990.2009.01033.x; Simoes GF, 2014, BRAIN BEHAV, V4, P738, DOI 10.1002/brb3.250; SMITH RS, 1970, AM J PHYSIOL, V219, P1256, DOI 10.1152/ajplegacy.1970.219.5.1256; Snow WM, 2013, NEUROSCI BIOBEHAV R, V37, P743, DOI 10.1016/j.neubiorev.2013.03.016; Sorci G, 2013, BBA-MOL CELL RES, V1833, P101, DOI 10.1016/j.bbamcr.2012.10.021; Spencer MJ, 2001, CLIN IMMUNOL, V98, P235, DOI 10.1006/clim.2000.4966; Stay TL, 2020, DIS MODEL MECH, V13, DOI 10.1242/dmm.040840; Stirling DP, 2010, TRENDS MOL MED, V16, P160, DOI 10.1016/j.molmed.2010.02.002; Sun CM, 2020, GENES-BASEL, V11, DOI 10.3390/genes11080837; SUNADA Y, 1995, HUM MOL GENET, V4, P1055, DOI 10.1093/hmg/4.6.1055; Tassone DM, 2007, CLIN THER, V29, P26, DOI 10.1016/j.clinthera.2007.01.013; Tedeschi A, 2016, NEURON, V92, P419, DOI 10.1016/j.neuron.2016.09.026; Tierney M, 2016, MUSCLE NERVE, V54, P763, DOI 10.1002/mus.25115; TORRES LFB, 1987, BRAIN, V110, P269, DOI 10.1093/brain/110.2.269; Venugopal V., 2021, DUCHENNE MUSCULAR DY; Vidal CJ, 2013, CHEM-BIOL INTERACT, V203, P330, DOI 10.1016/j.cbi.2012.08.001; XIN L, 1990, BRAIN RES, V510, P144, DOI 10.1016/0006-8993(90)90741-S; Yu WM, 2007, MOL NEUROBIOL, V35, P288, DOI 10.1007/s12035-007-0026-x	65	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22511	10.1096/fj.202200411RR	http://dx.doi.org/10.1096/fj.202200411RR			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3X8TC	35998000				2022-12-26	WOS:000843305900001
J	Murata, M; Noda, K; Kase, S; Hase, K; Wu, D; Ando, R; Ishida, S				Murata, Miyuki; Noda, Kousuke; Kase, Satoru; Hase, Keitaro; Wu, Di; Ando, Ryo; Ishida, Susumu			Placental growth factor stabilizes VEGF receptor-2 protein in retinal pigment epithelial cells by downregulating glycogen synthase kinase 3 activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURVIVAL FACTOR; MACULAR DEGENERATION; ANGIOGENESIS; EXPRESSION	Placental growth factor (PlGF) belongs to the vascular endothelial growth factor (VEGF) family of proteins that participate in angiogenesis and vasculogenesis. Anti-VEGF therapy has become the standard treatment for ocular angiogenic disorders in ophthalmological practice. However, there is emerging evidence that anti-VEGF treatment may increase the risk of atrophy of the retinal pigment epithelium (RPE), which is important for the homeostasis of retinal tissue. Whereas the cytoprotective role of VEGF family molecules, particularly that of VEGF A (VEGFA) through its receptor VEGF receptor-2 (VEGFR-2), has been recognized, the physiological role of PlGF in the retina is still unknown. In this study, we explored the role of PlGF in the RPE using PlGF-knockdown RPE cells generated by retrovirus-based PlGF-shRNA transduction. We show that VEGFA reduced apoptosis induced by serum starvation in RPE cells, whereas the antiapoptotic effect of VEGFA was abrogated by VEGFR-2 knockdown. Furthermore, PlGF knockdown increased serum starvation-induced cell apoptosis and unexpectedly reduced the protein level of VEGFR-2 in the RPE. The antiapoptotic effect of VEGFA was also diminished in PlGF-knockdown RPE cells. In addition, we found that degradation of VEGFR-2 in RPE cells and inactivated by PlGF via AKT phosphorylation. Overall, the present data inactivation.	[Murata, Miyuki; Noda, Kousuke; Kase, Satoru; Hase, Keitaro; Wu, Di; Ishida, Susumu] Hokkaido Univ, Lab Ocular Cell Biol & Visual Sci, Sapporo, Japan; [Murata, Miyuki; Noda, Kousuke; Kase, Satoru; Hase, Keitaro; Wu, Di; Ando, Ryo; Ishida, Susumu] Hokkaido Univ, Fac Med, Dept Ophthalmol, Sapporo, Japan; [Murata, Miyuki; Noda, Kousuke; Kase, Satoru; Hase, Keitaro; Wu, Di; Ando, Ryo; Ishida, Susumu] Hokkaido Univ, Grad Sch Med, Sapporo, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Noda, K (corresponding author), Hokkaido Univ, Lab Ocular Cell Biol & Visual Sci, Sapporo, Japan.; Noda, K (corresponding author), Hokkaido Univ, Fac Med, Dept Ophthalmol, Sapporo, Japan.; Noda, K (corresponding author), Hokkaido Univ, Grad Sch Med, Sapporo, Japan.	nodako@med.hokudai.ac.jp		Ando, Ryo/0000-0001-9937-6363	Japan Society for the Promotion of Science [18K16915, 21K09667, 21H03091, 20H03837]; Novartis Pharma K.K. (Tokyo,Japan)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Novartis Pharma K.K. (Tokyo,Japan)	We thank Ikuyo Hirose and Shiho Yoshida(Hokkaido University) for their technical assistance. This study was supported by Grant-in-Aid for Young Scientists (grant no.:18K16915), Grant-in-Aid for Scientific Research (C) (grant no.: 21K09667), Grant-in-Aid for Scientific Research (B) (grant no.:21H03091), and Grant-in-Aid for Scientific Research (B) (grant no.: 20H03837) from the Japan Society for the Promotion of Science. This study was funded by Novartis Pharma K.K. (Tokyo,Japan).	Ablonczy Z, 2007, EXP EYE RES, V85, P762, DOI 10.1016/j.exer.2007.08.010; Adini A, 2002, CANCER RES, V62, P2749; Akrami H, 2019, J CELL BIOCHEM, V120, P3268, DOI 10.1002/jcb.27593; Akrami H, 2011, GRAEF ARCH CLIN EXP, V249, P537, DOI 10.1007/s00417-010-1567-7; Albonici L, 2009, INT J IMMUNOPATH PH, V22, P389, DOI 10.1177/039463200902200216; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Bharti K, 2011, PIGM CELL MELANOMA R, V24, P21, DOI 10.1111/j.1755-148X.2010.00772.x; Byeon SH, 2010, INVEST OPHTH VIS SCI, V51, P1190, DOI 10.1167/iovs.09-4144; Cai J, 2003, DIABETES, V52, P2959, DOI 10.2337/diabetes.52.12.2959; Cao YH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.259re1; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Ford KM, 2011, INVEST OPHTH VIS SCI, V52, P9478, DOI 10.1167/iovs.11-8353; Foxton RH, 2013, AM J PATHOL, V182, P1379, DOI 10.1016/j.ajpath.2012.12.032; Freitas-Andrade M, 2008, J NEUROCHEM, V107, P756, DOI 10.1111/j.1471-4159.2008.05660.x; Hata M, 2014, INVEST OPHTH VIS SCI, V55, P7874, DOI 10.1167/iovs.14-14610; Hollborn M, 2006, GRAEF ARCH CLIN EXP, V244, P732, DOI 10.1007/s00417-005-0154-9; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Kuroda Y, 2016, AM J OPHTHALMOL, V161, P94, DOI 10.1016/j.ajo.2015.09.032; McCubrey JA, 2016, BBA-MOL CELL RES, V1863, P2942, DOI 10.1016/j.bbamcr.2016.09.004; Miyamoto N, 2007, DIABETOLOGIA, V50, P461, DOI 10.1007/s00125-006-0539-2; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Odorisio T, 2002, J CELL SCI, V115, P2559; Oura H, 2003, BLOOD, V101, P560, DOI 10.1182/blood-2002-05-1516; PLYTE SE, 1992, BIOCHIM BIOPHYS ACTA, V1114, P147, DOI 10.1016/0304-419X(92)90012-N; Ribatti D, 2008, ANGIOGENESIS, V11, P215, DOI 10.1007/s10456-008-9114-4; Rofagha S, 2013, OPHTHALMOLOGY, V120, P2292, DOI 10.1016/j.ophtha.2013.03.046; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Van Bergen T, 2019, PROG RETIN EYE RES, V69, P116, DOI 10.1016/j.preteyeres.2018.10.006; Wu W, 2016, INT J MOL MED, V37, P911, DOI 10.3892/ijmm.2016.2493; Yang W, 2003, J REPROD IMMUNOL, V60, P53, DOI 10.1016/S0165-0378(03)00082-2	31	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102378	10.1016/j.jbc.2022.102378	http://dx.doi.org/10.1016/j.jbc.2022.102378			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4V3XX	35970387	gold, Green Published			2022-12-26	WOS:000859414300009
J	Yurgel, SN; Johnson, SA; Rice, J; Sa, N; Bailes, C; Baumgartner, J; Pitzer, JE; Roop, RM; Roje, S				Yurgel, Svetlana N.; Johnson, Skylar A.; Rice, Jennifer; Sa, Na; Bailes, Clayton; Baumgartner, John; Pitzer, Josh E.; Roop, R. Martin I. I. I. I.; Roje, Sanja			A novel formamidase is required for riboflavin biosynthesis in invasive bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINORHIZOBIUM; IDENTIFICATION; LUMICHROME; TRANSPORT; VECTORS; REVEALS; PATHWAY; CLONING	Biosynthesis of riboflavin (RF), the precursor of the redox cofactors FMN and FAD, was thought to be well understood in bacteria, with all the pathway enzymes presumed to be known and essential. Our previous research has challenged this view by showing that, in the bacterium Sinorhizobium meliloti, deletion of the ribBA gene encoding the enzyme that catalyzes the initial steps on the RF biosynthesis pathway only causes a reduction in flavin secretion rather than RF auxotrophy. This finding led us to hypothesize that RibBA participates in the biosynthesis of flavins destined for secretion, whereas S. meliloti has another enzyme that performs this function for internal cellular metabolism. Here, we identify and biochemically characterize a novel formamidase (SMc02977) involved in the production of RF for intracellular functions in S. meliloti. This catalyst, which we named Sm-BrbF, releases formate from the early RF precursor 2-amino-5-formylamino-6-ribosylamino-4(3H)-pyrimidinone 5'-phosphate to yield 2,5-diamino-6-ribosylamino-4(3H)-pyrimidinone 5'-phosphate. We show that homologs of this enzyme are present in many bacteria, are highly abundant in the Rhizobiales order, and that sequence homologs from Brucella abortus and Liberobacter solanacearum complement the RF auxotrophy of the Sm1021 Delta SMc02977 mutant. Furthermore, we show that the B. abortus enzyme (Bab2_0247, Ba-BrbF) is also an 2-amino-5-formylamino-6-ribosylamino-4(3H)-pyrimidinone 5'-phosphate formamidase, and that the bab2_0247 mutant is a RF auxotroph exhibiting a lower level of intracellular infection than the wildtype strain. Finally, we show that Sm-BrbF and Ba-BrbF directly interact with other RF biosynthesis pathway enzymes. Together, our results provide novel insight into the intricacies of RF biosynthesis in bacteria.	[Yurgel, Svetlana N.] USDA, Grain Legume Genet & Physiol Res Unit, ARS, Prosser, WA 99350 USA; [Johnson, Skylar A.; Rice, Jennifer; Sa, Na; Bailes, Clayton; Roje, Sanja] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Baumgartner, John; Pitzer, Josh E.; Roop, R. Martin I. I. I. I.] East Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC USA	United States Department of Agriculture (USDA); Washington State University; University of North Carolina; East Carolina University	Yurgel, SN (corresponding author), USDA, Grain Legume Genet & Physiol Res Unit, ARS, Prosser, WA 99350 USA.	svetlana.yurgel@usad.gov		Pitzer, Joshua/0000-0002-6915-4628; Johnson, Skylar/0000-0002-8393-4452	Natural Sciences and Engineering Research Council of Canada [EGP 485260]; USDA ARS Project [2090-21000-003-00D]; National Institute of Allergy and Infectious Disease [AI112745]; USDA NIFA Hatch grant [1015621]; Emerging Research Issues Internal Competitive grant from the Agricultural Research Center at Washington State University, College of Agricultural, Human, and Natural Resource Sciences; Biologically-Intensive Agriculture and Organic Farming (BIOAg) Internal Competitive grant from The Center for Sustaining Agriculture and Natural Resources at Washington State University	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); USDA ARS Project; National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); USDA NIFA Hatch grant; Emerging Research Issues Internal Competitive grant from the Agricultural Research Center at Washington State University, College of Agricultural, Human, and Natural Resource Sciences; Biologically-Intensive Agriculture and Organic Farming (BIOAg) Internal Competitive grant from The Center for Sustaining Agriculture and Natural Resources at Washington State University	This work was supported in part, with an Emerging Research Issues Internal Competitive grant from the Agricultural Research Center at Washington State University, College of Agricultural, Human, and Natural Resource Sciences; Biologically-Intensive Agriculture and Organic Farming (BIOAg) Internal Competitive grant from The Center for Sustaining Agriculture and Natural Resources at Washington State University; and Natural Sciences and Engineering Research Council of Canada grant EGP 485260; and USDA ARS Project 2090-21000-003-00D to S. N. Y. and also grant (AI112745) from the National Institute of Allergy and Infectious Disease to R. M. R. and USDA NIFA Hatch grant 1015621 to S. R.	Abbas CA, 2011, MICROBIOL MOL BIOL R, V75, P321, DOI 10.1128/MMBR.00030-10; Garcia-Angulo VA, 2017, CRIT REV MICROBIOL, V43, P196, DOI 10.1080/1040841X.2016.1192578; Den Herder G, 2009, CURR OPIN PLANT BIOL, V12, P491, DOI 10.1016/j.pbi.2009.05.010; ELZER PH, 1994, INFECT IMMUN, V62, P4135, DOI 10.1128/IAI.62.10.4135-4139.1994; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; FINAN TM, 1984, J BACTERIOL, V159, P120, DOI 10.1128/JB.159.1.120-124.1984; Fischer M, 2011, CHEMBIOCHEM, V12, P670, DOI 10.1002/cbic.201000681; Frelin O, 2015, BIOCHEM J, V466, P137, DOI 10.1042/BJ20141237; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Gouws LM, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00120; Graham DE, 2002, BIOCHEMISTRY-US, V41, P15074, DOI 10.1021/bi0268798; Griffitts JS, 2008, MOL MICROBIOL, V67, P1292, DOI 10.1111/j.1365-2958.2008.06123.x; Grochowski LL, 2009, BIOCHEMISTRY-US, V48, P4181, DOI 10.1021/bi802341p; HUANG HC, 1992, J BACTERIOL, V174, P6878, DOI 10.1128/JB.174.21.6878-6885.1992; Karimova G, 2000, INT J MED MICROBIOL, V290, P441; Knobloch JKM, 2003, APPL ENVIRON MICROB, V69, P5812, DOI 10.1128/AEM.69.10.5812-5818.2003; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Maerk M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-192; Matiru VN, 2005, NEW PHYTOL, V166, P439, DOI 10.1111/j.1469-8137.2005.01344.x; Phillips DA, 1999, P NATL ACAD SCI USA, V96, P12275, DOI 10.1073/pnas.96.22.12275; Pholo M, 2018, PLANTA, V248, P477, DOI 10.1007/s00425-018-2916-8; Ren J, 2005, J BIOL CHEM, V280, P36912, DOI 10.1074/jbc.M507725200; Roop RM, 2004, MOL MICROBIOL, V52, P621, DOI 10.1111/j.1365-2958.2004.04017.x; Bonomi HR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009435; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SIMON R, 1989, GENE, V80, P161, DOI 10.1016/0378-1119(89)90262-X; Singh M, 2013, ACTA CRYSTALLOGR D, V69, P1633, DOI 10.1107/S0907444913011402; SOMERVILLE JE, 1983, J BACTERIOL, V156, P168, DOI 10.1128/JB.156.1.168-176.1983; SPRATT BG, 1986, GENE, V41, P337, DOI 10.1016/0378-1119(86)90117-4; Swartz TE, 2007, SCIENCE, V317, P1090, DOI 10.1126/science.1144306; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Xie ZM, 2012, J CHROMATOGR SCI, V50, P464, DOI 10.1093/chromsci/bms023; Yang GP, 2002, MOL PLANT MICROBE IN, V15, P456, DOI 10.1094/MPMI.2002.15.5.456; Yoshimoto T, 2004, J MOL BIOL, V337, P399, DOI 10.1016/j.jmb.2004.01.022; Yurgel SN, 2005, J BACTERIOL, V187, P1161, DOI 10.1128/JB.187.3.1161-1172.2005; Yurgel SN, 2007, MICROBIOL-SGM, V153, P399, DOI 10.1099/mic.0.2006/002634-0; Yurgel SN, 2014, MOL PLANT MICROBE IN, V27, P437, DOI 10.1094/MPMI-11-13-0338-R; Zhao YJJ, 2009, J ORG CHEM, V74, P5297, DOI 10.1021/jo900768c	39	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102377	10.1016/j.jbc.2022.102377	http://dx.doi.org/10.1016/j.jbc.2022.102377			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5B1GH	35970388	gold, Green Published			2022-12-26	WOS:000863323200006
J	Carron, R; Blanc, N; Brigaud, E				Carron, Robin; Blanc, Nathalie; Brigaud, Emmanuelle			Contextualizing sacrificial dilemmas within Covid-19 for the study of moral judgment	PLOS ONE			English	Article							REAL-LIFE; PERCEIVED REALISM; TROLLEY PROBLEMS; DECISION-MAKING; TELEVISION; BEHAVIOR	"Sacrificial dilemmas" are the scenarios typically used to study moral judgment and human morality. However, these dilemmas have been criticized regarding their lack of ecological validity. The COVID-19 pandemic offers a relevant context to further examine individuals' moral judgment and choice of action with more realistic sacrificial dilemmas. Using this context, the purpose of the present study is to investigate how moral responses are influenced by the contextualization of the dilemma (i.e., contextualized or not within the Covid-19 pandemic). By comparing two versions of one dilemma, Experiment 1 revealed that the more realistic version (the one contextualized within the Covid-19 pandemic) did not elicit more utilitarian responses than the less realistic version (the one not contextualized within the Covid-19 pandemic). In Experiment 2, we examined more specifically whether both the perceived realism of the dilemma and the plausibility of a utilitarian action influence moral responses. Results confirmed that the contextualization of the dilemma does not make any difference in moral responses. However, the plausibility of an action appears to exert an influence on the choice of action. Indeed, participants were more inclined to choose the utilitarian action in the plausible action versions than in the implausible action versions of the dilemma. Overall, these results shed light on the importance for future research of using mundane and dramatic realistic dilemmas displaying full information regarding a sacrificial action and its consequences.	[Carron, Robin; Blanc, Nathalie; Brigaud, Emmanuelle] Univ Paul Valery Montpellier 3, Epsylon EA 4556, Dept Psychol, Montpellier, France	Universite de Montpellier; Universite Paul-Valery	Blanc, N (corresponding author), Univ Paul Valery Montpellier 3, Epsylon EA 4556, Dept Psychol, Montpellier, France.	nathalie.blanc@univ-montp3.fr		BRIGAUD, Emmanuelle/0000-0002-3476-3239; Blanc, Nathalie/0000-0003-1327-0280				Aronson E., 1998, HDB SOCIAL PSYCHOL, P1; Bauman CW, 2014, SOC PERSONAL PSYCHOL, V8, P536, DOI 10.1111/spc3.12131; Bostyn DH, 2018, PSYCHOL SCI, V29, P1084, DOI 10.1177/0956797617752640; Buckwalter W, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240651; Busselle R, 2008, COMMUN THEOR, V18, P255, DOI 10.1111/j.1468-2885.2008.00322.x; Cho H, 2014, COMMUN RES, V41, P828, DOI 10.1177/0093650212450585; Christen M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247273; Christensen JF, 2012, NEUROSCI BIOBEHAV R, V36, P1249, DOI 10.1016/j.neubiorev.2012.02.008; Colman AM, 2019, PSYCHOL SCI, V30, P1386, DOI 10.1177/0956797619827880; Dubljevic V., 2014, AJOB NEUROSCIENCE, V5, P3, DOI [10.1080/21507740.2014.939381, DOI 10.1080/21507740.2014.939381]; Dubljevic V, 2020, SCI ENG ETHICS, V26, P2461, DOI 10.1007/s11948-020-00242-0; Dubljevic V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206750; Dubljevic V, 2017, BIOETHICS, V31, P338, DOI 10.1111/bioe.12355; Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114; Foot P, 1978, VIRTUES VICES OTHER; Francis KB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170133; GERBNER G, 1976, J COMMUN, V26, P173, DOI 10.1111/j.1460-2466.1976.tb01397.x; Gold N, 2015, J ECON PSYCHOL, V47, P50, DOI 10.1016/j.joep.2015.01.001; Gold N, 2014, JUDGM DECIS MAK, V9, P65; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Greene JD, 2008, COGNITION, V107, P1144, DOI 10.1016/j.cognition.2007.11.004; Greene JD, 2009, COGNITION, V111, P364, DOI 10.1016/j.cognition.2009.02.001; Hall A, 2003, J COMMUN, V53, P624, DOI 10.1093/joc/53.4.624; Hall A., 2017, INT ENCY MEDIA EFFEC, P1; Huang KR, 2021, JUDGM DECIS MAK, V16, P1; Kahane G, 2015, SOC NEUROSCI-UK, V10, P551, DOI 10.1080/17470919.2015.1023400; Kneer M, 2022, COGNITION EMOTION, V36, P137, DOI 10.1080/02699931.2021.1964940; Korner A, 2019, J EXP SOC PSYCHOL, V84, DOI 10.1016/j.jesp.2019.103834; Kusev P, 2016, PSYCHON B REV, V23, P1961, DOI 10.3758/s13423-016-1029-2; Lallart E, 2014, PSYCHOLOGIE CLINIQUE, P82, DOI DOI 10.1051/PSYC/201437082; Loomis JM, 1999, BEHAV RES METH INS C, V31, P557, DOI 10.3758/BF03200735; McDonald MM, 2017, EVOL HUM BEHAV, V38, P770, DOI 10.1016/j.evolhumbehav.2017.06.001; McHugh C, 2022, PERSPECT PSYCHOL SCI, V17, P131, DOI 10.1177/1745691621990636; Navarrete CD, 2012, EMOTION, V12, P364, DOI 10.1037/a0025561; Niforatos E, 2020, PROCEEDINGS OF THE 2020 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI'20), DOI 10.1145/3313831.3376788; Patil I, 2014, SOC NEUROSCI-UK, V9, P94, DOI 10.1080/17470919.2013.870091; Pletti C, 2017, BRIT J PSYCHOL, V108, P351, DOI 10.1111/bjop.12205; POTTER WJ, 1988, J BROADCAST ELECTRON, V32, P23, DOI 10.1080/08838158809386682; Robert R, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00702-7; Rovira A, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.059.2009; Savulescu J, 2020, BIOETHICS, V34, P620, DOI 10.1111/bioe.12771; Schein C, 2020, PERSPECT PSYCHOL SCI, V15, P207, DOI 10.1177/1745691620904083; Shortland N, 2020, PSYCHOL TRAUMA-US, V12, pS128, DOI 10.1037/tra0000612; Shou YY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233127; Shou YY, 2017, JUDGM DECIS MAK, V12, P481; Skulmowski A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00426; Slater M, 2016, FRONT ROBOT AI, V3, DOI 10.3389/frobt.2016.00074; Slater M, 2009, PHILOS T R SOC B, V364, P3549, DOI 10.1098/rstb.2009.0138; Tassy S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00250; Terbeck S, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18158039; THOMSON JJ, 1976, MONIST, V59, P205; Watkins HM, 2019, EUR J SOC PSYCHOL, V49, P447, DOI 10.1002/ejsp.2393; Weber S, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.628298; Wilkinson D, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-045593	55	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0273521	10.1371/journal.pone.0273521	http://dx.doi.org/10.1371/journal.pone.0273521			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994508	Green Published, gold			2022-12-26	WOS:000877093400055
J	Celeste-Villalvir, A; Wilkerson, JM; Markham, C; Rodriguez, L; Schick, V				Celeste-Villalvir, Alane; Wilkerson, J. Michael; Markham, Christine; Rodriguez, Lourdes; Schick, Vanessa			A qualitative investigation of organizational challenges and facilitators to screening individuals experiencing homelessness for hepatitis C virus (HCV) in Houston, Texas	PLOS ONE			English	Article							UNITED-STATES; B-VIRUS; CARE; ADULTS; COST	Background Individuals experiencing homelessness may be at a disproportionately high risk for hepatitis C (HCV) because they may be more likely to engage in HCV risk behaviors. Community organizations that provide services to these vulnerable individuals can effectively screen, diagnose, and navigate them into HCV care. However, screening people experiencing homelessness for HCV at such organizations is limited by various challenges that remain understudied, including budgetary considerations and strategies to improve teamwork and communication. Accordingly, this study investigated the organizational challenges and facilitators to HCV screening of individuals experiencing homelessness as reported by homeless services providers. Methods Staff (N = 21) at two community organizations in Houston, Texas, completed an interviewer-administered survey and a semi-structured interview in August 2020 to assess the challenges and facilitators to screening people experiencing homelessness for HCV. Interviews were coded, and a thematic analysis was conducted to identify challenges as well as facilitators to HCV screening among individuals experiencing homelessness. Results Almost half of participants were employed in social services (42.86%; n = 9), while the remainder were employed in management/administration and health services. Barriers to HCV screening included funding, logistics, and resource-related challenges; and limited communication and collaboration around HCV screening. Facilitators to HCV screening included providing HCV education and training for all staff; and incentivizing, formalizing, and funding HCV screening. Conclusions Community organizations can help minimize barriers to HCV screening among individuals experiencing homelessness by providing staff with training specific to HCV, client education around HCV and the screening process, and providing clients with incentives for participation, as well as by maximizing community and clinic partnerships to provide linkage to care and services to this high-risk population.	[Celeste-Villalvir, Alane; Schick, Vanessa] Univ Texas Houston Hlth Sci Ctr Houston UTHlth, Sch Publ Hlth, Div Management Policy & Community Hlth, Houston, TX 77030 USA; [Wilkerson, J. Michael; Markham, Christine] Univ Texas Houston Hlth Sci Ctr Houston UTHlth, Sch Publ Hlth, Div Hlth Promot & Behav Sci, Houston, TX USA; [Wilkerson, J. Michael; Markham, Christine] Univ Texas Houston Hlth Sci Ctr Houston UTHlth, Ctr Hlth Promot & Prevent Res, Houston, TX USA; [Rodriguez, Lourdes] St Davids Fdn, Austin, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Celeste-Villalvir, A (corresponding author), Univ Texas Houston Hlth Sci Ctr Houston UTHlth, Sch Publ Hlth, Div Management Policy & Community Hlth, Houston, TX 77030 USA.	alane.k.celestevillalvir@uth.tmc.edu		Rodriguez, Lourdes/0000-0003-4158-1262	Robert Wood Johnson Foundation's Health Policy Research Scholars (HPRS) program	Robert Wood Johnson Foundation's Health Policy Research Scholars (HPRS) program	ACV received a dissertation award from The Robert Wood Johnson Foundation's Health Policy Research Scholars (HPRS) program (https://healthpolicyresearch-scholars.org/).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], HEPATITIS C; [Anonymous], LIVER CANC RISK FACT; [Anonymous], HEPATITIS C REFLEX T; Baggett TP, 2010, AM J PUBLIC HEALTH, V100, P1326, DOI 10.2105/AJPH.2009.180109; Cole AM, 2019, J PRIM CARE COMMUNIT, V10, DOI 10.1177/2150132719884298; Dan C., 2019, NEW STATE LEVEL MAPS; Fusch PI, 2015, QUAL REP, V20, P1408; Fuster D, 2019, J COMMUN HEALTH, V44, P1044, DOI 10.1007/s10900-019-00679-w; Gowda Charitha, 2018, Curr Hepatol Rep, V17, P111, DOI 10.1007/s11901-018-0394-x; Harney BL, 2019, INT J DRUG POLICY, V72, P195, DOI 10.1016/j.drugpo.2019.02.012; Hodges J, 2019, J COMMUN HEALTH, V44, P169, DOI 10.1007/s10900-018-0568-z; Hofmeister MG, 2019, HEPATOLOGY, V69, P1020, DOI 10.1002/hep.30297; IBM Corp, 2017, IBM SPSS STAT V 25; Irvin R., 2016, J COMMUNITY MED HLTH, V6, DOI [10.4172/2161-0711.1000431, DOI 10.4172/2161-0711.1000431]; Kim HS, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa191; Kim HS, 2019, J VIRAL HEPATITIS, V26, P596, DOI 10.1111/jvh.13060; Masson CL, 2013, AM J PUBLIC HEALTH, V103, pE81, DOI 10.2105/AJPH.2013.301458; Microsoft Corporation, MICR EXC; Noska AJ, 2017, CLIN INFECT DIS, V65, P252, DOI 10.1093/cid/cix295; Page K, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4102-5; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Razavi H, 2013, HEPATOLOGY, V57, P2164, DOI 10.1002/hep.26218; Reader SW, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa322; Rich KM, 2018, CURR HIV-AIDS REP, V15, P266, DOI 10.1007/s11904-018-0396-x; Ryerson AB, 2020, MMWR-MORBID MORTAL W, V69, P399, DOI 10.15585/mmwr.mm6914a2; Schackman BR, 2015, ADDICTION, V110, P129, DOI 10.1111/add.12754; Schillie S, 2020, MMWR RECOMM REP, V69, P1, DOI 10.15585/mmwr.rr6902a1; Scientific Software Development GmbH, 2019, ATLAS TI V8; Socias ME, 2019, INT J DRUG POLICY, V72, P146, DOI 10.1016/j.drugpo.2019.05.023; Terrault Norah A, 2019, F1000Res, V8, DOI 10.12688/f1000research.15892.1; Texas Department of State Health Services, 2014, HEP C TEX; Texas Department of State Health Services, 2018, HEP C; Trooskin SB, 2015, J GEN INTERN MED, V30, P950, DOI 10.1007/s11606-015-3209-6; Weber R.P., 1990, BASIC CONTENT ANAL, V2nd ed., DOI 10.4135/9781412983488; Weick A., 2019, QUALITY IMPROVEMENT	35	0	0	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0273302	10.1371/journal.pone.0273302	http://dx.doi.org/10.1371/journal.pone.0273302			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994438	Green Published, gold			2022-12-26	WOS:000877093400042
J	Wen, Y; Song, PT; Yang, DY; Gao, C				Wen, Ya; Song, Pingting; Yang, Deyong; Gao, Chen			Does governance impact on the financial development-carbon dioxide emissions nexus in G20 countries	PLOS ONE			English	Article							CO2 EMISSIONS; ECONOMIC-GROWTH; ENERGY-CONSUMPTION; TRADE; URBANIZATION; INSTITUTIONS; POPULATION; QUALITY; OUTPUT; ROLES	In the past 40 years, the continuous strengthening of the greenhouse effect has led to a significant increase in the global average temperature. Although people's understanding of climate change has been strengthened, the world has not yet witnessed a significant decline in pollutant emissions; hence it is imperative to get to the root cause. This paper is based on the STIRPAT model framework and uses the panel data of G20 countries over the period 1999-2019 to examine the role of financial development on carbon emissions under good governance. The results show that financial development significantly promotes carbon dioxide emissions, and the impact presents an inverted "U"-shaped trend when the quadratic term of financial development is introduced. Surprisingly, governance quality indicators increase carbon emissions. However, financial development accompanied by good governance suppresses carbon emissions. Moreover, according to the grouped results of developed and developing countries, different nations should adopt differentiated strategies in development finance to implement the carbon emission targets proposed by the G20. In addition, this paper also confirms the existence of the Environmental Kuznets Curve hypothesis. In light of this, policymakers should optimize the quality of governance while shifting their agendas toward environmentally responsible financial practices to promote financial development to improve environmental quality effectively. Furthermore, strengthen international cooperation, enhance public environmental protection concepts, and take joint actions to achieve low-carbon and win-win results.	[Wen, Ya; Yang, Deyong] Beijing Technol & Business Univ, Sch Econ, Beijing, Peoples R China; [Song, Pingting] Harbin Univ Commerce, Accounting Sch, Harbin, Peoples R China; [Gao, Chen] Cent Univ Finance & Econ, China Econ & Management Acad, Beijing, Peoples R China	Beijing Technology & Business University; Harbin University of Commerce; Central University of Finance & Economics	Gao, C (corresponding author), Cent Univ Finance & Econ, China Econ & Management Acad, Beijing, Peoples R China.	gaoc9206@163.com		Gao, Chen/0000-0002-7732-5909; Wen, Ya/0000-0002-7180-9777				Abbasi MA, 2020, ENVIRON SCI POLLUT R, V27, P18029, DOI 10.1007/s11356-020-08262-w; Ahmed Z, 2021, ECOL INDIC, V121, DOI 10.1016/j.ecolind.2020.107060; Asongu SA, 2021, ENERG EXPLOR EXPLOIT, V39, P444, DOI 10.1177/0144598719900657; Asongu SA, 2020, ENERG EXPLOR EXPLOIT, V38, P18, DOI 10.1177/0144598719835594; Azam M, 2016, ENVIRON SCI POLLUT R, V23, P6376, DOI 10.1007/s11356-015-5817-4; Bekhet HA, 2017, RENEW SUST ENERG REV, V70, P117, DOI 10.1016/j.rser.2016.11.089; Bello A.K., 2010, PAKISTAN J SOCIAL SC, V7, P325, DOI DOI 10.3923/PJSSCI.2010.325.329; Ben Youssef A, 2016, ENERG ECON, V60, P266, DOI 10.1016/j.eneco.2016.10.005; Bhattacharya M, 2017, RENEW ENERG, V111, P157, DOI 10.1016/j.renene.2017.03.102; Braune E, 2020, TECHNOL FORECAST SOC, V154, DOI 10.1016/j.techfore.2020.119934; Cai W, 2019, SCI TOTAL ENVIRON, V665, P23, DOI 10.1016/j.scitotenv.2019.02.069; Caselles A, 2021, INT J GLOBAL WARM, V23, P91, DOI 10.1504/IJGW.2021.112490; Cowan WN, 2014, ENERG POLICY, V66, P359, DOI 10.1016/j.enpol.2013.10.081; Danish, 2019, STRUCT CHANGE ECON D, V51, P119, DOI 10.1016/j.strueco.2019.08.007; Dash DP, 2020, COGENT ECON FINANC, V8, DOI 10.1080/23322039.2020.1742023; Dogan E, 2016, ENVIRON SCI POLLUT R, V23, P1203, DOI 10.1007/s11356-015-5323-8; EHRLICH PR, 1971, SCIENCE, V171, P1212, DOI 10.1126/science.171.3977.1212; Erdogan S, 2020, J ENVIRON MANAGE, V267, DOI 10.1016/j.jenvman.2020.110637; Farooq U, 2022, ENVIRON SCI POLLUT R, V29, P7532, DOI 10.1007/s11356-021-16115-3; Favero LP, 2022, INT J GLOBAL WARM, V26, P38, DOI 10.1504/IJGW.2022.120067; GANI AZMAT, 2012, Journal of Economic Development, V37, P77; Gok A, 2021, ENVIRON SCI POLLUT R, V28, P32995, DOI 10.1007/s11356-021-12903-z; Gok A, 2020, ENVIRON SCI POLLUT R, V27, P11618, DOI 10.1007/s11356-020-07641-7; Guney T, 2022, RENEW ENERG, V184, P791, DOI 10.1016/j.renene.2021.11.124; Le HP, 2020, ENVIRON SCI POLLUT R, V27, P22680, DOI 10.1007/s11356-020-08812-2; HOLTZEAKIN D, 1995, J PUBLIC ECON, V57, P85, DOI 10.1016/0047-2727(94)01449-X; Huang YF, 2010, WORLD DEV, V38, P1667, DOI 10.1016/j.worlddev.2010.04.001; Jiang C, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11195241; Li X., 2019, J FINANC EC RES, V45, P4; Liu XY, 2021, INT J GLOBAL WARM, V25, P100, DOI 10.1504/IJGW.2021.117435; Lu W., 2013, EC RES J, V48, P106; Morrissey O, 2012, WORLD DEV, V40, P437, DOI 10.1016/j.worlddev.2011.07.004; Muhammad S, 2020, ENERGY, V196, DOI 10.1016/j.energy.2020.117102; Omri A, 2021, ENVIRON SCI POLLUT R, V28, P47503, DOI 10.1007/s11356-021-14014-1; Omri A, 2020, ENVIRON IMPACT ASSES, V83, DOI 10.1016/j.eiar.2020.106388; Omri A, 2020, J BUS RES, V108, P277, DOI 10.1016/j.jbusres.2019.11.027; Omri A, 2015, ENERG ECON, V48, P242, DOI 10.1016/j.eneco.2015.01.008; Ozturk I, 2013, ENERG ECON, V36, P262, DOI 10.1016/j.eneco.2012.08.025; Riti JS, 2017, J CLEAN PROD, V166, P1448, DOI 10.1016/j.jclepro.2017.08.117; Sadorsky P, 2011, ENERG POLICY, V39, P999, DOI 10.1016/j.enpol.2010.11.034; Saidi K, 2017, ENVIRON SCI POLLUT R, V24, P12748, DOI 10.1007/s11356-016-6303-3; Sarhangi K., 2021, J CONT ISSUES BUS GO, V27, P2790; Saud S, 2020, J CLEAN PROD, V250, DOI 10.1016/j.jclepro.2019.119518; Shahbaz M, 2016, ENERG POLICY, V98, P353, DOI 10.1016/j.enpol.2016.09.002; Shahbaz M, 2013, ECON MODEL, V35, P145, DOI 10.1016/j.econmod.2013.06.037; Shahbaz M, 2013, RENEW SUST ENERG REV, V25, P109, DOI 10.1016/j.rser.2013.04.009; Shen, 2019, EC RES J, V54, P188; Sheng B, 2019, J WORLD EC, V4, P29; Sun CR., 2021, WORLD EC STU, V1, P17, DOI [10.13516/j.cnki.wes.2021.01.002, DOI 10.13516/J.CNKI.WES.2021.01.002]; Tamazian A, 2010, ENERG ECON, V32, P137, DOI 10.1016/j.eneco.2009.04.004; Ulucak ZS, 2020, RESOUR POLICY, V67, DOI 10.1016/j.resourpol.2020.101698; Veganzones MA., 2007, ECON BULL, V5, P1; Wang C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237597; Wang S, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0258147; Wang YA, 2019, NAT HAZARDS, V96, P627, DOI 10.1007/s11069-018-3561-z; Wawrzyniak D, 2020, ECON RES-EKON ISTRAZ, V33, P124, DOI 10.1080/1331677X.2019.1708770; Xiao B., 2015, SOC SCI CHINA, V5, P125; Yan C.-L., 2016, J FINANC RES, V39, P14; Yu Z., 2013, EC MANAG J, V35, P24, DOI [10.19616/j.cnki.bmj.2013.07.005, DOI 10.19616/J.CNKI.BMJ.2013.07.005]; Zhang YJ, 2011, ENERG POLICY, V39, P2197, DOI 10.1016/j.enpol.2011.02.026; Zhao XC, 2022, INT J ENV RES PUB HE, V19, DOI 10.3390/ijerph19052893; Zuo SM, 2022, INT J ENV RES PUB HE, V19, DOI 10.3390/ijerph19010130	62	2	2	7	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0273546	10.1371/journal.pone.0273546	http://dx.doi.org/10.1371/journal.pone.0273546			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994507	gold, Green Published			2022-12-26	WOS:000877093400056
J	Kang, YH; Tucker, SA; Quevedo, SF; Inal, A; Korzenik, JR; Haigis, MC				Kang, Yu Hui; Tucker, Sarah A.; Quevedo, Silvia F.; Inal, Aslihan; Korzenik, Joshua R.; Haigis, Marcia C.			Metabolic analyses reveal dysregulated NAD(+) metabolism and altered mitochondrial state in ulcerative colitis	PLOS ONE			English	Article							CD38; GLYCOHYDROLASE; INFLAMMATION; DYSFUNCTION; EXPRESSION; RESISTANCE; EPITHELIUM; COMPLEX; INJURY	Ulcerative colitis (UC) is a complex, multifactorial disease driven by a dysregulated immune response against host commensal microbes. Despite rapid advances in our understanding of host genomics and transcriptomics, the metabolic changes in UC remain poorly understood. We thus sought to investigate distinguishing metabolic features of the UC colon (14 controls and 19 patients). Metabolomics analyses revealed inflammation state as the primary driver of metabolic variation rather than diagnosis, with multiple metabolites differentially regulated between inflamed and uninflamed tissues. Specifically, inflamed tissues were characterized by reduced levels of nicotinamide adenine dinucleotide (NAD(+)) and enhanced levels of nicotinamide (NAM) and adenosine diphosphate ribose (ADPr). The NAD(+)/NAM ratio, which was reduced in inflamed patients, served as an effective classifier for inflammation in UC. Mitochondria were also structurally altered in UC, with UC patient colonocytes displaying reduced mitochondrial density and number. Together, these findings suggest a link between mitochondrial dysfunction, inflammation, and NAD(+) metabolism in UC.	[Kang, Yu Hui; Tucker, Sarah A.; Inal, Aslihan; Haigis, Marcia C.] Harvard Med Sch, Blavatnik Inst, Dept Cell Biol, Boston, MA 02115 USA; [Kang, Yu Hui] Boston Childrens Hosp, Div Gastroenterol Hepatol & Nutr, Boston, MA USA; [Quevedo, Silvia F.; Korzenik, Joshua R.] Brigham & Womens Hosp, Div Gastroenterol Hepatol & Endoscopy, 75 Francis St, Boston, MA 02115 USA; [Quevedo, Silvia F.; Korzenik, Joshua R.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Kang, Yu Hui] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore; [Inal, Aslihan] Univ Hosp Heidelberg, Inst Pathol, Heidelberg, Germany	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Ruprecht Karls University Heidelberg	Haigis, MC (corresponding author), Harvard Med Sch, Blavatnik Inst, Dept Cell Biol, Boston, MA 02115 USA.	Marcia_haigis@hms.harvard.edu	Kang, Yu Hui/GYA-3690-2022	Kang, Yu Hui/0000-0001-9081-3969	Job's Research Foundation, USA; predoctoral T32 fellowship through the Joslin Diabetes Center [DK07260-042]; NCI [U54-CA225088]; NIDDK [DK127278]	Job's Research Foundation, USA; predoctoral T32 fellowship through the Joslin Diabetes Center; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Y.H.K. was supported by the Job's Research Foundation, USA. S.A.T. was supported by a predoctoral T32 fellowship through the Joslin Diabetes Center (DK07260-042). M.C.H. is supported by NCI grant U54-CA225088 and NIDDK grant DK127278. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa MTP, 2007, FASEB J, V21, P3629, DOI 10.1096/fj.07-8290com; Camacho-Pereira J, 2016, CELL METAB, V23, P1127, DOI 10.1016/j.cmet.2016.05.006; Caruso R, 2014, MUCOSAL IMMUNOL, V7, P1467, DOI 10.1038/mi.2014.35; Colombo G, 2020, J MOL MED, V98, P595, DOI 10.1007/s00109-020-01892-0; Covarrubias AJ, 2021, NAT REV MOL CELL BIO, V22, P119, DOI 10.1038/s41580-020-00313-x; Daniluk U, 2019, INFLAMM BOWEL DIS, V25, P1120, DOI 10.1093/ibd/izy402; de Souza HSP, 2017, NAT REV GASTRO HEPAT, V14, P739, DOI 10.1038/nrgastro.2017.110; Diab J, 2019, METABOLITES, V9, DOI 10.3390/metabo9120291; Dolle C, 2013, FEBS J, V280, P3530, DOI 10.1111/febs.12304; Fang EF, 2014, CELL, V157, P882, DOI 10.1016/j.cell.2014.03.026; Franzosa EA, 2019, NAT MICROBIOL, V4, P293, DOI 10.1038/s41564-018-0306-4; German NJ, 2015, CURR BIOL, V25, pR569, DOI 10.1016/j.cub.2015.05.012; Gerner RR, 2018, GUT, V67, P1813, DOI 10.1136/gutjnl-2017-314241; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Graham DB, 2020, NATURE, V578, P527, DOI 10.1038/s41586-020-2025-2; Haberman Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07841-3; Hogan KA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01187; Hughes ER, 2017, CELL HOST MICROBE, V21, P208, DOI 10.1016/j.chom.2017.01.005; Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Karamanlidis G, 2013, CELL METAB, V18, P239, DOI 10.1016/j.cmet.2013.07.002; Katsyuba E, 2020, NAT METAB, V2, P9, DOI 10.1038/s42255-019-0161-5; Kolho KL, 2017, J CROHNS COLITIS, V11, P321, DOI 10.1093/ecco-jcc/jjw158; Kumar M, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-02174-1; Lahiri A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15614; Larmonier CB, 2016, J BIOL CHEM, V291, P8918, DOI 10.1074/jbc.M116.714386; Litvak Y, 2018, SCIENCE, V362, P1017, DOI 10.1126/science.aat9076; Liu FY, 2017, MOL MED, V23, P272, DOI 10.2119/molmed.2017.00085; Lloyd-Price J, 2019, NATURE, V569, P655, DOI 10.1038/s41586-019-1237-9; Lo Sasso G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103573; Lo Sasso G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102495; Mehta MM, 2017, NAT REV IMMUNOL, V17, P608, DOI 10.1038/nri.2017.66; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Moschen AR, 2007, J IMMUNOL, V178, P1748, DOI 10.4049/jimmunol.178.3.1748; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Muise AM, 2012, GUT, V61, P1028, DOI 10.1136/gutjnl-2011-300078; Ning LG, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/3950628; Pang ZQ, 2020, METABOLITES, V10, DOI 10.3390/metabo10050186; Popoff I, 2002, J PHARMACOL EXP THER, V303, P1145, DOI 10.1124/jpet.102.039768; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; ROEDIGER WEW, 1980, LANCET, V2, P712; Schneider M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126007; Smith SA, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI133371; Srivastava S, 2016, CLIN TRANSL MED, V5, DOI 10.1186/s40169-016-0104-7; Starr AE, 2017, GUT, V66, P1573, DOI 10.1136/gutjnl-2015-310705; Tarrago MG, 2018, CELL METAB, V27, P1081, DOI 10.1016/j.cmet.2018.03.016; van de Donk NWCJ, 2016, IMMUNOL REV, V270, P95, DOI 10.1111/imr.12389; Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang F, 2017, CELL REP, V19, P2331, DOI 10.1016/j.celrep.2017.05.065; Wellman AS, 2017, GASTROENTEROLOGY, V153, P772, DOI 10.1053/j.gastro.2017.05.022; Xia JG, 2010, BIOINFORMATICS, V26, P2342, DOI 10.1093/bioinformatics/btq418; Zhang Y, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-017-0002-0; ZOCCHI E, 1993, BIOCHEM BIOPH RES CO, V196, P1459, DOI 10.1006/bbrc.1993.2416	54	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0273080	10.1371/journal.pone.0273080	http://dx.doi.org/10.1371/journal.pone.0273080			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976971	Green Published, gold			2022-12-26	WOS:000847227000074
J	Tendulkar, KK; Cope, B; Dong, JH; Plumb, TJ; Campbell, WS; Ganti, AK				Tendulkar, Ketki K.; Cope, Brendan; Dong, Jianghu; Plumb, Troy J.; Campbell, W. Scott; Ganti, Apar Kishor			Risk of malignancy in patients with chronic kidney disease	PLOS ONE			English	Article							CANCER; ASSOCIATION; CKD	Background Fifteen percent of US adults have chronic kidney disease (CKD). The effect of CKD on the development of different malignancies is unknown. Understanding the effect of CKD on the risk of development of cancer could have important implications for screening and early detection of cancer in these patients. Methods Adult CKD patients [estimated GFR (eGFR) <60ml/min/1.73m(2)] between January 2001 and December 2020 were identified in this single institution study. Patients were divided into four stages of CKD by eGFR. The incidence of cancer and time to development of the first cancer were identified. Multivariable models were used to compare the overall cancer incidence while considering death as a competing risk event and adjusting for relevant covariates (sex, race, diabetes, hypertension, CAD, smoking or not, BMI, and CKD stages). Separate multivariable models of the incidence of cancers were conducted in each age group. Multivariable Cox models were used to fit the overall death adjusting for relevant covariates. Patients were censored at the conclusion of the study period (December 31, 2020). Statistical analysis was performed with SAS software (version 9.4). Results Of the 13,750 patients with a diagnosis of CKD in this cohort, 2,758 (20.1%) developed a malignancy. The median time to development of cancer following a diagnosis of CKD was 8.5 years. Factors associated with the risk of developing cancer in CKD patients included increasing age, male sex and worsening chronic kidney disease, while diabetes was associated with a lower risk of malignancy. On multivariate analysis, the factors associated with increased mortality in patients who developed cancer included increasing age, diabetes and lower eGFR. Conclusion CKD is an increased risk factor for the development of various malignancies. Age appropriate cancer screening should be aggressively pursued in those with progressive CKD.	[Tendulkar, Ketki K.; Dong, Jianghu; Plumb, Troy J.] Univ Nebraska Med Ctr, Dept Internal Med, Div Nephrol, Omaha, NE 68198 USA; [Cope, Brendan] Univ Nebraska Med Ctr, Dept Internal Med, Div Rheumatol, Omaha, NE USA; [Dong, Jianghu] Univ Nebraska Med Ctr, Coll Publ Hlth, Dept Biostat, Omaha, NE USA; [Campbell, W. Scott] Univ Nebraska Med Ctr, Dept Pathol Microbiol, Omaha, NE USA; [Ganti, Apar Kishor] VA Nebraska Western Iowa Hlth Care Syst, Dept Internal Med, Div Hematol & Oncol, Omaha, NE USA; [Ganti, Apar Kishor] Univ Nebraska Med Ctr, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; University of Nebraska System; University of Nebraska Medical Center	Tendulkar, KK (corresponding author), Univ Nebraska Med Ctr, Dept Internal Med, Div Nephrol, Omaha, NE 68198 USA.	ktendulkar@unmc.edu						Andersen KM, 2022, LANCET RHEUMATOL, V4, pE33, DOI 10.1016/S2665-9913(21)00325-8; Anderson JL, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.7429; Bach LA, 2015, AM J KIDNEY DIS, V65, P327, DOI 10.1053/j.ajkd.2014.05.024; Carnahan RM, 2020, JCO CLIN CANCER INFO, V4, P724, DOI 10.1200/CCI.19.00142; Espi M, 2020, TOXINS, V12, DOI 10.3390/toxins12050300; Fernandes JV, 2015, PATHOL ONCOL RES, V21, P527, DOI 10.1007/s12253-015-9913-z; Forrest CB, 2021, J CLIN EPIDEMIOL, V129, P60, DOI 10.1016/j.jclinepi.2020.09.036; Haendel MA, 2021, J AM MED INFORM ASSN, V28, P427, DOI 10.1093/jamia/ocaa196; Horng S, 2019, APPL CLIN INFORM, V10, P409, DOI 10.1055/s-0039-1691842; Iff S, 2014, AM J KIDNEY DIS, V63, P23, DOI 10.1053/j.ajkd.2013.07.008; Ishii T, 2020, INT J CLIN ONCOL, V25, P1587, DOI 10.1007/s10147-020-01715-9; Lees JS, 2021, ECLINICALMEDICINE, V38, DOI 10.1016/j.eclinm.2021.101030; Liu LL, 2020, J CANCER, V11, P6429, DOI 10.7150/jca.47175; Lowrance WT, 2014, J AM SOC NEPHROL, V25, P2327, DOI 10.1681/ASN.2013060604; Malyszko J, 2017, ONCOTARGET, V8, P66601, DOI 10.18632/oncotarget.18094; Martin B, 2022, JAMA NETW OPEN, V5, DOI 10.1001/jamanetworkopen.2021.43151; Park S, 2019, KIDNEY RES CLIN PRAC, V38, P60, DOI 10.23876/j.krcp.18.0131; Scully T, 2021, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.615375; Shebl FM, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-65; Siegel RL, 2021, CA-CANCER J CLIN, V71, P7, DOI 10.3322/caac.21654; Stengel B, 2010, J NEPHROL, V23, P253; Sun CY, 2012, KIDNEY INT, V81, P640, DOI 10.1038/ki.2011.445; Vajdic CM, 2006, JAMA-J AM MED ASSOC, V296, P2823, DOI 10.1001/jama.296.23.2823; Weng PH, 2011, CLIN J AM SOC NEPHRO, V6, P1121, DOI 10.2215/CJN.09011010; Wong G, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2532-6; Wong G, 2009, J AM SOC NEPHROL, V20, P1341, DOI 10.1681/ASN.2008090998; Xu H, 2019, CLIN J AM SOC NEPHRO, V14, P530, DOI 10.2215/CJN.10820918; Yang J, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014420	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0272910	10.1371/journal.pone.0272910	http://dx.doi.org/10.1371/journal.pone.0272910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976968	Green Published, gold			2022-12-26	WOS:000847227000066
J	Saccoccia, F; Pozzetti, L; Gimmelli, R; Butini, S; Guidi, A; Papoff, G; Giannaccari, M; Brogi, S; Scognamiglio, V; Gemma, S; Ruberti, G; Campiani, G				Saccoccia, Fulvio; Pozzetti, Luca; Gimmelli, Roberto; Butini, Stefania; Guidi, Alessandra; Papoff, Giuliana; Giannaccari, Marialaura; Brogi, Simone; Scognamiglio, Viviana; Gemma, Sandra; Ruberti, Giovina; Campiani, Giuseppe			Crystal structures of Schistosoma mansoni histone deacetylase 8 reveal a novel binding site for allosteric inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROMOLECULAR STRUCTURES; SPACE-GROUP; ALGORITHM; ALIGNMENT; DYNAMICS; HDAC8	Parasitic diseases cause significant global morbidity and mortality particularly in the poorest regions of the world. Schistosomiasis, one of the most widespread neglected tropical diseases, affects more than 200 million people worldwide. Histone deacetylase (HDAC) inhibitors are prominent epigenetic drugs that are being investigated in the treatment of several diseases, including cancers and parasitic diseases. Schistosoma mansoni HDAC8 (SmHDAC8) is highly expressed in all life cycle stages of the parasite, and selective inhibition is required in order to avoid undesirable off-target effects in the host. Herein, by X-ray crystal structures of SmHDAC8inhibitor complexes, biochemical and phenotypic studies, we found two schistosomicidal spiroindoline derivatives binding a novel site, next to Trp198, on the enzyme surface. We determined that by acting on this site, either by mutation of the Trp198 or by compound binding, a decrease in the activity of the enzyme is achieved. Remarkably, this allosteric site differs from the human counterpart; rather, it is conserved in all Schistosoma species, as well as Rhabidoptera and Trematoda classes, thus paving the way for the design of HDAC8-selective allosteric inhibitors with improved properties.	[Saccoccia, Fulvio; Gimmelli, Roberto; Guidi, Alessandra; Papoff, Giuliana; Giannaccari, Marialaura; Ruberti, Giovina] Italian Natl Res Council IBBC CNR, Inst Biochem & Cell Biol, Adriano Buzzati Traverso Campus, Monterotondo, Italy; [Pozzetti, Luca; Butini, Stefania; Gemma, Sandra; Campiani, Giuseppe] Univ Siena, Dept Biotechnol Chem & Pharm, DoE Dept Excellence 2018 2022, Siena, Italy; [Brogi, Simone] Univ Pisa, Dept Pharm, Pisa, Italy; [Scognamiglio, Viviana] Italian Natl Res Council, Inst Crystallog, Dept Chem Sci & Mat Technol, Monterotondo, Italy; [Guidi, Alessandra] Sapienza Univ Rome, Italian Natl Res Council IBPM CNR, Inst Mol Biol & Pathol, Dept Biol & Biotechnol Charles Darwin, Ple Aldo Moro 5, I-00185 Rome, Italy	University of Siena; University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome	Saccoccia, F; Ruberti, G (corresponding author), Italian Natl Res Council IBBC CNR, Inst Biochem & Cell Biol, Adriano Buzzati Traverso Campus, Monterotondo, Italy.; Campiani, G (corresponding author), Univ Siena, Dept Biotechnol Chem & Pharm, DoE Dept Excellence 2018 2022, Siena, Italy.	fulvio.saccoccia@cnr.it; giovina.ruberti@cnr.it; campiani@unisi.it	Guidi, Alessandra/AEO-0770-2022; Saccoccia, Fulvio/ADI-5036-2022	Saccoccia, Fulvio/0000-0002-3527-6694; RUBERTI, Giovina/0000-0003-2367-9709; Giannaccari, Marialaura/0000-0002-1790-9398; Guidi, Alessandra/0000-0002-2537-1428; Campiani, Giuseppe/0000-0001-5295-9529; PAPOFF, GIULIANA/0000-0003-2251-8794; Brogi, Simone/0000-0001-9375-6242	Ministero dell Universite della Ricerca (MUR) [20154JRJPP]; CNR (National Research Council) - CNCCS (Collezione Nazionale di Composti Chimici e Centro di Screening) "Rare, Neglected and Poverty Related Diseases Schisto-discovery Project" [DSB.AD011.001.003]; Lazio Innova POR FESR Lazio 2014 to 2020 HDACiPLAT Project [A0375-2020-36575]; MUR-PRIN grant; CNR-CNCCS grant	Ministero dell Universite della Ricerca (MUR)(Ministry of Education, Universities and Research (MIUR)); CNR (National Research Council) - CNCCS (Collezione Nazionale di Composti Chimici e Centro di Screening) "Rare, Neglected and Poverty Related Diseases Schisto-discovery Project"; Lazio Innova POR FESR Lazio 2014 to 2020 HDACiPLAT Project; MUR-PRIN grant; CNR-CNCCS grant	This work was supported by Ministero dell Universite della Ricerca (MUR) (PRIN Project No. 20154JRJPP to G. C. and G. R.) ; CNR (National Research Council) -CNCCS (Collezione Nazionale di Composti Chimici e Centro di Screening) "Rare, Neglected and Poverty Related Diseases Schisto-discovery Project" (DSB.AD011.001.003 to G. R.) , Lazio Innova POR FESR Lazio 2014 to 2020 HDACiPLAT Project (grant number A0375-2020-36575 to G. R.) . R. G. was the recipient of a post-doctoral fellowship from MUR-PRIN and CNR-CNCCS grants.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Bayer T, 2018, CHEMMEDCHEM, V13, P1517, DOI 10.1002/cmdc.201800238; Bellelli A., 2018, REVERSIBLE LIGAND BI; Buker SM, 2019, SLAS DISCOV, V24, P515, DOI 10.1177/2472555219829898; Cioli D, 2014, MOL BIOCHEM PARASIT, V195, P23, DOI 10.1016/j.molbiopara.2014.06.002; Copeland RA, 2013, EVALUATION OF ENZYME INHIBITORS IN DRUG DISCOVERY: A GUIDE FOR MEDICINAL CHEMISTS AND PHARMACOLOGISTS, 2ND EDITION, P1, DOI 10.1002/9781118540398; Dubois F, 2009, MOL BIOCHEM PARASIT, V168, P7, DOI 10.1016/j.molbiopara.2009.06.001; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ghazy E, 2022, PHARMACEUTICALS-BASE, V15, DOI 10.3390/ph15010080; Ghazy E, 2021, EUR J MED CHEM, V225, DOI 10.1016/j.ejmech.2021.113745; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Guidi A, 2020, METHODS MOL BIOL, V2151, P219, DOI 10.1007/978-1-0716-0635-3_18; Guidi A, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3268-8; Guidi A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005994; Hailu GS, 2017, J MED CHEM, V60, P4780, DOI 10.1021/acs.jmedchem.6b01595; Heinnburg T, 2016, J MED CHEM, V59, P2423, DOI 10.1021/acs.jmedchem.5b01478; KABSCH W, 1978, ACTA CRYSTALLOGR A, V34, P827, DOI 10.1107/S0567739478001680; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Lalli C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003484; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lebedev AA, 2014, ACTA CRYSTALLOGR D, V70, P2430, DOI 10.1107/S1399004714014795; Leger E, 2017, PARASITOLOGY, V144, P65, DOI 10.1017/S0031182016001190; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Marek M, 2018, J MED CHEM, V61, P10000, DOI 10.1021/acs.jmedchem.8b01087; Marek M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003645; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McManus DP, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0013-8; Millard CJ, 2017, TRENDS PHARMACOL SCI, V38, P363, DOI 10.1016/j.tips.2016.12.006; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakagawa M, 2007, ONCOL REP, V18, P769; Oger F, 2008, BIOCHEM BIOPH RES CO, V377, P1079, DOI 10.1016/j.bbrc.2008.10.090; Osko JD, 2021, J STRUCT BIOL, V213, DOI 10.1016/j.jsb.2020.107681; Palmer T., 1985, UNDERSTANDING ENZYME, V2; Pierce RJ, 2011, MEM I OSWALDO CRUZ, V106, P794, DOI 10.1590/S0074-02762011000700003; Roversi P, 2012, ACTA CRYSTALLOGR D, V68, P418, DOI 10.1107/S0907444912006737; Saccoccia F, 2020, ACS INFECT DIS, V6, P100, DOI 10.1021/acsinfecdis.9b00224; Shukla VK, 2021, CHEM SCI, V12, P9318, DOI 10.1039/d1sc01929e; Simoben CV, 2018, MOLECULES, V23, DOI 10.3390/molecules23030566; Skjaerven L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002004; Stiers KM, 2019, STRUCT DYNAM-US, V6, DOI 10.1063/1.5092803; Stolfa DA, 2014, J MOL BIOL, V426, P3442, DOI 10.1016/j.jmb.2014.03.007; Su H, 2008, MOL CANCER THER, V7, P1007, DOI 10.1158/1535-7163.MCT-07-2289; Toro TB, 2015, PROTEIN SCI, V24, P2020, DOI 10.1002/pro.2813; van de Weert M, 2011, J MOL STRUCT, V998, P144, DOI 10.1016/j.molstruc.2011.05.023; Werbeck ND, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17610-w; Wharton C. W., 1981, MOL ENZYMOLOGY, V1; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yao XQ, 2013, BIOPHYS J, V105, pL8, DOI [10.1016/j.bpj.2013.06.006, 10.1016/j.bpj.2013.06.00]; Zhou JW, 2017, J CHEM INF MODEL, V57, P2309, DOI 10.1021/acs.jcim.7b00251	56	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102375	10.1016/j.jbc.2022.102375	http://dx.doi.org/10.1016/j.jbc.2022.102375			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5L6PJ	35970392	Green Published, gold			2022-12-26	WOS:000870533300006
J	Cui, L; Li, DP; Wu, ZJ; Xue, Y; Xiao, FR; Gong, P; Zhang, LL; Song, YC; Yu, CX; Du, YD; Li, YH; Zheng, Y				Cui, Lei; Li, Dongpo; Wu, Zhijie; Xue, Yan; Xiao, Furong; Gong, Ping; Zhang, Lili; Song, Yuchao; Yu, Chunxiao; Du, Yandi; Li, Yonghua; Zheng, Ye			Effects of combined nitrification inhibitors on soil nitrification, maize yield and nitrogen use efficiency in three agricultural soils	PLOS ONE			English	Article							3,4-DIMETHYLPYRAZOLE PHOSPHATE DMPP; AMMONIA-OXIDIZING BACTERIA; OXIDE EMISSIONS; NITRIFYING ORGANISMS; DICYANDIAMIDE DCD; ENZYME-ACTIVITIES; N2O EMISSIONS; MINERAL-N; UREASE; WHEAT	Application of nitrification inhibitors (NIs) with nitrogen (N) fertilizer is one of the most efficient ways to improve nitrogen use efficiency (NUE). To fully understand the efficiency of NIs with N fertilizer on soil nitrification, yield and NUE of maize (Zea mays L.), an outdoor pot experiment with different NIs in three soils with different pH was conducted. Five treatments were established: no fertilizer (Control); ammonium sulfate (AS); ammonium sulfate + 3, 4-dimethyl-pyrazolate phosphate (DMPP) (AD); ammonium sulfate + nitrogen protectant (N-GD) (AN); ammonium sulfate + 3, 4-dimethyl-pyrazolate phosphate + nitrogen protectant (ADN). The results showed that NIs treatments (AD, AN and ADN) significantly reduced soil nitrification in the brown and red soil, especially in AD and ADN, which decreased apparent nitrification rate by 28% - 44% (P < 0.05). All NIs treatments significantly increased yield and NUE of maize in three soils, especially ADN in the cinnamon soil and AD in the red soil were more efficiency, which significantly increased maize yield and apparent nitrogen recovery by 5.07 and 6.81 times, 4.39 and 8.16 times, respectively. No significant difference on maize yield was found in the brown soil, but AN significantly increased apparent nitrogen recovery by 70%. Given that the effect of NIs on both soil nitrification and NUE of maize, DMPP+N-GD was more efficient in the cinnamon soil, while N-GD and DMPP was the most efficiency in the brown and red soil, respectively. In addition, soil pH and soil organic matter play important role in the efficiency of NIs.	[Cui, Lei; Li, Dongpo; Wu, Zhijie; Xue, Yan; Xiao, Furong; Gong, Ping; Zhang, Lili; Song, Yuchao; Yu, Chunxiao] Chinese Acad Sci, Inst Appl Ecol, Shenyang, Liaoning, Peoples R China; [Cui, Lei; Xiao, Furong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Du, Yandi] Chaoyang Cty Agr Technol Extens Ctr, Chaoyang, Liaoning, Peoples R China; [Li, Yonghua] North Huajin Chem Ind Grp Corp, Panjin, Liaoning, Peoples R China; [Zheng, Ye] Jinxi Nat Gas Chem Co Ltd, Huludao, Liaoning, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, DP (corresponding author), Chinese Acad Sci, Inst Appl Ecol, Shenyang, Liaoning, Peoples R China.	lidp@iae.ac.cn			State Key Program of China	State Key Program of China(State Key Development Program for Basic Research of China)	This work was financially supported by the State Key Program of China	Abalos D, 2014, AGR ECOSYST ENVIRON, V189, P136, DOI 10.1016/j.agee.2014.03.036; Ahmed M, 2018, PLANT SOIL ENVIRON, V64, P164, DOI 10.17221/46/2018-PSE; Barth G, 2008, PEDOSPHERE, V18, P378, DOI 10.1016/S1002-0160(08)60028-4; Benckiser G, 2013, PLANT SOIL, V371, P257, DOI 10.1007/s11104-013-1664-6; BRIGGS GG, 1975, J SCI FOOD AGR, V26, P1083, DOI 10.1002/jsfa.2740260806; Coskun D, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.74; Cui M, 2011, J SOIL SEDIMENT, V11, P722, DOI 10.1007/s11368-011-0357-0; Di HJ, 2011, J SOIL SEDIMENT, V11, P432, DOI [10.1007/s11368-011-0372-1, 10.1007/s11368-010-0318-z]; Dong D, 2018, SOIL TILL RES, V180, P82, DOI 10.1016/j.still.2018.02.010; Dong XX, 2013, PLANT SOIL ENVIRON, V59, P398, DOI 10.17221/165/2013-PSE; Fan CH, 2018, SCI TOTAL ENVIRON, V612, P480, DOI 10.1016/j.scitotenv.2017.08.159; Fangueiro D, 2009, COMMUN SOIL SCI PLAN, V40, P3387, DOI 10.1080/00103620903325976; Gao JC, 2021, J SOIL SCI PLANT NUT, V21, P497, DOI 10.1007/s42729-020-00378-9; Giltrap DL, 2010, AGR ECOSYST ENVIRON, V136, P310, DOI 10.1016/j.agee.2009.08.007; Gong P, 2013, PEDOSPHERE, V23, P729, DOI 10.1016/S1002-0160(13)60065-X; GORING CLEVE A. I., 1962, SOIL SCI, V93, P211, DOI 10.1097/00010694-196203000-00010; Guardia G, 2018, SCI TOTAL ENVIRON, V624, P1202, DOI 10.1016/j.scitotenv.2017.12.250; Guardia G, 2017, FIELD CROP RES, V204, P135, DOI 10.1016/j.fcr.2017.01.009; Guo YJ, 2014, J SOIL SEDIMENT, V14, P897, DOI 10.1007/s11368-013-0843-7; HAYNES RJ, 1978, BIOL REV, V53, P465, DOI 10.1111/j.1469-185X.1978.tb00862.x; He TH, 2018, SCI TOTAL ENVIRON, V628-629, P121, DOI 10.1016/j.scitotenv.2018.02.048; Hu HW, 2015, FEMS MICROBIOL REV, V39, P729, DOI 10.1093/femsre/fuv021; Huerfano X, 2018, ATMOS ENVIRON, V187, P255, DOI 10.1016/j.atmosenv.2018.05.065; KEMPERS AJ, 1988, ANALYST, V113, P1117, DOI 10.1039/an9881301117; Li H, 2008, J ENVIRON SCI-CHINA, V20, P149, DOI 10.1016/S1001-0742(08)60023-6; Liu R, 2015, J SOIL SEDIMENT, V15, P1113, DOI 10.1007/s11368-015-1086-6; Lu YF, 2019, SOIL BIOL BIOCHEM, V129, P48, DOI 10.1016/j.soilbio.2018.11.008; Ma Q, 2019, APPL SOIL ECOL, V136, P158, DOI 10.1016/j.apsoil.2018.12.007; Ma Q, 2015, SOIL BIOL BIOCHEM, V89, P72, DOI 10.1016/j.soilbio.2015.06.024; Mahmood T, 2011, BIOL FERT SOILS, V47, P619, DOI 10.1007/s00374-011-0559-z; Majumdar D, 2002, AGR ECOSYST ENVIRON, V91, P283, DOI 10.1016/S0167-8809(01)00223-7; McCarty GW, 1999, BIOL FERT SOILS, V29, P1, DOI 10.1007/s003740050518; Moir JL, 2012, GRASS FORAGE SCI, V67, P391, DOI 10.1111/j.1365-2494.2012.00857.x; MOLL RH, 1982, AGRON J, V74, P562, DOI 10.2134/agronj1982.00021962007400030037x; Pasda G, 2001, BIOL FERT SOILS, V34, P85, DOI 10.1007/s003740100381; Patra AK, 2006, EUR J SOIL BIOL, V42, P173, DOI 10.1016/j.ejsobi.2005.12.007; Pfab H, 2012, AGR ECOSYST ENVIRON, V150, P91, DOI 10.1016/j.agee.2012.01.001; Shi XZ, 2016, APPL ENVIRON MICROB, V82, P5236, DOI 10.1128/AEM.01031-16; Subbarao GV, 2006, CRIT REV PLANT SCI, V25, P303, DOI 10.1080/07352680600794232; Sutton MA., 2011, EFFECTS POLICY PERSP; Tao R, 2018, ENVIRON SCI POLLUT R, V25, P9155, DOI 10.1007/s11356-018-1226-9; Weiske A, 2001, BIOL FERT SOILS, V34, P109, DOI 10.1007/s003740100386; Yang LJ, 2016, GEODERMA, V283, P32, DOI 10.1016/j.geoderma.2016.07.022; Yang M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22075; Zaman M, 2009, SOIL BIOL BIOCHEM, V41, P1270, DOI 10.1016/j.soilbio.2009.03.011; Zaman M, 1999, SOIL USE MANAGE, V15, P188, DOI 10.1111/j.1475-2743.1999.tb00087.x; Zerulla W, 2001, BIOL FERT SOILS, V34, P79, DOI 10.1007/s003740100380; Zhang HJ, 2004, PEDOSPHERE, V14, P395; Zhao ZC, 2017, ATMOS ENVIRON, V166, P142, DOI 10.1016/j.atmosenv.2017.07.034; Zhao ZQ, 2004, ENVIRON INT, V29, P973, DOI 10.1016/S0160-4120(03)00081-3	50	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0272935	10.1371/journal.pone.0272935	http://dx.doi.org/10.1371/journal.pone.0272935			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994496	gold, Green Published			2022-12-26	WOS:000877093400031
J	Wu, YZ; Wang, TW; Zhao, MY; Dong, SM; Wang, SW; Shi, JC				Wu, Yuanzhe; Wang, Tingwei; Zhao, Mingyi; Dong, Shumin; Wang, Shiwen; Shi, Jingcheng			Spatiotemporal cluster patterns of hand, foot, and mouth disease at the province level in mainland China, 2011-2018	PLOS ONE			English	Article							ENTEROVIRUS 71; CLIMATE FACTORS; EPIDEMIOLOGY; OUTBREAKS; REGION; MODEL; RISK; HFMD	Although three monovalent EV-A71 vaccines have been launched in mainland China since 2016, hand, foot, and mouth disease (HFMD) still causes a considerable disease burden in China. Vaccines' use may change the epidemiological characters of HFMD. Spatial autocor-relation analysis and space-time scan statistics analysis were used to explore the spatiotemporal distribution pattern of this disease at the provincial level in mainland China. The effects of meteorological factors, socio-economic factors, and health resources on HFMD incidence were analyzed using Geodetector. Interrupted time series (ITS) was used to analyze the impact of the EV-A71 vaccine on the incidence of HFMD. This study found that the median annual incidence of HFMD was 153.78 per 100,000 (ranging from 120.79 to 205.06) in mainland China from 2011 to 2018. Two peaks of infections were observed per year. Children 5 years and under were the main morbid population. The spatial distribution of HFMD was presented a significant clustering pattern in each year (P<0.001). The distribution of HFMD cases was clustered in time and space. The range of cluster time was between April and October. The most likely cluster appeared in the southern coastal provinces (Guangxi, Guangdong, Hainan) from 2011 to 2017 and in the eastern coastal provinces (Shanghai, Jiangsu, Zhejiang) in 2018. The spatial heterogeneity of HFMD incidence could be attributed to meteorological factors, socioeconomic factors, and health resource. After introducing the EV-A71 vaccine, the instantaneous level of HFMD incidence decreased at the national level, and HFMD incidence trended downward in the southern coastal provinces and increased in the eastern coastal provinces. The prevention and control policies of HFMD should be adapted to local conditions in different provinces. It is necessary to advance the EV-A71 vaccination plan, expand the vaccine coverage and develop multivalent HFMD vaccines as soon as possible.	[Wu, Yuanzhe] Univ New South Wales, Sch Civil & Environm Engn, Sydney, NSW, Australia; [Wang, Tingwei; Wang, Shiwen; Shi, Jingcheng] Xiangya Sch Publ Hlth, Cent South Univ, Changsha, Hunan, Peoples R China; [Zhao, Mingyi] Cent South Univ, Xiangya Hosp 3, Dept Pediat, Changsha, Hunan, Peoples R China; [Dong, Shumin] Fujian Med Univ, Sch Technol & Engn, Fuzhou, Fujian, Peoples R China	University of New South Wales Sydney; Central South University; Central South University; Fujian Medical University	Shi, JC (corresponding author), Xiangya Sch Publ Hlth, Cent South Univ, Changsha, Hunan, Peoples R China.	jingzhengs@126.com			Natural Science Foundation of Hunan Province, China [2020JJ4772]; National Science & Technology Foundational Resource Investigation Program of China [2018FY100900]	Natural Science Foundation of Hunan Province, China(Natural Science Foundation of Hunan Province); National Science & Technology Foundational Resource Investigation Program of China	Grant 1 Recipient: JS. Grant Number: 2020JJ4772. Funding Source: Natural Science Foundation of Hunan Province, China. Grant 2 Recipient: JS. Grant Number: 2018FY100900. Funding Source: National Science & Technology Foundational Resource Investigation Program of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], STANDARD MAP SERVICE; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Bernal JL, 2017, INT J EPIDEMIOL, V46, P348, DOI 10.1093/ije/dyw098; Chen B, 2021, MEDICINE, V100, DOI 10.1097/MD.0000000000025930; Chew SP, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1195-2; Deng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056943; Ding L, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10385-9; Du ZC., 2021, INT J ENV RES PUB HE, V18; Du ZC, 2021, HUM VACC IMMUNOTHER, V17, P217, DOI 10.1080/21645515.2020.1763076; Fang CY, 2022, EXPERT OPIN DRUG DIS, V17, P27, DOI 10.1080/17460441.2021.1965987; Fong SY, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-96083-3; Fu XM, 2020, VIROL SIN, V35, P21, DOI 10.1007/s12250-019-00169-2; Gao YB, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18094919; Geodetector, US; Gonzalez G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205201; Han YT, 2020, PEDIATR INFECT DIS J, V39, P969, DOI 10.1097/INF.0000000000002745; Pham HV, 2019, WEST PAC SURVEILL RE, V10, DOI 10.5365/wpsar.2017.8.1.003; Hjalmars U, 1996, STAT MED, V15, P707, DOI 10.1002/(SICI)1097-0258(19960415)15:7/9<707::AID-SIM242>3.3.CO;2-W; Hong SZ., 2021, SCI TOTAL ENVIRON, P775; Hu BS, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08607-7; Huang JX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143411; Huang JX, 2014, INT J ENV RES PUB HE, V11, P3407, DOI 10.3390/ijerph110303407; Huang RF, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0009210; Nguyen HX, 2017, SCI TOTAL ENVIRON, V581, P766, DOI [10.1016/j.scitotenv2017.01.006, 10.1016/j.scitotenv.2017.01.006]; Ji H, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-018-3659-7; Jiang L., 2021, BMC INFECT DIS, V21; Jones SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048036; Koh WM, 2016, PEDIATR INFECT DIS J, V35, pE285, DOI 10.1097/INF.0000000000001242; Kulldorff M, 1997, AM J EPIDEMIOL, V146, P161; Lau SYF, 2021, ATMOS ENVIRON, V244, DOI 10.1016/j.atmosenv.2020.117984; Nhan LNT, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008544; Li XW, 2018, WORLD J PEDIATR, V14, P437, DOI 10.1007/s12519-018-0189-8; Liao YL, 2018, STOCH ENV RES RISK A, V32, P1531, DOI 10.1007/s00477-018-1547-8; Liu H, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7619-y; Liu LL, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11665-0; Liu Si-yuan, 2021, Chinese Journal of Biologicals, V34, P186, DOI 10.13200/j.cnki.cjb.003270; Liu ZX, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06157-w; Ma Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147918; National Bureau of Statistics of the People's Republic of China, US; National Meteorological Information Center, US; Nie T R, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P1047, DOI 10.3760/cma.j.cn112338-20200114-00030; NikNadia NMN, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004562; Ning K., 2021, CHINA TROPICAL MED, V21; Noisumdaeng P, 2019, INT J INFECT DIS, V80, P84, DOI 10.1016/j.ijid.2018.12.020; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; Pan Q, 2021, ENVIRON HEALTH PREV, V26, DOI 10.1186/s12199-020-00927-9; Pfeiffer DU, 2008, Spatial Analysis in Epidemiology, P1, DOI 10.1093/acprof:oso/9780198509882.001.0001; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Public Health Science Data Center, US; Qin C., 2021, CHINESE PRIMARY HLTH, V35, P51; Rao HX, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2643-y; Sabanathan S, 2014, J EPIDEMIOL COMMUN H, V68, P500, DOI 10.1136/jech-2014-203836; Samphutthanon R, 2014, INT J ENV RES PUB HE, V11, P312, DOI 10.3390/ijerph110100312; Schoffel N, 2018, ZENTRALBLATT ARB ARB, V68, P91, DOI 10.1007/s40664-017-0222-0; Shi C, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3385-1; Song C, 2019, SCI TOTAL ENVIRON, V648, P550, DOI 10.1016/j.scitotenv.2018.08.114; Tango Toshiro, 2005, Int J Health Geogr, V4, P11, DOI 10.1186/1476-072X-4-11; Thammasonthijarern N, 2021, PATHOGENS, V10, DOI 10.3390/pathogens10050576; Verma S, 2021, COMPUT MATH METHOD M, V2021, DOI 10.1155/2021/6697522; Wang C, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0151633, 10.1371/journal.pone.0148017]; Wang JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092745; Wang JF, 2016, ECOL INDIC, V67, P250, DOI 10.1016/j.ecolind.2016.02.052; Wang JF, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-25; Wang JF, 2010, INT J GEOGR INF SCI, V24, P107, DOI 10.1080/13658810802443457; Wang J, 2021, VACCINE, V39, P3319, DOI 10.1016/j.vaccine.2021.05.009; Wang XL, 2019, HUM VACC IMMUNOTHER, V15, P1183, DOI 10.1080/21645515.2019.1581539; Wei Jian-Hui, 2021, Zhongguo Dang Dai Er Ke Za Zhi, V23, P1141, DOI 10.7499/j.issn.1008-8830.2107031; Wu XR, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2742-9; Xiao Ge-xin, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P808; Xie YH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085440, 10.1371/journal.pone.0088065]; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Yang BY, 2017, EUROSURVEILLANCE, V22, P38, DOI 10.2807/1560-7917.ES.2017.22.50.16-00824; [杨芬 Yang Fen], 2020, [中国公共卫生, China Journal of Public Health], V36, P351; Ye LX, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11198-6; Yi LN, 2011, CRIT REV MICROBIOL, V37, P313, DOI 10.3109/1040841X.2011.580723; Yu CC, 2021, INFECT DRUG RESIST, V14, P2809, DOI 10.2147/IDR.S304652; Zhang XX, 2020, SCI TOTAL ENVIRON, V713, DOI 10.1016/j.scitotenv.2020.136623; Zhang XX, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3546-2; Zhang Z, 2021, CLIN INFECT DIS, V73, pE2552, DOI 10.1093/cid/ciaa1853; Zhao JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163789; Zhu B, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9101784; Zhu Q, 2011, BIOMED ENVIRON SCI, V24, P349, DOI 10.3967/0895-3988.2011.04.005	82	0	0	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0270061	10.1371/journal.pone.0270061	http://dx.doi.org/10.1371/journal.pone.0270061			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994464	Green Submitted, gold, Green Published			2022-12-26	WOS:000877093400005
J	Wang, J; Li, JJ; Yin, LJ; Pu, TJ; Wei, J; Karthikeyan, V; Lin, TP; Gao, AC; Wu, BJ				Wang, Jing; Li, Jingjing; Yin, Lijuan; Pu, Tianjie; Wei, Jing; Karthikeyan, Varsha; Lin, Tzu-Ping; Gao, Allen C.; Wu, Boyang Jason			Neuropilin-2 promotes lineage plasticity and progression to neuroendocrine prostate cancer	ONCOGENE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CELL-LINE; RECEPTOR; STAT3; DIFFERENTIATION; TYROSINE; PROTEIN; TRANSCRIPTION; ASSOCIATION; EXPRESSION	Neuroendocrine prostate cancer (NEPC), a lethal subset of prostate cancer, is characterized by loss of AR signaling and resulting resistance to AR-targeted therapy during neuroendocrine transdifferentiation, for which the molecular mechanisms remain unclear. Here, we report that neuropilin 2 (NRP2) is upregulated in both de novo and therapy-induced NEPC, which induces neuroendocrine markers, neuroendocrine cell morphology, and NEPC cell aggressive behavior. NRP2 silencing restricted NEPC tumor xenograft growth. Mechanistically, NRP2 engages in reciprocal crosstalk with AR, where NRP2 is transcriptionally inhibited by AR, and in turn suppresses AR signaling by downregulating the AR transcriptional program and confers resistance to enzalutamide. Moreover, NRP2 physically interacts with VEGFR2 through the intracellular SEA domain to activate STAT3 phosphorylation and subsequently SOX2, thus driving NEPC differentiation and growth. Collectively, these results characterize NRP2 as a driver of NEPC and suggest NRP2 as a potential therapeutic target in NEPC.	[Wang, Jing; Li, Jingjing; Pu, Tianjie; Wei, Jing; Wu, Boyang Jason] Washington State Univ, Coll Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Spokane, WA 99202 USA; [Yin, Lijuan] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Dept Med, Uro Oncol Res Program, Los Angeles, CA 90048 USA; [Karthikeyan, Varsha] Washington State Univ, Coll Pharm & Pharmaceut Sci, Summer Undergrad Res Fellowship Program, Spokane, WA 99202 USA; [Karthikeyan, Varsha] Oregon State Univ, Coll Sci, Sch Life Sci, Dept Integrat Biol, Corvallis, OR 97331 USA; [Lin, Tzu-Ping] Taipei Vet Gen Hosp, Dept Urol, Taipei 11217, Taiwan; [Lin, Tzu-Ping] Natl Yang Ming Chiao Tung Univ, Sch Med, Dept Urol, Taipei 11221, Taiwan; [Lin, Tzu-Ping] Natl Yang Ming Chiao Tung Univ, Shu Tien Urol Res Ctr, Taipei 11221, Taiwan; [Gao, Allen C.] Univ Calif Davis, Dept Urol Surg, Sacramento, CA 95817 USA; [Li, Jingjing] Shanghai Jiao Tong Univ, Sch Pharm, Lab Regener, Shanghai 200240, Peoples R China; [Yin, Lijuan] Sichuan Univ, West China Hosp, Dept Pathol, Chengdu 610041, Sichuan, Peoples R China	Washington State University; Cedars Sinai Medical Center; Washington State University; Oregon State University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; University of California System; University of California Davis; Shanghai Jiao Tong University; Sichuan University	Wu, BJ (corresponding author), Washington State Univ, Coll Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Spokane, WA 99202 USA.	boyang.wu@wsu.edu		Karthikeyan, Varsha/0000-0003-3196-8850; Li, Jingjing/0000-0002-0661-5642	Department of Defense Prostate Cancer Research Program [W81XWH-19-1-0279]; NIH/NCI [R37CA233658]; WSU	Department of Defense Prostate Cancer Research Program(United States Department of Defense); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); WSU	This work was supported by the Department of Defense Prostate Cancer Research Program grant W81XWH-19-1-0279, NIH/NCI grant R37CA233658, and WSU startup funding to B.J.W. We thank Yidi Xu (Washington State University) for providing technical assistance, Mahul Amin (Cedars-Sinai Medical Center) for providing NEPC clinical samples, and Gary Mawyer for editorial assistance.	Abida W, 2019, P NATL ACAD SCI USA, V116, P11428, DOI 10.1073/pnas.1902651116; Aparicio A, 2011, CANCER DISCOV, V1, P466, DOI 10.1158/2159-8290.CD-11-0259; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Beltran H, 2016, NAT MED, V22, P298, DOI 10.1038/nm.4045; Beltran H, 2014, CLIN CANCER RES, V20, P2846, DOI 10.1158/1078-0432.CCR-13-3309; Bishop JL, 2017, CANCER DISCOV, V7, P54, DOI 10.1158/2159-8290.CD-15-1263; Bland T, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2020.101970; Borkowetz A, 2020, INT J CANCER, V146, P2619, DOI 10.1002/ijc.32679; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cai HB, 1999, J NEUROSCI, V19, P6519; Chen SY, 2019, AM J CLIN EXP UROL, V7, P327; Davies AH, 2018, NAT REV UROL, V15, P271, DOI 10.1038/nrurol.2018.22; Dutta S, 2022, ONCOGENE, V41, P3747, DOI 10.1038/s41388-022-02382-y; Ellis LM, 2006, MOL CANCER THER, V5, P1099, DOI 10.1158/1535-7163.MCT-05-0538; Favier B, 2006, BLOOD, V108, P1243, DOI 10.1182/blood-2005-11-4447; Foshay KM, 2008, STEM CELLS DEV, V17, P269, DOI 10.1089/scd.2007.0098; Gerhauser C, 2018, CANCER CELL, V34, P996, DOI 10.1016/j.ccell.2018.10.016; Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X; Goel HL, 2012, CANCER DISCOV, V2, P906, DOI 10.1158/2159-8290.CD-12-0085; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gray MJ, 2008, J NATL CANCER I, V100, P109, DOI 10.1093/jnci/djm279; Gritsina G, 2019, ASIAN J ANDROL, V21, P215, DOI 10.4103/aja.aja_19_19; Hahn D, 2000, J UROLOGY, V164, P506, DOI 10.1016/S0022-5347(05)67414-9; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Huss WJ, 2004, PROSTATE, V60, P91, DOI 10.1002/pros.20032; Jackson MW, 2002, CANCER RES, V62, P854; Kaushal V, 2005, CLIN CANCER RES, V11, P584; Khoury A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13753-7; Labrecque MP, 2019, J CLIN INVEST, V129, P4492, DOI 10.1172/JCI128212; Lajoie BR, 2015, METHODS, V72, P65, DOI 10.1016/j.ymeth.2014.10.031; Liu YZ, 2019, SCI TRANSL MED, V11, DOI [10.1126/scitranslmed.aaw4993, 10.1126/scitranslmed.aax9364]; Mu P, 2017, SCIENCE, V355, P84, DOI 10.1126/science.aah4307; Neufeld G, 2002, ADV EXP MED BIOL, V515, P81; Polavaram NS, 2021, BONE RES, V9, DOI 10.1038/s41413-021-00136-2; Potiron VA, 2007, CANCER RES, V67, P8708, DOI 10.1158/0008-5472.CAN-06-3612; Prahst C, 2008, J BIOL CHEM, V283, P25110, DOI 10.1074/jbc.C800137200; Ren SC, 2018, EUR UROL, V73, P322, DOI 10.1016/j.eururo.2017.08.027; Ren XM, 2010, ACS MED CHEM LETT, V1, P454, DOI 10.1021/ml100146z; Rizzolio S, 2011, CURR MED CHEM, V18, P3563, DOI 10.2174/092986711796642544; ROCHE PJ, 1992, MOL ENDOCRINOL, V6, P2229, DOI 10.1210/me.6.12.2229; Spiotto MT, 2000, PROSTATE, V42, P186, DOI 10.1002/(SICI)1097-0045(20000215)42:3<186::AID-PROS4>3.0.CO;2-E; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Sulpice E, 2008, BLOOD, V111, P2036, DOI 10.1182/blood-2007-04-084269; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Taberlay PC, 2016, GENOME RES, V26, P719, DOI 10.1101/gr.201517.115; Tai S, 2011, PROSTATE, V71, P1668, DOI 10.1002/pros.21383; Tam KJ, 2017, ONCOTARGET, V8, P9617, DOI 10.18632/oncotarget.14168; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tolomeo M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22020603; Tsai HK, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3729-z; Tse BWC, 2017, ONCOGENE, V36, P3417, DOI 10.1038/onc.2016.482; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; Wang HT, 2014, J CLIN ONCOL, V32, P3383, DOI 10.1200/JCO.2013.54.3553; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Xu X, 2017, ASIAN J ANDROL, V19, P686, DOI 10.4103/1008-682X.191518; Zhang XQ, 2003, ONCOGENE, V22, P6704, DOI 10.1038/sj.onc.1206764; Zhao D, 2015, ONCOGENE, V34, P3107, DOI 10.1038/onc.2014.257; Zhu H, 2018, THERANOSTICS, V8, P676, DOI 10.7150/thno.21463	58	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 9	2022	41	37					4307	4317		10.1038/s41388-022-02437-0	http://dx.doi.org/10.1038/s41388-022-02437-0		AUG 2022	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	4L2AN	35986103				2022-12-26	WOS:000843252700001
J	Fukuoka, T; Moriwaki, K; Takamatsu, S; Kondo, J; Tanaka-Okamoto, M; Tomioka, A; Semba, M; Komazawa-Sakon, S; Kamada, Y; Kaji, H; Miyamoto, Y; Inoue, M; Bessho, K; Miyoshi, Y; Ozono, K; Nakano, H; Miyoshi, E				Fukuoka, Tomoya; Moriwaki, Kenta; Takamatsu, Shinji; Kondo, Jumpei; Tanaka-Okamoto, Miki; Tomioka, Azusa; Semba, Manami; Komazawa-Sakon, Sachiko; Kamada, Yoshihiro; Kaji, Hiroyuki; Miyamoto, Yasuhide; Inoue, Masahiro; Bessho, Kazuhiko; Miyoshi, Yoko; Ozono, Keiichi; Nakano, Hiroyasu; Miyoshi, Eiji			Lewis glycosphingolipids as critical determinants of TRAIL sensitivity in cancer cells	ONCOGENE			English	Article							HEPATOCELLULAR-CARCINOMA; LIPID RAFTS; RECEPTOR; NECROSIS; FUCOSYLATION; EXPRESSION; APOPTOSIS; ACTIVATION; COMPLEX; GLYCOSYLATION	Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces cancer cell death and contributes to tumor rejection by cytotoxic lymphocytes in cancer immunosurveillance and immunotherapy. TRAIL and TRAIL receptor agonists have garnered wide popularity as promising agents for cancer therapy. We previously demonstrated that the loss of fucosylation in cancer cells impairs TRAIL sensitivity; however, the precise structures of the fucosylated glycans that regulate TRAIL sensitivity and their carrier molecules remain elusive. Herein, we observed that Lewis glycans among various fucosylated glycans positively regulate TRAIL-induced cell death. Specifically, Lewis glycans on lacto/neolacto glycosphingolipids, but not glycoproteins including TRAIL receptors, enhanced TRAIL-induced formation of the cytosolic caspase 8 complex, without affecting the formation of the membranous receptor complex. Furthermore, type I Lewis glycan expression in colon cancer cell lines and patient-derived cancer organoids was positively correlated with TRAIL sensitivity. These findings provide novel insights into the regulatory mechanism of TRAIL-induced cell death and facilitate the identification of novel predictive biomarkers for TRAIL-related cancer therapies in future.	[Fukuoka, Tomoya; Takamatsu, Shinji; Kondo, Jumpei; Kamada, Yoshihiro; Miyoshi, Eiji] Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Suita, Osaka 5650871, Japan; [Fukuoka, Tomoya; Bessho, Kazuhiko; Miyoshi, Yoko; Ozono, Keiichi] Osaka Univ, Grad Sch Med, Dept Pediat, Suita, Osaka 5650871, Japan; [Moriwaki, Kenta; Semba, Manami; Komazawa-Sakon, Sachiko; Nakano, Hiroyasu] Toho Univ, Sch Med, Dept Biochem, Ota Ku, Tokyo 1438540, Japan; [Kondo, Jumpei; Inoue, Masahiro] Kyoto Univ, Grad Sch Med, Dept Clin Bioresource Res & Dev, Sakyou Ku, Kyoto 6068501, Japan; [Tanaka-Okamoto, Miki; Miyamoto, Yasuhide] Osaka Int Canc Inst, Dept Mol Biol, Chuo Ku, Osaka 5418567, Japan; [Tomioka, Azusa; Kaji, Hiroyuki] Natl Inst Adv Ind Sci & Technol, Cellular & Mol Biotechnol Res Inst, Mol & Cellular Glycoprote Res Grp, Tsukuba, Ibaraki 3058565, Japan; [Semba, Manami] Tokyo Univ Sci, Fac Adv Engn, Dept Biol Sci & Technol, Katsushika Ku, Tokyo 1258585, Japan; [Kamada, Yoshihiro] Osaka Univ, Grad Sch Med, Dept Adv Metab Hepatol, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Kyoto University; National Institute of Advanced Industrial Science & Technology (AIST); Tokyo University of Science; Osaka University	Miyoshi, E (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Suita, Osaka 5650871, Japan.; Moriwaki, K (corresponding author), Toho Univ, Sch Med, Dept Biochem, Ota Ku, Tokyo 1438540, Japan.	kenta.moriwaki@med.toho-u.ac.jp; emiyoshi@sahs.med.osaka-u.ac.jp	; Kaji, Hiroyuki/L-7122-2018	Moriwaki, Kenta/0000-0002-8724-4715; TAKAMATSU, Shinji/0000-0003-1996-7740; Kaji, Hiroyuki/0000-0002-0910-9999	Japan Society for the Promotion of Science [16H06945, 19K07399]; Takeda Science Foundation; GSK Japan Research Grant; Japan Agency for Medical Research and Development [JP20ae0101042, JP20gm1210002]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); GSK Japan Research Grant; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study was supported by the Japan Society for the Promotion of Science (KM: 16H06945 and 19K07399), the Takeda Science Foundation (KM), GSK Japan Research Grant 2020 (KM), and the Japan Agency for Medical Research and Development (JP20ae0101042 to KM and JP20gm1210002 to HN).	Akazawa Y, 2009, GASTROENTEROLOGY, V136, P2365, DOI 10.1053/j.gastro.2009.02.071; Deng D, 2020, TRENDS CANCER, V6, P989, DOI 10.1016/j.trecan.2020.06.006; Dickens LS, 2012, MOL CELL, V47, P291, DOI 10.1016/j.molcel.2012.05.004; Dufour F, 2017, CELL DEATH DIFFER, V24, P500, DOI 10.1038/cdd.2016.150; Dufva O, 2020, BLOOD, V135, P597, DOI 10.1182/blood.2019002121; Fox JL, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20806-9; Henry CM, 2017, MOL CELL, V65, P715, DOI 10.1016/j.molcel.2017.01.022; Holdener BC, 2019, CURR OPIN STRUC BIOL, V56, P78, DOI 10.1016/j.sbi.2018.12.005; Jiang YL, 2020, FASEB J, V34, P11786, DOI 10.1096/fj.201900053RR; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; Kohlhaas SL, 2007, J BIOL CHEM, V282, P12831, DOI 10.1074/jbc.M700438200; Kondo J, 2011, P NATL ACAD SCI USA, V108, P6235, DOI 10.1073/pnas.1015938108; Lafont E, 2018, TRENDS BIOCHEM SCI, V43, P44, DOI 10.1016/j.tibs.2017.11.002; Lafont E, 2017, EMBO J, V36, P1147, DOI 10.15252/embj.201695699; Lavrik IN, 2008, J BIOL CHEM, V283, P26401, DOI 10.1074/jbc.M800823200; Lemke J, 2014, CELL DEATH DIFFER, V21, P1350, DOI 10.1038/cdd.2014.81; Lemoine J, 2021, CLIN CANCER RES, V27, P6298, DOI 10.1158/1078-0432.CCR-21-1559; Linderoth E, 2013, J BIOL CHEM, V288, P32922, DOI 10.1074/jbc.M113.481507; Liu C, 2020, INT J ONCOL, V56, P900, DOI 10.3892/ijo.2020.4989; Ma B, 2006, GLYCOBIOLOGY, V16, p158R, DOI 10.1093/glycob/cwl040; Marconi M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.389; Miyoshi E, 2008, J BIOCHEM, V143, P725, DOI 10.1093/jb/mvn011; Moriwaki K, 2007, GLYCOBIOLOGY, V17, P1311, DOI 10.1093/glycob/cwm094; Moriwaki K, 2013, GENE DEV, V27, P1640, DOI 10.1101/gad.223321.113; Moriwaki K, 2011, J BIOL CHEM, V286, P43123, DOI 10.1074/jbc.M111.262741; Moriwaki K, 2009, GASTROENTEROLOGY, V137, P188, DOI 10.1053/j.gastro.2009.04.002; Nakayama K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070298; Noda K, 2003, CANCER RES, V63, P6282; Ouyang W, 2013, INT J ONCOL, V42, P699, DOI 10.3892/ijo.2012.1748; Pan LQ, 2019, CELL, V176, P1477, DOI 10.1016/j.cell.2019.02.001; Seko A, 2008, J BIOL CHEM, V283, P33094, DOI 10.1074/jbc.M806933200; Singh N, 2020, CANCER DISCOV, V10, P552, DOI 10.1158/2159-8290.CD-19-0813; Song JJ, 2010, CELL SIGNAL, V22, P553, DOI 10.1016/j.cellsig.2009.11.012; Stern HM, 2010, CLIN CANCER RES, V16, P1587, DOI 10.1158/1078-0432.CCR-09-3108; Togayachi A, 2001, J BIOL CHEM, V276, P22032, DOI 10.1074/jbc.M011369200; Togayachi A, 2010, P NATL ACAD SCI USA, V107, P11900, DOI 10.1073/pnas.0914298107; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; YAGO K, 1993, CANCER RES, V53, P5559; Zhang BJ, 2019, FEBS J, V286, P555, DOI 10.1111/febs.14742	40	0	0	3	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 16	2022	41	38					4385	4396		10.1038/s41388-022-02434-3	http://dx.doi.org/10.1038/s41388-022-02434-3		AUG 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	4O3TC	35970887				2022-12-26	WOS:000840610900001
J	Izidoro, MS; Sokabe, M; Villa, N; Merrick, WC; Fraser, CS				Izidoro, Mario Servulo; Sokabe, Masaaki; Villa, Nancy; Merrick, William C.; Fraser, Christopher S.			Human eukaryotic initiation factor 4E (eIF4E) and the nucleotide-bound state of eIF4A regulate eIF4F binding to RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX PROTEIN EIF4A; TRANSLATION INITIATION; HELICASE ACTIVITY; UNWINDING ACTIVITIES; CAP; ATPASE; RECRUITMENT; MODULATION	During translation initiation, the underlying mechanism by which the eukaryotic initiation factor (eIF) 4E, eIF4A, and eIF4G components of eIF4F coordinate their binding activities to regulate eIF4F binding to mRNA is poorly defined. Here, we used fluorescence anisotropy to generate thermodynamic and kinetic frameworks for the interaction of uncapped RNA with human eIF4F. We demonstrate that eIF4E binding to an autoinhibitory domain in eIF4G generates a high-affinity binding conformation of the eIF4F complex for RNA. In addition, we show that the nucleotide-bound state of the eIF4A component further regulates uncapped RNA binding by eIF4F, with a four-fold decrease in the equilibrium dissociation con-stant observed in the presence versus the absence of ATP. Monitoring uncapped RNA dissociation in real time reveals that ATP reduces the dissociation rate constant of RNA for eIF4F by ,-,4-orders of magnitude. Thus, release of ATP from eIF4A places eIF4F in a dynamic state that has very fast asso-ciation and dissociation rates from RNA. Monitoring the ki-netic framework for eIF4A binding to eIF4G revealed two different rate constants that likely reflect two conformational states of the eIF4F complex. Furthermore, we determined that the eIF4G autoinhibitory domain promotes a more stable, less dynamic, eIF4A-binding state, which is overcome by eIF4E binding. Overall, our data support a model whereby eIF4E binding to eIF4G/4A stabilizes a high-affinity RNA-binding state of eIF4F and enables eIF4A to adopt a more dynamic interaction with eIF4G. This dynamic conformation may contribute to the ability of eIF4F to rapidly bind and release mRNA during scanning.	[Izidoro, Mario Servulo; Sokabe, Masaaki; Villa, Nancy; Fraser, Christopher S.] Univ Calif Davis, Coll Biol Sci, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Merrick, William C.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH USA	University of California System; University of California Davis; Case Western Reserve University	Fraser, CS (corresponding author), Univ Calif Davis, Coll Biol Sci, Dept Mol & Cellular Biol, Davis, CA 95616 USA.	csfraser@ucdavis.edu		Sokabe, Masaaki/0000-0002-1824-4818	National Institutes of Health [R01 GM092927, R01 GM128981]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information - This work was supported by the National Institutes of Health grant R01 GM092927 to C. S. F. and R01 GM128981 to W. C. M. The content is solely theresponsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABRAMSON RD, 1988, J BIOL CHEM, V263, P6016; ABRAMSON RD, 1987, J BIOL CHEM, V262, P3826; Andreou AZ, 2017, RNA BIOL, V14, P113, DOI 10.1080/15476286.2016.1259782; Andreou AZ, 2014, J MOL BIOL, V426, P51, DOI 10.1016/j.jmb.2013.09.027; Avanzino BC, 2017, P NATL ACAD SCI USA, V114, P9611, DOI 10.1073/pnas.1704390114; Bi XP, 2000, BIOCHEMISTRY-US, V39, P5758, DOI 10.1021/bi992322p; DUNCAN R, 1983, J BIOL CHEM, V258, P7228; Feoktistova K, 2013, P NATL ACAD SCI USA, V110, P13339, DOI 10.1073/pnas.1303781110; Fraser CS, 2015, BIOCHIMIE, V114, P58, DOI 10.1016/j.biochi.2015.02.017; Garcia-Garcia C, 2015, SCIENCE, V348, P1486, DOI 10.1126/science.aaa5089; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Harms U, 2014, NUCLEIC ACIDS RES, V42, P7911, DOI 10.1093/nar/gku440; Hilbert M, 2011, NUCLEIC ACIDS RES, V39, P2260, DOI 10.1093/nar/gkq1127; Korneeva NL, 2005, J BIOL CHEM, V280, P1872, DOI 10.1074/jbc.M406168200; Krause L, 2022, NUCLEIC ACIDS RES, V50, P6497, DOI 10.1093/nar/gkac437; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2180, DOI 10.1021/bi972430g; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2194, DOI 10.1021/bi9724319; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Merrick W C, 1979, Methods Enzymol, V60, P101, DOI 10.1016/S0076-6879(79)60010-1; Merrick WC, 2015, J BIOL CHEM, V290, P24091, DOI 10.1074/jbc.R115.675280; Mitchell SF, 2010, MOL CELL, V39, P950, DOI 10.1016/j.molcel.2010.08.021; O'Leary SE, 2013, STRUCTURE, V21, P2197, DOI 10.1016/j.str.2013.09.016; Ozes AR, 2011, J MOL BIOL, V412, P674, DOI 10.1016/j.jmb.2011.08.004; Querido JB, 2020, SCIENCE, V369, P1220, DOI 10.1126/science.aba4904; RAY BK, 1985, J BIOL CHEM, V260, P7651; Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Sokabe M, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a032706; Sokabe M, 2017, P NATL ACAD SCI USA, V114, P6304, DOI 10.1073/pnas.1620426114; Sokabe M, 2014, J BIOL CHEM, V289, P31827, DOI 10.1074/jbc.M114.602870; SONENBERG N, 1978, P NATL ACAD SCI USA, V75, P4843, DOI 10.1073/pnas.75.10.4843; Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105; Yourik P, 2017, ELIFE, V6, DOI 10.7554/eLife.31476; Zhao P, 2017, J BIOL CHEM, V292, P5921, DOI [10.1074/jbc.M116.764902, 10.1074/jbc.m116.764902]	36	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	10							102368	10.1016/j.jbc.2022.102368	http://dx.doi.org/10.1016/j.jbc.2022.102368			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6G8HI	35963437	Green Published, gold			2022-12-26	WOS:000884990700003
J	Yadav, SPS; Yu, AY; Zhao, JF; Singh, J; Kakkar, S; Chakraborty, S; Mechref, Y; Molitoris, B; Wagner, MC				Yadav, Shiv Pratap Singh; Yu, Aiying; Zhao, Jingfu; Singh, Jasdeep; Kakkar, Saloni; Chakraborty, Srinivas; Mechref, Yehia; Molitoris, Bruce; Wagner, Mark C.			Glycosylation of a key cubilin Asn residue results in reduced binding to albumin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC KIDNEY-DISEASE; FACTOR VITAMIN-B-12 RECEPTOR; BRUSH-BORDER EXPRESSION; PROTEIN CARBAMYLATION; CONGENITAL DISORDERS; PROXIMAL TUBULE; ENDOCYTIC RECEPTORS; CANCER BIOMARKERS; O-GLYCOSYLATION; LDL-RECEPTOR	Kidney disease often manifests with an increase in protein-uria, which can result from both glomerular and/or proximal tubule injury. The proximal tubules are the major site of pro-tein and peptide endocytosis of the glomerular filtrate, and cubilin is the proximal tubule brush border membrane glyco-protein receptor that binds filtered albumin and initiates its processing in proximal tubules. Albumin also undergoes mul-tiple modifications depending upon the physiologic state. We previously documented that carbamylated albumin had reduced cubilin binding, but the effects of cubilin modifica-tions on binding albumin remain unclear. Here, we investigate the cubilin-albumin binding interaction to define the impact of cubilin glycosylation and map the key glycosylation sites while also targeting specific changes in a rat model of proteinuria. We identified a key Asn residue, N1285, that when glycosylated reduced albumin binding. In addition, we found a pH-induced conformation change may contribute to ligand release. To further define the albumin-cubilin binding site, we determined the solution structure of cubilin's albumin-binding domain, CUB7,8, using small-angle X-ray scattering and molecular modeling. We combined this information with mass spec-trometry crosslinking experiments of CUB7,8 and albumin that provides a model of the key amino acids required for cubilin-albumin binding. Together, our data supports an important role for glycosylation in regulating the cubilin interaction with albumin, which is altered in proteinuria and provides new insight into the binding interface necessary for the cubilin- albumin interaction.	[Yadav, Shiv Pratap Singh; Molitoris, Bruce; Wagner, Mark C.] Indiana Univ Sch Med, Dept Med, Nephrol Div, Indianapolis, IN 46202 USA; [Yu, Aiying; Zhao, Jingfu; Mechref, Yehia] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX USA; [Singh, Jasdeep] Indian Inst Technol Delhi, Dept Biochem Engn & Biotechnol, New Delhi, India; [Kakkar, Saloni] CSIR Inst Microbial Technol, Chandigarh, India; [Chakraborty, Srinivas] IIT, BioCAT Beamline APS, Chicago, IL USA; [Molitoris, Bruce] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Texas Tech University System; Texas Tech University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Illinois Institute of Technology; Indiana University System; Indiana University Bloomington	Wagner, MC (corresponding author), Indiana Univ Sch Med, Dept Med, Nephrol Div, Indianapolis, IN 46202 USA.	wangnerm@iu.edu		Yu, Aiying/0000-0002-3323-8184; Wagner, Mark/0000-0001-9920-2603				Abdelhafiz AH, 2010, NEPHRON CLIN PRACT, V116, pC19, DOI 10.1159/000314545; Ahuja R, 2008, BIOCHEM J, V410, P301, DOI 10.1042/BJ20070919; Akella NM, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0671-3; Andersen CBF, 2014, TRENDS BIOCHEM SCI, V39, P82, DOI 10.1016/j.tibs.2013.12.003; Andersen CBF, 2010, NATURE, V464, P445, DOI 10.1038/nature08874; Andersen JT, 2013, J BIOL CHEM, V288, P24277, DOI 10.1074/jbc.M113.463000; Andersen JT, 2010, J BIOL CHEM, V285, P4826, DOI 10.1074/jbc.M109.081828; Basile DP, 2016, J AM SOC NEPHROL, V27, P687, DOI 10.1681/ASN.2015030309; Bedin M, 2020, J CLIN INVEST, V130, P335, DOI 10.1172/JCI129937; Beglova N, 2005, TRENDS BIOCHEM SCI, V30, P309, DOI 10.1016/j.tibs.2005.03.007; Bermingham ML, 2018, DIABETES CARE, V41, P79, DOI 10.2337/dc17-1042; Birn H, 2000, J CLIN INVEST, V105, P1353, DOI 10.1172/JCI8862; Boger CA, 2011, J AM SOC NEPHROL, V22, P555, DOI 10.1681/ASN.2010060598; Bowling CB, 2012, J GERONTOL A-BIOL, V67, P1379, DOI 10.1093/gerona/gls173; Brown MS, 1997, NATURE, V388, P629, DOI 10.1038/41672; Bu GJ, 1998, TRENDS CELL BIOL, V8, P272, DOI 10.1016/S0962-8924(98)01283-5; Chaudhury C, 2006, BIOCHEMISTRY-US, V45, P4983, DOI 10.1021/bi052628y; Chen TK, 2019, JAMA-J AM MED ASSOC, V322, P1294, DOI 10.1001/jama.2019.14745; Chiu J, 2019, J BIOL CHEM, V294, P2949, DOI 10.1074/jbc.REV118.005604; Christensen EI, 2001, AM J PHYSIOL-RENAL, V280, pF562, DOI 10.1152/ajprenal.2001.280.4.F562; Chun KJ, 2021, KIDNEY MED, V3, P732, DOI 10.1016/j.xkme.2021.04.009; Ciancio Jose I R, 2019, JIMD Rep, V49, P43, DOI 10.1002/jmd2.12072; Coudroy G, 2005, J AM SOC NEPHROL, V16, P2330, DOI 10.1681/ASN.2004110925; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; Dennis JW, 1999, BIOESSAYS, V21, P412, DOI 10.1002/(SICI)1521-1878(199905)21:5<412::AID-BIES8>3.0.CO;2-5; Dickson LE, 2014, J AM SOC NEPHROL, V25, P443, DOI 10.1681/ASN.2013090950; Dirlam-Schatz KA, 1998, J LIPID RES, V39, P402; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; El Karoui K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10330; El-Achkar TM, 2015, AM J PHYSIOL-RENAL, V308, pF1317, DOI 10.1152/ajprenal.00030.2015; Eshbach ML, 2017, ANNU REV PHYSIOL, V79, P425, DOI 10.1146/annurev-physiol-022516-034234; Fan Sheng-Bo, 2015, Curr Protoc Bioinformatics, V49, DOI 10.1002/0471250953.bi0821s49; Fang RP, 2020, ONCOGENE, V39, P2290, DOI 10.1038/s41388-019-1146-2; Fyfe JC, 2004, BLOOD, V103, P1573, DOI 10.1182/blood-2003-08-2852; Gosavi P, 2018, J CELL SCI, V131, DOI 10.1242/jcs.211987; Greaser ML, 2019, METHODS MOL BIOL, V1855, P203, DOI 10.1007/978-1-4939-8793-1_18; Greig KT, 2007, MOL CELL BIOL, V27, P5849, DOI 10.1128/MCB.00802-07; Haas ME, 2018, AM J HUM GENET, V103, P461, DOI 10.1016/j.ajhg.2018.08.004; Haraldsson B, 2008, PHYSIOL REV, V88, P451, DOI 10.1152/physrev.00055.2006; He LY, 2017, KIDNEY INT, V92, P1071, DOI 10.1016/j.kint.2017.06.030; He QC, 2005, BLOOD, V106, P1447, DOI 10.1182/blood-2005-03-1197; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hennet T, 2015, TRENDS BIOCHEM SCI, V40, P377, DOI 10.1016/j.tibs.2015.03.002; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Hirano M, 2017, BBA-GEN SUBJECTS, V1861, P3106, DOI 10.1016/j.bbagen.2016.10.015; Honorato RV, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.729513; Hopkins JB, 2017, J APPL CRYSTALLOGR, V50, P1545, DOI 10.1107/S1600576717011438; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Jayaprakash NG, 2017, BIOCHEM J, V474, P2333, DOI 10.1042/BCJ20170111; Jerabek-Willemsen M, 2014, J MOL STRUCT, V1077, P101, DOI 10.1016/j.molstruc.2014.03.009; Kalim S, 2014, AM J KIDNEY DIS, V64, P793, DOI 10.1053/j.ajkd.2014.04.034; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Klammt S, 2012, NEPHROL DIAL TRANSPL, V27, P2377, DOI 10.1093/ndt/gfr616; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Kristiansen M, 2000, BLOOD, V96, P405; Kristiansen M, 1999, J BIOL CHEM, V274, P20540, DOI 10.1074/jbc.274.29.20540; Larsen C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07468-4; Laskowski RA, 2018, PROTEIN SCI, V27, P129, DOI 10.1002/pro.3289; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lindblom A, 1999, J BIOL CHEM, V274, P6374, DOI 10.1074/jbc.274.10.6374; Long J, 2018, ADV CLIN CHEM, V87, P37, DOI 10.1016/bs.acc.2018.07.002; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Lyons JJ, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00054; Macconi D, 2006, AM J PATHOL, V168, P42, DOI 10.2353/ajpath.2006.050398; Makhoul Christian, 2021, Fac Rev, V10, P50, DOI 10.12703/r/10-50; Manalastas-Cantos K, 2021, J APPL CRYSTALLOGR, V54, P343, DOI 10.1107/S1600576720013412; Marques-da-Silva D, 2017, J INHERIT METAB DIS, V40, P657, DOI 10.1007/s10545-017-0066-y; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Mechref Y, 2012, BIOANALYSIS, V4, P2457, DOI 10.4155/bio.12.246; Mechref Y, 2012, ELECTROPHORESIS, V33, P1755, DOI 10.1002/elps.201100715; Mechref Yehia, 2009, V534, P53, DOI 10.1007/978-1-59745-022-5_4; Moestrup SK, 1998, J BIOL CHEM, V273, P5235, DOI 10.1074/jbc.273.9.5235; Molitoris BA, 2022, PHYSIOL REV, V102, P1625, DOI 10.1152/physrev.00014.2021; Monticelli M, 2016, J INHERIT METAB DIS, V39, P765, DOI 10.1007/s10545-016-9954-9; Mooers BHM, 2020, PROTEIN SCI, V29, P268, DOI 10.1002/pro.3781; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Nilsen J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32817-0; Parker RB, 2010, ACS CHEM BIOL, V5, P35, DOI 10.1021/cb9002514; Peanne R, 2018, EUR J MED GENET, V61, P643, DOI 10.1016/j.ejmg.2017.10.012; Peng WJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53984-8; Peng WJ, 2018, EXPERT REV PROTEOMIC, V15, P1007, DOI 10.1080/14789450.2018.1543594; Pyzik M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01540; Ravida A, 2015, KIDNEY INT, V87, P963, DOI 10.1038/ki.2014.387; Reece KL, 2007, ANAL BIOCHEM, V365, P274, DOI 10.1016/j.ab.2007.03.029; Reily C, 2019, NAT REV NEPHROL, V15, P346, DOI 10.1038/s41581-019-0129-4; Risso MA, 2019, INT J NEPHROL RENOV, V12, P257, DOI 10.2147/IJNRD.S216673; Sand KMK, 2015, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00682; Sarav M, 2009, J AM SOC NEPHROL, V20, P1941, DOI 10.1681/ASN.2008090976; Schulz A, 2008, PHYSIOL GENOMICS, V35, P30, DOI 10.1152/physiolgenomics.90270.2008; Scott CC, 2011, BIOESSAYS, V33, P103, DOI 10.1002/bies.201000108; Scott RP, 2015, J CELL BIOL, V209, P199, DOI 10.1083/jcb.201410017; SEETHARAM S, 1992, J BIOL CHEM, V267, P7421; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Shastri S, 2012, J AM GERIATR SOC, V60, P1201, DOI 10.1111/j.1532-5415.2012.04046.x; Sun MA, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3668-8; Tamaki M, 2014, KIDNEY INT, V85, P1330, DOI 10.1038/ki.2013.473; Tenten V, 2013, J AM SOC NEPHROL, V24, P1966, DOI 10.1681/ASN.2013010018; Teumer A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11576-0; Tian E, 2019, P NATL ACAD SCI USA, V116, P25196, DOI 10.1073/pnas.1909573116; Udagawa T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20731-4; Ullah MM, 2019, SEMIN NEPHROL, V39, P567, DOI 10.1016/j.semnephrol.2019.10.006; Venkatachalam MA, 2015, J AM SOC NEPHROL, V26, P1765, DOI 10.1681/ASN.2015010006; Verbrugge FH, 2015, KIDNEY INT, V88, P474, DOI 10.1038/ki.2015.166; Wagner MC, 2016, AM J PHYSIOL-RENAL, V310, pF1089, DOI 10.1152/ajprenal.00605.2015; Wagner MC, 2016, J AM SOC NEPHROL, V27, P482, DOI 10.1681/ASN.2014111107; Wagner MC, 1999, PEDIATR NEPHROL, V13, P163, DOI 10.1007/s004670050586; Waikar SS, 2016, NEPHROL DIAL TRANSPL, V31, P1460, DOI 10.1093/ndt/gfw203; Wang SJ, 2018, J BIOL CHEM, V293, P7408, DOI 10.1074/jbc.M117.817981; Xia BY, 2005, GLYCOBIOLOGY, V15, P747, DOI 10.1093/glycob/cwi061; Yadav SPS, 2021, AM J PHYSIOL-RENAL, V320, pF114, DOI 10.1152/ajprenal.00428.2020; Yammani RR, 2001, J BIOL CHEM, V276, P44777, DOI 10.1074/jbc.M106419200; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yu AY, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11111677; Yu AY, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11111560; Yu CY, 2013, BIOINFORMATICS, V29, P1706, DOI 10.1093/bioinformatics/btt190; Zhang H, 2008, BBA-GEN SUBJECTS, V1780, P479, DOI 10.1016/j.bbagen.2007.10.012; Zhao HY, 2011, BIOPHYS J, V100, P2309, DOI 10.1016/j.bpj.2011.03.004; Zhou SY, 2015, J AM SOC MASS SPECTR, V26, P596, DOI 10.1007/s13361-014-1054-1	119	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	10							102371	10.1016/j.jbc.2022.102371	http://dx.doi.org/10.1016/j.jbc.2022.102371			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6G8HI	35970386	gold, Green Published			2022-12-26	WOS:000884990700001
J	Stewart, TM; Foley, JR; Holbert, CE; Klinke, G; Poschet, G; Steimbach, RR; Miller, AK; Casero, RAC				Stewart, Tracy Murray; Foley, Jackson R.; Holbert, Cassandra E.; Klinke, Glynis; Poschet, Gernot; Steimbach, Raphael R.; Miller, Aubry K.; Casero Jr, Robert A.			Histone deacetylase-10 liberates spermidine to support polyamine homeostasis and tumor cell growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORT INHIBITORS; N-8-ACETYLSPERMIDINE; ACETYLATION; DERIVATIVES; IDENTIFICATION; COMBINATION; METABOLISM; HDAC10; CANCER; URINE	Cytosolic histone deacetylase-10 (HDAC10) specifically deacetylates the modified polyamine N8-acetylspermidine (N8-AcSpd). Although intracellular concentrations of N8- AcSpd are low, extracellular sources can be abundant, particularly in the colonic lumen. Extracellular polyamines, including those from the diet and microbiota, can support tumor growth both locally and at distant sites. However, the contribution of N8-AcSpd in this context is unknown. We hypothesized that HDAC10, by converting N8- AcSpd to spermidine, may provide a source of this growth-supporting polyamine in circumstances of reduced polyamine biosyn-thesis, such as in polyamine-targeting anticancer therapies. Inhibitors of polyamine biosynthesis, including alpha-difluor-omethylornithine (DFMO), inhibit tumor growth, but compensatory uptake of extracellular polyamines has limited their clinical success. Combining DFMO with inhibitors of polyamine uptake have improved the antitumor response. However, acetylated polyamines may use different transport machinery than the parent molecules. Here, we use CRISPR/ Cas9-mediated HDAC10-knockout cell lines and HDAC10-specific inhibitors to investigate the contribution of HDAC10 in maintaining tumor cell proliferation. We demonstrate inhibition of cell growth by DFMO-associated polyamine depletion is successfully rescued by exogenous N8-AcSpd (at physiological concentrations), which is con-verted to spermidine and spermine, only in cell lines with HDAC10 activity. Furthermore, we show loss of HDAC10 prevents both restoration of polyamine levels and growth rescue, implicating HDAC10 in supporting polyamine-associated tumor growth. These data suggest the utility of HDAC10-specific inhibitors as an antitumor strategy that may have value in improving the response to polyamine-blocking therapies. Additionally, the cell-based assay devel-oped in this study provides an inexpensive, high-throughput method of screening potentially selective HDAC10 inhibitors.	[Stewart, Tracy Murray; Foley, Jackson R.; Holbert, Cassandra E.; Casero Jr, Robert A.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Sch Med, Baltimore, MD 21205 USA; [Klinke, Glynis; Poschet, Gernot] Heidelberg Univ, Ctr Organismal Studies COS, Metabol Core Technol Platform, Heidelberg, Germany; [Steimbach, Raphael R.] Heidelberg Univ, Biosci Fac, Heidelberg, Germany; [Steimbach, Raphael R.; Miller, Aubry K.] German Canc Res Ctr, Canc Drug Dev, Heidelberg, Germany; [Miller, Aubry K.] German Canc Consortium DKTK, Heidelberg, Germany	Johns Hopkins University; Johns Hopkins Medicine; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Stewart, TM; Casero, RAC (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Sch Med, Baltimore, MD 21205 USA.	tmurray2@jhmi.edu; rcasero@jhmi.edu		Steimbach, Raphael/0000-0002-5509-3959; Holbert, Cassandra/0000-0002-4869-1301	US National Institutes of Health, United States [CA204345, CA235863]; Samuel Waxman Cancer Research Foundation, United States; University of Pennsylvania Orphan Disease Center, United States Million Dollar Bike Ride [MDBR-20-135-SRS]; Chan Zuckerberg Initiative	US National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Samuel Waxman Cancer Research Foundation, United States; University of Pennsylvania Orphan Disease Center, United States Million Dollar Bike Ride; Chan Zuckerberg Initiative	Work in the Casero and Stewart laboratory is supported by grants from the US National Institutes of Health, United States (CA204345 and CA235863), the Samuel Waxman Cancer Research Foundation, United States, the University of Pennsylvania Orphan Disease Center, United States Million Dollar Bike Ride (MDBR-20-135-SRS), the Chan Zuckerberg Initiative, and a research contract from Panbela Therapeutics, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abela L, 2016, J INHERIT METAB DIS, V39, P131, DOI 10.1007/s10545-015-9876-y; Alexander ET, 2021, CANCER BIOL THER, V22, P225, DOI 10.1080/15384047.2021.1883185; Alexander ET, 2020, MOL CANCER THER, V19, P2012, DOI 10.1158/1535-7163.MCT-19-1116; Bassiri H, 2015, TRANSL PEDIATR, V4, P226, DOI 10.3978/j.issn.2224-4336.2015.04.06; BLANKENSHIP J, 1984, P SOC EXP BIOL MED, V177, P180, DOI 10.3181/00379727-177-41930; BLANKENSHIP J, 1978, ARCH BIOCHEM BIOPHYS, V189, P20, DOI 10.1016/0003-9861(78)90109-1; BLANKENSHIP J, 1977, ARCH BIOCHEM BIOPHYS, V179, P235, DOI 10.1016/0003-9861(77)90108-4; Burns MR, 2009, J MED CHEM, V52, P1983, DOI 10.1021/jm801580w; Casero RA, 2018, NAT REV CANCER, V18, P681, DOI 10.1038/s41568-018-0050-3; Cheng FJ, 2021, BIOSCIENCE REP, V41, DOI 10.1042/BSR20210462; Chin Alexander, 2022, Med Sci (Basel), V10, DOI 10.3390/medsci10020031; Conway LP, 2020, ANGEW CHEM INT EDIT, V59, P14342, DOI 10.1002/anie.202005915; DESIDERIO MA, 1992, EXP CELL RES, V202, P501, DOI 10.1016/0014-4827(92)90105-H; Ferioli ME, 1996, BBA-MOL BASIS DIS, V1317, P15, DOI 10.1016/0925-4439(96)00029-4; Gerner EW, 2018, J BIOL CHEM, V293, P18770, DOI 10.1074/jbc.TM118.003343; Gitto SB, 2018, MOL PHARMACEUT, V15, P369, DOI 10.1021/acs.molpharmaceut.7b00718; Hai Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15368; Hayes CS, 2014, CANCER IMMUNOL RES, V2, P274, DOI 10.1158/2326-6066.CIR-13-0120-T; Holbert CE, 2022, NAT REV CANCER, V22, P467, DOI 10.1038/s41568-022-00473-2; KABRA PM, 1986, J CHROMATOGR, V380, P19, DOI 10.1016/S0378-4347(00)83621-X; LOSER C, 1990, CANCER, V65, P958, DOI 10.1002/1097-0142(19900215)65:4<958::AID-CNCR2820650423>3.0.CO;2-Z; MAMONT PS, 1981, MED BIOL, V59, P347; Minois N, 2011, AGING-US, V3, P716, DOI 10.18632/aging.100361; Mudumba S, 2002, BIOCHEM PHARMACOL, V63, P2011, DOI 10.1016/S0006-2952(02)00991-7; Muth A, 2014, J MED CHEM, V57, P348, DOI 10.1021/jm401174a; Nakajima T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030756; Nakamura A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22212-1; Nayak A, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.016055; Oehme I, 2013, P NATL ACAD SCI USA, V110, pE2592, DOI 10.1073/pnas.1300113110; PORTER CW, 1985, CANCER RES, V45, P2050; Rao JN, 2020, PHYSIOLOGY, V35, P328, DOI 10.1152/physiol.00011.2020; Ridinger J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28265-5; Saiki S, 2019, ANN NEUROL, V86, P251, DOI 10.1002/ana.25516; Sanchez-Alcoholado L, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22179549; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Seiler N, 2004, AMINO ACIDS, V26, P217, DOI 10.1007/s00726-004-0070-z; SEILER N, 1987, CAN J PHYSIOL PHARM, V65, P2024, DOI 10.1139/y87-317; Steimbach R. R., 2022, CHEMRXIV, DOI [10.26434/chemrxiv-2021-37shs-v2, DOI 10.26434/CHEMRXIV-2021-37SHS-V2]; Stewart TM, 2018, J BIOL CHEM, V293, P18736, DOI 10.1074/jbc.TM118.003337; Tao XX, 2017, ONCOL LETT, V14, P4923, DOI 10.3892/ol.2017.6818; Tong JJ, 2002, NUCLEIC ACIDS RES, V30, P1114, DOI 10.1093/nar/30.5.1114; Udo R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78038-2; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Viltard M, 2019, AGING-US, V11, P4783, DOI 10.18632/aging.102116; Wallace HM, 1998, BIOCHEM SOC T, V26, P571, DOI 10.1042/bst0260571; Weeks RS, 2000, EXP CELL RES, V261, P293, DOI 10.1006/excr.2000.5033; Weiss TS, 2004, INFLAMM BOWEL DIS, V10, P529, DOI 10.1097/00054725-200409000-00006; Xie XZ, 1997, J BIOL CHEM, V272, P20484, DOI 10.1074/jbc.272.33.20484; Yang YW, 2016, ONCOTARGET, V7, P59388, DOI 10.18632/oncotarget.10673; Yoshimoto S, 2021, GUT MICROBES, V13, P1, DOI 10.1080/19490976.2020.1865705; Zhang T, 2022, J ONCOL, V2022, DOI 10.1155/2022/3938652	51	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	298	10							102407	10.1016/j.jbc.2022.102407	http://dx.doi.org/10.1016/j.jbc.2022.102407			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5K6GU	35988653	Green Published, gold			2022-12-26	WOS:000869823800013
J	Shearer, HL; Pace, PE; Paton, JC; Hampton, MB; Dickerhof, N				Shearer, Heather L.; Pace, Paul E.; Paton, James C.; Hampton, Mark B.; Dickerhof, Nina			A newly identified flavoprotein disulfide reductase Har protects Streptococcus pneumoniae against hypothiocyanous acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELOPEROXIDASE-DERIVED OXIDANTS; PEROXIDASE-CATALYZED OXIDATION; THIOREDOXIN REDUCTASE; OXIDIZED GLUTATHIONE; GENOME SEQUENCE; HOST-DEFENSE; THIOCYANATE; LACTOPEROXIDASE; QUANTITATION; FLUID	Hypothiocyanous acid (HOSCN) is an antimicrobial oxidant produced from hydrogen peroxide and thiocyanate anions by heme peroxidases in secretory fluids such as in the human respiratory tract. Some respiratory tract pathogens display tolerance to this oxidant, which suggests that there might be therapeutic value in targeting HOSCN defense mechanisms. However, surprisingly little is known about how bacteria protect themselves from HOSCN. We hypothesized that tolerant pathogens have a flavoprotein disulfide reductase that uses NAD(P)H to directly reduce HOSCN, similar to thioredoxin reductase in mammalian cells. Here, we report the discovery of a previously uncharacterized flavoprotein disulfide reductase with HOSCN reductase activity, which we term Har (hypothiocyanous acid reductase), in Streptococcus pneumoniae, a bacterium previously found to be tolerant of HOSCN. S. pneumoniae generates large amounts of hydrogen peroxide that can be converted to HOSCN in the respiratory tract. Using deletion mutants, we demonstrate that the HOSCN reductase is dispensable for growth of S. pneumoniae in the presence of lactoperoxidase and thiocyanate. However, bacterial growth in the HOSCN-generating system was completely crippled when deletion of HOSCN reductase activity was combined with disruption of GSH import or recycling. Our findings identify a new bacterial HOSCN reductase and demonstrate a role for this protein in combination with GSH utilization to protect S. pneumoniae from HOSCN.	[Shearer, Heather L.; Pace, Paul E.; Hampton, Mark B.; Dickerhof, Nina] Univ Otago Christchurch, Ctr Free Rad Res, Dept Pathol & Biomed Sci, Christchurch, New Zealand; [Paton, James C.] Univ Adelaide, Res Ctr Infect Dis, Dept Mol & Biomed Sci, Adelaide, SA, Australia	University of Otago; University of Adelaide	Dickerhof, N (corresponding author), Univ Otago Christchurch, Ctr Free Rad Res, Dept Pathol & Biomed Sci, Christchurch, New Zealand.	nina.dickerhof@otago.ac.nz		Shearer, Heather/0000-0001-8191-7723	Canterbury Medical Research Foundation, New Zealand [05/20]; University of Otago, New Zealand [3579]; Health Research Council of New Zealand, New Zealand	Canterbury Medical Research Foundation, New Zealand; University of Otago, New Zealand; Health Research Council of New Zealand, New Zealand(Health Research Council of New Zealand)	This study was supported by the Canterbury Medical Research Foundation, New Zealand (project grant number: #05/20), a University of Otago, New Zealand research grant (grant number: #3579), and a Sir Charles Hercus Health Research Fellowship from the Health Research Council of New Zealand, New Zealand to N.D.	ARNER ESJ, 1995, J BIOL CHEM, V270, P3479, DOI 10.1074/jbc.270.8.3479; Ashby MT, 2004, J AM CHEM SOC, V126, P15976, DOI 10.1021/ja0438361; AUNE TM, 1978, BIOCHEMISTRY-US, V17, P1005, DOI 10.1021/bi00599a010; AUNE TM, 1977, EUR J BIOCHEM, V80, P209, DOI 10.1111/j.1432-1033.1977.tb11873.x; Auzat I, 1999, MOL MICROBIOL, V34, P1018, DOI 10.1046/j.1365-2958.1999.01663.x; Baek Y, 2020, J BIOL CHEM, V295, P3202, DOI 10.1074/jbc.RA119.011530; BEERS RF, 1952, J BIOL CHEM, V195, P133; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brouwer S, 2022, MBIO, V13, DOI 10.1128/mbio.00676-22; BUNNELL E, 1993, AM REV RESPIR DIS, V148, P1174, DOI 10.1164/ajrccm/148.5.1174; CANTIN AM, 1987, J APPL PHYSIOL, V63, P152, DOI 10.1152/jappl.1987.63.1.152; CARLSSON J, 1983, INFECT IMMUN, V40, P70, DOI 10.1128/IAI.40.1.70-80.1983; Chandler JD, 2013, J BIOL CHEM, V288, P18421, DOI 10.1074/jbc.M113.468090; Chandler JD, 2012, BIOCHEM PHARMACOL, V84, P1381, DOI 10.1016/j.bcp.2012.07.029; Coker MSA, 2008, CHEM RES TOXICOL, V21, P2334, DOI 10.1021/tx800232v; Derke RM, 2020, MBIO, V11, DOI 10.1128/mBio.01905-20; Dickerhof N, 2014, BIOCHEM J, V462, P303, DOI 10.1042/BJ20140612; GRISHAM MB, 1984, J BIOL CHEM, V259, P404; Hajaj B, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00210; Hajaj B, 2012, INFECT IMMUN, V80, P4333, DOI 10.1128/IAI.00126-12; Harbut MB, 2015, P NATL ACAD SCI USA, V112, P4453, DOI 10.1073/pnas.1504022112; HARRISON JE, 1976, J BIOL CHEM, V251, P1371; HORECKER BL, 1948, J BIOL CHEM, V175, P385; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Kettle AJ, 2014, EUR RESPIR J, V44, P122, DOI 10.1183/09031936.00170213; KUMARESAN KR, 1995, J BACTERIOL, V177, P3641, DOI 10.1128/jb.177.13.3641-3646.1995; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Lorentzen D, 2011, FREE RADICAL BIO MED, V50, P1144, DOI 10.1016/j.freeradbiomed.2011.02.013; Meredith Julia D, 2022, Proc Natl Acad Sci U S A, V119, pe2119368119, DOI 10.1073/pnas.2119368119; Nagy P, 2009, CHEM RES TOXICOL, V22, P1833, DOI 10.1021/tx900249d; Pattison DI, 2006, CURR MED CHEM, V13, P3271, DOI 10.2174/092986706778773095; Pattison DI, 2012, FREE RADICAL RES, V46, P975, DOI 10.3109/10715762.2012.667566; Paul K. G., 1985, Immunology Series, V27, P15; Pericone CD, 2000, INFECT IMMUN, V68, P3990, DOI 10.1128/IAI.68.7.3990-3997.2000; Pericone CD, 2003, J BACTERIOL, V185, P6815, DOI 10.1128/JB.185.23.6815-6825.2003; Potter AJ, 2012, J BACTERIOL, V194, P6248, DOI 10.1128/JB.01393-12; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Schultz CP, 1996, ANAL BIOCHEM, V240, P7, DOI 10.1006/abio.1996.0323; Seidel A, 2014, J BIOL CHEM, V289, P21937, DOI 10.1074/jbc.M113.544957; Shearer HL, 2022, INFECT IMMUN, V90, DOI [10.1128/iai.00530-21, 10.1128/IAI.00530-21]; Shearer HL, 2022, FREE RADICAL BIO MED, V179, P24, DOI 10.1016/j.freeradbiomed.2021.12.261; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; THOMAS EL, 1978, INFECT IMMUN, V20, P456, DOI 10.1128/IAI.20.2.456-463.1978; THOMAS EL, 1978, ANTIMICROB AGENTS CH, V13, P1006, DOI 10.1128/AAC.13.6.1006; THOMAS EL, 1994, J DENT RES, V73, P544, DOI 10.1177/00220345940730021001; THOMPSON ST, 1975, P NATL ACAD SCI USA, V72, P669, DOI 10.1073/pnas.72.2.669; Thomson E, 2010, FREE RADICAL BIO MED, V49, P1354, DOI 10.1016/j.freeradbiomed.2010.07.010; van Dalen CJ, 2001, BIOCHEM J, V358, P233, DOI 10.1042/0264-6021:3580233; van der Vliet A, 2008, FREE RADICAL BIO MED, V44, P938, DOI 10.1016/j.freeradbiomed.2007.11.016; van Opijnen Tim, 2014, Curr Protoc Mol Biol, V106, DOI [10.1002/9780471729259.mc01e03s36, 10.1002/0471142727.mb0716s106]; vanDalen CJ, 1997, BIOCHEM J, V327, P487; VANHAERINGEN NJ, 1979, EXP EYE RES, V28, P343, DOI 10.1016/0014-4835(79)90095-2; Vergauwen B, 2013, MOL MICROBIOL, V89, P288, DOI 10.1111/mmi.12274; VILJA P, 1991, J IMMUNOL METHODS, V141, P277, DOI 10.1016/0022-1759(91)90154-8; Weiser JN, 2018, NAT REV MICROBIOL, V16, P354, DOI 10.1038/s41579-018-0001-8; Wijkstrom-Frei C, 2003, AM J RESP CELL MOL, V29, P206, DOI 10.1165/rcmb.2002-0152OC; Winterbourn CC, 2016, ANNU REV BIOCHEM, V85, P765, DOI 10.1146/annurev-biochem-060815-014442; Yesilkaya H, 2013, TRENDS MICROBIOL, V21, P187, DOI 10.1016/j.tim.2013.01.004	58	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102359	10.1016/j.jbc.2022.102359	http://dx.doi.org/10.1016/j.jbc.2022.102359			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5B1GH	35952759	Green Published, gold			2022-12-26	WOS:000863323200002
J	Zhao, J; Chen, J; Zhu, W; Qi, XM; Wu, YG				Zhao, Jing; Chen, Juan; Zhu, Wei; Qi, Xiang-ming; Wu, Yong-gui			Exosomal miR-7002-5p derived from highglucose-induced macrophages suppresses autophagy in tubular epithelial cells by targeting Atg9b	FASEB JOURNAL			English	Article						Atg9b; autophagy; exosomes; macrophages; tubular epithelial cells		Macrophage infiltration plays an important role in the progression of diabetic nephropathy (DN). Previously, we demonstrated that highglucose-stimulated macrophage-derived exosomes (HG-exo) induces proliferation and extracellular matrix accumulation in glomerular mesangial cells, but its effect on tubular cells is unclear. This study aimed to explore the role of HG-exo on renal tubular injury in DN. The results show that HG-exo could induce dysfunction, autophagy inhibition, and inflammation in mouse tubular epithelial cell (mTEC) and C57 mouse kidney. Moreover, miR-7002-5p was differentially expressed in HG-exo based on miRNAs sequencing and bioinformatics analysis. A dual-luciferase reporter assay confirmed that Atg9b was the direct target gene of miR-7002-5p. Further experimentation showed that miR-7002-5p inhibition in vivo and vitro reserves HG-exo effects. These results demonstrated that HG-exo carries excessive miR-7002-5p and inhibits autophagy through targeting Atg9b; this process then induces renal tubular dysfunction and inflammation. In conclusion, our study clarifies the important role of macrophage-derived exosomes in DN and is expected to provide new insight on DN prevention and treatment.	[Zhao, Jing; Chen, Juan; Zhu, Wei; Qi, Xiang-ming; Wu, Yong-gui] Anhui Med Univ, Dept Nephropathy, Affiliated Hosp 1, Hefei 230022, Anhui, Peoples R China; [Wu, Yong-gui] Anhui Med Univ, Ctr Sci Res, Hefei, Peoples R China	Anhui Medical University; Anhui Medical University	Qi, XM; Wu, YG (corresponding author), Anhui Med Univ, Dept Nephropathy, Affiliated Hosp 1, Hefei 230022, Anhui, Peoples R China.	qxm119@126.com; wuyonggui@medmail.com.cn			National Natural Science Foundation of China [81770722]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported financially by National Natural Science Foundation of China (grant no. 81770722).	Chen SJ, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12763; Cole JB, 2020, NAT REV NEPHROL, V16, P377, DOI 10.1038/s41581-020-0278-5; Dikic I, 2018, NAT REV MOL CELL BIO, V19, P349, DOI 10.1038/s41580-018-0003-4; Fan Z, 2018, IMMUNOL INVEST, V47, P303, DOI 10.1080/08820139.2018.1428199; Fan Z, 2018, INT IMMUNOPHARMACOL, V58, P145, DOI 10.1016/j.intimp.2018.03.019; Fu J, 2019, J AM SOC NEPHROL, V30, P533, DOI 10.1681/ASN.2018090896; Gao C, 2021, NUTR DIABETES, V11, DOI 10.1038/s41387-021-00175-y; Gluhovschi C, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/4626125; Javier PH., 2021, HYPERTENSION, V77, P960; Jia YL, 2017, ONCOTARGET, V8, P41717, DOI 10.18632/oncotarget.16684; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Koga Y, 2011, J GASTROINTEST ONCOL, V2, P215, DOI 10.3978/j.issn.2078-6891.2011.015; Li Z, 2021, CANCER MANAG RES, V13, P25, DOI 10.2147/CMAR.S272140; Liang WJ, 2020, AGING CELL, V19, DOI 10.1111/acel.13187; Ma ZW, 2020, J CLIN INVEST, V130, P5011, DOI 10.1172/JCI135536; Maeda S, 2020, NAT STRUCT MOL BIOL, V27, P1194, DOI 10.1038/s41594-020-00520-2; Milane L, 2015, J CONTROL RELEASE, V219, P278, DOI 10.1016/j.jconrel.2015.06.029; Mizushima N, 2020, NEW ENGL J MED, V383, P1564, DOI 10.1056/NEJMra2022774; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Nolte-'t Hoen ENM, 2012, NUCLEIC ACIDS RES, V40, P9272, DOI 10.1093/nar/gks658; Panfoli I, 2020, EXPERT REV PROTEOMIC, V17, P735, DOI 10.1080/14789450.2020.1866993; Peng L, 2022, STEM CELL RES THER, V13, DOI 10.1186/s13287-021-02696-w; Robert CL., 2018, CURR PHARM DESIGN, V24, P2241; Schlondorff D, 2009, J AM SOC NEPHROL, V20, P1179, DOI 10.1681/ASN.2008050549; Selby NM, 2020, DIABETES OBES METAB, V22, P3, DOI 10.1111/dom.14007; Suzuki C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010155; Thomas MC, 2005, ADV CHRONIC KIDNEY D, V12, P177, DOI 10.1053/j.ackd.2005.01.008; Van JAD, 2017, J AM SOC NEPHROL, V28, P1050, DOI 10.1681/ASN.2016091018; Wang N, 2017, THERANOSTICS, V7, P2325, DOI 10.7150/thno.18225; Wang X, 2017, DIABETES, V66, P494, DOI 10.2337/db16-0773; Xiao DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046874; Yang C, 2021, AUTOPHAGY, V17, P2325, DOI 10.1080/15548627.2020.1824694; Zeng HX, 2020, INFLAMM RES, V69, P1215, DOI 10.1007/s00011-020-01411-4; Zhu M, 2020, INT IMMUNOPHARMACOL, V84, DOI 10.1016/j.intimp.2020.106551; Zhu QJ, 2019, FASEB J, V33, P9279, DOI 10.1096/fj.201802427RRR	35	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22501	10.1096/fj.202200550RR	http://dx.doi.org/10.1096/fj.202200550RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3U0VK	35971776				2022-12-26	WOS:000840688400001
J	Wessels, F; Schmitt, M; Krieghoff-Henning, E; Kather, JN; Nientiedt, M; Kriegmair, MC; Worst, TS; Neuberger, M; Steeg, M; Popovic, ZV; Gaiser, T; von Kalle, C; Utikal, JS; Frohling, S; Michel, MS; Nuhn, P; Brinker, TJ				Wessels, Frederik; Schmitt, Max; Krieghoff-Henning, Eva; Kather, Jakob N.; Nientiedt, Malin; Kriegmair, Maximilian C.; Worst, Thomas S.; Neuberger, Manuel; Steeg, Matthias; Popovic, Zoran, V; Gaiser, Timo; von Kalle, Christof; Utikal, Jochen S.; Froehling, Stefan; Michel, Maurice S.; Nuhn, Philipp; Brinker, Titus J.			Deep learning can predict survival directly from histology in clear cell renal cell carcinoma	PLOS ONE			English	Article							VALIDATION; DIAGNOSIS; MODELS	For clear cell renal cell carcinoma (ccRCC) risk-dependent diagnostic and therapeutic algorithms are routinely implemented in clinical practice. Artificial intelligence-based image analysis has the potential to improve outcome prediction and thereby risk stratification. Thus, we investigated whether a convolutional neural network (CNN) can extract relevant image features from a representative hematoxylin and eosin-stained slide to predict 5-year overall survival (5y-OS) in ccRCC. The CNN was trained to predict 5y-OS in a binary manner using slides from TCGA and validated using an independent in-house cohort. Multivariable logistic regression was used to combine of the CNNs prediction and clinicopathological parameters. A mean balanced accuracy of 72.0% (standard deviation [SD] = 7.9%), sensitivity of 72.4% (SD = 10.6%), specificity of 71.7% (SD = 11.9%) and area under receiver operating characteristics curve (AUROC) of 0.75 (SD = 0.07) was achieved on the TCGA training set (n = 254 patients / WSIs) using 10-fold cross-validation. On the external validation cohort (n = 99 patients / WSIs), mean accuracy, sensitivity, specificity and AUROC were 65.5% (95%-confidence interval [CI]: 62.9-68.1%), 86.2% (95%-CI: 81.8-90.5%), 44.9% (95%-CI: 40.2-49.6%), and 0.70 (95%-CI: 0.69-0.71). A multivariable model including age, tumor stage and metastasis yielded an AUROC of 0.75 on the TCGA cohort. The inclusion of the CNN-based classification (Odds ratio = 4.86, 95%-CI: 2.70-8.75, p < 0.01) raised the AUROC to 0.81. On the validation cohort, both models showed an AUROC of 0.88. In univariable Cox regression, the CNN showed a hazard ratio of 3.69 (95%-CI: 2.60-5.23, p < 0.01) on TCGA and 2.13 (95%-CI: 0.92-4.94, p = 0.08) on external validation. The results demonstrate that the CNN's image-based prediction of survival is promising and thus this widely applicable technique should be further investigated with the aim of improving existing risk stratification in ccRCC.	[Wessels, Frederik; Schmitt, Max; Krieghoff-Henning, Eva; Brinker, Titus J.] German Canc Res Ctr, Natl Ctr Tumor Dis NCT, Digital Biomarkers Oncol Grp, Heidelberg, Germany; [Wessels, Frederik; Nientiedt, Malin; Kriegmair, Maximilian C.; Worst, Thomas S.; Neuberger, Manuel; Michel, Maurice S.; Nuhn, Philipp] Heidelberg Univ, Univ Med Ctr Mannheim, Med Fac Mannheim, Dept Urol & Urol Surg, Mannheim, Germany; [Kather, Jakob N.] Univ Hosp RWTH Aachen, Dept Med 3, Aachen, Germany; [Kather, Jakob N.] Univ Leeds, Div Pathol & Data Analyt, Leeds Inst Med Res & St Jamess, Leeds, W Yorkshire, England; [Kather, Jakob N.] Univ Hosp Heidelberg, Natl Ctr Tumor Dis NCT, Med Oncol, Heidelberg, Germany; [Steeg, Matthias; Popovic, Zoran, V; Gaiser, Timo] Heidelberg Univ, Univ Med Ctr Mannheim, Med Fac Mannheim, Inst Pathol, Mannheim, Germany; [von Kalle, Christof] Charite, Berlin Inst Hlth BIH, Dept Clin Translat Sci, Berlin, Germany; [Utikal, Jochen S.] Heidelberg Univ, German Canc Res Ctr DKFZ, Univ Med Ctr Mannheim, Clin Cooperat Unit Dermatooncol, Mannheim, Germany; [Froehling, Stefan] German Canc Res Ctr, Natl Ctr Tumor Dis, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; RWTH Aachen University; RWTH Aachen University Hospital; University of Leeds; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Brinker, TJ (corresponding author), German Canc Res Ctr, Natl Ctr Tumor Dis NCT, Digital Biomarkers Oncol Grp, Heidelberg, Germany.	titus.brinker@dkfz.de		Wessels, Frederik/0000-0003-4213-8692	Federal Ministry of Health, Berlin, Germany [2519DAT712]; German Federal Ministry of Health (DEEP LIVER) [ZMVI1-2520DAT111]; Max-EderProgramme of the German Cancer Aid [70113864]	Federal Ministry of Health, Berlin, Germany; German Federal Ministry of Health (DEEP LIVER); Max-EderProgramme of the German Cancer Aid	This study was funded by the Federal Ministry of Health, Berlin, Germany (grant: Tumorverhalten-Praediktions-Initiative; grant holder: Titus J. Brinker, German Cancer Research Center; #2519DAT712). JNK is supported by the German Federal Ministry of Health (DEEP LIVER, #ZMVI1-2520DAT111) and the Max-EderProgramme of the German Cancer Aid (#70113864). The sponsors had no role in the design and conduct of the study, collection, management, analysis and interpretation of the data, preparation, review or approval of the manuscript, and decision to submit the manuscript for publication.	Abu-Ghanem Y, 2021, EUR UROL ONCOL, V4, P473, DOI 10.1016/j.euo.2020.09.005; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen ST, 2021, INT J CANCER, V148, P780, DOI 10.1002/ijc.33288; Cheng J, 2018, BIOINFORMATICS, V34, P1024, DOI 10.1093/bioinformatics/btx723; Chilamkurthy S, 2018, LANCET, V392, P2388, DOI 10.1016/S0140-6736(18)31645-3; Collins GS, 2015, BRIT J CANCER, V112, P251, DOI 10.1038/bjc.2014.639; Faust K, 2020, JCO CLIN CANCER INFO, V4, P811, DOI 10.1200/CCI.20.00035; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Fu Y, 2020, NAT CANCER, V1, P800, DOI 10.1038/s43018-020-0085-8; Graziani M, 2020, COMPUT BIOL MED, V123, DOI 10.1016/j.compbiomed.2020.103865; Heng DYC, 2013, LANCET ONCOL, V14, P141, DOI 10.1016/S1470-2045(12)70559-4; Heng DYC, 2009, J CLIN ONCOL, V27, P5794, DOI 10.1200/JCO.2008.21.4809; Howard FM, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24698-1; Howard J, 2020, INFORMATION, V11, DOI 10.3390/info11020108; Kather JN, 2020, NAT CANCER, V1, P789, DOI 10.1038/s43018-020-0087-6; Kather JN, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002730; Leibovich BC, 2018, EUR UROL, V73, P772, DOI 10.1016/j.eururo.2018.01.005; Leslie N. Smith, 2018, Arxiv, DOI arXiv:1803.09820; Ljungberg B, 2019, EUR UROL, V75, P799, DOI 10.1016/j.eururo.2019.02.011; Loeffler CML, 2022, EUR UROL FOCUS, V8, P472, DOI 10.1016/j.euf.2021.04.007; Margulis V, 2013, EUR UROL, V63, P947, DOI 10.1016/j.eururo.2012.11.040; Marostica E, 2021, CLIN CANCER RES, V27, P2868, DOI 10.1158/1078-0432.CCR-20-4119; Mehbodniya A, 2022, EXPERT SYST, V39, DOI 10.1111/exsy.12899; Pandya S, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21237786; Pantanowitz L, 2020, LANCET DIGIT HEALTH, V2, pE407, DOI 10.1016/S2589-7500(20)30159-X; Paszke A, 2019, ADV NEUR IN, V32; Shah APK, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.762303; Shim WS, 2021, CANCERS, V13, DOI 10.3390/cancers13133308; Skrede OJ, 2020, LANCET, V395, P350, DOI 10.1016/S0140-6736(19)32998-8; Suarez-Ibarrola R, 2020, WORLD J UROL, V38, P2329, DOI 10.1007/s00345-019-03000-5; Tabibu S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46718-3; Tolkach Y, 2020, NAT MACH INTELL, V2, P411, DOI 10.1038/s42256-020-0200-7; Woerl AC, 2020, EUR UROL, V78, P256, DOI 10.1016/j.eururo.2020.04.023; Zheng WW, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-07586-7; Zhu J, 2020, TRANSL ANDROL UROL, V9, P2629, DOI 10.21037/tau-19-687	36	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0272656	10.1371/journal.pone.0272656	http://dx.doi.org/10.1371/journal.pone.0272656			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976907	Green Published, gold			2022-12-26	WOS:000847227000053
J	Lv, SL; Zhao, XF; Zhang, EL; Yan, YY; Ma, XY; Li, N; Zou, QL; Sun, LD; Song, TJ				Lv, Suli; Zhao, Xuefeng; Zhang, Erlei; Yan, Yingying; Ma, Xianyun; Li, Neng; Zou, Qingli; Sun, Lidong; Song, Tanjing			Lysine demethylase KDM1A promotes cell growth via FKBP8-BCL2 axis in hepatocellular carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SORAFENIB RESISTANCE; LSD1; BCL-2; APOPTOSIS; FKBP38; SYSTEM; DEATH	Advanced hepatocellular carcinoma (HCC) has a dismal prognosis. KDM1A (lysine demethylase 1A), overexpressed in multiple cancer types, is a lysine demethylase that targets both histone and nonhistone proteins. However, it is unclear how KDM1A expression affects HCC etiology. Here, we show that KDM1A can interact with and demethylate FKBP8 (FKBP prolyl isomerase 8), a cytoplasmic protein that regulates cell survival through the antiapoptotic protein BCL2 (B-cell lymphoma-2). We show that demethylation of FKBP8 enhances its ability to stabilize BCL2. Consistently, we observed positive correlation between KDM1A and BCL2 protein levels in liver cancer patients. Functionally, we reveal that FKBP8 demethylation by KDM1A is critical for liver cancer cell growth in vitro and in vivo. We went on to explore the mechanisms that might regulate KDM1A cytoplasmic localization. We found that the cytoplasmic localization and protein stability of KDM1A were promoted by acetylation at lysine-117 by the acetyl transferase KAT8 (lysine acetyltransferase 8). In agreement with this, we show that KDM1A-K117 (lysine 117) acetylation promotes demethylation of FKBP8 and level of BCL2. Finally, it has been shown that the efficacy of sorafenib, a first-line treatment for advanced HCC, is limited by clinical resistance. We show that KDM1A and BCL2 protein levels are increased during acquired sorafenib resistance, whereas inhibiting KDM1A can antagonize sorafenib resistance. Collectively, these results define a functional KDM1A-FKBP8-BCL2 axis in HCC.	[Lv, Suli; Zhao, Xuefeng; Yan, Yingying; Ma, Xianyun; Li, Neng; Zou, Qingli; Sun, Lidong; Song, Tanjing] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Biochem & Mol Biol, Wuhan, Peoples R China; [Zhang, Erlei] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Hepat Surg Ctr, Wuhan, Peoples R China; [Zhang, Erlei] Chinese Acad Med Sci, Key Lab Organ Transplantat, Wuhan, Peoples R China; [Sun, Lidong; Song, Tanjing] Huazhong Univ Sci & Technol, Cell Architecture Res Inst, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Huazhong University of Science & Technology	Sun, LD; Song, TJ (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Biochem & Mol Biol, Wuhan, Peoples R China.; Sun, LD; Song, TJ (corresponding author), Huazhong Univ Sci & Technol, Cell Architecture Res Inst, Wuhan, Hubei, Peoples R China.	LidongSun@hust.edu.cn; SongT@hust.edu.cm			National Natural Science Foundation of China [31871284, 32071296, 31971149, 31800641, 81902839]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (grant nos.: 31871284 and 32071296 to L. S.; 31971149 and 31800641 to T. S.; and 81902839 to E. Z.).	Bhujabal Z, 2017, EMBO REP, V18, P947, DOI 10.15252/embr.201643147; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Choi BH, 2011, CURR OPIN PHARMACOL, V11, P354, DOI 10.1016/j.coph.2011.04.013; Choi BH, 2010, J BIOL CHEM, V285, P9770, DOI 10.1074/jbc.M109.032466; Demir T, 2021, ADV CANCER RES, V149, P257, DOI 10.1016/bs.acr.2020.12.001; Edlich F, 2005, EMBO J, V24, P2688, DOI 10.1038/sj.emboj.7600739; Edlich F, 2007, J BIOL CHEM, V282, P36496, DOI 10.1074/jbc.M705061200; Edlich F, 2011, CURR OPIN PHARMACOL, V11, P348, DOI 10.1016/j.coph.2011.03.011; Engstrom AK, 2020, P NATL ACAD SCI USA, V117, P29133, DOI 10.1073/pnas.2013552117; Puisieux MF, 2022, CANCERS, V14, DOI 10.3390/cancers14102357; Forneris F, 2005, J BIOL CHEM, V280, P41360, DOI 10.1074/jbc.M509549200; Gao Q, 2019, CELL, V179, P561, DOI 10.1016/j.cell.2019.08.052; Gu FY, 2020, CELL MOL LIFE SCI, V77, P3341, DOI 10.1007/s00018-020-03489-9; Han X, 2014, MOL CELL, V55, P482, DOI 10.1016/j.molcel.2014.06.006; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Huang A, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00264-x; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang MX, 2017, CANCER LETT, V398, P12, DOI 10.1016/j.canlet.2017.03.038; Jin YH, 2014, J BIOCHEM, V156, P305, DOI 10.1093/jb/mvu042; Kim D, 2021, J BIOMED SCI, V28, DOI 10.1186/s12929-021-00737-3; Lei ZJ, 2015, ONCOGENE, V34, P3188, DOI 10.1038/onc.2015.129; Liu CG, 2018, CANCER RES, V78, P938, DOI 10.1158/0008-5472.CAN-17-1236; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Lo J, 2015, HEPATOLOGY, V62, P534, DOI 10.1002/hep.27859; Luo HC, 2016, CELL REP, V15, P2665, DOI 10.1016/j.celrep.2016.05.050; Majello B, 2019, CANCERS, V11, DOI 10.3390/cancers11030324; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Nalawansha DA, 2017, ACS CHEM BIOL, V12, P254, DOI 10.1021/acschembio.6b00776; Perillo B, 2020, EXP MOL MED, V52, P1936, DOI 10.1038/s12276-020-00542-2; Qiu ZX, 2016, SCI REP-UK, V6, DOI 10.1038/srep27411; Galle PR, 2021, FUTURE ONCOL, V17, P1237, DOI 10.2217/fon-2020-0758; Sareddy GR, 2017, ONCOGENE, V36, P2423, DOI 10.1038/onc.2016.395; Sheng WQ, 2018, CELL, V174, P549, DOI 10.1016/j.cell.2018.05.052; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Song HW, 2018, AUTOPHAGY, V14, P825, DOI 10.1080/15548627.2017.1389357; Song TJ, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109739; Tang WW, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0187-x; Tudor G, 2000, CELL DEATH DIFFER, V7, P574, DOI 10.1038/sj.cdd.4400688; Tutusaus Anna, 2018, Oncotarget, V9, P16701, DOI 10.18632/oncotarget.24673; Wang HQ, 2005, HUM MOL GENET, V14, P1889, DOI 10.1093/hmg/ddi195; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Wong RLY, 2008, HUM MOL GENET, V17, P587, DOI 10.1093/hmg/ddm333; Yoo SM, 2020, FASEB J, V34, P2944, DOI 10.1096/fj.201901735R; Zhang J, 2021, CANCER LETT, V516, P84, DOI 10.1016/j.canlet.2021.05.035; Zheng YC, 2013, J MED CHEM, V56, P8543, DOI 10.1021/jm401002r; Zhu YJ, 2017, ACTA PHARMACOL SIN, V38, P614, DOI 10.1038/aps.2017.5	47	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102374	10.1016/j.jbc.2022.102374	http://dx.doi.org/10.1016/j.jbc.2022.102374			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5B1GH	35970393	Green Published, gold			2022-12-26	WOS:000863323200003
J	Polino, AJ; Miller, JJ; Bhakat, S; Mukherjee, S; Bobba, S; Bowman, GR; Goldberg, DE				Polino, Alexander J.; Miller, Justin J.; Bhakat, Soumendranath; Mukherjee, Sumit; Bobba, Suhas; Bowman, Gregory R.; Goldberg, Daniel E.			The nepenthesin insert in the Plasmodium falciparum aspartic protease plasmepsin V is necessary for enzyme function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINS; EXPORT; SITE; INHIBITION; MECHANISMS; VIRULENCE; EFFICIENT; SEQUENCE	Plasmepsin V (PM V) is a pepsin-like aspartic protease essential for growth of the malarial parasite Plasmodium falciparum. Previous work has shown PM V to be an endoplasmic reticulum-resident protease that processes parasite proteins destined for export into the host cell. Depletion or inhibition of the enzyme is lethal during asexual replication within red blood cells as well as during the formation of sexual stage gametocytes. The structure of the Plasmodium vivax PM V has been characterized by X-ray crystallography, revealing a canonical pepsin fold punctuated by structural features uncommon to secretory aspartic proteases; however, the function of this unique structure is unclear. Here, we used parasite genetics to probe these structural features by attempting to rescue lethal PM V depletion with various mutant enzymes. We found an unusual nepenthesin 1-type insert in the PM V gene to be essential for parasite growth and PM V activity. Mutagenesis of the nepenthesin insert suggests that both its amino acid sequence and one of the two disulfide bonds that undergird its structure are required for the insert's role in PM V function. Furthermore, molecular dynamics simulations paired with Markov state modeling suggest that mutations to the nepenthesin insert may allosterically affect PM V catalysis through multiple mechanisms. Taken together, these data provide further insights into the structure of the P. falciparum PM V protease.	[Polino, Alexander J.; Mukherjee, Sumit; Bobba, Suhas; Goldberg, Daniel E.] Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63130 USA; [Polino, Alexander J.; Mukherjee, Sumit; Bobba, Suhas; Goldberg, Daniel E.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis 63130, MO USA; [Miller, Justin J.; Bhakat, Soumendranath; Bowman, Gregory R.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Goldberg, DE (corresponding author), Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63130 USA.; Goldberg, DE (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis 63130, MO USA.	dgoldberg@wustl.edu	Bhakat, Soumendranath/AAX-6185-2021	Bhakat, Soumendranath/0000-0002-1184-9259; Bobba, Suhas/0000-0002-9276-1469; Miller, Justin/0000-0001-9400-8916	National Institute of Allergy and Infection Diseases [RO1 AI047798]; American Heart Association Predoctoral Fellowship [18PRE33960417]; National Institute on Aging training grant [T32AG058518]	National Institute of Allergy and Infection Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); American Heart Association Predoctoral Fellowship(American Heart Association); National Institute on Aging training grant	This work was supported by the National Institute of Allergy and Infection Diseases (grant no.: RO1 AI047798; awarded to D. E. G.) . A. J. P. was supported by an American Heart Association Predoctoral Fellowship (grant no.: 18PRE33960417) . J. J. M. is supported by a National Institute on Aging training grant (grant no.: T32AG058518) .	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Andreeva NS, 2001, PROTEIN SCI, V10, P2439, DOI 10.1110/ps.ps.25801; Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Athauda SBP, 2004, BIOCHEM J, V381, P295, DOI 10.1042/BJ20031575; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Banerjee R, 2002, P NATL ACAD SCI USA, V99, P990, DOI 10.1073/pnas.022630099; Bhakat S., 2022, BIORXIV, DOI [10.1101/2020.04.27.062539, DOI 10.1101/2020.04.27.062539]; Bhakat S, 2021, RSC ADV, V11, P11026, DOI 10.1039/d0ra10359d; Bobrovs R, 2019, J MED CHEM, V62, P8931, DOI 10.1021/acs.jmedchem.9b00184; Boddey JA, 2013, TRAFFIC, V14, P532, DOI 10.1111/tra.12053; Boddey JA, 2010, NATURE, V463, P627, DOI 10.1038/nature08728; Bordoli Lorenza, 2012, Methods Mol Biol, V857, P107, DOI 10.1007/978-1-61779-588-6_5; Bowman G. R., 2014, ADV EXP MED BIOL; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Ganesan SM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10727; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Garten M, 2018, NAT MICROBIOL, V3, P1090, DOI 10.1038/s41564-018-0222-7; Goldberg DE, 2015, NAT STRUCT MOL BIOL, V22, P647, DOI 10.1038/nsmb.3077; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hodder AN, 2015, NAT STRUCT MOL BIOL, V22, P590, DOI 10.1038/nsmb.3061; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Husic BE, 2018, J AM CHEM SOC, V140, P2386, DOI 10.1021/jacs.7b12191; Jennison C, 2019, CELL REP, V29, P3796, DOI 10.1016/j.celrep.2019.11.073; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klemba M, 2005, MOL BIOCHEM PARASIT, V143, P183, DOI 10.1016/j.molbiopara.2005.05.015; Loymunkong C, 2019, MOL BIOCHEM PARASIT, V231, DOI 10.1016/j.molbiopara.2019.111188; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Matthews KM, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.13009; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; Muralidharan V, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2306; Muralidharan V, 2011, P NATL ACAD SCI USA, V108, P4411, DOI 10.1073/pnas.1018449108; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Park YN, 1997, J BIOCHEM-TOKYO, V121, P118, DOI 10.1093/oxfordjournals.jbchem.a021553; Polino AJ, 2020, ACS INFECT DIS, V6, P738, DOI 10.1021/acsinfecdis.9b00460; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Russo I, 2010, NATURE, V463, P632, DOI 10.1038/nature08726; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Silva AM, 1996, P NATL ACAD SCI USA, V93, P10034, DOI 10.1073/pnas.93.19.10034; Singh GP, 2004, MOL BIOCHEM PARASIT, V137, P307, DOI 10.1016/j.molbiopara.2004.05.016; Sleebs BE, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001897; Spillman NJ, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12719; Spillman NJ, 2015, ANNU REV BIOCHEM, V84, P813, DOI 10.1146/annurev-biochem-060614-034157; Wang XW, 2021, CURR OPIN STRUC BIOL, V67, P69, DOI 10.1016/j.sbi.2020.10.005; Yang ML, 2015, ANAL CHEM, V87, P6681, DOI 10.1021/acs.analchem.5b00831	47	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102355	10.1016/j.jbc.2022.102355	http://dx.doi.org/10.1016/j.jbc.2022.102355			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4V3XX	35952758	gold, Green Published			2022-12-26	WOS:000859414300001
J	Thomas, ACQ; Brown, A; Hatt, AA; Manta, K; Costa-Parke, A; Kamal, M; Joanisse, S; McGlory, C; Phillips, SM; Kumbhare, D; Parise, G				Thomas, Aaron C. Q.; Brown, Alex; Hatt, Aidan A.; Manta, Katherine; Costa-Parke, Anamaria; Kamal, Michael; Joanisse, Sophie; McGlory, Chris; Phillips, Stuart M.; Kumbhare, Dinesh; Parise, Gianni			Short-term aerobic conditioning prior to resistance training augments muscle hypertrophy and satellite cell content in healthy young men and women	FASEB JOURNAL			English	Article						aerobic conditioning; aerobic training; capillarization; muscle stem cells; resistance training; responder; satellite cells; single-leg cycling	HUMAN SKELETAL-MUSCLE; MYONUCLEAR ADDITION; STEM-CELLS; EXERCISE; CAPILLARIZATION; ACTIVATION; GROWTH; EXPANSION; DYNAMICS; STRENGTH	Factors influencing inter-individual variability of responses to resistance training (RT) remain to be fully elucidated. We have proposed the importance of capillarization in skeletal muscle for the satellite cell (SC) response to RT-induced muscle hypertrophy, and hypothesized that aerobic conditioning (AC) would augment RT-induced adaptations. Fourteen healthy young (22 +/- 2 years) men and women underwent AC via 6 weeks of unilateral cycling followed by 10 weeks of bilateral RT to investigate how AC alters SC content, activity, and muscle hypertrophy following RT. Muscle biopsies were taken at baseline (unilateral), post AC (bilateral), and post RT (bilateral) in the aerobically conditioned (AC + RT) and unconditioned (RT) legs. Immunofluorescence was used to determine muscle capillarization, fiber size, SC content, and activity. Type I and type II fiber cross-sectional area (CSA) increased following RT, and when legs were analyzed independently, AC + RT increased type I, type II, and mixed-fiber CSA, where the RT leg tended to increase type II (p = .05), but not type I or mixed-fiber CSA. SC content, activation, and differentiation increased with RT, where type I total and quiescent SC content was greater in AC + RT compared to the RT leg. Those with the greatest capillary-to-fiber perimeter exchange index before RT had the greatest change in CSA following RT and a significant relationship was observed between type II fiber capillarization and the change in type II-fiber CSA with RT (r = 0.35). This study demonstrates that AC prior to RT can augment RT-induced muscle adaptions and that these differences are associated with increases in capillarization.	[Thomas, Aaron C. Q.; Brown, Alex; Hatt, Aidan A.; Manta, Katherine; Costa-Parke, Anamaria; Kamal, Michael; Joanisse, Sophie; Phillips, Stuart M.; Parise, Gianni] McMaster Univ, Dept Kinesiol, Exercise Metab Res Grp, Hamilton, ON, Canada; [Joanisse, Sophie] Manchester Metropolitan Univ, Dept Sport & Exercise Sci, Musculoskeletal Sci & Sport Med Res Ctr, Fac Sci & Engn, Manchester, Lancs, England; [Joanisse, Sophie] Manchester Metropolitan Univ Inst Sport, Manchester, Lancs, England; [McGlory, Chris] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada; [McGlory, Chris] Queens Univ, Dept Med, Kingston, ON, Canada; [Kumbhare, Dinesh] Toronto Rehabil Inst, Toronto, ON, Canada	McMaster University; Manchester Metropolitan University; Queens University - Canada; Queens University - Canada; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute	Parise, G (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON L8S 4L8, Canada.	pariseg@mcmaster.ca	Phillips, Stuart/B-2343-2009	Phillips, Stuart/0000-0002-1956-4098; Joanisse, Sophie/0000-0001-9983-9401	Natural Sciences and Engineering Research Council of Canada [RGPIN-2016-05633]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Natural Sciences and Engineering Research Council of Canada, Grant/ Award Number: RGPIN--2016--05633	Abbiss CR, 2011, J APPL PHYSIOL, V110, P1248, DOI 10.1152/japplphysiol.01247.2010; Allen DL, 1999, MUSCLE NERVE, V22, P1350, DOI 10.1002/(SICI)1097-4598(199910)22:10<1350::AID-MUS3>3.0.CO;2-8; Bellamy LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109739; Bentzinger CF, 2013, EMBO REP, V14, P1062, DOI 10.1038/embor.2013.182; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; Blaauw B, 2014, J MUSCLE RES CELL M, V35, P3, DOI 10.1007/s10974-014-9376-y; Burns KJ, 2014, EUR J APPL PHYSIOL, V114, P961, DOI 10.1007/s00421-014-2830-0; Christov C, 2007, MOL BIOL CELL, V18, P1397, DOI 10.1091/mbc.E06-08-0693; Damas F, 2018, EUR J APPL PHYSIOL, V118, P2607, DOI 10.1007/s00421-018-3984-y; Davidsen PK, 2011, J APPL PHYSIOL, V110, P309, DOI 10.1152/japplphysiol.00901.2010; Dinulovic I, 2017, ADV EXP MED BIOL, V1041, P141, DOI 10.1007/978-3-319-69194-7_8; Dumont NA, 2015, COMPR PHYSIOL, V5, P1027, DOI 10.1002/cphy.c140068; Egginton S, 2009, PFLUG ARCH EUR J PHY, V457, P963, DOI 10.1007/s00424-008-0563-9; Elmer SJ, 2012, MED SCI SPORT EXER, V44, P1504, DOI 10.1249/MSS.0b013e31824fb8bd; Fukada S, 2020, BBA-MOL CELL RES, V1867, DOI 10.1016/j.bbamcr.2020.118742; Gliemann L, 2016, EUR J APPL PHYSIOL, V116, P1443, DOI 10.1007/s00421-016-3419-6; Hepple RT, 1997, CAN J APPL PHYSIOL, V22, P11, DOI 10.1139/h97-002; Hiscock N, 2003, AM J PHYSIOL-HEART C, V285, pH1759, DOI 10.1152/ajpheart.00150.2003; Hoier B, 2012, J PHYSIOL-LONDON, V590, P595, DOI 10.1113/jphysiol.2011.216135; Hoier B, 2014, MICROCIRCULATION, V21, P301, DOI 10.1111/micc.12117; Holloway TM, 2018, MED SCI SPORT EXER, V50, P36, DOI 10.1249/MSS.0000000000001409; Joanisse S, 2015, AM J PHYSIOL-REG I, V309, pR1101, DOI 10.1152/ajpregu.00249.2015; Joanisse S, 2013, FASEB J, V27, P4596, DOI 10.1096/fj.13-229799; Kadi F, 2000, HISTOCHEM CELL BIOL, V113, P99, DOI 10.1007/s004180050012; Knuiman P, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0055-9; Kostrominova TY, 2011, MICROSC RES TECHNIQ, V74, P18, DOI 10.1002/jemt.20865; Kraus RM, 2004, J APPL PHYSIOL, V96, P1445, DOI 10.1152/japplphysiol.01031.2003; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Lundberg TR, 2013, J APPL PHYSIOL, V114, P81, DOI 10.1152/japplphysiol.01013.2012; MacInnis MJ, 2017, APPL PHYSIOL NUTR ME, V42, P563, DOI 10.1139/apnm-2016-0645; Montarras D, 2013, FEBS J, V280, P4036, DOI 10.1111/febs.12372; Morton RW, 2019, J PHYSIOL-LONDON, V597, P4601, DOI 10.1113/JP278056; Murach KA, 2018, PHYSIOLOGY, V33, P26, DOI 10.1152/physiol.00019.2017; Nederveen JP, 2015, ACTA PHYSIOL, V215, P177, DOI 10.1111/apha.12601; Nederveen JP, 2018, J PHYSIOL-LONDON, V596, P1063, DOI 10.1113/JP275155; Nederveen JP, 2017, AM J PHYSIOL-REG I, V312, pR85, DOI 10.1152/ajpregu.00221.2016; Nederveen JP, 2016, J CACHEXIA SARCOPENI, V7, P547, DOI 10.1002/jcsm.12105; Petrella JK, 2008, J APPL PHYSIOL, V104, P1736, DOI 10.1152/japplphysiol.01215.2007; Petrella JK, 2006, AM J PHYSIOL-ENDOC M, V291, pE937, DOI 10.1152/ajpendo.00190.2006; Phillips BE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003389; Rodgers JT, 2014, NATURE, V510, P393, DOI 10.1038/nature13255; Snijders T, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13278; Snijders T, 2017, J CACHEXIA SARCOPENI, V8, P267, DOI 10.1002/jcsm.12137; Snijders T, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00283; Terzis G, 2008, EUR J APPL PHYSIOL, V102, P145, DOI 10.1007/s00421-007-0564-y; Timmons JA, 2011, J APPL PHYSIOL, V110, P846, DOI 10.1152/japplphysiol.00934.2010; West DWD, 2010, J APPL PHYSIOL, V108, P60, DOI 10.1152/japplphysiol.01147.2009; Whitham M, 2016, NAT REV DRUG DISCOV, V15, P719, DOI 10.1038/nrd.2016.153	48	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22500	10.1096/fj.202200398RR	http://dx.doi.org/10.1096/fj.202200398RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3U0JH	35971745				2022-12-26	WOS:000840655900001
J	Mooney, RE; Linden, GJ; Winning, L; Linden, K; Kee, F; McKeown, PP; Woodside, JV; Patterson, CC; McKay, GJ				Mooney, Rachel E.; Linden, Gerry J.; Winning, Lewis; Linden, Katie; Kee, Frank; McKeown, Pascal P.; Woodside, Jayne V.; Patterson, Christopher C.; McKay, Gareth J.			Association of TGFB1 rs1800469 and BCMO1 rs6564851 with coronary heart disease and IL1B rs16944 with all-cause mortality in men from the Northern Ireland PRIME study	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MYOCARDIAL-INFARCTION; VITAMIN-A; GENE POLYMORPHISMS; INTERLEUKIN-1-BETA GENE; ISCHEMIC-STROKE; BLOOD-PRESSURE; RISK; ATHEROSCLEROSIS; CAROTENE	Background Historically, high levels of morbidity and mortality have been associated with cardiovascular disease in the Northern Ireland population. Previously reported associations between single nucleotide polymorphisms (SNPs) and cardiovascular disease within other populations have not always been consistent. Objective To investigate associations between 33 SNPs with fatal or non-fatal incident coronary heart disease (CHD) events and all-cause mortality in the Northern Irish participants of the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Method Phase 2 of the PRIME study prospectively evaluated 2,010 men aged 58-74 years in Northern Ireland for more than 10 years for incident CHD events (myocardial infarction, percutaneous coronary intervention, coronary artery bypass, and cardiac death) and more than 15 years for all-cause mortality. SNPs previously reported in association with cardiovascular outcomes were evaluated against incident CHD events and all-cause mortality using Cox's proportional hazards models adjusted for established cardiovascular disease risk factors. Results During the follow-up period, 177 incident CHD events were recorded, and 821 men died. Both BCM01 rs6564851 (Hazard ratio [HR] = 0.76; 95% confidence intervals [CI]: 0.60-0.96; P = 0.02) and TGFB1 rs1800469 (HR = 1.30; CI: 1.02-1.65; P = 0.04) were significantly associated with incident CHD events in adjusted models. Only IL1B rs16944 was significantly associated with all-cause mortality (HR = 1.18; CI: 1.05-1.33; P = 0.005). No associations remained significant following Bonferonni correction for multiple testing. Conclusion We report a novel association between BCMO1 rs6564851 and risk of incident CHD events. In addition, TGFB1 rs1800469 and IL1B rs16944 were associated with the risk of incident CHD events and all-cause mortality outcomes respectively, supporting previously reported associations.	[Mooney, Rachel E.; Linden, Gerry J.; Linden, Katie; Kee, Frank; McKeown, Pascal P.; Woodside, Jayne V.; Patterson, Christopher C.; McKay, Gareth J.] Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Winning, Lewis] Trin Coll Dublin, Dublin Dent Univ Hosp, Dublin, Ireland	Queens University Belfast; Trinity College Dublin	McKay, GJ (corresponding author), Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland.	g.j.mckay@qub.ac.uk	McKay, Gareth/AAZ-2601-2020	McKay, Gareth/0000-0001-8197-6280; Woodside, Jayne/0000-0002-5691-4659; Winning, Lewis/0000-0002-8783-8089	British Heart Foundation [PG/14/9/30632]; Northern Ireland NHS Research and Development Fund [RRG 5.22]; Heart Trust Fund (Royal Victoria Hospital Belfast)	British Heart Foundation(British Heart Foundation); Northern Ireland NHS Research and Development Fund; Heart Trust Fund (Royal Victoria Hospital Belfast)	The Belfast PRIME rescreening study was supported by grants from the British Heart Foundation (PG/14/9/30632), the Northern Ireland NHS Research and Development Fund (RRG 5.22) and the Heart Trust Fund (Royal Victoria Hospital Belfast). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman MJ, 2011, HEART RHYTHM, V8, P1308, DOI [10.1016/j.hrthm.2011.05.020, 10.1093/europace/eur245]; Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; Jimenez-Sousa MA, 2017, EUR J CLIN INVEST, V47, P53, DOI 10.1111/eci.12702; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Gonzalez-Castro TB, 2019, EXCLI J, V18, P331, DOI 10.17179/excli2019-1248; Bell S, 2020, ATHEROSCLEROSIS, V313, P111, DOI 10.1016/j.atherosclerosis.2020.09.029; Beller J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66291-4; BENSI G, 1987, GENE, V52, P95, DOI 10.1016/0378-1119(87)90398-2; Bhopal R, 2002, BRIT MED J, V324, P625, DOI 10.1136/bmj.324.7338.625; Bots SH, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000298; British Heart Foundation, 2020, HEART CIRC DIS STAT; Cai X, 2019, ASIA PAC J CLIN NUTR, V28, P192, DOI 10.6133/apjcn.201903_28(1).0025; Cain BS, 1999, CRIT CARE MED, V27, P1309, DOI 10.1097/00003246-199907000-00018; Cambien F, 1996, HYPERTENSION, V28, P881, DOI 10.1161/01.HYP.28.5.881; Chen PY, 2019, NAT METAB, V1, P912, DOI 10.1038/s42255-019-0102-3; Clark DA, 1998, INT J BIOCHEM CELL B, V30, P293, DOI 10.1016/S1357-2725(97)00128-3; Clifford AJ, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-66; Congrains A, 2012, ATHEROSCLEROSIS, V220, P449, DOI 10.1016/j.atherosclerosis.2011.11.017; Cooney MT, 2009, ATHEROSCLEROSIS, V206, P611, DOI 10.1016/j.atherosclerosis.2009.02.041; Cross DS, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-51; Dainis AM, 2018, JACC-BASIC TRANSL SC, V3, P313, DOI 10.1016/j.jacbts.2018.01.003; Dastani Z, 2010, EUR J HUM GENET, V18, P342, DOI 10.1038/ejhg.2009.157; de Mestral C, 2017, CURR CARDIOL REP, V19, DOI 10.1007/s11886-017-0917-z; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Du L., 2019, MEDICINE, V98, P1594, DOI [10.1097/MD.0000000000015946, DOI 10.1097/MD.0000000000015946, 10.1097/md.0000000000015946]; Ducimetiere P, 2001, INT J EPIDEMIOL, V30, P1057, DOI 10.1093/ije/30.5.1057; Estruch R, 2018, NEW ENGL J MED, V378, DOI [10.1056/NEJMoa1800389, 10.1056/nejmoa1800389]; Felkin LE, 2009, J HEART LUNG TRANSPL, V28, P117, DOI 10.1016/j.healun.2008.11.910; Ferrucci L, 2009, AM J HUM GENET, V84, P123, DOI 10.1016/j.ajhg.2008.12.019; Fleenor BS, 2010, J PHYSIOL-LONDON, V588, P3971, DOI 10.1113/jphysiol.2010.194753; GAMBLE JR, 1988, SCIENCE, V242, P97; GAMBLE JR, 1991, J IMMUNOL, V146, P1149; Gey KF, 2010, ATHEROSCLEROSIS, V208, P270, DOI 10.1016/j.atherosclerosis.2009.07.018; Golia E, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0435-z; GOODMAN DS, 1966, J BIOL CHEM, V241, P1929; GRAINGER DJ, 1995, NAT MED, V1, P74, DOI 10.1038/nm0195-74; Grainger DJ, 2004, ARTERIOSCL THROM VAS, V24, P399, DOI 10.1161/01.ATV.0000114567.76772.33; Grainger DJ, 1999, HUM MOL GENET, V8, P93, DOI 10.1093/hmg/8.1.93; Hackshaw A, 2018, BMJ-BRIT MED J, V360, DOI [10.1136/bmj.j5855, 10.1136/bmj.k1611]; Harrison P, 2008, RHEUMATOLOGY, V47, P1768, DOI 10.1093/rheumatology/ken374; Hein S, 2003, CIRCULATION, V107, P984, DOI 10.1161/01.CIR.0000051865.66123.B7; Huang HT, 2017, ONCOTARGET, V8, P103499, DOI 10.18632/oncotarget.21498; Huang JQ, 2018, CIRC RES, V123, P1339, DOI 10.1161/CIRCRESAHA.118.313409; Iacoviello L, 2005, ARTERIOSCL THROM VAS, V25, P222, DOI 10.1161/01.ATV.0000150039.60906.02; Kaur N, 2019, BIOCHEM GENET, V57, P129, DOI 10.1007/s10528-018-9880-7; Khera AV, 2018, NAT GENET, V50, P1219, DOI 10.1038/s41588-018-0183-z; Kobylecki CJ, 2015, AM J CLIN NUTR, V101, P1135, DOI 10.3945/ajcn.114.104497; Koch W, 2006, ARTERIOSCL THROM VAS, V26, P1114, DOI 10.1161/01.ATV.0000217747.66517.11; Lane D, 2002, J HUM HYPERTENS, V16, P267, DOI 10.1038/sj.jhh.1001371; Lietz G, 2012, MOL NUTR FOOD RES, V56, P241, DOI 10.1002/mnfr.201100387; Lietz G, 2012, J NUTR, V142, p161S, DOI 10.3945/jn.111.140756; Love-Gregory L, 2008, HUM MOL GENET, V17, P1695, DOI 10.1093/hmg/ddn060; Lutgens E, 2002, ARTERIOSCL THROM VAS, V22, P975, DOI 10.1161/01.ATV.0000019729.39500.2F; Maia J, 2016, APPL CLIN GENET, V9, P131, DOI 10.2147/TACG.S101410; Mallat Z, 2002, CURR OPIN LIPIDOL, V13, P523, DOI 10.1097/00041433-200210000-00008; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; McKay GJ, 2021, EUR J NUTR, V60, P2631, DOI 10.1007/s00394-020-02455-2; Mesa F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087023; Miller NA, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0221-8; Morange PE, 2004, EUR J HUM GENET, V12, P1041, DOI 10.1038/sj.ejhg.5201277; Miramontes-Gonzalez JP, 2019, ATHEROSCLEROSIS, V285, P17, DOI 10.1016/j.atherosclerosis.2019.03.019; Pereira RMR, 2016, OSTEOPOROSIS INT, V27, P3319, DOI 10.1007/s00198-016-3664-x; Ren K, 2009, BRAIN RES REV, V60, P57, DOI 10.1016/j.brainresrev.2008.12.020; Richards JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000768; Rodgers JL, 2019, J CARDIOVASC DEV DIS, V6, DOI 10.3390/jcdd6020019; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Shah R, 2006, HUM GENET, V120, P461, DOI 10.1007/s00439-006-0194-1; Sie MPS, 2006, STROKE, V37, P2667, DOI 10.1161/01.STR.0000244779.30070.1a; Sommer C, 2004, NEUROSCI LETT, V361, P184, DOI 10.1016/j.neulet.2003.12.007; Sun X, 2011, J PERIODONTAL RES, V46, P354, DOI 10.1111/j.1600-0765.2011.01350.x; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Vargas-Alarcon G, 2015, IMMUNOL LETT, V168, P7, DOI 10.1016/j.imlet.2015.08.005; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wagner A, 2003, EUR J EPIDEMIOL, V18, P321, DOI 10.1023/A:1023625110856; Wang XY, 2009, STROKE, V40, P683, DOI 10.1161/STROKEAHA.108.524587; Weber D, 2012, MOL NUTR FOOD RES, V56, P251, DOI 10.1002/mnfr.201100230; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867; Winning L, 2021, J CLIN PERIODONTOL, V48, P1260, DOI 10.1111/jcpe.13510; Winning L, 2020, J CLIN PERIODONTOL, V47, P1446, DOI 10.1111/jcpe.13377; World Health Organization, 2017, CARD DIS CVDS FACT S; Yabuta S, 2016, J NUTR HEALTH AGING, V20, P267, DOI 10.1007/s12603-015-0577-x; Yarnell JWG, 1998, QJM-INT J MED, V91, P667, DOI 10.1093/qjmed/91.10.667; Zhang Y, 2006, CLIN CHEM LAB MED, V44, P37, DOI 10.1515/CCLM.2006.008; Zhong M, 2012, NUTRIENTS, V4, P2069, DOI 10.3390/nu4122069; Zienolddiny S, 2004, INT J CANCER, V109, P353, DOI 10.1002/ijc.11695; Zile MH, 2001, J NUTR, V131, P705, DOI 10.1093/jn/131.3.705	86	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0273333	10.1371/journal.pone.0273333	http://dx.doi.org/10.1371/journal.pone.0273333			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994463	Green Published, gold			2022-12-26	WOS:000877093400045
J	Noble, A; Owens, B; Thulien, N; Suleiman, A				Noble, Amanda; Owens, Benjamin; Thulien, Naomi; Suleiman, Amanda			"I feel like I'm in a revolving door, and COVID has made it spin a lot faster": The impact of the COVID-19 pandemic on youth experiencing homelessness in Toronto, Canada	PLOS ONE			English	Article							MENTAL-HEALTH; SATURATION; INTERVIEWS	Purpose Research has shown that youth experiencing homelessness (YEH) face barriers to social inclusion and are at risk for poor mental health. With the COVID-19 pandemic threatening the health, wellbeing, and economic circumstances of people around the world, this study aims to assess the impacts of the pandemic on YEH in Toronto, Ontario, as well as to identify recommendations for future waves of COVID-19. Methods Semi-structured interviews were conducted with YEH (ages 16-24, n = 45) and staff who work in one of four downtown emergency shelters for youth (n = 31) in Toronto, Ontario. Results YEH experienced both structural changes and psychosocial impacts resulting from the pandemic. Structural changes included a reduction in services, barriers to employment and housing, and changes to routines. Psychosocial outcomes included isolation, worsened mental health, and increased substance use. Impacts were magnified and distinct for subpopulations of youth, including for youth that identified as Black, 2SLGBTQ+, or those new to Canada. Conclusions The COVID-19 pandemic increased distress among YEH while also limiting access to services. There is therefore a need to balance health and safety with continued access to in-person services, and to shift the response to youth homelessness to focus on prevention, housing, and equitable supports for subpopulations of youth.	[Noble, Amanda] Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada; [Noble, Amanda; Owens, Benjamin; Suleiman, Amanda] Covenant House Toronto, Res & Evaluat Dept, Toronto, ON, Canada; [Thulien, Naomi] St Michaels Hosp, Li Ka Shing Knowledge Inst, MAP Ctr Urban Hlth Solut, Toronto, ON, Canada; [Thulien, Naomi] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Thulien, Naomi] Univ Toronto, Ctr Crit Qualitat Hlth Res, Toronto, ON, Canada	University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto	Noble, A (corresponding author), Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada.; Noble, A (corresponding author), Covenant House Toronto, Res & Evaluat Dept, Toronto, ON, Canada.	anoble@covenanthouse.ca			Making the Shift (MtS) Network of Centres of Excellence [R900206525]	Making the Shift (MtS) Network of Centres of Excellence	This work was funded by Making the Shift (MtS) Network of Centres of Excellence, Grant R900206525 (https://makingtheshiftinc.ca).The funding was awarded to AN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovich A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0257693; Auerswald CL, 2020, J ADOLESCENT HEALTH, V67, P461, DOI 10.1016/j.jadohealth.2020.07.026; Bor J, 2018, LANCET, V392, P302, DOI [10.1016/S0140-6736(18)31130-9, 10.1016/s0140-6736(18)31130-9]; Borato M., 2020, FAMILY SUPPORTS FRAM; Braciszewski JM, 2016, J COMMUNITY PSYCHOL, V44, P358, DOI 10.1002/jcop.21773; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; City of Toronto, 2021, STREET NEEDS ASSESSM; City of Toronto, 2021, TORONTO OVERDOSE ACT; City of Toronto, 2021, PHYS DISTANCING SHEL; Cohen RIS, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-1306; Collins SB, 2021, J SOC DISTRESS HOMEL, DOI 10.1080/10530789.2021.1940719; Collins SB, 2018, J SOC DISTRESS HOMEL, V27, P99, DOI 10.1080/10530789.2018.1480892; Czeisler ME, 2020, MMWR-MORBID MORTAL W, V69, P1049, DOI [10.1101/2020.04.22.20076141v1, 10.15585/mmwr.mm6932a1]; Dwyer SC, 2018, INT J QUAL METH, V17, DOI 10.1177/1609406918788176; Fernandes N., 2020, WP1240E IESE BUS SCH, DOI [10.2139/ssrn.3557504, DOI 10.2139/SSRN.3557504]; Ford CL, 2010, SOC SCI MED, V71, P1390, DOI 10.1016/j.socscimed.2010.07.030; Gaetz S., 2020, YOUTH RECONNECT PROG; Gaetz S., 2021, THIS IS HOUSING 1 YO; Gaetz S., 2017, NEW DIRECTION FRAMEW; Gaetz S., 2014, COMING AGE REIMAGINI; Gaetz S., 2013, YOUTH HOMELESSNESS C; Gaetz S., 2010, SURVIVING CRIME VIOL; Gaetz S., 2018, ROADMAP PREVENTION Y; Gaetz S., 2016, HOME NATL YOUTH HOME; Gianfredi V, 2021, PUBLIC HEALTH, V198, P44, DOI 10.1016/j.puhe.2021.06.024; Green AE., 2020, IMPLICATIONS COVID 1; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hawke LD, 2021, PSYCHOL SEX ORIENTAT, V8, P180, DOI 10.1037/sgd0000467; Hennink MM, 2017, QUAL HEALTH RES, V27, P591, DOI 10.1177/1049732316665344; Hodgetts D, 2007, J HEALTH PSYCHOL, V12, P709, DOI 10.1177/1359105307080593; Kidd S., 2018, MENTAL HLTH ADDICTIO; Kidd SA, 2016, CHILD ADOLESC SOC WO, V33, P207, DOI 10.1007/s10560-015-0424-2; Kirst M, 2011, INT J MENT HEALTH AD, V9, P543, DOI 10.1007/s11469-011-9328-3; Lambovska M., 2021, EKONOMICKO MANAZERSK, V15, P55, DOI [DOI 10.26552/EMS.2021.1.55-63, 10.26552/ems.2021.1.55-63]; Lee FKS, 2019, PERS INDIV DIFFER, V146, P68, DOI 10.1016/j.paid.2019.04.001; LePera N., 2011, NEW SCH PSYCHOL B, V8, P15, DOI DOI 10.1037/E741452011-003; Liu SR, 2020, PSYCHOL TRAUMA-US, V12, P439, DOI 10.1037/tra0000784; Maozami Y., 2016, U MIAMI INT COMP REV, V24, P609; Maynard R., 2017, POLICING BLACK LIVES; Merriam S. B., 1998, QUALITATIVE RES GUID; Nichols N., 2017, CHILD WELFARE YOUTH; O'Brien JRG, 2021, J ADOLESCENT HEALTH, V68, P236, DOI 10.1016/j.jadohealth.2020.11.005; Oosterhoff B, 2020, J ADOLESCENT HEALTH, V67, P179, DOI 10.1016/j.jadohealth.2020.05.004; Oreopoulos P., 2012, SSRN; Orgiles M, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.579038; Rew L, 2021, ARCH PSYCHIAT NURS, V35, P653, DOI 10.1016/j.apnu.2021.08.002; Salerno JP, 2020, PSYCHOL TRAUMA-US, V12, pS239, DOI 10.1037/tra0000837; Serlachius A, 2020, JMIR PEDIATR PARENT, V3, DOI 10.2196/23057; Thomas J, 2021, MENT HEALTH PHYS ACT, V21, DOI 10.1016/j.mhpa.2021.100407; Thulien N., 2020, PANDEMIC PROOF SYNTH; Thulien NS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256288; Thulien NS, 2018, CAN J PUBLIC HEALTH, V109, P89, DOI 10.17269/s41997-018-0029-6; Tucker JS, 2020, J ADOLESCENT HEALTH, V67, P603, DOI 10.1016/j.jadohealth.2020.07.013; Tynes BM, 2019, J ADOLESCENT HEALTH, V65, P371, DOI 10.1016/j.jadohealth.2019.03.006; Wilkinson L, 2016, CAN ETHN STUD, V48, P5, DOI 10.1353/ces.2016.0023; Williams AJ, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245268; Yan LL, 2021, J ANXIETY DISORD, V77, DOI 10.1016/j.janxdis.2020.102328	57	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0273502	10.1371/journal.pone.0273502	http://dx.doi.org/10.1371/journal.pone.0273502			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994505	gold, Green Published			2022-12-26	WOS:000877093400054
J	Hu, XS; Liu, RC; Hou, JB; Peng, W; Wan, SC; Xu, MH; Li, YS; Zhang, GH; Zhai, X; Liang, P; Cui, HJ				Hu, Xiaosong; Liu, Ruochen; Hou, Jianbing; Peng, Wen; Wan, Sicheng; Xu, Minghao; Li, Yongsen; Zhang, Guanghui; Zhai, Xuan; Liang, Ping; Cui, Hongjuan			SMARCE1 promotes neuroblastoma tumorigenesis through assisting MYCN-mediated transcriptional activation	ONCOGENE			English	Article							N-MYC; THERAPEUTIC TARGET; DNA-BINDING; GENE; EXPRESSION; COMPLEX; PROTEIN; STABILIZATION; PROLIFERATION; AMPLIFICATION	SMARCE1 gene, encoding a core subunit of SWI/SNF chromatin remodeling complex, is situated on chromosome 17q21-ter region that is frequently gained in neuroblastoma. However, its role in the tumorigenesis remains unknown. Here, we showed that high expression of SMARCE1 was associated with poor prognosis of patients with neuroblastoma, especially those with MYCN amplification. Knockdown of SMARCE1 reduced proliferation, colony formation, and tumorigenicity of neuroblastoma cells. Mechanistically, SMARCE1 directly interacted with MYCN, which was necessary for MYCN-mediated transcriptional activation of downstream target genes including PLK1, ODC1, and E2F2. Overexpression of PLK1, ODC1 or E2F2 significantly reversed the inhibiting effect of SMARCE1 knockdown on the proliferation, colony formation, and tumorigenicity of MYCN-amplified neuroblastoma cells. Moreover, we revealed that MYCN directly regulated SMARCE1 transcription through binding to a non-canonical E-box of SMARCE1 promoter, thus enhancing SMARCE1-MYCN cooperativity. These findings establish SMARCE1 is a critical oncogenic factor in neuroblastoma and provide a new potential target for treatment of neuroblastoma with 17q21-ter gain and MYCN amplification.	[Hu, Xiaosong; Liu, Ruochen; Hou, Jianbing; Peng, Wen; Wan, Sicheng; Xu, Minghao; Li, Yongsen; Zhang, Guanghui; Cui, Hongjuan] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China; [Hu, Xiaosong; Liu, Ruochen; Hou, Jianbing; Peng, Wen; Wan, Sicheng; Xu, Minghao; Li, Yongsen; Zhang, Guanghui; Cui, Hongjuan] Southwest Univ, Canc Ctr, Med Res Inst, Chongqing 400716, Peoples R China; [Zhai, Xuan; Liang, Ping] Chongqing Med Univ, Childrens Hosp, Dept Neurosurg, Chongqing 400014, Peoples R China; [Zhai, Xuan; Liang, Ping] Chongqing Key Lab Pediat, Chongqing 400010, Peoples R China	Southwest University - China; Southwest University - China; Chongqing Medical University	Cui, HJ (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China.; Cui, HJ (corresponding author), Southwest Univ, Canc Ctr, Med Res Inst, Chongqing 400716, Peoples R China.; Liang, P (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Neurosurg, Chongqing 400014, Peoples R China.; Liang, P (corresponding author), Chongqing Key Lab Pediat, Chongqing 400010, Peoples R China.	pingliangnet@163.com; hcui@swu.edu.cn	Zhang, Guanghui/HHS-1240-2022	Zhang, Guanghui/0000-0002-6289-4965; Xu, Minghao/0000-0003-0535-8231	Natural Science Foundation of Chongqing [cstc2019jcyj-zdxmX0033, cstc2022ycjh-bgzxm0145]; pilot program of Southwest University [SWU-XDZD22006]	Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing); pilot program of Southwest University	This research was supported by the Natural Science Foundation of Chongqing (cstc2019jcyj-zdxmX0033, cstc2022ycjh-bgzxm0145), the pilot program of Southwest University (SWU-XDZD22006).	Albihn A, 2010, ADV CANCER RES, V107, P163, DOI 10.1016/S0065-230X(10)07006-5; Amente S, 2015, ONCOTARGET, V6, P14572, DOI 10.18632/oncotarget.3990; Amente S, 2011, NUCLEIC ACIDS RES, V39, P9498, DOI 10.1093/nar/gkr638; Baluapuri A, 2020, NAT REV MOL CELL BIO, V21, P255, DOI 10.1038/s41580-020-0215-2; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bell E, 2010, CANCER LETT, V293, P144, DOI 10.1016/j.canlet.2010.01.015; Bell JL, 2015, J CLIN ONCOL, V33, P1285, DOI 10.1200/JCO.2014.55.9880; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Bourdeaut F, 2009, J PATHOL, V219, P463, DOI 10.1002/path.2614; Bown N, 1999, NEW ENGL J MED, V340, P1954, DOI 10.1056/NEJM199906243402504; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Burkhart CA, 2003, J NATL CANCER I, V95, P1394, DOI 10.1093/jnci/djg045; Chen H, 2018, SIGNAL TRANSDUCT TAR, V3, DOI 10.1038/s41392-018-0008-7; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; Clapier CR, 2017, NAT REV MOL CELL BIO, V18, P407, DOI 10.1038/nrm.2017.26; Cole KA, 2011, P NATL ACAD SCI USA, V108, P3336, DOI 10.1073/pnas.1012351108; Cowling VH, 2006, MOL CELL BIOL, V26, P4226, DOI 10.1128/MCB.01959-05; Davis CA, 2018, NUCLEIC ACIDS RES, V46, pD794, DOI 10.1093/nar/gkx1081; DIAS P, 1990, INT J CANCER, V45, P593, DOI 10.1002/ijc.2910450403; Duffy DJ, 2018, GENE REP, V12, P187, DOI 10.1016/j.genrep.2018.06.018; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Fetahu IS, 2021, CANCER METAST REV, V40, P173, DOI 10.1007/s10555-020-09946-y; Gryder BE, 2017, CANCER DISCOV, V7, P884, DOI 10.1158/2159-8290.CD-16-1297; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Heo Y, 2020, BIOCHEM BIOPH RES CO, V533, P919, DOI 10.1016/j.bbrc.2020.09.094; Hogarty MD, 2008, CANCER RES, V68, P9735, DOI 10.1158/0008-5472.CAN-07-6866; Hou J, 2017, ONCOGENE, V36, P1134, DOI 10.1038/onc.2016.280; Hu XS, 2022, BIOCHEM BIOPH RES CO, V599, P148, DOI 10.1016/j.bbrc.2022.01.124; Huang M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014415; Hui ABY, 2001, LAB INVEST, V81, P717, DOI 10.1038/labinvest.3780280; Islam A, 2000, ONCOGENE, V19, P617, DOI 10.1038/sj.onc.1203358; Kadoch C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500447; Kocak H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.84; Krstic A, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.612518; Kumar P, 2020, SEMIN CANCER BIOL, V67, P105, DOI 10.1016/j.semcancer.2019.06.016; Lee TH, 2009, NAT CELL BIOL, V11, P97, DOI 10.1038/ncb1818; LEE WH, 1984, NATURE, V309, P458, DOI 10.1038/309458a0; Li YS, 2021, MEDCOMM, V2, P467, DOI 10.1002/mco2.73; Mao L, 2011, CANCER RES, V71, P4314, DOI 10.1158/0008-5472.CAN-11-0051; Mastronikolis N, 2019, J BUON, V24, P2242; Matthay KK, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.78; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Molenaar JJ, 2012, NAT GENET, V44, P1199, DOI 10.1038/ng.2436; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Monclair T, 2009, J CLIN ONCOL, V27, P298, DOI 10.1200/JCO.2008.16.6876; Nagy Z, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22143-x; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Nakayama RT, 2017, NAT GENET, V49, P1613, DOI 10.1038/ng.3958; NISEN PD, 1986, CANCER RES, V46, P6217; O'Neill S, 2001, GENE CHROMOSOME CANC, V30, P87, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1055>3.0.CO;2-J; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Peng W, 2022, ONCOGENE, V41, P3051, DOI 10.1038/s41388-022-02296-9; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Rust K, 2018, EMBO J, V37, DOI 10.15252/embj.201798659; Sethuraman A, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0738-9; Sokol ES, 2017, P NATL ACAD SCI USA, V114, P4153, DOI 10.1073/pnas.1703931114; Sun JR, 2018, J INVEST DERMATOL, V138, P1795, DOI 10.1016/j.jid.2018.02.028; Tonelli R, 2005, MOL CANCER THER, V4, P779, DOI 10.1158/1535-7163.MCT-04-0213; Tsukiyama T, 2002, NAT REV MOL CELL BIO, V3, P422, DOI 10.1038/nrm828; Vervoorts J, 2003, EMBO REP, V4, P484, DOI 10.1038/sj.embor.embor821; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; Wan M, 2009, EUR J IMMUNOL, V39, P580, DOI 10.1002/eji.200838909; Wattler F, 1999, GENOMICS, V60, P172, DOI 10.1006/geno.1999.5913; Wei JC, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00176; WENZEL A, 1995, EUR J CANCER, V31A, P516, DOI 10.1016/0959-8049(95)00060-V; Wong M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11132-w; Wong M, 2017, CANCER RES, V77, P2522, DOI 10.1158/0008-5472.CAN-16-1663; Xiao DB, 2016, MOL CELL, V64, P493, DOI 10.1016/j.molcel.2016.09.016; Yang R, 2020, ONCOGENE, V39, P2975, DOI 10.1038/s41388-020-1199-2; Zafar AT, 2021, MED RES REV, V41, P961, DOI 10.1002/med.21750; Zeid R, 2018, NAT GENET, V50, P515, DOI 10.1038/s41588-018-0044-9; Zhang K, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1086-8; Zhang WW, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0581-9	74	2	2	9	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 9	2022	41	37					4295	4306		10.1038/s41388-022-02428-1	http://dx.doi.org/10.1038/s41388-022-02428-1		AUG 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	4L2AN	35978151				2022-12-26	WOS:000843817400001
J	Jurkenbeck, K; Mehlhose, C; Zuhlsdorf, A				Juerkenbeck, Kristin; Mehlhose, Clara; Zuehlsdorf, Anke			The influence of the Nutri-Score on the perceived healthiness of foods labelled with a nutrition claim of sugar	PLOS ONE			English	Article							FAT; BEHAVIORS; IMPACT	High sugar intake in humans is associated with the development of overweight and other diet-related diseases. The World Health Organization and other health organizations recommend limiting the sugar intake to 10% of the total energy intake. There have been different approaches of front-of-pack labelling to reduce the amount of sugar in food products. Companies use nutrition claims to advertise the sugar content (e.g., without added sugar, 30% less sugar). Such nutrition claims can lead to false assumptions about the healthiness of foods and can lead to health-halo effects. Nutrition claims make products appear healthier than they really are, the aspect advertised in the nutrition claim is transferred to the entire food product. As a result, food products can be perceived as healthy even though they are not. Recently, the Nutri-Score was introduced in an increasing number of countries throughout Europe to provide consumers with an overview of the overall nutritional quality of a product. This study analyzes if the Nutri-Score can help to prevent health-halo effects caused by nutrition claims on sugar. Therefore, an online survey consisting of a split-sample design with more than 1,000 respondents was assessed. The results show that, depending on the initial perceived healthiness of a product, the Nutri-Score is able to prevent health-halo effects caused by claims on sugar. Making the Nutri-Score mandatory when using nutrition claims would be one possible way to reduce misperceptions about unhealthy food and reduce health-halo effects caused by claims on sugar.	[Juerkenbeck, Kristin; Mehlhose, Clara; Zuehlsdorf, Anke] Univ Goettingen, Dept Agr Econ & Rural Dev, Mkt Food & Agr Prod, Gottingen, Germany; [Mehlhose, Clara] German Inst Food Technol DIL eV, Quakenbruck, Germany	University of Gottingen	Jurkenbeck, K (corresponding author), Univ Goettingen, Dept Agr Econ & Rural Dev, Mkt Food & Agr Prod, Gottingen, Germany.	kristin.juerkenbeck@uni-goettingen.de		Jurkenbeck, Kristin/0000-0003-4119-0632	Federation of German Consumer Organizations; German Research Foundation; Open Access Publication Funds of the University of Goettingen	Federation of German Consumer Organizations; German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the University of Goettingen	This research was funded by the Federation of German Consumer Organizations (Verbraucherzentrale Bundesverband (vzbv)). For publication we acknowledge support by the German Research Foundation and the Open Access Publication Funds of the University of Goettingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ani HH, 2016, BRIT J NUTR, V116, P1087, DOI 10.1017/S0007114516002981; Arthur R, 2019, BEVERAGEDAILY; Aschemann-Witzel J, 2010, J MARK COMMUN, V16, P47, DOI [10.1080/13527260903342746, DOI 10.1080/13527260903342746]; Bagus T, 2016, KARLSRUHE; Benson T, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092058; Bernstein JT, 2017, APPL PHYSIOL NUTR ME, V42, P1217, DOI 10.1139/apnm-2017-0169; Bivoltsis A, 2018, INT J HEALTH GEOGR, V17, DOI 10.1186/s12942-018-0139-7; Bix L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139732; Branca F, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l296; BRAUN CC, 1995, INT J IND ERGONOM, V15, P179, DOI 10.1016/0169-8141(94)00036-3; Brownbill AL, 2018, PUBLIC HEALTH NUTR, V21, P3335, DOI 10.1017/S1368980018002392; Buxel H., 2019, STUDIE ZUCKERUND FET; Cecchini M, 2016, OBES REV, V17, P201, DOI 10.1111/obr.12364; Chandon P, 2012, NUTR REV, V70, P571, DOI 10.1111/j.1753-4887.2012.00518.x; Chantal J, 2017, PUBLIC HLTH PANORAMA, V3, P712, DOI DOI 10.1016/S2468-2667(18)30009-4; Christoph MJ, 2016, PUBLIC HEALTH NUTR, V19, P2135, DOI 10.1017/S1368980015003183; de Edelenyi FS, 2019, ARCH PUBLIC HEALTH, V77, DOI 10.1186/s13690-019-0357-x; De Temmerman J, 2021, APPETITE, V157, DOI 10.1016/j.appet.2020.104995; Deutsche Landwirtschafts Gesellschaft (DLG),, 2018, REDUKTION ZUCKER FET; Dubois P, 2021, J ACAD MARKET SCI, V49, P119, DOI 10.1007/s11747-020-00723-5; Ernst JB, 2018, BONN; European Commission, 2006, REG EC NO 1924 2006; Fernan C, 2018, HEALTH COMMUN, V33, P1425, DOI 10.1080/10410236.2017.1358240; Fialon M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082307; Fischbach Thomas, 2016, MMW Fortschr Med, V158, P38; Franco-Arellano B, 2020, APPETITE, V149, DOI 10.1016/j.appet.2020.104629; Garcia AL, 2019, ARCH DIS CHILD, V104, P541, DOI 10.1136/archdischild-2018-315870; Goodman S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111624; Gravel K, 2012, APPETITE, V59, P877, DOI 10.1016/j.appet.2012.08.028; Hall MG, 2020, PREV MED, V132, DOI 10.1016/j.ypmed.2020.105998; Ikonen I, 2020, J ACAD MARKET SCI, V48, P360, DOI 10.1007/s11747-019-00663-9; Julia C, 2017, ERNAHRUNGS UMSCHAU, V64, pM685, DOI 10.4455/eu.2017.048; Kaur A, 2016, EUR J CLIN NUTR, V70, P1388, DOI 10.1038/ejcn.2016.114; Kaur A, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0548-1; Kleis LD, 2020, ERN RHUNGS UMSCHAU, pM582; Maubach N, 2014, APPETITE, V82, P67, DOI 10.1016/j.appet.2014.07.006; Mela DJ, 2018, ADV NUTR, V9, P63, DOI 10.1093/advances/nmx020; Nilsson E, 2017, INT REV RETAIL DISTR, V27, P334, DOI 10.1080/09593969.2017.1309674; Oostenbach LH, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7622-3; Pitt E, 2017, PUBLIC HEALTH NUTR, V20, P2393, DOI [10.1017/s1368980017001069, 10.1017/S1368980017001069]; Roe B, 1999, J PUBLIC POLICY MARK, V18, P89, DOI 10.1177/074391569901800110; Spiller A., 2020, BERICHTE BER LANDWIR, V230, DOI [10.12767/buel.vi230.308, DOI 10.12767/BUEL.VI230.308]; Spiller A, 2017, ERNAHRUNGS UMSCHAU, V64, pM146, DOI 10.4455/eu.201Z012; Statistisches Bundesamt (Destatis), 2019, VERK ZEITR 2019; Stoltze FM, 2021, APPETITE, V163, DOI 10.1016/j.appet.2021.105229; Taillie LS, 2017, J ACAD NUTR DIET, V117, P1366, DOI 10.1016/j.jand.2017.01.011; Talati Z, 2017, NUTR REV, V75, P260, DOI 10.1093/nutrit/nuw070; van Buul VJ, 2015, CRIT REV FOOD SCI, V55, P1552, DOI 10.1080/10408398.2012.754738; Wansink B, 2006, J MARKETING RES, V43, P605, DOI 10.1509/jmkr.43.4.605; WHO, 2015, SUG INT AD CHILDR; Zuhlsdorf A, 2021, G TTINGEN; Zuhlsdorf A, 2019, GESUNDHEITSUND ZUTAT	52	1	1	10	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0272220	10.1371/journal.pone.0272220	http://dx.doi.org/10.1371/journal.pone.0272220			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976882	Green Published, gold			2022-12-26	WOS:000847227000025
J	Kasiviswanathan, P; Swanner, ED; Halverson, LJ; Vijayapalani, P				Kasiviswanathan, Pooja; Swanner, Elizabeth D.; Halverson, Larry J.; Vijayapalani, Paramasivan			Farming on Mars: Treatment of basaltic regolith soil and briny water simulants sustains plant growth	PLOS ONE			English	Article							LIFE-SUPPORT; SPACE AGRICULTURE; MARTIAN SOIL; GALE CRATER; WASTE-WATER; BACTERIA; SYSTEM; EARTH; BIODESALINATION; HABITABILITY	A fundamental challenge in human missions to Mars is producing consumable foods efficiently with the in situ resources such as soil, water, nutrients and solar radiation available on Mars. The low nutrient content of martian soil and high salinity of water render them unfit for direct use for propagating food crops on Mars. It is therefore essential to develop strategies to enhance nutrient content in Mars soil and to desalinate briny water for long-term missions on Mars. We report simple and efficient strategies for treating basaltic regolith simulant soil and briny water simulant for suitable resources for growing plants. We show that alfalfa plants grow well in a nutrient-limited basaltic regolith simulant soil and that the alfalfa biomass can be used as a biofertilizer to sustain growth and production of turnip, radish and lettuce in the basaltic regolith simulant soil. Moreover, we show that marine cyanobacterium Synechococcus sp. PCC 7002 effectively desalinates the briny water simulant, and that desalination can be further enhanced by filtration through basalt-type volcanic rocks. Our findings indicate that it is possible to grow food crops with alfalfa treated basaltic regolith martian soil as a substratum watered with biodesalinated water.	[Kasiviswanathan, Pooja] Ames High, Ames, IA USA; [Swanner, Elizabeth D.] Dept Geol & Atmospher Sci, Ames, IA USA; [Halverson, Larry J.; Vijayapalani, Paramasivan] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA 50011 USA; [Kasiviswanathan, Pooja] Iowa State Univ, Microbiol Undergrad Program, Ames, IA USA; [Vijayapalani, Paramasivan] Iowa State Univ, PathoVacs Inc, Res Pk, Ames, IA 50010 USA	Iowa State University; Iowa State University; Iowa State University	Vijayapalani, P (corresponding author), Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA 50011 USA.; Vijayapalani, P (corresponding author), Iowa State Univ, PathoVacs Inc, Res Pk, Ames, IA 50010 USA.	vijaya@iastate.edu		Halverson, Larry/0000-0002-9164-8691				Aerts Joost W., 2014, Life-Basel, V4, P535, DOI 10.3390/life4040535; Amezaga JM, 2014, PLANT PHYSIOL, V164, P1661, DOI 10.1104/pp.113.233973; Aureli L, 2020, LIFE-BASEL, V10, DOI 10.3390/life10120306; Bohle S, 2016, ASTRON GEOPHYS, V57, P18; Bryanskaya AV, 2020, INT J ASTROBIOL, V19, P1, DOI 10.1017/S1473550419000077; Carlton CA., 2014, JSC MARS 1 MARTIAN R; Carr MH, 2015, GEOPHYS RES LETT, V42, P726, DOI 10.1002/2014GL062464; Chevrier V, 2007, PLANET SPACE SCI, V55, P289, DOI 10.1016/j.pss.2006.05.039; Cockell CS, 2014, ASTROBIOLOGY, V14, P182, DOI 10.1089/ast.2013.1106; Cockell CS, 2011, INT J ASTROBIOL, V10, P315, DOI 10.1017/S1473550411000164; Cousins Claire, 2015, Life-Basel, V5, P568, DOI 10.3390/life5010568; Crisler JD, 2012, ASTROBIOLOGY, V12, P98, DOI 10.1089/ast.2011.0720; Eichler A, 2021, ICARUS, V354, DOI 10.1016/j.icarus.2020.114022; El-Nakhel C, 2019, LIFE-BASEL, V9, DOI 10.3390/life9030061; Elimelech M, 2011, SCIENCE, V333, P712, DOI 10.1126/science.1200488; Fox-Powell MG, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00739; Godia F, 2002, J BIOTECHNOL, V99, P319, DOI 10.1016/S0168-1656(02)00222-5; Greenlee LF, 2009, WATER RES, V43, P2317, DOI 10.1016/j.watres.2009.03.010; Greenwood J.P., 2007, 7 INT C MARS; Hecht MH, 2009, SCIENCE, V325, P64, DOI 10.1126/science.1172466; Heinz J, 2020, LIFE-BASEL, V10, DOI 10.3390/life10050053; Hendrickx L, 2006, RES MICROBIOL, V157, P77, DOI 10.1016/j.resmic.2005.06.014; Hosein Riad, 2014, Life-Basel, V4, P566, DOI 10.3390/life4040566; Kanazawa S, 2008, ADV SPACE RES, V41, P696, DOI 10.1016/j.asr.2007.09.040; Lam MK, 2012, BIOTECHNOL ADV, V30, P673, DOI 10.1016/j.biotechadv.2011.11.008; Larkin RP, 2015, ANNU REV PHYTOPATHOL, V53, P199, DOI 10.1146/annurev-phyto-080614-120357; Lin SH, 2020, ENVIRON SCI TECHNOL, V54, P76, DOI 10.1021/acs.est.9b04788; Maggi F, 2010, PLANET SPACE SCI, V58, P1996, DOI 10.1016/j.pss.2010.09.025; Martin-Torres FJ, 2015, NAT GEOSCI, V8, P357, DOI [10.1038/ngeo2412, 10.1038/NGEO2412]; Martinez GM, 2013, SPACE SCI REV, V175, P29, DOI 10.1007/s11214-012-9956-3; McSween HY, 2009, SCIENCE, V324, P736, DOI 10.1126/science.1165871; MEHLICH A, 1984, COMMUN SOIL SCI PLAN, V15, P1409, DOI 10.1080/00103628409367568; Minas K, 2015, DESALIN WATER TREAT, V55, P2647, DOI 10.1080/19443994.2014.940647; Nelson M, 2008, ADV SPACE RES, V41, P675, DOI 10.1016/j.asr.2007.02.075; Newcombe DA, 2005, APPL ENVIRON MICROB, V71, P8147, DOI 10.1128/AEM.71.12.8147-8156.2005; Oehler DZ, 2010, ICARUS, V208, P636, DOI 10.1016/j.icarus.2010.03.031; Ojha L, 2015, NAT GEOSCI, V8, P829, DOI [10.1038/ngeo2546, 10.1038/NGEO2546]; Olguin EJ, 2012, BIOTECHNOL ADV, V30, P1031, DOI 10.1016/j.biotechadv.2012.05.001; Oren A, 2014, EXTREMOPHILES, V18, P75, DOI 10.1007/s00792-013-0594-9; Osman S, 2008, APPL ENVIRON MICROB, V74, P959, DOI 10.1128/AEM.01973-07; Oze C, 2021, SOIL SYST, V5, DOI 10.3390/soilsystems5030037; Perchonok MH, 2012, ANNU REV FOOD SCI T, V3, P311, DOI 10.1146/annurev-food-022811-101222; Peters GH, 2008, ICARUS, V197, P470, DOI 10.1016/j.icarus.2008.05.004; Plaut JJ, 2007, SCIENCE, V316, P92, DOI 10.1126/science.1139672; Preston LJ, 2014, INT J ASTROBIOL, V13, P81, DOI 10.1017/S1473550413000396; Ramirez DA, 2019, INT J ASTROBIOL, V18, P18, DOI 10.1017/S1473550417000453; Rettberg P, 2004, ADV SPACE RES-SERIES, V33, P1294, DOI 10.1016/j.asr.2003.09.050; Rickman D, 2007, CHARACTERIZATION SUM; Schlesinger A, 2012, BIOTECHNOL ADV, V30, P1023, DOI 10.1016/j.biotechadv.2012.01.011; Silverstone S, 2005, ADV SPACE RES, V35, P1544, DOI 10.1016/j.asr.2005.06.008; Silverstone S, 2003, ADV SPACE RES-SERIES, V31, P69, DOI 10.1016/S0273-1177(02)00661-0; Stern JC, 2015, P NATL ACAD SCI USA, V112, P4245, DOI 10.1073/pnas.1420932112; Taylor SR, 2009, PLANETARY CRUSTS: THEIR COMPOSITION, ORIGIN AND EVOLUTION, P1; Tong TZ, 2016, ENVIRON SCI TECHNOL, V50, P6846, DOI 10.1021/acs.est.6b01000; Uduman N, 2010, CHEM ENG J, V162, P935, DOI 10.1016/j.cej.2010.06.046; utoronto, US; Valdivia-Silva JE, 2016, PALAIOS, V31, P1, DOI 10.2110/palo.2015.010; Verseux C, 2016, INT J ASTROBIOL, V15, P65, DOI 10.1017/S147355041500021X; Wamelink G W Wieger, 2014, PLoS One, V9, pe103138, DOI 10.1371/journal.pone.0103138; Wilks JM, 2019, INT J ASTROBIOL, V18, P502, DOI [10.1017/S1473550418000502, 10.1017/s1473550418000502]; Wolff SA, 2018, LIFE-BASEL, V8, DOI 10.3390/life8040045	61	1	1	10	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0272209	10.1371/journal.pone.0272209	http://dx.doi.org/10.1371/journal.pone.0272209			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976812	Green Published, gold			2022-12-26	WOS:000847227000024
J	Khan, ZS; Van Bussel, F; Hussain, F				Khan, Zeina S.; Van Bussel, Frank; Hussain, Fazle			Modeling the change in European and US COVID-19 death rates	PLOS ONE			English	Article								Motivated by several possible differences in Covid-19 virus strains, age demographics, and face mask wearing between continents and countries, we focussed on changes in Covid death rates in 2020. We have extended our Covid-19 multicompartment model (Khan et al., 2020) to fit cumulative case and death data for 49 European countries and 52 US states and territories during the recent pandemic, and found that the case mortality rate had decreased by at least 80% in most of the US and at least 90% in most of Europe. We found that death rate decreases do not have strong correlations to other model parameters (such as contact rate) or other standard state/national metrics such as population density, GDP, and median age. Almost all the decreases occurred between mid-April and mid-June 2020, which corresponds to the time when many state and national lockdowns were relaxed resulting in surges of new cases. We examine here several plausible causes for this drop-improvements in treatment, face mask wearing, new virus strains, testing, potentially changing demographics of infected patients, and changes in data collection and reporting-but none of their effects are as significant as the death rate changes suggest. In conclusion, this work shows that a two death rate model is effective in quantifying the reported drop in death rates.	[Khan, Zeina S.; Van Bussel, Frank; Hussain, Fazle] Texas Tech Univ, Dept Mech Engn, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	Khan, ZS (corresponding author), Texas Tech Univ, Dept Mech Engn, Lubbock, TX 79409 USA.	zeina.khan@ttu.edu		Khan, Zeina/0000-0002-4665-9391	TTU President's Distinguished Chair Funds; Distinguished Chair Funds	TTU President's Distinguished Chair Funds; Distinguished Chair Funds	This study was supported by TTU President's Distinguished Chair Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors Zeina S. Khan and Fazle Hussain received salary from the Distinguished Chair Funds; Frank Van Bussel worked with no salary.	Al Zobbi M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155574; [Anonymous], 2020, TESTS PER CONF CAS; [Anonymous], 2020, DAILY STATE BY STATE; Becerra-Flores M, 2020, INT J CLIN PRACT, V74, DOI 10.1111/ijcp.13525; Betsch C, 2020, P NATL ACAD SCI USA, V117, P21851, DOI 10.1073/pnas.2011674117; Biran N, 2020, LANCET RHEUMATOL, V2, pE603, DOI 10.1016/S2665-9913(20)30277-0; Blenkinsop P, 2020, REUTERS HEALTHC 0826; Bureau of Economic Analysis, 2020, GROSS DOMESTIC PRODU; Campbell J., 2020, CORONAVIRUS DEATH RA; Central Intelligence Agency, 2019, WORLD FACTB MED AG 2; Ciceri F, 2020, PATHOG GLOB HEALTH, V114, P281, DOI 10.1080/20477724.2020.1785782; Crowley M., 2020, NEW YORK TIMES; Dennis JM, 2021, CRIT CARE MED, V49, P209, DOI 10.1097/CCM.0000000000004747; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Drum K, 2020, MOTHER JONES; Fan GH, 2021, TRANSBOUND EMERG DIS, V68, P213, DOI 10.1111/tbed.13819; Gandhi M, 2020, J GEN INTERN MED, V35, P3063, DOI 10.1007/s11606-020-06067-8; Gettleman J, 2020, NEW YORK TIMES; Gomez-Carballa A, 2020, GENOME RES, V30, P1434, DOI 10.1101/gr.266221.120; Griffiths J., 2020, THE CNN; Gupta M, 2021, APPL SOFT COMPUT, V101, DOI 10.1016/j.asoc.2020.107039; Haischer MH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240785; Han E, 2020, LANCET, V396, P1525, DOI 10.1016/S0140-6736(20)32007-9; Heneghan C., 2020, PUBLIC HLTH ENGLAND, P12; Horowitz J, 2020, NEW YORK TIMES; Horwitz LI, 2021, J HOSP MED, V16, P90, DOI 10.12788/jhm.3552; International Monetary Fund, 2018, WORLD EC OUTL APR 20; Jiang Feiyu, 2023, J Econom, V232, P1, DOI 10.1016/j.jeconom.2020.07.039; Katella K, 2021, OUR PANDEMIC YEAR A; Khachfe HH, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7313; Khan ZS, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820002423; Kifer D, 2021, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.607786; Klopfenstein T, 2020, MED MALADIES INFECT, V50, P397, DOI 10.1016/j.medmal.2020.05.001; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Lan FY, 2021, PATHOG GLOB HEALTH, V115, P4, DOI 10.1080/20477724.2020.1847778; Ledford H, 2020, NATURE, V587, P190, DOI 10.1038/d41586-020-03132-4; Leffler CT, 2020, AM J TROP MED HYG, V103, P2400, DOI 10.4269/ajtmh.20-1015; Leung K, 2020, EMPIRICAL TRANSMISSI, DOI [10.1101/2020.09.22.20199810v1, DOI 10.1101/2020.09.22.20199810V1, 10.1101/2020.09.22.20199810, DOI 10.1101/2020.09.22.20199810]; Long SW, 2020, MBIO, V11, DOI 10.1128/mBio.02707-20; Maghbooli Z, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239799; MATLAB, 2010, VERS 7100 R2010A; Mervosh S., 2020, NEW YORK TIMES; Mohammad A, 2021, INT J INFECT DIS, V103, P611, DOI 10.1016/j.ijid.2020.10.033; New York State Department of Health, 2020, NYS HLTH PROF MONT N; Organization WH, 2020, WORLD HLTH ORGANIZAT; Organization WH, 2020, NOV COR CHIN; Pachetti M, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02501-x; Promislow DEL, 2020, J GERONTOL A-BIOL, V75, pE30, DOI 10.1093/gerona/glaa094; Ritchie H., 2020, OURWORLD DATA; Roberts M, 2021, BBC NEWS 1223; Roser M., 2020, DAILY NEW CONFIRMED; Salazar E, 2020, AM J PATHOL, V190, P2290, DOI 10.1016/j.ajpath.2020.08.001; Signorelli C, 2020, INT J PUBLIC HEALTH, V65, P1435, DOI 10.1007/s00038-020-01486-0; Staff R, 2020, REUTERS HEALTHCARE P; StatsAmerica, 2020, MED AG 2019; Strizova Z, 2020, CENT EUR J PUBL HEAL, V28, P161, DOI 10.21101/cejph.a6290; Terriau A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-01034-7; Titus RK., 2020, MATH MODELLING APPL, V5, P176, DOI [10.11648/j.mma.20200503.16, DOI 10.11648/J.MMA.20200503.16]; U.S. Census Bureau, 2021, AM HOUS SURV HOUS SU; Venkatesan P, 2020, LANCET RESP MED, V8, pE95, DOI 10.1016/S2213-2600(20)30461-6; Vicentini C, 2020, AM J TROP MED HYG, V103, P2382, DOI 10.4269/ajtmh.20-0862; Wei C, 2020, EPIDEMIOL INFECT, V149, DOI 10.1017/S0950268820003076; World Bank, GINI IND WORLD BANK; Wu KJ, 2020, NEW YORK TIMES	65	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0268332	10.1371/journal.pone.0268332	http://dx.doi.org/10.1371/journal.pone.0268332			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976910	Green Published, gold			2022-12-26	WOS:000847227000005
J	Orlando, BJ; Dominik, PK; Roy, S; Ogbu, CP; Erramilli, SK; Kossiakoff, AA; Vecchio, AJ				Orlando, Benjamin J.; Dominik, Pawel K.; Roy, Sourav; Ogbu, Chinemerem P.; Erramilli, Satchal K.; Kossiakoff, Anthony A.; Vecchio, Alex J.			Development, structure, and mechanism of synthetic antibodies that target claudin and Clostridium perfringens enterotoxin complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEINS; CRYO-EM; FOODBORNE ILLNESS; UNITED-STATES; INSIGHT; LOSSES	Strains of Clostridium perfringens produce a two-domain enterotoxin (CpE) that afflicts humans and domesticated animals, causing prevalent gastrointestinal illnesses. CpE's C-terminal domain (cCpE) binds cell surface receptors, followed by a restructuring of its N-terminal domain to form a membranepenetrating fl-barrel pore, which is toxic to epithelial cells of the gut. The claudin family of membrane proteins are known receptors for CpE and also control the architecture and function of cell-cell contacts (tight junctions) that create barriers to intercellular molecular transport. CpE binding and assembly disables claudin barrier function and induces cytotoxicity via fl-pore formation, disrupting gut homeostasis; however, a structural basis of this process and strategies to inhibit the claudin-CpE interactions that trigger it are both lacking. Here, we used a synthetic antigen-binding fragment (sFab) library to discover two sFabs that bind claudin-4 and cCpE complexes. We established these sFabs' mode of molecular recognition and binding properties and determined structures of each sFab bound to claudin-4-cCpE complexes using cryo-EM. The structures reveal that the sFabs bind a shared epitope, but conform distinctly, which explains their unique binding equilibria. Mutagenesis of antigen/sFab interfaces observed therein result in binding changes, validating the structures, and uncovering the sFab's targeting mechanism. From these insights, we generated a model for CpE's claudin-bound fl-pore that predicted sFabs would not prevent cytotoxicity, which we then verified in vivo. Taken together, this work demonstrates diseases.	[Orlando, Benjamin J.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI USA; [Dominik, Pawel K.; Erramilli, Satchal K.; Kossiakoff, Anthony A.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL USA; [Roy, Sourav; Ogbu, Chinemerem P.; Vecchio, Alex J.] Univ Nebraska Lincoln, Dept Biochem, Lincoln, NE 68588 USA; [Dominik, Pawel K.] Pfizer, San Diego, CA 92121 USA	Michigan State University; University of Chicago; University of Nebraska System; University of Nebraska Lincoln; Pfizer	Vecchio, AJ (corresponding author), Univ Nebraska Lincoln, Dept Biochem, Lincoln, NE 68588 USA.	avecchio@unl.edu	ROY, SOURAV/AAI-2678-2021	ROY, SOURAV/0000-0002-3927-571X; Ogbu, Chinemerem/0000-0001-5663-7148; Erramilli, Satchal/0000-0001-8694-7681	National Institute of General Medical Sciences of the National Institutes of Health [R35GM138368, R01GM117372]	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding and additional information-Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R35GM138368 (to A. J. V.) and R01GM117372 (to A. A. K) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Bloch JS, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2115435118; Bokori-Brown M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11293; Bukowska MA, 2013, CURR OPIN STRUC BIOL, V23, P409, DOI 10.1016/j.sbi.2013.03.003; Chiba H, 2008, BBA-BIOMEMBRANES, V1778, P588, DOI 10.1016/j.bbamem.2007.08.017; Cirauqui N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13714-4; De Colibus L, 2012, STRUCTURE, V20, P1498, DOI 10.1016/j.str.2012.06.011; Dominik PK, 2016, STRUCTURE, V24, P300, DOI 10.1016/j.str.2015.11.014; DUNCAN CL, 1972, J BACTERIOL, V110, P378, DOI 10.1128/JB.110.1.378-391.1972; Dutka P, 2019, STRUCTURE, V27, P1862, DOI 10.1016/j.str.2019.10.004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Freedman JC, 2016, TOXINS, V8, DOI 10.3390/toxins8030073; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Hoffmann S, 2012, J FOOD PROTECT, V75, P1292, DOI 10.4315/0362-028X.JFP-11-417; Katahira J, 1997, J BIOL CHEM, V272, P26652, DOI 10.1074/jbc.272.42.26652; Kidmose RT, 2019, IUCRJ, V6, P526, DOI 10.1107/S2052252519007619; Kirk MD, 2015, PLOS MED, V12, DOI [10.1371/journal.pmed.1001921, 10.1371/journal.pmed.1001940]; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Maeda T, 2012, PROSTATE, V72, P351, DOI 10.1002/pros.21436; McClane BA, 2001, TOXICON, V39, P1781, DOI 10.1016/S0041-0101(01)00164-7; Mitchell LA, 2010, TOXINS, V2, P1595, DOI 10.3390/toxins2071595; Mitic LL, 2003, PROTEIN SCI, V12, P218, DOI 10.1110/ps.0233903; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Mukherjee S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15363-0; Nakamura S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08760-7; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pahle J, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3123-x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Robertson SL, 2007, CELL MICROBIOL, V9, P2734, DOI 10.1111/j.1462-5822.2007.00994.x; Rood JI, 2018, ANAEROBE, V53, P5, DOI 10.1016/j.anaerobe.2018.04.011; Saitoh Y, 2015, SCIENCE, V347, P775, DOI 10.1126/science.1261833; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Scharff RL, 2012, J FOOD PROTECT, V75, P123, DOI 10.4315/0362-028X.JFP-11-058; Schrodinger L., 2022, PYMOL VERSION 2 2 3; Shinoda T, 2016, SCI REP-UK, V6, DOI 10.1038/srep33632; Shinoda T, 2016, SCI REP-UK, V6, DOI 10.1038/srep30442; Suzuki H, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02320; Suzuki H, 2014, SCIENCE, V344, P304, DOI 10.1126/science.1248571; Tachibana K, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12121236; Torres JB, 2020, J NUCL MED, V61, DOI 10.2967/jnumed.120.243113; Uzal FA, 2014, FUTURE MICROBIOL, V9, P361, DOI 10.2217/fmb.13.168; Vecchio AJ, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2024651118; Vecchio AJ, 2019, P NATL ACAD SCI USA, V116, P17817, DOI 10.1073/pnas.1908929116; Veshnyakova A, 2010, TOXINS, V2, P1336, DOI 10.3390/toxins2061336; Wu SP, 2012, STRUCTURE, V20, P582, DOI 10.1016/j.str.2012.02.017	50	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102357	10.1016/j.jbc.2022.102357	http://dx.doi.org/10.1016/j.jbc.2022.102357			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5A7IQ	35952760	Green Published, gold, Green Submitted			2022-12-26	WOS:000863057500008
J	Kocelak, P; Mossakowska, M; Puzianowska-Kuznicka, M; Sworczak, K; Wyszomirski, A; Handzlik, G; Stefanski, A; Zdrojewski, T; Chudek, J				Kocelak, Piotr; Mossakowska, Malgorzata; Puzianowska-Kuznicka, Monika; Sworczak, Krzysztof; Wyszomirski, Adam; Handzlik, Gabriela; Stefanski, Adrian; Zdrojewski, Tomasz; Chudek, Jerzy			Prevalence and risk factors of untreated thyroid dysfunctions in the older Caucasian adults: Results of PolSenior 2 survey	PLOS ONE			English	Article							SUBCLINICAL HYPERTHYROIDISM; HYPOTHYROIDISM; DISEASE; POPULATION; ASSOCIATION; HEALTH; GUIDELINES; DISORDERS; DIAGNOSIS; SYMPTOMS	Introduction To determine the prevalence of treated and untreated thyroid dysfunction and to identify factors associated with increased risk of undiagnosed thyroid dysfunction in older adults. Methods The population of 5987 community-dwelling Polish Caucasian seniors aged 60 years and above who participated in the PolSenior 2 study (2018-2019). Population-based cross-sectional multidisciplinary study in design. Data from structured questionnaires, geriatric tests, and scales were obtained from all study participants who underwent anthropometric and blood pressure measurements during three home visits. Assessment of thyroid function was based on TSH serum measurements. Results The prevalence of thyroid dysfunction in the Polish population aged 60 years or above was estimated at 15.5% (21.5% in women and 7.2% in men), with 3.2% of undiagnosed individuals among them. The prevalence of hypothyroidism and hyperthyroidism in the studied group was 13.9% (19.4% in women and 6.3% in men) and 1.6% (2.1% in women and 0.9% in men) respectively, untreated hypothyroidism was revealed in 21.9% (in 160 out of 732 subjects) and untreated hyperthyroidism in 34.2% of subjects (in 41 out of 120 participants). In multiple regression analysis independent risk factors for thyroid disorders being untreated were older age (> 75 years), male sex, a low education level (primary or lower), and low utilization of medical services. Conclusions One-fifth of Polish Caucasian seniors with hypothyroidism and one-third with hyperthyroidism are untreated. Older, poorly educated and rarely utilizing medical services seniors, especially men, are more frequently untreated for thyroid dysfunction and some of them do not benefit from contemporary achievements in medicine.	[Kocelak, Piotr] Med Univ Silesia, Med Fac Katowice, Dept Pathophysiol, Pathophysiol Unit, Katowice, Poland; [Mossakowska, Malgorzata] Int Inst Mol & Cell Biol, Warsaw, Poland; [Puzianowska-Kuznicka, Monika] Med Ctr Postgrad Educ, Dept Geriatr & Gerontol, Warsaw, Poland; [Puzianowska-Kuznicka, Monika] Polish Acad Sci, Mossakowski Med Res Inst, Dept Human Epigenet, Warsaw, Poland; [Sworczak, Krzysztof] Med Univ Gdansk, Dept Endocrinol & Internal Dis, Gdansk, Poland; [Wyszomirski, Adam] Med Univ Gdansk, Dept Adult Neurol, Fac Med, Gdansk, Poland; [Handzlik, Gabriela; Chudek, Jerzy] Med Univ Silesia, Med Fac Katowice, Dept Internal Med & Oncol Chemotherapy, Katowice, Poland; [Stefanski, Adrian; Zdrojewski, Tomasz] Med Univ Gdansk, Div Prevent Med & Educ, Gdansk, Poland	Medical University Silesia; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Centre of Postgraduate Medical Education - Poland; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Medical University Silesia; Fahrenheit Universities; Medical University Gdansk	Kocelak, P (corresponding author), Med Univ Silesia, Med Fac Katowice, Dept Pathophysiol, Pathophysiol Unit, Katowice, Poland.	pkocelak@sum.edu.pl		Chudek, Jerzy/0000-0002-6367-7794; Stefanski, Adrian/0000-0002-7019-1928	 [6/5/4.2/NPZ/2017/1203/1257]		This paper was implemented under contract No. 6/5/4.2/NPZ/2017/1203/1257 for the implementation of the task in the field of public health of the Operational Objective No. 5 points 4.2. of the National Health Program for years 20162020, entitled "Health Status and Its Socioeconomic Covariates of the Older Population in Poland -the Nationwide PolSenior2 Survey"(PolSenior2). The funders had no role in study design, data collection and analysis, decision to publish, or reparation of the manuscript.	Aoki Y, 2007, THYROID, V17, P1211, DOI 10.1089/thy.2006.0235; Bar-Andziak E, 2012, ENDOKRYNOL POL, V63, P346; BEMBEN DA, 1994, J FAM PRACTICE, V38, P577; Boelaert K, 2010, J CLIN ENDOCR METAB, V95, P2715, DOI 10.1210/jc.2009-2495; Bollerslev J, 2015, EUR J ENDOCRINOL, V173, pEG1, DOI 10.1530/EJE-15-0628; Cai J, 2016, ENDOCR J, V63, P381, DOI 10.1507/endocrj.EJ15-0574; Calsolaro V, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00177; Canaris GJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-351; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Carle A, 2015, CLIN ENDOCRINOL, V83, P717, DOI 10.1111/cen.12787; Chaker L, 2017, LANCET, V390, P1550, DOI 10.1016/S0140-6736(17)30703-1; Dew R, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0457-z; Diab N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49540-z; Donangelo I, 2017, AM FAM PHYSICIAN, V95, P710; Elenkova A, 2017, ENDOCRINE, V57, P486, DOI 10.1007/s12020-017-1372-8; Empson M, 2007, INTERN MED J, V37, P448, DOI 10.1111/j.1445-5994.2007.01367.x; Faber J, 1998, CLIN ENDOCRINOL, V48, P285; Garber JR, 2012, ENDOCR PRACT, V18, P989, DOI 10.4158/EP12280.GL; Madariaga AG, 2014, J CLIN ENDOCR METAB, V99, P923, DOI 10.1210/jc.2013-2409; Gencer B, 2012, CIRCULATION, V126, P1040, DOI 10.1161/CIRCULATIONAHA.112.096024; Gronich N, 2015, DIABETES CARE, V38, P1657, DOI 10.2337/dc14-2515; Ittermann T, 2015, EUR J ENDOCRINOL, V172, P261, DOI 10.1530/EJE-14-0898; Klein I, 2001, NEW ENGL J MED, V344, P501, DOI 10.1056/NEJM200102153440707; Laurberg P, 2000, THYROID, V10, P951, DOI 10.1089/thy.2000.10.951; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Mendes D, 2019, EUR THYROID J, V8, P130, DOI 10.1159/000499751; Mungas D, 1996, NEUROLOGY, V46, P700, DOI 10.1212/WNL.46.3.700; Nations U., 2011, ADOLESCENCE AGE OPPO, V17; Olmos RD, 2015, BRAZ J MED BIOL RES, V48, P751, DOI 10.1590/1414-431X20154445; Raval AD, 2012, J THROID RES, V2012, DOI 10.1155/2012/418345; Razvi S, 2016, THYROID RES, V9, DOI 10.1186/s13044-016-0034-x; Rodondi N, 2010, JAMA-J AM MED ASSOC, V304, P1365, DOI 10.1001/jama.2010.1361; Ross DS, 2016, THYROID, V26, P1343, DOI 10.1089/thy.2016.0229; SAWIN CT, 1985, ARCH INTERN MED, V145, P1386, DOI 10.1001/archinte.145.8.1386; Stott DJ, 2017, NEW ENGL J MED, V376, P2534, DOI 10.1056/NEJMoa1603825; Vigario PD, 2013, ENDOCRINE, V44, P434, DOI 10.1007/s12020-013-9886-1; Wierucki L, 2022, ARCH MED SCI, V18, P92, DOI 10.5114/aoms.2020.100898; Wilson S, 2006, J CLIN ENDOCR METAB, V91, P4809, DOI 10.1210/jc.2006-1557; Wouters HJCM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242795; Yamamoto H, 2021, BMC CARDIOVASC DISOR, V21, DOI 10.1186/s12872-021-01935-5	40	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0272045	10.1371/journal.pone.0272045	http://dx.doi.org/10.1371/journal.pone.0272045			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994462	Green Submitted, gold, Green Published			2022-12-26	WOS:000877093400015
J	Stavem, K; Einvik, G; Tholin, B; Ghanima, W; Hessen, E; Lundqvist, C				Stavem, Knut; Einvik, Gunnar; Tholin, Birgitte; Ghanima, Waleed; Hessen, Erik; Lundqvist, Christofer			Cognitive function in non-hospitalized patients 8-13 months after acute COVID-19 infection: A cohort study in Norway	PLOS ONE			English	Article							IMPAIRMENTS; FATIGUE	Studies have reported reduced cognitive function following COVID-19 illness, mostly from hospital settings with short follow-up times. This study recruited non-hospitalized COVID-19 patients from a general population to study prevalence of late cognitive impairment and associations with initial symptoms. We invited patients with PCR-confirmed COVID-19. A postal questionnaire addressed basic demographics, initial COVID-19 symptoms and comorbidity about 4 months after diagnosis. About 7 months later, we conducted cognitive tests using the Cambridge Neuropsychological Test Automated Battery, comprising four tests for short-term memory, attention and executive function. We present descriptive statistics using z-scores relative to UK population norms and defined impairment as z-score <-1.5. We used multivariable logistic regression with impairment as outcome. Continuous domain scores were analysed by multiple linear regression. Of the initial 458 participants; 305 were invited, and 234 (77%) completed cognitive testing. At median 11 (range 8-13) months after PCR positivity, cognitive scores for short term memory, visuospatial processing, learning and attention were lower than norms (p <= 0.001). In each domain, 4-14% were cognitively impaired; 68/232 (29%) were impaired in >= 1 of 4 tests. There was no association between initial symptom severity and impairment. Multivariable linear regression showed association between spatial working memory and initial symptom load (6-9 symptoms vs. 0-5, coef. 4.26, 95% CI: 0.65; 7.86). No other dimension scores were associated with symptom load. At median 11 months after out-of-hospital SARS-Cov-2 infection, minor cognitive impairment was seen with little association between COVID-19 symptom severity and outcome.	[Stavem, Knut; Einvik, Gunnar] Akershus Univ Hosp, Dept Pulm Med, Div Med, Nordbyhagen, Norway; [Stavem, Knut] Akershus Univ Hosp, Hlth Serv Res Unit, Nordbyhagen, Norway; [Stavem, Knut; Einvik, Gunnar; Tholin, Birgitte; Ghanima, Waleed; Lundqvist, Christofer] Univ Oslo, Inst Clin Med, Oslo, Norway; [Tholin, Birgitte; Ghanima, Waleed] Ostfold Hosp, Clin Internal Med, Gralum, Norway; [Hessen, Erik; Lundqvist, Christofer] Akershus Univ Hosp, Div Med, Dept Neurol, Nordbyhagen, Norway; [Hessen, Erik] Univ Oslo, Dept Psychol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Stavem, K (corresponding author), Akershus Univ Hosp, Dept Pulm Med, Div Med, Nordbyhagen, Norway.; Stavem, K (corresponding author), Akershus Univ Hosp, Hlth Serv Res Unit, Nordbyhagen, Norway.; Stavem, K (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	knut.stavem@medisin.uio.no		Stavem, Knut/0000-0003-4512-8000				Almeria M, 2020, Brain Behav Immun Health, V9, P100163, DOI 10.1016/j.bbih.2020.100163; Bailey EK, 2021, NEUROPSYCHOLOGY, V35, P335, DOI 10.1037/neu0000731; Becker JH, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.30645; CANTAB Connect Research, 2019, ADM APPL US GUID; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Daroische Rania, 2021, Front Neurol, V12, P699582, DOI 10.3389/fneur.2021.699582; Del Brutto OH, 2021, EUR J NEUROL, V28, P3245, DOI 10.1111/ene.14775; Dressing A, 2022, J NUCL MED, V63, P1058, DOI 10.2967/jnumed.121.262677; Ferrucci R, 2021, BRAIN SCI, V11, DOI 10.3390/brainsci11020235; Folkehelseinstituttet, 2020, COVID 19 UK UK 22; Graham EL, 2021, ANN CLIN TRANSL NEUR, V8, P1073, DOI 10.1002/acn3.51350; Grover S, 2021, ASIAN J PSYCHIATR, V64, DOI 10.1016/j.ajp.2021.102815; Hampshire A, 2021, ECLINICALMEDICINE, V39, DOI 10.1016/j.eclinm.2021.101044; Hellmuth J, 2021, J NEUROVIROL, V27, P191, DOI 10.1007/s13365-021-00954-4; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Hopkins RO, 1999, AM J RESP CRIT CARE, V160, P50, DOI 10.1164/ajrccm.160.1.9708059; Jackson JC, 2003, CRIT CARE MED, V31, P1226, DOI 10.1097/01.CCM.0000059996.30263.94; Karlsen RH, 2022, APPL NEUROPSYCH-ADUL, V29, P146, DOI 10.1080/23279095.2020.1722126; Katz JN, 1996, MED CARE, V34, P73, DOI 10.1097/00005650-199601000-00006; Mattioli F, 2021, J NEUROL, V268, P4422, DOI 10.1007/s00415-021-10579-6; Mendez R, 2021, J INTERN MED, V290, P621, DOI 10.1111/joim.13262; Miskowiak KW, 2021, EUR NEUROPSYCHOPHARM, V46, P39, DOI 10.1016/j.euroneuro.2021.03.019; Pickett I., 2021, CAMBRIDGE COGNITION; Ritchie K, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa069; Smith PJ, 2013, J CLIN EXP NEUROPSYC, V35, P319, DOI 10.1080/13803395.2013.771618; Stavem K, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18042030; Stavem K, 2021, THORAX, V76, P405, DOI 10.1136/thoraxjnl-2020-216377; Sudre CH, 2021, NAT MED, V27, DOI 10.1038/s41591-021-01292-y; Torgersen J, 2011, ACTA ANAESTH SCAND, V55, P1044, DOI 10.1111/j.1399-6576.2011.02500.x; Townsend L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240784; van den Borst B, 2021, CLIN INFECT DIS, V73, pE1089, DOI 10.1093/cid/ciaa1750; Vannorsdall TD, 2022, J ACAD CONSULT-LIAIS, V63, P133, DOI 10.1016/j.jaclp.2021.10.006; Woo MS, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa205	33	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0273352	10.1371/journal.pone.0273352	http://dx.doi.org/10.1371/journal.pone.0273352			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994448	gold, Green Published			2022-12-26	WOS:000877093400047
J	Balgopal, MM; Weinberg, AE; McMeeking, LBS; Hunter, DEL; Wright, DS				Balgopal, Meena M.; Weinberg, Andrea E.; McMeeking, Laura B. Sample; Hunter, Danielle E. Lin; Wright, Diane S.			A sense of belonging: The role of higher education in retaining quality STEM teachers	PLOS ONE			English	Article							OUTCOMES; MODEL	There is an alarming shortage of qualified STEM teachers in American PK-12 schools. The COVID-19 pandemic may exacerbate this crisis and consequently affect who participates in future STEM innovation. At three points during the pandemic, we surveyed early career teachers who were supported by the National Science Foundation as they began teaching in high-needs school districts. Teachers who felt connected to their professional and academic communities reported intentions to remain in the profession, while those who felt isolated reported intentions of leaving. It is critical for STEM academics to maintain professional relationships with graduates who pursue STEM teaching professions after graduation.	[Balgopal, Meena M.; Hunter, Danielle E. Lin; Wright, Diane S.] Colorado State Univ, Dept Biol, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Weinberg, Andrea E.] Arizona State Univ, Mary Lou Fulton Teachers Coll, Tempe, AZ 85281 USA; [McMeeking, Laura B. Sample] Colorado State Univ, CSU STEM Ctr, Ft Collins, CO 80523 USA	Colorado State University; Arizona State University; Arizona State University-Tempe; Colorado State University	Balgopal, MM (corresponding author), Colorado State Univ, Dept Biol, Grad Degree Program Ecol, Ft Collins, CO 80523 USA.; Weinberg, AE (corresponding author), Arizona State Univ, Mary Lou Fulton Teachers Coll, Tempe, AZ 85281 USA.	meena.balgopal@colostate.edu; andrea.weinberg@asu.edu		Balgopal, Meena/0000-0002-3846-9256; Lin Hunter, Danielle/0000-0001-5328-595X; Sample McMeeking, Laura/0000-0001-6463-3454	National Foundation [2029302]	National Foundation(National Science Foundation (NSF))	This research was supported by a National Foundation grant (2029302) awarded to MMB, AEW, and LBSM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apriceno M, 2020, J COLL STUDENT DEV, V61, P643, DOI 10.1353/csd.2020.0061; Asbury K., 2020, TEACHERS PERCEPTIONS, DOI 10.31234/osf.io/65k8q; Balgopal M.M., 2021, COVID 19 DISTURBANCE, DOI [10.25675/10217/232378, DOI 10.25675/10217/232378]; Basham JD, 2010, J SPEC EDUC TECHNOL, V25, P9, DOI 10.1177/016264341002500303; Bastian KC, 2017, AM EDUC RES J, V54, P360, DOI 10.3102/0002831217690517; Bell A, 2019, Q J ECON, V134, P647, DOI 10.1093/qje/qjy028; Borman GD, 2008, REV EDUC RES, V78, P367, DOI 10.3102/0034654308321455; Buchanan J, 2013, AUST J TEACH EDUC, V38, P112; Carver-Thomas D., 2020, SHARPENING DIVIDE CA; Chetty R, 2014, AM ECON REV, V104, P2633, DOI 10.1257/aer.104.9.2633; Crompton H, 2021, BRIT J EDUC TECHNOL, V52, P1554, DOI 10.1111/bjet.13114; Garbe A., 2020, AM J QUALITATIVE RES, V4, P45, DOI [10.29333/ajqr/8471, DOI 10.29333/AJQR/8471]; Garcia E., 2019, PERFECT STORM TEACHE; Hartshorne R., 2020, J TECHNOLOGY TEACHER, V28, P137; Haynes M., 2014, PATH EQUITY IMPROVIN; Ingersoll RM, 2012, EDUC EVAL POLICY AN, V34, P435, DOI 10.3102/0162373712454326; Knowlton S., 2015, J COLL SCI TEACH, V44, P46; Kuhfeld M, 2020, EDUC RESEARCHER, V49, P549, DOI 10.3102/0013189X20965918; Kunter M, 2013, J EDUC PSYCHOL, V105, P805, DOI 10.1037/a0032583; Luthans F, 2006, J ORGAN BEHAV, V27, P387, DOI 10.1002/job.373; Master A., 2020, INT J GENDER SCI TEC, V12, P152; Milgron-Elcott T., 2019, FORBES; Morgan GA., 2006, PSYCHOL PR; National Academies of Sciences Engineering and Medicine, 2021, CALL ACTION SCI ED B, DOI [10.17226/26152, DOI 10.17226/26152]; Onwuegbuzie AJ, 2010, J MIX METHOD RES, V4, P56, DOI 10.1177/1558689809355805; Opper IM., 2012, TEACHERS MATTER UNDE, DOI [10.7249/RR4312, DOI 10.7249/RR4312]; Peltonen K, 2015, EDUC TRAIN, V57, P492, DOI 10.1108/ET-03-2014-0033; Richardson GE, 2002, J CLIN PSYCHOL, V58, P307, DOI 10.1002/jclp.10020; Richmond G, 2017, MENTOR TUTOR, V25, P5, DOI 10.1080/13611267.2017.1308097; Schuck S, 2018, PROF DEV EDUC, V44, P209, DOI 10.1080/19415257.2016.1274268; Sebald AM, 2022, SCHOOL SCI MATH, V122, P4, DOI 10.1111/ssm.12508; SHELLEY M, 1984, J AM STAT ASSOC, V79, P240, DOI 10.2307/2288384; Skaalvik EM, 2011, TEACH TEACH EDUC, V27, P1029, DOI 10.1016/j.tate.2011.04.001; Sutcher L., 2016, COMING CRISIS TEACHI; Switzer GE, 1999, SOC PSYCH PSYCH EPID, V34, P399, DOI 10.1007/s001270050161; Trust T., 2021, ITALIAN J ED TECH, V29, P10, DOI https://doi.org/10.17471/2499-4324/1192; van Dam K, 2010, TEACH TEACH EDUC, V26, P965, DOI 10.1016/j.tate.2009.10.038; Watlington E, 2010, J EDUC FINANC, V36, P22, DOI 10.1353/jef.0.0028; Wong PM, 2010, PSYCHOLOGIA, V53, P151, DOI 10.2117/psysoc.2010.151	39	1	1	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0272552	10.1371/journal.pone.0272552	http://dx.doi.org/10.1371/journal.pone.0272552			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976904	gold, Green Published			2022-12-26	WOS:000847227000049
J	Aryee, KE; Burzenski, LM; Yao, LC; Keck, JG; Greiner, DL; Shultz, LD; Brehm, MA				Aryee, Ken-Edwin; Burzenski, Lisa M.; Yao, Li-Chin; Keck, James G.; Greiner, Dale L.; Shultz, Leonard D.; Brehm, Michael A.			Enhanced development of functional human NK cells in NOD-scid-IL2rg(null) mice expressing human IL15	FASEB JOURNAL			English	Article						Hu-IL15; humanized mice; NK cells; NSG; transgenic	NATURAL-KILLER-CELLS; T-CELLS; PROGNOSTIC-SIGNIFICANCE; MELANOMA-CELLS; MOUSE MODELS; SERUM-LEVELS; CANCER; IL-15; INTERLEUKIN-15; RESISTANCE	Human innate immunity plays a critical role in tumor surveillance and in immunoregulation within the tumor microenvironment. Natural killer (NK) cells are innate lymphoid cells that have opposing roles in the tumor microenvironment, including NK cell subsets that mediate tumor cell cytotoxicity and subsets with regulatory function that contribute to the tumor immune suppressive environment. The balance between effector and regulatory NK cell subsets has been studied extensively in murine models of cancer, but there is a paucity of models to study human NK cell function in tumorigenesis. Humanized mice are a powerful alternative to syngeneic mouse tumor models for the study of human immuno-oncology and have proven effective tools to test immunotherapies targeting T cells. However, human NK cell development and survival in humanized NOD-scid-IL2rg(null) (NSG) mice are severely limited. To enhance NK cell development, we have developed NSG mice that constitutively expresses human Interleukin 15 (IL15), NSG-Tg(Hu-IL15). Following hematopoietic stem cell engraftment of NSG-Tg(Hu-IL15) mice, significantly higher levels of functional human CD56+ NK cells are detectable in blood and spleen, as compared to NSG mice. Hematopoietic stem cell (HSC)-engrafted NSG-Tg(Hu-IL15) mice also supported the development of human CD3+ T cells, CD20+ B cells, and CD33+ myeloid cells. Moreover, the growth kinetics of a patient-derived xenograft (PDX) melanoma were significantly delayed in HSC-engrafted NSG-Tg(Hu-IL15) mice as compared to HSC-engrafted NSG mice demonstrating that human NK cells have a key role in limiting the tumor growth. Together, these data demonstrate that HSC-engrafted NSG-Tg(Hu-IL15) mice support enhanced development of functional human NK cells, which limit the growth of PDX tumors.	[Aryee, Ken-Edwin; Greiner, Dale L.; Brehm, Michael A.] Univ Massachusetts, Chan Med Sch, Diabet Ctr Excellence, Program Mol Med, Worcester, MA 01605 USA; [Burzenski, Lisa M.; Shultz, Leonard D.] Jackson Lab, Bar Harbor, MA USA; [Yao, Li-Chin; Keck, James G.] Jackson Lab, Sacramento, CA USA	University of Massachusetts System; University of Massachusetts Worcester; Jackson Laboratory	Brehm, MA (corresponding author), Univ Massachusetts, Chan Med Sch, Diabet Ctr Excellence, Program Mol Med, Worcester, MA 01605 USA.	michael.brehm@umassmed.edu			HHS | National Institutes of Health (NIH) [CA034196, AI132963, DK104218]	HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS | National Institutes of Health (NIH), Grant/Award Number: CA034196, AI132963 and DK104218	Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bazhin AV, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02878; Besser MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057922; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Brehm MA, 2003, J IMMUNOL, V170, P4077, DOI 10.4049/jimmunol.170.8.4077; Brehm MA, 2010, DIABETES, V59, P2265, DOI 10.2337/db10-0323; Campbell KS, 2013, J ALLERGY CLIN IMMUN, V132, P536, DOI 10.1016/j.jaci.2013.07.006; Carotta S, 2011, BLOOD, V117, P5449, DOI 10.1182/blood-2010-11-318956; Chauvin JM, 2020, CLIN CANCER RES, V26, P5520, DOI 10.1158/1078-0432.CCR-20-0575; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Chen QF, 2009, P NATL ACAD SCI USA, V106, P21783, DOI 10.1073/pnas.0912274106; Chijioke O, 2013, CELL REP, V5, P1489, DOI 10.1016/j.celrep.2013.11.041; Cichocki F, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaz5618; Coca S, 1997, CANCER-AM CANCER SOC, V79, P2320, DOI 10.1002/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P; Cooper MA, 2002, BLOOD, V100, P3633, DOI 10.1182/blood-2001-12-0293; Crespo J, 2013, CURR OPIN IMMUNOL, V25, P214, DOI 10.1016/j.coi.2012.12.003; de Andrade LF, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.133103; De La Rochere P, 2018, TRENDS IMMUNOL, V39, P748, DOI 10.1016/j.it.2018.07.001; Delconte RB, 2016, IMMUNITY, V44, P103, DOI 10.1016/j.immuni.2015.12.007; Douam F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07478-2; Elpek KG, 2010, P NATL ACAD SCI USA, V107, P21647, DOI 10.1073/pnas.1012128107; Fang F, 2017, SEMIN IMMUNOL, V31, P37, DOI 10.1016/j.smim.2017.07.009; Felices M, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.96219; Fiore PF, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-001428; French AR, 2003, CURR OPIN IMMUNOL, V15, P45, DOI 10.1016/S095279150200002X; Gangemi S, 2005, MEDIAT INFLAMM, P245, DOI 10.1155/MI.2005.245; Greppi M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040890; Guil-Luna S, 2021, ANNU REV CANC BIOL, V5, P119, DOI 10.1146/annurev-cancerbio-050520-100526; Hasgur S, 2016, METHODS MOL BIOL, V1438, P67, DOI 10.1007/978-1-4939-3661-8_4; Hatfield SD, 2018, VIROLOGY, V519, P131, DOI 10.1016/j.virol.2018.04.012; Hauser A, 2013, CYTOM PART A, V83A, P316, DOI 10.1002/cyto.a.22245; Herndler-Brandstetter D, 2017, P NATL ACAD SCI USA, V114, pE9626, DOI 10.1073/pnas.1705301114; Huntington ND, 2014, IMMUNOL CELL BIOL, V92, P210, DOI 10.1038/icb.2014.1; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; KAGESHITA T, 1993, CANCER RES, V53, P3349; Kakumu S, 1997, CLIN EXP IMMUNOL, V109, P458, DOI 10.1046/j.1365-2249.1997.4861382.x; Katano I, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.532684; Katano I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17442-7; Katano I, 2015, J IMMUNOL, V194, P3513, DOI 10.4049/jimmunol.1401323; Koury J, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/9585614; Koyama S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10501; Lamana A, 2010, EUR CYTOKINE NETW, V21, P186, DOI 10.1684/ecn.2010.0203; Landtwing V, 2016, J CLIN INVEST, V126, P3772, DOI 10.1172/JCI86923; Li Y, 2016, EUR J IMMUNOL, V46, P1291, DOI 10.1002/eji.201546132; Li Y, 2015, SCI CHINA LIFE SCI, V58, P1233, DOI 10.1007/s11427-015-4970-9; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Lopez-Verges S, 2010, BLOOD, V116, P3865, DOI 10.1182/blood-2010-04-282301; Maeng H, 2018, CURR OPIN IMMUNOL, V51, P111, DOI 10.1016/j.coi.2018.03.001; Marshall HT, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00315; Martinov T, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.643852; Matsuda M, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201800195; Maykel J, 2014, DIGEST DIS SCI, V59, P1169, DOI 10.1007/s10620-014-3168-5; Nielsen CM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00422; O'Donnell JS, 2017, CANCER TREAT REV, V52, P71, DOI 10.1016/j.ctrv.2016.11.007; OLDHAM RK, 1983, CANCER METAST REV, V2, P323, DOI 10.1007/BF00048565; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Parkhurst MR, 2011, CLIN CANCER RES, V17, P6287, DOI 10.1158/1078-0432.CCR-11-1347; Patel SA, 2018, IMMUNITY, V48, P417, DOI 10.1016/j.immuni.2018.03.007; Patidar M, 2016, CYTOKINE GROWTH F R, V31, P49, DOI 10.1016/j.cytogfr.2016.06.001; Pearson Todd, 2008, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1521s81; Pek EA, 2011, IMMUNOBIOLOGY, V216, P218, DOI 10.1016/j.imbio.2010.04.008; Phung SK, 2021, MOL DIAGN THER, V25, P577, DOI 10.1007/s40291-021-00550-6; Rajashekar JK, 2021, CELL HOST MICROBE, V29, P904, DOI 10.1016/j.chom.2021.04.014; Ranson T, 2003, BLOOD, V101, P4887, DOI 10.1182/blood-2002-11-3392; Rautela J, 2017, CURR OPIN IMMUNOL, V44, P1, DOI 10.1016/j.coi.2016.10.004; Rongvaux A, 2014, NAT BIOTECHNOL, V32, P364, DOI 10.1038/nbt.2858; Rusakiewicz S, 2013, CANCER RES, V73, P3499, DOI 10.1158/0008-5472.CAN-13-0371; Schleypen JS, 2006, CLIN CANCER RES, V12, P718, DOI 10.1158/1078-0432.CCR-05-0857; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Sottile R, 2016, EUR J IMMUNOL, V46, P409, DOI 10.1002/eji.201445289; Stolk D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01990; Suzuki J, 2001, J RHEUMATOL, V28, P2389; Vallera DA, 2016, CLIN CANCER RES, V22, P3440, DOI 10.1158/1078-0432.CCR-15-2710; Villegas FR, 2002, LUNG CANCER-J IASLC, V35, P23, DOI 10.1016/S0169-5002(01)00292-6; Waldhauer I, 2008, ONCOGENE, V27, P5932, DOI 10.1038/onc.2008.267; Waldmann Thomas A, 2013, J Investig Dermatol Symp Proc, V16, pS28, DOI 10.1038/jidsymp.2013.8; Walsh NC, 2017, ANNU REV PATHOL-MECH, V12, P187, DOI 10.1146/annurev-pathol-052016-100332; Wang MA, 2018, FASEB J, V32, P1537, DOI 10.1096/fj.201700740R; Webb JR, 2014, CLIN CANCER RES, V20, P434, DOI 10.1158/1078-0432.CCR-13-1877; Wege AK, 2018, BIODRUGS, V32, P245, DOI 10.1007/s40259-018-0275-4; Woan KV, 2021, CELL STEM CELL, V28, P2062, DOI 10.1016/j.stem.2021.08.013; Yao LC, 2019, METHODS MOL BIOL, V1954, P241, DOI 10.1007/978-1-4939-9145-7_15; Yee C, 2018, CURR OPIN IMMUNOL, V51, P197, DOI 10.1016/j.coi.2018.04.007; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958	85	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22476	10.1096/fj.202200045R	http://dx.doi.org/10.1096/fj.202200045R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3S4EP	35959876	hybrid			2022-12-26	WOS:000839551400001
J	Manville, RW; Redford, KE; van der Horst, J; Hogenkamp, DJ; Jepps, TA; Abbott, GW				Manville, Rian W.; Redford, Kaitlyn E.; van der Horst, Jennifer; Hogenkamp, Derk J.; Jepps, Thomas A.; Abbott, Geoffrey W.			KCNQ5 activation by tannins mediates vasorelaxant effects of barks used in Native American botanical medicine	FASEB JOURNAL			English	Article						bark; hypotensive; KCNQ; Kv7; tannin; vasorelaxant	POTASSIUM CHANNELS; KV7.4; EXPRESSION; CELLS; ACID; ELLAGITANNINS; VASOPRESSIN; BEHAVIOR; EXTRACT; ASPIRIN	Tree and shrub barks have been used as folk medicine by numerous cultures across the globe for millennia, for a variety of indications, including as vasorelaxants and antispasmodics. Here, using electrophysiology and myography, we discovered that the KCNQ5 voltage-gated potassium channel mediates vascular smooth muscle relaxant effects of barks used in Native American folk medicine. Bark extracts (1%) from Birch, Cramp Bark, Slippery Elm, White Oak, Red Willow, White Willow, and Wild Cherry each strongly activated KCNQ5 expressed in Xenopus oocytes. Testing of a subset including both the most and the least efficacious extracts revealed that Red Willow, White Willow, and White Oak KCNQ-dependently relaxed rat mesenteric arteries; in contrast, Black Haw bark neither activated KCNQ5 nor induced vasorelaxation. Two compounds common to the active barks (gallic acid and tannic acid) had similarly potent and efficacious effects on both KCNQ5 activation and vascular relaxation, and this together with KCNQ5 modulation by other tannins provides a molecular basis for smooth muscle relaxation effects of Native American folk medicine bark extracts.	[Manville, Rian W.; Redford, Kaitlyn E.; Hogenkamp, Derk J.; Abbott, Geoffrey W.] Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Bioelect Lab, Med Sci D,ZOT 4560, Irvine, CA 92697 USA; [van der Horst, Jennifer; Jepps, Thomas A.] Univ Copenhagen, Panum Inst, Dept Biomed Sci, Vasc Biol Grp, 12-5-30,Blegdamsvej 3B, DK-2200 Copenhagen, Denmark	University of California System; University of California Irvine; University of Copenhagen	Abbott, GW (corresponding author), Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Bioelect Lab, Med Sci D,ZOT 4560, Irvine, CA 92697 USA.; Jepps, TA (corresponding author), Univ Copenhagen, Panum Inst, Dept Biomed Sci, Vasc Biol Grp, 12-5-30,Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	tjepps@sund.ku.dk; ahhottg@hs.uci.edu		Abbott, Geoffrey/0000-0003-4552-496X; Manville, Rian/0000-0002-0057-3541	European Union's Horizon 2020 Research and Innovation Program [801199]; HHS | NIH | National Institute of General Medical Sciences (NIGMS) [GM130377]; HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) [T32NS045540]; Lundbeckfonden (Lundbeck Foundation) [R323-2018-3674]; Samueli Scholarship	European Union's Horizon 2020 Research and Innovation Program; HHS | NIH | National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS); Lundbeckfonden (Lundbeck Foundation); Samueli Scholarship	European Union & apos;s Horizon 2020 Research and Innovation Program, Grant/Award Number: 801199; HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: GM130377; HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS), Grant/Award Number: T32NS045540; Lundbeckfonden (Lundbeck Foundation), Grant/Award Number: R323--2018--3674; Samueli Scholarship	Abbott GW, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.777057; Abbott GW, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00583; Abbott GW, 2014, NEW J SCI, V2014, P1, DOI [10.1155/2014/237431, DOI 10.1155/2014/237431]; Baldwin SN, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.598779; Brueggemann LI, 2007, AM J PHYSIOL-HEART C, V292, pH1352, DOI 10.1152/ajpheart.00065.2006; Brueggemann LI, 2014, J BIOL CHEM, V289, P2099, DOI 10.1074/jbc.M113.527820; Brueggemann LI, 2011, MOL PHARMACOL, V79, P10, DOI 10.1124/mol.110.067496; Brueggemann LI, 2014, MOL PHARMACOL, V86, P330, DOI 10.1124/mol.114.093799; Chadha PS, 2014, ARTERIOSCL THROM VAS, V34, P887, DOI 10.1161/ATVBAHA.114.303405; CHANDLER RF, 1979, J ETHNOPHARMACOL, V1, P49, DOI 10.1016/0378-8741(79)90016-3; Densmore F., 1928, SI BAE ANN REP, V44, P273; Desborough MJR, 2017, BRIT J HAEMATOL, V177, P674, DOI 10.1111/bjh.14520; Dwivedi S, 2007, J ETHNOPHARMACOL, V114, P114, DOI 10.1016/j.jep.2007.08.003; Gilmore MR., 1933, SOME CHIPPEWA USES P; Grieve M., 1971, MODERN HERBAL MED CU; Hamel P.B., 1975, CHEROKEE PLANTS THEI; Hardy K, 2012, NATURWISSENSCHAFTEN, V99, P617, DOI 10.1007/s00114-012-0942-0; Hartzfeld PW, 2002, J AGR FOOD CHEM, V50, P1785, DOI 10.1021/jf0111155; Herrick JW., 1977, IROQUOIS MEDICAL BOT; Inskeep RR., 1969, S AFR ARCHAEOL BULL, V24, P21; JARBOE CH, 1967, J MED CHEM, V10, P488, DOI 10.1021/jm00315a045; Jensen HS, 2005, MOL BRAIN RES, V139, P52, DOI 10.1016/j.molbrainres.2005.05.007; Jepps TA, 2011, CIRCULATION, V124, P602, DOI 10.1161/CIRCULATIONAHA.111.032136; Joshi S, 2009, J PHARMACOL EXP THER, V329, P368, DOI 10.1124/jpet.108.147785; Knuth S, 2013, PLANTA MED, V79, P1489, DOI 10.1055/s-0033-1350898; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lerche C, 2000, J BIOL CHEM, V275, P22395, DOI 10.1074/jbc.M002378200; Levesque H, 2000, REV MED INTERNE, V21, p8S, DOI 10.1016/S0248-8663(00)88720-2; Mackie AR, 2008, J PHARMACOL EXP THER, V325, P475, DOI 10.1124/jpet.107.135764; MAKKAR HPS, 1993, J CHEM ECOL, V19, P613, DOI 10.1007/BF00984996; Manville RW, 2019, P NATL ACAD SCI USA, V116, P21236, DOI 10.1073/pnas.1907511116; Manville RW, 2019, FASEB J, V33, P11349, DOI 10.1096/fj.201900485R; Manville RW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06339-2; Matschke V, 2016, CELL PHYSIOL BIOCHEM, V40, P1549, DOI 10.1159/000453205; McCallum LA, 2009, PFLUG ARCH EUR J PHY, V457, P1111, DOI 10.1007/s00424-008-0567-5; Miller A L, 1998, Altern Med Rev, V3, P422; Mistry HD, 2011, HYPERTENSION, V58, P497, DOI 10.1161/HYPERTENSIONAHA.111.173740; Moerman D.E., 2009, NATIVE AM MED PLANTS; Newsome AG, 2016, J AGR FOOD CHEM, V64, P1326, DOI 10.1021/acs.jafc.5b04966; NICHOLSON JA, 1972, P SOC EXP BIOL MED, V140, P457; Oh KS, 2008, BIOL PHARM BULL, V31, P2090, DOI 10.1248/bpb.31.2090; Panchal SK, 2013, EUR J NUTR, V52, P397, DOI 10.1007/s00394-011-0277-1; Redford Kaitlyn E, 2021, Cell Physiol Biochem, V55, P46, DOI 10.33594/000000337; Redford KE, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-1089-8; Smith H.H., 1932, B PUBLIC MUSEUM CITY, V4, P327; Syed AA, 2016, J ETHNOPHARMACOL, V193, P555, DOI 10.1016/j.jep.2016.10.008; Tantaquidgeon G., 1972, PENN HIST COMM ANTH, V3, P28; Taylor LA., 1940, PLANTS USED CURATIVE; van der Horst J, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00727; Vlachojannis J, 2011, PHYTOTHER RES, V25, P1102, DOI 10.1002/ptr.3386; Weyrich LS, 2017, NATURE, V544, P357, DOI 10.1038/nature21674; Yeung SYM, 2008, BRIT J PHARMACOL, V155, P62, DOI 10.1038/bjp.2008.231; Yeung SYM, 2007, BRIT J PHARMACOL, V151, P758, DOI 10.1038/sj.bjp.0707284; Zhang XM, 2011, AM J PHYSIOL-CELL PH, V301, pC1017, DOI 10.1152/ajpcell.00185.2011; Zhang X, 2015, EUR J PHARMACOL, V764, P633, DOI 10.1016/j.ejphar.2015.06.048; Zhang YY, 2016, J PHARM PHARMACOL, V68, P494, DOI 10.1111/jphp.12527; Zhao CY, 2019, TETRAHEDRON, V75, P1997, DOI 10.1016/j.tet.2019.02.024	57	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22457	10.1096/fj.202200724R	http://dx.doi.org/10.1096/fj.202200724R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3X7AQ	35997997				2022-12-26	WOS:000843190200001
J	Varnon, CA; Barrera, EI; Wilkes, IN				Varnon, Christopher A.; Barrera, Erandy I.; Wilkes, Isobel N.			Learning and memory in the orange head cockroach (Eublaberus posticus)	PLOS ONE			English	Article							LONG-TERM-MEMORY; APIS-MELLIFERA; HONEY-BEES; DROSOPHILA; BEHAVIOR; HELPLESSNESS; EVOLUTION; RUNWAY; AGE	This paper describes two experiments aimed at establishing the orange head cockroach (Eublaberus posticus) as a model organism for behavioral research. While many invertebrate models are available, cockroaches have several benefits over others that show impressive behavioral abilities. Most notably, cockroaches are long-lived generalists that can be maintained in controlled indoor laboratory conditions. While the most popular cockroaches in behavioral research, Periplaneta americana and Blattella germanica, have the potential to become domestic pests, our E. posticus is extremely unlikely to escape or infest a human environment, making it a very practical species. In our first experiment, we investigated the ability of E. posticus to associate novel odors with appetitive and aversive solutions. They quickly learned to approach odors associated with a dog food sucrose solution and learned to avoid odors associated with salt water. The second experiment repeated the methods of the first experiment, while also testing retained preferences for conditioned odors, from 15 to 1,215 minutes after the conditioning procedure ended. We found that preferences for odors associated with food were strongest 45 minutes after training, then decreased as a function of time. Our work is the first to show associative learning and memory in the orange head cockroach. Findings are discussed in comparison to other invertebrate models as well as to other cockroach research.	[Varnon, Christopher A.; Barrera, Erandy I.; Wilkes, Isobel N.] Converse Univ, Dept Psychol, Lab Comparat Psychol & Behav Ecol, Spartanburg, SC 29302 USA		Varnon, CA (corresponding author), Converse Univ, Dept Psychol, Lab Comparat Psychol & Behav Ecol, Spartanburg, SC 29302 USA.	Christopher.Varnon@Converse.edu			National Institute of General Medical Sciences, National Institutes of Health [P20GM103499]	National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by grant P20GM103499 (SC INBRE) from the National Institute of General Medical Sciences, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Shaara HF, 2014, VET MED-CZECH, V59, P1, DOI 10.17221/7240-VETMED; ABRAMSON CI, 1986, TEACH PSYCHOL, V13, P24, DOI 10.1207/s15328023top1301_6; Amaya-Marquez M, 2019, INSECTS, V10, DOI 10.3390/insects10110412; Arican C, 2020, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01539; Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04577; Bell W.J., 1990, P7; BELL WJ, 1978, Z TIERPSYCHOL, V48, P203; Belles X, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0415; Belvin MP, 1997, BIOESSAYS, V19, P1083, DOI 10.1002/bies.950191207; Blacquiere Tjeerd, 2007, Proceedings of the Netherlands Entomological Society Meeting, V18, P71; BROWN GE, 1988, BEHAV NEURAL BIOL, V50, P246, DOI 10.1016/S0163-1047(88)90921-1; Brown S, 2009, LEARN MEMORY, V16, P210, DOI 10.1101/lm.1241909; CHEN WY, 1970, ANIM BEHAV, V18, P725, DOI 10.1016/0003-3472(70)90018-7; CLOGG CC, 1995, AM J SOCIOL, V100, P1261, DOI 10.1086/230638; Cohen RW, 2002, J INSECT BEHAV, V15, P37, DOI 10.1023/A:1014428011892; Crall JD, 2016, ANIM BEHAV, V111, P297, DOI 10.1016/j.anbehav.2015.10.032; Davis H, 2004, BEHAV PROCESS, V67, P539, DOI 10.1016/j.beproc.2004.08.003; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Decker S, 2007, P NATL ACAD SCI USA, V104, P15905, DOI 10.1073/pnas.0702082104; Dinges CW, 2017, J EXP PSYCHOL-ANIM L, V43, P147, DOI 10.1037/xan0000133; Eisenhardt D, 2014, LEARN MEMORY, V21, P534, DOI 10.1101/lm.033118.113; EISERER LA, 1981, J GEN PSYCHOL, V104, P213, DOI 10.1080/00221309.1981.9921038; Frost EH, 2012, NATURWISSENSCHAFTEN, V99, P677, DOI 10.1007/s00114-012-0955-8; Garren MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058693; Gautier J.Y., 1988, P335; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; Giurfa M, 2012, LEARN MEMORY, V19, P54, DOI 10.1101/lm.024711.111; GORTON R E JR, 1979, Journal of the Kansas Entomological Society, V52, P334; Hamanaka Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160531; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; Hardin JW, 2012, GEN ESTIMATING EQUAT; Hosono S, 2016, LEARN MEMORY, V23, P669, DOI 10.1101/lm.043513.116; Inward D, 2007, BIOL LETTERS, V3, P331, DOI 10.1098/rsbl.2007.0102; Laurent G, 2020, NAT REV NEUROSCI, V21, P395, DOI 10.1038/s41583-020-0323-1; Laurent-Salazar MO., 2019, ENCY SOCIAL INSECTS; Leadbeater E, 2017, P NATL ACAD SCI USA, V114, P7838, DOI 10.1073/pnas.1620744114; Lemanski NJ, 2019, INSECTS, V10, DOI 10.3390/insects10110370; Lent DD, 2004, J EXP BIOL, V207, P369, DOI 10.1242/jeb.00736; Liu JL, 2013, APPL ENTOMOL ZOOL, V48, P387, DOI 10.1007/s13355-013-0199-x; LONGO N, 1970, BEHAV RES METH INSTR, V2, P118, DOI 10.3758/BF03211018; Louapre P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014251; Matsumoto CS, 2013, NEUROSCI LETT, V541, P4, DOI 10.1016/j.neulet.2013.01.010; McMonigle O, 2016, LOVE COCKROACHES HUS; MENZEL R, 1983, NATURWISSENSCHAFTEN, V70, P504, DOI 10.1007/BF00394056; Modi MN, 2020, ANNU REV NEUROSCI, V43, P465, DOI 10.1146/annurev-neuro-080317-0621333; Muth F, 2018, METHODS ECOL EVOL, V9, P78, DOI 10.1111/2041-210X.12852; Paternoster R, 1998, CRIMINOLOGY, V36, P859, DOI 10.1111/j.1745-9125.1998.tb01268.x; Perktold J, 2018, STATSMODELS VERSION; Perry CJ, 2017, CURR OPIN BEHAV SCI, V16, P111, DOI 10.1016/j.cobeha.2017.05.011; Proctor D., 2020, SCHOLARSH TEACH LEAR, V7, P237, DOI [10.1037/stl0000235, DOI 10.1037/STL0000235]; Remolina SC, 2007, J INSECT PHYSIOL, V53, P1027, DOI 10.1016/j.jinsphys.2007.05.015; Roberts DB, 2006, ENTOMOL EXP APPL, V121, P93, DOI 10.1111/j.1570-8703.2006.00474.x; Sakura M, 2001, ZOOL SCI, V18, P21, DOI 10.2108/zsj.18.21; SCHAL C, 1984, BIOL REV, V59, P209, DOI 10.1111/j.1469-185X.1984.tb00408.x; Schneider D, 2000, NAT REV GENET, V1, P218, DOI 10.1038/35042080; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; Simons M, 2019, CURR OPIN INSECT SCI, V34, P117, DOI 10.1016/j.cois.2019.05.009; Sun YN, 2013, METHODS MOL BIOL, V1048, P77, DOI 10.1007/978-1-62703-556-9_7; Takahashi N, 2019, J NEUROSCI, V39, P8690, DOI 10.1523/JNEUROSCI.0088-19.2019; Truman JW, 1999, NATURE, V401, P447, DOI 10.1038/46737; Varnon CA., 2018, INT J COMP PSYCHOL, V31, P1, DOI DOI 10.46867/IJCP.2018.31.01.08; Varnon CA, 2021, INSECTS, V12, DOI 10.3390/insects12040339; Varnon CA, 2021, PEERJ, V9, DOI 10.7717/peerj.10997; Varnon CA, 2018, ALCOHOL CLIN EXP RES, V42, P1260, DOI 10.1111/acer.13761; Watanabe H, 2003, ZOOL SCI, V20, P1447, DOI 10.2108/zsj.20.1447; Watanabe H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000529; Watanabe H, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00032; ZAJONC RB, 1969, J PERS SOC PSYCHOL, V13, P83, DOI 10.1037/h0028063; Zars T, 2000, CURR OPIN NEUROBIOL, V10, P790, DOI 10.1016/S0959-4388(00)00147-1	69	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0272598	10.1371/journal.pone.0272598	http://dx.doi.org/10.1371/journal.pone.0272598			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994454	Green Published, gold			2022-12-26	WOS:000877093400024
J	Anindita, PD; Halbeisen, M; Reha, D; Tuma, R; Franta, Z				Anindita, Paulina Duhita; Halbeisen, Marco; Reha, David; Tuma, Roman; Franta, Zdenek			Mechanistic insight into the RNA-stimulated ATPase activity of tick-borne encephalitis virus helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; NS3 HELICASE; MOLECULAR-DYNAMICS; TRANSLOCATION; HYDROLYSIS; FEATURES; DOMAIN; MOTIF	The helicase domain of nonstructural protein 3 (NS3H) unwinds the double-stranded RNA replication intermediate in an ATP-dependent manner during the flavivirus life cycle. While the ATP hydrolysis mechanism of Dengue and Zika vi-ruses NS3H has been extensively studied, little is known in the case of the tick-borne encephalitis virus NS3H. We demon-strate that ssRNA binds with nanomolar affinity to NS3H and strongly stimulates the ATP hydrolysis cycle, whereas ssDNA binds only weakly and inhibits ATPase activity in a noncom-petitive manner. Thus, NS3H is an RNA-specific helicase, whereas DNA might act as an allosteric inhibitor. Using modeling, we explored plausible allosteric mechanisms by which ssDNA inhibits the ATPase via nonspecific binding in the vicinity of the active site and ATP repositioning. We captured several structural snapshots of key ATP hydrolysis stages using X-ray crystallography. One intermediate, in which the inorganic phosphate and ADP remained trapped inside the ATPase site after hydrolysis, suggests that inorganic phosphate release is the rate-limiting step. Using structure-guided modeling and molecular dynamics simulation, we identified putative RNA-binding residues and observed that the opening and closing of the ATP-binding site modulates RNA affinity. Site-directed mutagenesis of the conserved RNA-binding resi-dues revealed that the allosteric activation of ATPase activity is primarily communicated via an arginine residue in domain 1. In summary, we characterized conformational changes associ-ated with modulating RNA affinity and mapped allosteric communication between RNA-binding groove and ATPase site of tick-borne encephalitis virus helicase.	[Anindita, Paulina Duhita; Halbeisen, Marco; Reha, David; Tuma, Roman; Franta, Zdenek] Univ South Bohemia, Fac Sci, Dept Chem, Ceske Budejovice, Czech Republic	University of South Bohemia Ceske Budejovice	Franta, Z (corresponding author), Univ South Bohemia, Fac Sci, Dept Chem, Ceske Budejovice, Czech Republic.	zfranta@prf.jcu.cz		Anindita, Paulina Duhita/0000-0001-9885-5813; Reha, David/0000-0002-9500-0569; Franta, Zdenek/0000-0002-7709-0097	European Regional Development Fund;  [CZ.02.1.01/0.0/0.0/15_003/0000441]	European Regional Development Fund(European Commission); 	Acknowledgments - We are grateful to the help and support of Drs Pavlfna M. R ? ez?c ? ov?, Jir ? f Brynda, and Manfred Weiss during diffraction data collection in BESSY II electron storage ring oper- ated by the Helmholtz - Zentrum Berlin. We also like to acknowledge Dr Filip Dyc ? ka for his contribution in MALDI-TOF mass spectrometry and Petra Havlfc ? kov? and Dr Pavel Grinkevich for helpful discussions and contribution during structural re f inement. This work was supported by European Regional Development Fund (grant no.: CZ.02.1.01/0.0/0.0/15_003/0000441) .	Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Beaute J, 2018, EUROSURVEILLANCE, V23, P2, DOI 10.2807/1560-7917.ES.2018.23.45.1800201; Benarroch D, 2004, VIROLOGY, V328, P208, DOI 10.1016/j.virol.2004.07.004; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009; Brand C, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1437; Chen C, 2020, BIOCHEM BIOPH RES CO, V528, P601, DOI 10.1016/j.bbrc.2020.05.138; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crampton DJ, 2004, P NATL ACAD SCI USA, V101, P4373, DOI 10.1073/pnas.0400968101; Davidson RB, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006103; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Du Pont KE, 2020, J BIOL CHEM, V295, P1551, DOI 10.1074/jbc.RA119.011922; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fang JN, 2019, ACS INFECT DIS, V5, P177, DOI 10.1021/acsinfecdis.8b00214; Fuzik T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02882-0; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; Gwack Y, 1997, EUR J BIOCHEM, V250, P47, DOI 10.1111/j.1432-1033.1997.00047.x; Holm L, 2020, PROTEIN SCI, V29, P128, DOI 10.1002/pro.3749; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Li L, 2018, ACTA CRYSTALLOGR F, V74, P205, DOI 10.1107/S2053230X18003813; Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232; Mallam AL, 2014, ELIFE, V3, DOI 10.7554/eLife.04630; Mastrangelo E, 2007, J MOL BIOL, V372, P444, DOI 10.1016/j.jmb.2007.06.055; Mueller U, 2015, EUR PHYS J PLUS, V130, DOI 10.1140/epjp/i2015-15141-2; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pal A, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006768; PARRINELLO M, 1981, B AM PHYS SOC, V26, P380; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Potterton L, 2018, ACTA CRYSTALLOGR D, V74, P68, DOI 10.1107/S2059798317016035; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rudack T, 2012, P NATL ACAD SCI USA, V109, P15295, DOI 10.1073/pnas.1204333109; Ruzek D, 2019, ANTIVIR RES, V164, P23, DOI 10.1016/j.antiviral.2019.01.014; Sarto C, 2020, BBA-PROTEINS PROTEOM, V1868, DOI 10.1016/j.bbapap.2020.140441; Sparta KM, 2016, ACTA CRYSTALLOGR A, V72, pS191, DOI 10.1107/S2053273316097151; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Swarbrick CMD, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx1127; Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang CC, 2009, FEBS LETT, V583, P691, DOI 10.1016/j.febslet.2009.01.008; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wang QX, 2010, NUCLEIC ACIDS RES, V38, P1312, DOI 10.1093/nar/gkp1118; Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005; Yamashita T, 2008, VIROLOGY, V373, P426, DOI 10.1016/j.virol.2007.12.018; Yang XY, 2018, FASEB J, V32, P5250, DOI 10.1096/fj.201701140R	51	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102383	10.1016/j.jbc.2022.102383	http://dx.doi.org/10.1016/j.jbc.2022.102383			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5H1DF	35987382	gold, Green Submitted, Green Published			2022-12-26	WOS:000867425500009
J	Wurz, AI; Bunner, WP; Szatmari, EM; Hughes, RM				Wurz, Anna I.; Bunner, Wyatt P.; Szatmari, Erzsebet M.; Hughes, Robert M.			CRY-BARs: Versatile light-gated molecular tools for the remodeling of membrane architectures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN PROTEIN; MIM; INDUCTION	BAR (Bin, Amphiphysin, and Rvs) protein domains are responsible for the generation of membrane curvature and represent a critical mechanical component of cellular func-tions. Thus, BAR domains have great potential as components of membrane-remodeling tools for cell biologists. In this work, we describe the design and implementation of a family of versatile light-gated I-BAR (inverse BAR) domain containing tools derived from the fusion of the Arabidopsis thaliana cryptochrome 2 photoreceptor and I-BAR protein domains ("CRY-BARs") with applications in the remodeling of mem-brane architectures and the control of cellular dynamics. By taking advantage of the intrinsic membrane-binding propensity of the I-BAR domain, CRY-BARs can be used for spatial and temporal control of cellular processes that require induction of membrane protrusions. Using cell lines and primary neuron cultures, we demonstrate here that the CRY-BAR optogenetic tool evokes membrane dynamic changes associated with cellular activity. Moreover, we provide evidence that ezrin, an actin and phosphatidylinositol 4,5-bisphosphate-binding protein, acts as a relay between the plasma membrane and the actin cytoskeleton and therefore is an important mediator of switch function. Overall, we propose that CRY-BARs hold promise as a useful addition to the optogenetic toolkit to study membrane remodeling in live cells.	[Wurz, Anna I.; Hughes, Robert M.] East Carolina Univ, Dept Chem, Greenville, NC 27858 USA; [Bunner, Wyatt P.; Szatmari, Erzsebet M.] East Carolina Univ, Dept Phys Therapy, Greenville, NC USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University	Hughes, RM (corresponding author), East Carolina Univ, Dept Chem, Greenville, NC 27858 USA.			Szatmari, Erzsebet-Maria/0000-0002-2914-6148; Bunner, Wyatt/0000-0001-7590-5312; Hughes, Robert/0000-0002-4465-4212	National Institutes of Health [1R15NS125564-01]; East Carolina University Biomaterials Research Cluster	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); East Carolina University Biomaterials Research Cluster	This work was supported by a seed grant to R. M. H. and E. M. S. from the East Carolina University Biomaterials Research Cluster and by the National Institutes of Health (grant no.: 1R15NS125564-01) . The content is solely the responsibility of the authors and does not necessarily represent the of fi cial views of the National Institutes of Health.	Antonny B, 2011, ANNU REV BIOCHEM, V80, P101, DOI 10.1146/annurev-biochem-052809-155121; Bunner W, 2021, BIO-PROTOCOL, V11, DOI 10.21769/BioProtoc.3990; Cao M, 2012, BIOCHEM J, V446, P469, DOI 10.1042/BJ20120329; Chang JY, 2017, NEURON, V94, P800, DOI 10.1016/j.neuron.2017.04.041; Chatzi C, 2019, ELIFE, V8, DOI 10.7554/eLife.45920; Che DL, 2015, ACS SYNTH BIOL, V4, P1124, DOI 10.1021/acssynbio.5b00048; Hao JJ, 2009, J CELL BIOL, V184, P451, DOI 10.1083/jcb.200807047; Hughes JH, 2016, CURR OPIN BIOTECH, V40, P82, DOI 10.1016/j.copbio.2016.03.004; Jones T, 2020, ACS SYNTH BIOL, V9, P893, DOI 10.1021/acssynbio.9b00516; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Khamo JS, 2019, CELL CHEM BIOL, V26, P400, DOI 10.1016/j.chembiol.2018.11.004; Kichuk TC, 2021, WIRES MECH DIS, V13, DOI 10.1002/wsbm.1500; Klewer L, 2019, CHEM-EUR J, V25, P12452, DOI 10.1002/chem.201900562; Li LS, 2016, BIOCHEM BIOPH RES CO, V479, P787, DOI 10.1016/j.bbrc.2016.09.131; Linkert M, 2010, J CELL BIOL, V189, P777, DOI 10.1083/jcb.201004104; Linkner J, 2014, J CELL SCI, V127, P1279, DOI 10.1242/jcs.140756; Nepal B, 2021, STRUCTURE, V29, P1440, DOI 10.1016/j.str.2021.07.010; O'Banion CP, 2019, CELL CHEM BIOL, V26, P1393, DOI 10.1016/j.chembiol.2019.07.004; O'Banion CP, 2018, CELL CHEM BIOL, V25, P100, DOI 10.1016/j.chembiol.2017.09.011; Park H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00060-2; Paunola E, 2002, FEBS LETT, V513, P92, DOI 10.1016/S0014-5793(01)03242-2; Pipathsouk A, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202003086; Prevost C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9529; Pykalainen A, 2011, NAT STRUCT MOL BIOL, V18, P902, DOI 10.1038/nsmb.2079; Redchuk TA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14460-4; Saarikangas J, 2015, DEV CELL, V33, P644, DOI 10.1016/j.devcel.2015.04.014; Saarikangas J, 2011, J CELL SCI, V124, P1245, DOI 10.1242/jcs.082610; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Salem FB, 2020, J BIOL CHEM, V295, P11231, DOI 10.1074/jbc.RA119.012427; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shaaya M, 2020, ELIFE, V9, DOI 10.7554/eLife.60647; Sun Y, 2021, J NEUROSCI, V41, P7003, DOI 10.1523/JNEUROSCI.1964-20.2021; Taslimi A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5925; Tsai FC, 2018, ELIFE, V7, DOI 10.7554/eLife.37262; Tu MK, 2016, CELL CALCIUM, V59, P91, DOI 10.1016/j.ceca.2016.02.005; Ueda Y, 2018, BIOCHEM BIOPH RES CO, V506, P387, DOI 10.1016/j.bbrc.2017.11.091; Wu YI, 2011, METHOD ENZYMOL, V497, P393, DOI 10.1016/B978-0-12-385075-1.00016-0; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020845; Zhao HX, 2011, CURR OPIN CELL BIOL, V23, P14, DOI 10.1016/j.ceb.2010.10.005	40	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102388	10.1016/j.jbc.2022.102388	http://dx.doi.org/10.1016/j.jbc.2022.102388			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5L6PJ	35987384	Green Submitted, Green Published, gold			2022-12-26	WOS:000870533300004
J	Pisa, R; Rapoport, TA				Pisa, Rudolf; Rapoport, Tom A.			Disulfide-crosslink analysis of the ubiquitin ligase Hrd1 complex during endoplasmic reticulum-associated protein degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISFOLDED GLYCOPROTEINS; IDENTIFIES YOS9P; ERAD; RETROTRANSLOCATION; RECOGNITION; REDUCTASE; LECTIN; SIGNAL	Misfolded proteins in the lumen of the endoplasmic reticulum (ER) are retrotranslocated into the cytosol and degraded by the ubiquitin-proteasome system, a pathway termed luminal ERassociated protein degradation. Retrotranslocation is mediated by a conserved protein complex, consisting of the ubiquitin ligase Hrd1 and four associated proteins (Der1, Usa1, Hrd3, and Yos9). Photocrosslinking experiments provided preliminary evidence for the polypeptide path through the membrane but did not reveal specific interactions between amino acids in the substrate and Hrd1 complex. Here, we have used site-specific disulfide crosslinking to map the interactions of a glycosylated model substrate with the Hrd1 complex in live S. cerevisiae cells. Together with available electron cryo-microscopy structures, the results show that the substrate interacts on the luminal side with both a groove in Hrd3 and the lectin domain of Yos9 and inserts a loop into the membrane, with one side of the loop interacting with the lateral gate of Der1 and the other with the lateral gate of Hrd1. Our disulfide crosslinking experiments also show that two Hrd1 molecules can interact through their lateral gates and that Hrd1 autoubiquitination is required for the disassembly of these Hrd1 dimers. Taken together, these data define the path of a polypeptide through the ER membrane and suggest that autoubiquitination of inactive Hrd1 dimers is required to generate active Hrd1 monomers.	[Pisa, Rudolf; Rapoport, Tom A.] Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA; [Pisa, Rudolf; Rapoport, Tom A.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Rapoport, TA (corresponding author), Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA.; Rapoport, TA (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu		Pisa, Rudolf/0000-0001-7571-7135	NIGMS grant [R01 GM052586]; American Heart Association [833683/2021]	NIGMS grant; American Heart Association(American Heart Association)	The research was supported by NIGMS grant (R01 GM052586) to T. A. R. and by American Heart Association grant #833683/2021 to R. P. The content is solely the responsibility of the authors and does not necessarily represent the of fi cial views of the National Institutes of Health or American Heart Association. T. A. R. is a Howard Hughes Medical Institute investigator.	Baldridge RD, 2016, CELL, V166, P394, DOI 10.1016/j.cell.2016.05.048; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Buschhorn BA, 2004, FEBS LETT, V577, P422, DOI 10.1016/j.febslet.2004.10.039; Carroll SM, 2010, J BIOL CHEM, V285, P5146, DOI 10.1074/jbc.M109.067876; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Chin JW, 2017, NATURE, V550, P53, DOI 10.1038/nature24031; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Cho S, 2019, NAT STRUCT MOL BIOL, V26, P910, DOI 10.1038/s41594-019-0296-9; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Horn SC, 2009, MOL CELL, V36, P782, DOI 10.1016/j.molcel.2009.10.015; IWAKURA M, 1995, J BIOCHEM, V117, P480, DOI 10.1093/oxfordjournals.jbchem.a124733; Kandel RR, 2020, BBA-MOL CELL RES, V1867, DOI 10.1016/j.bbamcr.2020.118793; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Kostova Z, 2005, J CELL SCI, V118, P1485, DOI 10.1242/jcs.01740; Mehnert M, 2015, MOL BIOL CELL, V26, P185, DOI 10.1091/mbc.E14-07-1202; Mehnert M, 2014, NAT CELL BIOL, V16, P77, DOI 10.1038/ncb2882; Peterson BG, 2019, ELIFE, V8, DOI 10.7554/eLife.50903; Phillips B, 2020, CURR OPIN CELL BIOL, V65, P96, DOI 10.1016/j.ceb.2020.04.002; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Stanley AM, 2011, FEBS LETT, V585, P1281, DOI 10.1016/j.febslet.2011.04.009; Stein A, 2014, CELL, V158, P1375, DOI 10.1016/j.cell.2014.07.050; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; Ticha A, 2018, TRENDS BIOCHEM SCI, V43, P726, DOI 10.1016/j.tibs.2018.06.009; Vashistha N, 2016, P NATL ACAD SCI USA, V113, P5934, DOI 10.1073/pnas.1603079113; Vasic V, 2020, NAT CELL BIOL, V22, P274, DOI 10.1038/s41556-020-0473-4; Wu XD, 2021, TRENDS CELL BIOL, V31, P473, DOI 10.1016/j.tcb.2021.01.002; Wu XD, 2020, SCIENCE, V368, P385, DOI 10.1126/science.aaz2449; Wu XD, 2018, CURR OPIN CELL BIOL, V53, P22, DOI 10.1016/j.ceb.2018.04.004	40	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102373	10.1016/j.jbc.2022.102373	http://dx.doi.org/10.1016/j.jbc.2022.102373			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4V3XX	35970394	gold, Green Published			2022-12-26	WOS:000859414300003
J	Itagaki, T; Akimoto, Y; Nakano, Y; Ueno, Y; Ishihara, M; Tane, N; Tsunano, Y; Oto, J				Itagaki, Taiga; Akimoto, Yusuke; Nakano, Yuki; Ueno, Yoshitoyo; Ishihara, Manabu; Tane, Natsuki; Tsunano, Yumiko; Oto, Jun			Relationships between double cycling and inspiratory effort with diaphragm thickness during the early phase of mechanical ventilation: A prospective observational study	PLOS ONE			English	Article							PROTECTIVE VENTILATION; LUNG INJURY; CARE; SEDATION; IMPACT; MUSCLE; ASYNCHRONY; PATTERNS; WEAKNESS	Background Increased and decreased diaphragm thickness during mechanical ventilation is associated with poor outcomes. Some types of patient-ventilator asynchrony theoretically cause myotrauma of the diaphragm. However, the effects of double cycling on structural changes in the diaphragm have not been previously evaluated. Hence, this study aimed to investigate the relationship between double cycling during the early phase of mechanical ventilation and changes in diaphragm thickness, and the involvement of inspiratory effort in the occurrence of double cycling. Methods We evaluated adult patients receiving invasive mechanical ventilation for more than 48 h. The end-expiratory diaphragm thickness (Tdi(ee)) was assessed via ultrasonography on days 1, 2, 3, 5 and 7 after the initiation of mechanical ventilation. Then, the maximum rate of change from day 1 (Delta Tdi(ee)%) was evaluated. Concurrently, we recorded esophageal pressure and airway pressure on days 1, 2 and 3 for 1 h during spontaneous breathing. Then, the waveforms were retrospectively analyzed to calculate the incidence of double cycling (double cycling index) and inspiratory esophageal pressure swing (Delta P-es). Finally, the correlation between double cycling index as well as Delta P-es and Delta Tdi(ee)% was investigated using linear regression models. Results In total, 19 patients with a median age of 69 (interquartile range: 65-78) years were enrolled in this study, and all received pressure assist-control ventilation. The Tdi(ee) increased by more than 10% from baseline in nine patients, decreased by more than 10% in nine and remained unchanged in one. The double cycling indexes on days 1, 2 and 3 were 2.2%, 1.3% and 4.5%, respectively. There was a linear correlation between the double cycling index on day 3 and Delta Tdi(ee)% (R-2 = 0.446, p = 0.002). The double cycling index was correlated with the Delta P-es on days 2 (R-2 = 0.319, p = 0.004) and 3 (R-2 = 0.635, p < 0.001). Conclusions Double cycling on the third day of mechanical ventilation was associated with strong inspiratory efforts and, possibly, changes in diaphragm thickness.	[Itagaki, Taiga] Tokushima Univ Hosp, Dept Emergency & Disaster Med, Tokushima, Japan; [Akimoto, Yusuke; Nakano, Yuki; Ueno, Yoshitoyo; Ishihara, Manabu] Tokushima Univ Hosp, Dept Emergency & Crit Care Med, Tokushima, Japan; [Tane, Natsuki; Tsunano, Yumiko; Oto, Jun] Tokushima Univ, Dept Emergency & Crit Care Med, Grad Sch, Tokushima, Japan	Tokushima University; Tokushima University; Tokushima University	Itagaki, T (corresponding author), Tokushima Univ Hosp, Dept Emergency & Disaster Med, Tokushima, Japan.	taiga@tokushima-u.ac.jp		Itagaki, Taiga/0000-0002-8387-834X	JSPS KAKENHI [JP21K16574]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by JSPS KAKENHI Grant Number JP21K16574 awarded to Dr. Taiga Itagaki. https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-21K16574/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Alhazzani W, 2020, INTENS CARE MED, V46, P1977, DOI 10.1007/s00134-020-06227-8; BAYDUR A, 1982, AM REV RESPIR DIS, V126, P788; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Brochard L, 2017, AM J RESP CRIT CARE, V195, P438, DOI 10.1164/rccm.201605-1081CP; Bunnell A, 2015, MUSCLE NERVE, V52, P701, DOI 10.1002/mus.24728; Chanques G, 2013, CRIT CARE MED, V41, P2177, DOI 10.1097/CCM.0b013e31828c2d7a; de Haro C, 2018, CRIT CARE MED, V46, P1385, DOI 10.1097/CCM.0000000000003256; Devabhakthuni S, 2012, ANN PHARMACOTHER, V46, P530, DOI 10.1345/aph.1Q525; Dres M, 2017, INTENS CARE MED, V43, P1441, DOI 10.1007/s00134-017-4928-4; Dres M, 2017, AM J RESP CRIT CARE, V195, P57, DOI 10.1164/rccm.201602-0367OC; Dres M, 2016, CURR OPIN CRIT CARE, V22, P246, DOI 10.1097/MCC.0000000000000307; Ferguson LM, 2006, BRIT J ANAESTH, V96, P384, DOI 10.1093/bja/ael011; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Goligher EC, 2020, AM J RESP CRIT CARE, V202, P950, DOI 10.1164/rccm.202003-0655CP; Goligher EC, 2019, LANCET RESP MED, V7, P90, DOI 10.1016/S2213-2600(18)30366-7; Goligher EC, 2018, AM J RESP CRIT CARE, V197, P204, DOI 10.1164/rccm.201703-0536OC; Goligher EC, 2015, AM J RESP CRIT CARE, V192, P1080, DOI 10.1164/rccm.201503-0620OC; Jiang TX, 1998, AM J RESP CRIT CARE, V157, P230, DOI 10.1164/ajrccm.157.1.9702051; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Mauri T, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.06.55; Mellado Artigas Ricard, 2021, Anesthesiology, V134, P760, DOI 10.1097/ALN.0000000000003726; Nakanishi N, 2019, J INTENSIVE CARE, V7, DOI 10.1186/s40560-019-0410-4; Orozco-Levi M, 2001, AM J RESP CRIT CARE, V164, P1734, DOI 10.1164/ajrccm.164.9.2011150; Pohlman MC, 2008, CRIT CARE MED, V36, P3019, DOI 10.1097/CCM.0b013e31818b308b; Proske U, 2001, J PHYSIOL-LONDON, V537, P333, DOI 10.1111/j.1469-7793.2001.00333.x; Schepens T, 2019, CURR OPIN CRIT CARE, V25, P77, DOI 10.1097/MCC.0000000000000578; Schreiber A, 2018, CRIT CARE CLIN, V34, P357, DOI 10.1016/j.ccc.2018.03.005; Thille AW, 2006, INTENS CARE MED, V32, P1515, DOI 10.1007/s00134-006-0301-8; Tokioka H, 2001, ANESTH ANALG, V92, P161; Tremblay LN, 2006, INTENS CARE MED, V32, P24, DOI 10.1007/s00134-005-2817-8; Vassilakopoulos T, 2004, AM J RESP CRIT CARE, V169, P336, DOI 10.1164/rccm.200304-489CP	31	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0273173	10.1371/journal.pone.0273173	http://dx.doi.org/10.1371/journal.pone.0273173			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976965	Green Published, gold			2022-12-26	WOS:000847227000083
J	Singh, J; Sahil, M; Ray, S; Dcosta, C; Panjikar, S; Krishnamoorthy, G; Mondal, J; Anand, R				Singh, Jayanti; Sahil, Mohammad; Ray, Shamayeeta; Dcosta, Criss; Panjikar, Santosh; Krishnamoorthy, G.; Mondal, Jagannath; Anand, Ruchi			Phenol sensing in nature is modulated via a conformational switch governed by dynamic allostery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BINDING PROTEINS; STRUCTURAL BASIS; SIMULATIONS; REGULATOR; ALGORITHM; PROLINE; LINKER; DOMAIN; MOPR	The NtrC family of proteins senses external stimuli and accordingly stimulates stress and virulence pathways via activation of associated a54-dependent RNA polymerases. However, the structural determinants that mediate this activation are not well understood. Here, we establish using computational, structural, biochemical, and biophysical studies that MopR, an NtrC protein, harbors a dynamic bidirectional electrostatic network that connects the phenol pocket to two distal regions, namely the "G-hinge" and the "allosteric linker." While the Ghinge influences the entry of phenol into the pocket, the allosteric linker passes the signal to the downstream ATPase domain. We show that phenol binding induces a rewiring of the electrostatic connections by eliciting dynamic allostery and demonstrates that perturbation of the core relay residues results in a complete loss of ATPase stimulation. Furthermore, we found a mutation of the G-hinge, X20 angstrom from the phenol pocket, promotes altered flexibility by shifting the pattern of conformational states accessed, leading to a protein with 7-fold enhanced phenol binding ability and enhanced transcriptional activation. Finally, we conducted a global analysis that illustrates that dynamic allostery-driven conserved community networks are universal and evolutionarily conserved across species. Taken together, these results provide insights into the mechanisms of dynamic allostery-mediated conformational changes in NtrC sensor proteins.	[Singh, Jayanti; Ray, Shamayeeta; Dcosta, Criss; Anand, Ruchi] Indian Inst Technol, Dept Chem, Mumbai, Maharashtra, India; [Sahil, Mohammad; Mondal, Jagannath] Tata Inst Fundamental Res, Hyderabad, Telangana, India; [Panjikar, Santosh] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Panjikar, Santosh] Australian Synchrotron, Clayton, Vic, Australia; [Krishnamoorthy, G.] Anna Univ, Dept Biotechnol, Chennai, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Tata Institute of Fundamental Research (TIFR); Monash University; Anna University; Anna University Chennai	Anand, R (corresponding author), Indian Inst Technol, Dept Chem, Mumbai, Maharashtra, India.; Mondal, J (corresponding author), Tata Inst Fundamental Res, Hyderabad, Telangana, India.	jmondal@tifrh.res.in; ruchi@chem.iitb.ac.in		Ray, Shamayeeta/0000-0001-7906-0572; Anand, Ruchi/0000-0002-2045-3758	DST, Government of India; BRNS, Government of India [EMR/2015/002121]; DBT, Government of India [20150237B02RP00614-BRNS]; Department of Atomic Energy, Government of India [BT/PR18927/BCE/8/1376/2016]; Department of Science and Technology (DST) of India [RTI 4007];  [CRG/2019/001219]	DST, Government of India(Department of Science & Technology (India)); BRNS, Government of India(Department of Atomic Energy (DAE)Board of Research in Nuclear Sciences (BRNS)); DBT, Government of India(Department of Biotechnology (DBT) India); Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE)); Department of Science and Technology (DST) of India(Department of Science & Technology (India)); 	R. A. acknowledges support of DST, Government of India (EMR/2015/002121), BRNS, Government of India (20150237B02RP00614-BRNS) and DBT, Government of India (BT/PR18927/BCE/8/1376/2016). J. M. acknowledges support of the Department of Atomic Energy, Government of India, under Project Identification No. RTI 4007 and Core Research grants provided by the Department of Science and Technology (DST) of India (CRG/2019/001219).	Ayres CM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00966; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bhattacharjee S, 2021, BIOPHYS J, V120, P4512, DOI 10.1016/j.bpj.2021.08.037; Bush M, 2012, MICROBIOL MOL BIOL R, V76, P497, DOI 10.1128/MMBR.00006-12; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ding SH, 2005, J GEN PHYSIOL, V126, P213, DOI 10.1085/jgp.200509287; Duro N, 2019, STRUCTURE, V27, P1601, DOI 10.1016/j.str.2019.07.005; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Flores SC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-215; Flores SC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-167; Gupta S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043527; Ha JH, 2012, CHEM-EUR J, V18, P7984, DOI 10.1002/chem.201200348; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hilser VJ, 2012, ANNU REV BIOPHYS, V41, P585, DOI 10.1146/annurev-biophys-050511-102319; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Hubbard R. E., 2010, ENCY LIFE SCI, P1, DOI [DOI 10.1002/9780470015902.A0003011.PUB2, 10.1002/9780470015902.a0003011.pub2]; Jiao WT, 2020, J BIOL CHEM, V295, P6252, DOI 10.1074/jbc.RA120.012605; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KARPLUS M, 1984, ADV BIOPHYS, V18, P165, DOI 10.1016/0065-227X(84)90011-X; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Khade PM, 2020, J MOL BIOL, V432, P508, DOI 10.1016/j.jmb.2019.11.018; Kityk R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9308; Kumawat A, 2020, J PHYS CHEM LETT, V11, P9026, DOI 10.1021/acs.jpclett.0c02885; Kumawat A, 2017, P NATL ACAD SCI USA, V114, pE5825, DOI 10.1073/pnas.1705311114; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Li SC, 1996, P NATL ACAD SCI USA, V93, P6676, DOI 10.1073/pnas.93.13.6676; Liao SM, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-44; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Nussinov R, 2014, J AM CHEM SOC, V136, P17692, DOI 10.1021/ja510028c; O'Neill E, 2001, EMBO J, V20, P819, DOI 10.1093/emboj/20.4.819; Pall S, 2013, COMPUT PHYS COMMUN, V184, P2641, DOI 10.1016/j.cpc.2013.06.003; Park K. H., 2020, NAT COMMUN, V11, P1; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Perozzo R, 2004, J RECEPT SIG TRANSD, V24, P1, DOI 10.1081/RRS-120037896; Petit CM, 2009, P NATL ACAD SCI USA, V106, P18249, DOI 10.1073/pnas.0904492106; Piovesan D, 2016, NUCLEIC ACIDS RES, V44, pW367, DOI 10.1093/nar/gkw315; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Rajasekaran N, 2017, J PHYS CHEM LETT, V8, P4779, DOI 10.1021/acs.jpclett.7b02021; Ramanathan A, 2014, ACCOUNTS CHEM RES, V47, P149, DOI 10.1021/ar400084s; Ramanathan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015827; Ray S, 2018, ACS SENSORS, V3, P1632, DOI 10.1021/acssensors.8b00190; Ray S, 2018, ANAL CHEM, V90, P8960, DOI 10.1021/acs.analchem.8b01130; Ray S, 2017, ACS SENSORS, V2, P411, DOI 10.1021/acssensors.6b00843; Ray S, 2016, ACS CHEM BIOL, V11, P2357, DOI 10.1021/acschembio.6b00020; Saavedra HG, 2018, NATURE, V558, P324, DOI 10.1038/s41586-018-0183-2; Schirmer F, 1997, J BACTERIOL, V179, P1329, DOI 10.1128/jb.179.4.1329-1336.1997; Schmidtke P, 2011, BIOINFORMATICS, V27, P3276, DOI 10.1093/bioinformatics/btr550; Schrank TP, 2009, P NATL ACAD SCI USA, V106, P16984, DOI 10.1073/pnas.0906510106; Schumacher J, 2006, J STRUCT BIOL, V156, P190, DOI 10.1016/j.jsb.2006.01.006; Singh J, 2022, J BACTERIOL, V204, DOI 10.1128/jb.00179-22; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tjornhammar R, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3428381; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Wodak SJ, 2019, STRUCTURE, V27, P566, DOI 10.1016/j.str.2019.01.003; WOOTTON JC, 1989, PROTEIN ENG, V2, P535, DOI 10.1093/protein/2.7.535; Yu HR, 2015, BBA-PROTEINS PROTEOM, V1854, P65, DOI 10.1016/j.bbapap.2014.10.017	67	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102399	10.1016/j.jbc.2022.102399	http://dx.doi.org/10.1016/j.jbc.2022.102399			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5S8ED	35988639	Green Submitted, Green Published, gold			2022-12-26	WOS:000875415100002
J	Alam, I; Gerard-O'Riley, RL; Acton, D; Hardman, SL; Murphy, M; Alvarez, MB; Blosser, RJ; Sinn, A; Srour, EF; Kacena, MA; Econs, MJ				Alam, Imranul; Gerard-O'Riley, Rita L.; Acton, Dena; Hardman, Sara L.; Murphy, Madeline; Alvarez, Marta B.; Blosser, Rachel J.; Sinn, Anthony; Srour, Edward F.; Kacena, Melissa A.; Econs, Michael J.			Bone marrow transplantation as a therapy for autosomal dominant osteopetrosis type 2 in mice	FASEB JOURNAL			English	Article						bone marrow transplantation; bone phenotypes; chloride channel 7; osteoclasts; osteopetrosis	STEM-CELL TRANSPLANTATION; ALBERS-SCHONBERG-DISEASE; HEMATOPOIETIC STEM; INTERFERON-GAMMA; MUTATIONS	Autosomal dominant osteopetrosis type II (ADO2) is a heritable bone disease of impaired osteoclastic bone resorption caused by missense mutations in the chloride channel 7 (CLCN7) gene. Clinical features of ADO2 include fractures, osteomyelitis of jaw, vision loss, and in severe cases, bone marrow failure. Currently, there is no effective therapy for ADO2, and patients usually receive symptomatic treatments. Theoretically, bone marrow transplantation (BMT), which is commonly used in recessive osteopetrosis, could be used to treat ADO2, although the frequency of complications related to BMT is quite high. We created an ADO2 knock-in (p.G213R mutation) mouse model on the 129 genetic background, and their phenotypes mimic the human disease of ADO2. To test whether BMT could restore osteoclast function and rescue the bone phenotypes in ADO2 mice, we transplanted bone marrow cells from 6-8 weeks old male WT donor mice into recipient female ADO2 mice. Also, to determine whether age at the time of transplant may play a role in transplant success, we performed BMT in young (12-week-old) and old (9-month-old) ADO2 mice. Our data indicate that ADO2 mice transplanted with WT marrow achieved more than 90% engraftment up to 6 months post-transplantation at both young and old ages. The in-vivo DXA data revealed that young ADO2 mice transplanted with WT marrow had significantly lower whole body and spine areal bone mineral density (aBMD) at month 6 post-transplantation compared to the ADO2 control mice. The old ADO2 mice also displayed significantly lower whole body, femur, and spine aBMD at months 4 and 5 post-transplantation compared to the age-matched control mice. The in-vivo micro-CT data showed that ADO2 experimental mice transplanted with WT marrow had significantly lower BV/TV at months 2 and 4 post-transplantation compared to the ADO2 control mice at a young age. In contrast, ADO2 control and experimental mice displayed similar BV/TV values for all post-transplantation time points at old age. In addition, serum CTX was significantly higher at month 2 post-transplantation in both young and old ADO2 experimental mice compared to the ADO2 control mice. Serum P1NP levels in young ADO2 experimental mice were significantly higher at baseline and month 2 post-transplantation compared to the ADO2 control mice. These data suggest that BMT may provide, at least, some beneficial effect at both young and adult ages.	[Alam, Imranul; Gerard-O'Riley, Rita L.; Acton, Dena; Hardman, Sara L.; Murphy, Madeline; Srour, Edward F.; Econs, Michael J.] Indiana Univ Sch Med, Dept Med, 1120 West Michigan St,CL459, Indianapolis, IN 46202 USA; [Alvarez, Marta B.; Blosser, Rachel J.; Kacena, Melissa A.] Indiana Univ Sch Med, Dept Orthopaed Surg, Indianapolis, IN 46202 USA; [Sinn, Anthony; Srour, Edward F.; Kacena, Melissa A.] Indiana Univ Sch Med, Melvin & Bren Simon Comprehens Canc Ctr, Indianapolis, IN 46202 USA; [Econs, Michael J.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Alam, I (corresponding author), Indiana Univ Sch Med, Dept Med, 1120 West Michigan St,CL459, Indianapolis, IN 46202 USA.	ialam@iu.edu		Kacena, Melissa/0000-0001-7293-0088	National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR069583]	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	National Institute of Arthritis and Musculoskeletal and Skin Diseases, Grant/Award Number: AR069583	Abinun M, 2010, ARCH DIS CHILD, V95, P984, DOI 10.1136/adc.2010.194928; Alam I, 2015, J BONE MINER RES, V30, P2005, DOI 10.1002/jbmr.2545; Benichou OD, 2000, BONE, V26, P87, DOI 10.1016/S8756-3282(99)00244-6; Capulli M, 2015, MOL THER-NUCL ACIDS, V4, P1, DOI 10.1038/mtna.2015.21; Chu K, 2006, J BONE MINER RES, V21, P1089, DOI 10.1359/JBMR.060409; Cleiren E, 2001, HUM MOL GENET, V10, P2861, DOI 10.1093/hmg/10.25.2861; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Driessen GJA, 2003, BONE MARROW TRANSPL, V32, P657, DOI 10.1038/sj.bmt.1704194; Duran-Struuck R, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-10; Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025; Eapen M, 1998, BONE MARROW TRANSPL, V22, P941, DOI 10.1038/sj.bmt.1701474; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Henriksen K, 2004, AM J PATHOL, V164, P1537, DOI 10.1016/S0002-9440(10)63712-1; Imel EA, 2019, J BONE MINER RES, V34, P1436, DOI 10.1002/jbmr.3715; JOHNSTON CC, 1968, MEDICINE, V47, P149, DOI 10.1097/00005792-196803000-00004; KEY L, 1984, NEW ENGL J MED, V310, P409, DOI 10.1056/NEJM198402163100701; KEY LL, 1992, J PEDIATR-US, V121, P119, DOI 10.1016/S0022-3476(05)82557-0; KEY LL, 1995, NEW ENGL J MED, V332, P1594, DOI 10.1056/NEJM199506153322402; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Martinez C, 2010, BONE MARROW TRANSPL, V45, P939, DOI 10.1038/bmt.2009.277; Maurizi A, 2018, BONE, V110, P343, DOI 10.1016/j.bone.2018.02.031; Maximova N, 2020, BONE, V130, DOI 10.1016/j.bone.2019.115144; Morrison SJ, 2002, J IMMUNOL, V168, P635, DOI 10.4049/jimmunol.168.2.635; Palagano E, 2017, BONE, V97, P126, DOI 10.1016/j.bone.2017.01.012; Penna S, 2021, DIS MODEL MECH, V14, DOI 10.1242/dmm.048940; Schulz AS., 2015, CONSENSUS GUIDELINES; Shadur B, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.27010; Stepensky P, 2019, BLOOD ADV, V3, P862, DOI 10.1182/bloodadvances.2018025890; Steward CG, 2010, PEDIATR CLIN N AM, V57, P171, DOI 10.1016/j.pcl.2009.11.006; VANOS R, 1993, RADIAT RES, V136, P118, DOI 10.2307/3578648; Waguespack SG, 2003, J BONE MINER RES, V18, P1513, DOI 10.1359/jbmr.2003.18.8.1513; Waguespack SG, 2007, J CLIN ENDOCR METAB, V92, P771, DOI 10.1210/jc.2006-1986; Weber DR., 2014, IBMS BONEKEY, V11, P520; Zhu GH, 2021, ORPHANET J RARE DIS, V16, DOI 10.1186/s13023-021-01955-6	34	1	1	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22471	10.1096/fj.202200678R	http://dx.doi.org/10.1096/fj.202200678R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3S4BV	35959867				2022-12-26	WOS:000839544000001
J	Abeysuriya, V; Wijesinha, NAI; Priyadharshan, PP; Chandrasena, LG; Wickremasinghe, AR				Abeysuriya, Visula; Wijesinha, Nirmala A. I.; Priyadharshan, Prakash P.; Chandrasena, Lal G.; Wickremasinghe, Ananda Rajitha			Composite carotid intima-media thickness as a risk predictor of coronary heart disease in a selected population in Sri Lanka	PLOS ONE			English	Article							NORMATIVE VALUES; ARTERY-DISEASE; PLAQUE; PROGRESSION; CALCIUM; IMPACT	Background Segment-specific variations of carotid intima-media thickness (CIMT) have not been assessed in South Asian populations. The purpose of this study was to determine if segment-specific CIMTs or a composite-CIMT score is a better risk predictor of coronary heart disease in South Asian populations. Methods A comparative prospective study was conducted from November 2019 to October 2020 in a hospital in Colombo, Sri Lanka. Based on pre-defined inclusion and exclusion criteria, cases (having a diagnosis of Coronary Heart Disease (CHD), n = 338) and controls (non-CHD group, n = 356) were recruited. Ultrasound examination of the common carotid (CCA), the carotid bulb (CB) and the internal carotid segments (ICA) of the carotid vessels was conducted by a radiologist, and CIMTs were measured. A composite-CIMT score defined as the average value of all six segments of the left and right sides was derived. Results 694 participants were enrolled (male n = 399, 57.5%). The mean (+/- SD) age of the study sample was 60.2 (+/- 9.86) years. There were variations in segment-specific values between the left and right vessels. The mean composite-CIMT value of the CHD group was significantly higher than that of the non-CHD group. A composite-CIMT score of 0.758 had a sensitivity of 98.4% and a specificity of 64.6% in distinguishing CHD from non-CHD groups (Area under the curve (AUC): 0.926). Conclusions Carotid artery segment-specific CIMT variations were present in this population. The composite CIMT score is better than segment-specific CIMTs in predicting CHD and may be used to predict CHD in this population.	[Abeysuriya, Visula; Wickremasinghe, Ananda Rajitha] Univ Kelaniya, Dept Publ Hlth, Fac Med, Ragama, Sri Lanka; [Abeysuriya, Visula] Nawaloka Hosp Res & Educ Fdn, Colombo, Sri Lanka; [Wijesinha, Nirmala A. I.] Nawaloka Hosp Plc, Dept Radiol, Colombo, Sri Lanka; [Priyadharshan, Prakash P.; Chandrasena, Lal G.] Nawaloka Hosp Plc, Dept Cardiol, Colombo, Sri Lanka	University Kelaniya	Abeysuriya, V (corresponding author), Univ Kelaniya, Dept Publ Hlth, Fac Med, Ragama, Sri Lanka.; Abeysuriya, V (corresponding author), Nawaloka Hosp Res & Educ Fdn, Colombo, Sri Lanka.	visulasrilanka@hotmail.com		, visula/0000-0001-7583-602X				Alexander J, 2017, WHO TECH REP SER, V1002, P1; Anderssen SA, 2005, ATHEROSCLEROSIS, V178, P387, DOI 10.1016/j.atherosclerosis.2004.08.033; Denise OO, 2018, ANN MED HEALTH SCI R, V8, P24; Fang N, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001920; Gaibazzi N, 2014, INT J CARDIOL, V177, P708, DOI 10.1016/j.ijcard.2014.09.195; Ghosh Uday Sankar, 2012, J Assoc Physicians India, V60, P26; Gonzalez J, 2008, RADIOLOGY, V247, P465, DOI 10.1148/radiol.2472070691; Grau M, 2012, REV ESP CARDIOL, V65, P1086, DOI [10.1016/j.recesp.2012.04.026, 10.1016/j.rec.2012.04.019]; Gruszfeld D, 2015, ANN NUTR METAB, V66, P51, DOI 10.1159/000369980; Haberka M, 2015, ATHEROSCLEROSIS, V243, P307, DOI 10.1016/j.atherosclerosis.2015.09.022; Johri AM, 2016, ECHOCARDIOGR-J CARD, V33, P281, DOI 10.1111/echo.13007; Jourdan C, 2005, J HYPERTENS, V23, P1707, DOI 10.1097/01.hjh.0000178834.26353.d5; Kablak-Ziembicka A, 2008, HEART VESSELS, V23, P295, DOI 10.1007/s00380-008-1044-y; Katulanda P, 2011, ASIA-PAC J PUBLIC HE, V23, P861, DOI 10.1177/1010539509355599; Kiriyama H, 2020, HEART VESSELS, V35, P22, DOI 10.1007/s00380-019-01455-5; Klop B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075573; Lee K, 2012, EUR J PREV CARDIOL, V19, P1161, DOI 10.1177/1741826711422763; Liao XM, 2016, EUR J PREV CARDIOL, V23, P1165, DOI 10.1177/2047487315625543; Liu DM, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/9879463; Luo X, 2011, CLIN RADIOL, V66, P393, DOI 10.1016/j.crad.2010.12.002; Muller-Scholden L, 2019, BMC CARDIOVASC DISOR, V19, DOI 10.1186/s12872-019-1044-0; Murphy DJ, 2017, J CARDIOVASC COMPUT, V11, P227, DOI 10.1016/j.jcct.2017.02.004; Nambi V, 2012, EUR HEART J, V33, P183, DOI 10.1093/eurheartj/ehr192; Naqvi TZ, 2014, JACC-CARDIOVASC IMAG, V7, P1025, DOI 10.1016/j.jcmg.2013.11.014; Oren A, 2003, ARCH INTERN MED, V163, P1787, DOI 10.1001/archinte.163.15.1787; Pearson TA, 2002, CIRCULATION, V105, P886, DOI 10.1161/hc0702.103727; Polak JF., 2010, ASSOCIATIONS CAROTID; Qu BG, 2015, CARDIOVASC ULTRASOUN, V13, DOI 10.1186/s12947-015-0041-4; Raju K., 2019, 42 INT J RADIOLOGY D, V2, DOI [10.33545/26644436.2019.v2.i1a.27, DOI 10.33545/26644436.2019.V2.I1A.27]; Ravani A, 2015, CURR PHARM DESIGN, V21, P1164, DOI 10.2174/1381612820666141013121545; Reynolds HR, 2010, AM HEART J, V159, P1059, DOI 10.1016/j.ahj.2010.03.026; Santos IS, 2015, ARTERIOSCL THROM VAS, V35, P2054, DOI 10.1161/ATVBAHA.115.305765; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; Touboul PJ, 2009, CEREBROVASC DIS, V27, P361, DOI 10.1159/000202013; Verma B, 2022, CLIN INVEST ARTERIOS, V34, P183, DOI 10.1016/j.arteri.2021.12.001; World Health Organization Web site, 2017, CARD DIS CVDS; Yokoi H, 2014, INT HEART J, V55, P146, DOI 10.1536/ihj.13-216; Zaid M, 2017, J ATHEROSCLER THROMB, V24, P227, DOI 10.5551/jat.RV16005	39	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0271986	10.1371/journal.pone.0271986	http://dx.doi.org/10.1371/journal.pone.0271986			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994446	Green Published, gold			2022-12-26	WOS:000877093400013
J	Denslow, S; Wingert, JR; Hanchate, AD; Rote, A; Westreich, D; Sexton, L; Cheng, KD; Curtis, J; Jones, WS; Lanou, AJ; Halladay, JR				Denslow, Sheri; Wingert, Jason R.; Hanchate, Amresh D.; Rote, Aubri; Westreich, Daniel; Sexton, Laura; Cheng, Kedai; Curtis, Janis; Jones, William Schuyler; Lanou, Amy Joy; Halladay, Jacqueline R.			Rural-urban outcome differences associated with COVID-19 hospitalizations in North Carolina	PLOS ONE			English	Article							HEALTH-CARE ACCESS; UNITED-STATES; DISEASE; COMORBIDITIES; DISPARITIES; DEATH; AREAS	People living in rural regions in the United States face more health challenges than their non-rural counterparts which could put them at additional risks during the COVID-19 pandemic. Few studies have examined if rurality is associated with additional mortality risk among those hospitalized for COVID-19. We studied a retrospective cohort of 3,991 people hospitalized with SARS-CoV-2 infections discharged between March 1 and September 30, 2020 in one of 17 hospitals in North Carolina that collaborate as a clinical data research network. Patient demographics, comorbidities, symptoms and laboratory data were examined. Logistic regression was used to evaluate associations of rurality with a composite outcome of death/hospice discharge. Comorbidities were more common in the rural patient population as were the number of comorbidities per patient. Overall, 505 patients died prior to discharge and 63 patients were discharged to hospice. Among rural patients, 16.5% died or were discharged to hospice vs. 13.3% in the urban cohort resulting in greater odds of death/hospice discharge (OR 1.3, 95% CI 1.1, 1.6). This estimate decreased minimally when adjusted for age, sex, race/ethnicity, payer, disease comorbidities, presenting oxygen levels and cytokine levels (adjusted model OR 1.2, 95% CI 1.0, 1.5). This analysis demonstrated a higher COVID-19 mortality risk among rural residents of NC. Implementing policy changes may mitigate such disparities going forward.	[Denslow, Sheri] UNC Hlth Sci, Dept Res, MAHEC, Asheville, NC USA; [Wingert, Jason R.; Rote, Aubri] Univ North Carolina Asheville, Dept Hlth & Wellness, Asheville, NC 28804 USA; [Hanchate, Amresh D.] Wake Forest Univ, Bowman Gray Sch Med, Social Sci & Hlth Policy, Winston Salem, NC USA; [Westreich, Daniel] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Sexton, Laura] Univ North Carolina Asheville, Sage Nutr Associates, Asheville, NC USA; [Cheng, Kedai] Univ North Carolina Asheville, Dept Math, Asheville, NC USA; [Curtis, Janis] Duke Univ, Clin Data Res Networks, Durham, NC USA; [Jones, William Schuyler] Duke Univ, Med, Populat Hlth Sci, Durham, NC USA; [Jones, William Schuyler] Duke Univ, Duke Clin Res Inst, Durham, NC USA; [Lanou, Amy Joy] Univ North Carolina Asheville, Dept Hlth & Wellness, NC Ctr Hlth & Wellness, Asheville, NC USA; [Halladay, Jacqueline R.] Univ N Carolina, Dept Family Med, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina - Asheville; Wake Forest University; Wake Forest Baptist Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina - Asheville; University of North Carolina; University of North Carolina - Asheville; Duke University; Duke University; Duke University; University of North Carolina; University of North Carolina - Asheville; University of North Carolina; University of North Carolina Chapel Hill	Wingert, JR (corresponding author), Univ North Carolina Asheville, Dept Hlth & Wellness, Asheville, NC 28804 USA.	jwingert@unca.edu		Wingert, Jason/0000-0002-7894-1279	North Carolina Policy Collaboratory; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health [UL1TR002489];  [7/1/2020-12/30/2020]	North Carolina Policy Collaboratory; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); 	The North Carolina Policy Collaboratory, awarded to Dr. Amy Joy Lanou. The North Carolina Collaboratory award does not have an award number, but the grant's title is Title Back-to-College Challenge: Health Ambassadors for a Coordinated Culture of Safety and Wellness on WNC Campuses and Statewide Co-Morbidity Study with funding from 7/1/2020-12/30/2020. The project described was also supported by the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, through Grant Award Number UL1TR002489. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healtcare Research and Quality, SID DATABASE DOCUMEN; Ahmed R, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8030330; Anderson TJ, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1053-3; Atkins GT, 2017, ANN AM THORAC SOC, V14, P403, DOI 10.1513/AnnalsATS.201606-469OC; Bailey M., 2017, WASHINGTON POST NOV; Beckershospitalreview, BECKERS HOSP CFO REP; Brittain A, WASH POST; Centers for Disease Control and Prevention, 2020, PEOPLE CERTAIN MEDIC; Centers for Disease Control and Prevention, 2021, ICD ICD 10 900 INT C; Centers for Disease Control and Prevention, 2019, TERMINOLOGY; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coffey R., 2012, METHODS APPLYING AHR, P47; Cohen PN., 2020, SOCARXIV CTR OPEN SC; Cossman J, 2017, SSM-POPUL HLTH, V3, P618, DOI 10.1016/j.ssmph.2017.07.013; Croft JB, 2018, MMWR-MORBID MORTAL W, V67, P205, DOI 10.15585/mmwr.mm6707a1; Cuadros DF, 2021, ANN EPIDEMIOL, V59, P16, DOI 10.1016/j.annepidem.2021.04.007; Diaz A., 2020, COVID 19 PANDEMIC RU, V2021, DOI [10.1377/hblog20200429.583513/full/, DOI 10.1377/HBLOG20200429.583513/FULL]; Douthit N, 2015, PUBLIC HEALTH, V129, P611, DOI 10.1016/j.puhe.2015.04.001; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Estes C, FORBES; Fathi M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246190; Fleurence RL, 2014, J AM MED INFORM ASSN, V21, P578, DOI 10.1136/amiajnl-2014-002747; Gagne JJ, 2011, J CLIN EPIDEMIOL, V64, P749, DOI 10.1016/j.jclinepi.2010.10.004; Gasparrini A., 2018, J OPEN SOURCE SOFTW, V3, P648, DOI DOI 10.21105/JOSS.00648; Gateway RHR., 2018, RURAL COMMUNITIES AG; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Gupta S, 2020, JAMA INTERN MED, V180, P1436, DOI 10.1001/jamainternmed.2020.3596; Haischer MH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240785; Halpern NA, 2020, US RESOURCE AVAILABI, P1; Henning-Smith C, 2020, J AGING SOC POLICY, V32, P396, DOI 10.1080/08959420.2020.1770036; Housing and Urban Development-Office of Policy Development and Research, HUD USPS ZIP CODE CR; Huang Q, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246548; Ingram Deborah D, 2014, Vital Health Stat 2, P1; Ioannou GN, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.22310; Johnson KM., 2020, OLDER POPULATION INC; Kail B, 2020, J GERONTOL B-PSYCHOL, V75, P448, DOI 10.1093/geronb/gby027; Kaufman BG, 2020, J RURAL HEALTH, V36, P584, DOI 10.1111/jrh.12481; Kulshreshtha A, 2014, PUBLIC HEALTH REP, V129, P19, DOI 10.1177/003335491412900105; Lakhani HV, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124279; Lucia K., 2017, COMMONWEALTH FUND; Martino S., 2019, RURAL URBAN DISPARIT; Massey CN., 2010, CLIN DIABETES, V28, P20, DOI [10.2337/diaclin.28.1.20, DOI 10.2337/DIACLIN.28.1.20]; Moy E, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6601a1; Murthy BP, 2021, MMWR-MORBID MORTAL W, V70, P759, DOI 10.15585/mmwr.mm7020e3; NC COVID-19, VACCINATIONS NC COVI; North Carolina Department of Health and Human Services, COVID 19 RURAL REPOR; North Carolina State Data Center, URBAN RURAL FACES N; Pathman DE, 2006, HEALTH SERV RES, V41, P79, DOI 10.1111/j.1475-6773.2005.00454.x; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686; Pro G, 2020, RURAL REMOTE HEALTH, V20, DOI 10.22605/RRH6074; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Rural Health Information Hub, N CAROLINA RURAL HEA; Shah P, 2020, ANN MED, V52, P354, DOI 10.1080/07853890.2020.1791356; Sheps Center, RURAL HOSP CLOSURES; Singer L, 2019, SSM-POPUL HLTH, V8, DOI 10.1016/j.ssmph.2019.100413; Singh GK, 2014, AM J PREV MED, V46, pE19, DOI 10.1016/j.amepre.2013.10.017; Sood L, 2021, J RURAL HEALTH, V37, P217, DOI 10.1111/jrh.12459; Souch JM, 2021, J RURAL HEALTH, V37, P188, DOI 10.1111/jrh.12450; Sparks PJ, 2012, INT HANDB POPUL, V3, P255, DOI 10.1007/978-94-007-1842-5_18; Tan L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0148-4; Thomas TL, 2014, HEALTH EDUC J, V73, P285, DOI 10.1177/0017896912471049; Ullrich F., 2020, METROPOLITANNONMETRO; United States Census Bureau, 2016, NEW CENS DAT SHOW DI; US Department of Agriculture-Economic Research Service, USDA ERS RURAL URBAN; USAFacts, DETAILED METHODOLOGY; van Dorn A, 2020, LANCET, V395, P1243, DOI 10.1016/S0140-6736(20)30893-X; Wang BL, 2020, AGING-US, V12, P6049, DOI 10.18632/aging.103000; WBTV Web, 1 CASE COMMUNITY SPR; Yehia BR, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.18039; Yu XH, 2020, SAGE OPEN MED, V8, DOI 10.1177/2050312120974168; Zheng MJ, 2020, CELL MOL IMMUNOL, V17, P533, DOI 10.1038/s41423-020-0402-2; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	74	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0271755	10.1371/journal.pone.0271755	http://dx.doi.org/10.1371/journal.pone.0271755			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976813	gold, Green Published			2022-12-26	WOS:000847227000014
J	Cheng, CH; Yang, JH; Liu, PC				Cheng, Ching-Hsue; Yang, Jun-He; Liu, Po-Chien			Rule-based classifier based on accident frequency and three-stage dimensionality reduction for exploring the factors of road accident injuries	PLOS ONE			English	Article							FEATURE-SELECTION; CRASHES; TIME; ALGORITHMS; MODEL	Road accidents are one of the primary causes of death worldwide; hence, they constitute an important research field. Taiwan is a small country with a high-density population. It particularly has a considerable number of locomotives. Furthermore, Taiwan's traffic accident fatality rate increased by 23.84% in 2019 compared with 2018, primarily because of human factors. Road safety has long been a challenging problem in Taiwanese cities. This study collected public data pertaining to traffic accidents from the Taoyuan city government in Taiwan and generated six datasets based on the various accident frequencies at the same location. To find key attributes, this study proposes a three-stage dimension reduction to filter attributes, which includes removing multicollinear attributes, the integrated attribute selection method, and statistical factor analysis. We applied five rule-based classifiers to classify six different frequency datasets and generate the rules of accident severity. The order of top ten key attributes was hit vehicle > certificate type > vehicle > action type > drive quality > escape > accident type > gender > job > trip purposes in the maximum accident frequency CF >= 10 dataset. When locomotives, bicycles, and people collide with other locomotives or trucks, injury or death can easily occur, and the motorcycle riders are at the highest risk. The findings of this study provide a reference for governments and stakeholders to reduce the road accident risk factors.	[Cheng, Ching-Hsue; Yang, Jun-He; Liu, Po-Chien] Natl Yunlin Univ Sci & Technol, Dept Informat Management, Touliou, Yunlin, Taiwan; [Yang, Jun-He] Cheng Shiu Univ, Dept E Sport Technol Management, Kaohsiung, Taiwan	National Yunlin University Science & Technology; Cheng Shiu University	Yang, JH (corresponding author), Cheng Shiu Univ, Dept E Sport Technol Management, Kaohsiung, Taiwan.	blackwhale@gcloud.csu.edu.tw	Cheng, Ching-Hsue/D-1785-2012	Cheng, Ching-Hsue/0000-0002-5509-6965; Yang, Jun-He/0000-0002-4008-4785				Anish CM, 2016, J KOREAN STAT SOC, V45, P64, DOI 10.1016/j.jkss.2015.07.002; Attanasi ED, 2020, J PETROL SCI ENG, V191, DOI 10.1016/j.petrol.2020.107150; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Britsch M., 2008, ARXIV; Cai J, 2018, NEUROCOMPUTING, V300, P70, DOI 10.1016/j.neucom.2017.11.077; Cantillo V, 2020, ACCIDENT ANAL PREV, V146, DOI 10.1016/j.aap.2020.105749; Chand A, 2021, MATER TODAY-PROC, V47, P5135, DOI 10.1016/j.matpr.2021.05.415; Cohen W. W., 1995, Machine Learning. Proceedings of the Twelfth International Conference on Machine Learning, P115; Dumais S., 1998, Proceedings of the 1998 ACM CIKM International Conference on Information and Knowledge Management, P148, DOI 10.1145/288627.288651; Fayyad U, 1996, AI MAG, V17, P37; FHWA, 2021, HIGHWAY SAFETY IMPRO; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Furnkranz J, 2020, MACH LEARN, V109, P853, DOI 10.1007/s10994-019-05856-5; Geurts P, 2006, MACH LEARN, V63, P3, DOI 10.1007/s10994-006-6226-1; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th ed; Hall M. A., 1999, Proceedings of the Twelfth International Florida AI Research Society Conference, P235; Ho TK, 1995, P 3 INT C DOC AN REC, V1, P278; Hu L, 2020, J SAFETY RES, V72, P21, DOI 10.1016/j.jsr.2019.12.011; Landwehr N, 2005, MACH LEARN, V59, P161, DOI 10.1007/s10994-005-0466-3; Liu H, 2005, IEEE T KNOWL DATA EN, V17, P491, DOI 10.1109/TKDE.2005.66; Martensen H, 2013, ACCIDENT ANAL PREV, V60, P466, DOI 10.1016/j.aap.2013.03.005; Moayedikia A, 2017, ENG APPL ARTIF INTEL, V57, P38, DOI 10.1016/j.engappai.2016.10.008; MOTC, 2021, STAT REP TAIW MIN TR; NPA, 2019, ANN STAT REP NAT POL; Pahukula J, 2015, ACCIDENT ANAL PREV, V75, P155, DOI 10.1016/j.aap.2014.11.021; Pande A, 2010, J SAFETY RES, V41, P391, DOI 10.1016/j.jsr.2010.06.004; PRAAGMAN J, 1985, EUR J OPER RES, V19, P144, DOI 10.1016/0377-2217(85)90321-2; Prati G, 2017, ACCIDENT ANAL PREV, V101, P44, DOI 10.1016/j.aap.2017.01.008; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Rahman MS, 2019, J SAFETY RES, V70, P275, DOI 10.1016/j.jsr.2019.04.008; Rodriguez-Lujan I, 2010, QUADRATIC PROGRAMMIN; Rolison JJ, 2018, ACCIDENT ANAL PREV, V115, P11, DOI 10.1016/j.aap.2018.02.025; Sammut C., 2011, ENCY MACHINE LEARNIN, DOI [10.1007/978-0-387-30164-8-469, DOI 10.1007/978-0-387-30164-8_469, DOI 10.1007/978-0-387-30164-8469]; Sette S, 2000, ENG APPL ARTIF INTEL, V13, P381, DOI 10.1016/S0952-1976(00)00020-8; Sun J, 2015, TRANSPORT RES C-EMER, V54, P176, DOI 10.1016/j.trc.2015.03.006; Tharwat A., 2018, APPL COMPUT INFORM, V17, P168, DOI [10.1016/j.aci.2018.08.003, DOI 10.1016/J.ACI.2018.08.003]; Uddin M, 2020, ACCIDENT ANAL PREV, V141, DOI 10.1016/j.aap.2020.105529; Uncu O, 2007, INFORM SCIENCES, V177, P449, DOI 10.1016/j.ins.2006.03.022; Vorko-Jovic A, 2006, J SAFETY RES, V37, P93, DOI 10.1016/j.jsr.2005.08.009; World Health Organization, 2020, GLOBAL STATUS REPORT, DOI DOI 10.1037/COU0000248; Zhang GN, 2014, TRANSPORT RES F-TRAF, V23, P113, DOI 10.1016/j.trf.2013.12.009; Zhen Chen, 2019, International Journal of Transportation Science and Technology, V8, P43, DOI 10.1016/j.ijtst.2018.10.001	42	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0272956	10.1371/journal.pone.0272956	http://dx.doi.org/10.1371/journal.pone.0272956			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994471	gold, Green Published			2022-12-26	WOS:000877093400032
J	Marsum, M; Sunarto, S; Widodo, W; Khayan, K; Wardoyo, S				Marsum, Marsum; Sunarto, Sunarto; Widodo, Widodo; Khayan, Khayan; Wardoyo, Slamet			Waste treatment innovation for infusion bottles using soil solution	PLOS ONE			English	Article							CLAY; INCINERATION; MANAGEMENT	The amount of medical waste, especially infusion bottles, is a problem for environmental pollution. Improper management of infusion bottle waste can have an impact on disease transmission. The medical waste treatment used high technology and high costs will be a financial burden, so simple and effective treatment innovations is needed. This study uses an experimental method of removing bacteria from infusion bottles using a mixture of water and Andoso soil as a solution for washing infusion bottle waste. The soil solution concentration used in washing was 45% with a contact time of 2 minutes. The experiment was carried out with two repetitions. The treatment effect on decreasing the number of bacteria using a multiple linear regression mathematical model. The results showed that the disinfection process of bacterial-contaminated infusion bottles using water required rinsing up to six times, whereas using 45% andosol soil solution only rinsed once. The effectiveness of the disinfection of infusion bottles contaminated with bacteria using soil solution reduces the number of bacteria by 98%.	[Marsum, Marsum; Sunarto, Sunarto; Widodo, Widodo] Poltekkes Kemenkes Semarang, Semarang, Indonesia; [Khayan, Khayan] Poltekkes Kemenkes Banten, Serang, Indonesia; [Wardoyo, Slamet] Poltekkes Kemenkes Surabaya, Surabaya, Indonesia		Marsum, M (corresponding author), Poltekkes Kemenkes Semarang, Semarang, Indonesia.	marsumrahma1963@gmail.com	Wardoyo, Slamet/GSD-3991-2022	Wardoyo, Slamet/0000-0003-3936-1893				Babayara Y., 2013, INT J ENVIRON EALTH, V11, P1, DOI DOI 10.5281/ZENODO.1089052; Behroozian S, 2020, MBIO, V11, DOI 10.1128/mBio.02350-20; Das AK, 2021, SCI TOTAL ENVIRON, V778, DOI 10.1016/j.scitotenv.2021.146220; Dong WK, 2020, CHEM ENG J, V382, DOI 10.1016/j.cej.2019.122984; Gautam V, 2010, INDIAN J MED MICROBI, V28, P191, DOI 10.4103/0255-0857.66465; Hardjowigeno S., 2012, ILMU TANAH JAKARTA A; Herigstad B, 2001, J MICROBIOL METH, V44, P121, DOI 10.1016/S0167-7012(00)00241-4; Holesova S, 2021, MATER TODAY-PROC, V37, P21, DOI 10.1016/j.matpr.2020.02.101; Ihekweme GO, 2021, COGENT ENG, V8, DOI 10.1080/23311916.2021.1883232; Irfa'i M., 2020, J KESEHAT LINGKUNG, V12, P254, DOI [10.20473/jkl.v12i4.2020.254-261, DOI 10.20473/JKL.V12I4.2020.254-261]; Jang YC, 2006, J ENVIRON MANAGE, V80, P107, DOI 10.1016/j.jenvman.2005.08.018; Liang JJ, 2014, J VIROL, V88, P4218, DOI 10.1128/JVI.03256-13; Londono SC, 2017, ENVIRON SCI TECHNOL, V51, P2401, DOI 10.1021/acs.est.6b04670; Maharani E., 2017, J KESEHAT MASY, V5, P599; Marsum A., 2020, SYST REV PHARM, V11, P663; Morrison KD, 2016, SCI REP-UK, V6, DOI 10.1038/srep19043; Morrison KD, 2014, ENVIRON GEOCHEM HLTH, V36, P613, DOI 10.1007/s10653-013-9585-0; Negron-Mendoza A., 2004, SPRINGER, P181; Otto CC, 2016, J MED MICROBIOL, V65, P19, DOI 10.1099/jmm.0.000195; Pardo L, 2020, MINERALS-BASEL, V10, DOI 10.3390/min10020130; Pemerintah P., 2021, PP NOMOR 22 TAHUN 20; Permenkes RI., 2019, PERATURAN MENTERI KE; Rao Skm, 2004, Med J Armed Forces India, V60, P379, DOI 10.1016/S0377-1237(04)80016-9; Singh S, 2007, ENVIRON MONIT ASSESS, V132, P67, DOI 10.1007/s10661-006-9503-3; Sutrisno H., 2020, J KESEHAT LINGKUNG, V12, P104, DOI [10.20473/jkl.v12i1si.2020.104-120, DOI 10.20473/JKL.V12I1SI.2020.104, DOI 10.20473/JKL.V12I1SI.2020]; Taghipour H, 2016, HEALTH PROMOT PERSPE, V6, P202, DOI 10.15171/hpp.2016.33; Widjanarko B., 2020, SYST REV PHARM, V11; Williams LB, 2019, CLAY CLAY MINER, V67, P7, DOI 10.1007/s42860-018-0002-8; Williams LB, 2011, ENVIRON SCI TECHNOL, V45, P3768, DOI 10.1021/es1040688; Williams LB, 2010, INT GEOL REV, V52, P745, DOI 10.1080/00206811003679737; Wohlsen T, 2006, LETT APPL MICROBIOL, V42, P350, DOI 10.1111/j.1472-765X.2006.01854.x	31	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0273394	10.1371/journal.pone.0273394	http://dx.doi.org/10.1371/journal.pone.0273394			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994450	gold, Green Published			2022-12-26	WOS:000877093400050
J	Loko, YLE; Gbemavo, CDSJ; Agre, PA; Dassou, AG; Yelome, OI; Idossou, R; Afoha, SAE; Dadonougbo, E; Fakorede, J; Dansi, AA				Loko, Yeyinou Laura Estelle; Gbemavo, Charlemagne D. S. J.; Agre, Paterne A.; Dassou, Anicet G.; Yelome, Octaviano Igor; Idossou, Roger; Afoha, S. Alban Etchiha; Dadonougbo, Eric; Fakorede, Jeannette; Dansi, Alexandre A.			White Guinea yam (Dioscorea rotundata Poir.) landraces trait profiling and setting benchmark for breeding programs in the Republic of Benin	PLOS ONE			English	Article							GENETIC DIVERSITY; CULTIVARS; MANAGEMENT; MOISTURE; VARIETAL; FARMERS; QUALITY; GROWTH	To meet the high demand for white Guinea yam, there is a need to develop and release improved varieties to farmers. Unfortunately, low rate of adoption of most of the improved yam varieties by both producers and consumers was observed. Information regarding agronomic characteristics and food qualities of popular white Guinea yam landraces with high market value are not available to establish minimum standards to be considered by breeding programs. To fill this gap, surveys using rural appraisal tools were carried out in 20 villages and 16 markets throughout Benin. Data on the agronomic performance suggested that for an improved variety to be adopted by Beninese farmers it should have a minimum yield of 4.16 +/- 0.15 kg per mound, and average number of marketable tubers of 1.23 +/- 0.05, a mean tuber length of 36.41 +/- 1.22 cm, and a minimum diameter of 25.44 +/- 1.16 cm. The sensorial attributes for boiled and pounded tubers of this improved variety should have minimum score of 3.16 for texture, 0.75 for softness, 3.75 for elasticity, and 1.34 for colour during the sensory evaluation. The improved variety must also have a minimum average severity score of 1.1 for yam mosaic virus disease, 1.33 for anthracnose and 1 for nematodes. Landraces Amoula, Laboko, and Djilaadja should be considered as the standard for yield, sensory attributes, and tolerance to pest and diseases while landraces Danwari, Kodjewe, Mondji, and Gnidou should be characterized as possessing good flowering and fruit setting capacities for breeding programs.	[Loko, Yeyinou Laura Estelle; Gbemavo, Charlemagne D. S. J.; Dassou, Anicet G.; Yelome, Octaviano Igor; Idossou, Roger; Afoha, S. Alban Etchiha; Dadonougbo, Eric; Fakorede, Jeannette; Dansi, Alexandre A.] Natl High Sch Appl Biosci & Biotechnol ENSBBA UNS, Lab Biotechnol Genet Resources & Plant & Anim Bre, Dassa Zoume, Benin; [Loko, Yeyinou Laura Estelle] Natl Univ Sci Technol Engn & Math, Natl High Sch Appl Biosci & Biotechnol ENSBBA, Lab Appl Entomol LEnA, Dassa, Benin; [Agre, Paterne A.] Int Inst Trop Agr IITA, Ibadan, Nigeria	CGIAR; International Institute of Tropical Agriculture (IITA)	Loko, YLE (corresponding author), Natl High Sch Appl Biosci & Biotechnol ENSBBA UNS, Lab Biotechnol Genet Resources & Plant & Anim Bre, Dassa Zoume, Benin.; Loko, YLE (corresponding author), Natl Univ Sci Technol Engn & Math, Natl High Sch Appl Biosci & Biotechnol ENSBBA, Lab Appl Entomol LEnA, Dassa, Benin.	lokoestelle@yahoo.fr	Estelle, Loko yêyinou Laura/N-6651-2015	Estelle, Loko yêyinou Laura/0000-0002-7310-1334; AGRE, Paterne/0000-0003-1231-2530	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by funded by Bill and Melinda Gates Foundation, through AfricaYam project, coordinated in Benin by Prof DANSI Anagonou Alexandre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola YP., 2010, RATE DETERMINANTS AG; Adifon FS., 2019, EUR SCI J, V15, P211; Agre PA, 2021, PLANT GENET RESOUR-C, V19, P437, DOI [10.1017/S1479262121000626, 10.1017/S1479262121000526]; Aighewi BA, 2015, FOOD SECUR, V7, P823, DOI 10.1007/s12571-015-0481-6; Akissoe N, 2009, J FOOD PROCESS PRES, V33, P75, DOI 10.1111/j.1745-4549.2008.00252.x; Amegbeto NK, 2008, AGR ECON-BLACKWELL, V39, P349, DOI 10.1111/j.1574-0862.2008.00338.x; [Anonymous], 2018, R PACKAGE VERSION 20; [Anonymous], 2019, FAO FAOSTAT DATABASE; Anyanwu CF., 2015, INT J ADV RES, V3, P110; Asfaw A., 2016, Standard operating protocol for yam variety performance evaluation trial; Banson K., 2013, J LIFE SCI, V7, P732; Bougeard S, 2018, J STAT SOFTW, V86, P1, DOI 10.18637/jss.v086.i01; Cornet D, 2015, AGRON J, V107, P241, DOI 10.2134/agronj14.0370; Darkwa K, 2020, PLANT BREEDING, V139, P474, DOI 10.1111/pbr.12783; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Escofier B., 1998, DUNOD; Etchiha ASAP., 2019, INT J CURR MICROBIOL, V8, P1119; Fakorede J., 2020, INT J CURR MICROBIOL, V9, P2083; Fakorede J., 2020, INT J CURR MICROBIOL, V9, P1663; Floquet AB., 2016, CAH AGRIC, V21, P427; Girma G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216912; Hamadina EI, 2009, J AGR SCI-CAMBRIDGE, V147, P469, DOI 10.1017/S0021859609008697; Hounnou FE, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11236569; Institut international des ressources phytogenetiques (IPGRI); Institut international d'agriculture tropicale (IITA), 1997, DESCRIPTEURS LIGNAME; Iseki K, 2020, PLANT PROD SCI, V23, P75, DOI 10.1080/1343943X.2019.1667835; Ita EE, 2020, S AFR J BOT, V130, P123, DOI 10.1016/j.sajb.2019.12.022; Kinhoegbe G, 2020, J ETHNOBIOL ETHNOMED, V16, DOI 10.1186/s13002-020-00378-0; Kombo GR, 2012, GENET RESOUR CROP EV, V59, P1789, DOI 10.1007/s10722-012-9803-0; Loko YL, 2015, GENET RESOUR CROP EV, V62, P1181, DOI 10.1007/s10722-015-0221-y; Loko Y. L., 2013, International Research Journal of Agricultural Science and Soil Science, V3, P219; Loko YL, 2017, GENET RESOUR CROP EV, V64, P1205, DOI 10.1007/s10722-016-0430-z; Norman PE, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9040527; Nwankwo IIM., 2017, RES J AGRIC SCI, V7, P1; Olasantan FO, 1999, SOIL TILL RES, V50, P215, DOI 10.1016/S0167-1987(98)00192-5; Otegbayo B, 2006, FOOD CHEM, V99, P663, DOI 10.1016/j.foodchem.2005.08.041; Otoo E, 2009, AFR J BIOTECHNOL, V8, P5747; R Core Team, 2021, R LANG ENV STAT; Scarcelli N, 2006, GENET RESOUR CROP EV, V53, P121, DOI 10.1007/s10722-004-1950-5; Tostain Serge, 2007, Plant Genetic Resources Characterization and Utilization, V5, P71, DOI 10.1017/S1479262107672323; Vaissie P., 2021, FACTOSHINY PERFORM F; Vernier P., 2006, Plant Genetic Resources Newsletter, P38; Zannou A., 2007, International Journal of Agricultural Sustainability, V5, P140; Zannou A, 2004, NJAS-WAGEN J LIFE SC, V52, P393, DOI 10.1016/S1573-5214(04)80023-X; Zoundjihekpon J., DIOSCOREA CAYENENSIS	45	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0273043	10.1371/journal.pone.0273043	http://dx.doi.org/10.1371/journal.pone.0273043			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976964	gold, Green Published			2022-12-26	WOS:000847227000072
J	Lee, D; Nakai, A; Miwa, Y; Tomita, Y; Kunimi, H; Chen, JH; Ikeda, SI; Tsubota, K; Negishi, K; Kurihara, T				Lee, Deokho; Nakai, Ayaka; Miwa, Yukihiro; Tomita, Yohei; Kunimi, Hiromitsu; Chen, Junhan; Ikeda, Shin-Ichi; Tsubota, Kazuo; Negishi, Kazuno; Kurihara, Toshihide			Retinal degeneration induced in a mouse model of ischemia-reperfusion injury and its management by pemafibrate treatment	FASEB JOURNAL			English	Article						fibroblast growth factor 21 (FGF21); inflammation; neuroprotection; pemafibrate; peroxisome proliferator-activated receptor alpha (PPAR alpha); retinal ischemia and degeneration	GANGLION-CELL DEATH; VASCULAR-PERMEABILITY; CAPILLARY DEGENERATION; C-JUN; EXPRESSION; APOPTOSIS; MINOCYCLINE; ACTIVATION; INDUCTION; GLAUCOMA	Retinal ischemia-reperfusion (I/R) injury is a common cause of visual impairment. To date, no effective treatment is available for retinal I/R injury. In addition, the precise pathological mechanisms still need to be established. Recently, pemafibrate, a peroxisome proliferator-activated receptor alpha (PPAR alpha) modulator, was shown to be a promising drug for retinal ischemia. However, the role of pemafibrate in preventing retinal I/R injury has not been documented. Here, we investigated how retinal degeneration occurs in a mouse model of retinal I/R injury by elevation of intraocular pressure and examined whether pemafibrate could be beneficial against retinal degeneration. Adult mice were orally administered pemafibrate (0.5 mg/kg/day) for 4 days, followed by retinal I/R injury. The mice were continuously administered pemafibrate once every day until the end of the experiments. Retinal functional changes were measured using electroretinography. Retina, liver, and serum samples were used for western blotting, quantitative PCR, immunohistochemistry, or enzyme linked immunosorbent assay. Retinal degeneration induced by retinal inflammation was prevented by pemafibrate administration. Pemafibrate administration increased the hepatic PPARa target gene expression and serum levels of fibroblast growth factor 21, a neuroprotective molecule in the eye. The expression of hypoxia-response and pro-and an ti-apoptotic/inflam matory genes increased in the retina following retinal I/R injury; however, these changes were modulated by pemafibrate administration. In conclusion, pemafibrate is a promising preventive drug for ischemic retinopathies.	[Lee, Deokho; Nakai, Ayaka; Miwa, Yukihiro; Tomita, Yohei; Kunimi, Hiromitsu; Chen, Junhan; Ikeda, Shin-Ichi; Negishi, Kazuno; Kurihara, Toshihide] Keio Univ, Lab Photobiol, Sch Med, Tokyo 1608582, Japan; [Lee, Deokho; Nakai, Ayaka; Miwa, Yukihiro; Tomita, Yohei; Kunimi, Hiromitsu; Chen, Junhan; Ikeda, Shin-Ichi; Kurihara, Toshihide] Keio Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan; [Nakai, Ayaka] Nihon Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan; [Miwa, Yukihiro] Aichi Anim Eye Clin, Aichi, Aichi 4, Japan; [Tomita, Yohei] Harvard Med Sch, Boston Childrens Hosp, Dept Ophthalmol, Boston, MA 02115 USA; [Tsubota, Kazuo] Tsubota Lab Inc, Tokyo, Japan	Keio University; Keio University; Nihon University; Harvard University; Boston Children's Hospital; Harvard Medical School	Kurihara, T (corresponding author), Keio Univ, Lab Photobiol, Sch Med, Tokyo 1608582, Japan.	kurihara@z8.keio.jp		Kurihara, Toshihide/0000-0002-5457-2720; Lee, Deokho/0000-0002-5992-9039	JST SPRING [JPMJSP2123]; KAKENHI [15K10881, 18K09424, 20K18393]	JST SPRING; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	JST SPRING, Grant/Award Number: JPMJSP2123; KAKENHI, Grant/Award Number: 15K10881, 18K09424 and 20K18393	Abcouwer SF, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02237-5; Abcouwer SF, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-149; Abcouwer SF, 2010, INVEST OPHTH VIS SCI, V51, P5920, DOI 10.1167/iovs.10-5264; Ahmed A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14450-5; Akopian A, 2014, J NEUROSCI, V34, P10582, DOI 10.1523/JNEUROSCI.1912-14.2014; Andreeva K, 2014, OPHTHALMOL EYE DIS, V6, P43, DOI 10.4137/OED.S17671; Araki E, 2018, DIABETES CARE, V41, P538, DOI 10.2337/dc17-1589; Araki M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072148; Ascaso FJ, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/432685; Bando Hidenori, 2021, JMA J, V4, P135, DOI 10.31662/jmaj.2020-0104; Barber AJ, 2011, INVEST OPHTH VIS SCI, V52, P1156, DOI 10.1167/iovs.10-6293; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Belhocine S, 2022, GLIA, V70, P572, DOI 10.1002/glia.24124; BossyWetzel E, 1997, EMBO J, V16, P1695, DOI 10.1093/emboj/16.7.1695; Cao X, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/3487607; Chang Yo-Chen, 2013, Rev Diabet Stud, V10, P121, DOI 10.1900/RDS.2013.10.121; Chen M, 2010, INVEST OPHTH VIS SCI, V51, P5888, DOI 10.1167/iovs.09-5103; Cheng ZQ, 2021, PPAR RES, V2021, DOI 10.1155/2021/6632137; Chidlow G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114838; Chin CH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S4-S11; Chopra Rupali, 2012, Indian J Endocrinol Metab, V16 Suppl 1, pS6, DOI 10.4103/2230-8210.94244; Dohmen K, 2021, KOR J GASTROENTEROL, V78, P227, DOI 10.4166/kjg.2021.092; Dordoe C, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.671131; Ergorul C, 2010, J MOL NEUROSCI, V42, P183, DOI 10.1007/s12031-010-9343-z; Ezra-Elia R, 2017, CURR EYE RES, V42, P452, DOI 10.1080/02713683.2016.1193615; Fu ZJ, 2018, DIABETES, V67, P974, DOI 10.2337/db17-0830; Fu ZJ, 2017, CELL REP, V18, P1606, DOI 10.1016/j.celrep.2017.01.014; Fujita N, 2021, MOL BIOL REP, V48, P195, DOI 10.1007/s11033-020-06032-y; Goebel U, 2021, NEURAL REGEN RES, V16, P192, DOI 10.4103/1673-5374.290098; Grotegut P, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-02012-y; Hartsock MJ, 2016, JOVE-J VIS EXP, DOI 10.3791/54065; He MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084800; Horikawa T, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05431; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang RJ, 2018, MOL VIS, V24, P367; Ida S, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0845-x; Itoh N, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00107; Ji KB, 2021, EXP EYE RES, V209, DOI 10.1016/j.exer.2021.108683; Jiang Y, 2020, SEMIN OPHTHALMOL, V35, P280, DOI 10.1080/08820538.2020.1818796; Jiang YH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030824; Kawanishi H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235362; Kim BJ, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0093-4; Kim SJ, 2016, CURR EYE RES, V41, P844, DOI 10.3109/02713683.2015.1050736; Komiya I, 2021, LIPIDS HEALTH DIS, V20, DOI 10.1186/s12944-021-01434-8; Krueger-Naug AMR, 2002, NEUROSCIENCE, V110, P653, DOI 10.1016/S0306-4522(01)00453-5; Kunimi H, 2021, FASEB J, V35, DOI 10.1096/fj.202100572R; Kunimi H, 2019, PEERJ, V7, DOI 10.7717/peerj.7849; Kunimi H, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133171; Kurokawa T, 1999, INVEST OPHTH VIS SCI, V40, P3006; Lee DA, 2005, AM J HEALTH-SYST PH, V62, P691, DOI 10.1093/ajhp/62.7.691; Lee DK, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/7727648; Lee DK, 2021, LIFE-BASEL, V11, DOI 10.3390/life11111168; Lee D, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22179408; Lee D, 2021, PEERJ, V9, DOI 10.7717/peerj.11665; Lee D, 2022, KEIJO J MED, V71, P1, DOI [10.2302/kjm.2021-0004-IR, 10.2302/kjm.2021-0004-IR)]; Lee D, 2021, PHARMACEUTICALS-BASE, V14, DOI 10.3390/ph14030223; Lee D, 2020, JOVE-J VIS EXP, DOI 10.3791/61865; Lee D, 2020, EXP EYE RES, V201, DOI 10.1016/j.exer.2020.108275; Levkovitch-Verbin H, 2006, ARCH OPHTHALMOL-CHIC, V124, P520, DOI 10.1001/archopht.124.4.520; Li J, 2016, CELL PHYSIOL BIOCHEM, V39, P1196, DOI 10.1159/000447826; Li Y, 2003, INVEST OPHTH VIS SCI, V44, P1299, DOI 10.1167/iovs.02-0235; Lima-Fontes Mario, 2020, Porto Biomed J, V5, pe104, DOI 10.1097/j.pbj.0000000000000104; Lin W, 2021, DIABET METAB SYND OB, V14, P3281, DOI 10.2147/DMSO.S317096; Liu L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204346; Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Manaenko A, 2011, J NEUROSCI METH, V195, P206, DOI 10.1016/j.jneumeth.2010.12.013; Minhas G, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00444; Miyamoto K, 2000, AM J PATHOL, V156, P1733, DOI 10.1016/S0002-9440(10)65044-4; Muthusamy A, 2014, J CEREBR BLOOD F MET, V34, P522, DOI 10.1038/jcbfm.2013.230; Nakajima A, 2021, ALIMENT PHARM THER, V54, P1263, DOI 10.1111/apt.16596; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Oshitari T, 2014, BRAIN RES BULL, V101, P18, DOI 10.1016/j.brainresbull.2013.12.002; Park JW, 2007, NEUROSCI LETT, V413, P260, DOI 10.1016/j.neulet.2006.11.052; Park JW, 2020, CURR EYE RES, V45, P955, DOI 10.1080/02713683.2019.1705493; Park Sang-Woo, 2012, Chonnam Med J, V48, P116, DOI 10.4068/cmj.2012.48.2.116; Pertl L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08295-1; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Ramirez AI, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00214; Rangasamy S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108508; Rashid K, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01975; Renner M, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00254; Ritzel RM, 2016, MOL VIS, V22, P575; Sasaki Y, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225682; Saunders NR, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3339/fnins.2015.00385, 10.3389/fnins.2015.00385]; SellesNavarro I, 1996, INVEST OPHTH VIS SCI, V37, P2002; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shimazawa M, 2005, BRAIN RES, V1053, P185, DOI 10.1016/j.brainres.2005.06.053; Shinojima A, 2021, J CLIN MED, V10, DOI 10.3390/jcm10235496; Shiono A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67579-1; Smith RO, 2020, ELIFE, V9, DOI 10.7554/eLife.54056; Storgaard L, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.733080; Sun MH, 2010, INVEST OPHTH VIS SCI, V51, P4798, DOI 10.1167/iovs.09-4086; Sung MS, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205159; Szklarczyk D, 2021, NUCLEIC ACIDS RES, V49, pD605, DOI 10.1093/nar/gkaa1074; Tezel G, 2000, ARCH OPHTHALMOL-CHIC, V118, P511, DOI 10.1001/archopht.118.4.511; Tezel G, 2000, J NEUROSCI, V20, P3552, DOI 10.1523/JNEUROSCI.20-10-03552.2000; Tomita Y, 2021, J CLIN MED, V10, DOI 10.3390/jcm10204666; Tomita Y, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8100433; Tomita Y, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176243; Tomita Y, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20235878; Tsukamoto Y, 2019, J VET MED SCI, V81, P937, DOI 10.1292/jvms.18-0712; Vidal-Sanz M, 2001, SURV OPHTHALMOL, V45, pS261, DOI 10.1016/S0039-6257(01)00205-3; Wang DX, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01921-2; Wang YY, 2014, DRUG DES DEV THER, V8, P2075, DOI 10.2147/DDDT.S68872; Wei YH, 2011, FREE RADICAL BIO MED, V51, P216, DOI 10.1016/j.freeradbiomed.2011.04.026; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Xiong WJ, 2015, J CLIN INVEST, V125, P1433, DOI 10.1172/JCI79735; Yamashita S, 2020, CURR ATHEROSCLER REP, V22, DOI 10.1007/s11883-020-0823-5; Yao F., 2021, ORIGINAL RES, V8, DOI [10.3389/fmed.2021.788663, DOI 10.3389/FMED.2021.788663]; Ye LX, 2019, EXP NEUROL, V317, P34, DOI 10.1016/j.expneurol.2019.02.013; Yoshida M, 2020, CARDIOVASC DIABETOL, V19, DOI 10.1186/s12933-020-01132-2; Zadeh JK, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194685; Zheng L, 2007, INVEST OPHTH VIS SCI, V48, P361, DOI 10.1167/iovs.06-0510; Zoppini G, 2012, METABOLISM, V61, P22, DOI 10.1016/j.metabol.2011.05.004	117	2	2	6	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22497	10.1096/fj.202200455RRR	http://dx.doi.org/10.1096/fj.202200455RRR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3T7JT	35969144				2022-12-26	WOS:000840446400001
J	Liu, TT; Zhu, XL; Huang, CL; Chen, J; Shu, S; Chen, GQ; Xu, Y; Hu, YM				Liu, Tingting; Zhu, Xiaolei; Huang, Chaoli; Chen, Jiang; Shu, Shu; Chen, Guiquan; Xu, Yun; Hu, Yimin			ERK inhibition reduces neuronal death and ameliorates inflammatory responses in forebrain-specific Ppp2c alpha knockout mice	FASEB JOURNAL			English	Article						ERK1; 2; neuroinflammation; neuronal apoptosis; PD98059; PP2A	SIGNAL-REGULATED KINASE; TAU HYPERPHOSPHORYLATION; ADULT NEUROGENESIS; MOUSE MODEL; APOPTOSIS; ACTIVATION; PROTEIN; PP2A; PATHWAYS; PHOSPHORYLATION	It has been shown that PP2A is critical for apoptosis in neural progenitor cells. However, it remains unknown whether PP2A is required for neuronal survival. To address this question, we generated forebrain-specific Ppp2c alpha knockout (KO) mice. We show that Ppp2c alpha KO mice display robust neuronal apoptosis and inflammatory responses in the postnatal cortex. Previous evidence has revealed that PD98059 is a potent ERK inhibitor and may protect the brain against cell death after cardiac arrest. To study whether PD98059 may have any effects on Ppp2c alpha KO mice, the latter was treated with this inhibitor. We demonstrated that the total number of cleaved caspase3 positive (+) cells in the cortex was significantly reduced in Ppp2c alpha KO mice treated with PD98059 compared with those without PD98059 treatment. We observed that the total number of IBA1+ cells in the cortex was significantly decreased in Ppp2c alpha KO mice treated with PD98059. Mechanistic analysis reveals that deletion of PP2Aca causes DNA damage, which may be attenuated by PD98059. Together, this study suggests that inhibition of ERK may be an effective strategy to reduce cell death in brain diseases with abnormal neuronal apoptosis.	[Liu, Tingting; Zhu, Xiaolei; Chen, Jiang; Shu, Shu; Xu, Yun] Nanjing Univ, Med Sch, Drum Tower Hosp, Dept Neurol, Nanjing 210008, Peoples R China; [Liu, Tingting; Zhu, Xiaolei; Chen, Jiang; Shu, Shu; Xu, Yun] Nanjing Univ, Inst Brain Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Peoples R China; [Huang, Chaoli; Chen, Guiquan] Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, MOE Key Lab Model Anim Dis Study, Nanjing, Peoples R China; [Hu, Yimin] Nanjing Med Univ, Dept Anesthesiol, Affiliated Changzhou 2 Peoples Hosp, Changzhuu 213003, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing Medical University	Xu, Y (corresponding author), Nanjing Univ, Med Sch, Drum Tower Hosp, Dept Neurol, Nanjing 210008, Peoples R China.; Xu, Y (corresponding author), Nanjing Univ, Inst Brain Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Peoples R China.; Hu, YM (corresponding author), Nanjing Med Univ, Dept Anesthesiol, Affiliated Changzhou 2 Peoples Hosp, Changzhuu 213003, Peoples R China.	xuyun20042001@aliyun.com; guyueym@njmu.edu.cn		Zhu, Xiaolei/0000-0003-4696-9696	Changzhou Municipal Key Research Program [CJ20210112]; China Postdoctoral Science Foundation [2021M691547]; Jiangsu Postdoctoral Research Funding Program [2021K155B]; National Natural Science Foundation of China (NSFC) [82101388]; Natural Science Foundation of Jiangsu Province (Jiangsu Natural Science Foundation) [BK20201255]	Changzhou Municipal Key Research Program; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jiangsu Postdoctoral Research Funding Program; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province (Jiangsu Natural Science Foundation)(Natural Science Foundation of Jiangsu Province)	Changzhou Municipal Key Research Program, Grant/Award Number: CJ20210112; China Postdoctoral Science Foundation, Grant/Award Number: 2021M691547; Jiangsu Postdoctoral Research Funding Program, Grant/Award Number: 2021K155B; National Natural Science Foundation of China (NSFC), Grant/Award Number: 82101388; Natural Science Foundation of Jiangsu Province (Jiangsu Natural Science Foundation), Grant/Award Number: BK20201255	Bi HR, 2021, CNS NEUROSCI THER, V27, P174, DOI 10.1111/cns.13454; Bodai L, 2012, BIOESSAYS, V34, P142, DOI 10.1002/bies.201100116; Boudreau RM, 2007, CELL SIGNAL, V19, P139, DOI 10.1016/j.cellsig.2006.05.030; Broad KD, 2009, DEV NEUROBIOL, V69, P314, DOI 10.1002/dneu.20702; Chen LX, 2021, HEPATOLOGY, V73, P2411, DOI 10.1002/hep.31545; Chen L, 2008, J NEUROCHEM, V105, P251, DOI 10.1111/j.1471-4159.2007.05133.x; Chen WF, 2017, PHYTOMEDICINE, V25, P93, DOI 10.1016/j.phymed.2016.12.017; Cheng SS, 2019, J NEUROSCI, V39, P2195, DOI 10.1523/JNEUROSCI.2523-18.2019; Cheng SS, 2015, SCI REP-UK, V5, DOI 10.1038/srep10535; Cheng SS, 2014, INT J BIOCHEM CELL B, V57, P186, DOI 10.1016/j.biocel.2014.10.029; Chi H, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103082; Ehling M, 2020, CIRC RES, V127, P707, DOI 10.1161/CIRCRESAHA.119.316071; Fujita Y, 2014, APOPTOSIS, V19, P339, DOI 10.1007/s10495-013-0917-4; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Gokce O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005292; Gorski JA, 2002, J NEUROSCI, V22, P6309; Gu PY, 2012, GENESIS, V50, P429, DOI 10.1002/dvg.20815; Hebert SS, 2010, HUM MOL GENET, V19, P3959, DOI 10.1093/hmg/ddq311; Hou JX, 2016, CNS NEUROSCI THER, V22, P244, DOI 10.1111/cns.12509; Hou JX, 2022, FASEB J, V36, DOI 10.1096/fj.202200463R; Hou JX, 2021, J NEUROSCI, V41, P4976, DOI 10.1523/JNEUROSCI.2455-19.2021; Huang CL, 2020, CEREB CORTEX, V30, P4183, DOI 10.1093/cercor/bhaa042; Javadpour P, 2019, CELL MOL LIFE SCI, V76, P2277, DOI 10.1007/s00018-019-03063-y; Kanterewicz BI, 2000, J NEUROSCI, V20, P3057, DOI 10.1523/JNEUROSCI.20-09-03057.2000; Kins S, 2003, AM J PATHOL, V163, P833, DOI 10.1016/S0002-9440(10)63444-X; Lee HR, 2019, PHARMACOL RES, V149, DOI 10.1016/j.phrs.2019.104466; Lee YJ, 2014, CHEMOSPHERE, V94, P121, DOI 10.1016/j.chemosphere.2013.09.059; Liu B, 2018, INT J BIOCHEM CELL B, V95, P53, DOI 10.1016/j.biocel.2017.12.015; Liu D., 2022, ADV NEUROL, V1; Liu TT, 2017, CNS NEUROSCI THER, V23, P885, DOI 10.1111/cns.12763; Maino B, 2017, EXPERT OPIN DRUG DIS, V12, P249, DOI 10.1080/17460441.2017.1280023; Martin L, 2011, NEUROCHEM INT, V59, P235, DOI 10.1016/j.neuint.2011.05.010; Nagata S, 2018, ANNU REV IMMUNOL, V36, P489, DOI 10.1146/annurev-immunol-042617-053010; Okouchi M, 2007, ANTIOXID REDOX SIGN, V9, P1059, DOI 10.1089/ars.2007.1511; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Russo C, 2002, J BIOL CHEM, V277, P35282, DOI 10.1074/jbc.M110785200; Salguero I, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12929-5; Schafe GE, 2000, J NEUROSCI, V20, P8177; Seshacharyulu P, 2013, CANCER LETT, V335, P9, DOI 10.1016/j.canlet.2013.02.036; Shen YN, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-02013-x; Subramaniam S, 2010, FEBS J, V277, P22, DOI 10.1111/j.1742-4658.2009.07367.x; Sun J, 2017, INT J MOL MED, V39, P1338, DOI 10.3892/ijmm.2017.2962; Tabuchi K, 2009, J NEUROSCI, V29, P7290, DOI 10.1523/JNEUROSCI.1320-09.2009; Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200; Teng XY, 2022, FASEB J, V36, DOI 10.1096/fj.202101652R; Thiels E, 2002, J NEUROSCI, V22, P2054, DOI 10.1523/JNEUROSCI.22-06-02054.2002; Wang H, 2021, J NEUROSCI, V41, P8163, DOI 10.1523/JNEUROSCI.2432-20.2021; Wang H, 2021, NEUROBIOL DIS, V148, DOI 10.1016/j.nbd.2020.105212; Wang H, 2017, CNS NEUROSCI THER, V23, P99, DOI 10.1111/cns.12647; Wang QH, 2021, EXP NEUROL, V343, DOI 10.1016/j.expneurol.2021.113788; Wong FK, 2019, ANNU REV CELL DEV BI, V35, P523, DOI 10.1146/annurev-cellbio-100818-125204; Xia Y., 2022, DEVELOPMENT, V149; Xu CY, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00330; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Zeng QY, 2015, CELL MOL LIFE SCI, V72, P4867, DOI 10.1007/s00018-015-1976-1; Zheng JH, 2020, DRUG DES DEV THER, V14, P1107, DOI 10.2147/DDDT.S231980; Zhu LQ, 2010, J NEUROSCI, V30, P3839, DOI 10.1523/JNEUROSCI.5174-09.2010	58	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22515	10.1096/fj.202200293R	http://dx.doi.org/10.1096/fj.202200293R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3X5DG	35997299				2022-12-26	WOS:000843060700001
J	Cortes, JD				Cortes, Julian D.			What is the mission of innovation? Lexical structure, sentiment analysis, and cosine similarity of mission statements of research-knowledge intensive institutions	PLOS ONE			English	Article							PERFORMANCE; HOSPITALS; BUSINESS; MATTER	Mission statements (henceforth: missions) are strategic planning communication tools used by all types of organizations worldwide. Missions communicate an organization's purpose, values, standards, and strategy. Research on missions has been prolific over the past 30 years, nevertheless several empirical gaps remain, such as single sector or country studies and restricted mission samples. In this article, we identify similarities and differences in the content of missions from government, private, higher education, and health research-knowledge intensive institutions in a sample of 1,900+ institutions from 89 countries through the deployment of sentiment analysis, readability, and lexical diversity; semantic networks; and a similarity computation between document corpus. We found that missions of research-knowledge intensive institutions are challenging to read texts with lower lexical diversity that favors positive rather than negative words. In stark contrast to this, the non-profit sector is consonant in multiple dimensions in its use of Corporate Social Responsibility jargon. The lexical appearance of 'research' in the missions varies according to mission sectorial context, and each sector has a cluster-specific focus. Utilizing the mission as a strategic planning tool in higher-income regions might serve to explain corpora similarities shared by sectors and continents. Furthermore, our open-access dataset on missions worldwide can be used as a source for further replication, triangulation, or crowdsourcing-data studies. Also, practitioners could use our open-access dataset and insights to facilitate strategic planning activities in organizations from multiple sectors.	[Cortes, Julian D.] Univ Rosario, Sch Management & Business, Bogota, Colombia; [Cortes, Julian D.] Fudan Univ, Fudan Dev Inst, Shanghai, Peoples R China; [Cortes, Julian D.] Woxsen Univ, Sch Business, Hyderabad, Telangana, India	Universidad del Rosario; Fudan University	Cortes, JD (corresponding author), Univ Rosario, Sch Management & Business, Bogota, Colombia.; Cortes, JD (corresponding author), Fudan Univ, Fudan Dev Inst, Shanghai, Peoples R China.; Cortes, JD (corresponding author), Woxsen Univ, Sch Business, Hyderabad, Telangana, India.	julian.cortess@urosario.edu.co	Cortés, Julián D./B-7716-2016	Cortés, Julián D./0000-0002-1246-2160	JDC Research grant IMA Research Foundation	JDC Research grant IMA Research Foundation	JDC Research grant IMA Research Foundation https://www.imanet.org/educators/research-foundation?ssopc=1 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Amit S., 2001, IEEE DATA ENG B, V24, P35; [Anonymous], 2020, QUANTITATIVE ANAL TE; Balasubramanian S, 2020, STRATEG ENTREP J, V14, P661, DOI 10.1002/sej.1341; Baregheh A, 2009, MANAGE DECIS, V47, P1323, DOI 10.1108/00251740910984578; Bart Christopher K, 2004, J Health Organ Manag, V18, P92; Bart CK, 1999, HEALTH CARE MANAGE R, V24, P18, DOI 10.1097/00004010-199907000-00003; Bart CK, 1997, IND MARKET MANAG, V26, P371, DOI 10.1016/S0019-8501(96)00146-0; Bart CK, 1998, J MANAGE STUD, V35, P823, DOI 10.1111/1467-6486.00121; Bart CK, 2001, INTERNET RES, V11, P360, DOI 10.1108/10662240110402812; Bart CK, 2000, HEALTH CARE MANAGE R, V25, P45, DOI 10.1097/00004010-200004000-00005; Bartkus B., 2006, European Management Journal, V24, P86, DOI 10.1016/j.emj.2005.12.010; Bastian M., 2009, GEPHI OPEN SOURCE SO; Berbegal-Mirabent J, 2021, REV MANAG SCI, V15, P705, DOI 10.1007/s11846-019-00355-2; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Campbell A., 1989, LEADERSHIP ORG DEV J, V10, P3, DOI [10.1108/EUM0000000001134, DOI 10.1108/EUM0000000001134]; Campbell KM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247154; Chawla DS., 2016, NATURE, V531, P11, DOI [10.1038/531011f, DOI 10.1038/531011F]; Chen S, 2009, J BUS ETHICS, V87, P299, DOI 10.1007/s10551-008-9794-0; Cortes JD, 2021, ESTIMATING RELATIONS; Cortes JD, 2021, J INF SCI, DOI 10.1177/01655515211043707; Cortes-Sanchez J.D., 2019, BUS THEORY PRACT, V20, P270, DOI [10.3846/btp.2019.26, DOI 10.3846/BTP.2019.26]; Cortes-Sanchez JD, 2022, JOURNAL PRACT, V16, P218, DOI 10.1080/17512786.2020.1796762; CortUs JD., 2021, MANAGEMENT REV Q, DOI [10.1007/s11301-021-00240-x, DOI 10.1007/S11301-021-00240-X]; Dai X, 2021, REV ACCOUNT STUD, DOI 10.1007/s11142-021-09643-3; Cortes-Sanchez JD, 2018, INTANG CAP, V14, P584, DOI 10.3926/ic.1258; Desmidt S, 2011, MANAGE DECIS, V49, P468, DOI 10.1108/00251741111120806; Doerfel ML, 1999, HUM COMMUN RES, V25, P589, DOI 10.1111/j.1468-2958.1999.tb00463.x; Fitzgerald C, 2016, J TECHNOL TRANSFER, V41, P1235, DOI 10.1007/s10961-015-9419-6; Gharleghi E., 2011, RES J BUS MANAG, V5, P117, DOI [10.3923/rjbm.2011.117.124, DOI 10.3923/RJBM.2011.117.124]; Godoy-Bejarano JMM., 2017, LAT AM BUS REV, V18, P211, DOI [10.1080/10978526.2017.1400389, DOI 10.1080/10978526.2017.1400389]; Intarakumnerd P, 2018, RES POLICY, V47, P1309, DOI 10.1016/j.respol.2018.04.011; Jones MH., 1960, ACAD MANAGE J, V3, P93, DOI [10.5465/254565, DOI 10.5465/254565]; Cortés-Sánchez JD, 2021, Arxiv, DOI arXiv:2104.07476; Kim EK, 2015, J KOREAN ACAD NURS, V45, P565, DOI 10.4040/jkan.2015.45.4.565; Kincaid J., 1975, I SIMUL TRAIN; Lehavy R, 2011, ACCOUNT REV, V86, P1087, DOI 10.2308/accr.00000043; LEVITT T, 1960, HARVARD BUS REV, V38, P45; Macedo IM, 2016, EUR MANAG J, V34, P36, DOI 10.1016/j.emj.2015.10.003; Munafo MR, 2018, NATURE, V553, P399, DOI 10.1038/d41586-018-01023-3; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Palmer TB, 2008, ACAD MANAG LEARN EDU, V7, P454, DOI 10.5465/AMLE.2008.35882187; Pandey S, 2017, NONPROFIT MANAG LEAD, V27, P389, DOI 10.1002/nml.21257; Pearce J. A., 1987, ACADEMY MANAGEMENT E, V1, P109, DOI [10.5465/AME.1987.4275821, DOI 10.5465/AME.1987.4275821]; Peirce C.S., 1906, MONIST, V16, P492, DOI [10.5840/monist190616436, DOI 10.5840/MONIST190616436]; Pencle N, 2016, J EMERG TECHNOL ACCO, V13, P109, DOI 10.2308/jeta-51615; Pfeffer J, 2006, HARD FACTS DANGEROUS; Plaven-Sigray P, 2017, ELIFE, V6, DOI 10.7554/eLife.27725; R Core Team, 2021, R LANG ENV STAT; Reilly J., 2020, H POTTER LEXICAL DIV; Sattari S, 2011, CORP COMMUN, V16, P282, DOI 10.1108/13563281111186931; Scimago, 2020, SCIM I RANK; Scopus, 2020, SCOPUS DOCUMENT SEAR; Shugars S, 2021, NAT PHYS, V17, P540, DOI 10.1038/s41567-021-01222-2; Spencer JW, 2005, ACAD MANAGE REV, V30, P321, DOI [10.2307/20159122, 10.5465/AMR.2005.16387889]; Subramanian R., 1993, J BUS COMMUN, V30, P49, DOI [DOI 10.1177/002194369303000103, 10.1177/002194369303000103]; The Economist,, 2021, ECONOMIST 1023; The igraph core team, 2019, IGRAPH NETWORK ANAL; Tweedie FJ, 1998, COMPUT HUMANITIES, V32, P323, DOI 10.1023/A:1001749303137; Udnv Yule G., 1944, STAT STUDY LIT VOCAB; Williams L.S., 2008, J BUS COMMUN, V45, P94, DOI [DOI 10.1177/0021943607313989, 10.1177/0021943607313989]; Young L, 2012, POLIT COMMUN, V29, P205, DOI 10.1080/10584609.2012.671234; Zhang H, 2015, ASIAN J TECHNOL INNO, V23, P157, DOI 10.1080/19761597.2015.1074495	64	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0267454	10.1371/journal.pone.0267454	http://dx.doi.org/10.1371/journal.pone.0267454			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976951	Green Published, gold			2022-12-26	WOS:000847227000004
J	Aryal, P; Devkota, SR; Jeevarajah, D; Law, R; Payne, RJ; Bhusal, RP; Stone, MJ				Aryal, Pramod; Devkota, Shankar Raj; Jeevarajah, Devadharshini; Law, Ruby; Payne, Richard J.; Bhusal, Ram Prasad; Stone, Martin J.			Swapping N-terminal regions among tick evasins reveals cooperative interactions influencing chemokine binding and selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINS	Class A tick evasins are natural chemokine-binding proteins that block the signaling of multiple chemokines from the CC subfamily through their cognate receptors, thus suppressing leukocyte recruitment and inflammation. Development of tick evasins as chemokine-targeted anti-inflammatory therapeutics requires an understanding of the factors controlling their chemokine recognition and selectivity. To investigate the role of the evasin N-terminal region for chemokine recognition, we prepared chimeric evasins by interchanging the N-terminal regions of four class A evasins, including a newly identified evasin, EVA-RPU02. We show through chemokine binding analysis of the parental and chimeric evasins that the N -ter-minal region is critical for chemokine binding affinity and selectivity. Notably, we found some chimeras were unable to bind certain cognate chemokine ligands of both parental eva-sins. Moreover, unlike any natural evasins characterized to date, some chimeras exhibited specific binding to a single chemokine. These results indicate that the evasin N terminus interacts cooperatively with the "body " of the evasin to enable optimum chemokine recognition. Furthermore, the altered chemokine selectivity of the chimeras validates the approach of engineering the N termini of evasins to yield unique chemokine recognition profiles.	[Aryal, Pramod; Devkota, Shankar Raj; Jeevarajah, Devadharshini; Law, Ruby; Bhusal, Ram Prasad; Stone, Martin J.] Monash Univ, Monash Biomed Discovery Inst, Clayton, Vic, Australia; [Aryal, Pramod; Devkota, Shankar Raj; Jeevarajah, Devadharshini; Law, Ruby; Bhusal, Ram Prasad; Stone, Martin J.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Payne, Richard J.] Univ Sydney, Sch Chem, Sydney, NSW, Australia; [Payne, Richard J.] Univ Sydney, Australian Res Council Ctr Excellence Innovat Pept, Sydney, NSW, Australia	Monash University; Monash University; University of Sydney; University of Sydney	Bhusal, RP; Stone, MJ (corresponding author), Monash Univ, Monash Biomed Discovery Inst, Clayton, Vic, Australia.; Bhusal, RP; Stone, MJ (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	ram.bhusal@monash.edu; martin.stone@monash.edu		Devkota, Shankar Raj/0000-0002-3154-7928	National Health and Medical Research Council Project [APP1140867, APP1140874, APP1174941]; Bridging Post-doctoral Fellowship from Monash University; Faculty Platform Access Grant from Monash University	National Health and Medical Research Council Project(National Health and Medical Research Council (NHMRC) of Australia); Bridging Post-doctoral Fellowship from Monash University; Faculty Platform Access Grant from Monash University	This research was supported by National Health and Medical Research Council Project Grants APP1140867 (M. J. S. and R. J. P.) and APP1140874 (M. J. S.) and Investigator Grant APP1174941 (R. J. P.) by a Bridging Post-doctoral Fellowship from Monash University (R. P. B.) and by a Faculty Platform Access Grant from Monash University (R. P. B. and M. J. S.) .	Akinyi MY, 2013, ANIM BEHAV, V85, P559, DOI 10.1016/j.anbehav.2012.12.012; Alenazi Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24568-9; Bhattacharya S, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.769542; Bhusal RP, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2122105119; Bhusal RP, 2020, TRENDS BIOCHEM SCI, V45, P108, DOI 10.1016/j.tibs.2019.10.003; Bonvin P, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00208; Bonvin P, 2014, J BIOL CHEM, V289, P31846, DOI 10.1074/jbc.M114.599233; Braunersreuther V, 2013, THROMB HAEMOSTASIS, V110, P807, DOI 10.1160/TH13-04-0297; Denisov SS, 2020, J BIOL CHEM, V295, P14367, DOI 10.1074/jbc.RA120.013891; Deruaz M, 2008, J EXP MED, V205, P2019, DOI 10.1084/jem.20072689; Deruaz M, 2013, FEBS J, V280, P4876, DOI 10.1111/febs.12463; Dias JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008514; Eaton JRO, 2018, J BIOL CHEM, V293, P6134, DOI 10.1074/jbc.RA117.000487; Franck C, 2020, P NATL ACAD SCI USA, V117, P12657, DOI 10.1073/pnas.2000605117; Frauenschuh A, 2007, J BIOL CHEM, V282, P27250, DOI 10.1074/jbc.M704706200; Gonzalez-Motos V, 2016, CYTOKINE GROWTH F R, V30, P71, DOI 10.1016/j.cytogfr.2016.02.007; Hayward J, 2017, J BIOL CHEM, V292, P15670, DOI 10.1074/jbc.M117.807255; Jiang LI, 2007, J BIOL CHEM, V282, P10576, DOI 10.1074/jbc.M609695200; Keane MP, 2000, CRIT CARE MED, V28, pN13, DOI 10.1097/00003246-200004001-00003; Kotal J, 2015, J PROTEOMICS, V128, P58, DOI 10.1016/j.jprot.2015.07.005; Kufareva I, 2015, IMMUNOL CELL BIOL, V93, P372, DOI 10.1038/icb.2015.15; Lee AW, 2019, J BIOL CHEM, V294, P11199, DOI 10.1074/jbc.RA119.008817; Lim HD, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22084232; Montecucco F, 2014, EUR J CLIN INVEST, V44, P940, DOI 10.1111/eci.12327; Russo RC, 2011, AM J RESP CELL MOL, V45, P72, DOI 10.1165/rcmb.2009-0406OC; Shah NB, 2014, JOVE-J VIS EXP, DOI 10.3791/51383; Singh K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04378-1; Vieira AT, 2009, AM J PATHOL, V175, P2382, DOI 10.2353/ajpath.2009.090093; Wanzala W, 2006, J MED ENTOMOL, V43, P789, DOI 10.1603/0022-2585(2006)43[789:TAIAWW]2.0.CO;2; Wanzala W, 2013, J RES MED SCI, V18, P918; Zhang H, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24438-5; Zhao SW, 2019, STRUCTURE, V27, P405, DOI 10.1016/j.str.2019.02.004	32	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	10							102382	10.1016/j.jbc.2022.102382	http://dx.doi.org/10.1016/j.jbc.2022.102382			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6G8HI	35973511	gold, Green Published			2022-12-26	WOS:000884990700002
J	Granel, MLS; Siburu, NG; Fricska, A; Maldonado, LL; Gargiulo, LB; Nudel, CB; Uttaro, AD; Nusblat, AD				Sanchez Granel, Maria L.; Siburu, Nicolas G.; Fricska, Annamaria; Maldonado, Lucas L.; Gargiulo, Laura B.; Nudel, Clara B.; Uttaro, Antonio D.; Nusblat, Alejandro D.			A novel Tetrahymena thermophila sterol C-22 desaturase belongs to the fatty acid hydroxylase/desaturase superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EVOLUTION; GENE; ENZYME; CHOLESTEROL; SEQUENCE; PROTEIN; IDENTIFICATION; BIOSYNTHESIS; METABOLISM; ERGOSTEROL	Sterols in eukaryotic cells play important roles in modu-lating membrane fluidity and in cell signaling and trafficking. During evolution, a combination of gene losses and acquisi-tions gave rise to an extraordinary diversity of sterols in different organisms. The sterol C-22 desaturase identified in plants and fungi as a cytochrome P-450 monooxygenase evolved from the first eukaryotic cytochrome P450 and was lost in many lineages. Although the ciliate Tetrahymena thermo-phila desaturates sterols at the C-22 position, no cytochrome P-450 orthologs are present in the genome. Here, we aim to identify the genes responsible for the desaturation as well as their probable origin. We used gene knockout and yeast het-erologous expression approaches to identify two putative genes, retrieved from a previous transcriptomic analysis, as sterol C-22 desaturases. Furthermore, we demonstrate using bioinformatics and evolutionary analyses that both genes encode a novel type of sterol C-22 desaturase that belongs to the large fatty acid hydroxylase/desaturase superfamily and the genes originated by genetic duplication prior to functional diversification. These results stress the widespread existence of nonhomologous isofunctional enzymes among different line-ages of the tree of life as well as the suitability for the use of T. thermophila as a valuable model to investigate the evolu-tionary process of large enzyme families.	[Sanchez Granel, Maria L.; Fricska, Annamaria; Gargiulo, Laura B.; Nudel, Clara B.; Nusblat, Alejandro D.] Univ Buenos Aires, Fac Farm & Bioquim, Inst Nanobiotecnol NANOBIOTEC, CONICET, Buenos Aires, Argentina; [Siburu, Nicolas G.; Uttaro, Antonio D.] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Inst Biol Mol & Celular Rosario, CONICET, Rosario, Argentina; [Maldonado, Lucas L.] Univ Buenos Aires, Fac Med, Inst Invest Microbiol & Parasitol Med IMPaM, CONICET, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Nusblat, AD (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Inst Nanobiotecnol NANOBIOTEC, CONICET, Buenos Aires, Argentina.; Uttaro, AD (corresponding author), Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Inst Biol Mol & Celular Rosario, CONICET, Rosario, Argentina.	uttaro@ibr-conicet.gov.ar; anusblat@ffyb.uba.ar			Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 11220120100213]; Ministerio de Ciencia, Tecnologia e Innovacion Productiva [PICT 2013-0701, ANPCYT-PICT 2014-1311]; Universidad de Buenos Aires [UBACYT 20020130100680BA]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Ministerio de Ciencia, Tecnologia e Innovacion Productiva; Universidad de Buenos Aires(University of Buenos Aires)	This work was supported by the Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 11220120100213); Ministerio de Ciencia, Tecnologia e Innovacion Productiva (PICT 2013-0701, ANPCYT-PICT 2014-1311); and Universidad de Buenos Aires (UBACYT 20020130100680BA).	Altenhoff AM, 2018, NUCLEIC ACIDS RES, V46, pD477, DOI 10.1093/nar/gkx1019; ARTHINGTON BA, 1991, GENE, V102, P39, DOI 10.1016/0378-1119(91)90535-J; Bai YH, 2015, NATURE, V524, P252, DOI 10.1038/nature14549; Becq J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009989; Bernsdorff C, 2003, J PHYS CHEM B, V107, P10658, DOI 10.1021/jp034922a; Bielawski Joseph P., 2003, Journal of Structural and Functional Genomics, V3, P201, DOI 10.1023/A:1022642807731; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Broun P, 1998, SCIENCE, V282, P1315, DOI 10.1126/science.282.5392.1315; Bucek A, 2015, P NATL ACAD SCI USA, V112, P12586, DOI 10.1073/pnas.1514566112; CassidyHanley D, 1997, GENETICS, V146, P135; Chen WP, 2014, GENOME BIOL EVOL, V6, P1620, DOI 10.1093/gbe/evu132; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Cid NG, 2017, MOL PHYLOGENET EVOL, V114, P1, DOI 10.1016/j.ympev.2017.05.023; CONNER RL, 1968, J PROTOZOOL, V15, P600, DOI 10.1111/j.1550-7408.1968.tb02178.x; CONNER RL, 1969, J BIOL CHEM, V244, P2325; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Csaba G, 2016, BIOCOMMUNICATION CIL, P121; Dahmen JL, 2013, EUKARYOT CELL, V12, P923, DOI 10.1128/EC.00332-12; Desmond E, 2009, GENOME BIOL EVOL, V1, P364, DOI 10.1093/gbe/evp036; Dyer JM, 2002, PLANT PHYSIOL, V130, P2027, DOI 10.1104/pp.102.010835; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; FERGUSON KA, 1975, J BIOL CHEM, V250, P6998; Fu CJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-208; Galperin MY, 2012, J BIOL CHEM, V287, P21, DOI 10.1074/jbc.R111.241976; Galperin MY, 1998, GENOME RES, V8, P779, DOI 10.1101/gr.8.8.779; Gao F, 2016, SCI REP-UK, V6, DOI 10.1038/srep24874; Gherardini PF, 2007, J MOL BIOL, V372, P817, DOI 10.1016/j.jmb.2007.06.017; GOTO M, 1982, BIOCHIM BIOPHYS ACTA, V693, P335, DOI 10.1016/0005-2736(82)90440-0; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hannich JT, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004762; Hayashi A, 2015, GENETICS, V201, P55, DOI 10.1534/genetics.115.178525; Jiang CQ, 2019, MOL PHYLOGENET EVOL, V132, P25, DOI 10.1016/j.ympev.2018.11.018; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keeling PJ, 2019, CURR BIOL, V29, pR808, DOI 10.1016/j.cub.2019.07.031; Kelly SL, 1995, FEBS LETT, V377, P217, DOI 10.1016/0014-5793(95)01342-3; Kelly SL, 1997, J BIOL CHEM, V272, P9986, DOI 10.1074/jbc.272.15.9986; Kohidai L, 2003, CELL BIOCHEM FUNCT, V21, P19, DOI 10.1002/cbf.996; Lamb DC, 1999, ANTIMICROB AGENTS CH, V43, P1725, DOI 10.1128/AAC.43.7.1725; Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li YB, 2018, CELL PHYSIOL BIOCHEM, V49, P947, DOI 10.1159/000493226; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; MALLORY FB, 1971, LIPIDS, V6, P149, DOI 10.1007/BF02533028; Mitchell AL, 2019, NUCLEIC ACIDS RES, V47, pD351, DOI 10.1093/nar/gky1100; Morikawa T, 2006, PLANT CELL, V18, P1008, DOI 10.1105/tpc.105.036012; Najle SR, 2020, J EUKARYOT MICROBIOL, V67, P209, DOI 10.1111/jeu.12774; Najle SR, 2013, MOL BIOL EVOL, V30, P1630, DOI 10.1093/molbev/mst076; NES WR, 1981, J LIPID RES, V22, P770; NES WR, 1980, J BIOL CHEM, V255, P1815; Nozaw Y, 2011, P JPN ACAD B-PHYS, V87, P450, DOI 10.2183/pjab.87.450; Nusblat AD, 2005, J EUKARYOT MICROBIOL, V52, P61, DOI 10.1111/j.1550-7408.2005.3279rr.x; Nusblat AD, 2009, EUKARYOT CELL, V8, P1287, DOI 10.1128/EC.00057-09; Omelchenko MV, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-31; PEDEN JF, 1999, THESIS U NOTTINGHAM; Petrini GA, 2004, EUR J BIOCHEM, V271, P1079, DOI 10.1111/j.1432-1033.2004.04005.x; Piergiorge RM, 2017, GENOME BIOL EVOL, V9, P1624, DOI 10.1093/gbe/evx119; Poklepovich TJ, 2012, STEROIDS, V77, P1313, DOI 10.1016/j.steroids.2012.08.015; Rahier A., 1989, ANAL STEROLS OTHER B, P223, DOI [10.1016/B978-0-12-515445-1.50016-1, DOI 10.1016/B978-0-12-515445-1.50016-1]; Ravenhall M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004095; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rooney AP, 1999, MOL BIOL EVOL, V16, P706, DOI 10.1093/oxfordjournals.molbev.a026153; Granel MLS, 2019, BBA-MOL CELL BIOL L, V1864, P1644, DOI 10.1016/j.bbalip.2019.08.003; Shanklin J, 2003, FEBS LETT, V545, P188, DOI 10.1016/S0014-5793(03)00529-5; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Skaggs BA, 1996, GENE, V169, P105, DOI 10.1016/0378-1119(95)00770-9; Sperling P, 2003, PROSTAG LEUKOTR ESS, V68, P73, DOI 10.1016/S0952-3278(02)00258-2; SUEOKA N, 1988, P NATL ACAD SCI USA, V85, P2653, DOI 10.1073/pnas.85.8.2653; Ternes P, 2002, J BIOL CHEM, V277, P25512, DOI 10.1074/jbc.M202947200; Tomazic ML, 2014, MOL PHYLOGENET EVOL, V74, P122, DOI 10.1016/j.ympev.2014.01.026; Tomazic ML, 2011, EUKARYOT CELL, V10, P423, DOI 10.1128/EC.00259-10; Valcarce G, 2000, APPL MICROBIOL BIOT, V53, P591, DOI 10.1007/s002530051661; van Beilen JB, 2006, APPL ENVIRON MICROB, V72, P59, DOI 10.1128/AEM.72.1.59-65.2006; Wilding M, 2017, MOL PHYLOGENET EVOL, V115, P50, DOI 10.1016/j.ympev.2017.07.012; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Xiong J, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000294; Yang WT, 2019, DATABASE-OXFORD, DOI 10.1093/database/baz029; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yoshiyama T, 2006, DEVELOPMENT, V133, P2565, DOI 10.1242/dev.02428; Zauner S, 2008, J BIOL CHEM, V283, P36734, DOI 10.1074/jbc.M807264200; ZANDER JM, 1970, J BIOL CHEM, V245, P1247; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708	81	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2022	298	10							102397	10.1016/j.jbc.2022.102397	http://dx.doi.org/10.1016/j.jbc.2022.102397			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6G8HI	35988640	gold, Green Published			2022-12-26	WOS:000884990700004
J	Wu, X; Zhou, XL; Lai, SQ; Liu, JC; Qi, JW				Wu, Xia; Zhou, Xueliang; Lai, Songqing; Liu, Jichun; Qi, Jianwei			Curcumin activates Nrf2/HO-1 signaling to relieve diabetic cardiomyopathy injury by reducing ROS in vitro and in vivo	FASEB JOURNAL			English	Article						curcumin; diabetic cardiomyopathy; hyperglycemia; Nrf2; HO-1 signaling; reactive oxygen species	ANTIOXIDANT; APOPTOSIS; MODEL	The hallmark feature of Diabetes mellitus (DM) is hyperglycemia which can lead to excess production of reactive oxygen species (ROS) in the myocardium, contributing to diabetic cardiomyopathy (DCM). Nuclear factor erythroid2-related factor2 (Nrf2), a transcriptional activator, enhances its ability to resist oxidative stress by activating multiple downstream anti-oxidants, anti-inflammatory proteins, and detoxifying enzymes. However, the mechanism of Nrf2 signaling in HG-induced DCM is unclear. In this study, we used HG pretreated H9c2 cells as the experimental basis in vitro, and established a high fat-diet, streptozotocin (STZ) induced Type 2 diabetic rat model in vivo. Meanwhile, we used shRNA-Nrf2 and curcumin (CUR) (as an activator) to affect H9c2 cells, to verify the role of the Nrf2 signaling pathway in DCM. The results showed that the excessive production of ROS caused by HG, which could inhibit the activation of Nrf2-related signaling, resulting in a decrease in cell energy metabolism and an increase in cell apoptosis. Surprisingly, we found that the activation of the Nrf2 signaling pathway significantly increased cardiomyocyte viability, reduced ROS formation, increased antioxidant enzyme activity, and inhibited cardiomyocyte apoptosis. In conclusion, these findings conclusively infer that CUR activation of the Nrf2/HO-1 signaling pathway exerts myocardial protection by reducing ROS formation.	[Wu, Xia] Nanjing Med Univ, Nanjing First Hosp, Dept Pharmacol, Nanjing, Peoples R China; [Zhou, Xueliang; Lai, Songqing; Liu, Jichun] Nanchang Univ, Affiliated Hosp 1, Dept Thorac & Cardiovasc Surg, 17 Yong Wai Zheng St, Nanchang 330006, Jiangxi, Peoples R China; [Qi, Jianwei] Nanjing Med Univ, Nanjing First Hosp, Dept Otolaryngol, 68 Chang Le Rd, Nanjing 210006, Jiangsu, Peoples R China	Nanjing Medical University; Nanchang University; Nanjing Medical University	Liu, JC (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Thorac & Cardiovasc Surg, 17 Yong Wai Zheng St, Nanchang 330006, Jiangxi, Peoples R China.; Qi, JW (corresponding author), Nanjing Med Univ, Nanjing First Hosp, Dept Otolaryngol, 68 Chang Le Rd, Nanjing 210006, Jiangsu, Peoples R China.	2826664060@qq.com; qjw70818@163.com			National Natural Science Foundation of China (NSFC) [81860054, 81570262]; Natural Science Foundation of Jiangxi Province (Jiangxi Province natural Science Fund) [700207006]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangxi Province (Jiangxi Province natural Science Fund)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81860054 and 81570262; Natural Science Foundation of Jiangxi Province (Jiangxi Province natural Science Fund), Grant/Award Number: 700207006	Abdelsamia EM, 2019, BIOMED PHARMACOTHER, V109, P2136, DOI 10.1016/j.biopha.2018.11.064; Adapala RK, 2020, BASIC RES CARDIOL, V115, DOI 10.1007/s00395-020-0775-5; Al-Rasheed NM, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1092015; Aleksunes LM, 2010, J PHARMACOL EXP THER, V333, P140, DOI 10.1124/jpet.109.162271; Althunibat OY, 2019, LIFE SCI, V221, P83, DOI 10.1016/j.lfs.2019.02.017; Arow M, 2020, CARDIOVASC DIABETOL, V19, DOI 10.1186/s12933-019-0980-4; Bayliss AL, 2020, ANGIOGENESIS, V23, P371, DOI 10.1007/s10456-020-09715-z; Bhakkiyalakshmi E, 2015, PHARMACOL RES, V91, P104, DOI 10.1016/j.phrs.2014.10.004; Chene G, 2014, EUR J OBSTET GYN R B, V183, P89, DOI 10.1016/j.ejogrb.2014.10.003; Corbi G, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00364; Dhalla NS, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072413; Dludla PV, 2017, MOLECULES, V22, DOI 10.3390/molecules22010129; Ge TW, 2019, AM J PHYSIOL-HEART C, V317, pH264, DOI 10.1152/ajpheart.00123.2019; Ge ZD, 2019, INT HEART J, V60, P512, DOI 10.1536/ihj.18-476; Hou G, 2018, CELL PHYSIOL BIOCHEM, V47, P257, DOI 10.1159/000489804; Huynh K, 2014, PHARMACOL THERAPEUT, V142, P375, DOI 10.1016/j.pharmthera.2014.01.003; Jiang GJ, 2017, PEERJ, V5, DOI 10.7717/peerj.3155; Kaludercic N, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00012; Knapp M, 2019, ACTA PHARMACOL SIN, V40, P1, DOI 10.1038/s41401-018-0042-6; Koeberle A, 2014, DRUG DISCOV TODAY, V19, P1871, DOI 10.1016/j.drudis.2014.08.006; Lahiri SK, 2020, BASIC RES CARDIOL, V115, DOI 10.1007/s00395-020-0807-1; Li H, 2019, CHEM-BIOL INTERACT, V310, DOI 10.1016/j.cbi.2019.108754; Li H, 2016, SCI REP-UK, V6, DOI 10.1038/srep23693; Li L, 2019, PHYTOMEDICINE, V59, DOI 10.1016/j.phymed.2018.11.034; Li R, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/3206542; Lindner M, 2020, BASIC RES CARDIOL, V115, DOI 10.1007/s00395-020-0810-6; Liu SX, 2012, INT J CARDIOL, V160, P95, DOI 10.1016/j.ijcard.2011.03.033; Lv MH, 2021, CELL BIOL TOXICOL, V37, P209, DOI 10.1007/s10565-020-09541-5; Murtaza G, 2019, PROG CARDIOVASC DIS, V62, P315, DOI 10.1016/j.pcad.2019.03.003; Nakamura M, 2020, J PHYSIOL-LONDON, V598, P2977, DOI 10.1113/JP276747; Nakmareong S, 2011, N-S ARCH PHARMACOL, V383, P519, DOI 10.1007/s00210-011-0624-z; Paolillo S, 2019, HEART FAIL CLIN, V15, P341, DOI 10.1016/j.hfc.2019.02.003; Parsamanesh N, 2018, PHARMACOL RES, V136, P181, DOI 10.1016/j.phrs.2018.09.012; Qiao KL, 2021, ANGIOGENESIS, V24, P83, DOI 10.1007/s10456-020-09744-8; Qin CX, 2017, PHARMACOL RES, V116, P45, DOI 10.1016/j.phrs.2016.12.016; Sikora E, 2010, Immun Ageing, V7, P1, DOI 10.1186/1742-4933-7-1; Topcu-Tarladacalisir Y, 2013, J MED FOOD, V16, P296, DOI 10.1089/jmf.2012.2550; Tsai CY, 2017, J CELL BIOCHEM, V118, P1659, DOI 10.1002/jcb.25785; Wang PJ, 2020, AM J HYPERTENS, V33, P610, DOI 10.1093/ajh/hpaa024; Wischmann P, 2020, BASIC RES CARDIOL, V115, DOI 10.1007/s00395-020-0799-x; Wu X, 2020, BIOCHEM BIOPH RES CO, V530, P15, DOI 10.1016/j.bbrc.2020.05.053; Yao Q, 2018, J MOL CELL CARDIOL, V124, P26, DOI 10.1016/j.yjmcc.2018.10.004; Zeng XY, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0498-2; Zhang Y, 2020, ANGIOGENESIS, V23, P17, DOI 10.1007/s10456-019-09684-y; Zhou XX, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01549-2	45	1	1	7	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22505	10.1096/fj.202200543RRR	http://dx.doi.org/10.1096/fj.202200543RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3U0ID	35971779				2022-12-26	WOS:000840652800001
J	Ikejezie, J; Langley, T; Lewis, S; Bisanzio, D; Phalkey, R				Ikejezie, Juniorcaius; Langley, Tessa; Lewis, Sarah; Bisanzio, Donal; Phalkey, Revati			The epidemiology of diphtheria in Haiti, December 2014-June 2021: A spatial modeling analysis	PLOS ONE			English	Article							IMMUNIZATION; OUTBREAK; DISEASE; HEALTH	Background Haiti has been experiencing a resurgence of diphtheria since December 2014. Little is known about the factors contributing to the spread and persistence of the disease in the country. Geographic information systems (GIS) and spatial analysis were used to characterize the epidemiology of diphtheria in Haiti between December 2014 and June 2021. Methods Data for the study were collected from official and open-source databases. Choropleth maps were developed to understand spatial trends of diphtheria incidence in Haiti at the commune level, the third administrative division of the country. Spatial autocorrelation was assessed using the global Moran's I. Local indicators of spatial association (LISA) were employed to detect areas with spatial dependence. Ordinary least squares (OLS) and geographically weighted regression (GWR) models were built to identify factors associated with diphtheria incidence. The performance and fit of the models were compared using the adjusted r-squared (R-2) and the corrected Akaike information criterion (AIC(c)). Results From December 2014 to June 2021, the average annual incidence of confirmed diphtheria was 0.39 cases per 100,000 (range of annual incidence = 0.04-0.74 per 100,000). During the study period, diphtheria incidence presented weak but significant spatial autocorrelation (I = 0.18, p<0.001). Although diphtheria cases occurred throughout Haiti, nine communes were classified as disease hotspots. In the regression analyses, diphtheria incidence was positively associated with health facility density (number of facilities per 100,000 population) and degree of urbanization (proportion of urban population). Incidence was negatively associated with female literacy. The GWR model considerably improved model performance and fit compared to the OLS model, as indicated by the higher adjusted R-2 value (0.28 v 0.15) and lower AIC(c) score (261.97 v 267.13). Conclusion This study demonstrates that GIS and spatial analysis can support the investigation of epidemiological patterns. Furthermore, it shows that diphtheria incidence exhibited spatial variability in Haiti. The disease hotspots and potential risk factors identified in this analysis could provide a basis for future public health interventions aimed at preventing and controlling diphtheria transmission.	[Ikejezie, Juniorcaius; Langley, Tessa; Lewis, Sarah; Bisanzio, Donal; Phalkey, Revati] Univ Nottingham, Sch Med, Div Epidemiol & Publ Hlth, Nottingham, England; [Bisanzio, Donal] RTI Int, Washington, DC USA; [Phalkey, Revati] UK Hlth Secur Agcy, Climate Change & Hlth Unit, London, England; [Phalkey, Revati] Heidelberg Univ, Heidelberg Inst Global Hlth, Heidelberg, Germany	University of Nottingham; Research Triangle Institute; Ruprecht Karls University Heidelberg	Ikejezie, J (corresponding author), Univ Nottingham, Sch Med, Div Epidemiol & Publ Hlth, Nottingham, England.	juniorcaius.ikejezie@nottingham.ac.uk		Ikejezie, Juniorcaius/0000-0002-8087-9734				Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Allen M.P., 1997, UNDERSTANDING REGRES, P176, DOI [10.1007/b102242, DOI 10.1007/978-0-585-25657-3_37]; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Blumberg LH, 2018, INT J INFECT DIS, V71, P122, DOI 10.1016/j.ijid.2018.05.002; Bosch-Capblanch X, 2009, TROP MED INT HEALTH, V14, P2, DOI 10.1111/j.1365-3156.2008.02181.x; Braveman P, 2014, PUBLIC HEALTH REP, V129, P19, DOI 10.1177/00333549141291S206; Brunsdon C, 1996, GEOGR ANAL, V28, P281, DOI 10.1111/j.1538-4632.1996.tb00936.x; Centers for Disease Control and Prevention, 2008, MANUAL SURVEILLANCE; Clerville J, 2018, INT J INFECT DIS, V73, P274, DOI 10.1016/j.ijid.2018.04.4041; European Centre for Disease Prevention and Control, 2017, GAP AN SEC DIPHTH DI; Evans AS., 1998, BACTERIAL INFECT HUM, V3rd; Exavier MM, 2019, J TROP PEDIATRICS, V65, P183, DOI 10.1093/tropej/fmy021; Finley AO, 2011, METHODS ECOL EVOL, V2, P143, DOI 10.1111/j.2041-210X.2010.00060.x; Forthofer RN., 2007, BURLINGTON MASS LOND, V2nd; Fotheringham AS, 1996, INT J GEOGR INF SYST, V10, P605, DOI 10.1080/026937996137909; Fotheringham AS., 2009, STEWART FOTHERINGHAM; Graves KA, 2006, HAITI CAPSTONE; Haitian Institute of Childhood (IHE) HIoSaI ICF International Ministry of Public Health and Population (Haiti), 2018, HAIT DEM HLTH SURV 2; Haitian Institute of Statistics and Informatics, 2015, DIRECTORATE DEMOGRAP; Hierink F, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244921; Holm MR, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.29882; Humanitarian Data Exchange, 2019, HAIT HUM DAT EXCH; ICF, 2019, FUNDED USAID; Ikejezie J., 2022, MODIFIABLE RIS UNPUB; Izza N, 2015, BUL PENELIT SIST KES, V18, P211; Juin S, 2018, AM J TROP MED HYG, V99, P596; Kirby RS, 2017, ANN EPIDEMIOL, V27, P1, DOI 10.1016/j.annepidem.2016.12.001; Kupferschmidt K, 2017, SCIENCE, V355, P118, DOI 10.1126/science.355.6321.118; LeVine RA, 2009, J DEV BEHAV PEDIATR, V30, P340, DOI 10.1097/DBP.0b013e3181b0eeff; Louis FJ., 2015, J AIDS CLIN RES, V6, DOI [10.4172/2155-6113.1000488, DOI 10.4172/2155-6113.1000488]; Marmot M, 2006, SOCIAL DETERMINANTS; Minta AA, 2020, AM J TROP MED HYG, V103, P1717, DOI 10.4269/ajtmh.20-0112; Mitchell A., 2005, ESRI GUIDE GIS ANAL; MORAN PAP, 1950, BIOMETRIKA, V37, P178, DOI 10.1093/biomet/37.1-2.178; Nelli L, 2020, INT J HEALTH GEOGR, V19, DOI 10.1186/s12942-020-00209-1; Norwegian Institute of Public Health, 2020, URB PREP OUTBR HIGH; Pan American Health Organization / World Health Organization, 2021, EP UPD DIPHTH HISP; Pan American Health Organization / World Health Organization, 2018, HAIT LAUNCH CAMP VAC; Podavalenko AP., 2018, ASIAN J EPIDEMIOLOGY, V11, P26, DOI DOI 10.3923/AJE.2018.26.33; QGIS Development Team, 2009, QGIS GEOGR INF SYST; QUESADA GM, 1978, DISASTERS, V2, P221, DOI 10.1111/j.1467-7717.1978.tb00100.x; R Development Core Team, R LANG ENV STAT COMP; Ripley BD, 2005, SPAT STAT-NETH; Robinson WS, 1950, AM SOCIOL REV, V15, P351, DOI 10.2307/2087176; Saker L, 2004, GLOBALIZATION INFECT; Seraphin Marie N, 2017, Glob Health Res Policy, V2, P3, DOI 10.1186/s41256-016-0022-7; Shi HJ, 2006, CAN J FOREST RES, V36, P996, DOI 10.1139/X05-295; Smith CM, 2015, EUROSURVEILLANCE, V20, P6, DOI 10.2807/1560-7917.ES.2015.20.39.30026; Stashko LA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216933; The World Bank, 2017, INT DEV ASS PROJ APP; Tiwari TSP., 2013, HUNTERS TROPICAL MED, V9th, P402; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Truelove SA, 2020, CLIN INFECT DIS, V71, P89, DOI 10.1093/cid/ciz808; United Nations Integrated Office in Haiti, 2020, REPORT SECRETARY GEN; Vikram K, 2012, SOC SCI MED, V75, P331, DOI 10.1016/j.socscimed.2012.02.043; Ward M.D., 2008, SPATIAL REGRESSION M; Wheeler DC, 2007, ENVIRON PLANN A, V39, P2464, DOI 10.1068/a38325; WHO, 2020, 61 WHO; World Health Organization, 2020, DIPHTH REP CAS WHO	60	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0273398	10.1371/journal.pone.0273398	http://dx.doi.org/10.1371/journal.pone.0273398			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994502	Green Published, gold			2022-12-26	WOS:000877093400051
J	Baek, KW; Kim, SJ; Kim, BG; Jung, YK; Hah, YS; Moon, HY; Yoo, JI; Park, JS; Kim, JS				Baek, Kyung-Wan; Kim, So-Jeong; Kim, Bo-Gyu; Jung, Youn-Kwan; Hah, Young-Sool; Moon, Hyo Youl; Yoo, Jun-Il; Park, Jin Sung; Kim, Ji-Seok			Effects of lifelong spontaneous exercise on skeletal muscle and angiogenesis in super-aged mice	PLOS ONE			English	Article							RESISTANCE EXERCISE; HEMODYNAMIC CONDITIONS; SENESCENCE; HYPERTROPHY; METABOLISM; EXPRESSION; SARCOPENIA; STRESS	There has been an increasing awareness of sarcopenia, which is characterized by a concomitant decrease in skeletal muscle mass and quality due to aging. Resistance exercise is considered more effective than aerobic exercise in terms of therapeutic exercise. To confirm the effect of long-term aerobic exercise in preventing sarcopenia, we evaluated the skeletal muscle mass, quality, and angiogenic capacity of super-aged mice that had undergone lifelong spontaneous exercise (LSE) through various experiments. Our findings show that LSE could maintain skeletal muscle mass, quality, and fitness levels in super-aged mice. In addition, ex vivo experiments showed that the angiogenic capacity was maintained at a high level. However, these results were not consistent with the related changes in the expression of genes and/or proteins involved in protein synthesis or angiogenesis. Based on the results of previous studies, it seems certain that the expression at the molecular level does not represent the phenotypes of skeletal muscle and angiogenesis. This is because aging and long-term exercise are variables that can affect both protein synthesis and the expression patterns of angiogenesis-related genes and proteins. Therefore, in aging and exercise-related research, various physical fitness and angiogenesis variables and phenotypes should be analyzed. In conclusion, LSE appears to maintain the potential of angiogenesis and slow the aging process to maintain skeletal muscle mass and quality. Aerobic exercise may thus be effective for the prevention of sarcopenia.	[Baek, Kyung-Wan; Kim, Ji-Seok] Gyeongsang Natl Univ, Dept Phys Educ, Jinju, South Korea; [Baek, Kyung-Wan; Kim, Ji-Seok] Gyeongsang Natl Univ, Res Inst Pharmaceut Sci, Jinju, South Korea; [Kim, So-Jeong; Kim, Bo-Gyu] Gyeongsang Natl Univ, Dept Convergence Med Sci, Jinju, South Korea; [Jung, Youn-Kwan; Hah, Young-Sool] Gyeongsang Natl Univ Hosp, Biomed Res Inst, Jinju, South Korea; [Moon, Hyo Youl] Seoul Natl Univ, Dept Phys Educ, Seoul, South Korea; [Yoo, Jun-Il] Gyeongsang Natl Univ Hosp, Dept Orthopaed Surg, Jinju, South Korea; [Park, Jin Sung] Gyeongsang Natl Univ, Dept Orthopaed Surg, Sch Med, Jinju, South Korea; [Park, Jin Sung] Gyeongsang Natl Univ, Inst Hlth Sci, Sch Med, Jinju, South Korea; [Park, Jin Sung] Gyeongsang Natl Univ Hosp, Jinju, South Korea	Gyeongsang National University; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University Hospital; Seoul National University (SNU); Gyeongsang National University; Gyeongsang National University Hospital; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University Hospital	Kim, JS (corresponding author), Gyeongsang Natl Univ, Dept Phys Educ, Jinju, South Korea.	kjs7952@gmail.com	Baek, Kyung-Wan/N-2071-2018	Baek, Kyung-Wan/0000-0002-8445-3773	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2018R1A6A3A01011328, 2019R1I1A3A01061144]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of KoreaNational Research Council for Economics, Humanities & Social Sciences, Republic of Korea)	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education ([KWB]2018R1A6A3A01011328; [JSK]2019R1I1A3A01061144). The funders had no role in study design, data collection and analysis,	Anker SD, 2016, J CACHEXIA SARCOPENI, V7, P512, DOI 10.1002/jcsm.12147; Baar K, 1999, AM J PHYSIOL-CELL PH, V276, pC120, DOI 10.1152/ajpcell.1999.276.1.C120; Baek KW, 2020, EXP GERONTOL, V141, DOI 10.1016/j.exger.2020.111091; Baek Kyung-Wan, 2020, J Bone Metab, V27, P97, DOI 10.11005/jbm.2020.27.2.97; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Bianco M, 2007, INT J SPORTS MED, V28, P697, DOI 10.1055/s-2007-964863; Bori Z, 2012, EXP GERONTOL, V47, P417, DOI 10.1016/j.exger.2012.03.004; Cheng CP, 2003, ATHEROSCLEROSIS, V168, P323, DOI 10.1016/S0021-9150(03)00099-6; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Curtis R, 2005, NAT REV DRUG DISCOV, V4, P569, DOI 10.1038/nrd1777; DENIS C, 1986, J PHYSIOLOGY PARIS, V81, P379; Drummond MJ, 2008, J APPL PHYSIOL, V104, P1452, DOI 10.1152/japplphysiol.00021.2008; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Egginton S, 2009, PFLUG ARCH EUR J PHY, V457, P963, DOI 10.1007/s00424-008-0563-9; Erusalimsky JD, 2009, J APPL PHYSIOL, V106, P326, DOI 10.1152/japplphysiol.91353.2008; Ethgen O, 2017, CALCIFIED TISSUE INT, V100, P229, DOI 10.1007/s00223-016-0220-9; Flurkey K, 2007, MOUSE BIOMEDICAL RES, P637, DOI DOI 10.1016/B978-012369454-6/50074-1; Fujio M, 2017, J TISSUE ENG REGEN M, V11, P2116, DOI 10.1002/term.2109; Gigante Bruna, 2004, Angiogenesis, V7, P277, DOI 10.1007/s10456-004-4179-1; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Harber MP, 2012, J APPL PHYSIOL, V113, P1495, DOI 10.1152/japplphysiol.00786.2012; Ji-Seok Kim，, 2021, [Exercise Science, 운동과학], V30, P213; Konopka AR, 2014, EXERC SPORT SCI REV, V42, P53, DOI 10.1249/JES.0000000000000007; Landi F, 2014, CURR OPIN CLIN NUTR, V17, P25, DOI 10.1097/MCO.0000000000000018; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Liao CD, 2017, AM J CLIN NUTR, V106, P1078, DOI 10.3945/ajcn.116.143594; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Marin C, 2013, INT J MOL SCI, V14, P8869, DOI 10.3390/ijms14058869; Morley JE, 2001, J LAB CLIN MED, V137, P231, DOI 10.1067/mlc.2001.113504; Morley JE, 2016, CALCIFIED TISSUE INT, V98, P319, DOI 10.1007/s00223-015-0022-5; Okabe T, 2007, CARDIOVASC RES, V74, P537, DOI 10.1016/j.cardiores.2007.02.019; Peterson MD, 2011, AM J MED, V124, P194, DOI 10.1016/j.amjmed.2010.08.020; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips SM, 2015, ADV NUTR, V6, P452, DOI 10.3945/an.115.008367; Phu S, 2015, J CLIN DENSITOM, V18, P488, DOI 10.1016/j.jocd.2015.04.011; Pospelova TV, 2012, CELL CYCLE, V11, P2402, DOI 10.4161/cc.20882; Richardson RS, 2000, AM J PHYSIOL-HEART C, V279, pH772, DOI 10.1152/ajpheart.2000.279.2.H772; Rivard A, 1999, CIRCULATION, V99, P111, DOI 10.1161/01.CIR.99.1.111; Sadoun E, 2003, J HISTOCHEM CYTOCHEM, V51, P1119, DOI 10.1177/002215540305100902; SHER J, 1976, ACTA NEUROL SCAND, V54, P45, DOI 10.1111/j.1600-0404.1976.tb07619.x; Taylor CA, 1999, J VASC SURG, V29, P1077, DOI 10.1016/S0741-5214(99)70249-1; Xu SH, 2014, AGING DIS, V5, P263, DOI 10.14336/AD.2014.0500263	42	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0263457	10.1371/journal.pone.0263457	http://dx.doi.org/10.1371/journal.pone.0263457			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976884	gold, Green Published			2022-12-26	WOS:000847227000001
J	Wenaas, L; Gulbrandsen, M				Wenaas, Lars; Gulbrandsen, Magnus			The green, gold grass of home: Introducing open access in universities in Norway	PLOS ONE			English	Article							JOURNALS	In this paper, we investigate how open access is reflected and implemented in all Norwegian universities and how they responded to national policy developments for open access in the period 2009-2021. We analyse how the universities adapted arguments for the three core missions of the universities-research, education, and societal impact-when they reacted to increasing pressures to facilitate open access. Our analysis is based on 182 institutional strategy documents, open access policies and annual reports. When considering the profile of the institutional policies and the explicit referrals to national policies, we find there is a great deal of homogeneity between Norwegian universities, and they are mostly aligned with national policy. Open access is connected to the third mission in all university strategies, but often in a very general manner and without documenting benefits for non-academic users. We find limited emphasis on open access as advantageous for education. All universities show commitment to open access, and several can be described as proactive as they tie it to different types of local incentives. Development over time suggests more mature and institutionalised polices that do not challenge what we may call the academic heartland and its core value of academic freedom, including where and how to publish. We propose a framework for analysing similar institutionalisation processes with three main dimensions: mimesis, adaptation/integration with existing practices, and maturation/commitment.	[Wenaas, Lars; Gulbrandsen, Magnus] Univ Oslo, TIK Ctr Technol Innovat & Culture, Oslo, Norway	University of Oslo	Wenaas, L (corresponding author), Univ Oslo, TIK Ctr Technol Innovat & Culture, Oslo, Norway.	lars.wenaas@sikt.no		Wenaas, Lars/0000-0002-4821-3289	Research Council Norway (RCN-project) [272456]; 'Oslo Institute for Research on the Impact of Science' (OSIRIS, RCN-project) [256240/O30]; Research Council Norway ('Oslo Institute for Research on the Impact of Science', OSIRIS, RCN-project) [256240/O30]	Research Council Norway (RCN-project)(Research Council of Norway); 'Oslo Institute for Research on the Impact of Science' (OSIRIS, RCN-project); Research Council Norway ('Oslo Institute for Research on the Impact of Science', OSIRIS, RCN-project)	LW is financed by the Research Council Norway (RCN-project: 272456) and the 'Oslo Institute for Research on the Impact of Science' (OSIRIS, RCN-project:256240/O30) MG is financed by the Research Council Norway ('Oslo Institute for Research on the Impact of Science', OSIRIS, RCNproject:256240/O30) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2015, SCI PUBL POLICY, V42, P725, DOI 10.1093/scipol/scu087; Bach TA., 2017, NORDIC PERSPECTIVES, V1, DOI [10.7557/11.4148, DOI 10.7557/11.4148]; Benneworth P, 2016, SCI PUBL POLICY, V43, P731, DOI 10.1093/scipol/scw018; Bjork BC, 2017, ELECTRON MARK, V27, P101, DOI 10.1007/s12525-017-0249-2; Bjork BC, 2013, PUBLICATIONS, V1, P5, DOI 10.3390/publications1010005; BOAI, 2002, BUDAPEST OPEN ACCESS; Boer H., 2009, EUROPEAN INTEGRATION, V26, P159, DOI [10.1007/978-1-4020-9505-4_7, DOI 10.1007/978-1-4020-9505-4_7, DOI 10.1007/978-1-4020-9505-4]; Borrego A, 2021, LEARN PUBL, V34, P216, DOI 10.1002/leap.1347; Bosman J, 2021, INSIGHTS, V34, DOI 10.1629/uksg.545; Brainard J, 2020, SCI AAAS; Brekke Brantsag., 2016, NASJONALE RETNINGSLI; Bryan KA., 2020, REV ECON STAT, P1, DOI [10.1162/rest_a_00926, DOI 10.1162/REST_A_00926]; CALLON M, 1994, SCI TECHNOL HUM VAL, V19, P395, DOI 10.1177/016224399401900401; Canadian Institutes of Health Research Natural Sciences and Engineering Research Council of Canada Social Sciences and Humanities Research Council of Canada, 2010, TRIC POL STAT ETH CO; cOAlition S, 2018, PLAN S; Colyvas JA, 2006, RES ORGAN BEHAV, V27, P305, DOI 10.1016/S0191-3085(06)27008-4; Commission European, 2017, EV RES CAR FULL ACKN, DOI [10.2777/75255, DOI 10.2777/75255]; Dalrymple, 2005, SOCIAL SCI KNOWLEDGE; Dalrymple, 2003, ROLE SCI TECHNICAL D, P35; DIMAGGIO PJ, 1983, AM SOCIOL REV, V48, P147, DOI 10.2307/2095101; Direktoratet for internasjonalisering og kvalitetsutvikling i hoyere utdanning [DIKU], 2021, TILST HOYER UTD 2021; Elsabry E, 2017, EXPANDING PERSPECTIVES ON OPEN SCIENCE: COMMUNITIES, CULTURES AND DIVERSITY IN CONCEPTS AND PRACTICES, P34, DOI 10.3233/978-1-61499-769-6-34; Etzkowitz H, 2000, RES POLICY, V29, P313, DOI 10.1016/S0048-7333(99)00069-4; European Commission, 2016, OPEN INNOVATION OPEN; Fecher B, 2016, PUBLICATIONS, V4, DOI 10.3390/publications4020017; Fell MJ, 2019, PUBLICATIONS, V7, DOI 10.3390/publications7030046; Frantsvag JE., 2019, FEW OPEN ACCESS J AR, DOI [10.20944/preprints201901.0165.v3, DOI 10.20944/PREPRINTS201901.0165.V3]; Gadd E, 2019, PUBLICATIONS, V7, DOI 10.3390/publications7030056; Gioia DA, 2013, ORGAN RES METHODS, V16, P15, DOI 10.1177/1094428112452151; Glynn MA, 2013, ADMIN SCI QUART, V58, P493, DOI 10.1177/0001839213492139; Greussing E, 2020, FRONT COMMUN, V5, DOI 10.3389/fcomm.2020.587465; Grudniewicz A, 2019, NATURE, V576, P210, DOI 10.1038/d41586-019-03759-y; Haug CJ, 2019, NEW ENGL J MED, V380, P1181, DOI 10.1056/NEJMms1900864; Houghton J., 2009, OPEN ACCESS WHAT ARE, DOI [10.2139/ssrn.1492578, DOI 10.2139/SSRN.1492578]; Huang CK, 2020, ELIFE, V9, DOI 10.7554/eLife.57067; Kamerlin SCL, 2021, DEV CHANGE, V52, P627, DOI 10.1111/dech.12635; Kielland T, 2019, RETTIGHETSOG LISENSS, P68; Kitagawa F, 2016, SCI PUBL POLICY, V43, P736, DOI 10.1093/scipol/scw015; Laakso M, 2022, J LIBR INF SCI, V54, P216, DOI 10.1177/09610006211006769; Lariviere V, 2018, NATURE, V562, P483, DOI 10.1038/d41586-018-07101-w; Look H., 2012, BENEFITS OPEN ACCESS, V92; Lyman S, 2011, NAT BIOTECHNOL, V29, P571, DOI 10.1038/nbt.1909; Merriam S. B., 2016, QUAL RES, V4th; Merton R.E., SOCIOLOGY SCI THEORE; Ministry of Education, 2009, NAT ST MELD NR 30 20; Ministry of Education, 2018, NAT MELD ST 4 LANGT; Ministry of Education, 2005, NAT ST MELD NR 20 20; Ministry of Education, 2017, NASJ MAL RETN AP TIL; Ministry of Education, 2013, NAT ST MELD 18 2012; Montgomery L., 2021, OPEN KNOWLEDGE I REI; Naidu S, 2016, DISTANCE EDUC, V37, P1, DOI 10.1080/01587919.2016.1157010; O'Connor C, 2020, INT J QUAL METH, V19, DOI 10.1177/1609406919899220; OECD, OP SCI OECD; Panitch Michalak, 2005, TERM SERIALS CRISIS; Parsons D., 2011, JISC; Perkmann M, 2021, RES POLICY, V50, DOI 10.1016/j.respol.2020.104114; Pinheiro R., 2015, EUROPEAN J HIGHER ED, V5, P227, DOI [10.1080/21568235.2015.1044551, DOI 10.1080/21568235.2015.1044551]; Piwowar H, 2018, PEERJ, V6, DOI 10.7717/peerj.4375; Prosser DC, 2003, LEARN PUBL, V16, P163, DOI 10.1087/095315103322110923; Rabesandratana T, 2019, SCIENCE, V363, P11, DOI 10.1126/science.363.6422.11; Research Council of Norway, 2014, FORSKN PRINS AP TILG; Rowley J, 2017, J ASSOC INF SCI TECH, V68, P1201, DOI 10.1002/asi.23710; Safner R., 2016, 2488655 SSRN; Samuelson PA, 1954, REV ECON STAT, V36, P387, DOI 10.2307/1925895; Sanchez-Barrioluengo M, 2014, RES POLICY, V43, P1760, DOI 10.1016/j.respol.2014.06.001; Severin A, 2019, INT J PUBLIC HEALTH, V64, P1123, DOI 10.1007/s00038-019-01284-3; Severin Anna, 2018, F1000Res, V7, P1925, DOI 10.12688/f1000research.17328.1; SPARC Europe, OPEN ACCESS CITATION; Strauss A., 2008, BASICS QUALITATIVE R; Strom T, 2011, SCIECOM INFO, V7; STRUTZEL E, 1968, NURS RES, V17, P364; Swan A., 2015, PASTEUR4OA WORK PACK; Tennant Jonathan P, 2016, F1000Res, V5, P632; The Norwegian Ministry of Education and Research, 2017, NAT GOALS GUID OP AC; UHR, 2009, NAT OKT TILG NORSK F; Vermeir K, 2013, SCI EDUC-NETHERLANDS, V22, P2485, DOI 10.1007/s11191-012-9524-y; Wakeling S., 2021, POLICIES, DOI [10.1101/2021.08.20.457045, DOI 10.1101/2021.08.20.457045]; Wenaas L., 2022, SUPPORTING DATA GREE, DOI 10.18710/IQGCHB; Yegros-Yegros A, 2018, P 23 INT C SCI TECHN; Young P, 2009, SERIALS CRISIS OPEN, P17	81	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0273091	10.1371/journal.pone.0273091	http://dx.doi.org/10.1371/journal.pone.0273091			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976952	gold, Green Published			2022-12-26	WOS:000847227000076
J	Yu, WY				Yu, Wuyang			Robust competitive facility location model with uncertain demand types	PLOS ONE			English	Article							CHAIN NETWORK DESIGN	In competitive settings, firms locate their facilities according to customers' behavior to maximize their market share. A common behavior is consuming from different motivations: one is for convenient demand, and the other is for quality demand. In this behavioral pattern, consumers patronize facilities within convenience for some demands, and patronize high quality facilities beyond convenience range for other demands. This behavior has never been included in competitive facility location problems. Given several other companies' facilities in the market offering similar products or services, we study how a new entrant company can locate facilities based on this customer behavior to maximize its market share. A two-level robust model for the new entrant company is proposed to locate its facilities by taking into account the uncertainty of the types of customers' demands. For medium size problems, we propose an equivalent mixed binary linear programming to obtain exact solutions. For large size problems, an exact algorithm (GCKP-A) for solving the inner-level model is given first by exploring the optimal solution. Then a heuristic algorithm is proposed by imbedding (GCKP-A) and 2-opt strategy into the framework of the improved ranking-based algorithm. The performance of the proposed heuristic algorithm is checked for different size problems. The sensitivity analysis of a quasi-real example shows that: (1) in most cases, the uncertainty between two types of demands does not affect the location scheme; (2) the convenience range, the quality range and the quality threshold play an important role in the market share of the new entrant company.	[Yu, Wuyang] Hangzhou Dianzi Univ, Sch Management, Hangzhou, Zhejiang, Peoples R China	Hangzhou Dianzi University	Yu, WY (corresponding author), Hangzhou Dianzi Univ, Sch Management, Hangzhou, Zhejiang, Peoples R China.	yu_wuyang@163.com		Yu, Wuyang/0000-0002-7831-7783				Aboolian R, 2021, EUR J OPER RES, V289, P31, DOI 10.1016/j.ejor.2020.06.044; Ahmadi Z, 2020, J CLEAN PROD, V273, DOI 10.1016/j.jclepro.2020.122971; Cai KY, 2020, ANN OPER RES, V287, P61, DOI 10.1007/s10479-019-03386-w; CONNOLLY D, 1991, J OPER RES SOC, V42, P513; Daskin M. S., 2011, NETWORK DISCRETE LOC; Drezner T, 2018, OPER RES LETT, V46, P312, DOI 10.1016/j.orl.2018.02.008; Fahimi K, 2017, COMPUT IND ENG, V107, P235, DOI 10.1016/j.cie.2017.03.020; Farahani RZ, 2014, OMEGA-INT J MANAGE S, V45, P92, DOI 10.1016/j.omega.2013.08.006; Fernandez J, 2019, COMPUT OPER RES, V101, P234, DOI 10.1016/j.cor.2018.08.001; Fernandez P, 2021, J COMPUT APPL MATH, V385, DOI 10.1016/j.cam.2020.113200; Hotelling H, 1929, ECON J, V39, P41, DOI 10.2307/2224214; HUFF DL, 1964, J MARKETING, V28, P34, DOI 10.1177/002224296402800307; Latifi SE, 2022, COMPUT OPER RES, V146, DOI 10.1016/j.cor.2022.105900; Lin YH, 2022, PROD OPER MANAG, V31, P3021, DOI 10.1111/poms.13737; Ljubic I, 2018, EUR J OPER RES, V266, P46, DOI 10.1016/j.ejor.2017.09.023; Mahmoodjanloo M, 2020, COMPUT OPER RES, V123, DOI 10.1016/j.cor.2020.105048; Mai T, 2020, EUR J OPER RES, V284, P874, DOI 10.1016/j.ejor.2020.01.020; Marianov V, 2020, NETW SPAT ECON, V20, P367, DOI 10.1007/s11067-019-09481-6; Plastria F, 2001, EUR J OPER RES, V129, P461, DOI 10.1016/S0377-2217(00)00169-7; Qi MY, 2017, COMPUT IND ENG, V112, P483, DOI 10.1016/j.cie.2017.04.024; ReVelle CS, 2008, EUR J OPER RES, V184, P817, DOI 10.1016/j.ejor.2006.12.044; Saha AK, 2020, COMPUT OPER RES, V117, DOI 10.1016/j.cor.2020.104884; Santos-Penate DR, 2007, NETW SPAT ECON, V7, P45, DOI 10.1007/s11067-006-9007-2; Santos-Penate DR, 2020, NETW SPAT ECON, V20, P73, DOI 10.1007/s11067-019-09472-7; Sazvar Z, 2022, ANN OPER RES, V315, P2057, DOI 10.1007/s10479-021-03961-0; Serra D, 1999, ENVIRON PLANN B, V26, P741, DOI 10.1068/b260741; Shakouhi F, 2021, ANN OPER RES, DOI 10.1007/s10479-021-04073-5; Yu WY, 2020, OPTIM LETT, V14, P2107, DOI 10.1007/s11590-020-01538-7; Yu WY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225693; Yu Z, 2022, INT J LOGIST-RES APP, V25, P1115, DOI 10.1080/13675567.2021.1879752; Yu Z, 2022, INT J FUZZY SYST, V24, P1170, DOI 10.1007/s40815-020-00979-7; Zhou WH, 2017, EUR J OPER RES, V257, P641, DOI 10.1016/j.ejor.2016.07.050	33	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0273123	10.1371/journal.pone.0273123	http://dx.doi.org/10.1371/journal.pone.0273123			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976967	gold, Green Published			2022-12-26	WOS:000847227000079
J	Gangopadhyay, K; Roy, A; Chandradasan, AC; Roy, S; Debnath, O; SenGupta, S; Chowdhury, S; Das, D; Das, R				Gangopadhyay, Kaustav; Roy, Arnab; Chandradasan, Athira C.; Roy, Swarnendu; Debnath, Olivia; SenGupta, Soumee; Chowdhury, Subhankar; Das, Dipjyoti; Das, Rahul			An evolutionary divergent thermodynamic brake in ZAP-70 fine-tunes the kinetic proofreading in T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; TANDEM SH2 DOMAINS; TCR-ZETA; ANTIGEN RECEPTOR; STRUCTURAL BASIS; SIGNAL-TRANSDUCTION; NEGATIVE SELECTION; ACTIVATION MOTIFS; CRYSTAL-STRUCTURE; CUTTING EDGE	T cell signaling starts with assembling several tyrosine kinases and adapter proteins to the T cell receptor (TCR), following the antigen binding to the TCR. The stability of the TCR-antigen complex and the delay between the recruitment and activation of each kinase determines the T cell response. Integration of such delays constitutes a kinetic proofreading mechanism to regulate T cell response to the antigen binding. However, the mechanism of these delays is not fully understood. Combining biochemical experiments and kinetic modeling, here we report a thermodynamic brake in the regulatory module of the tyrosine kinase ZAP-70, which determines the ligand selectivity, and may delay the ZAP-70 activation upon antigen binding to TCR. The regulatory module of ZAP-70 comprises of a tandem SH2 domain that binds to its ligand, doubly-phosphorylated ITAM peptide (ITAM-Y2P), in two kinetic steps: a fast step and a slow step. We show the initial encounter complex formation between the ITAM-Y2P and tandem SH2 domain follows a fast-kinetic step, whereas the conformational transition to the holo-state follows a slow-kinetic step. We further observed a thermodynamic penalty imposed during the second phosphate-binding event reduces the rate of structural transition to the holo-state. Phylogenetic analysis revealed the evolution of the thermodynamic brake coincides with the divergence of the adaptive immune system to the cell-mediated and humoral responses. In addition, the paralogous kinase Syk expressed in B cells does not possess such a functional thermodynamic brake, which may explain the higher basal activation and lack of ligand selectivity in Syk.	[Gangopadhyay, Kaustav; Roy, Arnab; Chandradasan, Athira C.; Roy, Swarnendu; Debnath, Olivia; SenGupta, Soumee; Chowdhury, Subhankar; Das, Dipjyoti; Das, Rahul] Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Mohanpur, India; [Das, Rahul] Indian Inst Sci Educ & Res Kolkata, Ctr Adv Funct Mat, Mohanpur, India	Indian Institute of Science Education & Research (IISER) - Kolkata; Indian Institute of Science Education & Research (IISER) - Kolkata	Das, D; Das, R (corresponding author), Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Mohanpur, India.; Das, R (corresponding author), Indian Inst Sci Educ & Res Kolkata, Ctr Adv Funct Mat, Mohanpur, India.			Das, Rahul/0000-0001-7841-8229; Das, Dipjyoti/0000-0002-5947-9090	IISER Kolkata; DST-FIST [SR/FST/LS-II/2017/93 (c)]; SERB [CRG/2020/000437]; DBT Ramalingaswami Fellowship [BT/RFF/Re-entry/14/2014]; CSIR-UGC; UGC; Ramalingaswami Fellowship [BT/RFF/Re-entry/52/2018]	IISER Kolkata; DST-FIST(Department of Science & Technology (India)); SERB(Department of Science & Technology (India)Science Engineering Research Board (SERB), India); DBT Ramalingaswami Fellowship; CSIR-UGC(Council of Scientific & Industrial Research (CSIR) - IndiaUniversity Grants Commission, India); UGC(University Grants Commission, India); Ramalingaswami Fellowship	The authors thank Prof. Pradipta Purkayastha for access to fluorimeter; Prof. Amit K Das and Dr Samiran S Gauri at I.I.T. Kharagpur for Mass Spectroscopy, Manas Pratim Chakra-borty and Prosad Kumar Das for their valuable inputs. The authors thank Pritha Ganguly for her help with phylogenetic analysis. The authors thank research funding from IISER Kolkata, infrastructural facilities supported by IISER Kolkata and DST-FIST (SR/FST/LS-II/2017/93 (c) ) .Funding and additional information-This work is supported by grant from SERB (CRG/2020/000437) and DBT Ramalingaswami Fellowship (BT/RFF/Re-entry/14/2014) to R. D.; Ramalingaswami Fellowship (BT/RFF/Re-entry/52/2018) to D. D. A. C. C. and S. S. G. are supported by the fellowships from CSIR-UGC and UGC, respectively.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI DOI 10.1093/NAR/GKX1095; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Au-Yeung BB, 2018, ANNU REV IMMUNOL, V36, P127, DOI 10.1146/annurev-immunol-042617-053335; Au-Yeung BB, 2009, IMMUNOL REV, V228, P41, DOI 10.1111/j.1600-065X.2008.00753.x; Bettini ML, 2017, J IMMUNOL, V199, P1555, DOI 10.4049/jimmunol.1700069; Borna S, 2020, J BIOL CHEM, V295, P12935, DOI 10.1074/jbc.RA120.013552; Brdicka T, 2005, MOL CELL BIOL, V25, P4924, DOI 10.1128/MCB.25.12.4924-4933.2005; BU JY, 1995, P NATL ACAD SCI USA, V92, P5106, DOI 10.1073/pnas.92.11.5106; Chakraborty AK, 2014, NAT IMMUNOL, V15, P798, DOI 10.1038/ni.2940; Chakraborty MP, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100449; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Chu DH, 1996, EMBO J, V15, P6251, DOI 10.1002/j.1460-2075.1996.tb01015.x; Clemens L, 2021, BIOPHYS J, V120, P379, DOI 10.1016/j.bpj.2020.11.2266; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; Courtney AH, 2018, TRENDS BIOCHEM SCI, V43, P108, DOI 10.1016/j.tibs.2017.11.008; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Erlendsson S, 2021, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.615565; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng C, 2016, PHYS CHEM CHEM PHYS, V18, P5807, DOI 10.1039/c5cp05417f; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Folmer RHA, 2002, BIOCHEMISTRY-US, V41, P14176, DOI 10.1021/bi026465e; Futterer K, 1998, J MOL BIOL, V281, P523, DOI 10.1006/jmbi.1998.1964; Gangopadhyay K, 2020, FASEB J, V34, DOI 10.1096/fasebj.2020.34.s1.02408; Gaud G, 2018, NAT REV IMMUNOL, V18, P485, DOI 10.1038/s41577-018-0020-8; Gradler U, 2013, J MOL BIOL, V425, P309, DOI 10.1016/j.jmb.2012.11.007; Grucza RA, 2000, BIOCHEMISTRY-US, V39, P10072, DOI 10.1021/bi000891n; Gururajan M, 2006, J IMMUNOL, V176, P5715, DOI 10.4049/jimmunol.176.10.5715; Haks MC, 2002, J EXP MED, V196, P1, DOI 10.1084/jem.20020268; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; Hobbs HT, 2021, PROTEIN SCI, V30, P2373, DOI 10.1002/pro.4199; Holst J, 2008, NAT IMMUNOL, V9, P658, DOI 10.1038/ni.1611; Huang WYC, 2016, P NATL ACAD SCI USA, V113, P8218, DOI 10.1073/pnas.1602602113; ISAKOV N, 1995, J EXP MED, V181, P375, DOI 10.1084/jem.181.1.375; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Katz ZB, 2017, NAT IMMUNOL, V18, P86, DOI 10.1038/ni.3631; Klammt C, 2015, NAT IMMUNOL, V16, P961, DOI 10.1038/ni.3231; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kumaran S, 2003, P NATL ACAD SCI USA, V100, P14828, DOI 10.1073/pnas.2432867100; Labadia ME, 1996, J LEUKOCYTE BIOL, V59, P740, DOI 10.1002/jlb.59.5.740; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Letunic I, 2021, NUCLEIC ACIDS RES, V49, pD458, DOI 10.1093/nar/gkaa937; Lo WL, 2019, NAT IMMUNOL, V20, P1481, DOI 10.1038/s41590-019-0502-2; Love PE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002485; Love PE, 2000, IMMUNITY, V12, P591, DOI 10.1016/S1074-7613(00)80210-1; Machida K, 2007, MOL CELL, V26, P899, DOI 10.1016/j.molcel.2007.05.031; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; MAYER BJ, 1991, P NATL ACAD SCI USA, V88, P627, DOI 10.1073/pnas.88.2.627; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Mukhopadhyay H, 2016, BIOPHYS J, V110, P1896, DOI 10.1016/j.bpj.2016.03.024; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Osman N, 1996, EUR J IMMUNOL, V26, P1063, DOI 10.1002/eji.1830260516; Ottinger EA, 1998, J BIOL CHEM, V273, P729, DOI 10.1074/jbc.273.2.729; Palacios EH, 2007, J EXP MED, V204, P1703, DOI 10.1084/jem.20070405; Rabinowitz JD, 1996, P NATL ACAD SCI USA, V93, P1401, DOI 10.1073/pnas.93.4.1401; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Sadras T, 2021, MOL CELL, V81, P2094, DOI 10.1016/j.molcel.2021.03.043; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sevlever F, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007929; SHORES EW, 1994, SCIENCE, V266, P1047, DOI 10.1126/science.7526464; Sjolin-Goodfellow H, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005596; Stepanek O, 2014, CELL, V159, P333, DOI 10.1016/j.cell.2014.08.042; Suzuki Y, 2004, J BIOL CHEM, V279, P35526, DOI 10.1074/jbc.M404831200; Tischer DK, 2019, ELIFE, V8, DOI 10.7554/eLife.42498; Tsang E, 2008, J BIOL CHEM, V283, P32650, DOI 10.1074/jbc.M806340200; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; Williams BL, 1999, EMBO J, V18, P1832, DOI 10.1093/emboj/18.7.1832; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Yan QR, 2013, MOL CELL BIOL, V33, P2188, DOI 10.1128/MCB.01637-12; YANAGI S, 1995, CELL SIGNAL, V7, P185, DOI 10.1016/0898-6568(94)00088-S; Yi J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08064-2; Yousefi OS, 2019, ELIFE, V8, DOI 10.7554/eLife.42475; Zenner G, 1996, J CELL BIOCHEM, V63, P94, DOI 10.1002/(SICI)1097-4644(199610)63:1<94::AID-JCB8>3.0.CO;2-V; Zimmermann K, 2017, J BIOL CHEM, V292, P17746, DOI 10.1074/jbc.M117.794370	82	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102376	10.1016/j.jbc.2022.102376	http://dx.doi.org/10.1016/j.jbc.2022.102376			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5J0EG	35970395	Green Published, gold, Green Submitted			2022-12-26	WOS:000868720100009
J	Liu, YX; Ribeiro, OD; Haapanen, O; Craven, GB; Sharma, V; Muench, SP; Goldman, A				Liu, Yixin; Ribeiro, Orquidea De Castro; Haapanen, Outi; Craven, Gregory B.; Sharma, Vivek; Muench, Stephen P.; Goldman, Adrian			Unexpected structures formed by the kinase RET C634R mutant extracellular domain suggest potential oncogenic mechanisms in MEN2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCRINE NEOPLASIA TYPE-2; NEUROTROPHIC FACTOR; DISEASE PHENOTYPE; GLYCAN READER; CRYO-EM; RECEPTOR; GDNF; MUTATIONS; DYNAMICS; PROTOONCOGENE	The RET receptor tyrosine kinase plays a pivotal role in cell survival, proliferation, and differentiation, and its abnormal activation leads to cancers through receptor fusions or point mutations. Mutations that disrupt the disulfide network in the extracellular domain (ECD) of RET drive multiple endocrine neoplasia type 2A (MEN2A), a hereditary syndrome associated with the development of thyroid cancers. However, structural details of how specific mutations affect RET are unclear. Here, we present the first structural insights into the ECD of the RET(C634R) mutant, the most common mutation in MEN2A. Using electron microscopy, we demonstrate that the C634R mutation causes ligand-independent dimerization of the RET ECD, revealing an unusual tail-to-tail conformation that is distinct from the ligand-induced signaling dimer of WT RET. Additionally, we show that the RETC634R ECD dimer can form complexes with at least two of the canonical RET ligands and that these complexes form very different structures than WT RET ECD upon ligand binding. In conclusion, this structural analysis of cysteine-mutant RET ECD suggests a potential key mechanism of cancer induction in MEN2A, both in the absence and presence of its native ligands, and may offer new targets for therapeutic intervention.	[Liu, Yixin; Ribeiro, Orquidea De Castro; Goldman, Adrian] Univ Helsinki, Fac Biol & Environm Sci, Mol & Integrat Biosci, Helsinki, Finland; [Haapanen, Outi; Sharma, Vivek] Univ Helsinki, Dept Phys, Helsinki, Finland; [Craven, Gregory B.; Muench, Stephen P.; Goldman, Adrian] Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds, England; [Craven, Gregory B.; Muench, Stephen P.; Goldman, Adrian] Univ Leeds, Astbury Ctr forStructural & Mol Biol, Leeds, England; [Sharma, Vivek] Univ Helsinki, HiLIFE Inst Biotechnol, Helsinki, Finland; [Goldman, Adrian] Univ Calif San Francisco, San Francisco, CA 94158 USA	University of Helsinki; University of Helsinki; University of Leeds; University of Leeds; University of Helsinki; University of California System; University of California San Francisco	Goldman, A (corresponding author), Univ Calif San Francisco, San Francisco, CA 94158 USA.	adrian.goldman@helsinki.fi		Liu, Yixin/0000-0003-1135-2805; Sharma, Vivek/0000-0002-8838-3151; Craven, Gregory/0000-0003-3414-8348; Ribeiro, Orquidea/0000-0003-0746-6666	Instruct-ERIC [PID 12751, 10661]; European Molecular Biology Organization short term fellowship [8476]; Academy of Finland [322609, 286429, 294652]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/M021610/1]; Sigrid Juselius Foundation; Jane and Aatos Erkko Foundation; Magnus Ehrnrooth Foundation	Instruct-ERIC; European Molecular Biology Organization short term fellowship; Academy of Finland(Academy of Finland); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Jane and Aatos Erkko Foundation; Magnus Ehrnrooth Foundation	This work is supported by Instruct-ERIC (PID 12751 and 10661), the European Molecular Biology Organization short term fellowship (No. 8476), the Academy of Finland (No. 322609), the Academy of Finland (No. 286429), the Biotechnology and Biological Sciences Research Council (BBSRC, BB/M021610/1), the Academy of Finland (No. 294652), the Sigrid Juselius Foundation, the Jane and Aatos Erkko Foundation, and the Magnus Ehrnrooth Foundation.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adams SE, 2021, STRUCTURE, V29, P694, DOI 10.1016/j.str.2020.12.012; Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Arighi E, 2004, MOL ENDOCRINOL, V18, P1004, DOI 10.1210/me.2003-0173; Baloh RH, 1998, NEURON, V21, P1291, DOI 10.1016/S0896-6273(00)80649-2; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bigalke JM, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau4202; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Carlomagno F, 1997, CANCER RES, V57, P391; Chappuis-Flament S, 1998, ONCOGENE, V17, P2851, DOI 10.1038/sj.onc.1202202; Coulpier M, 2002, J BIOL CHEM, V277, P1991, DOI 10.1074/jbc.M107992200; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; Emmerson PJ, 2017, NAT MED, V23, P1215, DOI 10.1038/nm.4393; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eng C, 1996, JAMA-J AM MED ASSOC, V276, P1575, DOI 10.1001/jama.276.19.1575; Freche B, 2005, J BIOL CHEM, V280, P36584, DOI 10.1074/jbc.M505707200; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Himanen JP, 2010, P NATL ACAD SCI USA, V107, P10860, DOI 10.1073/pnas.1004148107; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hsu JY, 2017, NATURE, V550, P255, DOI 10.1038/nature24042; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ito S, 1997, CANCER RES, V57, P2870; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jo S, 2011, J COMPUT CHEM, V32, P3135, DOI 10.1002/jcc.21886; Kjaer S, 2010, NAT STRUCT MOL BIOL, V17, P726, DOI 10.1038/nsmb.1808; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Li J, 2019, ELIFE, V8, DOI [10.7554/eLife.47650, 10.7554/eLife.47650.001]; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Liu YX, 2020, INT J BIOL MACROMOL, V164, P1621, DOI 10.1016/j.ijbiomac.2020.07.290; Liu YX, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198291; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Markham A, 2020, DRUGS, V80, P1119, DOI 10.1007/s40265-020-01343-7; Milbrandt J, 1998, NEURON, V20, P245, DOI 10.1016/S0896-6273(00)80453-5; Mograbi B, 2001, MOL CELL BIOL, V21, P6719, DOI 10.1128/MCB.21.20.6719-6730.2001; Mullican SE, 2017, NAT MED, V23, P1150, DOI 10.1038/nm.4392; MULLIGAN LM, 1994, NAT GENET, V6, P70, DOI 10.1038/ng0194-70; Needham SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13307; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Pall S, 2015, LECT NOTES COMPUT SC, V8759, P3, DOI 10.1007/978-3-319-15976-8_1; Pandurangan AP, 2012, J STRUCT BIOL, V177, P520, DOI 10.1016/j.jsb.2011.10.011; Park SJ, 2019, GLYCOBIOLOGY, V29, P320, DOI 10.1093/glycob/cwz003; Park SJ, 2017, BIOINFORMATICS, V33, P3051, DOI 10.1093/bioinformatics/btx358; Parkash V, 2008, J BIOL CHEM, V283, P35164, DOI 10.1074/jbc.M802543200; PARRINELLO M, 1980, PHYS REV LETT, V45, P1196, DOI 10.1103/PhysRevLett.45.1196; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Patel S, 2019, CELL METAB, V29, P707, DOI 10.1016/j.cmet.2018.12.016; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pintilie G, 2009, 2009 IEEE/NIH LIFE SCIENCE SYSTEMS AND APPLICATIONS WORKSHOP, P44, DOI 10.1109/LISSA.2009.4906705; Romei C, 2016, NAT REV ENDOCRINOL, V12, P192, DOI 10.1038/nrendo.2016.11; Schlee S, 2006, NAT CHEM BIOL, V2, P636, DOI 10.1038/nchembio823; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Serna M, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00033; Shah MH, 2020, J CLIN ONCOL, V38; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tansey MG, 2000, NEURON, V25, P611, DOI 10.1016/S0896-6273(00)81064-8; Topf M, 2008, STRUCTURE, V16, P295, DOI 10.1016/j.str.2007.11.016; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wagner SM, 2012, CLINICS, V67, P77, DOI 10.6061/clinics/2012(Sup01)14; Wagner T, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0437-z; Wells SA, 2015, THYROID, V25, P567, DOI 10.1089/thy.2014.0335; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Xiong YM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8732; Yang LD, 2017, NAT MED, V23, P1158, DOI 10.1038/nm.4394; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang MH, 2017, J CANCER RES THER, V13, P823, DOI 10.4103/jcrt.JCRT_274_17; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	70	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102380	10.1016/j.jbc.2022.102380	http://dx.doi.org/10.1016/j.jbc.2022.102380			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5H1DF	35985422	Green Published, gold			2022-12-26	WOS:000867425500010
J	Bhattarai, K; Richard, T; Fatica, T; Frangione, B; Willmore, WG; Holcik, M				Bhattarai, Krishna; Richard, Travis; Fatica, Thet; Frangione, Brianna; Willmore, William G.; Holcik, Martin			AMPK-related protein kinase ARK5 regulates subcellular localization of RNA-binding protein hnRNP A1 during hypertonic stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR IMPORT; RELOCALIZATION; TRANSLATION; EXPRESSION; TRANSPORT; SIGNAL; EXPORT	The heterogeneous nuclear ribonucleoprotein hnRNP A1 is a nucleocytoplasmic-shuttling RNA-binding protein that plays an important role in nucleic acid metabolism and gene expression regulation. The function of hnRNP A1 is determined in part by its specific location within the cell. Although some work has been done to elucidate the signaling pathways that regulate the cellular localization of hnRNP A1, the precise mechanism(s), including physiological and pathophysiological conditions that alter hnRNP A1 localization, are not known. We previously conducted an unbiased RNAi-based kinomewide screen to identify kinases that regulate hnRNP A1 localization during hypertonic stress. One of the hits from this screen is AMPK-related protein kinase 5 (ARK5). Here, we validate ARK5 as the kinase responsible for controlling hnRNP A1 subcellular localization in response to hypertonic stress. We find using immunoprecipitation and in vitro kinase assay methods that ARK5 directly interacts with and phosphorylates hnRNP A1 on serine residues within the F-peptide region. We further show that the M9 motif of hnRNP A1 is essential for the ARK5-hnRNP A1 interaction and subsequent phosphorylation. In addition, the silencing of ARK5 increases the expression of antiapoptotic protein Bcl-xL and consequently delays caspase activation during hypertonic stress. Our results indicate that ARK5 phosphorylates hnRNP A1 and regulates its subcellular localization during hypertonic stress.	[Bhattarai, Krishna; Fatica, Thet; Frangione, Brianna; Holcik, Martin] Carleton Univ, Dept Hlth Sci, Ottawa, ON, Canada; [Richard, Travis] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Willmore, William G.] Carleton Univ, Dept Biol, Ottawa, ON, Canada	Carleton University; University of Ottawa; Carleton University	Holcik, M (corresponding author), Carleton Univ, Dept Hlth Sci, Ottawa, ON, Canada.	martin.holcik@carleton.ca		Holcik, Martin/0000-0002-1922-5299	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2020-04731, RGPIN-2017-06414]; Alexander Graham Bell Canada Graduate Scholarships Doctoral Award; Ontario Graduate Scholarship	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alexander Graham Bell Canada Graduate Scholarships Doctoral Award; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	Acknowledgments Funding and additional information - This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) (Discovery Grants, RGPIN-2020-04731 to M. H. and RGPIN-2017-06414 to W. G. W.) ; Alexander Graham Bell Canada Graduate Scholarships Doctoral Award and Ontario Graduate Scholarship (to K. B.) .	Allemand E, 2005, P NATL ACAD SCI USA, V102, P3605, DOI 10.1073/pnas.0409889102; Banerjee S, 2014, BIOCHEM J, V461, P233, DOI 10.1042/BJ20140408; Banerjee S, 2014, BIOCHEM J, V457, P215, DOI 10.1042/BJ20131152; Bevilacqua E, 2010, J BIOL CHEM, V285, P17098, DOI 10.1074/jbc.M110.109439; Brocker Chad, 2012, Biomol Concepts, V3, P345; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Cammas A, 2007, MOL BIOL CELL, V18, P5048, DOI 10.1091/mbc.E07-06-0603; Cammas A, 2008, BIOCHEM PHARMACOL, V76, P1395, DOI 10.1016/j.bcp.2008.05.022; Chang XZ, 2012, J CANCER RES CLIN, V138, P247, DOI 10.1007/s00432-011-1102-1; Courteau L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.209; Criollo A, 2007, APOPTOSIS, V12, P3, DOI 10.1007/s10495-006-0328-x; Duan YJ, 2019, CELL RES, V29, P233, DOI 10.1038/s41422-019-0141-z; Faye MD, 2015, BBA-GENE REGUL MECH, V1849, P887, DOI 10.1016/j.bbagrm.2014.09.012; Fridell RA, 1997, J CELL SCI, V110, P1325; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; Hentze MW, 2018, NAT REV MOL CELL BIO, V19, P327, DOI 10.1038/nrm.2017.130; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hou X, 2011, ONCOGENE, V30, P2933, DOI 10.1038/onc.2011.19; Iijima M, 2006, FEBS LETT, V580, P1365, DOI 10.1016/j.febslet.2006.01.058; Izaurralde E, 1997, J CELL BIOL, V137, P27, DOI 10.1083/jcb.137.1.27; Jean-Philippe J, 2013, INT J MOL SCI, V14, P18999, DOI 10.3390/ijms140918999; Kaboord Barbara, 2008, V424, P349, DOI 10.1007/978-1-60327-064-9_27; Lewis SM, 2008, ONCOGENE, V27, P1033, DOI 10.1038/sj.onc.1210777; Lewis SM, 2007, MOL BIOL CELL, V18, P1302, DOI 10.1091/mbc.E06-06-0515; Lu SJ, 2013, EUR J CANCER, V49, P752, DOI 10.1016/j.ejca.2012.09.018; March ZM, 2016, BRAIN RES, V1647, P9, DOI 10.1016/j.brainres.2016.02.037; MICHAEL WM, 1995, CELL, V83, P415; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; Rebane A, 2004, RNA, V10, P590, DOI 10.1261/rna.5224304; Roy R, 2014, NUCLEIC ACIDS RES, V42, P12483, DOI 10.1093/nar/gku953; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SIOMI H, 1995, J CELL BIOL, V129, P551, DOI 10.1083/jcb.129.3.551; Smith JC, 2008, BIOCHEM CELL BIOL, V86, P137, DOI 10.1139/O08-007; Solomon ER, 2021, METHODSX, V8, DOI 10.1016/j.mex.2021.101504; Sun XL, 2013, J MOL ENDOCRINOL, V51, pR15, DOI 10.1530/JME-13-0063; Suzuki A, 2004, ONCOGENE, V23, P7067, DOI 10.1038/sj.onc.1207963; Suzuki A, 2003, J BIOL CHEM, V278, P48, DOI 10.1074/jbc.M206025200; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Zhao TT, 2009, CELL DEATH DIFFER, V16, P244, DOI 10.1038/cdd.2008.146	43	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102364	10.1016/j.jbc.2022.102364	http://dx.doi.org/10.1016/j.jbc.2022.102364			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4V3XX	35963429	gold, Green Published			2022-12-26	WOS:000859414300004
J	Yan, BW; Shashoua, M; Figueroa, JF				Yan, Brandon W.; Shashoua, Maya; Figueroa, Jose F.			Changes in spending, utilization, and quality of care among Medicare accountable care organizations during the COVID-19 pandemic	PLOS ONE			English	Article								The COVID pandemic disrupted health care spending and utilization, and the Medicare Shared Savings Program (MSSP), Medicare's largest value-based payment model with 11.2 million assigned beneficiaries, was no exception. Despite COVID, the 513 accountable care organizations (ACO) in MSSP returned a program record $1.9 billion in net savings to Medicare in 2020. To understand the extent of COVID's impact on MSSP cost and quality, we describe how ACO spending changed in 2020 and further analyze changes in measured quality and utilization. We found that non-COVID per capita spending in MSSP fell by 8.3 percent from $11,496 to $10,537 (95% confidence interval(CI),-1,223.8 to-695.4, p< 0.001), driven by 14.6% and 7.5% reductions in per capita acute inpatient and outpatient spending, respectively. Utilization fell across inpatient, emergency, and outpatient settings. On quality metrics, preventive screening rates remained stable or improved, while control of diabetes and blood pressure worsened. Large reductions in non-COVID utilization helped ACOs succeed financially in 2020, but worsening chronic disease measures are concerning. The appropriateness of the benchmark methodology and exclusion of COVID-related spending, especially as the virus approaches endemicity, should be revisited to ensure bonus payments reflect advances in care delivery and health outcomes rather than COVID-related shifts in spending and utilization patterns.	[Yan, Brandon W.; Shashoua, Maya; Figueroa, Jose F.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Yan, Brandon W.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; [Figueroa, Jose F.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco; Harvard University; Harvard Medical School	Yan, BW (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.; Yan, BW (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.	Brandon.Yan@ucsf.edu						Adam L., 2021, DECREASING PRIMARY C; Zuniga-Gonzalez CA, 2021, REV ELECTRON CALID E, V12, P279, DOI 10.22458/caes.v12i2.3730; [Anonymous], 2020, CMS ANN REL CLIN PRO; [Anonymous], 2020, TRUMP ADM ISS 2 ROUN; [Anonymous], 2020, SURV SHOWS ACOSCONCE; [Anonymous], 2019, PREV6NQF0034 CTR MED; Bleser W, 2018, HLTH AFFAIRS BLOG, DOI [10.1377/hblog20180918.957502/full/, DOI 10.1377/HBLOG20180918.957502/FULL]; Bleser WK, 2020, HLTH AFFAIRS BLOG, DOI [10.1377/hblog20200410.281882/full/, DOI 10.1377/HBLOG20200410.281882/FULL]; Chaudry B, 2020, HLTH AFFAIRS BLOG, DOI [10.1377/hblog20200406.985172/full/, DOI 10.1377/HBLOG20200406.985172/FULL]; Chernew ME, 2021, C MED HLTH CAR DEL S; Esposito C, 2020, J LAPAROENDOSC ADV S, V30, P915, DOI 10.1089/lap.2020.0251; Finkelstein A, 2020, NEW ENGL J MED, V382, P152, DOI 10.1056/NEJMsa1906848; Gonzalez-Smith J, 2019, HLTH AFFAIRS BLOG, DOI [10.1377/hblog20191024.65681/full/, DOI 10.1377/HBLOG20191024.65681/FULL]; Gonzalez-Smith J, 2020, HLTH AFFAIRS FOREFRO, DOI [10.1377/forefront.20201016.884678/full/, DOI 10.1377/FOREFRONT.20201016.884678/FULL]; Hacker KA, 2021, PREV CHRONIC DIS, V18, DOI 10.5888/pcd18.210086; Heist T, 2021, TRENDS OVERALL NONCO; Kazberouk A., 2020, HLTH AFFAIRS BLOG, DOI [10.1377/hblog20200331.712243/full/, DOI 10.1377/HBLOG20200331.712243/FULL]; Liu X., 2021, ENVIRON RES, V195, DOI [DOI 10.1016/j.envres.2021.110874, 10.1016/j.envres.2021.110874, DOI 10.1016/J.ENVRES.2021.110874]; McWilliams JM, 2017, JAMA INTERN MED, V177, P518, DOI 10.1001/jamainternmed.2016.9115; McWilliams JM, 2020, HLTH AFFAIRS BLOG, DOI [10.1377/hblog20201106.1578/full/, DOI 10.1377/HBLOG20201106.1578/FULL]; McWilliams JM, 2020, HLTH AFFAIRS BLOG, DOI [10.1377/hblog20201106.719550/full/, DOI 10.1377/HBLOG20201106.719550/FULL]; McWilliams JM, 2019, WORKING PAPER SERIES; Mechanic R, 2020, HLTH AFFAIRS BLOG, DOI [10.1377/hblog20200528.214278/full/, DOI 10.1377/HBLOG20200528.214278/FULL]; Mehrotra A, 2021, IMPACT COVID 19 OUTP; Ouayogode MH, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.6939; Si YJ, 2022, JAMA-HEALTH FORUM, V3, DOI 10.1001/jamahealthforum.2021.4452; Tsai TC, 2021, JAMA-HEALTH FORUM, V2, DOI 10.1001/jamahealthforum.2021.4214; Zhu M, 2021, HLTH AFFAIRS BLOG, DOI [10.1377/hblog20211008.785640/full/, DOI 10.1377/HBLOG20211008.785640/FULL]; Zuniga-Gonzalez CA A., 2021, CORRELATION SOLAR RA, P1	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2022	17	8							e0272706	10.1371/journal.pone.0272706	http://dx.doi.org/10.1371/journal.pone.0272706			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6W0BO	35960735	gold, Green Published			2022-12-26	WOS:000895401600001
J	Luciano, AK; Korobkina, ED; Lyons, SP; Haley, JA; Fluharty, SM; Jung, SM; Kettenbach, AN; Guertin, DA				Luciano, Amelia K.; Korobkina, Ekaterina D.; Lyons, Scott P.; Haley, John A.; Fluharty, Shelagh M.; Jung, Su Myung; Kettenbach, Arminja N.; Guertin, David A.			Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOTIN LIGASE; CELL-GROWTH; ACTIVATION; PHOSPHORYLATION; INSULIN; SUBSTRATE; PROTEINS; REVEALS; AKT/PKB; GTPASE	Mechanistic target of rapamycin (mTOR) complex 2 (mTORC2) regulates metabolism, cell proliferation, and cell survival. mTORC2 activity is stimulated by growth factors, and it phosphorylates the hydrophobic motif site of the AGC ki-nases AKT, SGK, and PKC. However, the proteins that interact with mTORC2 to control its activity and localization remain poorly defined. To identify mTORC2-interacting proteins in living cells, we tagged endogenous RICTOR, an essential mTORC2 subunit, with the modified BirA biotin ligase BioID2 and performed live-cell proximity labeling. We identified 215 RICTOR-proximal proteins, including proteins with known mTORC2 pathway interactions, and 135 proteins (63%) not previously linked to mTORC2 signaling, including nuclear and cytoplasmic proteins. Our imaging and cell fractionation ex-periments suggest nearly 30% of RICTOR is in the nucleus, hinting at potential nuclear functions. We also identified 29 interactors containing RICTOR-dependent, insulin-stimulated phosphorylation sites, thus providing insight into mTORC2-dependent insulin signaling dynamics. Finally, we identify the endogenous ADP ribosylation factor 1 (ARF1) GTPase as an mTORC2-interacting protein. Through gain-of-function and loss-of-function studies, we provide functional evidence that ARF1 may negatively regulate mTORC2. In summary, we present a new method of studying endogenous mTORC2, a resource of RICTOR/mTORC2 protein interactions in living cells, and a potential mechanism of mTORC2 regulation by the ARF1 GTPase.	[Luciano, Amelia K.; Korobkina, Ekaterina D.; Haley, John A.; Fluharty, Shelagh M.; Jung, Su Myung; Guertin, David A.] Univ Massachusetts, Program Mol Med, Chan Med Sch, Worcester, MA 01605 USA; [Lyons, Scott P.; Kettenbach, Arminja N.] Geisel Sch Med Dartmouth, Dept Biochem & Cell Biol, Hanover, NH USA; [Kettenbach, Arminja N.] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Hanover, NH USA; [Guertin, David A.] Univ Massachusetts, Dept Mol Cell & Canc Biol, Chan Med Sch, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; University of Massachusetts System; University of Massachusetts Worcester	Guertin, DA (corresponding author), Univ Massachusetts, Program Mol Med, Chan Med Sch, Worcester, MA 01605 USA.; Guertin, DA (corresponding author), Univ Massachusetts, Dept Mol Cell & Canc Biol, Chan Med Sch, Worcester, MA 01605 USA.	David.Guertin@umassmed.edu		Kettenbach, Arminja/0000-0003-3979-4576	National Institutes of Health (NIH); American Cancer Society Fellowship [R01CA196986, R01DK094004, R01DK116005, R35GM119455]; American Diabetes Association [PF-19-103-01-TBE];  [1-18-PDF-128]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Fellowship(American Cancer Society); American Diabetes Association(American Diabetes Association); 	D. A. G. is supported by National Institutes of Health (NIH) grants R01CA196986,R01DK094004, and R01DK116005. A. N. K is supported by NIH R35GM119455. A. K. L was supported by an American Cancer Society Fellowship (PF-19-103-01-TBE). S. M. J was supported by apostdoctoral fellowship from the American Diabetes Association (1-18-PDF-128). The content is solely the responsibility of the authorsand does not necessarily represent the official views of the NationalInstitutes of Health	Alvarado E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166984; Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Audet-Walsh E, 2017, GENE DEV, V31, P1228, DOI 10.1101/gad.299958.117; Boulay PL, 2008, J BIOL CHEM, V283, P36425, DOI 10.1074/jbc.M803603200; Casalou C, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00217; Che YL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13106-4; Chen XZ, 2018, CELL RES, V28, P518, DOI 10.1038/s41422-018-0029-3; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Condon KJ, 2019, J CELL SCI, V132, DOI 10.1242/jcs.222570; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Cui Y, 2019, ONCOGENE, V38, P6370, DOI 10.1038/s41388-019-0883-6; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Dumont AA, 2019, BBA-MOL CELL RES, V1866, DOI 10.1016/j.bbamcr.2019.118557; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Eng JK, 2013, PROTEOMICS, V13, P22, DOI 10.1002/pmic.201200439; Entwisle SW, 2020, MOL CELL PROTEOMICS, V19, P1104, DOI 10.1074/mcp.RA120.001946; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Furman C, 2002, J BIOL CHEM, V277, P7962, DOI 10.1074/jbc.M109149200; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Ghosh P, 2008, CELL CYCLE, V7, P373, DOI 10.4161/cc.7.3.5267; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Gong LM, 1999, J BIOL CHEM, V274, P12036, DOI 10.1074/jbc.274.17.12036; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Haines E, 2015, CANCER BIOL THER, V16, P1535, DOI 10.1080/15384047.2015.1071737; He LL, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1080-8; Holla S, 2014, AUTOPHAGY, V10, P311, DOI 10.4161/auto.27225; Horn M, 2014, DEV CELL, V28, P697, DOI 10.1016/j.devcel.2014.01.028; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Hung Victoria, 2019, Elife, V8, DOI 10.7554/eLife.50707; Hwang Y, 2019, CANCER RES, V79, P3178, DOI 10.1158/0008-5472.CAN-18-3658; Jain A, 2014, P NATL ACAD SCI USA, V111, P17833, DOI 10.1073/pnas.1419425111; Jung SM, 2019, MOL CELL, V75, P807, DOI 10.1016/j.molcel.2019.07.023; Karnam P, 1997, J BIOL CHEM, V272, P6136, DOI 10.1074/jbc.272.10.6136; Kim DI, 2016, MOL BIOL CELL, V27, P1188, DOI 10.1091/mbc.E15-12-0844; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim S, 2021, CANCERS, V13, DOI 10.3390/cancers13102405; Krieger KL, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20235876; Liu GX, 2020, NATURE, V577, P695, DOI 10.1038/s41586-020-1947-z; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Mirza AN, 2019, CELL, V176, P198, DOI 10.1016/j.cell.2018.10.054; Murray JT, 2004, BIOCHEM J, V384, P489, DOI 10.1042/BJ20041058; Nie XG, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007491; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Paek J, 2017, CELL, V169, P338, DOI 10.1016/j.cell.2017.03.028; Pan CP, 2009, MOL CELL PROTEOMICS, V8, P2796, DOI 10.1074/mcp.M900285-MCP200; Qin W, 2021, NAT METHODS, V18, P133, DOI 10.1038/s41592-020-01010-5; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Rosner M, 2007, AMINO ACIDS, V33, P575, DOI 10.1007/s00726-007-0541-0; Rosner M, 2008, HUM MOL GENET, V17, P2934, DOI 10.1093/hmg/ddn192; Rosner M, 2012, METHODS MOL BIOL, V821, P105, DOI 10.1007/978-1-61779-430-8_8; Roux Kyle J, 2013, Curr Protoc Protein Sci, V74, DOI 10.1002/0471140864.ps1923s74; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scaiola A, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc1251; Schonbrun M, 2013, J BIOL CHEM, V288, P19649, DOI 10.1074/jbc.M113.464974; Schwanhausser B, 2013, NATURE, V495, P126, DOI 10.1038/nature11848; Shome K, 1997, CURR BIOL, V7, P387, DOI 10.1016/S0960-9822(06)00186-2; Valot B, 2011, PROTEOMICS, V11, P3572, DOI 10.1002/pmic.201100120; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wallroth A, 2019, NAT CELL BIOL, V21, P1093, DOI 10.1038/s41556-019-0377-3; Wang T, 2012, MOL CELL BIOL, V32, P2203, DOI 10.1128/MCB.06474-11; Yan Lijun, 2008, Biochem J, V416, pe19, DOI 10.1042/BJ20082202; Yang PY, 2016, BIOINFORMATICS, V32, P252, DOI 10.1093/bioinformatics/btv550; Yoon SO, 2008, MOL CELL, V29, P362, DOI 10.1016/j.molcel.2007.12.024; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhao Y, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.125; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014	71	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102379	10.1016/j.jbc.2022.102379	http://dx.doi.org/10.1016/j.jbc.2022.102379			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5L6PJ	35973513	Green Published, gold			2022-12-26	WOS:000870533300001
J	Newson, L; Parody, FH				Newson, Lisa; Parody, Francesca Helen			Investigating the experiences of low-carbohydrate diets for people living with Type 2 Diabetes: A thematic analysis	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; QUALITATIVE RESEARCH; MANAGEMENT; RECOMMENDATIONS; ADULTS; FATS	Low-Carbohydrate Diets (LCDs) are becoming increasingly popular to manage Type 2 diabetes mellitus (T2DM). However, there is a need to identify people with T2DM's understanding of LCDs, their reasons for engaging in such a diet, how they sustain it and any challenges they face. This study aimed to assess the experience of adhering to a LCD within a sample of individuals with T2DM. Ten participants with T2DM were recruited using a self-selecting sampling method from an online diabetes community that promotes LCDs. Participants completed one-to-one digitally recorded semi-structured interviews, which were later transcribed verbatim and data subjected to Thematic Analysis. Five core themes and twelve subthemes were developed during the analysis: (1) Lack of professional guidance; (2) Fear of complications & long-term medication use; (3) Dietary control as motivation; (4) Positive health outcomes; and (5) Social support. The findings are discussed with reference to a psychological model of behaviour, COM-B. Participants reported gaining knowledge and skills to increase their Capability to engage in LCDs, Motivation to manage diabetes outcomes influenced adherence. However, challenges were reported with the Opportunity to engage in behaviour, mainly influenced by social support. Health professionals and significant others may benefit from resources to help build knowledge and understanding and assist with maintaining a LCD long-term.	[Newson, Lisa; Parody, Francesca Helen] Liverpool John Moores Univ, Fac Hlth, Sch Psychol, Liverpool, Merseyside, England; [Parody, Francesca Helen] Wellcome Trust Res Labs, London, England	Liverpool John Moores University; University of Liverpool	Newson, L (corresponding author), Liverpool John Moores Univ, Fac Hlth, Sch Psychol, Liverpool, Merseyside, England.	l.m.newson@ljmu.ac.uk		Newson, Lisa/0000-0002-5874-8762				Ajzen I., 1985, ACTION CONTROL, P11, DOI [10.1007/978-3-642-69746-3_2, DOI 10.1007/978-3-642-69746-3_2]; Amer Diabet Assoc, 2020, DIABETES CARE, V43, pS48, DOI 10.2337/dc20-S005; American Diabetes Association, 2019, Clin Diabetes, V37, P11, DOI 10.2337/cd18-0105; Arnason TG, 2017, WORLD J DIABETES, V8, P154, DOI 10.4239/wjd.v8.i4.154; Australia Diabetes., 2018, DIABETES AUSTR; Booth AO, 2013, PRIM HEALTH CARE RES, V14, P293, DOI 10.1017/S1463423612000412; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Braun V, 2019, QUAL RES SPORT EXERC, V11, P589, DOI 10.1080/2159676X.2019.1628806; Brouns F, 2018, EUR J NUTR, V57, P1301, DOI 10.1007/s00394-018-1636-y; Brown A., 2017, FEELING EUPHORIC LOW; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Choak C., 2012, RES RES METHODS YOUT, P90; Cucuzzella MT., 2017, J INSULIN RESISTANCE, V1, P1, DOI [10.4102/jir.v2i1.30, DOI 10.4102/JIR.V2I1.30]; Davies MJ, 2018, DIABETES CARE, V41, P2669, DOI 10.2337/dci18-0033; Dehghan M, 2017, LANCET, V390, P2050, DOI [10.1016/S0140-6736(17)32252-3, 10.1016/s0140-6736(17)32252-3]; diabetes.co.uk , 2022, EMPOWER YOUR PATIENT; Diabetes UK., 2014, COST DIABETES REPORT; Diabetes UK., 2021, POSITION STATEMENT L; Diabetes UK., 2021, DIABETES UK; Ebbeling CB, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4583; Eenfeldt A., 2020, LOW CARB IS LOW CARB; Evert AB, 2014, DIABETES CARE, V37, pS120, DOI 10.2337/dc14-S120; Fade SA, 2003, J HUM NUTR DIET, V16, P139, DOI 10.1046/j.1365-277X.2003.00433.x; Feinman RD, 2015, NUTRITION, V31, P1, DOI 10.1016/j.nut.2014.06.011; Forouhi NG, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2234; Forouhi NG, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2139; Hallberg SJ, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040766; Heale Roberta, 2013, Evid Based Nurs, V16, P98, DOI 10.1136/eb-2013-101494; Holman N, 2015, DIABETIC MED, V32, P1119, DOI 10.1111/dme.12791; Huntriss R, 2018, EUR J CLIN NUTR, V72, DOI 10.1038/s41430-017-0019-4; Kelly T, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072557; Khazrai YM, 2014, DIABETES-METAB RES, V30, P24, DOI 10.1002/dmrr.2515; Kirkpatrick CF, 2019, J CLIN LIPIDOL, V13, P689, DOI 10.1016/j.jacl.2019.08.003; Lean MEJ, 2018, LANCET, V391, P541, DOI 10.1016/S0140-6736(17)33102-1; Masharani U, 2015, EUR J CLIN NUTR, V69, P944, DOI 10.1038/ejcn.2015.39; McArdle PD, 2017, J HUM NUTR DIET, V30, P385, DOI 10.1111/jhn.12436; Michie S., 2014, BEHAV CHANGE WHEEL B; Morris E, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026460; Murdoch C, 2019, BRIT J GEN PRACT, V69, P360, DOI 10.3399/bjgp19X704525; National Health Service, 2022, EAT WELL NHS; National Institute for Health and Care Execllence (NICE), 2015, TYPE 2 DIAB AD MAN N; Patterson CC, 2019, DIABETES RES CLIN PR, V157, DOI 10.1016/j.diabres.2019.107842; Sacks FM, 2017, CIRCULATION, V136, pE1, DOI 10.1161/CIR.0000000000000510; Sainsbury E, 2018, DIABETES RES CLIN PR, V139, P239, DOI 10.1016/j.diabres.2018.02.026; Savoca M, 2001, J NUTR EDUC, V33, P224, DOI 10.1016/S1499-4046(06)60035-3; Shao YC, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/2804178; Snorgaard O, 2017, BMJ OPEN DIAB RES CA, V5, DOI 10.1136/bmjdrc-2016-000354; Tay J, 2015, AM J CLIN NUTR, V102, P780, DOI 10.3945/ajcn.115.112581; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vijan S, 2005, DIABETIC MED, V22, P32, DOI 10.1111/j.1464-5491.2004.01342.x; Wang LL, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060661; Webster CC, 2019, DIABETES METAB SYNDR, V12, P2567, DOI 10.2147/DMSO.S227090	52	0	0	9	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0273422	10.1371/journal.pone.0273422	http://dx.doi.org/10.1371/journal.pone.0273422			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994442	gold, Green Published, Green Accepted			2022-12-26	WOS:000877093400052
J	Wu, E; Ni, JT; Tao, L; Xie, T				Wu, E.; Ni, Juntao; Tao, Lin; Xie, Tian			A bidirectional Mendelian randomization study supports the causal effects of a high basal metabolic rate on colorectal cancer risk	PLOS ONE			English	Article							ADIPOSITY	Purpose We conducted a bidirectional two-sample Mendelian randomization (MR) study to determine whether genetically predicted basal metabolic rate (BMR) was a causal risk factor for colorectal cancer (CRC) or whether a genetically predicted CRC risk can influence the BMR level (i.e., reverse causation). Methods We employed 1,040 genetic variants as proxies for BMR to obtain effect estimates on CRC risk. Another 58 CRC-associated variants were used to estimate effects on BMR levels. Stratified analysis by tumor site was used to examine the causal associations between BMR and colon/rectal cancer risk. Results The inverse variance weighted (IVW) method indicated a significant causal effect of genetically determined BMR on CRC risk (ORSD = 1.27, 95% CI = 1.07-1.51). No significant reverse causal association was identified between genetically increased CRC risk and BMR levels [IVW (beta = 0, 95% CI = -0.01 to 0)]. The results of MR-Egger and the weighted median method were consistent with the IVW method. Stratified analysis by CRC sites identified significant causal associations between BMR and colon cancer [IVW (ORSD = 1.45, 95% CI = 1.16-1-80)], and null evidence of a causal association between BMR and rectal cancer risk was found (p > 0.05). Conclusion Our findings add to the current literature by validating a positive relationship between high BMR levels and CRC risk instead of reverse causality. The genetically predicted BMR level was causally associated with colon cancer risk but not rectal cancer risk.	[Wu, E.; Tao, Lin; Xie, Tian] Hangzhou Normal Univ, Sch Pharm, Hangzhou, Zhejiang, Peoples R China; [Wu, E.; Tao, Lin; Xie, Tian] Hangzhou Normal Univ, Collaborat Innovat Ctr Tradit Chinese Med Zhejian, Key Lab Elemene Class Anticanc Chinese Med, Engn Lab Dev & Applicat Tradit Chinese Med, Hangzhou, Zhejiang, Peoples R China; [Ni, Juntao] Zhejiang Univ, Womens Hosp, Sch Med, Hangzhou, Zhejiang, Peoples R China	Hangzhou Normal University; Hangzhou Normal University; Zhejiang University	Tao, L; Xie, T (corresponding author), Hangzhou Normal Univ, Sch Pharm, Hangzhou, Zhejiang, Peoples R China.; Tao, L; Xie, T (corresponding author), Hangzhou Normal Univ, Collaborat Innovat Ctr Tradit Chinese Med Zhejian, Key Lab Elemene Class Anticanc Chinese Med, Engn Lab Dev & Applicat Tradit Chinese Med, Hangzhou, Zhejiang, Peoples R China.	taolin@hznu.edu.cn; xbs@hznu.edu.cn		Wu, E/0000-0002-5454-552X	General Projects of National Natural Science Foundation of China [81973635]; Start-up Grant of HZNU [4125C5021720421]	General Projects of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Start-up Grant of HZNU	This research was funded by the General Projects of National Natural Science Foundation of China (81973635) (to Tian Xie), the Start-up Grant of HZNU (4125C5021720421) (to Lin Tao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SJ, 2020, ALZHEIMERS DEMENT, V16, P345, DOI 10.1016/j.jalz.2019.09.086; Araghi M, 2019, LANCET GASTROENTEROL, V4, P511, DOI 10.1016/S2468-1253(19)30147-5; Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bull Caroline J, 2020, BMC Med, V18, P396, DOI 10.1186/s12916-020-01855-9; Chen X, 2020, CANCER MED-US, V9, P9160, DOI 10.1002/cam4.3493; Cornish AJ, 2020, LANCET GASTROENTEROL, V5, P55, DOI 10.1016/S2468-1253(19)30294-8; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Dimou N, 2021, CANCER EPIDEM BIOMAR, V30, P953, DOI 10.1158/1055-9965.EPI-20-1218; Drabsch T, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00556; Emdin CA, 2017, JAMA-J AM MED ASSOC, V318, P1925, DOI 10.1001/jama.2017.17219; He YZ, 2022, INT J CANCER, V150, P303, DOI 10.1002/ijc.33779; Henry CJK, 2005, PUBLIC HEALTH NUTR, V8, P1133, DOI 10.1079/PHN2005801; Huyghe JR, 2019, NAT GENET, V51, P76, DOI 10.1038/s41588-018-0286-6; Kliemann N., 2018, REV D PID MIOLOGIE S, V66, DOI [10.1016/j.respe.2018.05.049, DOI 10.1016/J.RESPE.2018.05.049]; Kliemann N, 2020, INT J CANCER, V147, P648, DOI 10.1002/ijc.32753; Larsson SC, 2017, JAMA-J AM MED ASSOC, V318, P371, DOI 10.1001/jama.2017.8981; Liang XY, 2017, CANCER EPIDEM BIOMAR, V26, P155, DOI [10.1158/1055-9965.EPI-16-0761, 10.1158/1055-9965.epi-16-0761]; Liemburg-Apers DC, 2015, ARCH TOXICOL, V89, P1209, DOI 10.1007/s00204-015-1520-y; Little M, 2018, J R STAT SOC A STAT, V181, P549, DOI 10.1111/rssa.12343; Loh PR, 2018, NAT GENET, V50, P906, DOI 10.1038/s41588-018-0144-6; Ng JCM, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.735541; Porporato PE, 2018, CELL RES, V28, P265, DOI 10.1038/cr.2017.155; Rawla P, 2019, GASTROENTEROL REV, V14, P89, DOI 10.5114/pg.2018.81072; Rodriguez-Broadbent H, 2017, INT J CANCER, V140, P2701, DOI 10.1002/ijc.30709; Sanderson E, 2021, STAT MED, V40, P5434, DOI 10.1002/sim.9133; Siegel RL, 2019, GUT, V68, P2179, DOI 10.1136/gutjnl-2019-319511; Sui XB, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01371; Suzuki S, 2021, CANCER SCI, V112, P1579, DOI 10.1111/cas.14824; Trudel-Fitzgerald C, 2017, CURR OPIN BEHAV SCI, V15, P16, DOI 10.1016/j.cobeha.2017.05.003; Urakawa H, 2003, J CLIN ENDOCR METAB, V88, P4673, DOI 10.1210/jc.2003-030202; Xian W, 2021, J CANCER RES CLIN, V147, P177, DOI 10.1007/s00432-020-03409-1; Zhang XM, 2021, BRIT J CANCER, V124, P1330, DOI 10.1038/s41416-020-01236-2; Zhang Ying, 2016, Wei Sheng Yan Jiu, V45, P739; Zhao SS, 2020, ANN RHEUM DIS, V79, P883, DOI 10.1136/annrheumdis-2020-217200	35	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0273452	10.1371/journal.pone.0273452	http://dx.doi.org/10.1371/journal.pone.0273452			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994506	Green Published, gold			2022-12-26	WOS:000877093400053
J	Wu, J; Liu, Y; Zhu, YP; Li, Z				Wu, Jin; Liu, Yong; Zhu, Yuanpei; Li, Zun			Atrous residual convolutional neural network based on U-Net for retinal vessel segmentation	PLOS ONE			English	Article							IMAGES; MODEL	Extracting features of retinal vessels from fundus images plays an essential role in computer-aided diagnosis of diseases, such as diabetes, hypertension, and cerebrovascular diseases. Although a number of deep learning-based methods have been used in this field, the accuracy of retinal vessel segmentation remains challenging due to limited densely annotated data, inter-vessel differences, and structured prediction problems, especially in areas of small blood vessels and the optic disk. In this paper, we propose an ARN model with a atrous block to address these issues, which can avoid the loss of data structure, and enlarge the receptive field, so that each convolution output contains a larger range of information. In addition, we also introduce residual convolution network to increase the network depth and improve the network performance.Some key parameters are used to measure the feasibility of the model, such as sensitivity (Se), specificity (Sp), F1-score (F1), accuracy (Acc), and area under each curve (AUC). Experimental results on two benchmark datasets demonstrate the effectiveness of the proposed methods, which accuracy are 0.9686 on the DRIVE and 0.9746 on the CHASE DB1. The segmentation structure can assist the doctor in diagnosis more effectively.	[Wu, Jin; Liu, Yong] Wuhan Univ Sci & Technol, Sch Informat Sci & Engn, Wuhan, Peoples R China; [Liu, Yong] Xinxiang Med Univ, Sch Med Engn, Xinxiang, Peoples R China; [Zhu, Yuanpei; Li, Zun] Xinxiang Univ, Sch Phys & Elect Engn, Xinxiang, Peoples R China	Wuhan University of Science & Technology; Xinxiang Medical University; Xinxiang University	Liu, Y (corresponding author), Wuhan Univ Sci & Technol, Sch Informat Sci & Engn, Wuhan, Peoples R China.; Liu, Y (corresponding author), Xinxiang Med Univ, Sch Med Engn, Xinxiang, Peoples R China.	141001@xxmu.edu.cn						Adapa D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229831; Aghamohamadian-Sharbaf M, 2016, IEEE J BIOMED HEALTH, V20, P586, DOI 10.1109/JBHI.2015.2396198; Akram MU, 2009, ICDIP 2009: INTERNATIONAL CONFERENCE ON DIGITAL IMAGE PROCESSING, PROCEEDINGS, P34, DOI 10.1109/ICDIP.2009.70; Azzopardi G, 2015, MED IMAGE ANAL, V19, P46, DOI 10.1016/j.media.2014.08.002; Changlu Guo, 2020, Neural Information Processing. 27th International Conference, ICONIP 2020. Proceedings. Lecture Notes in Computer Science (LNCS 12532), P509, DOI 10.1007/978-3-030-63830-6_43; Chen LC, 2018, IEEE T PATTERN ANAL, V40, P834, DOI 10.1109/TPAMI.2017.2699184; Enhua Wu, 2019, Arxiv, DOI arXiv:1709.01507; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Fraz MM, 2012, COMPUT METH PROG BIO, V108, P600, DOI 10.1016/j.cmpb.2011.08.009; Fraz MM, 2012, COMPUT METH PROG BIO, V108, P407, DOI 10.1016/j.cmpb.2012.03.009; Fraz MM, 2012, IEEE T BIO-MED ENG, V59, P2538, DOI 10.1109/TBME.2012.2205687; Guariglia E, 2016, ENTROPY-SWITZ, V18, DOI 10.3390/e18030084; Guido R., 2009, ENG MED BIOL MAGAZIN, V28, P13, DOI [10.1109/MEMB.2009.934243, DOI 10.1109/MEMB.2009.934243]; Guido RC, 2015, IEEE SIGNAL PROC MAG, V32, P162, DOI 10.1109/MSP.2014.2368586; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; Hu K, 2018, NEUROCOMPUTING, V309, P179, DOI 10.1016/j.neucom.2018.05.011; Huang G., 2018, P INT C LEARNING REP, P1, DOI 10.48550/arXiv.1703.09844; Orlando JI, 2017, IEEE T BIO-MED ENG, V64, P16, DOI 10.1109/TBME.2016.2535311; Jian Sun, 2016, Arxiv, DOI arXiv:1603.05027; Jiang XY, 2003, IEEE T PATTERN ANAL, V25, P131, DOI 10.1109/TPAMI.2003.1159954; Juntang Zhuang, 2019, Arxiv, DOI arXiv:1810.07810; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Kumar S, 2020, OPT LASER TECHNOL, V121, DOI 10.1016/j.optlastec.2019.105815; Kushol R, 2020, IEEE IMAGE PROC, P398, DOI 10.1109/ICIP40778.2020.9190759; Li QL, 2016, IEEE T MED IMAGING, V35, P109, DOI 10.1109/TMI.2015.2457891; [梁礼明 Liang Liming], 2018, [计算机学报, Chinese Journal of Computers], V41, P1678; Liang M., 2017, APPL SCI TECHNOLOGY, V44, P67; Mondal SS, 2020, PROCEDIA COMPUT SCI, V167, P2060, DOI 10.1016/j.procs.2020.03.246; Orujov F, 2020, APPL SOFT COMPUT, V94, DOI 10.1016/j.asoc.2020.106452; Ronneberger O., 2015, U NET CONVOLUTIONAL, P234; Roychowdhury S, 2015, IEEE T BIO-MED ENG, V62, P1738, DOI 10.1109/TBME.2015.2403295; Roychowdhury S, 2015, IEEE J BIOMED HEALTH, V19, P1118, DOI 10.1109/JBHI.2014.2335617; Sahlsten J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47181-w; Sakaguchi A., 2019, P 2019 9 INT C BIOME, P190; Sato Y, 1998, Med Image Anal, V2, P143, DOI 10.1016/S1361-8415(98)80009-1; Shen Li, 2020, Neural Information Processing. 27th International Conference, ICONIP 2020. Proceedings. Lecture Notes in Computer Science (LNCS 12532), P592, DOI 10.1007/978-3-030-63830-6_50; Shen YX, 2020, MED IMAGE ANAL, V61, DOI 10.1016/j.media.2020.101654; Sohini R., 2015, BIOMED HLTH INFORM, V19, P1118, DOI [10.1109/TMI.2007.898551, DOI 10.1109/TMI.2007.898551]; Solomon SD, 2017, DIABETES CARE, V40, P412, DOI 10.2337/dc16-2641; Staal J, 2004, IEEE T MED IMAGING, V23, P501, DOI 10.1109/TMI.2004.825627; Wang B, 2019, LECT NOTES COMPUT SC, V11764, P84, DOI 10.1007/978-3-030-32239-7_10; Wang TT, 2017, IEEE I CONF COMP VIS, P4039, DOI 10.1109/ICCV.2017.433; Wang Y., 2020, NEURAL INFORM PROCES, V2532, DOI [10.1007/978-3-030-63830-6_6, DOI 10.1007/978-3-030-63830-6_6]; Wu YC, 2019, LECT NOTES COMPUT SC, V11764, P264, DOI 10.1007/978-3-030-32239-7_30; Wu YC, 2018, LECT NOTES COMPUT SC, V11071, P119, DOI 10.1007/978-3-030-00934-2_14; Zhang D., 2020, NEURAL INFORM PROCES, V2532, DOI [10.1007/978-3-030-63830-6_20, DOI 10.1007/978-3-030-63830-6_20]; Zhang J, 2017, PATTERN RECOGN, V69, P107, DOI 10.1016/j.patcog.2017.04.008; Zhang J, 2016, IEEE T MED IMAGING, V35, P2631, DOI 10.1109/TMI.2016.2587062; Zhao YT, 2015, IEEE T MED IMAGING, V34, P1797, DOI 10.1109/TMI.2015.2409024	50	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0273318	10.1371/journal.pone.0273318	http://dx.doi.org/10.1371/journal.pone.0273318			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994494	Green Published, gold			2022-12-26	WOS:000877093400044
J	Husain, F; Powys, VR; White, E; Jones, R; Goldsmith, LP; Heath, PT; Oakeshott, P; Razai, MS				Husain, Fatima; Powys, Veronica R.; White, Eleanor; Jones, Roxanne; Goldsmith, Lucy P.; Heath, Paul T.; Oakeshott, Pippa; Razai, Mohammad Sharif			COVID-19 vaccination uptake in 441 socially and ethnically diverse pregnant women	PLOS ONE			English	Article							INFECTION; ENGLAND	Objective To explore COVID-19 vaccination uptake, facilitators and barriers in ethnically-diverse pregnant women. Design and setting An anonymous quality improvement questionnaire survey exploring COVID-19 vaccination uptake, causes of vaccine hesitancy and trusted sources of information among pregnant women in two acute district general hospitals in England (Berkshire and Surrey) between 1.9.21 and 28.2.22. Population 441 pregnant women attending routine antenatal clinic appointments. Methods Consented pregnant women completed the survey either electronically using a QR code or on paper. Descriptive data were summarised and free text responses were thematically analysed. Results 441 pregnant women, mean age 32 years (range 17-44), completed the survey. Twenty-six percent were from ethnic minority groups, and 31% had a co-morbid health condition. Most respondents (66.2%) had been vaccinated against COVID-19 with at least one dose (White British 71.9%, Asian 67.9%, White-other 63.6%, Black 33%). The most common reasons for not being vaccinated were concerns about effects on the unborn baby and future pregnancies, anxiety about possible adverse impact on the mother, not enough known about the vaccine, and lack of trust in vaccines. Comments included: "I'd rather not risk injecting the unknown into my body", and "I don't trust it." Although 23% used social media for information on COVID-19 vaccination, the most trusted sources were the patient's GP and midwife (43%) and official health-related websites such as NHS (39%). Conclusions A third of these pregnant women had not been vaccinated against COVID-19. Trusted health professionals like midwives and GPs could have a crucial role in increasing vaccination uptake.	[Husain, Fatima; Powys, Veronica R.; White, Eleanor; Jones, Roxanne] Frimley Hlth Fdn Trust, Dept Obstet & Gynaecol, Wexham Pk Hosp, Frimley, England; [Goldsmith, Lucy P.; Oakeshott, Pippa; Razai, Mohammad Sharif] St Georges Univ London, Populat Hlth Res Inst, London, England; [Heath, Paul T.] St Georges Univ London, Vaccine Inst, London, England	St Georges University London; St Georges University London	Razai, MS (corresponding author), St Georges Univ London, Populat Hlth Res Inst, London, England.	mrazai@sgul.ac.uk	Goldsmith, Lucy/AFB-2121-2022	Goldsmith, Lucy/0000-0002-6934-1925; Razai, Mohammad Sharif/0000-0002-6671-5557				Blakeway H, 2022, AM J OBSTET GYNECOL, V226, DOI 10.1016/j.ajog.2021.08.007; Brailovskaia J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0260230; Department of Health and Social Care, 2021, JOINT COMM VACC IMM; Engjom H, 2022, LANCET REG HEALTH-EU, V13, DOI 10.1016/j.lanepe.2022.100313; Etti M, 2021, ECLINICALMEDICINE, V36, DOI 10.1016/j.eclinm.2021.100903; Hall VJ, 2021, LANCET, V397, P1725, DOI 10.1016/S0140-6736(21)00790-X; James D, 2017, HIGH RISK PREGNANCY; JCVI, 2021, JCVI ISSUES NEW ADVI; Jennings W, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9060593; Kadiwar S, 2021, LANCET, V397, P1539, DOI 10.1016/S0140-6736(21)00716-9; Knight M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2107; Larson HJ, 2018, NATURE, V562, P309, DOI 10.1038/d41586-018-07034-4; Lockyer B, 2021, HEALTH EXPECT, V24, P1158, DOI 10.1111/hex.13240; Loomba S, 2021, NAT HUM BEHAV, V5, P337, DOI 10.1038/s41562-021-01056-1; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Mathur R, 2021, LANCET, V397, P1711, DOI 10.1016/S0140-6736(21)00634-6; Odejinmi F., 2021, COVID 19 VACCINE HES; Office for National Statistics, 2021, CORONAVIRUS COVID 19; Razai MS, 2021, J ROY SOC MED, V114, P295, DOI 10.1177/01410768211018951; Razai MS, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1138; Razai MS., 2021, COVID 19 VACCINE HES; Shimabukuro TT, 2021, OBSTET GYNECOL SURV, V76, P729, DOI [10.1056/NEJMoa2104983, 10.1097/01.ogx.0000802676.57373.17, 10.1056/NEJMx210016]; Shook LL, 2022, AM J PERINAT, V39, P1048, DOI 10.1055/a-1673-5546; Siegel MR., 2021, MEDRXIV; Skirrow H, 2022, BMC PREGNANCY CHILDB, V22, DOI 10.1186/s12884-021-04321-3; Skjefte M, 2021, EUR J EPIDEMIOL, V36, P197, DOI 10.1007/s10654-021-00728-6; Stock SJ, 2022, NAT MED, V28, P504, DOI 10.1038/s41591-021-01666-2; Sutton D, 2021, AM J OBST GYNEC MFM, V3, DOI 10.1016/j.ajogmf.2021.100403; Takemoto MLS, 2020, BJOG-INT J OBSTET GY, V127, P1618, DOI 10.1111/1471-0528.16470; Treger S, 2022, AM J OBSTET GYNECOL, V226, P587, DOI 10.1016/j.ajog.2021.11.1365; Turocy J, 2021, SURVEY FERTILITY PAT; UKHSA, 2022, COVID 19 VACCINE SUR; Vousden N., 2021, MEDRXIV, DOI 2021.2007.2022.21261000	33	0	0	21	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0271834	10.1371/journal.pone.0271834	http://dx.doi.org/10.1371/journal.pone.0271834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976810	gold, Green Accepted, Green Published			2022-12-26	WOS:000847227000017
J	D'Agosto, S; Pezzini, F; Veghini, L; Delfino, P; Fiorini, C; Tane, GDT; Del Curatolo, A; Vicentini, C; Ferrari, G; Pasini, D; Andreani, S; Lupo, F; Fiorini, E; Lorenzon, G; Lawlor, RT; Rusev, B; Malinova, A; Luchini, C; Milella, M; Sereni, E; Pea, A; Bassi, C; Bailey, P; Scarpa, A; Bria, E; Corbo, V				D'Agosto, Sabrina; Pezzini, Francesco; Veghini, Lisa; Delfino, Pietro; Fiorini, Claudia; Tane, Gael D. Temgue; Del Curatolo, Anais; Vicentini, Caterina; Ferrari, Giorgia; Pasini, Davide; Andreani, Silvia; Lupo, Francesca; Fiorini, Elena; Lorenzon, Giulia; Lawlor, Rita T.; Rusev, Borislav; Malinova, Antonia; Luchini, Claudio; Milella, Michele; Sereni, Elisabetta; Pea, Antonio; Bassi, Claudio; Bailey, Peter; Scarpa, Aldo; Bria, Emilio; Corbo, Vincenzo			Loss of FGFR4 promotes the malignant phenotype of PDAC	ONCOGENE			English	Article							SET ENRICHMENT ANALYSIS; PANCREATIC-CANCER; CELL IDENTITY; GROWTH; ACTIVATION; INHIBITOR; SUBTYPES	Transcriptomic analyses of pancreatic ductal adenocarcinoma (PDAC) have identified two major epithelial subtypes with distinct biology and clinical behaviours. Here, we aimed to clarify the role of FGFR1 and FGFR4 in the definition of aggressive PDAC phenotypes. We found that the expression of FGFR4 is exclusively detected in epithelial cells, significantly elevated in the classical PDAC subtype, and associates with better outcomes. In highly aggressive basal-like/squamous PDAC, reduced FGFR4 expression aligns with hypermethylation of the gene and lower levels of histone marks associated with active transcription in its regulatory regions. Conversely, FGFR1 has more promiscuous expression in both normal and malignant pancreatic tissues and is strongly associated with the EMT phenotype but not with the basal-like cell lineage. Regardless of the genetic background, the increased proliferation of FGFR4-depleted PDAC cells correlates with hyperactivation of the mTORC1 pathway both in vitro and in vivo. Downregulation of FGFR4 in classical cell lines invariably leads to the enrichment of basal-like/squamous gene programs and is associated with either partial or full switch of phenotype. In sum, we show that endogenous levels of FGFR4 limit the malignant phenotype of PDAC cells. Finally, we propose FGFR4 as a valuable marker for the stratification of PDAC patients.	[D'Agosto, Sabrina; Pezzini, Francesco; Veghini, Lisa; Delfino, Pietro; Fiorini, Claudia; Tane, Gael D. Temgue; Ferrari, Giorgia; Pasini, Davide; Andreani, Silvia; Lupo, Francesca; Fiorini, Elena; Lorenzon, Giulia; Malinova, Antonia; Luchini, Claudio; Scarpa, Aldo; Corbo, Vincenzo] Univ & Hosp Trust Verona, Dept Diagnost & Publ Hlth, Verona, Italy; [Del Curatolo, Anais; Vicentini, Caterina; Lawlor, Rita T.; Rusev, Borislav; Scarpa, Aldo; Corbo, Vincenzo] Univ & Hosp Trust Verona, ARC Net Res Ctr, Verona, Italy; [Milella, Michele] Univ & Hosp Trust Verona, Dept Med, Sect Oncol, Verona, Italy; [Sereni, Elisabetta; Pea, Antonio; Bassi, Claudio] Univ & Hosp Trust Verona, Pancreas Inst, Dept Surg, Verona, Italy; [Bailey, Peter] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland; [Bailey, Peter] Canc Res UK Beatson Inst, Glasgow, Lanark, Scotland; [Bailey, Peter] Heidelberg Univ, Dept Gen Surg, Heidelberg, Germany; [Bria, Emilio] Fdn Policlin Univ Agostino Gemelli IRCCS, Comprehens Canc Ctr, Rome, Italy; [Bria, Emilio] Univ Cattolica Sacro Cuore, Dept Translat Med & Surg, Sect Med Oncol, Rome, Italy; [D'Agosto, Sabrina] Human Technopole, Milan, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Glasgow; Beatson Institute; Ruprecht Karls University Heidelberg; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Human Technopole	Corbo, V (corresponding author), Univ & Hosp Trust Verona, Dept Diagnost & Publ Hlth, Verona, Italy.; Corbo, V (corresponding author), Univ & Hosp Trust Verona, ARC Net Res Ctr, Verona, Italy.	vincenzo.corbo@univr.it		Malinova, Antonia/0000-0003-0325-501X; Pasini, Davide/0000-0002-8270-7143	Associazione Italiana Ricerca sul Cancro (AIRC) [18178]; EU (MSCA project PRECODE) [861196]; National Cancer Institute (NCI) [HHSN26100008]; AIRC [IG20583, 24043, 19404, 20872, 25286]; Universita Cattolica del Sacro Cuore (UCSC); AIRC 5x1000 [12182]; Fondazione Nadia Valsecchi Onlus; Ontario Institute for Cancer Research through Government of Ontario	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); EU (MSCA project PRECODE); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AIRC(Fondazione AIRC per la ricerca sul cancro); Universita Cattolica del Sacro Cuore (UCSC); AIRC 5x1000(Fondazione AIRC per la ricerca sul cancro); Fondazione Nadia Valsecchi Onlus; Ontario Institute for Cancer Research through Government of Ontario	We gratefully acknowledge the Centro Piattaforme Tecnologiche (CPT - University of Verona, Verona, Italy) for granting access to the genomic facility of University of Verona. In addition, we acknowledge the assistance provided by Serena Pedron, Valerio Crestani, Claudia Parolini, e Paola Perfetti for the execution of immunohistochemical staining. VC is supported by Associazione Italiana Ricerca sul Cancro (AIRC; Grant No. 18178). VC is also supported by the EU (MSCA project PRECODE, grant No: 861196) and the National Cancer Institute (NCI, HHSN26100008). EB is supported by the AIRC (Grant No. IG20583), and by Institutional funds of Universita Cattolica del Sacro Cuore (UCSC-project D1). AS is supported by AIRC 5x1000, grant n 12182. SDa is supported by AIRC (24043). CF was supported for by the Fondazione Umberto Veronesi. AdC was supported by AIRC (19404, 20872). PD is supported by Fondazione Nadia Valsecchi Onlus. EF is supported by AIRC (25286). This study was conducted with the support of the Ontario Institute for Cancer Research through funding provided by the Government of Ontario. The funding agencies had no role in the collection, analysis, and interpretation of data or in the writing of the paper.	Acevedo VD, 2007, CANCER CELL, V12, P559, DOI 10.1016/j.ccr.2007.11.004; Aguirre AJ, 2018, CANCER DISCOV, V8, P1096, DOI 10.1158/2159-8290.CD-18-0275; Aguirre AJ, 2017, CANCER CELL, V32, P185, DOI 10.1016/j.ccell.2017.07.007; Andricovich J, 2018, CANCER CELL, V33, P512, DOI 10.1016/j.ccell.2018.02.003; Aung KL, 2018, CLIN CANCER RES, V24, P1344, DOI 10.1158/1078-0432.CCR-17-2994; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Balli D, 2017, CLIN CANCER RES, V23, P3129, DOI 10.1158/1078-0432.CCR-16-2128; Bhushan A, 2001, DEVELOPMENT, V128, P5109; Brunton H, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107625; Chan-Seng-Yue M, 2020, NAT GENET, V52, P231, DOI 10.1038/s41588-019-0566-9; Collisson EA, 2019, NAT REV GASTRO HEPAT, V16, P207, DOI 10.1038/s41575-019-0109-y; Diaferia GR, 2016, EMBO J, V35, P595, DOI 10.15252/embj.201592404; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Dreyer SB, 2021, GASTROENTEROLOGY, V160, P362, DOI 10.1053/j.gastro.2020.09.043; Elghazi L, 2002, P NATL ACAD SCI USA, V99, P3884, DOI 10.1073/pnas.062321799; Frattini V, 2018, NATURE, V553, P222, DOI 10.1038/nature25171; Goncalves CA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23295-6; Grun D, 2016, CELL STEM CELL, V19, P266, DOI 10.1016/j.stem.2016.05.010; Guagnano V, 2011, J MED CHEM, V54, P7066, DOI 10.1021/jm2006222; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hagel M, 2015, CANCER DISCOV, V5, P424, DOI 10.1158/2159-8290.CD-14-1029; Hayashi A, 2020, NAT CANCER, V1, P59, DOI 10.1038/s43018-019-0010-1; Hebrok M, 1998, GENE DEV, V12, P1705, DOI 10.1101/gad.12.11.1705; Kalisz M, 2020, EMBO J, V39, DOI 10.15252/embj.2019102808; Kitai H, 2016, CANCER DISCOV, V6, P754, DOI 10.1158/2159-8290.CD-15-1377; Kloesch B, 2022, GUT, V71, P766, DOI 10.1136/gutjnl-2020-321397; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lin W, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00776-9; Martinelli P, 2017, GUT, V66, P1665, DOI 10.1136/gutjnl-2015-311256; Meyers N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62106-8; Michl P, 2021, UNITED EUR GASTROENT, V9, P860, DOI 10.1002/ueg2.12123; Moffitt RA, 2015, NAT GENET, V47, P1168, DOI 10.1038/ng.3398; Motoda N, 2011, INT J ONCOL, V38, P133, DOI 10.3892/ijo_00000832; Muraro MJ, 2016, CELL SYST, V3, P385, DOI 10.1016/j.cels.2016.09.002; Neben CL, 2019, DEV BIOL, V447, P71, DOI 10.1016/j.ydbio.2017.10.017; Nicolle R, 2020, EBIOMEDICINE, V57, DOI 10.1016/j.ebiom.2020.102858; Peng JY, 2019, CELL RES, V29, P725, DOI 10.1038/s41422-019-0195-y; Porter RL, 2019, P NATL ACAD SCI USA, V116, P26835, DOI 10.1073/pnas.1914915116; Rahib L, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.4708; Raoof S, 2019, ONCOGENE, V38, P6399, DOI 10.1038/s41388-019-0887-2; Sasaki N, 2020, CANCERS, V12, DOI 10.3390/cancers12102976; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Segerstolpe A, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; Shah P, 2013, CELL, V153, P1589, DOI 10.1016/j.cell.2013.05.049; Somerville TDD, 2020, P NATL ACAD SCI USA, V117, P11471, DOI 10.1073/pnas.1921484117; Somerville TDD, 2018, CELL REP, V25, P1741, DOI 10.1016/j.celrep.2018.10.051; Steele NG, 2020, NAT CANCER, V1, P1097, DOI 10.1038/s43018-020-00121-4; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Ulaganathan VK, 2015, NATURE, V528, P570, DOI 10.1038/nature16449	53	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 16	2022	41	38					4371	4384		10.1038/s41388-022-02432-5	http://dx.doi.org/10.1038/s41388-022-02432-5		AUG 2022	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	4O3TC	35963908	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000840288700001
J	Rosenau, J; Grothaus, IL; Yang, YK; Kumar, ND; Ciacchi, LC; Kelm, S; Waespy, M				Rosenau, Jana; Grothaus, Isabell Louise; Yang, Yikun; Kumar, Nilima Dinesh; Ciacchi, Lucio Colombi; Kelm, Sorge; Waespy, Mario			N-glycosylation modulates enzymatic activity of Trypanosoma congolense trans-sialidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; CRUZI TRYPOMASTIGOTES; STRUCTURAL-CHARACTERIZATION; SURFACE GLYCOPROTEINS; CATALYTIC MECHANISM; CORE FUCOSYLATION; PROTEIN-STRUCTURE; GLYCAN READER; I-TASSER; ACID	Trypanosomes cause the devastating disease trypanosomi-asis, in which the action of trans-sialidase (TS) enzymes harbored on their surface is a key virulence factor. TS enzymes are N-glycosylated, but the biological functions of their glycans have remained elusive. In this study, we investigated the in-fluence of N-glycans on the enzymatic activity and structural stability of TconTS1, a recombinant TS from the African parasite Trypanosoma congolense. We expressed the enzyme in Chinese hamster ovary Lec1 cells, which produce high-mannose type N-glycans similar to the TS N-glycosylation pattern in vivo. Our MALDI-TOF mass spectrometry data revealed that up to eight putative N-glycosylation sites were glycosylated. In addition, we determined that N-glycan removal via endoglycosidase Hf treatment of TconTS1 led to a decrease in substrate affinity relative to the untreated enzyme but had no impact on the conversion rate. Furthermore, we observed no changes in secondary structure elements of hypoglycosylated TconTS1 in CD experiments. Finally, our molecular dynamics simulations provided evidence for interactions between monosaccharide units of the highly flexible N-glycans and some conserved amino acids located at the catalytic site. These interactions led to conformational changes, possibly enhancing substrate accessibility and enzyme-substrate complex stability. The here-observed modulation of catalytic activity via N-gly-cans represents a so-far-unknown structure-function rela-tionship potentially inherent in several members of the TS enzyme family.	[Rosenau, Jana; Grothaus, Isabell Louise; Yang, Yikun; Kumar, Nilima Dinesh; Kelm, Sorge; Waespy, Mario] Univ Bremen, Fac Biol & Chem, Ctr Biomol Interact Bremen, Bremen, Germany; [Grothaus, Isabell Louise; Ciacchi, Lucio Colombi] Univ Bremen, Bremen Ctr Computat Mat Sci, Fac Prod Engn,Ctr Environm Res & Sustainable Tech, Hybrid Mat Interfaces Grp, Bremen, Germany; [Grothaus, Isabell Louise; Ciacchi, Lucio Colombi] Univ Bremen, MAPEX Ctr Mat & Proc, Bremen, Germany; [Yang, Yikun] Shandong Univ Tradit Chinese Med, Innovat Res Inst Tradit Chinese Med, Jinan 250355, Shandong, Peoples R China; [Kumar, Nilima Dinesh] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Sci Cells & Syst, NL-9712 CP Groningen, Netherlands	University of Bremen; University of Bremen; University of Bremen; Shandong University of Traditional Chinese Medicine; University of Groningen	Waespy, M (corresponding author), Univ Bremen, Fac Biol & Chem, Ctr Biomol Interact Bremen, Bremen, Germany.	ma_wa@uni-bremen.de	Kelm, Soerge/C-5403-2013	Kelm, Soerge/0000-0001-5277-9421; Grothaus, Isabell Louise/0000-0002-0441-3860; Rosenau, Jana/0000-0003-2757-0786	Deutsche Forschungsgemeinschaft (DFG) [Ke428/10-1, Ke428/13-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study's fnancial support came from the Deutsche Forschungsgemeinschaft (DFG: https:// www.dfg.de/, project grants to S. K., Ke428/10-1 and Ke428/13-1) . The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the article.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Amaya MF, 2004, STRUCTURE, V12, P775, DOI 10.1016/j.str.2004.02.036; Atwood JA, 2006, J PROTEOME RES, V5, P3376, DOI 10.1021/pr060364b; Barb AW, 2015, BIOCHEMISTRY-US, V54, P313, DOI 10.1021/bi501380t; Bonomi M, 2019, NAT METHODS, V16, P670, DOI 10.1038/s41592-019-0506-8; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Buschiazzo A, 2000, EMBO J, V19, P16, DOI 10.1093/emboj/19.1.16; Buschiazzo A, 1997, GLYCOBIOLOGY, V7, P1167, DOI 10.1093/glycob/7.8.1167; Buschiazzo A, 2002, MOL CELL, V10, P757, DOI 10.1016/S1097-2765(02)00680-9; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; CAMPETELLA OE, 1994, MOL BIOCHEM PARASIT, V64, P337, DOI 10.1016/0166-6851(94)00036-0; Casalino L, 2020, ACS CENTRAL SCI, V6, P1722, DOI 10.1021/acscentsci.0c01056; Chavaroche A, 2014, ANAL BIOCHEM, V449, P68, DOI 10.1016/j.ab.2013.12.018; Cooper CA, 2001, PROTEOMICS, V1, P340, DOI 10.1002/1615-9861(200102)1:2<340::AID-PROT340>3.0.CO;2-B; Coustou V, 2012, CELL MICROBIOL, V14, P431, DOI 10.1111/j.1462-5822.2011.01730.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DECARVALHO LCP, 1993, J EXP MED, V177, P465, DOI 10.1084/jem.177.2.465; Demir O, 2009, BIOCHEMISTRY-US, V48, P3398, DOI 10.1021/bi802230y; ENGSTLER M, 1995, ACTA TROP, V59, P117, DOI 10.1016/0001-706X(95)00077-R; ENGSTLER M, 1993, MOL BIOCHEM PARASIT, V61, P1, DOI 10.1016/0166-6851(93)90153-O; ENGSTLER M, 1992, MOL BIOCHEM PARASIT, V54, P21, DOI 10.1016/0166-6851(92)90091-W; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gattiker A, 2002, PROTEOMICS, V2, P1435, DOI 10.1002/1615-9861(200210)2:10<1435::AID-PROT1435>3.0.CO;2-9; Gbem TT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002549; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Guegan F, 2013, CELL MICROBIOL, V15, P1285, DOI 10.1111/cmi.12123; Guo SH, 2016, J BIOL CHEM, V291, P593, DOI 10.1074/jbc.M115.691097; Guvench O, 2011, J CHEM THEORY COMPUT, V7, P3162, DOI 10.1021/ct200328p; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Haynes CLF, 2015, ACTA CRYSTALLOGR F, V71, P577, DOI 10.1107/S2053230X15002496; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HOWARD S C, 1991, Glycobiology, V1, P411, DOI 10.1093/glycob/1.4.411; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jo S, 2011, J COMPUT CHEM, V32, P3135, DOI 10.1002/jcc.21886; Kita Y, 2007, MOL CELL PROTEOMICS, V6, P1437, DOI 10.1074/mcp.T600063-MCP200; Koliwer-Brandl H, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-39; Lageveen-Kammeijer GSM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09910-7; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Li HY, 2015, GLYCOBIOLOGY, V25, P1350, DOI 10.1093/glycob/cwv063; Ma JY, 2019, J BIOL ENG, V13, DOI 10.1186/s13036-019-0215-y; Alves MJM, 2017, J PROTEOMICS, V151, P182, DOI 10.1016/j.jprot.2016.05.034; Mathew C, 2021, RSC CHEM BIOL, V2, P917, DOI 10.1039/d1cb00019e; Mehlert A, 1998, MOL BIOCHEM PARASIT, V91, P145, DOI 10.1016/S0166-6851(97)00187-4; Micsonai A, 2018, NUCLEIC ACIDS RES, V46, pW315, DOI 10.1093/nar/gky497; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; MING M, 1993, MOL BIOCHEM PARASIT, V59, P243, DOI 10.1016/0166-6851(93)90222-J; Mitchell FL, 2013, BIOCHEMISTRY-US, V52, P3740, DOI 10.1021/bi301112p; Mitchell FL, 2010, BIOPHYS J, V98, pL38, DOI 10.1016/j.bpj.2010.01.006; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; Montagna GN, 2006, J BIOL CHEM, V281, P33949, DOI 10.1074/jbc.M604951200; Nagai Y, 2019, ANAL SCI, V35, P517, DOI 10.2116/analsci.18P500; Nagamune K, 2004, J EXP MED, V199, P1445, DOI 10.1084/jem.20030635; Nok AJ, 2003, J BIOCHEM, V133, P725, DOI 10.1093/jb/mvg093; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; Oliveira IA, 2014, J BIOL CHEM, V289, P423, DOI 10.1074/jbc.M112.399303; Pall S, 2013, COMPUT PHYS COMMUN, V184, P2641, DOI 10.1016/j.cpc.2013.06.003; Park SJ, 2019, GLYCOBIOLOGY, V29, P320, DOI 10.1093/glycob/cwz003; Park SJ, 2017, BIOINFORMATICS, V33, P3051, DOI 10.1093/bioinformatics/btx358; Parsons LM, 2019, J BIOL CHEM, V294, P7797, DOI 10.1074/jbc.RA119.007532; Pereira-Chioccola VL, 2000, J CELL SCI, V113, P1299; Pierdominici-Sottile G, 2011, BIOCHEMISTRY-US, V50, P10150, DOI 10.1021/bi2009618; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SAVAGE A, 1984, MOL BIOCHEM PARASIT, V11, P309, DOI 10.1016/0166-6851(84)90075-6; SCHENKMAN S, 1991, CELL, V65, P1117, DOI 10.1016/0092-8674(91)90008-M; SCHENKMAN S, 1993, MOL BIOCHEM PARASIT, V59, P293, DOI 10.1016/0166-6851(93)90227-O; SCHENKMAN S, 1992, J EXP MED, V175, P567, DOI 10.1084/jem.175.2.567; Sheng L, 2017, INT J BIOL MACROMOL, V96, P129, DOI 10.1016/j.ijbiomac.2016.12.043; Sillanaukee P, 1999, EUR J CLIN INVEST, V29, P413; Skropeta D, 2009, BIOORGAN MED CHEM, V17, P2645, DOI 10.1016/j.bmc.2009.02.037; STANLEY P, 1984, ANNU REV GENET, V18, P525, DOI 10.1146/annurev.ge.18.120184.002521; Stanley P., 2015, ESSENTIALS GLYCOBIOL; Stone, 1998, EFFICIENT LIB PARALL; Tiralongo E, 2003, BIOL CHEM, V384, P1203, DOI 10.1515/BC.2003.133; Tiralongo E, 2003, J BIOL CHEM, V278, P23301, DOI 10.1074/jbc.M212909200; TOMLINSON S, 1994, J IMMUNOL, V153, P3141; Treumann A, 1997, J MOL BIOL, V269, P529, DOI 10.1006/jmbi.1997.1066; Tribello GA, 2014, COMPUT PHYS COMMUN, V185, P604, DOI 10.1016/j.cpc.2013.09.018; Utz S, 2006, EUKARYOT CELL, V5, P1430, DOI 10.1128/EC.00067-06; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Waespy M, 2022, PLOS NEGLECT TROP D, V16, DOI 10.1371/journal.pntd.0009585; Waespy M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004120; Wilkins MR, 1997, ELECTROPHORESIS, V18, P403, DOI 10.1002/elps.1150180314; WITTWER AJ, 1989, BIOCHEMISTRY-US, V28, P7662, DOI 10.1021/bi00445a022; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yang Q, 2017, J BIOL CHEM, V292, P14796, DOI 10.1074/jbc.M117.804070; Yang Q, 2016, J BIOL CHEM, V291, P11064, DOI 10.1074/jbc.M116.720789; Yu XC, 1997, J BIOL CHEM, V272, P3511, DOI 10.1074/jbc.272.6.3511; ZAMZE SE, 1991, J BIOL CHEM, V266, P20244; ZAMZE SE, 1990, EUR J BIOCHEM, V187, P657, DOI 10.1111/j.1432-1033.1990.tb15350.x	95	0	0	7	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102403	10.1016/j.jbc.2022.102403	http://dx.doi.org/10.1016/j.jbc.2022.102403			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5J0EG	35995210	Green Published, gold, Green Submitted			2022-12-26	WOS:000868720100004
J	Lawson, LY; Migotsky, N; Chermside-Scabbo, CJ; Shuster, JT; Joeng, KS; Civitelli, R; Lee, B; Silva, MJ				Lawson, Lisa Y.; Migotsky, Nicole; Chermside-Scabbo, Christopher J.; Shuster, John T.; Joeng, Kyu Sang; Civitelli, Roberto; Lee, Brendan; Silva, Matthew J.			Loading-induced bone formation is mediated by Wnt1 induction in osteoblast-lineage cells	FASEB JOURNAL			English	Article						bone; mechanobiology; osteoblasts; osteocytes; osteogenesis; Wnt signaling pathway	OSTEOGENIC RESPONSE; MOUSE; MODEL; LRP5; MICE; AGE	Mechanical loading on the skeleton stimulates bone formation. Although the exact mechanism underlying this process remains unknown, a growing body of evidence indicates that the Wnt signaling pathway is necessary for the skeletal response to loading. Recently, we showed that Wnts produced by osteoblast lineage cells mediate the osteo-anabolic response to tibial loading in adult mice. Here, we report that Wnt1 specifically plays a crucial role in mediating the mechano-adaptive response to loading. Independent of loading, short-term loss of Wnt1 in the Osx-lineage resulted in a decreased cortical bone area in the tibias of 5-month-old mice. In females, strain-matched loading enhanced periosteal bone formation in Wnt1F/F controls, but not in Wnt1F/F; OsxCreERT2 knockouts. In males, strain-matched loading increased periosteal bone formation in both control and knockout mice; however, the periosteal relative bone formation rate was 65% lower in Wnt1 knockouts versus controls. Together, these findings show that Wnt1 supports adult bone homeostasis and mediates the bone anabolic response to mechanical loading.	[Lawson, Lisa Y.; Migotsky, Nicole; Chermside-Scabbo, Christopher J.; Shuster, John T.; Silva, Matthew J.] Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63130 USA; [Lawson, Lisa Y.; Migotsky, Nicole; Chermside-Scabbo, Christopher J.; Shuster, John T.; Civitelli, Roberto; Silva, Matthew J.] Washington Univ, Musculoskeletal Res Ctr, Sch Med, St Louis, MO 63130 USA; [Migotsky, Nicole; Silva, Matthew J.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [Chermside-Scabbo, Christopher J.] Washington Univ, Med Scient Training Program, Sch Med, St Louis, MO 63130 USA; [Joeng, Kyu Sang] Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, McKay Orthopaed Res Lab, Philadelphia, PA USA; [Civitelli, Roberto] Washington Univ, Div Bone & Mineral Dis, Dept Med, St Louis, MO 63130 USA; [Lee, Brendan] Baylor Coll Med, Dept Mol & Human Genet, Waco, TX USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Pennsylvania; Pennsylvania Medicine; Washington University (WUSTL); Baylor College of Medicine	Lawson, LY (corresponding author), Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63130 USA.	lylawson@wustl.edu		Lawson, Lisa/0000-0002-4436-5357	Washington University Musculoskeletal Research Center [P30 AR074992]; NIH [T32 AR060719, R01 AR047867]	Washington University Musculoskeletal Research Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Washington University Musculoskeletal Research Center, Grant/Award Number: P30 AR074992; NIH, Grant/Award Number: T32 AR060719 and R01 AR047867	Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Birkhold AI, 2014, BIOMATERIALS, V35, P9290, DOI 10.1016/j.biomaterials.2014.07.051; Chermside-Scabbo CJ, 2020, J BONE MINER RES, V35, P1751, DOI 10.1002/jbmr.4031; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Erben RG, 1997, J HISTOCHEM CYTOCHEM, V45, P307, DOI 10.1177/002215549704500215; Harris TL, 2021, BONE, V150, DOI 10.1016/j.bone.2021.116019; Holguin N, 2016, J BONE MINER RES, V31, P2215, DOI 10.1002/jbmr.2900; Joeng KS, 2017, J CLIN INVEST, V127, P2678, DOI 10.1172/JCI92617; Joeng KS, 2014, HUM MOL GENET, V23, P4035, DOI 10.1093/hmg/ddu117; Kelly NH, 2016, BONE, V86, P22, DOI 10.1016/j.bone.2016.02.007; Lawson LY, 2022, J BONE MINER RES, V37, P108, DOI 10.1002/jbmr.4445; Luther J, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aau7137; Maes C, 2007, ANN NY ACAD SCI, V1116, P149, DOI 10.1196/annals.1402.060; Main RP, 2020, J ORTHOP RES, V38, P233, DOI 10.1002/jor.24466; Meakin LB, 2014, J BONE MINER RES, V29, P1859, DOI 10.1002/jbmr.2222; Niziolek PJ, 2011, BONE, V49, P1010, DOI 10.1016/j.bone.2011.07.034; Rajagopal J, 2008, DEVELOPMENT, V135, P1625, DOI 10.1242/dev.015495; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Saxon LK, 2011, BONE, V49, P184, DOI 10.1016/j.bone.2011.03.683; Song DY, 2020, BONE RES, V8, DOI 10.1038/s41413-019-0081-8; Sun D, 2018, J ORTHOP RES, V36, P682, DOI 10.1002/jor.23727; Tu XL, 2012, BONE, V50, P209, DOI 10.1016/j.bone.2011.10.025; TURNER CH, 1995, J BONE MINER RES, V10, P1544; Wang F, 2021, BONE, V143, DOI 10.1016/j.bone.2020.115754; Zhong ZDA, 2015, BONE, V81, P614, DOI 10.1016/j.bone.2015.07.034	27	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22502	10.1096/fj.202200591R	http://dx.doi.org/10.1096/fj.202200591R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3T7JS	35969160	Green Submitted			2022-12-26	WOS:000840446300001
J	Alkhalfan, F; Gyftopoulos, A; Chen, YJ; Williams, CH; Perry, JA; Hong, CC				Alkhalfan, Fahad; Gyftopoulos, Alex; Chen, Yi-Ju; Williams, Charles H.; Perry, James A.; Hong, Charles C.			Identifying genetic variants associated with the ICD10 (International Classification of Diseases10)-based diagnosis of cerebrovascular disease using a large-scale biomedical database	PLOS ONE			English	Article							HEART-DISEASE; UPDATE	Objectives To utilize the UK Biobank to identify genetic variants associated with the ICD10 (International Classification of Diseases10)-based diagnosis of cerebrovascular disease (CeVD). Background Cerebrovascular disease occurs because of a complex interplay between vascular, environmental, and genetic factors. It is the second leading cause of disability worldwide. Understanding who may be genetically predisposed to cerebrovascular disease can help guide preventative efforts. Moreover, there is considerable interest in the use of real-world data, such as EHR (electronic health records) to better understand disease mechanisms and to discover new treatment strategies, but whether ICD10-based diagnosis can be used to study CeVD genetics is unknown. Methods Using the UK Biobank, we conducted a genome-wide association study (GWAS) where we analyzed the genomes of 11,155 cases and 122,705 controls who were sex, age and ancestry-matched in a 1:11 case: control design. Genetic variants were identified by Plink's firth logistic regression and assessed for association with the ICD10 codes corresponding to CeVD. Results We identified two groups of SNPs closely linked to PITX2 and LRRTM4 that were significantly associated with CeVD in this study (p < 5 x 10(-8)) and had a minor allele frequency of > 0.5%. Discussion Disease assignment based on ICD10 codes may underestimate prevalence; however, for CeVD, this does not appear to be the case. Compared to the age- and sex-matched control population, individuals with CeVD were more frequently diagnosed with comorbid conditions, such as hypertension, hyperlipidemia & atrial fibrillation or flutter, confirming their contribution to CeVD. The UK Biobank based ICD10 study identified 2 groups of variants that were associated with CeVD. The association between PITX2 and CeVD is likely explained by the increased rates of atrial fibrillation and flutter. While the mechanism explaining the relationship between LRRTM4 and CeVD is unclear, this has been documented in previous studies.	[Alkhalfan, Fahad; Gyftopoulos, Alex; Chen, Yi-Ju; Williams, Charles H.; Perry, James A.; Hong, Charles C.] Univ Maryland, Sch Med, Baltimore, MD 21228 USA	University System of Maryland; University of Maryland Baltimore	Perry, JA; Hong, CC (corresponding author), Univ Maryland, Sch Med, Baltimore, MD 21228 USA.	jperry@som.umaryland.edu; charles.hong@som.umaryland.edu	Williams, Charles/H-2351-2015	Williams, Charles/0000-0002-0331-5652; Hong, Charles/0000-0002-0424-8252	NHLBI [R01HL1351291, 1U01HL137181]	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI R01HL1351291 to CCH, and NHLBI 1U01HL137181 to JP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abul-Husn NS, 2019, CELL, V177, P58, DOI 10.1016/j.cell.2019.02.039; [Anonymous], CEREBROVASC DIS; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Casey JA, 2016, ANNU REV PUBL HEALTH, V37, P61, DOI 10.1146/annurev-publhealth-032315-021353; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen YC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8081124; Della-Morte D, 2016, CURR OPIN LIPIDOL, V27, P187, DOI 10.1097/MOL.0000000000000275; Hauer AJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07404-4; Initiative MG., 2017, UKBIOBANK ICD PHEWEB; Johnson J.L., 2017, BIORXIV164343, DOI [DOI 10.7150/ijms.5905, 10.1101/164343]; Lauren J, 2003, GENOMICS, V81, P411, DOI 10.1016/S0888-7543(03)00030-2; Ma C, 2013, GENET EPIDEMIOL, V37, P539, DOI 10.1002/gepi.21742; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Sinha R, 2020, NEURON, V105, P1007, DOI 10.1016/j.neuron.2019.12.028; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Syeda F, 2017, J PHYSIOL-LONDON, V595, P4019, DOI 10.1113/JP273123; Tong X, 2019, PREV CHRONIC DIS, V16, DOI 10.5888/pcd16.180411; Zhu J, 2014, FRONT GENET, V5, DOI [10.3389/fgene.2014.00149, 10.3389/fgene.2014.00187]	19	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0273217	10.1371/journal.pone.0273217	http://dx.doi.org/10.1371/journal.pone.0273217			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994481	Green Published, gold			2022-12-26	WOS:000877093400041
J	Valenchon, N; Bouteiller, Y; Jourde, HR; L'Heureux, X; Sobral, M; Coffey, EBJ; Beltrame, G				Valenchon, Nicolas; Bouteiller, Yann; Jourde, Hugo R.; L'Heureux, Xavier; Sobral, Milo; Coffey, Emily B. J.; Beltrame, Giovanni			The Portiloop: A deep learning-based open science tool for closed-loop brain stimulation	PLOS ONE			English	Article							AGE-RELATED-CHANGES; SLEEP SPINDLES; OSCILLATIONS; PERFORMANCE; MECHANISMS	Closed-loop brain stimulation refers to capturing neurophysiological measures such as electroencephalography (EEG), quickly identifying neural events of interest, and producing auditory, magnetic or electrical stimulation so as to interact with brain processes precisely. It is a promising new method for fundamental neuroscience and perhaps for clinical applications such as restoring degraded memory function; however, existing tools are expensive, cumbersome, and offer limited experimental flexibility. In this article, we propose the Portiloop, a deep learning-based, portable and low-cost closed-loop stimulation system able to target specific brain oscillations. We first document open-hardware implementations that can be constructed from commercially available components. We also provide a fast, lightweight neural network model and an exploration algorithm that automatically optimizes the model hyperparameters to the desired brain oscillation. Finally, we validate the technology on a challenging test case of real-time sleep spindle detection, with results comparable to off-line expert performance on the Massive Online Data Annotation spindle dataset (MODA; group consensus). Software and plans are available to the community as an open science initiative to encourage further development and advance closed-loop neuroscience research [https://github.com/Portiloop].	[Valenchon, Nicolas; Bouteiller, Yann; L'Heureux, Xavier; Sobral, Milo; Beltrame, Giovanni] Univ Montreal, MISTLab Polytechn, Montreal, PQ, Canada; [Jourde, Hugo R.; Coffey, Emily B. J.] Concordia Univ, CL ASP, Montreal, PQ, Canada	Universite de Montreal; Concordia University - Canada	Bouteiller, Y (corresponding author), Univ Montreal, MISTLab Polytechn, Montreal, PQ, Canada.	yann.bouteiller@polymtl.ca		Bouteiller, Yann/0000-0002-1390-6392; Sobral, Milo/0000-0002-7213-5970; Valenchon, Nicolas/0000-0003-4439-3398; L'Heureux, Xavier/0000-0002-5919-5397	AUDACE grant; Quebec Research Fund [FRQSC 279561, CER-2021-39-R]	AUDACE grant; Quebec Research Fund	This work was supported by the AUDACE grant, awarded to G.B and E.C. by the Quebec Research Fund (FRQSC 279561 -https://frq.gouv.qc.ca) and approved by Polytechnique Montreal (CER-2021-39-R -https://www.polymtl.ca).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albouy P, 2017, NEURON, V94, P193, DOI 10.1016/j.neuron.2017.03.015; Bergmann TO, 2017, STUD NEUROSCI, P185, DOI 10.1007/978-3-319-45066-7_12; Chen LL, 2013, IEEE T BIO-MED ENG, V60, P753, DOI 10.1109/TBME.2011.2109715; Choi J, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20102770; Feher KD, 2021, SLEEP MED REV, V58, DOI 10.1016/j.smrv.2021.101438; Fernandez LMJ, 2020, PHYSIOL REV, V100, P805, DOI 10.1152/physrev.00042.2018; Ferrarelli F, 2007, AM J PSYCHIAT, V164, P483, DOI 10.1176/appi.ajp.164.3.483; Fogel S, 2017, NEUROBIOL AGING, V49, P154, DOI 10.1016/j.neurobiolaging.2016.10.009; Fogel SM, 2006, J SLEEP RES, V15, P250, DOI 10.1111/j.1365-2869.2006.00522.x; Ha U, 2016, BIOMED CIRC SYST C, P536, DOI 10.1109/BioCAS.2016.7833850; Harrington MO, 2021, CURR SLEEP MED REP, V7, P112, DOI 10.1007/s40675-021-00207-0; Iber C., 2007, AASM MANUAL SCORING; Kosmyna N, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19235200; Kulkarni PM, 2019, J NEURAL ENG, V16, DOI 10.1088/1741-2552/ab0933; Lacourse K, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0533-4; Lacourse K, 2019, J NEUROSCI METH, V316, P3, DOI 10.1016/j.jneumeth.2018.08.014; Lafortune M, 2014, J SLEEP RES, V23, P159, DOI 10.1111/jsr.12108; Mark Hasegawa-Johnson, 2017, Arxiv, DOI arXiv:1710.02224; Martin N, 2013, NEUROBIOL AGING, V34, P468, DOI 10.1016/j.neurobiolaging.2012.05.020; McCrimmon CM, 2017, IEEE T BIO-MED ENG, V64, P2313, DOI 10.1109/TBME.2017.2667579; Molle M, 2002, J NEUROSCI, V22, P10941; Ngo HVV, 2019, J NEUROSCI METH, V316, P117, DOI 10.1016/j.jneumeth.2018.09.006; Ngo HVV, 2013, NEURON, V78, P545, DOI 10.1016/j.neuron.2013.03.006; O'Reilly C, 2014, J SLEEP RES, V23, P628, DOI 10.1111/jsr.12169; Parekh A, 2015, J NEUROSCI METH, V251, P37, DOI 10.1016/j.jneumeth.2015.04.006; Peters KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091047; Purcell SM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15930; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; Ray LB, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00507; Salfi F, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10050300; Shirinpour S, 2020, J NEURAL ENG, V17, DOI 10.1088/1741-2552/ab9dba; Sundararajan M, 2017, PR MACH LEARN RES, V70; Tan DK, 2015, IEEE ENG MED BIO, P2828, DOI 10.1109/EMBC.2015.7318980; Tapia NI., 2020, ARXIV; Tobin J, 2017, IEEE INT C INT ROBOT, P23; Vassileva A, 2018, EPILEPSY RES, V141, P95, DOI 10.1016/j.eplepsyres.2018.02.010; Vaswani A, 2017, ADV NEUR IN, V30; von Luhmann A, 2017, I IEEE EMBS C NEUR E, P349, DOI 10.1109/NER.2017.8008362; Wamsley EJ, 2012, BIOL PSYCHIAT, V71, P154, DOI 10.1016/j.biopsych.2011.08.008; Xu R, 2014, IEEE T BIO-MED ENG, V61, P288, DOI 10.1109/TBME.2013.2294203; Yang Y., 2021, ARXIV, DOI DOI 10.48550/ARXIV.2102.09554; Yasuhara N, 2019, MIDWEST SYMP CIRCUIT, P45, DOI 10.1109/MWSCAS.2019.8885106; Zarubin G., 2018, 6 INT C NEUROTECHNOL, P13, DOI [10.5220/0006927300130020, DOI 10.5220/0006927300130020]; Zotou S, 2017, LECT NOTES ARTIF INT, V10512, P159, DOI 10.1007/978-3-319-67615-9_14; Zrenner C, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00092	45	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0270696	10.1371/journal.pone.0270696	http://dx.doi.org/10.1371/journal.pone.0270696			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994482	gold, Green Submitted, Green Published			2022-12-26	WOS:000877093400006
J	Alterman, N; Johnson, S; Carson, C; Petrou, S; Kurinzcuk, JJ; Macfarlane, A; Boyle, E; Quigley, MA				Alterman, Neora; Johnson, Samantha; Carson, Claire; Petrou, Stavros; Kurinzcuk, Jennifer J.; Macfarlane, Alison; Boyle, Elaine; Quigley, Maria A.			Gestational age at birth and academic attainment in primary and secondary school in England: Evidence from a national cohort study	PLOS ONE			English	Article							EXTREMELY PRETERM CHILDREN; SPECIAL EDUCATIONAL-NEEDS; EARLY TERM; PERFORMANCE	Preterm birth (<37 weeks' gestation) is a risk factor for poor educational outcomes. A dose-response effect of earlier gestational age at birth on poor primary school attainment has been observed, but evidence for secondary school attainment is limited and focused predominantly on the very preterm (<32 weeks) population. We examined the association between gestational age at birth and academic attainment at the end of primary and secondary schooling in England. Data for children born in England from 2000-2001 were drawn from the population-based UK Millennium Cohort Study. Information about the child's birth, sociodemographic factors and health was collected from parents. Attainment on national tests at the end of primary (age 11) and secondary school (age 16) was derived from linked education records. Data on attainment in primary school was available for 6,950 pupils and that of secondary school was available for 7,131 pupils. Adjusted relative risks (aRRs) for these outcomes were estimated at each stage separately using modified Poisson regression. At the end of primary school, 17.7% of children had not achieved the expected level in both English and Mathematics and this proportion increased with increasing prematurity. Compared to full term (39-41 weeks) children, the strongest associations were among children born moderately (32-33 weeks; aRR = 2.13 (95% CI 1.44-3.13)) and very preterm (aRR = 2.06 (95% CI 1.46-2.92)). Children born late preterm (34-36 weeks) and early term (37-38 weeks) were also at higher risk with aRR = 1.18 (95% CI 0.94-1.49) and aRR = 1.21 (95% CI 1.05-1.38), respectively. At the end of secondary school, 45.2% had not passed at least five General Certificate of Secondary Education examinations including English and Mathematics. Following adjustment, only children born very preterm were at significantly higher risk (aRR = 1.26 (95% CI 1.03-1.54)). All children born before full term are at risk of poorer attainment during primary school compared with term-born children, but only children born very preterm remain at risk at the end of secondary schooling. Children born very preterm may require additional educational support throughout compulsory schooling.	[Alterman, Neora; Carson, Claire; Kurinzcuk, Jennifer J.; Quigley, Maria A.] Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit NPEU, Oxford, England; [Johnson, Samantha; Boyle, Elaine] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Petrou, Stavros] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Macfarlane, Alison] City Univ London, Dept Hlth Sci, London, England	University of Oxford; University of Leicester; University of Oxford; City University London	Alterman, N; Quigley, MA (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit NPEU, Oxford, England.	neora.alterman@gmail.com; maria.quigley@npeu.ox.ac.uk		Alterman, Neora/0000-0001-8027-4164	MRC [MR/M01228X/1]	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The TIGAR study was funded by a research grant from the MRC awarded to MAQ, SJ, CC, SP, JJK, AM, EB -MR/M01228X/1 (https://mrc.ukri.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alterman N, 2021, ARCH DIS CHILD, V106, P842, DOI 10.1136/archdischild-2020-320213; [Anonymous], 2013, Obstet Gynecol, V122, P1139, DOI 10.1097/01.AOG.0000437385.88715.4a; [Anonymous], 2015, SN7712 U LOND I ED C; [Anonymous], 2019, SN8481 U COLL LOND U; Beauregard JL, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-0509; Bilsteen JF, 2021, PAEDIATR PERINAT EP, V35, P726, DOI 10.1111/ppe.12766; Bonellie Sandra, 2008, BMC Pregnancy Childbirth, V8, P5, DOI 10.1186/1471-2393-8-5; Breeman LD, 2015, PEDIATRICS, V136, P415, DOI 10.1542/peds.2015-0608; Centre for Longitudinal Studies, 2019, MILLENNIUM COHORT ST, VFirst; Chan E, 2014, ARCH DIS CHILD-FETAL, V99, pF451, DOI 10.1136/archdischild-2014-306124; Chawanpaiboon S, 2019, LANCET GLOB HEALTH, V7, pE37, DOI 10.1016/S2214-109X(18)30451-0; Clayton S, 2022, CHILD NEUROPSYCHOL, V28, P82, DOI 10.1080/09297049.2021.1955847; Cullis A., 2007, TECHNICAL REPORT INF; Department for Education, 2012, NAT CURR ASS KEY STA; Department for Education, 2018, REV GCSE EQ RES ENGL; Department for Education, 2017, REV GCSE EQ RES ENGL; Department for Education, 2015, NAT PUP DAT US GUID; Department for Education, 2016, NAT PUP DAT DAT FLOW; Department of Education, PROGR 8 ATT 8 MEAS C; Dex S, 2004, MILLENNIUM COHORT ST; Doyle LW, 2021, ARCH DIS CHILD, V106, P834, DOI 10.1136/archdischild-2021-321668; Ene D, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.11027; Flores CT, 2021, J PEDIATR-US, V232, P31, DOI 10.1016/j.jpeds.2020.12.070; Hansen K., 2014, MILLENNIUM COHORT ST; Jay Matthew Alexander, 2019, Int J Popul Data Sci, V4, P1101, DOI 10.23889/ijpds.v4i1.1101; Johnson S, 2009, ARCH DIS CHILD-FETAL, V94, pF283, DOI 10.1136/adc.2008.152793; Johnson S, 2011, DEV NEUROPSYCHOL, V36, P74, DOI 10.1080/87565641.2011.540541; Linsell L, 2019, EUR CHILD ADOLES PSY, V28, P531, DOI 10.1007/s00787-018-1219-8; Linsell L, 2018, ARCH DIS CHILD, V103, P363, DOI 10.1136/archdischild-2017-313414; Mathiasen R, 2010, PEDIATRICS, V126, pE1553, DOI 10.1542/peds.2009-0829; Moser Kath, 2007, Health Stat Q, P13; Mostafa T, 2016, INT J SOC RES METHOD, V19, P355, DOI 10.1080/13645579.2015.1019264; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; Odd D, 2019, ARCH DIS CHILD, V104, P348, DOI 10.1136/archdischild-2018-315441; Odd D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155157; Plewis I., 2007, MILLENNIUM COHORT ST; Poulsen G, 2011, J CLIN EPIDEMIOL, V64, P1444, DOI 10.1016/j.jclinepi.2011.03.007; Quigley MA, 2012, ARCH DIS CHILD-FETAL, V97, pF167, DOI 10.1136/archdischild-2011-300888; Saigal S, 2000, PEDIATRICS, V105, P325, DOI 10.1542/peds.105.2.325; Shepherd P., 2019, MILLENNIUM COHORT ST; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; Twilhaar ES, 2020, CHILD NEUROPSYCHOL, V26, P274, DOI 10.1080/09297049.2019.1639652; Twilhaar ES, 2019, ARCH DIS CHILD-FETAL, V104, pF419, DOI 10.1136/archdischild-2018-315028; Twilhaar ES, 2018, ARCH DIS CHILD-FETAL, V103, pF322, DOI 10.1136/archdischild-2017-312916; UK Data Service, 2017, SN4683 U LOND I ED C, V12nd; UK Data Service, 2017, SN8472 U COLL LOND U, V2nd; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wolke D, 2019, ANN REV DEV PSYCHOL, V1, P69, DOI [10.1146/annurev-devpsych-121318-084804, DOI 10.1146/ANNUREV-DEVPSYCH-121318-084804]; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	49	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0271952	10.1371/journal.pone.0271952	http://dx.doi.org/10.1371/journal.pone.0271952			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976808	Green Accepted, Green Published, gold			2022-12-26	WOS:000847227000019
J	Plucarova, J; Jansen, S; Narasimhan, S; Lanikova, A; Lewitzky, M; Feller, SM; Zidek, L				Plucarova, Jitka; Jansen, Severine; Narasimhan, Subhash; Lanikova, Alice; Lewitzky, Marc; Feller, Stephan M.; Zidek, Lukas			Specific phosphorylation of microtubule-associated protein 2c by extracellular signal-regulated kinase reduces interactions at its Pro-rich regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; TAU-PROTEIN; CATALYZED PHOSPHORYLATION; NMR-SPECTROSCOPY; BINDING DOMAIN; RAT-BRAIN; MAP2; GRB2; EXPRESSION; SITES	Microtubule-associated protein 2 (MAP2) is an important neuronal target of extracellular signal-regulated kinase 2 (ERK2) involved in Raf signaling pathways, but mechanistic details of MAP2 phosphorylation are unclear. Here, we used NMR spectroscopy to quantitatively describe the kinetics of phosphorylation of individual serines and threonines in the embryonic MAP2 variant MAP2c. We carried out real-time monitoring of phosphorylation to discover major phosphorylation sites that were not identified in previous studies relying on specific antibodies. Our comparison with the phosphorylation of MAP2c by a model cyclin-dependent kinase CDK2 and with phosphorylation of the MAP2c homolog Tau revealed differences in phosphorylation profiles that explain specificity of regulation of biological functions of MAP2c and Tau. To probe the molecular basis of the regulatory effect of ERK2, we investigated the interactions of phosphorylated and unphosphorylated MAP2c by NMR with single-residue resolution. As ERK2 phosphorylates mostly outside the regions binding microtubules, we studied the binding of proteins other than tubulin, namely regulatory subunit RII alpha of cAMP-dependent PKA, adapter protein Grb2, Src homology domain 3 of tyrosine kinases Fyn and Abl, and ERK2 itself. We found ERK2 phosphorylation interfered mostly with binding to proline-rich regions of MAP2c. Furthermore, our NMR experiments in SHSY5Y neuroblastoma cell lysates showed that the kinetics of dephosphorylation are compatible with in-cell NMR studies and that residues targeted by ERK2 and PKA are efficiently phosphorylated in the cell lysates. Taken together, our results and its effects on interactions with other proteins.	[Plucarova, Jitka; Narasimhan, Subhash; Lanikova, Alice; Zidek, Lukas] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, Brno, Czech Republic; [Plucarova, Jitka; Jansen, Severine; Narasimhan, Subhash; Lanikova, Alice; Zidek, Lukas] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic; [Lewitzky, Marc; Feller, Stephan M.] Martin Luther Univ Halle Wittenberg, Inst Mol Med, Halle, Germany	Masaryk University Brno; Masaryk University Brno; Martin Luther University Halle Wittenberg	Zidek, L (corresponding author), Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, Brno, Czech Republic.; Zidek, L (corresponding author), Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic.	lzidek@chemi.muni.cz		Plucarova, Jitka/0000-0001-8990-4353; Lanikova, Alice/0000-0002-3977-069X; Narasimhan, Subhash/0000-0003-1201-0495	DFG RTG 2467 "Intrinsically disordered proteins" [391498659]	DFG RTG 2467 "Intrinsically disordered proteins"	S. F. is supported by the DFG RTG 2467 "Intrinsically disordered proteins" (project number 391498659).	AINSZTEIN AM, 1994, J BIOL CHEM, V269, P28465; Alderson TR, 2017, CELL STRESS CHAPERON, V22, P639, DOI 10.1007/s12192-017-0791-z; Alexa A, 2002, BIOCHEMISTRY-US, V41, P12427, DOI 10.1021/bi025916s; Amniai L, 2009, FASEB J, V23, P1146, DOI 10.1096/fj.08-121590; AVILA J, 1994, INT J DEV BIOL, V38, P13; Bardwell AJ, 2015, J BIOL CHEM, V290, P26661, DOI 10.1074/jbc.M115.691436; BAUMANN K, 1993, FEBS LETT, V336, P417, DOI 10.1016/0014-5793(93)80849-P; BERLING B, 1994, EUR J CELL BIOL, V64, P120; Berry RW, 2003, BIOCHEMISTRY-US, V42, P8325, DOI 10.1021/bi027348m; Bhat KM, 1998, INT J DEV BIOL, V42, P127; Bielska AA, 2006, BIOCHEMISTRY-US, V45, P5527, DOI 10.1021/bi052662c; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; BRANDT R, 1994, J BIOL CHEM, V269, P11776; BURNS RG, 1984, EUR J BIOCHEM, V141, P609, DOI 10.1111/j.1432-1033.1984.tb08236.x; CHARDIN P, 1995, FEBS LETT, V369, P47, DOI 10.1016/0014-5793(95)00578-W; Cotter D, 1997, BRAIN RES, V765, P238, DOI 10.1016/S0006-8993(97)00575-1; Dehmelt L, 2005, GENOME BIOL, V6; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Despres C, 2017, P NATL ACAD SCI USA, V114, P9080, DOI 10.1073/pnas.1708448114; Diaz-Hernandez M, 2010, J BIOL CHEM, V285, P32539, DOI 10.1074/jbc.M110.145003; DIAZNIDO J, 1990, J NEUROCHEM, V54, P211, DOI 10.1111/j.1471-4159.1990.tb13303.x; Drewes G, 1998, TRENDS BIOCHEM SCI, V23, P307, DOI 10.1016/S0968-0004(98)01245-6; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; DREWES G, 1992, EMBO J, V11, P2131, DOI 10.1002/j.1460-2075.1992.tb05272.x; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ebneth A, 1999, CELL MOTIL CYTOSKEL, V44, P209, DOI 10.1002/(SICI)1097-0169(199911)44:3<209::AID-CM6>3.0.CO;2-4; Edbauer D, 2009, MOL CELL PROTEOMICS, V8, P681, DOI 10.1074/mcp.M800233-MCP200; Fifre A, 2006, J BIOL CHEM, V281, P229, DOI 10.1074/jbc.M507378200; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Gamblin TC, 1996, BIOCHEMISTRY-US, V35, P12576, DOI 10.1021/bi961135d; Gandhi NS, 2015, ANGEW CHEM INT EDIT, V54, P6819, DOI 10.1002/anie.201501898; Grubisha MJ, 2021, MOL PSYCHIATR, V26, P5371, DOI 10.1038/s41380-021-01034-z; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Hashiguchi M, 2013, INT REV CEL MOL BIO, V300, P121, DOI 10.1016/B978-0-12-405210-9.00004-7; HOSHI M, 1988, EUR J BIOCHEM, V174, P225, DOI 10.1111/j.1432-1033.1988.tb14086.x; HOSHI M, 1992, EUR J BIOCHEM, V203, P43, DOI 10.1111/j.1432-1033.1992.tb19825.x; Houtman JCD, 2006, NAT STRUCT MOL BIOL, V13, P798, DOI 10.1038/nsmb1133; Illenberger S, 1998, MOL BIOL CELL, V9, P1495, DOI 10.1091/mbc.9.6.1495; Illenberger S, 1996, J BIOL CHEM, V271, P10834, DOI 10.1074/jbc.271.18.10834; Itoh TJ, 1997, BIOCHEMISTRY-US, V36, P12574, DOI 10.1021/bi962606z; Jalava NS, 2007, INT J DEV NEUROSCI, V25, P121, DOI 10.1016/j.ijdevneu.2006.12.001; Jansen S, 2017, J BIOL CHEM, V292, P6715, DOI 10.1074/jbc.M116.771097; Jicha GA, 1997, J NEUROCHEM, V69, P2087; Jones SB, 2004, J NEUROSCI, V24, P8510, DOI 10.1523/JNEUROSCI.1264-04.2004; Kadavath H, 2015, P NATL ACAD SCI USA, V112, P7501, DOI 10.1073/pnas.1504081112; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; Kazimierczuk K, 2008, J MAGN RESON, V192, P123, DOI 10.1016/j.jmr.2008.02.003; Kim Y, 2020, FASEB J, V34, P6965, DOI 10.1096/fj.201902122RR; Landrieu I, 2006, J AM CHEM SOC, V128, P3575, DOI 10.1021/ja054656+; Lesovoy DM, 2021, ANGEW CHEM INT EDIT, V60, P23540, DOI 10.1002/anie.202102758; Li T, 2006, BIOCHEMISTRY-US, V45, P3125, DOI 10.1021/bi051634r; Lim RWL, 2000, J BIOL CHEM, V275, P20578, DOI 10.1074/jbc.M001887200; Lu PJ, 1999, NATURE, V399, P784; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Melkova K, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9030105; Melkova K, 2018, J BIOL CHEM, V293, P13297, DOI 10.1074/jbc.RA118.001769; Novacek J, 2013, J BIOMOL NMR, V56, P291, DOI 10.1007/s10858-013-9761-7; Ozer RS, 2000, MOL BIOL CELL, V11, P3573, DOI 10.1091/mbc.11.10.3573; Pei JJ, 2002, MOL BRAIN RES, V109, P45, DOI 10.1016/S0169-328X(02)00488-6; Philpot BD, 1997, J NEUROSCI, V17, P9596; Pisabarro MT, 1998, J MOL BIOL, V281, P513, DOI 10.1006/jmbi.1998.1932; Qi HL, 2017, METHODS MOL BIOL, V1523, P179, DOI 10.1007/978-1-4939-6598-4_11; Qi HL, 2016, J BIOL CHEM, V291, P7742, DOI 10.1074/jbc.M115.700914; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; RESZKA AA, 1995, P NATL ACAD SCI USA, V92, P8881, DOI 10.1073/pnas.92.19.8881; Richter-Landsberg C, 2008, J MOL NEUROSCI, V35, P55, DOI 10.1007/s12031-007-9017-7; Rose HM, 2013, BBA-PROTEINS PROTEOM, V1834, P1396, DOI 10.1016/j.bbapap.2013.01.023; RUBINO HM, 1989, NEURON, V3, P631, DOI 10.1016/0896-6273(89)90273-0; Safaei J, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-S1-S6; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Sanchez C, 1996, EUR J BIOCHEM, V241, P765, DOI 10.1111/j.1432-1033.1996.00765.x; Sanchez C, 2000, EUR J CELL BIOL, V79, P252, DOI 10.1078/S0171-9335(04)70028-X; Sandhu P, 2017, BIOORG MED CHEM LETT, V27, P642, DOI 10.1016/j.bmcl.2016.11.087; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; Schwalbe M, 2015, STRUCTURE, V23, P1448, DOI 10.1016/j.str.2015.06.002; Sibille N, 2012, PROTEINS, V80, P454, DOI 10.1002/prot.23210; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; Stanek J, 2010, J BIOMOL NMR, V47, P65, DOI 10.1007/s10858-010-9411-2; Theillet FX, 2013, NAT PROTOC, V8, P1416, DOI 10.1038/nprot.2013.083; Theillet FX, 2012, J BIOMOL NMR, V54, P217, DOI 10.1007/s10858-012-9674-x; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; VALLEE R, 1980, P NATL ACAD SCI-BIOL, V77, P3206, DOI 10.1073/pnas.77.6.3206; VIERECK C, 1989, J NEUROSCI, V9, P3547; Vincent I, 1996, J CELL BIOL, V132, P413, DOI 10.1083/jcb.132.3.413; Welburn Julie, 2004, V296, P219; Wenzel J, 2001, FEBS LETT, V509, P255, DOI 10.1016/S0014-5793(01)03174-X; Woolf NJ, 1999, BRAIN RES, V821, P241, DOI 10.1016/S0006-8993(99)01064-1; YAMAUCHI T, 1983, BIOCHEM BIOPH RES CO, V110, P287, DOI 10.1016/0006-291X(83)91293-7; Yuzawa S, 2001, J MOL BIOL, V306, P527, DOI 10.1006/jmbi.2000.4396; Zamora-Leon SP, 2005, J BIOL CHEM, V280, P1962, DOI 10.1074/jbc.M411380200; Zamora-Leon SP, 2001, J BIOL CHEM, V276, P39950, DOI 10.1074/jbc.M107807200; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	95	0	0	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102384	10.1016/j.jbc.2022.102384	http://dx.doi.org/10.1016/j.jbc.2022.102384			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5H1DF	35987383	Green Published, gold			2022-12-26	WOS:000867425500004
J	Lazcano, P; Schmidtke, MW; Onu, CJ; Greenberg, ML				Lazcano, Pablo; Schmidtke, Michael W.; Onu, Chisom J.; Greenberg, Miriam L.			Phosphatidic acid inhibits inositol synthesis by inducing nuclear translocation of kinase IP6K1 and repression of myo-inositol-3-P synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; PHOSPHOLIPASE-D; GROWTH-FACTOR; AMPK; MYOINOSITOL; GLUCOSE; PYROPHOSPHATES; MEMBRANE; LITHIUM; PHOSPHOINOSITIDES	Inositol is an essential metabolite that serves as a precursor for structural and signaling molecules. Although perturbation of inositol homeostasis has been implicated in numerous human disorders, surprisingly little is known about how inositol levels are regulated in mammalian cells. A recent study in mouse embryonic fibroblasts demonstrated that nuclear translocation of inositol hexakisphosphate kinase 1 (IP6K1) mediates repression of myo-inositol-3-P synthase (MIPS), the rate-limiting inositol biosynthetic enzyme. Binding of IP6K1 to phosphatidic acid (PA) is required for this repression. Here, we elucidate the role of PA in IP6K1 repression. Our results indicate that increasing PA levels through pharmacological stimulation of phospholipase D (PLD) or direct supplementation of 18:1 PA induces nuclear translocation of IP6K1 and represses expression of the MIPS protein. We found that this effect was specific to PA synthesized in the plasma membrane, as endoplasmic reticulum-derived PA did not induce IP6K1 translocation. Furthermore, we determined that PLD-mediated PA synthesis can be stimulated by the master metabolic regulator 5' AMP-activated protein kinase (AMPK). We show that activation of AMPK by glucose deprivation or by treatment with the mood-stabilizing drugs valproate or lithium recapitulated IP6K1 nuclear translocation and decreased MIPS expression. This study demonstrates for the first time that modulation of PA levels through the AMPK-PLD pathway regulates IP6K1-mediated repression of MIPS.	[Lazcano, Pablo; Schmidtke, Michael W.; Onu, Chisom J.; Greenberg, Miriam L.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	Wayne State University	Greenberg, ML (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	mgreenberg@wayne.edu		Lazcano, Pablo/0000-0001-9218-5396; Schmidtke, Michael/0000-0002-6985-4835	National Institutes of Health [R01GM125082]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Acknowledgments Funding and additional information - This work was supported by the National Institutes of Health grant number R01GM125082 (to M. L. G) . The content is solely the responsibility of the authors and does not necessarily represent the of fi cial views of the National Institutes of Health.	Artini PG, 2013, GYNECOL ENDOCRINOL, V29, P375, DOI 10.3109/09513590.2012.743020; Avery LB, 2014, MOL PHARMACOL, V85, P1, DOI 10.1124/mol.113.089755; Bao H, 2019, FASEB J, V33, P14370, DOI 10.1096/fj.201901712R; Berridge M, 2014, CELL TISSUE RES, V357, P477, DOI 10.1007/s00441-014-1806-z; BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; Burton A, 2013, P NATL ACAD SCI USA, V110, P18970, DOI 10.1073/pnas.1309699110; Case KC, 2020, HANDB EXP PHARMACOL, V259, P221, DOI 10.1007/164_2018_181; Deranieh RM, 2013, J BIOL CHEM, V288, P26822, DOI 10.1074/jbc.M113.479121; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dogliotti G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15747; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; EAGLE H, 1957, J BIOL CHEM, V226, P191; Endo H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28074-w; Fazio A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155297; Foster DA, 2014, J BIOL CHEM, V289, P22583, DOI 10.1074/jbc.R114.566091; Ganesan R, 2015, BBA-MOL CELL BIOL L, V1851, P261, DOI 10.1016/j.bbalip.2014.12.007; Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032; Han H, 2018, MOL CELL, V72, P328, DOI 10.1016/j.molcel.2018.08.038; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hatton N, 2015, MOL CELL BIOL, V35, P3131, DOI 10.1128/MCB.00286-15; Hsu CC, 2021, MOL CELL, V81, P3803, DOI 10.1016/j.molcel.2021.08.025; Hu TH, 2003, J BIOL CHEM, V278, P2348, DOI 10.1074/jbc.M210093200; Kassas N, 2017, J BIOL CHEM, V292, P4266, DOI 10.1074/jbc.M116.742346; Kassie F, 2010, CARCINOGENESIS, V31, P1634, DOI 10.1093/carcin/bgq139; KEITH AD, 1977, BIOPHYS J, V17, P205, DOI 10.1016/S0006-3495(77)85650-6; Kim JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009600; Lee Y, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2019.158552; Lin SC, 2018, CELL METAB, V27, P299, DOI 10.1016/j.cmet.2017.10.009; Liscovitch M, 2000, BIOCHEM J, V345, P401, DOI 10.1042/0264-6021:3450401; Liu ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184818; MATILE P, 1966, SCIENCE, V151, P86, DOI 10.1126/science.151.3706.86; MINSKOFF SA, 1992, J BACTERIOL, V174, P4078, DOI 10.1128/jb.174.12.4078-4085.1992; Papaleo E, 2007, GYNECOL ENDOCRINOL, V23, P700, DOI 10.1080/09513590701672405; Salsaa M, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101110; Salt IP, 1998, BIOCHEM J, V335, P533, DOI 10.1042/bj3350533; Seelan RS, 2011, EPIGENOMICS-UK, V3, P111, DOI 10.2217/EPI.10.73; Shaltiel G, 2004, BIOL PSYCHIAT, V56, P868, DOI 10.1016/j.biopsych.2004.08.027; Shears Stephen B, 2015, Adv Biol Regul, V57, P203, DOI 10.1016/j.jbior.2014.09.015; Shi Yihui, 2006, V39, P265; Suliman M, 2022, BBA-MOL CELL BIOL L, V1867, DOI 10.1016/j.bbalip.2022.159137; Tanguy Emeline, 2021, Advances in Biological Regulation, V79, P100772, DOI 10.1016/j.jbior.2020.100772; Tei R, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201907013; Thakur R, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00083; Vaden DL, 2001, J BIOL CHEM, V276, P15466, DOI 10.1074/jbc.M004179200; Williams RSB, 2002, NATURE, V417, P292, DOI 10.1038/417292a; Willows R, 2017, BIOCHEM J, V474, P3059, DOI 10.1042/BCJ20170458; Wilson MSC, 2013, BIOCHEM J, V452, P369, DOI 10.1042/BJ20130118; Yu WX, 2016, J BIOL CHEM, V291, P10437, DOI 10.1074/jbc.M116.714816; Zhang CS, 2017, NATURE, V548, P112, DOI 10.1038/nature23275; Zhang F, 2014, MOL CELL BIOL, V34, P84, DOI 10.1128/MCB.00987-13; Zhu QZ, 2016, J CLIN INVEST, V126, P4273, DOI 10.1172/JCI85510; Zhukovsky MA, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00147	52	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102363	10.1016/j.jbc.2022.102363	http://dx.doi.org/10.1016/j.jbc.2022.102363			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4V3XX	35963434	Green Published, gold			2022-12-26	WOS:000859414300006
J	Kumar, A; Mondal, S; Lal, P				Kumar, Amit; Mondal, Subhasree; Lal, Preet			Analysing frequent extreme flood incidences in Brahmaputra basin, South Asia	PLOS ONE			English	Article							KERALA	The present study is focused on the flood inundation in Brahmaputra Basin, which is one of the most recurrent and destructive natural disasters of the region. The flood inundation was assessed using C-Band Sentinel 1 A synthetic aperture radar (SAR) during 2015-2020 with precipitation patterns, runoff discharge, and their impacts on land cover in the basin. The study exhibited a very high precipitation during monsoon in the upper catchment resulting in severe flood inundation in downslopes of Brahmaputra Basin. A very high (900-2000 mm) to extremely high (>2000 mm) monthly cumulative precipitation in the south and south-eastern parts of basin led to high discharge (16,000 to 18,000 m(3) s(-1)) during July-August months. The river discharge increases with cumulative effects of precipitation and melting of snow cover during late summer and monsoon season, and induced flood inundation in lower parts of basin. This flood has largely affected agricultural land (>77% of total basin), forests (similar to 3%), and settlement (426 to 1758 km(2)) affecting large wildlife and livelihood during 2015-2020. The study highlights the regions affected with recurrent flood and necessitates adopting an integrated, multi-hazard, multi-stakeholder approach with an emphasis on self-reliance of the community for sustenance with local resources and practices.	[Kumar, Amit; Mondal, Subhasree] Cent Univ Jharkhand, Dept Geoinformat, Ranchi, Jharkhand, India; [Lal, Preet] Michigan State Univ, Dept Civil & Environm Engn, E Lansing, MI 48824 USA	Central University of Jharkhand; Michigan State University	Lal, P (corresponding author), Michigan State Univ, Dept Civil & Environm Engn, E Lansing, MI 48824 USA.	lalpreet@msu.edu	Lal, Preet/R-7900-2018; Kumar, Amit/H-5240-2012	Lal, Preet/0000-0002-7119-4768; Kumar, Amit/0000-0002-4582-5677				Alfieri L, 2015, HYDROL EARTH SYST SC, V19, P2247, DOI 10.5194/hess-19-2247-2015; Alipour A, 2020, J FLOOD RISK MANAG, V13, DOI 10.1111/jfr3.12605; Borah SB, 2018, ENVIRON MONIT ASSESS, V190, DOI 10.1007/s10661-018-6893-y; Bronstert A, 2020, CLIM CHANG MANAG, P225, DOI 10.1007/978-3-030-37425-9_12; Chandel VS, 2021, WATER RESOUR RES, V57, DOI 10.1029/2020WR027589; Costache R, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12091422; Diksha, 2022, GEOCARTO INT, DOI 10.1080/10106049.2022.2086635; Dimri AP, 2020, FRONT ENV SCI-SWITZ, V8, DOI 10.3389/fenvs.2020.00096; Fossum KN, 2020, NPJ CLIM ATMOS SCI, V3, DOI 10.1038/s41612-020-0116-2; Fowler HJ, 2021, NAT REV EARTH ENV, V2, P107, DOI 10.1038/s43017-020-00128-6; Gupta K, 2020, PHILOS T R SOC A, V378, DOI 10.1098/rsta.2019.0211; Hu ZY, 2019, INT J CLIMATOL, V39, P1072, DOI 10.1002/joc.5863; Hunt KMR, 2020, CLIM DYNAM, V54, P2433, DOI 10.1007/s00382-020-05123-7; Kaushik S, 2020, SCI TOTAL ENVIRON, V714, DOI 10.1016/j.scitotenv.2019.136455; Kumar R., 2021, ADV REMOTE SENSING N, P389, DOI [10.1002/9781119616016.ch19, DOI 10.1002/9781119616016.CH19]; Kumar S, 2020, NAT HAZARDS, V103, P1613, DOI 10.1007/s11069-020-04033-5; Lal P., 2019, ISPRS ANN PHOTOGRAMM, DOI [10.5194/isprs-annals-IV-5-W2-49-2019, DOI 10.5194/ISPRS-ANNALS-IV-5-W2-49-2019]; Lal P, 2021, FRONT ENV SCI-SWITZ, V9, DOI 10.3389/fenvs.2021.766328; Lal P, 2020, NAT HAZARDS, V104, P1947, DOI 10.1007/s11069-020-04233-z; Lal P, 2020, REMOTE SENS LETT, V11, P436, DOI 10.1080/2150704X.2020.1730468; Li H, 2018, HYDROL EARTH SYST SC, V22, P5097, DOI 10.5194/hess-22-5097-2018; Li L, 2020, ECOL INDIC, V117, DOI 10.1016/j.ecolind.2020.106683; Mohanty MP, 2020, INT J DISAST RISK RE, V49, DOI 10.1016/j.ijdrr.2020.101660; Pandey AC, 2022, SUSTAINABILITY-BASEL, V14, DOI 10.3390/su14074210; Peter H, 2017, ADV SPACE RES, V60, P879, DOI 10.1016/j.asr.2017.05.034; Rao MP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19795-6; Rashid I, 2020, WATER-SUI, V12, DOI 10.3390/w12041168; Roy P, 2020, J CLEAN PROD, V272, DOI 10.1016/j.jclepro.2020.122757; Saidi ME, 2020, J WATER CLIM CHANGE, V11, P310, DOI 10.2166/wcc.2020.069; Schlaffer S, 2015, INT J APPL EARTH OBS, V38, P15, DOI 10.1016/j.jag.2014.12.001; Sharma A, 2018, GLOBAL CHANGE BIOL, V24, pE432, DOI 10.1111/gcb.13874; Tripathy P, 2022, NAT HAZARDS, V114, P1341, DOI 10.1007/s11069-022-05428-2; Vanama VSK, 2021, EUR J REMOTE SENS, V54, P42, DOI 10.1080/22797254.2020.1867901; Vionnet V, 2020, HYDROL EARTH SYST SC, V24, P2141, DOI 10.5194/hess-24-2141-2020	35	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0273384	10.1371/journal.pone.0273384	http://dx.doi.org/10.1371/journal.pone.0273384			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994487	gold, Green Published			2022-12-26	WOS:000877093400049
J	Zeleke, TC; Adimassu, NF; Alemayehu, AM; Dawud, TW; Mersha, GA				Zeleke, Tarekegn Cheklie; Adimassu, Nebiyat Feleke; Alemayehu, Abiy Maru; Dawud, Teshager Wondale; Mersha, Getasew Alemu			Symptomatic dry eye disease and associated factors among postgraduate students in Ethiopia	PLOS ONE			English	Article							RISK-FACTORS; PREVALENCE; POPULATION; DURATION; IMPACT; WOMEN	Background Symptomatic dry eye disease is a growing public health challenge especially among those who are visual display unit (VDU) users and other long-time near activity workers. Globally, computer user adults experience a surge in the prevalence of dry eye. Data is insufficient on the prevalence of dry eye disease among postgraduate students in Ethiopia. Therefore, the present was aimed to assess the prevalence of dry eye and its associated factors among postgraduate students at the University of Gondar, Northwest Ethiopia. Methods A cross-sectional study was conducted on a total of 423 postgraduate students who were selected based on a simple random sampling technique. Data was collected through online symptom-based ocular surface disease index questionnaire. Binary logistic regression was used to test the association and p-value of <0.05 was considered to determine the significance of the association. Results From the total postgraduate students, 404 completed the study with a response rate of 95.5%. The prevalence of symptomatic dry eye disease was 50.5% (95% CI, 45.1%54.9%). Average continuous visual display unit use for 2-4hours per day[AOR = 2.57 (95% CI, 1.27-5.21)] and for> 4hours per day[AOR = 3.77 (95% CI 1.87-7.59)], duration of visual display unit use for 3-5 years [AOR = 2.24 (95% CI, 1.17-4.31)], 6-8 years [AOR = 2.46 (95% CI,1.31-4.62)] and > 8 years [AOR = 3.25 (95% CI, 1.63-6.48)], average sleeping hour < 7 hours/day within last week [AOR = 2.17 (95% CI, 1.35-3.49)] and current known allergic conjunctivitis [AOR = 5.42 (95% CI, 2.43-12.10)] were significantly associated with symptomatic dry eye disease. Conclusion and recommendation In this study, about half of postgraduate students faced symptomatic dry eye disease. Significant association was observed between symptomatic dry eye disease and average continuous hours of visual display unit use, duration of visual display unit use in years, shortage of sleep and current known allergic conjunctivitis. It is advisable for postgraduate students to limit screen exposure hour and establish regular breaking time along their exposure. It is also advisable to have optimum sleep as possible. It is also important to explore dry eye disease on a large sample incorporating clinical tests.	[Zeleke, Tarekegn Cheklie; Adimassu, Nebiyat Feleke; Alemayehu, Abiy Maru; Mersha, Getasew Alemu] Univ Gondar, Tertiary Eye Care & Training Ctr, Dept Optometry, Sch Med, Gondar, Ethiopia; [Dawud, Teshager Wondale] Univ Gondar, Dept Ophthalmol, Sch Med, Tertiary Eye Care & Training Ctr, Gondar, Ethiopia	University of Gondar; University of Gondar	Zeleke, TC (corresponding author), Univ Gondar, Tertiary Eye Care & Training Ctr, Dept Optometry, Sch Med, Gondar, Ethiopia.	tarekegncheklie2691@gmail.com	Cheklie, Tarekegn/HIR-4066-2022	Maru, Abiy/0000-0002-6032-8978	light for the world non-profit non-governmental organization	light for the world non-profit non-governmental organization	We acknowledge light for the world non-profit non-governmental organization for the financial support during data collection.	Castellanos-Gonzalez JA, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0292-3; Alharbi A, 2018, J CLIN EXP OPHTHALMO, V9, P34; Alshamrani AA, 2017, MIDDLE EAST AFR J OP, V24, P67, DOI 10.4103/meajo.MEAJO_281_16; Arita R, 2010, CORNEA, V29, P858, DOI 10.1097/ICO.0b013e3181ca3668; Asiedu K, 2017, EYE CONTACT LENS, V43, P262, DOI 10.1097/ICL.0000000000000256; Blehm C, 2005, SURV OPHTHALMOL, V50, P253, DOI 10.1016/j.survophthal.2005.02.008; Cartes C, 2022, OPHTHAL EPIDEMIOL, V29, P245, DOI 10.1080/09286586.2021.1943457; Chen SP, 2013, CORNEA, V32, P423, DOI 10.1097/ICO.0b013e3182662390; Ferrero A, 2018, OCUL SURF, V16, P112, DOI 10.1016/j.jtos.2017.09.008; Galor A, 2011, AM J OPHTHALMOL, V152, P377, DOI 10.1016/j.ajo.2011.02.026; Guo B, 2010, OPHTHAL EPIDEMIOL, V17, P234, DOI 10.3109/09286586.2010.498659; Gupta N, 2010, ANN TROP MED PARASIT, V104, P247, DOI 10.1179/136485910X12647085215859; Hashemi H, 2014, CLIN EXP OPHTHALMOL, V42, P242, DOI 10.1111/ceo.12183; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P40, DOI 10.1016/j.sleh.2014.12.010; Le QH, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-22; Lee W, 2015, SLEEP MED, V16, P1327, DOI 10.1016/j.sleep.2015.06.021; Li SM, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.285; Lu F, 2018, J OPHTHALMOL, V2018, DOI 10.1155/2018/2401213; Martinez JD, 2016, CLIN OPHTHALMOL, V10, P1335, DOI 10.2147/OPTH.S106451; Miljanovic B, 2007, AM J OPHTHALMOL, V143, P409, DOI 10.1016/j.ajo.2006.11.060; Mrugacz Malgorzata, 2013, Klin Oczna, V115, P111; Muna'aim MA., 2016, MALAYS J MED SCI, V12, P30; Peck Travis, 2017, J Midlife Health, V8, P51, DOI 10.4103/jmh.JMH_41_17; Ravi Ranjan, 2016, Open Journal of Preventive Medicine, V6, P57, DOI 10.4236/ojpm.2016.61005; Sherry A, 2020, CONTACT LENS ANTERIO, V43, P355, DOI 10.1016/j.clae.2019.08.001; Sriprasert I, 2016, MENOPAUSE, V23, P343, DOI 10.1097/GME.0000000000000530; Suzuki S, 2006, CORNEA, V25, P277, DOI 10.1097/01.ico.0000178277.29010.bc; Tong L, 2010, EYE, V24, P1486, DOI 10.1038/eye.2010.67; Uchino M, 2008, AM J OPHTHALMOL, V146, P925, DOI 10.1016/j.ajo.2008.06.030; Uchino M, 2008, OPHTHALMOLOGY, V115, P1982, DOI 10.1016/j.ophtha.2008.06.022; Uchino M, 2011, OPHTHALMOLOGY, V118, P2361, DOI 10.1016/j.ophtha.2011.05.029; Vayisoglu SK, 2019, TURK OFTALMOL DERG, V49, P142, DOI 10.4274/tjo.galenos.2018.67915; Vehof J, 2014, BRIT J OPHTHALMOL, V98, P1712, DOI 10.1136/bjophthalmol-2014-305201; Viso E, 2009, OPHTHAL EPIDEMIOL, V16, P15, DOI 10.1080/09286580802228509; Waduthantri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037711; Yu JH, 2011, CORNEA, V30, P379, DOI 10.1097/ICO.0b013e3181f7f363; Yu-ping H., 2016, INT EYE SCI, V16, P1019; Zhang S, 2019, OPHTHAL EPIDEMIOL, V26, P393, DOI 10.1080/09286586.2019.1632905; Zhang Y, 2012, OPHTHAL EPIDEMIOL, V19, P226, DOI 10.3109/09286586.2012.670742	39	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0272808	10.1371/journal.pone.0272808	http://dx.doi.org/10.1371/journal.pone.0272808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994456	gold, Green Published			2022-12-26	WOS:000877093400028
J	Josan, C; Podinic, T; Pfaff, N; Raha, S				Josan, Chitmandeep; Podinic, Tina; Pfaff, Nikko; Raha, Sandeep			Effect of Delta-9-tetrahydrocannabinol and cannabidiol on milk proteins and lipid levels in HC11 cells	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; WHEY ACIDIC PROTEIN; PRENATAL MARIJUANA USE; CANNABINOID RECEPTOR; EARLY-PREGNANCY; SELF-REPORT; DIFFERENTIATION; ALCOHOL; EXPRESSION; POTENCY	Pregnant and lactating women have been discouraged from using cannabis by Health Canada. However, the increasing rate of cannabis use among pregnant women has presented an urgent need to investigate its physiological effects during the perinatal period. During pregnancy, the mammary gland (MG) undergoes remodeling, which involves alveolar differentiation of mammary epithelial cells (MECs), which is essential for breast milk production and secretion. Limited evidence has been reported on the impact of cannabis or its components, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), on MG development or MEC differentiation. In this study, we investigated the effects of THC and CBD on the differentiation of MECs by assessing changes in cellular viability, lipid accumulation, and gene and protein expression of major milk protein and lipid synthesizing markers. using the HC11 cells as a model. We hypothesized that THC and CBD will negatively impact the synthesis of milk proteins and lipids, as well as lipid markers in HC11 cells. Our results demonstrated that THC and CBD reduced cellular viability at concentrations above 30 mu M and 20 mu M, respectively. Relative to control, 10 mu M THC and 10 mu M CBD reduced mRNA levels of milk proteins (CSN2 and WAP), lipid synthesizing and glucose transport markers (GLUT 1, HK2, FASN, FABP4, PLIN2 and LPL), as well as whey acidic protein and lipid levels. In addition, co-treatment of a CB2 antagonist with THC, and a CB2 agonist with CBD, reversed the impact of THC and CBD on the mRNA levels of key markers, respectively. In conclusion, 10 mu M THC and CBD altered the differentiation of HC11 cells, in part via the CB2 receptor.	[Josan, Chitmandeep; Podinic, Tina; Pfaff, Nikko; Raha, Sandeep] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Josan, Chitmandeep; Podinic, Tina; Pfaff, Nikko; Raha, Sandeep] McMaster Univ, Grad Programme Med Sci, Hamilton, ON, Canada	McMaster University; McMaster University	Raha, S (corresponding author), McMaster Univ, Dept Pediat, Hamilton, ON, Canada.; Raha, S (corresponding author), McMaster Univ, Grad Programme Med Sci, Hamilton, ON, Canada.	rahas@mcmaster.ca	Raha, Sandeep/AAF-3655-2020	Raha, Sandeep/0000-0001-7307-3292	National Science and Engineering Research Council [RGPN-2019-07102]; Ontario Graduate Scholarship; NSERC	National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by funding from the National Science and Engineering Research Council (S.R.) -Discovery grant program (RGPN-2019-07102). TP received support through an Ontario Graduate Scholarship and NK received funding through NSERC undergraduate research summer assistantship (URSA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves P, 2021, ARCH TOXICOL, V95, P3393, DOI 10.1007/s00204-021-03122-z; Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; [Anonymous], 2015, LEG MAR NEW SCI WEED; [Anonymous], 2020, CANADIAN CANNABIS SU; [Anonymous], 2021, SOC OBSTETRICIANS GY; BAILEY JR, 1987, TOXICOL APPL PHARM, V90, P315, DOI 10.1016/0041-008X(87)90338-3; Bartlett K, 2020, J OBSTET GYNAECOL CA, V42, P1346, DOI 10.1016/j.jogc.2020.04.015; Beatty Jessica R, 2012, J Addict Res Ther, V3; Caffarel MM, 2006, CANCER RES, V66, P6615, DOI 10.1158/0008-5472.CAN-05-4566; Chiba T, 2014, BIOL PHARM BULL, V37, P1336, DOI 10.1248/bpb.b14-00273; Clauss A, 2002, BIOCHEM J, V368, P233, DOI 10.1042/BJ20020869; CLINE PR, 1982, IN VITRO CELL DEV B, V18, P694, DOI 10.1007/BF02796424; Corsi DJ, 2019, CAN J PUBLIC HEALTH, V110, P76, DOI 10.17269/s41997-018-0148-0; Cosentino S, 2010, J NUTR BIOCHEM, V21, P247, DOI 10.1016/j.jnutbio.2008.12.016; DAY N, 1991, NEUROTOXICOL TERATOL, V13, P329, DOI 10.1016/0892-0362(91)90079-C; Dempsey C, 2012, J NUTR, V142, P655, DOI 10.3945/jn.111.150623; DEVANE WA, 1988, MOL PHARMACOL, V34, P605; El Marroun H, 2011, EUR ADDICT RES, V17, P37, DOI 10.1159/000320550; ElSohly MA, 2016, BIOL PSYCHIAT, V79, P613, DOI 10.1016/j.biopsych.2016.01.004; Falcon M, 2012, FORENSIC SCI INT, V218, P92, DOI 10.1016/j.forsciint.2011.10.022; Fergusson DM, 2002, BJOG-INT J OBSTET GY, V109, P21, DOI 10.1016/S1470-0328(02)01020-0; FREUDENTHAL RI, 1972, BRIT J PHARMACOL, V44, P244, DOI 10.1111/j.1476-5381.1972.tb07260.x; Glass M, 1999, MOL PHARMACOL, V56, P1362, DOI 10.1124/mol.56.6.1362; GODWIN H, 1967, ANTIQUITY, V41, P42, DOI 10.1017/S0003598X00038928; Gurm H, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9030267; Hanlon KE, 2016, BREAST CANCER-TARGET, V8, P59, DOI 10.2147/BCTT.S100393; Hashiesh HM, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.702675; HATCH EE, 1986, AM J EPIDEMIOL, V124, P986, DOI 10.1093/oxfordjournals.aje.a114488; HENNIGHAUSEN L, 1994, CELL GROWTH DIFFER, V5, P607; HINGSON R, 1982, PEDIATRICS, V70, P539; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Huppertz B, 2006, AM J OBSTET GYNECOL, V195, P29, DOI 10.1016/j.ajog.2005.07.039; Ignatowska-Jankowska B, 2011, NEUROSCI LETT, V490, P82, DOI 10.1016/j.neulet.2010.12.031; Jager Richard, 2008, BMC Res Notes, V1, P29, DOI 10.1186/1756-0500-1-29; Kaarid K., 2020, J OBSTET GYNAECOL CA, V42; Kar P, 2021, DRUG ALCOHOL DEPEN, V225, DOI 10.1016/j.drugalcdep.2021.108760; KLINE J, 1987, INT J EPIDEMIOL, V16, P44, DOI 10.1093/ije/16.1.44; Kobayashi K, 2020, TOXICOL IN VITRO, V63, DOI 10.1016/j.tiv.2019.104741; KREUZ DS, 1973, SCIENCE, V179, P391, DOI 10.1126/science.179.4071.391; Lojpur T, 2019, REPROD TOXICOL, V87, P21, DOI 10.1016/j.reprotox.2019.04.008; Macias H, 2012, WIRES DEV BIOL, V1, P533, DOI 10.1002/wdev.35; Martin CE, 2015, J ADDICT MED, V9, P99, DOI 10.1097/ADM.0000000000000095; Martinez-Pinilla E, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00744; McManaman JL, 2009, CLIN LIPIDOL, V4, P391, DOI 10.2217/CLP.09.15; Merlo GR, 1996, EUR J CELL BIOL, V70, P97; Metz TD, 2019, OBSTET GYNECOL, V133, P98, DOI 10.1097/AOG.0000000000003028; Milian L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228909; Mohammad MA, 2013, AM J PHYSIOL-ENDOC M, V305, pE700, DOI 10.1152/ajpendo.00052.2013; Muthumalage T, 2019, TOXICOL APPL PHARM, V382, DOI 10.1016/j.taap.2019.114713; National Science Foundation, 2006, BRADF PROT ASS PROT; Nukumi N, 2004, DEV BIOL, V274, P31, DOI 10.1016/j.ydbio.2004.04.040; OHLSSON A, 1986, BIOMED ENVIRON MASS, V13, P77, DOI 10.1002/bms.1200130206; Ohrvik H, 2006, TOXICOL LETT, V164, P207, DOI 10.1016/j.toxlet.2005.12.008; Onaivi ES, 2008, ANN NY ACAD SCI, V1139, P426, DOI 10.1196/annals.1432.035; Passey ME, 2014, DRUG ALCOHOL DEPEN, V134, P44, DOI 10.1016/j.drugalcdep.2013.09.008; PITTIUS CW, 1988, MOL ENDOCRINOL, V2, P1027, DOI 10.1210/mend-2-11-1027; Plante I, 2011, JOVE-J VIS EXP, DOI 10.3791/2828; Raine JM., 1978, EUR J PHARMACOL; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; RAWITCH AB, 1979, GEN PHARMACOL, V10, P525, DOI 10.1016/0306-3623(79)90019-3; ROBINSON GW, 1995, DEVELOPMENT, V121, P2079; Rudolph MC, 2007, J MAMMARY GLAND BIOL, V12, P269, DOI 10.1007/s10911-007-9061-5; Saito T, 2008, ADV EXP MED BIOL, V606, P295, DOI 10.1007/978-0-387-74087-4_12; Saurel-Cubizolles MJ, 2014, BJOG-INT J OBSTET GY, V121, P971, DOI 10.1111/1471-0528.12626; Schwope DM, 2011, CLIN CHEM, V57, P1406, DOI 10.1373/clinchem.2011.171777; Sherwood RA, 1999, EUR J PEDIATR, V158, P488, DOI 10.1007/s004310051126; Silberstein GB, 2001, MICROSC RES TECHNIQ, V52, P155, DOI 10.1002/1097-0029(20010115)52:2<155::AID-JEMT1001>3.0.CO;2-P; Sornapudi TR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30122-4; Stoeckman AK, 2002, J BIOL CHEM, V277, P27029, DOI 10.1074/jbc.M202638200; Thomas A, 2007, BRIT J PHARMACOL, V150, P613, DOI 10.1038/sj.bjp.0707133; Triplett AA, 2005, GENESIS, V43, P1, DOI 10.1002/gene.20149; Walker OS, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83563-9; Walker OS, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14476; Walker OLS, 2019, J OVARIAN RES, V12, DOI 10.1186/s13048-018-0478-9; Westfall Rachel E, 2009, Complement Ther Clin Pract, V15, P242; Wilkinson TS, 2011, BIOCHEM SOC T, V39, P1409, DOI 10.1042/BST0391409; ZUCKERMAN B, 1989, NEW ENGL J MED, V320, P762, DOI 10.1056/NEJM198903233201203	77	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0272819	10.1371/journal.pone.0272819	http://dx.doi.org/10.1371/journal.pone.0272819			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976913	gold, Green Published			2022-12-26	WOS:000847227000060
J	Su, KV; Collins, MP; McGuire, CM; Alshagawi, MA; Alamoudi, MK; Li, Z; Forgac, M				Su, Kevin; Collins, Michael P.; McGuire, Christina M.; Alshagawi, Mohammed A.; Alamoudi, Mariam K.; Li, Zhen; Forgac, Michael			Isoform a4 of the vacuolar ATPase a subunit promotes 4T1-12B breast cancer cell-dependent tumor growth and metastasis in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V-ATPASE; PLASMA-MEMBRANE; PROTON PUMP; A3 ISOFORM; H+-ATPASE; TGF-BETA; HETEROGENEITY; ACIDIFICATION; EXPRESSION; INVASIVENESS	The vacuolar H+-ATPase (V-ATPase) is an ATP-dependent proton pump that governs the pH of various intracellular compartments and also functions at the plasma membrane in certain cell types, including cancer cells. Membrane targeting of the V-ATPase is controlled by isoforms of subunit a, and we have previously shown that isoforms a3 and a4 are important for the migration and invasion of several breast cancer cell lines in vitro. Using CRISPR-mediated genome editing to selectively disrupt each of the four a subunit isoforms, we also recently showed that a4 is critical to plasma membrane V-ATPase localization, as well as in vitro migration and invasion of 4T1 -12B murine breast cancer cells. We now report that a4 is important for the growth of 4T1-12B tumors in vivo. We found that BALB/c mice bearing a4-/-4T1-12B allografts had significantly smaller tumors than mice in the control group. In addition, we determined that a4-/- allografts showed dramat-ically reduced metastases to the lung and reduced lumines-cence intensity of metastases to bone relative to the control group. Taken together, these results suggest that the a4 isoform of the V-ATPase represents a novel potential therapeutic target to limit breast cancer growth and metastasis.	[Su, Kevin; Alshagawi, Mohammed A.; Li, Zhen; Forgac, Michael] Tufts Univ, Grad Sch Biomed Sci, Dept Pharmacol & Drug Dev, Boston, MA 02155 USA; [Collins, Michael P.; Forgac, Michael] Tufts Univ, Grad Sch Biomed Sci, Dept Cellular Mol & Dev Biol, Boston, MA 02155 USA; [McGuire, Christina M.; Forgac, Michael] Tufts Univ, Grad Sch Biomed Sci, Dept Biochem, Boston, MA 02155 USA; [Alamoudi, Mariam K.; Forgac, Michael] Tufts Univ, Dept Dev Mol & Chem Biol, Sch Med, Boston, MA 02155 USA; [Su, Kevin] Korral Bio, Cambridge, MA USA; [Collins, Michael P.] Foghorn Therapeut, Cambridge, MA USA; [McGuire, Christina M.] Guardian Therapeut, Lexington, MA USA; [Alamoudi, Mariam K.] Prince Sattam Bin Abdulaziz Univ, Coll Pharm, Pharmacol & Toxicol Dept, Al Kharj, Saudi Arabia	Tufts University; Tufts University; Tufts University; Tufts University; Prince Sattam Bin Abdulaziz University	Forgac, M (corresponding author), Tufts Univ, Grad Sch Biomed Sci, Dept Pharmacol & Drug Dev, Boston, MA 02155 USA.; Forgac, M (corresponding author), Tufts Univ, Grad Sch Biomed Sci, Dept Cellular Mol & Dev Biol, Boston, MA 02155 USA.; Forgac, M (corresponding author), Tufts Univ, Grad Sch Biomed Sci, Dept Biochem, Boston, MA 02155 USA.; Forgac, M (corresponding author), Tufts Univ, Dept Dev Mol & Chem Biol, Sch Med, Boston, MA 02155 USA.	michael.forgac@tufts.edu		Alamoudi, Mariam/0000-0001-7653-0401; Collins, Michael/0000-0002-1806-6775	National Institutes of Health [R21CA245172]; Breast Cancer Alliance; Tufts University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Alliance; Tufts University	Funding was provided by the National Institutes of Health research grant R21CA245172 (to M. F.), an Exceptional Project Award from the Breast Cancer Alliance (to M. F.), and the Sackler Family Collaborative Cancer Biology Award from Tufts University (to M. P. C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Ani A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204269; Alizadeh J, 2018, BBA-MOL CELL RES, V1865, P749, DOI 10.1016/j.bbamcr.2018.02.007; Arroyo-Crespo JJ, 2019, INT J CANCER, V145, P2267, DOI 10.1002/ijc.32270; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bray SJ, 2016, NAT REV MOL CELL BIO, V17, P722, DOI 10.1038/nrm.2016.94; Breton S, 2013, PHYSIOLOGY, V28, P318, DOI 10.1152/physiol.00007.2013; Capecci J, 2013, J BIOL CHEM, V288, P32731, DOI 10.1074/jbc.M113.503771; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; Collins MP, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00902; Cotter K, 2016, ONCOTARGET, V7, P46142, DOI 10.18632/oncotarget.10063; Cotter K, 2015, TRENDS BIOCHEM SCI, V40, P611, DOI 10.1016/j.tibs.2015.08.005; Cotter K, 2015, J BIOL CHEM, V290, P3680, DOI 10.1074/jbc.M114.611210; Croucher PI, 2016, NAT REV CANCER, V16, P373, DOI 10.1038/nrc.2016.44; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; DEXTER DL, 1978, CANCER RES, V38, P3174; Ding Y, 2014, J AM SOC NEPHROL, V25, P2835, DOI 10.1681/ASN.2013101068; duPre' SA, 2007, EXP MOL PATHOL, V82, P12, DOI 10.1016/j.yexmp.2006.06.007; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Gomez-Cuadrado L, 2017, DIS MODEL MECH, V10, P1061, DOI 10.1242/dmm.030403; Harbeck N, 2019, NAT REV DIS PRIMERS, V5, DOI [10.1038/s41572-019-0122-z, 10.1038/s41572-019-0111-2]; HEPPNER GH, 1978, CANCER RES, V38, P3758; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; Holliday L. S., 2014, NEW J SCI, V2014, P1, DOI [10.1155/2014/675430, DOI 10.1155/2014/675430]; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; Khan GN, 2017, ANTICANCER RES, V37, P2343, DOI 10.21873/anticanres.11572; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2016, NATURE, V529, P298, DOI 10.1038/nature17038; McGuire CM, 2019, J BIOL CHEM, V294, P11248, DOI 10.1074/jbc.RA119.007713; MILLER FR, 1983, INVAS METAST, V3, P22; Oot RA, 2017, PROTEIN SCI, V26, P896, DOI 10.1002/pro.3147; Pamarthy S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.347; Pamarthy S, 2015, ONCOTARGET, V6, P34206, DOI 10.18632/oncotarget.5275; Park Mi Kyung, 2018, Lab Anim Res, V34, P160, DOI 10.5625/lar.2018.34.4.160; Pietrement C, 2006, BIOL REPROD, V74, P185, DOI 10.1095/biolreprod.105.043752; Proskuryakov SY, 2010, CURR PHARM DESIGN, V16, P56, DOI 10.2174/138161210789941793; Schempp CM, 2014, MOL CANCER THER, V13, P926, DOI 10.1158/1535-7163.MCT-13-0484; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Sethi N, 2010, J BIOL CHEM, V285, P34757, DOI 10.1074/jbc.M110.158634; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; Stransky L, 2016, PHYSIOL REV, V96, P1071, DOI 10.1152/physrev.00035.2015; Sun-Wada GH, 2013, HISTOL HISTOPATHOL, V28, P805, DOI 10.14670/HH-28.805; Tao K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-228; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Toyomura T, 2000, J BIOL CHEM, V275, P8760, DOI 10.1074/jbc.275.12.8760; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vasanthakumar T, 2020, TRENDS BIOCHEM SCI, V45, P295, DOI 10.1016/j.tibs.2019.12.007; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Welch DR, 2019, CANCER RES, V79, P3011, DOI 10.1158/0008-5472.CAN-19-0458; Wiedmann RM, 2012, CANCER RES, V72, P5976, DOI 10.1158/0008-5472.CAN-12-1772; Yan Y, 2009, DEV CELL, V17, P387, DOI 10.1016/j.devcel.2009.07.001; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37; Zhang Y., 2017, COLD SPRING HARB PER, P9, DOI DOI 10.1101/CSHPERSPECT.A022145	57	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	298	10							102395	10.1016/j.jbc.2022.102395	http://dx.doi.org/10.1016/j.jbc.2022.102395			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5K6GU	35988642	gold, Green Published			2022-12-26	WOS:000869823800002
J	Meduri, R; Rubio, LS; Mohajan, S; Gross, DS				Meduri, Rajyalakshmi; Rubio, Linda S.; Mohajan, Suman; Gross, David S.			Phase-separation antagonists potently inhibit transcription and broadly increase nucleosome density	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK FACTOR; RNA-POLYMERASE; HSF1 ACTIVATION; YEAST; RECRUITMENT	Biomolecular condensates are self-organized membraneless bodies involved in many critical cellular activities, including ribosome biogenesis, protein synthesis, and gene transcription. Aliphatic alcohols are commonly used to study biomolecular condensates, but their effects on transcription are unclear. Here, we explore the impact of the aliphatic dialcohol, 1,6hexanediol (1,6-HD), on Pol II transcription and nucleosome occupancy in budding yeast. As expected, 1,6-HD, a reagent effective in disrupting biomolecular condensates, strongly suppressed the thermal stress-induced transcription of Heat Shock Factor 1-regulated genes that have previously been shown to physically interact and coalesce into intranuclear condensates. Surprisingly, the isomeric dialcohol, 2,5-HD, typically used as a negative control, abrogated Heat Shock Factor 1-target gene transcription under the same conditions. Each reagent also abolished the transcription of genes that do not detectably coalesce, including Msn2/Msn4-regulated heatinducible genes and constitutively expressed housekeeping genes. Thus, at elevated temperature (39 degrees C), HDs potently inhibit the transcription of disparate genes and as demonstrated by chromatin immunoprecipitation do so by abolishing occupancy of RNA polymerase in chromatin. Concurrently, histone H3 density increased at least twofold within all gene coding and regulatory regions examined, including quiescent euchromatic loci, silent heterochromatic loci, and Pol IIItranscribed loci. Our results offer a caveat for the use of HDs in studying the role of condensates in transcriptional control and provide evidence that exposure to these reagents elicits a widespread increase in nucleosome density and a concomitant loss of both Pol II and Pol III transcription.	[Meduri, Rajyalakshmi; Rubio, Linda S.; Mohajan, Suman; Gross, David S.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71115 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Gross, DS (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71115 USA.	david.gross@lsuhs.edu		Gross, David/0000-0002-7957-8790; Rubio, Linda/0000-0002-7260-6971	National Institutes of Health;  [R15 GM128065];  [R01 GM138988]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; 	This work was supported bygrants R15 GM128065 and R01 GM138988 from the National Institutes of Health awarded to D. S. G. and an Ike Muslow predoc-toral fellowship awarded to L. S. R. The content is solely theresponsibility of the authors and does not necessarily represent theofficial views of the National Institutes of Health.	Ahn JH, 2021, NATURE, V595, P591, DOI 10.1038/s41586-021-03662-5; Al-Husini N, 2018, MOL CELL, V71, P1027, DOI 10.1016/j.molcel.2018.08.003; Anandhakumar J, 2016, MOL CELL BIOL, V36, P1943, DOI 10.1128/MCB.00005-16; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Boehning M, 2018, NAT STRUCT MOL BIOL, V25, P833, DOI 10.1038/s41594-018-0112-y; Boija A, 2018, CELL, V175, P1842, DOI 10.1016/j.cell.2018.10.042; Cho WK, 2018, SCIENCE, V361, P412, DOI 10.1126/science.aar4199; Chong SS, 2018, SCIENCE, V361, DOI 10.1126/science.aar2555; Chowdhary S., 2021, BIORXIV; Chowdhary S, 2019, CELL REP, V26, P18, DOI 10.1016/j.celrep.2018.12.034; Chowdhary S, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00292-17; Ding DQ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13609-0; Duster R, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100260; Erkine AM, 1999, MOL CELL BIOL, V19, P1627; Fan XC, 2006, NAT STRUCT MOL BIOL, V13, P117, DOI 10.1038/nsmb1049; Feder ZA, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202005165; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gopaul D., 2022, GENOME RES, V4; Guo YE, 2019, NATURE, V572, P543, DOI 10.1038/s41586-019-1464-0; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hsieh THS, 2015, CELL, V162, P108, DOI 10.1016/j.cell.2015.05.048; Hung KL, 2021, NATURE, V600, P731, DOI 10.1038/s41586-021-04116-8; Iserman C, 2020, CELL, V181, P818, DOI 10.1016/j.cell.2020.04.009; Itoh Y, 2021, LIFE SCI ALLIANCE, V4, DOI 10.26508/lsa.202001005; Kainth AS, 2021, TRENDS CELL BIOL, V31, P801, DOI 10.1016/j.tcb.2021.04.004; Keuenhof KS, 2022, J CELL SCI, V135, DOI 10.1242/jcs.258325; Kim S, 2013, J BIOL CHEM, V288, P12197, DOI 10.1074/jbc.M112.449553; Krakowiak J, 2018, ELIFE, V7, DOI 10.7554/eLife.31668; Kremer SB, 2009, J BIOL CHEM, V284, P32914, DOI 10.1074/jbc.M109.058610; Ladouceur AM, 2020, P NATL ACAD SCI USA, V117, P18540, DOI 10.1073/pnas.2005019117; Lancaster L, 2021, LIFE SCI ALLIANCE, V4, DOI 10.26508/lsa.202000961; Lin Y, 2016, CELL, V167, P789, DOI 10.1016/j.cell.2016.10.003; Liu XY, 2021, GENOME BIOL, V22, DOI 10.1186/s13059-021-02455-3; Lu HS, 2018, NATURE, V558, P318, DOI 10.1038/s41586-018-0174-3; Masser AE, 2019, ELIFE, V8, DOI 10.7554/eLife.47791; McSwiggen DT, 2019, GENE DEV, V33, P1619, DOI 10.1101/gad.331520.119; Nair SJ, 2019, NAT STRUCT MOL BIOL, V26, P193, DOI 10.1038/s41594-019-0190-5; NONET M, 1987, MOL CELL BIOL, V7, P1602, DOI 10.1128/MCB.7.5.1602; Peffer S, 2019, J BIOL CHEM, V294, P12191, DOI 10.1074/jbc.RA119.008822; Pessina F, 2019, NAT CELL BIOL, V21, P1286, DOI 10.1038/s41556-019-0392-4; Pincus D, 2018, MOL BIOL CELL, V29, P3168, DOI 10.1091/mbc.E18-06-0353; Rawat P, 2021, MOL CELL, V81, P1013, DOI 10.1016/j.molcel.2021.01.016; Ryu JK, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe5905; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; Schilling M, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109277; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shi YY, 2021, BMC BIOL, V19, DOI 10.1186/s12915-021-01178-y; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Strom AR, 2017, NATURE, V547, P241, DOI 10.1038/nature22989; Tye BW, 2021, MOL BIOL CELL, V32, P1800, DOI 10.1091/mbc.E21-01-0014; Yamazaki T, 2018, MOL CELL, V70, P1038, DOI 10.1016/j.molcel.2018.05.019; Zhang HS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004202; Zhang HC, 2022, NAT CELL BIOL, V24, P340, DOI 10.1038/s41556-022-00846-7; Zhao J, 2005, MOL CELL BIOL, V25, P8985, DOI 10.1128/MCB.25.20.8985-8999.2005; Zheng X, 2016, ELIFE, V5, DOI [10.7554/eLife.18638, 10.7554/eLife.13374]	56	1	1	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102365	10.1016/j.jbc.2022.102365	http://dx.doi.org/10.1016/j.jbc.2022.102365			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5J0EG	35963432	gold, Green Published			2022-12-26	WOS:000868720100008
J	Araujo, NR; Hernando, G; Corradi, J; Bouzat, C				Rodriguez Araujo, Noelia; Hernando, Guillermina; Corradi, Jeremias; Bouzat, Cecilia			The nematode serotonin-gated chloride channel MOD-1: A novel target for anthelmintic therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION-CHANNELS; LOCOMOTORY BEHAVIOR; LIGAND RECOGNITION; RECEPTORS; IVERMECTIN; SITES; PHARMACOLOGY; MODULATION; ACTIVATION; MECHANISMS	Anthelmintics are used to treat human and veterinary parasitic diseases and to reduce crop and livestock production loss associated with parasitosis. The free-living nematode Caenorhabditis elegans, a model system for anthelmintic drug discovery, has a serotonin (5-HT)-gated chloride channel, MOD-1, which belongs to the Cys-loop receptor family and modulates locomotory and behavioral functions. Since MOD-1 is unique to nematodes, it is emerging as an attractive anthelmintic drug target, but details of MOD-1 function are unclear. Here, we revealed novel aspects of MOD-1 function from the molecular level to the organism level and identified compounds targeting this receptor, which may provide new directions for anthelmintic drug discovery. We used whole-cell current recordings from heterologously expressed MOD-1 to show that tryptamine (Tryp), a weak partial agonist of vertebrate serotonin type 3 (5-HT3) receptors, efficaciously activates MOD-1. A screen for modulators revealed that GABAergic ligands piperazine (PZE) and muscimol reduce 5-HT-elicited currents, thus identifying novel MOD-1 allosteric inhibitors. Next, we performed locomotor activity assays, and we found 5-HT and Tryp rapidly decrease worm motility, which is reversible only at low 5-HT concentrations. Mutants lacking MOD-1 are partially resistant to both drugs, demonstrating its role in locomotion. Acting as an antagonist of MOD-1, we showed PZE reduces the locomotor effects of exogenous 5-HT. Therefore, Tryp- and PZE-derived compounds, acting at MOD-1 through different molecular mechanisms, emerge as promising anthelmintic agents. This study enhances our knowledge of the function and drug selectivity of Cys-loop receptors and postulates MOD-1 as a potential target for anthelmintic therapy.	[Rodriguez Araujo, Noelia; Hernando, Guillermina; Corradi, Jeremias; Bouzat, Cecilia] Univ Nacl Sur UNS, Consejo Nacl Invest Cient & Tecn CONICET, Dept Biol Bioquim & Farm, Inst Invest Bioquim Bahia Blanca, Bahia Blanca, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South	Bouzat, C (corresponding author), Univ Nacl Sur UNS, Consejo Nacl Invest Cient & Tecn CONICET, Dept Biol Bioquim & Farm, Inst Invest Bioquim Bahia Blanca, Bahia Blanca, Buenos Aires, Argentina.	inbouzat@criba.edu.ar		Hernando, Guillermina/0000-0002-8411-5467; CORRADI, JEREMIAS/0000-0003-0258-6140; Rodriguez Araujo, Noelia/0000-0001-8264-9695	Universidad Nacional del Sur, Argentina [PGI 24/B298]; Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina [PICT 2017-1170, PICT 2019 01751, PICT 2019 01232]; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina [PIP 11220200102356]	Universidad Nacional del Sur, Argentina; Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from Universidad Nacional del Sur, Argentina (PGI 24/B298 to C. B.), Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina (PICT 2017-1170 to C. B., PICT 2019 01751 to G. H., PICT 2019 01232 to J. C.), and Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina (PIP 11220200102356 to C. B.).	Accardi MV, 2012, INVERTEBR NEUROSCI, V12, P3, DOI 10.1007/s10158-012-0129-6; Andersen ND, 2016, NEUROPHARMACOLOGY, V107, P189, DOI 10.1016/j.neuropharm.2016.02.032; ANGSTADT JD, 1989, J COMP NEUROL, V284, P374, DOI 10.1002/cne.902840305; Basak S, 2020, ELIFE, V9, DOI 10.7554/eLife.57870; Basak S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02997-4; Beech RN, 2015, PARASITOLOGY, V142, P303, DOI 10.1017/S003118201400170X; Beech RN, 2013, PARASITOL INT, V62, P599, DOI 10.1016/j.parint.2013.03.010; Beene DL, 2002, BIOCHEMISTRY-US, V41, P10262, DOI 10.1021/bi020266d; Blunden G, 2003, ACTA HORTIC, P23, DOI 10.17660/ActaHortic.2003.597.2; Bouzat C, 2002, BIOPHYS J, V82, P1920, DOI 10.1016/S0006-3495(02)75541-0; Bouzat C, 2008, J NEUROSCI, V28, P7808, DOI 10.1523/JNEUROSCI.0448-08.2008; Castro M. J., 2020, FRONT NEUROSCI-SWITZ, V14, P1; Chen IS, 2018, J PHYSIOL-LONDON, V596, P1833, DOI 10.1113/JP275236; Chrestia JF, 2021, CELL MOL LIFE SCI, V78, P5381, DOI 10.1007/s00018-021-03853-3; Churgin MA, 2017, J NEUROSCI, V37, P7811, DOI [10.1523/JNEUROSCI.2636-16.2017, 10.1523/jneurosci.2636-16.2017]; Corradi J, 2014, J NEUROSCI, V34, P16865, DOI 10.1523/JNEUROSCI.1970-14.2014; Corradi J, 2009, BIOPHYS J, V97, P1335, DOI 10.1016/j.bpj.2009.06.018; Crisford A, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008884; Degani-Katzav N, 2016, P NATL ACAD SCI USA, V113, pE644, DOI 10.1073/pnas.1423753113; Dent JA, 2006, J MOL EVOL, V62, P523, DOI 10.1007/s00239-005-0018-2; Gurel G, 2012, GENETICS, V192, P1359, DOI 10.1534/genetics.112.142125; Hamdan FF, 1999, J NEUROCHEM, V72, P1372, DOI 10.1046/j.1471-4159.1999.721372.x; Hansen TVA, 2022, MOLECULES, V27, DOI 10.3390/molecules27010312; Hapiak VM, 2009, GENETICS, V181, P153, DOI 10.1534/genetics.108.096891; Hernando G, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007895; Hernando G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095072; Hernando G, 2012, MOL PHARMACOL, V82, P550, DOI 10.1124/mol.112.079962; Hobert O., 2013, WORMBOOK ONLINE REV, DOI [10.1895/wormbook.1.1, DOI 10.1895/WORMBOOK.1.1]; Hobson RJ, 2003, J NEUROCHEM, V87, P22, DOI 10.1046/j.1471-4159.2003.01967.x; Holden-Dye L, 2006, INT J PARASITOL, V36, P395, DOI 10.1016/j.ijpara.2005.11.006; Iwanir S, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0232-y; Jenkins T, 1998, ACTA BIOL HUNG, V49, P421; Johnston GAR, 2014, NEUROCHEM RES, V39, P1942, DOI 10.1007/s11064-014-1245-y; Kesters D, 2013, EMBO REP, V14, P49, DOI 10.1038/embor.2012.189; Kullyev A, 2010, GENETICS, V186, P929, DOI 10.1534/genetics.110.118877; Lansdell SJ, 2015, MOL PHARMACOL, V87, P87, DOI 10.1124/mol.114.094540; Law WJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004794; Liu MX, 2019, VET PARASITOL, V265, P15, DOI 10.1016/j.vetpar.2018.11.014; LIU Y, 1991, BIOPHYS J, V60, P424, DOI 10.1016/S0006-3495(91)82068-9; Lynagh T, 2012, TRENDS PHARMACOL SCI, V33, P432, DOI 10.1016/j.tips.2012.05.002; Makhoba XH, 2020, DRUG DES DEV THER, V14, P3235, DOI 10.2147/DDDT.S257494; Morud J, 2021, CURR BIOL, V31, P4282, DOI 10.1016/j.cub.2021.07.036; Mu TW, 2003, J AM CHEM SOC, V125, P6850, DOI 10.1021/ja0348086; Olde B, 1997, J MOL NEUROSCI, V8, P53, DOI 10.1007/BF02736863; Papke RL, 2002, BRIT J PHARMACOL, V137, P49, DOI 10.1038/sj.bjp.0704833; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Peden AS, 2013, NAT NEUROSCI, V16, P1794, DOI 10.1038/nn.3575; Ranganathan R, 2000, NATURE, V408, P470, DOI 10.1038/35044083; Risi G, 2019, VET SCI, V6, DOI 10.3390/vetsci6010029; Araujo NR, 2020, BIOPHYS J, V119, P1670, DOI 10.1016/j.bpj.2020.08.029; Rufener L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003524; Sauguet L, 2015, BBA-GEN SUBJECTS, V1850, P511, DOI 10.1016/j.bbagen.2014.05.007; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; Sepulveda-Crespo D, 2020, MED RES REV, V40, P1715, DOI 10.1002/med.21668; Tsalik EL, 2003, DEV BIOL, V263, P81, DOI 10.1016/S0012-1606(03)00447-0; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	56	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102356	10.1016/j.jbc.2022.102356	http://dx.doi.org/10.1016/j.jbc.2022.102356			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5B1GH	35952761	gold, Green Published			2022-12-26	WOS:000863323200010
J	Wu, MR; Miao, LL; Liu, Y; Qian, XX; Hou, TT; Ai, GM; Yu, L; Ma, L; Gao, XY; Qin, YL; Zhu, HZ; Du, L; Li, SY; Tian, CL; Li, DF; Liu, ZP; Liu, SJ				Wu, Meng-Ru; Miao, Li-Li; Liu, Ying; Qian, Xin-Xin; Hou, Ting-Ting; Ai, Guo-Min; Yu, Lu; Ma, Lan; Gao, Xi-Yan; Qin, Ya-Ling; Zhu, Hai-Zhen; Du, Lei; Li, Sheng-Ying; Tian, Chang-Lin; Li, De-Feng; Liu, Zhi-Pei; Liu, Shuang-Jiang			Identification and characterization of a novel hydroxylamine oxidase, DnfA, that catalyzes the oxidation of hydroxylamine to N-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-OXYGENASE AURF; NITROSOMONAS-EUROPAEA; NITROUS-OXIDE; OXIDOREDUCTASE; INTERMEDIATE; NITRIFICATION	Nitrogen (N-2) gas in the atmosphere is partially replenished by microbial denitrification of ammonia. Recent study has shown that Alcaligenes ammonioxydans oxidizes ammonia to dinitrogen via a process featuring the intermediate hydroxylamine, termed "Dirammox" (direct ammonia oxidation). However, the unique biochemistry of this process remains unknown. Here, we report an enzyme involved in Dirammox that catalyzes the conversion of hydroxylamine to N-2. We tested previously annotated proteins involved in redox reactions, DnfA, DnfB, and DnfC, to determine their ability to catalyze the oxidation of ammonia or hydroxylamine. Our results showed that none of these proteins bound to ammonia or catalyzed its oxidation; however, we did find DnfA bound to hydroxylamine. Further experiments demonstrated that, in the presence of NADH and FAD, DnfA catalyzed the conversion of N-15-labeled hydroxylamine to N-15(2). This conversion did not happen under oxygen (O-2)-free conditions. Thus, we concluded that DnfA encodes a hydroxylamine oxidase. We demonstrate that DnfA is not homologous to any known hydroxylamine oxidoreductases and contains a diiron center, which was shown to be involved in catalysis via electron paramagnetic resonance experiments. Furthermore, enzyme kinetics of DnfA were assayed, revealing a Km of 92.9 +/- 3.0 mu M for hydroxylamine and a kcat of 0.028 +/- 0.001 s(-1). Finally, we show that DnfA was localized in the cytoplasm and periplasm as well as in tubular membrane invaginations in HO-1 cells. To the best of our knowledge, we conclude that DnfA is the first enzyme discovered that catalyzes oxidation of hydroxylamine to N-2.	[Wu, Meng-Ru; Miao, Li-Li; Liu, Ying; Qian, Xin-Xin; Hou, Ting-Ting; Ai, Guo-Min; Ma, Lan; Gao, Xi-Yan; Qin, Ya-Ling; Zhu, Hai-Zhen; Li, De-Feng; Liu, Zhi-Pei; Liu, Shuang-Jiang] Chinese Acad Sci, State Key Lab Microbial Resources, Inst Microbiol, Beijing, Peoples R China; [Wu, Meng-Ru; Miao, Li-Li; Liu, Ying; Qian, Xin-Xin; Hou, Ting-Ting; Ai, Guo-Min; Ma, Lan; Gao, Xi-Yan; Qin, Ya-Ling; Zhu, Hai-Zhen; Li, De-Feng; Liu, Zhi-Pei; Liu, Shuang-Jiang] Chinese Acad Sci, Environm Microbiol Res Ctr, Inst Microbiol, Beijing, Peoples R China; [Wu, Meng-Ru; Hou, Ting-Ting; Ma, Lan; Gao, Xi-Yan; Qin, Ya-Ling; Li, De-Feng; Liu, Zhi-Pei; Liu, Shuang-Jiang] Univ Chinese Acad Sci, Sch Life Sci, Beijing, Peoples R China; [Yu, Lu; Tian, Chang-Lin] Chinese Acad Sci, High Magnet Field Lab, Hefei, Peoples R China; [Du, Lei; Li, Sheng-Ying; Liu, Shuang-Jiang] Shandong Univ, State Key Lab Microbial Technol, Qingdao, Peoples R China; [Tian, Chang-Lin] Univ Sci & Technol China, Affiliated Hosp 1, Div Life Sci & Med, Hefei, Anhui, Peoples R China; [Tian, Chang-Lin] Univ Sci & Technol China, Ctr BioAnalyt Chem, Affiliated Hosp 1, Hefei Natl Lab Phys Sci Microscale, Hefei, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Shandong University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Li, DF; Liu, ZP; Liu, SJ (corresponding author), Chinese Acad Sci, State Key Lab Microbial Resources, Inst Microbiol, Beijing, Peoples R China.; Li, DF; Liu, ZP; Liu, SJ (corresponding author), Chinese Acad Sci, Environm Microbiol Res Ctr, Inst Microbiol, Beijing, Peoples R China.; Li, DF; Liu, ZP; Liu, SJ (corresponding author), Univ Chinese Acad Sci, Sch Life Sci, Beijing, Peoples R China.; Liu, SJ (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Qingdao, Peoples R China.	lidefeng@im.ac.cn; liuzhp@im.ac.cn; liusj@sdu.edu.cn		liu, ying/0000-0001-9381-0501; Yu, Lu/0000-0003-4852-0008	National Natural Science Foundation of China, China [91951101, 31861133002, 31870103]; National Key R&D Program of China, China [2019YFA0905500]	National Natural Science Foundation of China, China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China, China	This research was supported by grants from the National Natural Science Foundation of China, China (grant nos.: 91951101, 31861133002, and 31870103) and National Key R&D Program of China, China (grant no.: 2019YFA0905500).	BREMNER JM, 1980, SOIL BIOL BIOCHEM, V12, P263, DOI 10.1016/0038-0717(80)90072-3; Caranto JD, 2017, P NATL ACAD SCI USA, V114, P8217, DOI 10.1073/pnas.1704504114; Caranto JD, 2016, P NATL ACAD SCI USA, V113, P14704, DOI 10.1073/pnas.1611051113; Cedervall P, 2013, BIOCHEMISTRY-US, V52, P6211, DOI 10.1021/bi400960w; Choi YS, 2008, P NATL ACAD SCI USA, V105, P6858, DOI 10.1073/pnas.0712073105; de Almeida NM, 2015, J BACTERIOL, V197, P2432, DOI 10.1128/JB.00186-15; Devol AH, 2015, ANNU REV MAR SCI, V7, P403, DOI 10.1146/annurev-marine-010213-135040; DEWITT JG, 1991, J AM CHEM SOC, V113, P9219, DOI 10.1021/ja00024a031; Ettwig KF, 2012, BBA-BIOENERGETICS, V1817, pS155, DOI [10.3389/fmicb.2012.00273, 10.1016/j.bbabio.2012.06.406]; Ettwig KF, 2010, NATURE, V464, P543, DOI 10.1038/nature08883; FOX BG, 1993, P NATL ACAD SCI USA, V90, P2486, DOI 10.1073/pnas.90.6.2486; FREAR DS, 1955, ANAL CHEM, V27, P1664, DOI 10.1021/ac60106a054; Guo YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12250-1; Igarashi N, 1997, NAT STRUCT BIOL, V4, P276, DOI 10.1038/nsb0497-276; Kalvelage T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029299; Kartal B, 2011, NATURE, V479, P127, DOI 10.1038/nature10453; KNOWLES R, 1982, MICROBIOL REV, V46, P43, DOI 10.1128/MMBR.46.1.43-70.1982; Kuypers MMM, 2018, NAT REV MICROBIOL, V16, P263, DOI 10.1038/nrmicro.2018.9; Leipoldt F, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01975-6; Maalcke WJ, 2014, J BIOL CHEM, V289, P1228, DOI 10.1074/jbc.M113.525147; Makris TM, 2015, J AM CHEM SOC, V137, P1608, DOI 10.1021/ja511649n; Makris TM, 2010, P NATL ACAD SCI USA, V107, P15391, DOI 10.1073/pnas.1007953107; Merkx M, 2001, ANGEW CHEM INT EDIT, V40, P2782, DOI 10.1002/1521-3773(20010803)40:15<2782::AID-ANIE2782>3.0.CO;2-P; Ouyang L, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21400-3; REEM RC, 1987, J AM CHEM SOC, V109, P1216, DOI 10.1021/ja00238a035; REES MK, 1968, BIOCHEMISTRY-US, V7, P353, DOI 10.1021/bi00841a045; Schalk J, 2000, BIOCHEMISTRY-US, V39, P5405, DOI 10.1021/bi992721k; Simurdiak M, 2006, CHEMBIOCHEM, V7, P1169, DOI 10.1002/cbic.200600136; Soler-Jofra A, 2021, WATER RES, V190, DOI 10.1016/j.watres.2020.116723; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Strous M, 1999, NATURE, V400, P446, DOI 10.1038/22749; Vajrala N, 2013, P NATL ACAD SCI USA, V110, P1006, DOI 10.1073/pnas.1214272110; White CJ, 2016, P NATL ACAD SCI USA, V113, P14474, DOI 10.1073/pnas.1617953114; Wu MR, 2021, ENVIRON MICROBIOL, V23, P6965, DOI 10.1111/1462-2920.15751; Xu SQ, 2022, APPL ENVIRON MICROB, V88, DOI 10.1128/aem.02261-21; YAMANAKA T, 1980, CURR MICROBIOL, V4, P239, DOI 10.1007/BF02605864	36	0	0	17	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102372	10.1016/j.jbc.2022.102372	http://dx.doi.org/10.1016/j.jbc.2022.102372			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5B1GH	35970391	gold, Green Published			2022-12-26	WOS:000863323200009
J	Shazly, SA; Borah, BJ; Ngufor, CG; Torbenson, VE; Theiler, RN; Famuyide, AO				Shazly, Sherif A.; Borah, Bijan J.; Ngufor, Che G.; Torbenson, Vanessa E.; Theiler, Regan N.; Famuyide, Abimbola O.			Impact of labor characteristics on maternal and neonatal outcomes of labor: A machine-learning model	PLOS ONE			English	Article							CERVICOGRAPHS; PRIMIGRAVIDAE; MANAGEMENT; LINE	Introduction Since Friedman's seminal publication on laboring women, numerous publications have sought to define normal labor progress. However, there is paucity of data on contemporary labor cervicometry incorporating both maternal and neonatal outcomes. The objective of this study is to establish intrapartum prediction models of unfavorable labor outcomes using machine-learning algorithms. Materials and methods Consortium on Safe Labor is a large database consisting of pregnancy and labor characteristics from 12 medical centers in the United States. Outcomes, including maternal and neonatal outcomes, were retrospectively collected. We defined primary outcome as the composite of following unfavorable outcomes: cesarean delivery in active labor, postpartum hemorrhage, intra-amniotic infection, shoulder dystocia, neonatal morbidity, and mortality. Clinical and obstetric parameters at admission and during labor progression were used to build machine-learning risk-prediction models based on the gradient boosting algorithm. Results Of 228,438 delivery episodes, 66,586 were eligible for this study. Mean maternal age was 26.95 +/- 6.48 years, mean parity was 0.92 +/- 1.23, and mean gestational age was 39.35 +/- 1.13 weeks. Unfavorable labor outcome was reported in 14,439 (21.68%) deliveries. Starting at a cervical dilation of 4 cm, the area under receiver operating characteristics curve (AUC) of prediction models increased from 0.75 (95% confidence interval, 0.75-0.75) to 0.89 (95% confidence interval, 0.89-0.90) at a dilation of 10 cm. Baseline labor risk score was above 35% in patients with unfavorable outcomes compared to women with favorable outcomes, whose score was below 25%. Conclusion Labor risk score is a machine-learning-based score that provides individualized and dynamic alternatives to conventional labor charts. It predicts composite of adverse birth, maternal, and neonatal outcomes as labor progresses. Therefore, it can be deployed in clinical practice to monitor labor progress in real time and support clinical decisions.	[Shazly, Sherif A.; Borah, Bijan J.; Torbenson, Vanessa E.; Theiler, Regan N.; Famuyide, Abimbola O.] Mayo Clin, Dept Med, Rochester, MN 55902 USA; [Borah, Bijan J.] Mayo Clin, Div Hlth Care Delivery Res, Rochester, MN USA; [Borah, Bijan J.; Ngufor, Che G.] Mayo Clin, Robert & Patricia E Kern Ctr Sci Hlth Care Delive, Rochester, MN USA; [Ngufor, Che G.] Mayo Clin, Dept Artificial Intelligence & Informat, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Famuyide, AO (corresponding author), Mayo Clin, Dept Med, Rochester, MN 55902 USA.	famuyide.abimbola@mayo.edu						Bernitz S, 2019, LANCET, V393, P340, DOI 10.1016/S0140-6736(18)31991-3; Caughey AB, 2014, AM J OBSTET GYNECOL, V210, P179, DOI 10.1016/j.ajog.2014.01.026; Chen T., 2015, XGBOOST EXTREME GRAD, V1, P1; Clark SL, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.068; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Dallas KB, 2019, OBSTET GYNECOL, V133, p222S, DOI 10.1097/01.AOG.0000559139.13601.78; Emin EI, 2019, IN VIVO, V33, P1547, DOI 10.21873/invivo.11635; Friedman E., 1955, B SLOANE HOSP WOMEN, V1, P42; FRIEDMAN EA, 1954, AM J OBSTET GYNECOL, V68, P1568, DOI 10.1016/0002-9378(54)90311-7; Gimovsky AC, 2019, AM J OBST GYNEC MFM, V1, DOI 10.1016/j.ajogmf.2019.07.001; Gregory Kimberly D, 2012, Am J Perinatol, V29, P7, DOI 10.1055/s-0031-1285829; Hamilton BE., 2018, VITAL STAT RAPID REL; Hamilton BE., 2017, VITAL STAT RAPID REL, V2; Harrison W, 2015, JAMA PEDIATR, V169, P855, DOI 10.1001/jamapediatrics.2015.1305; Lavender T, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005461.pub5; Lavender T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005461.pub4; MITCHELL T, 1989, ANNU REV COMPUT SCI, V4, P417; Natekin A, 2013, FRONT NEUROROBOTICS, V7, DOI 10.3389/fnbot.2013.00021; Neal JL, 2015, J MIDWIFERY WOM HEAL, V60, P485, DOI 10.1111/jmwh.12355; Ngufor C, 2019, J BIOMED INFORM, V89, P56, DOI 10.1016/j.jbi.2018.09.001; PHILPOTT RH, 1972, J OBSTET GYN BR COMM, V79, P592; PHILPOTT RH, 1972, J OBSTET GYN BR COMM, V79, P599; Rosenbloom JI, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.10.007; Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597; Zhang J, 2002, AM J OBSTET GYNECOL, V187, P824, DOI 10.1067/mob.2002.127142; Zhang J, 2015, AM J OBSTET GYNECOL, V212, P750, DOI 10.1016/j.ajog.2015.04.014; Zhang J, 2010, OBSTET GYNECOL, V116, P1281, DOI 10.1097/AOG.0b013e3181fdef6e; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	28	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0273178	10.1371/journal.pone.0273178	http://dx.doi.org/10.1371/journal.pone.0273178			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994474	gold, Green Published			2022-12-26	WOS:000877093400039
J	Afrifa-Anane, GF; Larbi, RT; Addo, B; Agyekum, MW; Kyei-Arthur, F; Appiah, M; Agyemang, CO; Sakada, IG				Afrifa-Anane, Grace Frempong; Larbi, Reuben Tete; Addo, Bright; Agyekum, Martin Wiredu; Kyei-Arthur, Frank; Appiah, Margaret; Agyemang, Clara Opoku; Sakada, Ignatius Great			Facilitators and barriers to COVID-19 vaccine uptake among women in two regions of Ghana: A qualitative study	PLOS ONE			English	Article							INFLUENZA VACCINATION; DETERMINANTS; ACCEPTANCE; COVERAGE	Although COVID-19 vaccines are available, evidence suggests that several factors hinder or facilitate their use. Several studies have found gender differences in COVID-19 vaccine uptake, with women less likely to vaccinate than men in many countries, including Ghana. These studies, however, have primarily been quantitative. This study used a qualitative approach to examine the facilitators and barriers to vaccine uptake among women in Ghana. Using a cross-sectional descriptive qualitative research design, 30 women in the Greater Accra and Ashanti regions of Ghana were conveniently sampled and interviewed using a semi-structured interview guide. Fifteen (15) interviews were conducted in each region. The data were transcribed verbatim and analysed thematically using QSR NVivo version 10 software. Among the key factors that facilitate COVID-19 vaccination are the desire to protect oneself and family against COVID-19, education about COVID-19 vaccines, seeing others receive the COVID-19 vaccine, and vaccine being cost-free. On the other hand, long queues at the vaccination centres, fear of side effects, misconceptions about the vaccines, and shortage of vaccines were the main barriers against COVID-19 vaccination. The study results show that individual, institutional, and vaccine-related factors facilitate or hinder COVID-19 vaccination among women. Addressing these factors need continuous comprehensive health education, and ensuring vaccine availability at vaccination sites will improve women's uptake of the COVID-19 vaccines.	[Afrifa-Anane, Grace Frempong; Kyei-Arthur, Frank; Appiah, Margaret] Univ Environm & Sustainable Dev, Dept Environm & Publ Hlth, Somanya, Ghana; [Larbi, Reuben Tete; Agyemang, Clara Opoku] Univ Ghana, Reg Inst Populat Studies, Legon, Ghana; [Addo, Bright] Kwame Nkrumah Univ Sci & Technol, Dept Sociol & Social Work, Kumasi, Ghana; [Agyekum, Martin Wiredu] Univ Educ, Inst Educ Res & Innovat Studies, Winneba, Ghana; [Sakada, Ignatius Great] Kwame Nkrumah Univ Sci & Technol, Dept Populat Family & Reprod Hlth, Kumasi, Ghana	University of Ghana; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology	Kyei-Arthur, F (corresponding author), Univ Environm & Sustainable Dev, Dept Environm & Publ Hlth, Somanya, Ghana.	fkyei-arthur@uesd.edu.gh	Addo, Bright/I-8610-2019	Addo, Bright/0000-0002-8465-4671; Frempong Afrifa-Anane, Grace/0000-0003-1958-5646; Kyei-Arthur, Frank/0000-0001-9794-8524				Acheampong T, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9080814; Addae-Korankye A., 2013, International Journal of Asian Social Science, V3, P511; Agyekum MW, 2021, ADV PUBLIC HLTH, V2021, DOI 10.1155/2021/9998176; Al-Mohaithef M, 2020, J MULTIDISCIP HEALTH, V13, P1657, DOI 10.2147/JMDH.S276771; Alabdulla M, 2021, INFLUENZA OTHER RESP, V15, P361, DOI 10.1111/irv.12847; Alhassan RK, 2021, HUM RESOUR HEALTH, V19, DOI 10.1186/s12960-021-00657-1; Asante LA, 2020, AFR SPECTR, V55, P170, DOI 10.1177/0002039720943612; Assan A, 2022, J PUBLIC HEALTH POL, V43, P129, DOI 10.1057/s41271-021-00330-w; Attride-Stirling J, 2001, QUAL RES, V1, P385, DOI DOI 10.1177/146879410100100307; Burki TK, 2021, LANCET RESP MED, V9, pE42, DOI 10.1016/S2213-2600(21)00129-6; Callaghan T, 2021, SOC SCI MED, V272, DOI 10.1016/j.socscimed.2020.113638; Chia JL, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.756275; Cordina M, 2021, PHARM PRACT-GRANADA, V19, DOI [10.18549/PharmPract.2021.1.2317, 10.18549/pharmpract.2021.1.2317]; Cummings CL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232472; de Juanes JR, 2007, VACCINE, V25, P201, DOI 10.1016/j.vaccine.2005.10.057; Evans SJW, 2021, NEW ENGL J MED, V385, P650, DOI 10.1056/NEJMe2110605; Ghana Health Service, 2018, HLTH SECTOR GHANA FA; Ghana Statistical Service, 2021, POPULATION REGIONS D; Ghana Statistical Services ICF, 2020, GHAN MAL IND SURV 20; Green MS, 2021, ISR J HEALTH POLICY, V10, DOI 10.1186/s13584-021-00458-w; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Ioannidis JPA, 2021, B WORLD HEALTH ORGAN, V99, P19, DOI 10.2471/BLT.20.265892; Kadali RAK, 2021, INT J INFECT DIS, V106, P376, DOI 10.1016/j.ijid.2021.04.047; Kimura AC, 2007, AM J PUBLIC HEALTH, V97, P684, DOI 10.2105/AJPH.2005.082073; Kreps SE, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9080901; Lamptey E, 2021, CLIN EXP VACCINE RES, V10, P183, DOI 10.7774/cevr.2021.10.2.183; Lee K, 2009, GLOB INST, P1; Leshem E, 2021, LANCET, V397, P1783, DOI 10.1016/S0140-6736(21)01018-7; Letsosa R., 2021, HTS TEOLOGIESE STUDI, V77, P1; Luyten J, 2019, VACCINE, V37, P2494, DOI 10.1016/j.vaccine.2019.03.041; Machingaidze S, 2021, NAT MED, V27, P1338, DOI 10.1038/s41591-021-01459-7; Michel JP, 2021, J NUTR HEALTH AGING, V25, P698, DOI 10.1007/s12603-021-1627-1; Mo PKH, 2019, J ADV NURS, V75, P1188, DOI 10.1111/jan.13894; Munge K, 2014, HEALTH POLICY PLANN, V29, P912, DOI 10.1093/heapol/czt073; Nzaji MK, 2020, PRAGMAT OBS RES, V11, P103, DOI 10.2147/POR.S271096; Ogilvie GS, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11098-9; Quinn SC, 2013, BIOSECUR BIOTERROR, V11, P96, DOI 10.1089/bsp.2012.0048; Riad A, 2021, BRIT DENT J, V230, P59, DOI 10.1038/s41415-021-2615-x; Riad A, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9090948; Riad A, 2021, J CLIN MED, V10, DOI 10.3390/jcm10071428; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Schmidt T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244420; Schwarzinger M, 2021, LANCET PUBLIC HEALTH, V6, pE210, DOI 10.1016/S2468-2667(21)00012-8; Senokoane BB., 2021, HTS TEOLOGIESE STUDI, V77, pa6924; Sundaram N, 2015, HUM VACC IMMUNOTHER, V11, P2376, DOI 10.1080/21645515.2015.1062956; Tamysetty S, 2022, VACCINES-BASEL, V10, DOI 10.3390/vaccines10010060; Tesfaw A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0257897; The Conversation Africa, 2021, GHANAS COVID 19 VACC; Tregoning JS, 2021, NAT REV IMMUNOL, V21, P626, DOI 10.1038/s41577-021-00592-1; UK Health Security Agency, 2021, COVID 19 INF; Vaux S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-159; Vet R, 2011, HEALTH EDUC RES, V26, P192, DOI 10.1093/her/cyq074; Wise J, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n699; Wiysonge CS, 2022, HUM VACC IMMUNOTHER, V18, P1, DOI 10.1080/21645515.2021.1893062; World Health Organisation, 2021, GHANAS PRESIDENT REC; World Health Organisation, 2021, COVID COUNTRY UPDATE; World Health Organisation, 2021, GHANA SHARES SUCCESS; Wouters OJ, 2021, LANCET, V397, P1023, DOI 10.1016/S0140-6736(21)00306-8; Yalley C.., 2021, CELESTINE DONKOR APP; Yeung MPS, 2016, J PUBLIC HEALTH-UK, V38, P746, DOI 10.1093/pubmed/fdv194; Zhang Yanjie, 2021, Glob Health J, V5, P51, DOI 10.1016/j.glohj.2021.02.005; Zhuang WT, 2021, HUM VACC IMMUNOTHER, V17, P5016, DOI 10.1080/21645515.2021.1992212	62	0	0	13	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0272876	10.1371/journal.pone.0272876	http://dx.doi.org/10.1371/journal.pone.0272876			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976969	Green Published, gold			2022-12-26	WOS:000847227000064
J	Wang, QQ; Liu, FA; Zhao, XH; Tan, QQ				Wang, Qianqian; Liu, Fang'ai; Zhao, Xiaohui; Tan, Qiaoqiao			A CTR prediction model based on session interest	PLOS ONE			English	Article								Click-through rate prediction has become a hot research direction in the field of advertising. It is important to build an effective CTR prediction model. However, most existing models ignore the factor that the sequence is composed of sessions, and the user behaviors are highly correlated in each session and are not relevant across sessions. In this paper, we focus on user multiple session interest and propose a hierarchical model based on session interest (SIHM) for CTR prediction. First, we divide the user sequential behavior into session layer. Then, we employ a self-attention network obtain an accurate expression of interest for each session. Since different session interest may be related to each other or follow a sequential pattern, next, we utilize bidirectional long short-term memory network (BLSTM) to capture the interaction of different session interests. Finally, the attention mechanism based LSTM (A-LSTM) is used to aggregate their target ad to find the influences of different session interests. Experimental results show that the model performs better than other models.	[Wang, Qianqian] Shandong Womens Univ, Jinan, Peoples R China; [Liu, Fang'ai; Zhao, Xiaohui; Tan, Qiaoqiao] Shandong Normal Univ, Jinan, Peoples R China	Shandong Womens University; Shandong Normal University	Liu, FA (corresponding author), Shandong Normal Univ, Jinan, Peoples R China.	lfa_sdnu@163.com			National Natural Science Foundation of China [61772321]; Natural Science Foundation of Shandong Province [ZR2021QF071, ZR202011020044]; Opening Fund of Shandong Provincial Key Laboratory of Network based Intelligent Computing; Cultivation Fund of Shandong Women's University High-level Scientific Research Project [2020GSPSJ02]; Discipline Talent Team Cultivation Program of Shandong Women's University [1904]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Opening Fund of Shandong Provincial Key Laboratory of Network based Intelligent Computing; Cultivation Fund of Shandong Women's University High-level Scientific Research Project; Discipline Talent Team Cultivation Program of Shandong Women's University	This work was supported by the following grants: National Natural Science Foundation of China (61772321); Natural Science Foundation of Shandong Province (ZR2021QF071, ZR202011020044); Opening Fund of Shandong Provincial Key Laboratory of Network based Intelligent Computing; Cultivation Fund of Shandong Women's University High-level Scientific Research Project (2020GSPSJ02); Discipline Talent Team Cultivation Program of Shandong Women's University (1904).	Bai ZX, 2020, INT CONF ACOUST SPEE, P6819, DOI 10.1109/ICASSP40776.2020.9053674; Bin Y, 2019, IEEE T CYBERNETICS, V49, P2631, DOI 10.1109/TCYB.2018.2831447; Cao T., 2021, IEEE T PATTERN ANAL; Chapelle O, 2015, ACM T INTEL SYST TEC, V5, DOI 10.1145/2532128; Chen J H., 2017, COMPUT INTEL NEUROSC, P2017; Chen WS, 2021, ENG COMPUT-GERMANY, V37, P1455, DOI 10.1007/s00366-019-00895-x; Chen YH, 2020, APPL SOFT COMPUT, V86, DOI 10.1016/j.asoc.2019.105919; Fekri-Ershad S, 2020, EXPERT SYST APPL, V158, DOI 10.1016/j.eswa.2020.113509; Galassi A, 2021, IEEE T NEUR NET LEAR, V32, P4291, DOI 10.1109/TNNLS.2020.3019893; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Grbovic M, 2018, KDD'18: PROCEEDINGS OF THE 24TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY & DATA MINING, P311, DOI 10.1145/3219819.3219885; Guo H., 2018, DEEPFM END TO END WI; Huang GJ, 2020, ALGORITHMS, V13, DOI 10.3390/a13120342; Jacob I.J., 2021, J ISMAC, V3, P276, DOI [DOI 10.36548/JISMAC.2021.3.008, 10.36548/jismac.2021.3.008]; Jannach D, 2021, ACM COMPUT SURV, V54, DOI 10.1145/3453154; Jiang ZL, 2017, J INF PROCESS SYST, V13, P1052, DOI 10.3745/JIPS.02.0069; Juan YC, 2016, PROCEEDINGS OF THE 10TH ACM CONFERENCE ON RECOMMENDER SYSTEMS (RECSYS'16), P43, DOI 10.1145/2959100.2959134; Kumar R, 2015, IEEE INT ADV COMPUT, P1134, DOI 10.1109/IADCC.2015.7154880; Lin Z H., 2021, AUTOMAT CONSTR, V124; Liu B, 2020, KDD '20: PROCEEDINGS OF THE 26TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY & DATA MINING, P2636, DOI 10.1145/3394486.3403314; Liu B, 2019, WEB CONFERENCE 2019: PROCEEDINGS OF THE WORLD WIDE WEB CONFERENCE (WWW 2019), P1119, DOI 10.1145/3308558.3313497; Liu Q, 2015, P 24 ACM INT C INF K, P1743; Liu WW, 2018, 12TH ACM CONFERENCE ON RECOMMENDER SYSTEMS (RECSYS), P412, DOI 10.1145/3240323.3240396; McAuley J, 2015, SIGIR 2015: PROCEEDINGS OF THE 38TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P43, DOI 10.1145/2766462.2767755; Najafi-Asadolahi S, 2014, M&SOM-MANUF SERV OP, V16, P482, DOI 10.1287/msom.2014.0491; Qiao J., 2022, KNOWL-BASED SYST, V244, DOI [DOI 10.1016/J.KNOSYS.2022.108567, 10.1016/j.knosys.2022.108567]; Qu YR, 2016, IEEE DATA MINING, P1149, DOI [10.1109/ICDM.2016.0151, 10.1109/ICDM.2016.57]; Sisodia D, 2022, IETE TECH REV, V39, P789, DOI 10.1080/02564602.2021.1915892; Voulodimos A, 2018, COMPUT INTEL NEUROSC, V2018, DOI 10.1155/2018/7068349; Wang Q., 2018, COMPUT MATH METHOD M, V2018; Wang RX, 2017, ADKDD'17: 23RD ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD 2017), DOI 10.1145/3124749.3124754; Wolf T., 2020, P 2020 C EMPIRICAL M, P38, DOI [10.18653/v1/2020.emnlp-demos.6, DOI 10.18653/V1/2020.EMNLP-DEMOS.6]; Wu CH, 2019, 2019 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING AND THE 9TH INTERNATIONAL JOINT CONFERENCE ON NATURAL LANGUAGE PROCESSING (EMNLP-IJCNLP 2019), P6389; Xu SY, 2021, ARCH COMPUT METHOD E, V28, P3383, DOI 10.1007/s11831-020-09504-3; Yu Y, 2019, NEURAL COMPUT, V31, P1235, DOI 10.1162/neco_a_01199; Zhang HL, 2018, ICMLC 2020: 2020 12TH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND COMPUTING, P1, DOI 10.1145/3383972.3383991; Zhang J., 2022, NEUROCOMPUTING; Zhang W, 2021, ARXIV; Zhang W., 2016, EUR C INF RETR, P45; Zhang XD, 2021, ENTROPY-SWITZ, V23, DOI 10.3390/e23111500; Zhang Y, 2021, IEEE T INTELL TRANSP, V22, P5496, DOI 10.1109/TITS.2020.2987746; Zhou GR, 2019, AAAI CONF ARTIF INTE, P5941; Zhou GR, 2018, KDD'18: PROCEEDINGS OF THE 24TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY & DATA MINING, P1059, DOI 10.1145/3219819.3219823; Zhou RJ, 2021, IEEE T NETW SCI ENG, V8, P3061, DOI 10.1109/TNSE.2021.3102582	45	0	0	8	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0273048	10.1371/journal.pone.0273048	http://dx.doi.org/10.1371/journal.pone.0273048			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976962	Green Published, gold			2022-12-26	WOS:000847227000073
J	Wei, LY; Wang, WT; Yao, JX; Cui, ZY; Xu, ZH; Ding, HQ; Wu, XJ; Wang, DH; Luo, J; Ke, ZJ				Wei, Luyao; Wang, Wantao; Yao, Junxia; Cui, Zhengyu; Xu, Zihang; Ding, Hanqing; Wu, Xiaojun; Wang, Deheng; Luo, Jia; Ke, Zun-Ji			PACT promotes the metastasis of basal-like breast cancer through Rac1 SUMOylation and activation	ONCOGENE			English	Article							RNA-BINDING PROTEIN; MOLECULAR PORTRAITS; THERAPEUTIC TARGET; EXPRESSION; KINASE; UBC9; GENE; PKR; GTPASES; SUMO	Most basal-like breast cancers (BLBCs) are triple-negative breast cancers (TNBCs), which is associated with high malignancy, high rate of recurrence and distant metastasis, and poor prognosis among all types of breast cancer. However, there are currently no effective therapies for BLBC. Furthermore, chemoresistance limits the therapeutic options for BLBC treatment. In this study, we screen out protein activator of the interferon-induced protein kinase (PACT) as an essential gene in BLBC metastasis. We find that high PACT expression level was associated with poor prognosis among BLBC patients. In vivo and in vitro investigations indicated that PACT could regulate BLBC metastasis by interacting with SUMO-conjugating enzyme Ubc9 to stimulate the SUMOylation and thus consequently the activation of Rac1. BLBC patients receiving chemotherapy presents poorer prognosis with PACT high expression, and PACT disruption sensitizes experimental mammary tumor metastases to chemotherapy, thus providing insights to consider PACT as a potential therapeutic target to overcome acquired chemoresistance in BLBC.	[Wei, Luyao; Wang, Wantao; Ding, Hanqing; Wang, Deheng; Ke, Zun-Ji] Shanghai Univ Tradit Chinese Med, Acad Integrat Med, Dept Biochem, Shanghai Key Lab Hlth Identificat & Assessment, 1200 Cailun Rd, Shanghai 201203, Peoples R China; [Yao, Junxia] Fudan Univ, Dept Pathol, Qingpu Branch, Zhongshan Hosp, 1158 Gongyuan Rd, Shanghai 201700, Peoples R China; [Cui, Zhengyu] Tongji Univ, Shanghai East Hosp, Dept Internal Med Tradit Chinese Med, Sch Med, Shanghai 200120, PR, Peoples R China; [Xu, Zihang] Shanghai Univ Tradit Chinese Med, Sch Basic Med Sci, Dept Internal Class Med, 1200 Cailun Rd, Shanghai 201203, Peoples R China; [Wu, Xiaojun] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, Shanghai Key Lab Compound Chinese Med, 1200 Cailun Rd, Shanghai 201203, PR, Peoples R China; [Luo, Jia] Univ Iowa, Dept Pathol, Carver Coll Med, 51 Newton Rd, Iowa City, IA 52242 USA	Shanghai University of Traditional Chinese Medicine; Fudan University; Tongji University; Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; University of Iowa	Ke, ZJ (corresponding author), Shanghai Univ Tradit Chinese Med, Acad Integrat Med, Dept Biochem, Shanghai Key Lab Hlth Identificat & Assessment, 1200 Cailun Rd, Shanghai 201203, Peoples R China.	kezunji@shutcm.edu.cn	Ke, Zun-Ji/E-4822-2010	Ke, Zun-Ji/0000-0003-4038-2456	National Natural Science Foundation of China [31701217, 31570921]; Shanghai Key Laboratory of Health Identification and Assessment [13DZ2261000]; Shanghai Municipal Commission of Health and Family Planning [201540206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Key Laboratory of Health Identification and Assessment; Shanghai Municipal Commission of Health and Family Planning	This research was supported by the National Natural Science Foundation of China (31701217 to LW, and 31570921 to ZJK), Shanghai Key Laboratory of Health Identification and Assessment (13DZ2261000), Shanghai Municipal Commission of Health and Family Planning (201540206 to ZJK).	Garcia MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023887; Bennett RL, 2008, MECH DEVELOP, V125, P777, DOI 10.1016/j.mod.2008.06.009; Bennett RL, 2006, BLOOD, V108, P821, DOI 10.1182/blood-2005-11-006817; Bennett RL, 2012, CELL CYCLE, V11, P407, DOI 10.4161/cc.11.2.18999; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bristow JM, 2009, J CELL SCI, V122, P4535, DOI 10.1242/jcs.053728; Cannon AC, 2020, TRENDS CANCER, V6, P478, DOI 10.1016/j.trecan.2020.02.021; Castillo-Lluva S, 2010, NAT CELL BIOL, V12, P1078, DOI 10.1038/ncb2112; Chen HY, 2004, MOL CELL BIOL, V24, P10558, DOI 10.1128/MCB.24.24.10558-10572.2004; Chiosea S, 2008, BIOMARK INSIGHTS, V3, P253; DepMap Broad, 2021, DEPMAP 21Q3 PUBL FIG; Dickerman BK, 2015, FEBS J, V282, P4766, DOI 10.1111/febs.13533; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Dokmanovic M, 2009, MOL CANCER THER, V8, P1557, DOI 10.1158/1535-7163.MCT-09-0140; Dunnebier T, 2010, BREAST CANCER RES TR, V121, P185, DOI 10.1007/s10549-009-0530-y; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Hay RT, 2001, TRENDS BIOCHEM SCI, V26, P332, DOI 10.1016/S0968-0004(01)01849-7; Hisamatsu T, 2019, MOL CANCER THER, V18, P162, DOI 10.1158/1535-7163.MCT-17-1050; Ho CW, 2011, J BIOL CHEM, V286, P21826, DOI 10.1074/jbc.M111.234914; Huang X, 2002, BIOCHEM J, V366, P175, DOI 10.1042/BJ20020204; Jiang YZ, 2019, CANCER CELL, V35, P428, DOI 10.1016/j.ccell.2019.02.001; Jin X, 2020, NATURE, V588, P331, DOI 10.1038/s41586-020-2969-2; Kamai T, 2004, CLIN CANCER RES, V10, P4799, DOI 10.1158/1078-0432.CCR-0436-03; Kheradmand F, 1998, SCIENCE, V280, P898, DOI 10.1126/science.280.5365.898; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Li H, 2013, ONCOL REP, V29, P1588, DOI 10.3892/or.2013.2268; Li QJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15308-7; Liu Y, 2017, MOL THER, V25, P666, DOI 10.1016/j.ymthe.2016.12.021; Lorente M, 2019, J CELL SCI, V132, DOI 10.1242/jcs.234120; Mack NA, 2011, CELL CYCLE, V10, P1571, DOI 10.4161/cc.10.10.15612; Marei Hadir, 2017, Small GTPases, V8, P139, DOI 10.1080/21541248.2016.1211398; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Meyers RM, 2017, NAT GENET, V49, P1779, DOI 10.1038/ng.3984; Mullany LE, 2016, BMC MED GENOMICS, V9, DOI 10.1186/s12920-016-0181-x; Pan YL, 2004, BIOCHEM BIOPH RES CO, V315, P686, DOI 10.1016/j.bbrc.2004.01.108; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Peidis P, 2011, CELL DEATH DIFFER, V18, P145, DOI 10.1038/cdd.2010.76; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Peters GA, 2009, P NATL ACAD SCI USA, V106, P10696, DOI 10.1073/pnas.0900735106; Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Reijnders MRF, 2017, AM J HUM GENET, V101, P466, DOI 10.1016/j.ajhg.2017.08.007; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Rios AC, 2019, CANCER CELL, V35, P618, DOI 10.1016/j.ccell.2019.02.010; Rowe TM, 2006, P NATL ACAD SCI USA, V103, P5823, DOI 10.1073/pnas.0601287103; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Schwartz S, 2016, GENETICS, V203, P1249, DOI 10.1534/genetics.115.183194; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Su YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034250; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Svensmark JH, 2019, ONCOGENE, V38, P7447, DOI 10.1038/s41388-019-0963-7; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Tsherniak A, 2017, CELL, V170, P564, DOI 10.1016/j.cell.2017.06.010; Vincent S, 1997, MOL CELL BIOL, V17, P2247, DOI 10.1128/MCB.17.4.2247; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Xu J, 2016, Int J Chronic Dis Ther, V2, P31; YONG Y, 2015, SCI REP-UK, V5; Yoon C, 2017, MOL CANCER RES, V15, P1106, DOI 10.1158/1541-7786.MCR-17-0053; Yoon CH, 2009, P NATL ACAD SCI USA, V106, P7852, DOI 10.1073/pnas.0812148106	60	1	1	5	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 9	2022	41	37					4282	4294		10.1038/s41388-022-02431-6	http://dx.doi.org/10.1038/s41388-022-02431-6		AUG 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	4L2AN	35974143				2022-12-26	WOS:000841092200001
J	Morales-Valencia, J; Lau, L; Marti-Nin, T; Ozerdem, U; David, G				Morales-Valencia, Jorge; Lau, Lena; Marti-Nin, Teresa; Ozerdem, Ugur; David, Gregory			Therapy-induced senescence promotes breast cancer cells plasticity by inducing Lipocalin-2 expression	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CELLULAR SENESCENCE; GROWTH; FIBROBLASTS; RESISTANCE; MECHANISMS; INVASION; IRON	The acquisition of novel detrimental cellular properties following exposure to cytotoxic drugs leads to aggressive and metastatic tumors that often translates into an incurable disease. While the bulk of the primary tumor is eliminated upon exposure to chemotherapeutic treatment, residual cancer cells and non-transformed cells within the host can engage a stable cell cycle exit program named senescence. Senescent cells secrete a distinct set of pro-inflammatory factors, collectively termed the senescence-associated secretory phenotype (SASP). Upon exposure to the SASP, cancer cells undergo cellular plasticity resulting in increased proliferation, migration and epithelial-to-mesenchymal transition. The molecular mechanisms by which the SASP regulates these pro-tumorigenic features are poorly understood. Here, we report that breast cancer cells exposed to the SASP strongly upregulate Lipocalin-2 (LCN2). Furthermore, we demonstrate that LCN2 is critical for SASP-induced increased migration in breast cancer cells, and its inactivation potentiates the response to chemotherapeutic treatment in mouse models of breast cancer. Finally, we show that neoadjuvant chemotherapy treatment leads to LCN2 upregulation in residual human breast tumors, and correlates with worse overall survival. These findings provide the foundation for targeting LCN2 as an adjuvant therapeutic approach to prevent the emergence of aggressive tumors following chemotherapy.	[Morales-Valencia, Jorge; Lau, Lena; Marti-Nin, Teresa; David, Gregory] NYU, Dept Biochem & Mol Pharmacol, Langone Med Ctr, New York, NY 10016 USA; [Morales-Valencia, Jorge; David, Gregory] NYU Langone Hlth, NYU Langone Perlmutter Canc Ctr, New York, NY 10016 USA; [Ozerdem, Ugur] NYU, NYU Langone Hlth, Dept Pathol, Sch Med, New York, NY 10016 USA; [David, Gregory] NYU, NYU Langone Hlth, Dept Urol, Sch Med, New York, NY 10016 USA	New York University; NYU Langone Medical Center; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	David, G (corresponding author), NYU, Dept Biochem & Mol Pharmacol, Langone Med Ctr, New York, NY 10016 USA.; David, G (corresponding author), NYU Langone Hlth, NYU Langone Perlmutter Canc Ctr, New York, NY 10016 USA.; David, G (corresponding author), NYU, NYU Langone Hlth, Dept Urol, Sch Med, New York, NY 10016 USA.	gregory.david@nyulangone.org		David, Gregory/0000-0002-1849-3232	NIH/NCI [CA246416]; NYS DoH [C36617GG]; NYSTEM Institutional Training Grant [C322560GG]	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NYS DoH; NYSTEM Institutional Training Grant	The authors sincerely thank all members of the David lab for helpful discussions during the preparation of this manuscript. We wish to acknowledge the NYU Genome Technology Center for help with RNA sequencing (RNA-seq). We thank Dr. Richard Possemato (NYU School of Medicine), Dr. Eva Hernando (NYU School of Medicine), Dr. Thales Papagiannakopoulos (NYU School of Medicine), Dr. Benjamin Neel (NYU School of Medicine), and Dr. Judith Campisi (Buck Institute for Research on Aging) as well as members of their labs for the generous gift or reagents and plasmids and for helpful discussions. This work was funded by NIH/NCI (CA246416) [GD], NYS DoH (C36617GG) [GD] and the NYSTEM Institutional Training Grant (C322560GG) [JMV].	Asaoka M, 2020, BREAST CANCER-BASIC, V14, DOI 10.1177/1178223420980377; Birkenkamp-Demtroder K, 2002, CANCER RES, V62, P4352; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Canino C, 2012, ONCOGENE, V31, P3148, DOI 10.1038/onc.2011.485; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Chi Y, 2020, SCIENCE, V369, P276, DOI 10.1126/science.aaz2193; Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000; Coppe JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Demaria M, 2017, CANCER DISCOV, V7, P165, DOI 10.1158/2159-8290.CD-16-0241; Duy C, 2021, CANCER DISCOV, V11, P1542, DOI 10.1158/2159-8290.CD-20-1375; Espinoza-Sanchez Nancy Adriana, 2018, Oncotarget, V9, P26679, DOI 10.18632/oncotarget.25465; Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; Hu CX, 2018, ONCOTARGETS THER, V11, P8099, DOI 10.2147/OTT.S181223; Jung M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020273; Karabicici M, 2021, MOL ONCOL, V15, P2185, DOI 10.1002/1878-0261.12916; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; La Manna G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089497; Laberge RM, 2012, CANCER MICROENVIRON, V5, P39, DOI 10.1007/s12307-011-0069-4; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lau L, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00586-18; Leng XH, 2009, CANCER RES, V69, P8579, DOI 10.1158/0008-5472.CAN-09-1934; Li QQ, 2009, CLIN CANCER RES, V15, P2657, DOI 10.1158/1078-0432.CCR-08-2372; Milanovic M, 2018, NATURE, V553, P96, DOI 10.1038/nature25167; Moirangthem A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21903; Ortiz-Montero P, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-017-0172-3; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Pinnix ZK, 2010, SCI TRANSL MED, V2, DOI [10.1126/scitranslmed.3001127, 10.1126/scisignal.3001127]; Poli V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03264-2; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Saxena M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.61; Sharpless NE, 2005, NATURE, V436, P636, DOI 10.1038/436636a; Shi H, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-83; Tong ZM, 2008, CANCER RES, V68, P6100, DOI 10.1158/0008-5472.CAN-08-0540; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Villodre ES, 2021, MOL ONCOL, V15, P2752, DOI 10.1002/1878-0261.13074; Xiao X, 2017, ANNU REV NUTR, V37, P103, DOI 10.1146/annurev-nutr-071816-064559; Xu HX, 2015, ONCOTARGETS THER, V8, P3783, DOI 10.2147/OTT.S95470; Yang J, 2009, CELL CYCLE, V8, P2347, DOI 10.4161/cc.8.15.9224; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Yedjou CG, 2019, ADV EXP MED BIOL, V1152, P31, DOI 10.1007/978-3-030-20301-6_3; Young ARJ, 2009, EMBO REP, V10, P228, DOI 10.1038/embor.2009.22; Zhang N, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22020849; Zhao D, 2015, ONCOGENE, V34, P3107, DOI 10.1038/onc.2014.257	46	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 16	2022	41	38					4361	4370		10.1038/s41388-022-02433-4	http://dx.doi.org/10.1038/s41388-022-02433-4		AUG 2022	10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	4O3TC	35953598	Green Submitted			2022-12-26	WOS:000839543400001
J	Zhang, XM; Yin, XX; Dai, JD; Sun, GX; Zhang, HR; Liang, JY; Zhao, JG; Zhu, S; Chen, JR; Zhu, XD; Ni, YC; Wang, ZP; Liu, ZH; Chen, N; Shen, PF; Zeng, H				Zhang, Xingming; Yin, Xiaoxue; Dai, Jindong; Sun, Guangxi; Zhang, Haoran; Liang, Jiayu; Zhao, Jinge; Zhu, Sha; Chen, Junru; Zhu, Xudong; Ni, Yuchao; Wang, Zhipeng; Liu, Zhenhua; Chen, Ni; Shen, Pengfei; Zeng, Hao			The tumor-repressing effect of CYP27A1 on renal cell carcinoma by 27-HC arising from cholesterol metabolism	FASEB JOURNAL			English	Article						27-HC; apoptosis; CDKN1B; c-IAP2; RCC; TNFR1	NF-KAPPA-B; SURVIVAL OUTCOMES; EXPRESSION; 27-HYDROXYCHOLESTEROL; RECEPTOR; P27(KIP1); FAMILY; ROLES	As a key approach to mediate cholesterol metabolism, the role of the CYP27A1/27-HC axis in renal cell carcinoma (RCC) remains unclear. Analysis of CYP27A1 expression from public databases and metastatic cases in our center suggested that CYP27A1 was obviously downregulated in RCC tissues, and survival analysis further showed its correlation with favorable clinicopathological features and prognosis. In vitro, up and downregulation of CYP27A1 expression in RCC cell lines could definitely illustrate its anticipation involving apoptosis, proliferation, invasion, migration, and clonality. This could be achieved through upregulation of 27-HC concentration, which mediates the activation of signaling pathways of apoptosis and cell cycle arrest. Further, recovery of CYP27A1 expression could definitely inhibit the proliferation of RCC tumors in vivo. This is the first study to explore the role of the CYP27A1/27-HC axis in RCC. Attempts to maintain the normal function of the axis may be a potential strategy in the treatment of RCC, and the predictive value of CYP27A1 detection on the efficacy of targeted therapy in metastatic RCC is also worthy of attention.	[Zhang, Xingming; Dai, Jindong; Sun, Guangxi; Zhang, Haoran; Liang, Jiayu; Zhao, Jinge; Zhu, Sha; Chen, Junru; Zhu, Xudong; Ni, Yuchao; Wang, Zhipeng; Liu, Zhenhua; Shen, Pengfei; Zeng, Hao] Sichuan Univ, Inst Urol, West China Hosp, Dept Urol, 37 Guoxue Alley, Chengdu, Sichuan, Peoples R China; [Yin, Xiaoxue; Chen, Ni] Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Peoples R China	Sichuan University; Sichuan University	Shen, PF; Zeng, H (corresponding author), Sichuan Univ, Inst Urol, West China Hosp, Dept Urol, 37 Guoxue Alley, Chengdu, Sichuan, Peoples R China.	cdhx510@163.com; kucaizeng@163.com	Zhu, Sha/E-1703-2019; Dai, Jin/GVT-2414-2022; yin, xiaoxue/GSD-3308-2022	Dai, Jin/0000-0003-3063-746X; 	China Postdoctoral Science Foundation [2020M673239, 2021M692286]; National Natural Science Foundation of China (NSFC) [81902577, 82103097]; Post-Doctor Research Project, West China Hospital, Sichuan University [20HXBH026]; SPDST | Sichuan Province Science and Technology Support Program (Science and Technology Project of Sichuan) [2021YFS0119]; Research Foundation for the Postdoctoral Program of Sichuan University [2021SCU12014]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Post-Doctor Research Project, West China Hospital, Sichuan University; SPDST | Sichuan Province Science and Technology Support Program (Science and Technology Project of Sichuan); Research Foundation for the Postdoctoral Program of Sichuan University	China Postdoctoral Science Foundation, Grant/Award Number: 2020M673239 and 2021M692286; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81902577 and 82103097; Post-Doctor Research Project, West China Hospital, Sichuan University, Grant/Award Number: 20HXBH026; SPDST | Sichuan Province Science and Technology Support Program (Science and Technology Project of Sichuan), Grant/Award Number: 2021YFS0119; the Research Foundation for the Postdoctoral Program of Sichuan University, Grant/ Award Number: 2021SCU12014	Al-Lamki RS, 2010, AM J PATHOL, V177, P943, DOI 10.2353/ajpath.2010.091218; Alfaqih MA, 2017, CANCER RES, V77, P1662, DOI 10.1158/0008-5472.CAN-16-2738; Baek AE, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00910-z; Barata PC, 2017, CA-CANCER J CLIN, V67, P507, DOI 10.3322/caac.21411; Berquist SW, 2017, MINERVA UROL NEFROL, V69, P501, DOI 10.23736/S0393-2249.17.02788-6; Borghi A, 2016, BIOCHEM PHARMACOL, V116, P1, DOI 10.1016/j.bcp.2016.03.009; Haddad AQ, 2015, UROLOGY, V86, P1146, DOI 10.1016/j.urology.2015.09.015; He SS, 2019, ENDOCR-RELAT CANCER, V26, P659, DOI 10.1530/ERC-18-0572; Jensen MB, 2010, J STEROID BIOCHEM, V121, P376, DOI 10.1016/j.jsbmb.2010.03.069; Ji YC, 2016, AM J TRANSL RES, V8, P4434; Kimbung S, 2017, ENDOCR-RELAT CANCER, V24, P339, DOI 10.1530/ERC-16-0533; Kuzu OF, 2016, CANCER RES, V76, P2063, DOI 10.1158/0008-5472.CAN-15-2613; Lee H, 2017, CLIN GENITOURIN CANC, V15, pE935, DOI 10.1016/j.clgc.2017.05.008; Li B, 2020, INT BRAZ J UROL, V46, P158, DOI [10.1590/s1677-5538.ibju.2019.0560, 10.1590/S1677-5538.IBJU.2019.0560]; Liang ZJ, 2019, CELL CYCLE, V18, P34, DOI 10.1080/15384101.2018.1558868; Liu Z, 2018, BIOCHEM BIOPH RES CO, V502, P69, DOI 10.1016/j.bbrc.2018.05.122; Liu Z, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-51; Lu DL, 2019, JNCI-J NATL CANCER I, V111, P365, DOI 10.1093/jnci/djy115; Matusiak D, 2007, J HISTOCHEM CYTOCHEM, V55, P1257, DOI 10.1369/jhc.7A7286.2007; Migita T, 2008, INT J ONCOL, V33, P41; Naito S, 2017, BRIT J CANCER, V116, P1203, DOI 10.1038/bjc.2017.77; Porter PL, 1997, NAT MED, V3, P222, DOI 10.1038/nm0297-222; Santoni M, 2022, CRIT REV ONCOL HEMAT, V176, DOI 10.1016/j.critrevonc.2022.103731; Shi SZ, 2019, AM J CANCER RES, V9, P2194; Silke J, 2014, METHOD ENZYMOL, V545, P35, DOI 10.1016/B978-0-12-801430-1.00002-0; Sun GX, 2019, NEOPLASIA, V21, P921, DOI 10.1016/j.neo.2019.07.004; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Varfolomeev E, 2008, CELL CYCLE, V7, P1511, DOI 10.4161/cc.7.11.5959; Varfolomeev E, 2015, METHODS MOL BIOL, V1280, P269, DOI 10.1007/978-1-4939-2422-6_15; Wu Q, 2013, CELL REP, V5, P637, DOI 10.1016/j.celrep.2013.10.006; Xin J, 2018, ONCOL LETT, V16, P1439, DOI 10.3892/ol.2018.8846	31	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22499	10.1096/fj.202101146RR	http://dx.doi.org/10.1096/fj.202101146RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3T7LS	35969149				2022-12-26	WOS:000840451500001
J	Zhu, SY; Huang, JC; Xu, R; Wang, YK; Wan, YM; McNeel, R; Parker, E; Kolson, D; Yam, M; Webb, B; Zhao, C; Sigado, J; Du, JH				Zhu, Siyan; Huang, Jiancheng; Xu, Rong; Wang, Yekai; Wan, Yiming; McNeel, Rachel; Parker, Edward; Kolson, Douglas; Yam, Michelle; Webb, Bradley; Zhao, Chen; Sigado, Jenna; Du, Jianhai			Isocitrate dehydrogenase 3b is required for spermiogenesis but dispensable for retinal viability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID-COMPOSITION; TESTICULAR GERM-CELLS; MITOCHONDRIAL DYSFUNCTION; CARBOHYDRATE-METABOLISM; REDUCTIVE CARBOXYLATION; RETINITIS-PIGMENTOSA; KREBS CYCLE; DEFICIENCY; GOSSYPOL; ENZYMES	Isocitrate dehydrogenase 3 (IDH3) is a key enzyme in the mitochondrial tricarboxylic acid (TCA) cycle, which catalyzes the decarboxylation of isocitrate into alpha-ketoglutarate and concurrently converts NAD(+) into NADH. Dysfunction of IDH3B, the beta subunit of IDH3, has been previously correlated with retinal degeneration and male infertility in humans, but tissue-specific effects of IDH3 dysfunction are unclear. Here, we generated Idh3b-KO mice and found that IDH3B is essential for IDH3 activity in multiple tissues. We determined that loss of Idh3b in mice causes substantial accumulation of isocitrate and its precursors in the TCA cycle, particularly in the testes, whereas the levels of the downstream metabolites remain unchanged or slightly increased. However, the Idh3bKO mice did not fully recapitulate the defects observed in humans. Global deletion of Idh3b only causes male infertility but not retinal degeneration in mice. Our investigation showed that loss of Idh3b causes an energetic deficit and disrupts the biogenesis of acrosome and flagellum, resulting in spermiogenesis arrestment in sperm cells. Together, we demonstrate that IDH3B controls its substrate levels in the TCA cycle, and it is required for sperm mitochondrial metabolism and spermiogenesis, highlighting the importance of the tissue-specific function of the ubiquitous TCA cycle.	[Zhu, Siyan; Huang, Jiancheng; Xu, Rong; Wang, Yekai; McNeel, Rachel; Kolson, Douglas; Yam, Michelle; Sigado, Jenna; Du, Jianhai] West Virginia Univ, Dept Ophthalmol & Visual Sci, Morgantown, WV 26506 USA; [Zhu, Siyan; Huang, Jiancheng; Xu, Rong; Wang, Yekai; McNeel, Rachel; Yam, Michelle; Webb, Bradley; Sigado, Jenna; Du, Jianhai] West Virginia Univ, Dept Biochem, Morgantown, WV 26506 USA; [Zhu, Siyan] West Virginia Univ, Dept Pharmaceut & Pharmacol Sci, Morgantown, WV USA; [Huang, Jiancheng; Zhao, Chen] Fudan Univ, Eye & ENT Hosp, Shanghai Med Coll, Eye Inst, Shanghai, Peoples R China; [Huang, Jiancheng; Zhao, Chen] Fudan Univ, Chinese Acad Med Sci, Key Lab Myopia, NHC Key Lab Myopia, Shanghai, Peoples R China; [Huang, Jiancheng; Zhao, Chen] Fudan Univ, Shanghai Key Lab Visual Impairment & Restorat, Shanghai, Peoples R China; [Wan, Yiming] SUNY Stony Brook, Dept Biomed Engn Dept, Stony Brook, NY USA; [Parker, Edward] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA	West Virginia University; West Virginia University; West Virginia University; Fudan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fudan University; Fudan University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Washington; University of Washington Seattle	Du, JH (corresponding author), West Virginia Univ, Dept Ophthalmol & Visual Sci, Morgantown, WV 26506 USA.; Du, JH (corresponding author), West Virginia Univ, Dept Biochem, Morgantown, WV 26506 USA.	jianhai.du@hsc.wvu.edu	Webb, Bradley/HDO-7820-2022; Webb, Bradley/F-6946-2013	Webb, Bradley/0000-0002-5299-2852	National Institutes of Health [EY031324, EY032462]; Bright Focus Foundation [M2020141]; Retina Research Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bright Focus Foundation(BrightFocus Foundation); Retina Research Foundation	This work was supported by the National Institutes of Health grant (EY031324; to J. D.), EY032462 (to J. D.), Bright Focus Foundation grant (M2020141; to J. D.), the Retina Research Foundation (to J. D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal A, 2016, ASIAN J ANDROL, V18, P282, DOI 10.4103/1008-682X.170445; Aherne A, 2004, HUM MOL GENET, V13, P641, DOI 10.1093/hmg/ddh061; Arlow T., 2021, MUTS MISMATCH REPAIR, V11, pjkaa065, DOI [10.1093/g3journal/jkaa065, DOI 10.1093/G3JOURNAL/JKAA065]; Audouard C, 2011, FERTIL STERIL, V95, P1475, DOI 10.1016/j.fertnstert.2010.12.006; Bajpai M, 1998, EUR J ENDOCRINOL, V138, P322, DOI 10.1530/eje.0.1380322; Bajpai M, 1998, ANDROLOGIA, V30, P311; Bell EL, 2014, DEVELOPMENT, V141, P3495, DOI 10.1242/dev.110627; Boussouar F, 2004, TRENDS ENDOCRIN MET, V15, P345, DOI 10.1016/j.tem.2004.07.003; Breininger E, 2017, REPROD DOMEST ANIM, V52, P731, DOI 10.1111/rda.12973; Briere JJ, 2005, CELL MOL LIFE SCI, V62, P2317, DOI 10.1007/s00018-005-5237-6; Broeks MH, 2019, HUM GENET, V138, P1247, DOI 10.1007/s00439-019-02063-z; Bzymek KP, 2007, BIOCHEMISTRY-US, V46, P5391, DOI 10.1021/bi700061t; Dong Y, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00082-17; Du JH, 2016, P NATL ACAD SCI USA, V113, P14710, DOI 10.1073/pnas.1604572113; Du JH, 2013, P NATL ACAD SCI USA, V110, P18501, DOI 10.1073/pnas.1311193110; Duncan DM, 2017, G3-GENES GENOM GENET, V7, P789, DOI 10.1534/g3.116.037366; EHRLICH RS, 1983, J BIOL CHEM, V258, P7079; Ferguson LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067265; Findlay AS, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.036426; GABRIEL JL, 1986, METABOLISM, V35, P661, DOI 10.1016/0026-0495(86)90175-7; Galimov SN, 2021, J REPROD IMMUNOL, V148, DOI 10.1016/j.jri.2021.103383; Grenell A, 2019, P NATL ACAD SCI USA, V116, P3530, DOI 10.1073/pnas.1812941116; Guo JT, 2018, CELL RES, V28, P1141, DOI 10.1038/s41422-018-0099-2; Hale BJ, 2019, J BIOL CHEM, V294, P14394, DOI 10.1074/jbc.RA119.009972; Hartong DT, 2008, NAT GENET, V40, P1230, DOI 10.1038/ng.223; Hudry B, 2019, CELL, V178, P901, DOI 10.1016/j.cell.2019.07.029; IKEDA M, 1990, ANDROLOGIA, V22, P409; Jiang L, 2016, NATURE, V532, P255, DOI 10.1038/nature17393; Kavarthapu R, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00310; Kim W, 2019, CELL METAB, V29, P856, DOI 10.1016/j.cmet.2018.12.023; Koh HJ, 2004, J BIOL CHEM, V279, P39968, DOI 10.1074/jbc.M402260200; Ku HJ, 2015, FREE RADICAL BIO MED, V80, P84, DOI 10.1016/j.freeradbiomed.2014.12.018; Lan XR, 2020, AQUAT TOXICOL, V224, DOI 10.1016/j.aquatox.2020.105503; Lenzi A, 2000, MOL HUM REPROD, V6, P226, DOI 10.1093/molehr/6.3.226; Lindsay KJ, 2014, P NATL ACAD SCI USA, V111, P15579, DOI 10.1073/pnas.1412441111; Liu XJ, 2020, AM J CANCER RES, V10, P3212; Luense LJ, 2019, DEV CELL, V51, P745, DOI 10.1016/j.devcel.2019.10.024; Ma TF, 2017, SCI REP-UK, V7, DOI 10.1038/srep41882; MacDonald MJ, 2013, BBA-GEN SUBJECTS, V1830, P5104, DOI 10.1016/j.bbagen.2013.07.013; Martinez-Reyes I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13668-3; May JL, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aat0456; MITA M, 1982, BIOL REPROD, V26, P445, DOI 10.1095/biolreprod26.3.445; Moscatelli N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20123000; Park YJ, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10010098; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Peter VG, 2019, OPHTHALMIC GENET, V40, P177, DOI 10.1080/13816810.2019.1605391; Pierrache LHM, 2017, OPHTHALMOLOGY, V124, P992, DOI 10.1016/j.ophtha.2017.03.010; PLANK T, 1995, J BACTERIOL, V177, P6798, DOI 10.1128/jb.177.23.6798-6803.1995; QIAN SZ, 1984, ANNU REV PHARMACOL, V24, P329, DOI 10.1146/annurev.pa.24.040184.001553; RANDEL RD, 1992, J ANIM SCI, V70, P1628, DOI 10.2527/1992.7051628x; Roqueta-Rivera M, 2011, BIOL REPROD, V85, P721, DOI 10.1095/biolreprod.110.089524; Rustin P, 1997, BBA-MOL BASIS DIS, V1361, P185, DOI 10.1016/S0925-4439(97)00035-5; Ryan DG, 2019, NAT METAB, V1, P16, DOI 10.1038/s42255-018-0014-7; SAZANOV LA, 1994, FEBS LETT, V344, P109, DOI 10.1016/0014-5793(94)00370-X; Shami AN, 2020, DEV CELL, V54, P529, DOI 10.1016/j.devcel.2020.05.010; Shishikura K, 2019, FASEB J, V33, P14194, DOI 10.1096/fj.201901074R; Stroud CK, 2009, J LIPID RES, V50, P1870, DOI 10.1194/jlr.M900039-JLR200; Sun PK, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-00220-7; Sun WM, 2018, OPHTHALMIC GENET, V39, P662, DOI 10.1080/13816810.2018.1502788; Tang A, 2012, ANDROLOGIA, V44, P16, DOI 10.1111/j.1439-0272.2010.01095.x; White K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23436-w; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Xu R, 2020, J BIOL CHEM, V295, P2324, DOI 10.1074/jbc.RA119.011727; Yamada S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05952; Yan FH, 2009, ENVIRON TOXICOL PHAR, V28, P19, DOI 10.1016/j.etap.2009.01.011; Yao RJ, 2002, P NATL ACAD SCI USA, V99, P11211, DOI 10.1073/pnas.162027899; Ye D, 2018, TRENDS CANCER, V4, P151, DOI 10.1016/j.trecan.2017.12.005; Yin HQ, 2021, NUCLEIC ACIDS RES, V49, P5106, DOI 10.1093/nar/gkab313; Yu J, 2019, MOL MED REP, V19, P1561, DOI 10.3892/mmr.2019.9834; Zenteno JC, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1044; Zhang Y, 2019, MOL MED REP, V20, P1893, DOI 10.3892/mmr.2019.10418	71	0	0	7	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102387	10.1016/j.jbc.2022.102387	http://dx.doi.org/10.1016/j.jbc.2022.102387			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5B1GH	35985423	Green Published, gold			2022-12-26	WOS:000863323200014
J	Hasebe, D; Alexandre, M; Nakamoto, T				Hasebe, Daisuke; Alexandre, Manuel; Nakamoto, Takamichi			Exploration of sensing data to realize intended odor impression using mass spectrum of odor mixture	PLOS ONE			English	Article								Recently, olfactory information on odorants has been associated with their corresponding molecular features. Such information has been obtained by predicting the sensory test evaluation scores from the molecular structure parameters or the sensing data. On the other hand, we develop a method of the prediction of molecular features corresponding to the odor impression. We utilize a machine-learning-based odor predictive model introduced in our previous research, and we propose a mathematical model for exploring the sensing data space. By using mass spectrum as sensing data in the predictive model, we can represent predicted mass spectrum as those of an odor mixture, and the mixing ratio can be obtained. We show that the mass spectrum of apple flavor with enhanced 'fruit' and 'sweet' impressions can be obtained using 59 and 60 molecules respectively by using our analysis method.	[Hasebe, Daisuke; Alexandre, Manuel; Nakamoto, Takamichi] Tokyo Inst Technol, Sch Engn, Yokohama, Kanagawa, Japan; [Alexandre, Manuel; Nakamoto, Takamichi] Tokyo Inst Technol, Inst Innovat Res, Yokohama, Kanagawa, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology	Nakamoto, T (corresponding author), Tokyo Inst Technol, Sch Engn, Yokohama, Kanagawa, Japan.; Nakamoto, T (corresponding author), Tokyo Inst Technol, Inst Innovat Res, Yokohama, Kanagawa, Japan.	nakamoto@mn.ee.titech.ac.jp	; Aleixandre, Manuel/D-7391-2014	Nakamoto, Takamichi/0000-0002-0599-226X; Aleixandre, Manuel/0000-0003-0620-2757	JSPS (Japan Society for the Promotion of Science) KAKENHI grant [21H04889]	JSPS (Japan Society for the Promotion of Science) KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by JSPS (Japan Society for the Promotion of Science) KAKENHI grant (No. 21H04889). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], DREAM OLFACTION PRED; CHUI CK, 1992, J APPROX THEORY, V70, P131, DOI 10.1016/0021-9045(92)90081-X; Glorot X, 2010, ICML; Guo J, 2021, IEEE SENS J, V21, P15012, DOI 10.1109/JSEN.2021.3074173; Hasebe D, 2021, IEEE SENSOR, DOI 10.1109/SENSORS47087.2021.9639553; Ito K, 2020, IEEE SENSOR; Keller A, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0287-2; Khan RM, 2007, J NEUROSCI, V27, P10015, DOI 10.1523/JNEUROSCI.1158-07.2007; Lemmon E.W., 2017, NIST CHEM WEBBOOK; Nakamoto T, 2001, SENSOR ACTUAT B-CHEM, V76, P465, DOI 10.1016/S0925-4005(01)00587-1; Nakamoto T., 2016, ESSENTIALS MACHINE O, DOI [10.1002/9781118768495, DOI 10.1002/9781118768495]; Nozaki Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198475; Nozaki Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157030; Shang L, 2017, ANAL CHEM, V89, P11999, DOI 10.1021/acs.analchem.7b02389; Tobara K, 2015, J OTOLARYNGOLOGY JAP, V118, P1072, DOI [10.3950/jibiinkouka.118.1072, DOI 10.3950/JIBIINKOUKA.118.1072]	15	1	1	10	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0273011	10.1371/journal.pone.0273011	http://dx.doi.org/10.1371/journal.pone.0273011			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976921	Green Published, gold			2022-12-26	WOS:000847227000071
J	Lorthe, E; Bellon, M; Michielin, G; Berthelot, J; Zaballa, ME; Pennacchio, F; Bekliz, M; Laubscher, F; Arefi, F; Perez-Saez, J; Azman, AS; L'Huillier, AG; Posfay-Barbe, KM; Kaiser, L; Guessous, I; Maerkl, SJ; Eckerle, I; Stringhini, S				Lorthe, Elsa; Bellon, Mathilde; Michielin, Gregoire; Berthelot, Julie; Zaballa, Maria-Eugenia; Pennacchio, Francesco; Bekliz, Meriem; Laubscher, Florian; Arefi, Fatemeh; Perez-Saez, Javier; Azman, Andrew S.; L'Huillier, Arnaud G.; Posfay-Barbe, Klara M.; Kaiser, Laurent; Guessous, Idris; Maerkl, Sebastian J.; Eckerle, Isabella; Stringhini, Silvia		SEROCoV-Sch Study Grp	Epidemiological, virological and serological investigation of a SARS-CoV-2 outbreak (Alpha variant) in a primary school: A prospective longitudinal study	PLOS ONE			English	Article							A H1N1 VIRUS; HOUSEHOLD TRANSMISSION; ELEMENTARY-SCHOOL; COUNTY	Objectives To report a prospective epidemiological, virological and serological investigation of a SARS-CoV-2 outbreak in a primary school. Methods As part of a longitudinal, prospective, school-based surveillance study, this investigation involved repeated testing of 73 pupils, 9 teachers, 13 non-teaching staff and 26 household members of participants who tested positive, with rapid antigen tests and/or RT-PCR (Day 0-2 and Day 5-7), serologies on dried capillary blood samples (Day 0-2 and Day 30), contact tracing interviews and SARS-CoV-2 whole genome sequencing. Results We identified 20 children (aged 4 to 6 years from 4 school classes), 2 teachers and a total of 4 household members who were infected by the Alpha variant during this outbreak. Infection attack rates were between 11.8 and 62.0% among pupils from the 4 school classes, 22.2% among teachers and 0% among non-teaching staff. Secondary attack rate among household members was 15.4%. Symptoms were reported by 63% of infected children, 100% of teachers and 50% of household members. All analysed sequences but one showed 100% identity. Serological tests detected 8 seroconversions unidentified by SARS-CoV-2 virological tests. Conclusions This study confirmed child-to-child and child-to-adult SARS-CoV-2 transmission and introduction into households. Effective measures to limit transmission in schools have the potential to reduce the overall community circulation.	[Lorthe, Elsa; Berthelot, Julie; Zaballa, Maria-Eugenia; Pennacchio, Francesco; Perez-Saez, Javier; Azman, Andrew S.; Stringhini, Silvia] Geneva Univ Hosp, Div Primary Care Med, Unit Populat Epidemiol, Geneva, Switzerland; [Bellon, Mathilde; Bekliz, Meriem; Eckerle, Isabella] Univ Geneva, Fac Med, Dept Microbiol & Mol Med, Geneva, Switzerland; [Bellon, Mathilde; Kaiser, Laurent; Eckerle, Isabella] Geneva Univ Hosp, Ctr Emerging Viral Dis, Geneva, Switzerland; [Bellon, Mathilde; Kaiser, Laurent; Eckerle, Isabella] Univ Geneva, Geneva, Switzerland; [Michielin, Gregoire; Arefi, Fatemeh; Maerkl, Sebastian J.] Ecole Polytech Fed Lausanne, Inst Bioengn, Sch Engn, Lausanne, Switzerland; [Laubscher, Florian; L'Huillier, Arnaud G.; Eckerle, Isabella] Geneva Univ Hosp, Dept Diagnost, Lab Virol, Geneva, Switzerland; [Perez-Saez, Javier; Azman, Andrew S.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Azman, Andrew S.] Univ Geneva, Fac Med, Inst Global Hlth, Geneva, Switzerland; [L'Huillier, Arnaud G.; Posfay-Barbe, Klara M.] Geneva Univ Hosp, Dept Pediat Gynecol & Obstet, Pediat Infect Dis Unit, Geneva, Switzerland; [L'Huillier, Arnaud G.; Posfay-Barbe, Klara M.] Fac Med, Geneva, Switzerland; [Kaiser, Laurent; Eckerle, Isabella] Geneva Univ Hosp, Dept Med, Div Infect Dis, Geneva, Switzerland; [Guessous, Idris] Geneva Univ Hosp, Div Primary Care, Geneva, Switzerland; [Guessous, Idris; Stringhini, Silvia] Univ Geneva, Fac Med, Dept Hlth & Community Med, Geneva, Switzerland; [Stringhini, Silvia] Univ Lausanne, Univ Ctr Gen Med & Publ Hlth, Lausanne, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Lausanne	Lorthe, E (corresponding author), Geneva Univ Hosp, Div Primary Care Med, Unit Populat Epidemiol, Geneva, Switzerland.	elsa.lorthe@gmail.com	Lorthe, Elsa/I-9902-2019	Lorthe, Elsa/0000-0002-9654-8104; Berthelot, Julie/0000-0003-3534-6549; Michielin, Gregoire/0000-0002-6809-9612; Kaiser, Laurent/0000-0002-0857-2252; Eckerle, Isabella/0000-0002-4850-7172	Federal Office of Public Health; Private Foundation of the Geneva University Hospitals; Fondation des Grangettes; Center for Emerging Viral Diseases; SNF NRP (National Research Program) 78 Covid-19 Grant [198412]	Federal Office of Public Health; Private Foundation of the Geneva University Hospitals; Fondation des Grangettes; Center for Emerging Viral Diseases; SNF NRP (National Research Program) 78 Covid-19 Grant	The SEROCoV-Schools study was supported by the Federal Office of Public Health, the Private Foundation of the Geneva University Hospitals, the Fondation des Grangettes, the Center for Emerging Viral Diseases, and a SNF NRP (National Research Program) 78 Covid-19 Grant 198412 (to S.J.M., I.E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso S, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0263741; Althaus C.L., 2021, MEDRXIV; BAG, 2021, COVID 19 REC PROC SU; Baggio S, 2021, CLIN INFECT DIS, V73, P148, DOI 10.1093/cid/ciaa1157; Bellon M, 2021, CLIN INFECT DIS, V73, pE1384, DOI 10.1093/cid/ciab396; Brandal LT, 2021, EUROSURVEILLANCE, V26, P2, DOI 10.2807/1560-7917.ES.2020.26.1.2002011; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Cevik M, 2021, CLIN INFECT DIS, V73, pS170, DOI 10.1093/cid/ciaa1442; Dattner I, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1008559; Dawson P, 2021, MMWR-MORBID MORTAL W, V70, P449, DOI 10.15585/mmwr.mm7012e4; Fontanet A, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.15.2001695; Gettings JR, 2022, CLIN INFECT DIS, V74, P319, DOI 10.1093/cid/ciab332; Ghinai I, 2020, MMWR-MORBID MORTAL W, V69, P446, DOI 10.15585/mmwr.mm6915e1; Head Jennifer R, 2022, Lancet Reg Health Am, V5, P100133, DOI 10.1016/j.lana.2021.100133; Heavey L, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.21.2000903; Hershow RB, 2021, MMWR-MORBID MORTAL W, V70, P442, DOI 10.15585/mmwr.mm7012e3; Hommes F, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052739; Ismail SA, 2021, LANCET INFECT DIS, V21, P344, DOI 10.1016/S1473-3099(20)30882-3; Jones TC, 2021, SCIENCE, V373, P180, DOI 10.1126/science.abi5273; Katz SE, 2021, J PEDIATR-US, V237, P302, DOI 10.1016/j.jpeds.2021.06.015; Kolodziej LM, 2022, CLIN INFECT DIS, V75, pE10, DOI 10.1093/cid/ciac261; Kriemler S, 2021, FRONT PEDIATR, V9, DOI 10.3389/fped.2021.645577; L'Huillier AG, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.00991-21; L'Huillier AG, 2020, EMERG INFECT DIS, V26, P2494, DOI 10.3201/eid2610.202403; Ladhani SN, 2021, LANCET CHILD ADOLESC, V5, P417, DOI 10.1016/S2352-4642(21)00061-4; Lam-Hine T, 2021, MMWR-MORBID MORTAL W, V70, P1214, DOI 10.15585/mmwr.mm7035e2; Larosa E, 2020, EUROSURVEILLANCE, V25, DOI 10.2807/1560-7917.ES.2020.25.49.2001911; Li BS, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28089-y; Loenenbach A, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.21.2100433; Lorthe E., 2022, LANCET INFECT DIS; Macartney K, 2020, LANCET CHILD ADOLESC, V4, P807, DOI 10.1016/S2352-4642(20)30251-0; Marchbanks TL, 2011, CLIN INFECT DIS, V52, pS154, DOI 10.1093/cid/ciq058; Meuris C, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.28757; Monto AS, 2020, J INFECT DIS, V222, P9, DOI 10.1093/infdis/jiaa161; Naimark D, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.3793; Nsoga MTN, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253321; Paul LA, 2021, JAMA PEDIATR, V175, P1151, DOI 10.1001/jamapediatrics.2021.2770; Posfay-Barbe KM, 2021, CLIN INFECT DIS, V72, pE192, DOI 10.1093/cid/ciaa1702; Stehle J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023176; Stein-Zamir C, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.29.2001352; Swank Z, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2025289118; Theuring S, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.34.2100184; Torres JP, 2021, CLIN INFECT DIS, V73, pE458, DOI 10.1093/cid/ciaa955; Ulyte A, 2021, SWISS MED WKLY, V151, DOI [10.4414/SMW.2021.w30092, 10.4414/smw.2021.w30092]; Ulyte A, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-047483; Varma JK, 2021, PEDIATRICS, V147, DOI 10.1542/peds.2021-050605; Villani A, 2021, ITAL J PEDIATR, V47, DOI 10.1186/s13052-021-00978-w; Viner R., 2021, J INFECT; Viner RM, 2020, LANCET CHILD ADOLESC, V4, P397, DOI 10.1016/S2352-4642(20)30095-X; Wiedenmann M, 2021, SWISS MED WKLY, V151, DOI [10.4414/SMW.2021.w30058, 10.4414/smw.2021.w30058]; Yung CF, 2021, CLIN INFECT DIS, V72, P1055, DOI 10.1093/cid/ciaa794; Zhu YS, 2021, CLIN INFECT DIS, V72, pE1146, DOI 10.1093/cid/ciaa1825; Zinszer K, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.35975	53	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0272663	10.1371/journal.pone.0272663	http://dx.doi.org/10.1371/journal.pone.0272663			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976947	Green Published, gold			2022-12-26	WOS:000847227000054
J	Thu, PNT; Quynh, MNT; Van, HN; Thanh, HN; Minh, KP				Phuong Nguyen Thi Thu; Mai Ngo Thi Quynh; Hung Nguyen Van; Hoi Nguyen Thanh; Khue Pham Minh			A logistic regression model based on inpatient health records to predict drug-induced liver injury caused by ramipril-An angiotensin- converting enzyme inhibitor	PLOS ONE			English	Article								Drug-induced liver injury (DILI) is a rare side effect of angiotensin-converting enzyme inhibitors (ACEIs). Ramipril is a widely used ACE compound because of its effectiveness in the treatment of hypertension and heart failure, as well as its low risk of adverse effects. However, the clinical features of ramipril, and the risk of DILI, have not been adequately studied. A retrospective cohort study was performed based on data from 3909 inpatients to compare the risk of DILI conferred by ramipril and other ACEIs. A logistic regression model was then constructed and validated against data from 1686 patients using ramipril, of which 117 patients were diagnosed with DILI. The use of ramipril increased the risk of DILI by 2.68 times (odds ratio = 2.68; 95% confident interval (CI):1.96-3.71) compared with the group using other ACEIs. The clinical features of DILI in the ramipril group were similar to those from the ACEI group (P>0.05), except that the ALT level was higher (P<0.05). A logistic regression model including Body mass index (BMI), comorbidity, liver disease, daily dose, alanine aminotransferase (ALT), and alkaline phosphatase (ALP) was built and successfully validated for DILI risk prediction, with the area under the receiver operating characteristic curve of the model of 0.82 (95% CI: 0.752-0.888). We recommend that clinicians should be aware of the levels of ALT and ALP as well as BMI, comorbidities, and liver disease before prescribing ramipril to avoid the risk of DILI in patients.	[Phuong Nguyen Thi Thu; Mai Ngo Thi Quynh; Hung Nguyen Van; Khue Pham Minh] Hai Phong Univ Med & Pharm, Hai Phong, Vietnam; [Phuong Nguyen Thi Thu; Hoi Nguyen Thanh] Hai Phong Int Hosp, Hai Phong, Vietnam	Hai Phong University Medicine & Pharmacy	Thu, PNT (corresponding author), Hai Phong Univ Med & Pharm, Hai Phong, Vietnam.; Thu, PNT (corresponding author), Hai Phong Int Hosp, Hai Phong, Vietnam.	nttphuong@hpmu.edu.vn		Pham Minh, Khue/0000-0003-2974-3484; Nguyen, Hung/0000-0002-6830-5279; Nguyen, Phuong/0000-0003-0523-0852	Haiphong University of Medicine and Pharmacy	Haiphong University of Medicine and Pharmacy	This work is funded by Haiphong University of Medicine and Pharmacy.	[Anonymous], 2012, CLIN RES INFORM DRUG; Brier G. W., 1950, MONTHLY WEATHER REVI, V78, P1, DOI DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2; CARRE A, 1991, J CARDIOVASC PHARM, V18, pS141; Chalasani N, 2008, GASTROENTEROLOGY, V135, P1924, DOI 10.1053/j.gastro.2008.09.011; Chen MJ, 2016, HEPATOLOGY, V64, P931, DOI 10.1002/hep.28678; Chen SS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004683; DANAN G, 1993, J CLIN EPIDEMIOL, V46, P1323, DOI 10.1016/0895-4356(93)90101-6; Davern TJ, 2012, CLIN LIVER DIS, V16, P231, DOI 10.1016/j.cld.2012.03.002; Douros A, 2013, AM J HYPERTENS, V26, P1070, DOI 10.1093/ajh/hpt090; Forner D., 2017, GASTROENT HEPAT-BARC, V10, P143; Ghabril M, 2019, GASTROENTEROLOGY, V157, P1245, DOI 10.1053/j.gastro.2019.07.006; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Nguyen KD, 2018, DRUG SAFETY, V41, P151, DOI 10.1007/s40264-017-0598-y; Larrey D, 2002, SEMIN LIVER DIS, V22, P145, DOI 10.1055/s-2002-30101; Lee WM, 2003, NEW ENGL J MED, V349, P474, DOI 10.1056/NEJMra021844; MEISEL S, 1994, CLIN PHARMACOKINET, V26, P7, DOI 10.2165/00003088-199426010-00002; R Core Team, 2020, R LANG ENV STAT COMP; REDELMEIER DA, 1991, J CLIN EPIDEMIOL, V44, P1141, DOI 10.1016/0895-4356(91)90146-Z; Schattner A, 2001, AM J MED SCI, V322, P236, DOI 10.1097/00000441-200110000-00016; Shapiro Max A, 2007, Clin Liver Dis, V11, P477, DOI 10.1016/j.cld.2007.06.003; Stirnimann G, 2010, SWISS MED WKLY, V140, P18, DOI 10.4414/smw.2010.13080; Le TT, 2020, J CLIN PHARM THER, V45, P122, DOI 10.1111/jcpt.13037; TODD P, 1990, J ROY SOC MED, V83, P271, DOI 10.1177/014107689008300422; TODD PA, 1990, DRUGS, V39, P110, DOI 10.2165/00003495-199039010-00009; WU RA, 1994, J HYPERTENS, V12, P1243; Yeung E, 2003, ARCH PATHOL LAB MED, V127, P1493; Zalawadiya SK, 2010, AM J HEALTH-SYST PH, V67, P1354, DOI 10.2146/ajhp100083	27	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0272786	10.1371/journal.pone.0272786	http://dx.doi.org/10.1371/journal.pone.0272786			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976917	Green Published, gold			2022-12-26	WOS:000847227000059
J	Zeng, XH; Cai, JP; Liang, CZ; Yuan, CP				Zeng, Xiaohua; Cai, Jieping; Liang, Changzhou; Yuan, Chiping			A hybrid model integrating long short-term memory with adaptive genetic algorithm based on individual ranking for stock index prediction	PLOS ONE			English	Article							TECHNICAL ANALYSIS; FINANCIAL MARKET; NEURAL-NETWORKS	Modeling and forecasting stock prices have been important financial research topics in academia. This study seeks to determine whether improvements can be achieved by forecasting a stock index using a hybrid model and incorporating financial variables. We extend the literature on stock market forecasting by applying a hybrid model that combines wavelet transform (WT), long short-term memory (LSTM), and an adaptive genetic algorithm (AGA) based on individual ranking to predict stock indices for the Dow Jones Industrial Average (DJIA) index of the New York Stock Exchange, Standard & Poor's 500 (S&P 500) index, Nikkei 225 index of Tokyo, Hang Seng Index of Hong Kong market, CSI300 index of Chinese mainland stock market, and NIFTY50 index of India. The results indicate an overall improvement in forecasting of the stock index using the AGA-LSTM model compared to the benchmark models. The evaluation indicators prove that this model has a higher prediction accuracy when forecasting six stock indices.	[Zeng, Xiaohua; Cai, Jieping; Liang, Changzhou] Guangzhou Xinhua Univ, Sch Econ & Trade, Dongguan, Peoples R China; [Yuan, Chiping] Sun Yat Sen Univ, Lingnan Coll, Guangzhou, Peoples R China	Sun Yat Sen University	Yuan, CP (corresponding author), Sun Yat Sen Univ, Lingnan Coll, Guangzhou, Peoples R China.	yuanchip@sysu.edu.cn		Zeng, Xiaohua/0000-0003-0934-7118	"public Administration" construction project of Distinctive Key Disciplines from Guangdong Education Department, China [F2017STSZD01]	"public Administration" construction project of Distinctive Key Disciplines from Guangdong Education Department, China	This work was supported by "public Administration" construction project of Distinctive Key Disciplines from Guangdong Education Department, China (F2017STSZD01).	Althelaya KA, 2018, 2018 21ST SAUDI COMPUTER SOCIETY NATIONAL COMPUTER CONFERENCE (NCC); Arevalo R, 2017, EXPERT SYST APPL, V81, P177, DOI 10.1016/j.eswa.2017.03.028; Baek Y, 2018, EXPERT SYST APPL, V113, P457, DOI 10.1016/j.eswa.2018.07.019; Bergstra J, 2012, J MACH LEARN RES, V13, P281; Berradi Z, 2019, PROCEDIA COMPUT SCI, V148, P55, DOI 10.1016/j.procs.2019.01.008; Chang PC, 2012, EXPERT SYST APPL, V39, P611, DOI 10.1016/j.eswa.2011.07.051; Chollet F., 2018, DEEP LEARNING PYTHON; Chung H, 2020, NEURAL COMPUT APPL, V32, P7897, DOI 10.1007/s00521-019-04236-3; Chung H, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10103765; Devan P, 2020, NEURAL COMPUT APPL, V32, P12499, DOI 10.1007/s00521-020-04708-x; Di Persio Luca, 2016, International Journal of Circuits, Systems and Signal Processing, V10, P403; DIEDE RIKP., 2014, ADAM METHOD STOCHAST, P1572; Ersan D., 2019, J COMPUT SOC SCI, P1; Feelders A.J, 2019, INT WORKSHOP ADV ANA, P55; Fernandes FE, 2019, SWARM EVOL COMPUT, V49, P62, DOI 10.1016/j.swevo.2019.05.010; Fischer T, 2018, EUR J OPER RES, V270, P654, DOI 10.1016/j.ejor.2017.11.054; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P363; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Hajiabotorabi Z, 2019, EXPERT SYST APPL, V138, DOI 10.1016/j.eswa.2019.112842; He FF, 2019, APPL ENERG, V237, P103, DOI 10.1016/j.apenergy.2019.01.055; Henrique BM, 2019, EXPERT SYST APPL, V124, P226, DOI 10.1016/j.eswa.2019.01.012; Ho Y.-C., 1992, J DISCRETE EVENT DYN, V2, P61; Hochreiter S, 1998, INT J UNCERTAIN FUZZ, V6, P107, DOI 10.1142/S0218488598000094; Holland J, 1975, ADAPTATION NATURAL A, P183; Jaddi NS, 2016, INFORM PROCESS LETT, V116, P22, DOI 10.1016/j.ipl.2015.08.001; Jin ZG, 2020, NEURAL COMPUT APPL, V32, P9713, DOI 10.1007/s00521-019-04504-2; Karathanasopoulos A, 2019, J FORECASTING, V38, P346, DOI 10.1002/for.2560; Kim HJ, 2007, APPL SOFT COMPUT, V7, P569, DOI 10.1016/j.asoc.2006.03.004; Kim T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212320; Kim Y., 2017, SUSTAINABILITY-BASEL, V10, P40; Kristjanpoller W, 2018, EXPERT SYST APPL, V109, P1, DOI 10.1016/j.eswa.2018.05.011; McCluskey J, 2017, 2017 2ND INTERNATIONAL CONFERENCE ON IMAGE, VISION AND COMPUTING (ICIVC 2017), P965, DOI 10.1109/ICIVC.2017.7984698; Moghar A, 2020, PROCEDIA COMPUT SCI, V170, P1168, DOI 10.1016/j.procs.2020.03.049; Nguyen Duc Huu Dat, 2019, P INT C APPL INF, P199, DOI DOI 10.1007/978-3-030-32475-9_15; Nti IK, 2020, ARTIF INTELL REV, V53, P3007, DOI 10.1007/s10462-019-09754-z; Pavlo Liashchynskyi, 2019, Arxiv, DOI arXiv:1912.06059; Petersen NC, 2019, EXPERT SYST APPL, V120, P426, DOI 10.1016/j.eswa.2018.11.028; Qiu JY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227222; [曲志坚 Qu Zhijian], 2015, [计算机应用研究, Application Research of Computers], V32, P3222; Ruimin Ke, 2020, Arxiv, DOI arXiv:2005.11627; Rundo F, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9245574; Shah D, 2019, INT J FINANC STUD, V7, DOI 10.3390/ijfs7020026; Skehin T., 2018, CEUR WORKSHOP PROC; SRINIVAS M, 1994, IEEE T SYST MAN CYB, V24, P656, DOI 10.1109/21.286385; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Tran TTK, 2020, ATMOSPHERE-BASEL, V11, DOI 10.3390/atmos11050487; Wang JX, 2017, IEEE INT CONF BIG DA, P4176; Wang QL, 2018, NEUROCOMPUTING, V299, P51, DOI 10.1016/j.neucom.2018.02.095; Zhang Jing-zhao, 2010, Computer Engineering and Applications, V46, P53, DOI 10.3778/j.issn.1002-8331.2010.11.016; Zhong X, 2017, NEUROCOMPUTING, V267, P152, DOI 10.1016/j.neucom.2017.06.010; Zolfaghari M, 2019, ENERG EFFIC, V12, P2099, DOI 10.1007/s12053-019-09800-3	51	0	0	9	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0272637	10.1371/journal.pone.0272637	http://dx.doi.org/10.1371/journal.pone.0272637			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976906	gold, Green Published			2022-12-26	WOS:000847227000051
J	Guoid, AH				Guoid, Aihua			ReLU-FCM trained by quasi-oppositional bare bone imperialist competition algorithm for predicting employment rate	PLOS ONE			English	Article							FUZZY COGNITIVE MAPS	Fuzzy cognitive maps (FCMs) are a powerful tool for system modeling, which can be used for static and dynamic analysis. However, traditional FCMs are usually learned by gradient-based methods, and the adopted sigmoid nonlinear activation function frequently causes gradient saturation. These two shortcomings set a limit on the modeling accuracy. To overcome those problems, we propose in this paper a new FCM with two improvements. First, the rectified linear unit (ReLu) activation function is adopted to replace the sigmoid function. Second, a newly proposed quasi-oppositional bare bone imperialist competition algorithm (QBBICA) is used to learn the FCM. The improved FCM is used to predict the employment rate of graduates from Liren College, Yanshan University. Experimental results show that the improved FCM is effective in employment rate prediction.	[Guoid, Aihua] Yanshan Univ, LiRen Coll, Qinhuangdao, Hebei, Peoples R China	Yanshan University	Guoid, AH (corresponding author), Yanshan Univ, LiRen Coll, Qinhuangdao, Hebei, Peoples R China.	ahguo@ysu.edu.cn						Afonso LD, 2013, EXPERT SYST APPL, V40, P3794, DOI 10.1016/j.eswa.2012.12.093; Ahmadi N, 2020, NEURAL COMPUT APPL, V32, P2267, DOI 10.1007/s00521-018-3754-0; Ahmadi S, 2015, NEURAL COMPUT APPL, V26, P1333, DOI 10.1007/s00521-014-1797-4; Amirkhani A, 2020, ISA T, V100, P454, DOI 10.1016/j.isatra.2019.12.011; Amirkhani A, 2020, IEEE ACM T COMPUT BI, V17, P1372, DOI 10.1109/TCBB.2018.2890261; Atashpaz-Gargari E, 2007, IEEE C EVOL COMPUTAT, P4661, DOI 10.1109/CEC.2007.4425083; Barkhoda W, 2020, AD HOC NETW, V106, DOI 10.1016/j.adhoc.2020.102183; Chen CH, 2016, NEUROCOMPUTING, V173, P1519, DOI 10.1016/j.neucom.2015.09.025; Chen Mingxu, COMPOS PART B-ENG, V186, P107821, DOI [10.1016/j.sjbs.2020.10.002, DOI https://doi.org/10.3390/pathogens9020148, 10.1016/j.compositesb.2020.107821, DOI 10.1016/J.COMPOSITESB.2020.107821]; Elsisi M, 2019, NEURAL COMPUT APPL, V31, P5017, DOI 10.1007/s00521-018-03995-9; Goldansaz SM, 2013, APPL MATH MODEL, V37, P9603, DOI 10.1016/j.apm.2013.05.002; Goldansaz Seyed Morteza, APPL MATH MODEL, V37, P9603, DOI [10.1016/j.apm.2013.05.002, DOI 10.1016/J.APM.2013.05.002, 10.1016/j.apm.2020.06.055.URL]; Guo T, 2020, AAAI CONF ARTIF INTE, V34, P670; Idoumghar L, 2013, APPL MATH COMPUT, V219, P11149, DOI 10.1016/j.amc.2013.05.027; Ighravwe DE, 2019, AFRICON; Jiang Z, 2019, VALUE ENG, V38, P232; Kaveh A, 2010, COMPUT STRUCT, V88, P1220, DOI 10.1016/j.compstruc.2010.06.011; Kiani M, 2022, IEEE T COGN DEV SYST, V14, P50, DOI 10.1109/TCDS.2019.2958423; Kosko Bart, INT J MAN MACH STUD, V24, P65, DOI [10.1016/S0020-7373(86)80040-2, DOI 10.1016/J.EM0SPA.2009.09.001, DOI 10.1016/S0020-7373(86)80040-2]; Li M, 2021, ENG APPL ARTIF INTEL, V103, DOI 10.1016/j.engappai.2021.104307; Lu W, 2020, IEEE T FUZZY SYST, V28, P2958, DOI 10.1109/TFUZZ.2019.2946119; Ma D, 2014, JOURNAAL JIAMUSI U N, V32, P751; Moazzami M, 2016, INT J ELEC POWER, V79, P263, DOI 10.1016/j.ijepes.2016.01.022; Mortazavi A, 2015, NEURAL COMPUT APPL, V26, P1709, DOI 10.1007/s00521-015-1828-9; Pan W, 2018, STAT DECISION, P73; Papageorgiou EI, 2012, IEEE T SYST MAN CY C, V42, P150, DOI 10.1109/TSMCC.2011.2138694; Parsopoulos KE, 2003, IEEE C EVOL COMPUTAT, P1440; Peri D, 2019, COMPUT IND ENG, V137, DOI 10.1016/j.cie.2019.106069; Rabiee A, 2018, J CLEAN PROD, V202, P273, DOI 10.1016/j.jclepro.2018.08.129; Rickard JT, 2020, IEEE T FUZZY SYST, V28, P3122, DOI 10.1109/TFUZZ.2019.2953615; Salmeron JL, 2019, KNOWL-BASED SYST, V163, P723, DOI 10.1016/j.knosys.2018.09.034; Shen F, 2020, IEEE T FUZZY SYST, V28, P1035, DOI 10.1109/TFUZZ.2020.2975482; Stach W, 2008, IEEE T FUZZY SYST, V16, P61, DOI 10.1109/TFUZZ.2007.902020; Stach W, 2012, IEEE T SYST MAN CY B, V42, P900, DOI 10.1109/TSMCB.2011.2182646; Tizhoosh HR, 2006, International Conference on Computational Intelligence for Modelling, Control & Automation Jointly with International Conference on Intelligent Agents, Web Technologies & Internet Commerce, Vol 1, Proceedings, P695, DOI 10.1109/cimca.2005.1631345; Wang T, 2020, NEURAL COMPUT APPL, V32, P16413, DOI 10.1007/s00521-019-04019-w; Wang Y, 2018, RES U STUDENTS EMPLO; Wu K, 2020, IEEE T FUZZY SYST, V28, P3110, DOI 10.1109/TFUZZ.2019.2956904; Yang Shi-da, 2012, Proceedings of the 2012 International Conference on Computer Distributed Control and Intelligent Environmental Monitoring (CDCIEM 2012), P352, DOI 10.1109/CDCIEM.2012.90; Yin Z, 2019, PROC CIRP, V80, P762, DOI 10.1016/j.procir.2019.01.103; Yousefi M, 2012, INT J HEAT MASS TRAN, V55, P3178, DOI 10.1016/j.ijheatmasstransfer.2012.02.041; Zandieh M, 2017, APPL SOFT COMPUT, V58, P449, DOI 10.1016/j.asoc.2017.04.060; [张稳 ZHANG Wen], 2009, [计算机工程与科学, Computer Engineering and Science], V31, P141	43	0	0	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2022	17	8							e0272624	10.1371/journal.pone.0272624	http://dx.doi.org/10.1371/journal.pone.0272624			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6O4ET	35980884	gold, Green Published			2022-12-26	WOS:000890196300001
J	Bederka, LH; Sanchez, JR; Rebeles, J; Araujo, PR; Grayson, MH; Lai, SC; DePalo, LR; Habib, SA; Hill, DG; Lopez, K; Patriquin, L; Sussman, R; Humphreys, J; Reveles, XT; Rebel, VI				Bederka, Lydia H.; Sanchez, Jamila R.; Rebeles, Jennifer; Araujo, Patricia R.; Grayson, Marcia H.; Lai, Shao-Chiang; DePalo, Louis R.; Habib, Sheila A.; Hill, David G.; Lopez, Kathleen; Patriquin, Lara; Sussman, Robert; Humphreys, James; Reveles, Xavier T.; Rebel, Vivienne, I			Sputum analysis by flow cytometry; an effective platform to analyze the lung environment	PLOS ONE			English	Article							PULMONARY CYTOLOGY; TUMOR-CELLS; CANCER; DIAGNOSIS; ALVEOLAR; MACROPHAGES; CARCINOMA; FLUORESCENCE; PERFORMANCE; MORTALITY	Low dose computed tomography (LDCT) is the standard of care for lung cancer screening in the United States (US). LDCT has a sensitivity of 93.8% but its specificity of 73.4% leads to potentially harmful follow-up procedures in patients without lung cancer. Thus, there is a need for additional assays with high accuracy that can be used as an adjunct to LDCT to diagnose lung cancer. Sputum is a biological fluid that can be obtained non-invasively and can be dissociated to release its cellular contents, providing a snapshot of the lung environment. We obtained sputum from current and former smokers with a 30+ pack-year smoking history and who were either confirmed to have lung cancer or at high risk of developing the disease. Dissociated sputum cells were counted, viability determined, and labeled with a panel of markers to separate leukocytes from non-leukocytes. After excluding debris and dead cells, including squamous epithelial cells, we identified reproducible population signatures and confirmed the samples' lung origin. In addition to leukocyte and epithelial-specific fluorescent antibodies, we used the highly fluorescent meso-tetra(4-carboxyphenyl) porphyrin (TCPP), known to preferentially stain cancer (associated) cells. We looked for differences in cell characteristics, population size and fluorescence intensity that could be useful in distinguishing cancer samples from high-risk samples. We present our data demonstrating the feasibility of a flow cytometry platform to analyze sputum in a high-throughput and standardized matter for the diagnosis of lung cancer.	[Bederka, Lydia H.; Sanchez, Jamila R.; Rebeles, Jennifer; Araujo, Patricia R.; Grayson, Marcia H.; Lai, Shao-Chiang; Reveles, Xavier T.; Rebel, Vivienne, I] bioAffin Technol, San Antonio, TX 78249 USA; [DePalo, Louis R.] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Habib, Sheila A.] Audie L Murphy Mem Vet Adm Med Ctr, South Texas Vet Hlth Care Syst STVHCS, 7400 Merton Minter Blvd, San Antonio, TX 78284 USA; [Hill, David G.] Waterbury Pulm Associates LLC, Waterbury, CT USA; [Lopez, Kathleen; Patriquin, Lara] Radiol Associates Albuquerque, Albuquerque, NM USA; [Sussman, Robert] Atlantic Resp Inst, Summit, NJ USA; [Humphreys, James] Precis Pathol Serv, San Antonio, TX USA; [Rebel, Vivienne, I] Univ Texas Hlth Sci Ctr San Antonio, Dept Cell Syst & Anat, San Antonio, TX 78229 USA; [Patriquin, Lara] Zia Diagnost Imaging, Albuquerque, NM USA	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio	Rebel, VI (corresponding author), bioAffin Technol, San Antonio, TX 78249 USA.; Rebel, VI (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cell Syst & Anat, San Antonio, TX 78229 USA.	vr@bioaffinitytech.com			bioAffinity Technologies, Inc.	bioAffinity Technologies, Inc.	This study was funded by bioAffinity Technologies, Inc. LHB, JRS, JR, PRA, MHG, SCL, XTR, VIR are current or former employees of the company. The specific roles of these authors are articulated in the `author contributions' section.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Agusti C, 2001, RESP MED, V95, P822, DOI 10.1053/rmed.2001.1173; American College of Radiology Committee on Lung-RADS&REG;, LUNG RADS ASS CAT VE; Anjuman N, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-15; Baba AI., 2007, COMP ONCOLOGY; Baumgarth N, 2000, J IMMUNOL METHODS, V243, P77, DOI 10.1016/S0022-1759(00)00229-5; Behbahaninia M, 2013, CLIN NEUROL NEUROSUR, V115, P517, DOI 10.1016/j.clineuro.2013.02.019; Bharat A, 2016, AM J RESP CELL MOL, V54, P147, DOI 10.1165/rcmb.2015-0147LE; Brooks CR, 2013, CYTOM PART B-CLIN CY, V84B, P104, DOI 10.1002/cyto.b.21069; Cai YH, 2014, J IMMUNOL, V192, P2821, DOI 10.4049/jimmunol.1302269; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; CLEE MD, 1981, THORAX, V36, P143, DOI 10.1136/thx.36.2.143; Clinical and Laboratory Standards Institute, 2021, CLSI GUID H62, V1st; Datta S, 2017, LANCET GLOB HEALTH, V5, pE760, DOI 10.1016/S2214-109X(17)30201-2; Dewhurst JA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07101-2; Eberth Jan M, 2018, Prev Med Rep, V11, P93, DOI 10.1016/j.pmedr.2018.05.013; El-Far M, 1984, Prog Clin Biol Res, V170, P661; Fan YB, 2010, CYTOTECHNOLOGY, V62, P53, DOI 10.1007/s10616-010-9261-5; FARBER SM, 1961, JAMA-J AM MED ASSOC, V175, P345, DOI 10.1001/jama.1961.03040050001001; Fathi M, 2001, EXP MOL PATHOL, V70, P77, DOI 10.1006/exmp.2000.2344; FIGGE FHJ, 1948, P SOC EXP BIOL MED, V68, P640; Fillmore CM, 2015, NATURE, V520, P239, DOI 10.1038/nature14122; FLOURNOY DJ, 1994, LAB MED, V25, P456, DOI 10.1093/labmed/25.7.456; GOATES CY, 1993, BIOCHIM BIOPHYS ACTA, V1153, P289, DOI 10.1016/0005-2736(93)90418-Y; Grayson M, 2021, JOVE-J VIS EXP, DOI 10.3791/62785; Greenstreet P, 2002, COLOR ATLAS OF PULMONARY CYTOPATHOLOGY, P6; Hayashi N, 2015, MOL CANCER THER, V14, P452, DOI 10.1158/1535-7163.MCT-14-0348; He YT, 2020, CANCER MANAG RES, V12, P841, DOI 10.2147/CMAR.S240773; Henderson Louise M, 2017, Risk Manag Healthc Policy, V10, P189, DOI 10.2147/RMHP.S143152; HINSON K. F. W., 1963, THORAX, V18, P350, DOI 10.1136/thx.18.4.350; Hulspas R, 2009, CYTOM PART B-CLIN CY, V76B, P355, DOI 10.1002/cyto.b.20485; Jiang F, 2009, LUNG CANCER, V66, P58, DOI 10.1016/j.lungcan.2009.01.004; JOHNSTON WW, 1981, ACTA CYTOL, V25, P103; Kasai Y, 2016, REGEN THER, V4, P71, DOI 10.1016/j.reth.2016.02.008; Katz RL, 2008, MODERN PATHOL, V21, P950, DOI 10.1038/modpathol.2008.71; Keeney M, 1998, CYTOMETRY, V34, P280, DOI 10.1002/(SICI)1097-0320(19981215)34:6<280::AID-CYTO6>3.0.CO;2-H; Kemp RA, 2007, J THORAC ONCOL, V2, P993, DOI 10.1097/JTO.0b013e318158d488; Khan MS, 2007, LANCET, V369, P1955, DOI 10.1016/S0140-6736(07)60916-7; KORBELIK M, 1991, BRIT J CANCER, V64, P508, DOI 10.1038/bjc.1991.339; KOSS LG, 1964, ACTA CYTOL, V8, P104; Krombach F, 1997, ENVIRON HEALTH PERSP, V105, P1261, DOI 10.2307/3433544; Krutzik PO, 2004, CLIN IMMUNOL, V110, P206, DOI 10.1016/j.clim.2003.11.009; Lay JC, 2011, INHAL TOXICOL, V23, P392, DOI 10.3109/08958378.2011.575568; Lee H, 2019, BIOINFORM BIOL INSIG, V13, DOI 10.1177/1177932219838851; Li G, 2012, ANAL CELL PATHOL, V35, P187, DOI [10.3233/ACP-2012-0053, 10.1155/2012/289625]; Liegeois M, 2018, CELL IMMUNOL, V330, P91, DOI 10.1016/j.cellimm.2018.02.001; Maecker HT, 2006, CYTOM PART A, V69A, P1037, DOI 10.1002/cyto.a.20333; Maestre-Batlle D, 2017, SCI REP-UK, V7, DOI 10.1038/srep42214; Mazzone PJ, 2018, CHEST, V153, P954, DOI 10.1016/j.chest.2018.01.016; McKee Brady J, 2016, J Am Coll Radiol, V13, pR25, DOI 10.1016/j.jacr.2015.12.009; McWilliams A, 2013, NEW ENGL J MED, V369, P910, DOI 10.1056/NEJMoa1214726; NG ABP, 1983, ACTA CYTOL, V27, P397; NICOD LP, 1989, J LEUKOCYTE BIOL, V45, P458, DOI 10.1002/jlb.45.5.458; OSWALD NC, 1971, THORAX, V26, P623, DOI 10.1136/thx.26.6.623; PAPANICOLAOU GN, 1946, JAMA-J AM MED ASSOC, V131, P372, DOI 10.1001/jama.1946.02870220006002; Paszkiewicz GM, 2008, CANCER EPIDEM BIOMAR, V17, P239, DOI 10.1158/1055-9965.EPI-07-0162; Patriquin L, 2015, J THORAC ONCOL, V10, P1311, DOI 10.1097/JTO.0000000000000627; PEDERSEN B, 1985, ACTA CYTOL, V29, P750; Pinsky PF, 2015, ANN INTERN MED, V162, P485, DOI 10.7326/M14-2086; Pinsky PF, 2013, CANCER-AM CANCER SOC, V119, P3976, DOI 10.1002/cncr.28326; Rana DN, 2001, CYTOPATHOLOGY, V12, P390, DOI 10.1046/j.1365-2303.2001.00351.x; ROME DS, 1961, ACTA CYTOL, V5, P173; SACCOMANNO G, 1974, CANCER-AM CANCER SOC, V33, P256, DOI 10.1002/1097-0142(197401)33:1<256::AID-CNCR2820330139>3.0.CO;2-G; SACCOMANNO G, 1963, ACTA CYTOL, V7, P305; Saeys Y, 2016, NAT REV IMMUNOL, V16, P449, DOI 10.1038/nri.2016.56; Schnell U, 2013, BBA-BIOMEMBRANES, V1828, P1989, DOI 10.1016/j.bbamem.2013.04.018; Schreiber G, 2003, CHEST, V123, p115S, DOI 10.1378/chest.123.1_suppl.115S; Steinkuhler J, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0583-3; Strzelak A, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15051033; Suen KC, 1999, DIAGN CYTOPATHOL, V21, P61, DOI 10.1002/(SICI)1097-0339(199907)21:1<61::AID-DC17>3.0.CO;2-O; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Triplette M, 2018, ANN AM THORAC SOC, V15, P69, DOI 10.1513/AnnalsATS.201705-392OC; UMIKER WO, 1960, DIS CHEST, V37, P82, DOI 10.1378/chest.37.1.82; Went P, 2006, BRIT J CANCER, V94, P128, DOI 10.1038/sj.bjc.6602924; Wheater P. R., 1979, FUNCTIONAL HISTOLOGY; WINKELMAN J, 1962, CANCER RES, V22, P589; Witjes JA, 2007, NAT CLIN PRACT UROL, V4, P542, DOI 10.1038/ncpuro0917; XIAO ML, 1989, J SURG ONCOL, V40, P107, DOI 10.1002/jso.2930400210; Yu YRA, 2016, AM J RESP CELL MOL, V54, P13, DOI 10.1165/rcmb.2015-0146OC; Zhao SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063682	80	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0272069	10.1371/journal.pone.0272069	http://dx.doi.org/10.1371/journal.pone.0272069			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976857	gold, Green Published			2022-12-26	WOS:000847227000021
J	Cruz, M; Pinho, S; Castro-Lopes, JM; Sampaio, R				Cruz, Mariana; Pinho, Simao; Castro-Lopes, Jose Manuel; Sampaio, Rute			Patients and healthcare professionals perspectives on creating a chronic pain support line in Portugal: A qualitative study protocol	PLOS ONE			English	Article							EPIDEMIOLOGY; NATIONWIDE; IMPACT	Chronic pain affects almost 38% of the Portuguese adult population, with high costs for both patients and society. Those who suffer with chronic pain frequently complain of feeling misunderstood and of lack of support. These complaints are the main reason why support telephone lines for chronic pain were created in some countries. However, there is no scientific data supporting their creation or evaluating their performance. This paper presents a qualitative study protocol to assess patients and healthcare professionals' perspectives on the creation of a telephone support line for chronic pain. It constitutes the first step to attain the main goal of developing and implementing a functioning support line for chronic pain in Portugal. The methodology to assess patients and healthcare professionals' perspectives and needs is presented. In order to gather information as close to reality as possible, focus groups interviews were chosen as data sources. Given the present context of the COVID-19 pandemic, meetings will take place online, using a digital platform. All interviews will be transcribed verbatim, coded and synthesised into categories and main themes. Thematic analysis will be conducted using NVivo (R) V12 software, employing an iterative and reflexive approach. Finally, comparative and relational analysis will be performed in order to identify topics where patients and professionals converge or greatly diverge. The findings will be useful for grounding the creation of a telephone support line for chronic pain patients. Results dissemination will be important for policy-makers to develop a new perspective towards chronic pain services available.	[Cruz, Mariana; Pinho, Simao; Castro-Lopes, Jose Manuel; Sampaio, Rute] Univ Porto, Dept Biomed, Fac Med, Porto, Portugal; [Castro-Lopes, Jose Manuel] I3S Inst Res & Innovat Hlth, Porto, Portugal; [Sampaio, Rute] CINTESIS Ctr Hlth Technol & Serv Res, Porto, Portugal	Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto	Cruz, M (corresponding author), Univ Porto, Dept Biomed, Fac Med, Porto, Portugal.	m.belo.cruz@gmail.com	Pinho, Simão/AAR-2801-2021	Cruz, Mariana/0000-0003-4653-9004; Pinho, Simao/0000-0003-1433-3052				[Anonymous], 2022, CANADA PAIN SUPPORT; [Anonymous], 2022, IRELAND CHRONIC PAIN; Azevedo LF, 2016, EUR J HEALTH ECON, V17, P87, DOI 10.1007/s10198-014-0659-4; Azevedo LF, 2012, J PAIN, V13, P773, DOI 10.1016/j.jpain.2012.05.012; Barata Ana Nunes, 2016, J Family Med Prim Care, V5, P518, DOI 10.4103/2249-4863.197255; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Bushey MA, 2020, J TELEMED TELECARE, V26, P619, DOI 10.1177/1357633X19856156; Currie M, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0825-0; Duenas M, 2016, J PAIN RES, V9, P457, DOI 10.2147/JPR.S105892; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Kong TC, 2020, DIGIT HEALTH, V6, DOI 10.1177/2055207620907187; Maher C, 2018, INT J QUAL METH, V17, DOI 10.1177/1609406918786362; Matthias MS, 2020, PAIN MED, V21, P2137, DOI 10.1093/pm/pnz345; Mays Nicholas, 2005, J Health Serv Res Policy, V10 Suppl 1, P6, DOI 10.1258/1355819054308576; Nost TH, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2668-3; Raffaeli W, 2017, J PAIN RES, V10, P2003, DOI 10.2147/JPR.S138864; Schneider EF, 2014, AM J PHARM EDUC, V78, DOI 10.5688/ajpe788148; Solem IKL, 2019, J MED INTERNET RES, V21, DOI 10.2196/13205; Stemler S., 2000, PRACT ASSESS RES EVA, V7, DOI DOI 10.7275/Z6FM-2E34; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Treede RD, 2019, PAIN, V160, P19, DOI 10.1097/j.pain.0000000000001384; Treede RD, 2018, PAIN REP, V3, DOI 10.1097/PR9.0000000000000643; Ulin PR, 2005, QUALITATIVE METHODS; van Hecke O, 2013, BRIT J ANAESTH, V111, P13, DOI 10.1093/bja/aet123; Varsi C, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-021-06278-7; Wettergren L, 2016, JMIR RES PROTOC, V5, DOI [10.2196/resprot.5616, 10.2196/resprot.5971]; www.action-on-pain.co.uk, UK PAIN SUPPORT LINE; www.painaustralia.org.au, AUSTR PAIN SUPPORT S; Yong RJ, 2022, PAIN, V163, pE328, DOI 10.1097/j.pain.0000000000002291; Zwaanswijk Marieke, 2014, BMC Res Notes, V7, P756, DOI 10.1186/1756-0500-7-756	30	0	0	93	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0273213	10.1371/journal.pone.0273213	http://dx.doi.org/10.1371/journal.pone.0273213			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976966	gold, Green Published			2022-12-26	WOS:000847227000084
J	Mulugeta, B; Tesfaye, K; Geleta, M; Johansson, E; Hailesilassie, T; Hammenhag, C; Hailu, F; Ortiz, R				Mulugeta, Behailu; Tesfaye, Kassahun; Geleta, Mulatu; Johansson, Eva; Hailesilassie, Teklehaimanot; Hammenhag, Cecilia; Hailu, Faris; Ortiz, Rodomiro			Multivariate analyses of Ethiopian durum wheat revealed stable and high yielding genotypes	PLOS ONE			English	Article							X ENVIRONMENT INTERACTIONS; GGE BIPLOT ANALYSIS; TRITICUM-TURGIDUM L; GRAIN-YIELD; LANDRACE POPULATIONS; CLIMATE-CHANGE; AMMI ANALYSIS; STATISTICAL-ANALYSIS; MODEL SELECTION; SPRING WHEAT	Improving crop adaptation and stability across diverse and changing environmental conditions is essential to increasing grain yield per unit area. In turn, this contributes to meeting the increasing global food demand. Nevertheless, a number of factors challenge the efficiency of crop improvement programs, of which genotype-by-environment interaction (GEI) is one of the major factors. This study aimed to evaluate the performance and phenotypic stability of 385 Ethiopian durum wheat landraces and 35 cultivars; assess the pattern of genotype by environment interaction (GEI) effect, and identify stable and high-yielding land-races or cultivars using the additive main effect and multiplicative interaction (AMMI) and genotype main effect plus genotype by environment interaction biplot (GGE-biplot). The experiment was laid out in an alpha lattice design with two replications at five test sites (Akaki, Chefe Donsa, Holeta, Kulumsa, and Sinana). The combined analysis of variance revealed highly significant effects (P <= 0.01) of environments (E), genotype (G), and GEI on a phenotypic variation of traits evaluated, including grain yield. For all traits, the amount of phenotypic variance and GEI explained by the GGE biplot was higher than in AMMI2, but both exhibited significant effects of E and GEI on the genotypes. The AMMI model identified G169, G420, G413, G139, G415, G416, G417, and G418 as stable genotypes across testing sites. Whereas, the GGE biplot identified G169, G420, G415, G139, G106, G412, G413, and G417 as both high-yielding and stable across test sites. Hence, genotypes identified as stable and high yielding in the present study could be used in a durum wheat breeding program aimed at identifying genes and molecular markers associated with the crop's productivity traits as well as developing stable and high-yielding cultivars for use in East Africa and beyond.	[Mulugeta, Behailu; Tesfaye, Kassahun; Hailesilassie, Teklehaimanot] Addis Ababa Univ, Inst Biotechnol, Addis Ababa, Ethiopia; [Mulugeta, Behailu; Geleta, Mulatu; Johansson, Eva; Hammenhag, Cecilia; Ortiz, Rodomiro] Swedish Univ Agr Sci, Dept Plant Breeding, Alnarp, Sweden; [Mulugeta, Behailu] OARI, Sinana Agr Res Ctr, Bale Robe, Ethiopia; [Tesfaye, Kassahun] Ethiopian Biotechnol Inst, Addis Ababa, Ethiopia; [Hailu, Faris] Wollo Univ, Dept Biol & Biotechnol, Dessie, Ethiopia	Addis Ababa University; Swedish University of Agricultural Sciences	Mulugeta, B (corresponding author), Addis Ababa Univ, Inst Biotechnol, Addis Ababa, Ethiopia.; Mulugeta, B (corresponding author), Swedish Univ Agr Sci, Dept Plant Breeding, Alnarp, Sweden.; Mulugeta, B (corresponding author), OARI, Sinana Agr Res Ctr, Bale Robe, Ethiopia.	behailu.mulugeta@slu.se		Hammenhag, Cecilia/0000-0003-1354-1909	Swedish International Development Cooperation Agency (Sida)	Swedish International Development Cooperation Agency (Sida)	This work was funded by the Swedish International Development Cooperation Agency (Sida) grant awarded to Addis Ababa University and the Swedish University of Agricultural Sciences for a bilateral capacity-building program in biotechnology; https://sida.aau.edu.et/index.php/biotechnology-phdprogram/; accessed on May 21, 2022). The funders played no role in the design of the study, data collection, analysis, decision to publish or preparation of the manuscript.	Alemu A, 2020, CROP J, V8, P757, DOI 10.1016/j.cj.2020.01.001; Alipour H, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-96576-1; Aruna C, 2016, J AGR SCI-CAMBRIDGE, V154, P73, DOI 10.1017/S0021859615000106; Arzani A, 2017, COMPR REV FOOD SCI F, V16, P477, DOI 10.1111/1541-4337.12262; Askander HSA, 2020, PAK J BOT, V52, P1685, DOI 10.30848/PJB2020-5(4); Banyai J, 2020, CEREAL RES COMMUN, V48, P355, DOI 10.1007/s42976-020-00034-z; Bechere E, 1996, HEREDITAS, V124, P165, DOI 10.1111/j.1601-5223.1996.00165.x; BELAY G, 1994, HEREDITAS, V121, P45, DOI 10.1111/j.1601-5223.1994.00045.x; Borlaug N., 2000, FEEDING WORLD 10 BIL, P3; Borlaug NE, 2007, EUPHYTICA, V157, P287, DOI 10.1007/s10681-007-9480-9; Carbonell SAM, 2004, SCI AGRIC, V61, P169, DOI 10.1590/S0103-90162004000200008; Casanoves F, 2005, CROP SCI, V45, P18, DOI 10.2135/cropsci2005.0018; Chairi F, 2020, CROP J, V8, P623, DOI 10.1016/j.cj.2020.01.005; CSA, 2012, AGR SAMPLE SURVEY 20, VI; de Leon N, 2016, CROP SCI, V56, P2081, DOI 10.2135/cropsci2016.07.0002in; De Vita P, 2010, FIELD CROP RES, V119, P68, DOI 10.1016/j.fcr.2010.06.016; Dehghani H, 2006, AGRON J, V98, P388, DOI 10.2134/agronj2004.0310; Elias AA, 2016, CROP SCI, V56, P2090, DOI 10.2135/cropsci2015.01.0061; Eticha F, 2006, GENET RESOUR CROP EV, V53, P387, DOI 10.1007/s10722-004-6095-z; Farshadfar E, 2011, AUST J CROP SCI, V5, P1837; Fick G. W., 1988, Alfalfa and alfalfa improvement, P163; GABRIEL KR, 1971, BIOMETRIKA, V58, P453, DOI 10.1093/biomet/58.3.453; Gadisa A. Wardofa, 2019, Journal of Plant Breeding and Genetics, V7, P87, DOI 10.33687/pbg.007.02.2847; GAUCH HG, 1988, BIOMETRICS, V44, P705, DOI 10.2307/2531585; Gauch HG, 1997, CROP SCI, V37, P311, DOI 10.2135/cropsci1997.0011183X003700020002x; Gauch HG, 2008, CROP SCI, V48, P866, DOI 10.2135/cropsci2007.09.0513; Gauch HG, 2013, CROP SCI, V53, P1860, DOI 10.2135/cropsci2013.04.0241; George N, 2019, CROP SCI, V59, P1960, DOI 10.2135/cropsci2019.01.0010; Goncalves E, 2020, AUST J GRAPE WINE R, V26, P259, DOI 10.1111/ajgw.12432; Hagos H. G., 2013, Journal of Plant Breeding and Genetics, V1, P12; Haile JK, 2007, CEREAL RES COMMUN, V35, P1661, DOI 10.1556/CRC.35.2007.4.13; Hailu F, 2010, GENET RESOUR CROP EV, V57, P781, DOI 10.1007/s10722-009-9518-z; Hochman Z, 2017, GLOBAL CHANGE BIOL, V23, P2071, DOI 10.1111/gcb.13604; Homma Shitaye., 2015, ACAD J ENTOMOL, V8, P132, DOI DOI 10.5829/idosi.aje.2015.8.3.1117; IBPGR, 1985, DESCR WHEAT, P1; Johansson E., 2020, Wheat Quality For Improving Processing And Human Health, P171, DOI 10.1007/978-3-030-34163-3_8; KANG MS, 1993, AGRON J, V85, P754, DOI 10.2134/agronj1993.00021962008500030042x; Karimizadeh R, 2012, BULG J AGRIC SCI, V18, P595; Karimizadeh R, 2016, TURK J FIELD CROPS, V21, P174, DOI 10.17557/tjfc.17390; Khan A, 2020, PAK J BOT, V52, P1981, DOI 10.30848/RT132020-6(30); Letta T, 2008, J FOOD AGRIC ENVIRON, V6, P217; Li W, 2006, J AGRON CROP SCI, V192, P221, DOI 10.1111/j.1439-037X.2006.00200.x; Liliane T.N., 2020, AGRONOMY CLIMATE CHA, DOI [10.5772/intechopen.90672, DOI 10.5772/INTECHOPEN.90672]; Lodhi R. D., 2015, SABRAO Journal of Breeding and Genetics, V47, P143; Malik WA, 2019, THEOR APPL GENET, V132, P2087, DOI 10.1007/s00122-019-03339-8; Malosetti M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00044; Mekonnen A., 2019, J AGR SCI PRACT, V4, P9; Mengistu D. K., 2016, Journal of Plant Breeding and Crop Science, V8, P45; Mengistu DK, 2015, CROP J, V3, P190, DOI 10.1016/j.cj.2015.04.003; Soriano JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160983; Mishra C. N., 2015, SABRAO Journal of Breeding and Genetics, V47, P40; Mohammadi R, 2008, EUPHYTICA, V159, P419, DOI 10.1007/s10681-007-9600-6; Mohammadi R, 2018, EXP AGR, V54, P670, DOI 10.1017/S0014479717000308; Mohammadi R, 2009, CROP SCI, V49, P1177, DOI 10.2135/cropsci2008.09.0537; Mohammadi R, 2015, CROP J, V3, P526, DOI 10.1016/j.cj.2015.08.003; Mohammadi R, 2010, CROP PASTURE SCI, V61, P92, DOI 10.1071/CP09151; Muez Mehari, 2015, Communications in Biometry and Crop Science, V10, P17; Negisho K, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247016; Newton AC, 2012, ADV APPL MICROBIOL, V81, P89, DOI 10.1016/B978-0-12-394382-8.00003-4; Norris JR, 2016, NATURE, V536, P72, DOI 10.1038/nature18273; Ortiz R, 2008, AGR ECOSYST ENVIRON, V126, P46, DOI 10.1016/j.agee.2008.01.019; Othmani A, 2021, PAK J BOT, V53, P823, DOI 10.30848/PJB2021-3(5); Pal D., 2015, SABRAO Journal of Breeding and Genetics, V47, P89; PATTERSON HD, 1976, BIOMETRIKA, V63, P83, DOI 10.1093/biomet/63.1.83; Pecetti L, 1996, GENET RESOUR CROP EV, V43, P395; Poudel M. R., 2020, Journal of Biology and Today's World, V9; Purchase J. L., 2000, South African Journal of Plant and Soil, V17, P101; Qaseem MF, 2021, PAK J BOT, V53, P227, DOI 10.30848/PJB2021-1(29); Rani M.H., 2018, ARCH ANESTHESIOL CRI, V4, P527, DOI DOI 10.54910/SABRAO2022.54.1.1; Romagosa I., 2009, HDB PLANT BREEDING, V3, P1; Sabaghnia N., 2013, Bulgarian Journal of Agricultural Science, V19, P756; Sarfraz Z, 2016, SABRAO J BREED GENET, V48, P105; Semenov MA, 2014, J CEREAL SCI, V59, P245, DOI 10.1016/j.jcs.2014.01.006; Shiferaw B, 2013, FOOD SECUR, V5, P291, DOI 10.1007/s12571-013-0263-y; Stagnari F, 2013, PLANT BREEDING, V132, P266, DOI 10.1111/pbr.12044; Tekdal S, 2018, J AGR SCI TECH-IRAN, V20, P153; Tesemma T, 1998, EUPHYTICA, V102, P323, DOI 10.1023/A:1018360432426; TESFAYE T, 1991, HEREDITAS, V114, P171, DOI 10.1111/j.1601-5223.1991.tb00321.x; Tsegaye S, 1996, THEOR APPL GENET, V93, P600, DOI 10.1007/BF00417954; Vikrant Singh, 2012, SABRAO Journal of Breeding and Genetics, V44, P370; Xu NY., 2013, CHINESE J ECO AGR, V20, P1500; Yan W, 2006, CAN J PLANT SCI, V86, P623, DOI 10.4141/P05-169; Yan WK, 2007, CROP SCI, V47, P643, DOI 10.2135/cropsci2006.06.0374; Yan WK, 2016, CROP SCI, V56, P2106, DOI 10.2135/cropsci2015.06.0336; Yan WeiKai, 2003, GGE biplot analysis: a graphical tool for breeders, geneticists, and agronomists; Yan WK, 2000, CROP SCI, V40, P597, DOI 10.2135/cropsci2000.403597x; Yan WK, 2001, AGRON J, V93, P1111, DOI 10.2134/agronj2001.9351111x; Yan WK, 2005, CROP SCI, V45, P1004, DOI 10.2135/cropsci2004.0076; Yan WK, 2002, CROP SCI, V42, P11, DOI 10.2135/cropsci2002.0011; Zhang Y, 2006, EUPHYTICA, V147, P409, DOI 10.1007/s10681-005-9038-7; ZOBEL RW, 1988, AGRON J, V80, P388, DOI 10.2134/agronj1988.00021962008000030002x	92	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0273008	10.1371/journal.pone.0273008	http://dx.doi.org/10.1371/journal.pone.0273008			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976886	Green Published, gold			2022-12-26	WOS:000847227000070
J	Chen, J; Lu, HX; Wang, XY; Yang, J; Luo, J; Wang, LM; Yi, XL; He, YN; Chen, KH				Chen, Jia; Lu, Hongxiang; Wang, Xiaoyue; Yang, Jie; Luo, Jia; Wang, Limin; Yi, Xiangling; He, Yani; Chen, Kehong			VNN1 contributes to the acute kidney injury-chronic kidney disease transition by promoting cellular senescence via affecting RB1 expression	FASEB JOURNAL			English	Article						AKI-CKD transition; cellular senescence; renal tubular cells; retinoblastoma 1; vanin-1	OXIDATIVE STRESS; VANIN-1; PANTETHEINASE; REPLICATION; PATHWAY; CYCLE	The mechanisms underlying acute kidney injury (AKI) and chronic kidney disease (CKD) progression include interstitial inflammation, cellular senescence, and oxidative stress (OS). Although vanin-1 (VNN1) plays an important role in OS, its contribution to the AKI-CKD transition remains unknown. Here, we explored the roles and mechanisms of VNN1 in the progression of the AKI-CKD transition. We observed that VNN1 expression was upregulated after ischemia/reperfusion (I/R) injury and high VNN1 expression levels were associated with poor renal repair after I/R injury. In VNN1 knockout (KO) mice, recovery of serum creatinine and blood urea nitrogen levels after I/R injury was accelerated and renal fibrosis was inhibited after severe I/R injury. Furthermore, in VNN1 KO mice, senescence of renal tubular cells was inhibited after severe I/R injury, as assessed by P16 expression and SA-beta-Gal assays. However, our results also revealed that VNN1 KO renal tubular cells did not resist senescence when OS was blocked. To elucidate the mechanism underlying VNN1-mediated regulation of senescence during the AKI-CKD transition, retinoblastoma 1 (RB1) was identified as a potential target. Our results suggest that the reduced senescence in VNN1 KO renal tubular cells was caused by suppressed RB1 expression and phosphorylation. Collectively, our results unveil a novel molecular mechanism by which VNN1 promotes AKI-CKD transition via inducing senescence of renal tubular cells by activating RB1 expression and phosphorylation after severe renal injury. The present study proposes a new strategy for designing therapies wherein VNN1 can be targeted to obstruct the AKI-CKD transition.	[Chen, Jia; Wang, Xiaoyue; Yang, Jie; Luo, Jia; Wang, Limin; Yi, Xiangling; He, Yani; Chen, Kehong] Army Med Univ, Daping Hosp, Dept Nephrol, Chongqing 400042, Peoples R China; [Lu, Hongxiang] Gen Hosp Xinjiang Mil Reg, Dept Traumat Orthopaed, Urumqi, Xinjiang, Peoples R China; [Lu, Hongxiang; He, Yani; Chen, Kehong] Army Med Univ, Daping Hosp, Inst Surg Res, Wound Trauma Med Ctr,State Key Lab Trauma Burns &, Chongqing, Peoples R China	Army Medical University; Army Medical University	He, YN; Chen, KH (corresponding author), Army Med Univ, Daping Hosp, Dept Nephrol, Chongqing 400042, Peoples R China.	heynmail@163.com; chenkehong@foxmail.com			Chongqing technology innovation project [2022YSZX-JCX0007CSTB]; National Natural Science Foundation of China (NSFC) [82102276]	Chongqing technology innovation project; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Chongqing technology innovation project, Grant/Award Number: 2022YSZX-JCX0007CSTB; National Natural Science Foundation of China (NSFC), Grant/Award Number: 82102276	Andrade L, 2018, CELL TRANSPLANT, V27, P739, DOI 10.1177/0963689717743512; Arai S, 2016, NAT MED, V22, P183, DOI 10.1038/nm.4012; Chandrasekaran A, 2017, REDOX BIOL, V11, P91, DOI 10.1016/j.redox.2016.11.005; Chen KH, 2020, FASEB J, V34, P8858, DOI 10.1096/fj.202000053R; Chen KH, 2019, FASEB J, V33, P4571, DOI 10.1096/fj.201801749RRR; Chen KH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0127-z; Daenen K, 2019, PEDIATR NEPHROL, V34, P975, DOI 10.1007/s00467-018-4005-4; Ferreira DW, 2015, CURR MED CHEM, V22, P2407, DOI 10.2174/092986732220150722124307; Fiorentino M, 2018, CONTRIB NEPHROL, V193, P45, DOI 10.1159/000484962; Fu JD, 2021, ACTA CIR BRAS, V36, DOI [10.1590/ACB360802, 10.1590/acb360802]; Hosohata K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222111448; Hosohata K, 2012, J PHARMACOL EXP THER, V341, P656, DOI 10.1124/jpet.112.192807; Hu JX, 2021, J TRANSL MED, V19, DOI 10.1186/s12967-021-02717-5; Hu YW, 2016, J LIPID RES, V57, P1398, DOI 10.1194/jlr.M065565; Jansen PAM, 2009, J INVEST DERMATOL, V129, P2167, DOI 10.1038/jid.2009.67; Kavian N, 2016, J IMMUNOL, V197, P3326, DOI 10.4049/jimmunol.1502511; Kellum JA, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-021-00284-z; Kim JY, 2020, BIOCHEM PHARMACOL, V177, DOI 10.1016/j.bcp.2020.113939; Kim SR, 2020, AM J PHYSIOL-RENAL, V318, pF1167, DOI 10.1152/ajprenal.00535.2019; Knoppert SN, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00770; Knudsen ES, 2019, TRENDS CANCER, V5, P308, DOI 10.1016/j.trecan.2019.03.005; Lewington AJP, 2013, KIDNEY INT, V84, P457, DOI 10.1038/ki.2013.153; Li CZ, 2021, FASEB J, V35, DOI 10.1096/fj.202001855RR; Li J, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.820071; Li YX, 2020, HYPERTENSION, V76, P1069, DOI 10.1161/HYPERTENSIONAHA.120.14594; Martin F, 2004, J CLIN INVEST, V113, P591, DOI 10.1172/JCI200419557; Naquet P, 2014, BIOCHEM SOC T, V42, P1094, DOI 10.1042/BST20140092; Pabla N, 2015, P NATL ACAD SCI USA, V112, P5231, DOI 10.1073/pnas.1424313112; Pitari G, 2000, FEBS LETT, V483, P149, DOI 10.1016/S0014-5793(00)02110-4; Sureshbabu A, 2015, REDOX BIOL, V4, P208, DOI 10.1016/j.redox.2015.01.001; Tanemoto F, 2022, PHARMACEUTICALS-BASE, V15, DOI 10.3390/ph15020123; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; Unterschemmann K, 2021, AM J PHYSIOL-RENAL, V320, pF61, DOI 10.1152/ajprenal.00373.2020; Valentijn FA, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10122020; Venkatachalam G, 2017, NUCLEIC ACIDS RES, V45, P10564, DOI 10.1093/nar/gkx684; Vlassara H, 2009, KIDNEY INT, V76, pS3, DOI 10.1038/ki.2009.401; Washino S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040899; Yamashita N, 2017, BIOCHEM BIOPH RES CO, V489, P466, DOI 10.1016/j.bbrc.2017.05.172; Yang JR, 2017, J AM SOC NEPHROL, V28, P532, DOI 10.1681/ASN.2016010009; Yang XA, 2017, TOXICOLOGY, V382, P75, DOI 10.1016/j.tox.2017.03.009; Zhang B, 2011, BLOOD, V117, P4569, DOI 10.1182/blood-2010-09-304931	41	0	0	7	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22472	10.1096/fj.202200496RR	http://dx.doi.org/10.1096/fj.202200496RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3S4MN	35959877				2022-12-26	WOS:000839572200001
J	Glaser, D; Heinick, A; Herting, JR; Massing, F; Muller, FU; Pauls, P; Rozhdestvensky, TS; Schulte, JS; Seidl, MD; Skryabin, BV; Stumpel, F; Kirchhefer, U				Glaser, Dennis; Heinick, Alexander; Herting, Julius R.; Massing, Fabian; Mueller, Frank U.; Pauls, Paul; Rozhdestvensky, Timofey S.; Schulte, Jan S.; Seidl, Matthias D.; Skryabin, Boris, V; Stuempel, Frank; Kirchhefer, Uwe			Impaired myocellular Ca2+ cycling in protein phosphatase PP2A-B56 alpha KO mice is normalized by beta-adrenergic stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B56 REGULATORY SUBUNIT; 2A PP2A; TRANSCRIPTIONAL REGULATION; CALCIUM-CHANNELS; CALYCULIN-A; PHOSPHORYLATION; RELEASE; SITE; INACTIVATION; ACTIVATION	The activity of protein phosphatase 2A (PP2A) is determined by the expression and localization of the regulatory B-subunits. PP2A-B56 alpha is the dominant isoform of the B'-family in the heart. Its role in regulating the cardiac response to beta-adrenergic stimulation is not yet fully understood. We therefore generated mice deficient in B56 alpha to test the functional cardiac effects in response to catecholamine administration versus corresponding WT mice. We found the decrease in basal PP2A activity in hearts of KO mice was accompanied by a counter-regulatory increase in the expression of B' subunits (beta and gamma) and higher phosphorylation of sarcoplasmic reticulum Ca2+ regulatory and myofilament proteins. The higher phosphorylation levels were associated with enhanced intraventricular pressure and relaxation in catheterized KO mice. In contrast, at the cellular level, we detected depressed Ca2+ transient and sarcomere shortening parameters in KO mice at basal conditions. Consistently, the peak amplitude of the L-type Ca2+ current was reduced and the inactivation kinetics of I-CaL were prolonged in KO cardiomyocytes. However, we show beta-adrenergic stimulation resulted in a comparable peak amplitude of Ca2+ transients and myocellular contraction between KO and WT cardiomyocytes. Therefore, we propose higher isoprenaline-induced Ca2+ spark frequencies might facilitate the normalized Ca2+ signaling in KO cardiomyocytes. In addition, the application of isoprenaline was associated with unchanged L-type Ca2+ current parameters between both groups. Our data suggest an important influence of PP2A-B56 alpha on the regulation of Ca2+ signaling and contractility in response to beta-adrenergic stimulation in the myocardium.	[Glaser, Dennis; Heinick, Alexander; Herting, Julius R.; Massing, Fabian; Mueller, Frank U.; Pauls, Paul; Schulte, Jan S.; Seidl, Matthias D.; Stuempel, Frank; Kirchhefer, Uwe] Univ Munster, Inst Pharmacol & Toxicol, Munster, Germany; [Rozhdestvensky, Timofey S.; Skryabin, Boris, V] Univ Munster, Dept Med, Core Facil Transgen Anim & Genet Engn Models TRAM, Munster, Germany	University of Munster; University of Munster	Kirchhefer, U (corresponding author), Univ Munster, Inst Pharmacol & Toxicol, Munster, Germany.	kirchhef@uni-muenster.de		Herting, Julius Roman/0000-0001-5653-0658; Heinick, Alexander/0000-0002-3770-105X				Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Avwioro G., 2011, JPCS, V1, P24; Bassani Jose W. M., 1995, American Journal of Physiology, V268, pC1313; Boknik P, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00013; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen HG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007019; Cho IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034860; Davare MA, 2000, J BIOL CHEM, V275, P39710, DOI 10.1074/jbc.M005462200; DeGrande ST, 2013, J BIOL CHEM, V288, P1032, DOI 10.1074/jbc.M112.426957; DEPAOLIROACH AA, 1984, J BIOL CHEM, V259, P2144; Dubell WH, 2002, AM J PHYSIOL-HEART C, V282, pH38, DOI 10.1152/ajpheart.00536.2001; El Refaey M, 2019, CIRC RES, V124, P737, DOI 10.1161/CIRCRESAHA.118.314350; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Frank S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-773; Gigena MS, 2005, AM J PHYSIOL-HEART C, V289, pH285, DOI 10.1152/ajpheart.01291.2004; Grandi E, 2010, PROG BIOPHYS MOL BIO, V103, P44, DOI 10.1016/j.pbiomolbio.2010.02.001; Hall DD, 2006, BIOCHEMISTRY-US, V45, P3448, DOI 10.1021/bi051593z; Harkness A, 2020, ECHO RES PRACT, V7, pG1, DOI 10.1530/ERP-19-0050; Heijman J, 2013, J MOL CELL CARDIOL, V64, P90, DOI 10.1016/j.yjmcc.2013.09.006; Heinick A, 2020, FASEB J, V34, P10489, DOI 10.1096/fj.201902094RR; Huang CLH, 2017, PHYSIOL REV, V97, P283, DOI 10.1152/physrev.00007.2016; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; KHEWGOODALL Y, 1991, BIOCHEMISTRY-US, V30, P89, DOI 10.1021/bi00215a014; Kirchhefer U, 2002, AM J PHYSIOL-HEART C, V283, pH1334, DOI 10.1152/ajpheart.00937.2001; Kirchhefer U, 2014, J BIOL CHEM, V289, P33862, DOI 10.1074/jbc.M114.598938; Kirchhefer U, 2014, J BIOL CHEM, V289, P163, DOI 10.1074/jbc.M113.507996; Kucerova D, 2012, AM J PHYSIOL-HEART C, V302, pH2008, DOI 10.1152/ajpheart.00457.2011; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Layland J, 1999, AM J PHYSIOL-HEART C, V276, pH9, DOI 10.1152/ajpheart.1999.276.1.H9; Lee TY, 2010, J BIOL CHEM, V285, P21567, DOI 10.1074/jbc.M109.094953; Lei M, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00013; Little SC, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa5876; Liu J, 2012, CURR MOL MED, V12, P982, DOI 10.2174/156652412802480916; Marshall M, 2009, CARDIOVASC RES, V82, P67, DOI 10.1093/cvr/cvp037; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; MCCRIGHT B, 1995, J BIOL CHEM, V270, P26123, DOI 10.1074/jbc.270.44.26123; ONEILL SC, 1990, J PHYSIOL-LONDON, V425, P55, DOI 10.1113/jphysiol.1990.sp018092; Ozanne BW, 2000, EUR J CANCER, V36, P1640, DOI 10.1016/S0959-8049(00)00175-1; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Picht E, 2007, AM J PHYSIOL-CELL PH, V293, pC1073, DOI 10.1152/ajpcell.00586.2006; Pluteanu F, 2009, AM J PHYSIOL-HEART C, V297, pH1304, DOI 10.1152/ajpheart.00528.2009; Puhl SL, 2019, CARDIOVASC RES, V115, P519, DOI 10.1093/cvr/cvy230; Ranieri A, 2018, J MOL CELL CARDIOL, V115, P20, DOI 10.1016/j.yjmcc.2017.12.016; Schulte JS, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0532-y; Shanley TP, 2001, J IMMUNOL, V166, P966, DOI 10.4049/jimmunol.166.2.966; Shannon TR, 2000, BIOPHYS J, V78, P334, DOI 10.1016/S0006-3495(00)76596-9; Shanware NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012173; SILVER PJ, 1986, J MOL CELL CARDIOL, V18, P31, DOI 10.1016/S0022-2828(86)80980-4; Solaro RJ, 2011, J BIOL CHEM, V286, P9935, DOI 10.1074/jbc.R110.197731; SPURGEON HA, 1992, J PHYSIOL-LONDON, V447, P83, DOI 10.1113/jphysiol.1992.sp018992; Terentyev D, 2009, CIRC RES, V104, P514, DOI 10.1161/CIRCRESAHA.108.181651; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Tong CW, 2004, J PHYSIOL-LONDON, V558, P927, DOI 10.1113/jphysiol.2004.062539; Varadkar P, 2014, DEV DYNAM, V243, P778, DOI 10.1002/dvdy.24111; Varian KD, 2007, AM J PHYSIOL-HEART C, V292, pH2212, DOI 10.1152/ajpheart.00778.2006; Weber S, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00270; WIER WG, 1994, J PHYSIOL-LONDON, V474, P463, DOI 10.1113/jphysiol.1994.sp020037; Wijnker PJM, 2011, J MUSCLE RES CELL M, V32, P221, DOI 10.1007/s10974-011-9261-x; Yao XQ, 2011, BIOCHEM J, V437, P335, DOI 10.1042/BJ20110347; Yin XK, 2010, MOL CELL PROTEOMICS, V9, P497, DOI 10.1074/mcp.M900275-MCP200; Zhao W, 2004, J MOL CELL CARDIOL, V37, P607, DOI 10.1016/j.yjmcc.2004.05.013	62	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102362	10.1016/j.jbc.2022.102362	http://dx.doi.org/10.1016/j.jbc.2022.102362			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5B1GH	35963431	gold, Green Published			2022-12-26	WOS:000863323200004
J	Cardona, C; OlaOlorun, FM; Omulabi, E; Gichangi, P; Thiogo, M; Tsui, A; Anglewicz, P				Cardona, Carolina; OlaOlorun, Funmilola M.; Omulabi, Elizabeth; Gichangi, Peter; Thiogo, Mary; Tsui, Amy; Anglewicz, Philip			The relationship between client dissatisfaction and contraceptive discontinuation among urban family planning clients in three sub-Saharan African countries	PLOS ONE			English	Article							QUALITY-OF-CARE; CONTINUATION; OUTCOMES	Although researchers and practitioners have suggested that the quality of family planning services impacts contraceptive discontinuation, establishing a causal relationship has been challenging, primarily due to data limitations and a lack of agreement on how to measure quality. This longitudinal study estimated the relationship of the dissatisfaction with family planning services on contraceptive discontinuation for a sample of 797 female clients who sought family planning services at urban facilities across Kenya, Nigeria, and Burkina Faso. Clients who sought family planning services were first interviewed in person at private and public health facilities and received a follow-up phone interview four to six months later. In our sample, 18.2% of clients who were using a modern contraceptive at baseline stopped using it by follow-up. At baseline, nearly 14% of clients reported experiencing a problem with service convenience, nearly 12% with the availability of medicines and contraceptives, and nearly 6% with facility cleanliness and/or staff treatment. We hypothesized that client dissatisfaction with the family planning services received informed their decision to discontinue contraception and estimated univariate and bivariate probit regression models, controlling for individual and health facility characteristics. We found that client's perceptions of staff treatment and facility cleanliness informed their expectations about service and contraceptive standards, affecting subsequent contraceptive discontinuation. The difference in the probability of discontinuing contraception was 8.2 percentage-points between dissatisfied and satisfied clients. Examining client dissatisfaction with family planning services can inform the family planning community on needed improvements to increase contraceptive adherence for women in need, which can prevent unplanned pregnancies and unwanted births in the long run.	[Cardona, Carolina; Tsui, Amy; Anglewicz, Philip] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21218 USA; [Cardona, Carolina] Inst Adv Dev Studies, La Paz, Bolivia; [OlaOlorun, Funmilola M.] Univ Ibadan, Dept Community Med, Ibadan, Oyo State, Nigeria; [Omulabi, Elizabeth] Univ Western Cape, Dept Stat & Populat Studies, Bellville, South Africa; [Gichangi, Peter; Thiogo, Mary] Int Ctr Reprod Hlth, Nairobi, Kenya; [Gichangi, Peter] Univ Ghent, Dept Publ Hlth & Primary Care, Fac Med & Hlth Sci, Ghent, Belgium	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Ibadan; University of the Western Cape; Ghent University; Ghent University Hospital	Cardona, C (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21218 USA.; Cardona, C (corresponding author), Inst Adv Dev Studies, La Paz, Bolivia.	ccardon4@jhu.edu		Anglewicz, Philip/0000-0002-7967-3843	Bill & Melinda Gates Foundation [1163884]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This work was supported by the Bill & Melinda Gates Foundation under grant number 1163884.	Ali M, 1999, J BIOSOC SCI, V31, P343, DOI 10.1017/S0021932099003430; Ali M., 2012, CAUSES CONSEQUENCES; Ali MM, 2010, CONTRACEPTION, V81, P22, DOI 10.1016/j.contraception.2009.06.009; Ali MM, 2010, STUD FAMILY PLANN, V41, P129, DOI 10.1111/j.1728-4465.2010.00234.x; Anglewicz P, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0254775; Barden-O'Fallon J, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0529-9; Barden-O'Fallon J, 2011, INT PERSPECT SEX R H, V37, P16, DOI 10.1363/3701611; Bearak J, 2018, LANCET GLOB HEALTH, V6, pE380, DOI 10.1016/S2214-109X(18)30029-9; Blanc AK, 2002, STUD FAMILY PLANN, V33, P127, DOI 10.1111/j.1728-4465.2002.00127.x; Bradley S.E.K., 2009, DHS ANAL STUDIES; Bradley WinfreyW., 2015, DHS METHODOLOGICAL R; Callahan RL, 2012, STUD FAMILY PLANN, V43, P213, DOI 10.1111/j.1728-4465.2012.00319.x; Cantril H., 1966, PATTERN HUMAN CONCER, Vxvii; Chakraborty NM, 2019, GLOB HEALTH-SCI PRAC, V7, P87, DOI 10.9745/GHSP-D-18-00407; Chin-Quee DS, 2007, CONTRACEPTION, V76, P377, DOI 10.1016/j.contraception.2007.07.003; Dasgupta ANZ, 2015, INT PERSPECT SEX R H, V41, P145, DOI 10.1363/4114515; Dehlendorf C, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.01.173; DeVellis RF., 2003, SCALE DEV THEORY APP, P102; Feeser Karla, 2019, Gates Open Res, V3, P1453, DOI 10.12688/gatesopenres.12974.1; Hair J. F., 2014, MULTIVARIATE ANAL, V7; Hibbard JH, 2013, HEALTH AFFAIR, V32, P207, DOI 10.1377/hlthaff.2012.1061; Jain AK, 2017, STUD FAMILY PLANN, V48, P269, DOI 10.1111/sifp.12023; Jain A, 2019, STUD FAMILY PLANN, V50, P179, DOI 10.1111/sifp.12093; Kahneman D, 2010, P NATL ACAD SCI USA, V107, P16489, DOI 10.1073/pnas.1011492107; Koenig MA, 1997, STUD FAMILY PLANN, V28, P278, DOI 10.2307/2137859; Kutney-Lee A, 2009, HEALTH AFFAIR, V28, pW669, DOI 10.1377/hlthaff.28.4.w669; Mahumud RA, 2015, OPEN ACCESS J CONTR, V6, P13, DOI 10.2147/OAJC.S76070; Moreau C, 2009, HUM REPROD, V24, P1387, DOI 10.1093/humrep/dep027; Moreau C, 2007, CONTRACEPTION, V76, P267, DOI 10.1016/j.contraception.2007.06.008; RamaRao S, 2003, INT FAM PLAN PERSPEC, V29, P76, DOI 10.2307/3181061; Tsui Amy, 2020, Gates Open Res, V4, P30, DOI 10.12688/gatesopenres.13119.1; Tsui AO, 2021, STUD FAMILY PLANN, V52, P361, DOI 10.1111/sifp.12172	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0271911	10.1371/journal.pone.0271911	http://dx.doi.org/10.1371/journal.pone.0271911			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994479	gold, Green Published			2022-12-26	WOS:000877093400012
J	Cowgill, KD; Erosheva, EA; Elder, A; Miljacic, L; Buskin, S; Duchin, JS				Cowgill, Karen D.; Erosheva, Elena A.; Elder, Adam; Miljacic, Ljubomir; Buskin, Susan; Duchin, Jeffrey S.			Anti-SARS-CoV-2 seroprevalence in King County, WA-Cross-sectional survey, August 2020	PLOS ONE			English	Article								We conducted a seroprevalence survey to estimate the true number of infections with SARS-CoV-2, the virus that causes COVID-19, in King County as of August 2020 by measuring the proportion of residents from who had antibodies against the virus. Participants from 727 households took part in a cross-sectional address-based household survey with random and non-random samples and provided dried blood spots that were tested for total antibody against the viral nucleocapsid protein, with confirmatory testing for immunoglobulin G against the spike protein. The data were weighted to match King County's population based on sex, age group, income, race, and Hispanic status. After weighting and accounting for the accuracy of the tests, our best overall estimate of anti-SARS-CoV-2 seroprevalence in King County as of August 2020 is 3.9% (95% confidence interval (CI) 2.4%-6.0%) with an effective sample size of 589. Comparing seroprevalence with positive test reports, our survey suggests that viral testing underestimated incidence by a factor of about five and suggests that the proportion of cases that were serious (based on hospitalization) or fatal was 2.4% and 0.8%, respectively. Prevalence varied by subgroup; households reporting incomes at or below $100,000 in 2019 had nearly five times higher estimated antibody prevalence than those with incomes above $100,000. Those reporting non-White/non-Asian race had roughly seven times higher estimated antibody prevalence than those reporting White race. This survey was noteworthy for including people of all ages; among all age groups, the weighted estimate of prevalence was highest in older teens and young adults and lowest in young children, although these differences were not statistically significant.	[Cowgill, Karen D.] Univ Washington, Sch Publ Hlth, Dept Global Hlth, Seattle, WA 98195 USA; [Erosheva, Elena A.] Univ Washington, Sch Social Work, Dept Stat, Seattle, WA 98195 USA; [Erosheva, Elena A.] Univ Washington, Ctr Stat & Social Sci, Seattle, WA 98195 USA; [Elder, Adam] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA; [Miljacic, Ljubomir] Mt Whisper Light, Seattle, WA USA; [Buskin, Susan; Duchin, Jeffrey S.] Publ Hlth Seattle & King Cty, Seattle, WA USA; [Buskin, Susan; Duchin, Jeffrey S.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Duchin, Jeffrey S.] Univ Washington, Sch Med, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Cowgill, KD (corresponding author), Univ Washington, Sch Publ Hlth, Dept Global Hlth, Seattle, WA 98195 USA.	kdc8@uw.edu		Cowgill, Karen/0000-0002-4188-3757	Centers for Disease Control and Prevention grant via Washington State Department of Health Division of Emergency Preparedness and Response -Contract [CLH18258]	Centers for Disease Control and Prevention grant via Washington State Department of Health Division of Emergency Preparedness and Response -Contract(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Centers for Disease Control and Prevention grant via Washington State Department of Health Division of Emergency Preparedness and Response -Contract #CLH18258 subcontract to Public Health-Seattle & King County The funders advised on study design and data collection.	Accorsi EK., 2020, SOCIAL RISK FACTORS; Angulo FJ, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.33706; [Anonymous], PUBLIC HLTH SEATTLE; [Anonymous], 2015, MULT AM PROUD DIV GR, DOI 10.1111/j.1813-6982.1967.tb01936.x; AusVet, 2021, EPITOOLS; Baker M, 2021, NEW YORK TIMES; Bendavid E, 2020, COVID 19 ANTIBODY SE, DOI [10.1101/2020.04.14.20062463, DOI 10.1101/2020.04.14.20062463, 10.1101/2020.04.14.20062463v2]; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Benjamin DJ, 2018, NAT HUM BEHAV, V2, P6, DOI 10.1038/s41562-017-0189-z; Benjamini Y, 2001, ANN STAT, V29, P1165; Biggs HM, 2020, MMWR-MORBID MORTAL W, V69, P965, DOI 10.15585/mmwr.mm6929e2; Centers for Disease Control and Prevention, COVID DAT TRACK NAT; Centers for Disease Control and Prevention, COVID DAT TRACK COMM; Cox D., 2011, PRINCIPLES APPL STAT, DOI [10.1017/CBO9781139005036, DOI 10.1017/CBO9781139005036]; EUROIMMUN, 2020, ANT SARS COV 2 ELISA; Famulare M., 2020, ONE STATE MANY OUTBR; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Havers FP, 2020, JAMA INTERN MED, V180, P1576, DOI 10.1001/jamainternmed.2020.4130; Jorden MA, 2020, MMWR-MORBID MORTAL W, V69, P680, DOI 10.15585/mmwr.mm6922e1; Laboratories Bio-Rad., 2020, PLAT SARS COV 2 TOT; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Melgaco JG, 2020, CELL IMMUNOL, V353, DOI 10.1016/j.cellimm.2020.104114; Menachemi N, 2020, MMWR-MORBID MORTAL W, V69, P960, DOI 10.15585/mmwr.mm6929e1; Shioda Kayoko, 2020, medRxiv, DOI 10.1101/2020.11.13.20231266; Sood N, 2020, JAMA-J AM MED ASSOC, V323, P2425, DOI 10.1001/jama.2020.8279; Urban Indian Health Institute, 2020, BEST PRACT AM IND AL; Washington State Office of Financial Management, 2021, EST APR 1 POP AG SEX; Wu SL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18272-4	29	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0272783	10.1371/journal.pone.0272783	http://dx.doi.org/10.1371/journal.pone.0272783			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994500	Green Published, gold			2022-12-26	WOS:000877093400027
J	Jim, HL; Plohovich, M; Marshall-Pescini, S; Range, F				Jim, Hoi-Lam; Plohovich, Marina; Marshall-Pescini, Sarah; Range, Friederike			Wolves and dogs fail to form reputations of humans after indirect and direct experience in a food-giving situation	PLOS ONE			English	Article							CANIS-FAMILIARIS; BEHAVIOR; CHIMPANZEES; LUPUS	Reputation is a key component in social interactions of group-living animals and appears to play a role in the establishment of cooperation. Animals can form reputations of individuals by directly interacting with them or by observing them interact with a third party, i.e., eavesdropping. Previous research has focused on whether dogs (Canis lupus familiaris) can eavesdrop on humans because of their ability to cooperate with humans, however the results are mixed and if they can eavesdrop, it is unknown whether this ability evolved during the domestication process or whether it was inherited from their ancestor, wolves (Canis lupus). Our study investigated whether equally hand-raised, pack-living dogs and wolves can form reputations of humans in a food-giving situation through indirect and/or direct experience. The experimental procedure comprised three parts: baseline (to test whether the subject preferred a person prior to the experiment), observation and testing. In the observation phase, the subject observed two humans interact with a dog demonstrator-one acted generously and fed the dog, and the other acted selfishly and refused to feed the dog. The subject could then choose which person to approach in the test phase. In the following experience phase, the animals interacted directly with the same two humans who behaved either in a generous or selfish manner. Then, they were again given a choice whom to approach. We found that dogs and wolves, at the group level, did not differentiate between a generous or selfish partner after indirect or direct experience, but wolves were more attentive towards the generous person during the observation phase and some dogs and wolves did prefer the generous partner, at least after indirect and direct experience was combined. Our study suggests that reputation formation may be more difficult than expected for animals and we emphasise the importance of context when studying reputation formation in animals.	[Jim, Hoi-Lam; Plohovich, Marina; Marshall-Pescini, Sarah; Range, Friederike] Univ Vet Med Vienna, Dept Interdisciplinary Life Sci, Konrad Lorenz Inst Ethol, Domesticat Lab, Vienna, Austria	University of Veterinary Medicine Vienna	Jim, HL; Range, F (corresponding author), Univ Vet Med Vienna, Dept Interdisciplinary Life Sci, Konrad Lorenz Inst Ethol, Domesticat Lab, Vienna, Austria.	hoi-lam.jim@outlook.com; friederike.range@vetmeduni.ac.at		Range, Friederike/0000-0003-3127-5536; Jim, Hoi-Lam/0000-0002-8590-7167	Austrian Science Fund (FWF) [W1262-B29]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	HLJ and FR were funded by the Austrian Science Fund (FWF): W1262-B29 (www.fwf.ac.at).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bates LA, 2007, CURR BIOL, V17, P1938, DOI 10.1016/j.cub.2007.09.060; Blum CR., 2020, FRONT PSYCHOL, V11, P2843; BOESCH C, 1989, AM J PHYS ANTHROPOL, V78, P547, DOI 10.1002/ajpa.1330780410; Bonnie KE, 2007, ANIM BEHAV, V74, P171, DOI 10.1016/j.anbehav.2006.12.009; Carballo F, 2020, LEARN BEHAV, V48, P411, DOI 10.3758/s13420-020-00425-6; Carballo F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116314; Chijiiwa H., 2021, ANIM BEHAV COGN, V8, P23, DOI [10.26451/abc.08.01.03.2021, DOI 10.26451/ABC.08.01.03.2021]; Chijiiwa H, 2015, ANIM BEHAV, V106, P123, DOI 10.1016/j.anbehav.2015.05.018; Clutton-Brock TH, 2001, ANIM BEHAV, V61, P705, DOI 10.1006/anbe.2000.1631; Cornell HN, 2012, P ROY SOC B-BIOL SCI, V279, P499, DOI 10.1098/rspb.2011.0957; Field A., 2009, DISCOVERING STAT USI, V3, DOI DOI 10.1080/1057610X.2016.1157408; Fleiss J.L., 2013, STAT METHODS RATES P; Fox J., 2019, R COMPANION APPL REG, V.; Freidin E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079198; Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003; Heberlein MTE, 2017, ANIM COGN, V20, P511, DOI 10.1007/s10071-017-1078-6; Heberlein MTE, 2016, ANIM BEHAV, V122, P59, DOI 10.1016/j.anbehav.2016.09.023; Herrmann E, 2013, J COMP PSYCHOL, V127, P63, DOI 10.1037/a0028929; Jim HL, 2021, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.604372; Jim HL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237373; Johnson S.G., NLOPT NONLINEAR OPTI; King SL, 2019, ANIM COGN, V22, P991, DOI 10.1007/s10071-019-01290-1; Klinghammer E., 1987, Perspectives in Vertebrate Science, V4, P31; Kundey SMA, 2011, ANIM COGN, V14, P291, DOI 10.1007/s10071-010-0362-5; Lampe M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12055-6; Leete J., 2020, Human-Animal Interaction Bulletin, V8, P35; MacNulty DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112884; Marshall-Pescini S, 2011, ANIM BEHAV, V81, P1177, DOI 10.1016/j.anbehav.2011.02.029; Marshall-Pescini S., 2014, SOCIAL DOG BEHAV COG, P3; Marshall-Pescini S, 2017, CURR OPIN BEHAV SCI, V16, P80, DOI 10.1016/j.cobeha.2017.05.002; Marshall-Pescini S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00180; Marzluff JM, 2010, ANIM BEHAV, V79, P699, DOI 10.1016/j.anbehav.2009.12.022; McCullagh P., 1989, GEN LINEAR MODELS, V(2nd), DOI [10.1007/978-1-4899-3242-6, https://doi.org/10.1007/978-1-4899-3242-6, DOI 10.1007/978-1-4899-3242-6]; McDonald J.H., 2014, HDB BIOL STAT; McGetrick J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253277; Melis AP, 2006, SCIENCE, V311, P1297, DOI 10.1126/science.1123007; Miklosi A, 2013, TRENDS COGN SCI, V17, P287, DOI 10.1016/j.tics.2013.04.005; Moretti L, 2015, ANIM BEHAV, V107, P159, DOI 10.1016/j.anbehav.2015.06.008; Nitzschner M, 2014, ANIM BEHAV, V90, P263, DOI 10.1016/j.anbehav.2014.01.035; Nitzschner M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046880; Piotti P, 2017, APPL ANIM BEHAV SCI, V195, P93, DOI 10.1016/j.applanim.2017.05.024; R Core Team, 2021, R LANG ENV STAT; Range F, 2022, TRENDS COGN SCI, V26, P337, DOI 10.1016/j.tics.2022.01.003; Range F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53632-1; Range F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40468-y; Range F, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01582; Range F, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00868; Range F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086559; Range F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016888; Rao A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203165; Rooney NJ, 2006, ANIM BEHAV, V72, P343, DOI 10.1016/j.anbehav.2005.10.014; RStudio Team, 2020, RSTUDIO INTEGRATED D; Russell YI, 2008, BEHAV PROCESS, V78, P108, DOI 10.1016/j.beproc.2007.10.009; Schielzeth H, 2009, BEHAV ECOL, V20, P416, DOI 10.1093/beheco/arn145; Silver ZA, 2021, ANIM COGN, V24, P75, DOI 10.1007/s10071-020-01417-9; Singh P., 2019, IRR VARIOUS COEFFICI; Subiaul F, 2008, ANIM COGN, V11, P611, DOI 10.1007/s10071-008-0151-6; Udell MAR, 2010, BIOL REV, V85, P327, DOI 10.1111/j.1469-185X.2009.00104.x; Vail AL, 2014, CURR BIOL, V24, pR791, DOI 10.1016/j.cub.2014.07.033; Werhahn G, 2016, J COMP PSYCHOL, V130, P288, DOI 10.1037/com0000036; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu JH, 2016, SOC PERSONAL PSYCHOL, V10, P350, DOI 10.1111/spc3.12255	63	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0271590	10.1371/journal.pone.0271590	http://dx.doi.org/10.1371/journal.pone.0271590			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976865	Green Published, gold			2022-12-26	WOS:000847227000013
J	Runke, W; Xiaoni, Y; Yaya, S; Chengyong, W; Baokang, L				Runke, Wang; Xiaoni, You; Yaya, Shi; Chengyong, Wu; Baokang, Liu			Study on air temperature estimation and its influencing factors in a complex mountainous area	PLOS ONE			English	Article							LAND-SURFACE TEMPERATURE; TIME-SERIES; MODIS; INTERPOLATION; NDVI; VALIDATION; VEGETATION; TRENDS	Near-surface air temperature (Ta) is an important parameter in agricultural production and climate change. Satellite remote sensing data provide an effective way to estimate regionalscale air temperature. Therefore, taking Gansu section of the upper Weihe River Basin as the study area, using the filtered reconstructed high-quality long-time series normalized difference vegetation index (NDVI), interpolated reconstructed land surface temperature (LST), surface albedo, and digital elevation model (DEM) as the input data, the back-propagation artificial neural network algorithm (BP-ANN) was combined with a multiple linear regression method to estimate regional air temperature, and the influencing factors of air temperature estimation were analyzed. This method effectively compensates for the fact that air temperature data provided by a single station cannot represent regional air temperature information. The result shows that the temperature estimation accuracy is high. In terms of interannual variation, the air temperature in the study area showed a slightly increasing trend, with an average annual increase of 0.047 degrees C. The calculation results of the interannual variation rate of temperature showed that the area with increased air temperature accounted for 75.8% of the total area. In terms of seasonal variation, compared with that in summer and winter, the air temperature rising trend in autumn was obvious, and the air temperature in the middle of the study area decreased in spring, which is prone to frost disasters. LST and NDVI in the study area were positively correlated with air temperature, and their positive correlation distribution areas accounted for 93.62% and 94.34% of the total study area, respectively. NDVI, LST and DEM influence the temperature change in the study area. The results show that there is a significant positive correlation between NDVI and air temperature, and the change of NDVI has a positive effect on the spatiotemporal variation of air temperature. The correlation coefficient between LST and air temperature in the southeast of the study area is negative, and there is a difference. In addition, the correlation coefficient between LST and air temperature in other areas of the study area is positive. The air temperature decreased with elevation, air temperature decreases by 0.27 degrees C every hundred meters.	[Runke, Wang; Xiaoni, You; Yaya, Shi; Chengyong, Wu; Baokang, Liu] Tianshui Normal Univ, Coll Resources & Environm Engn, Tianshui, Gansu, Peoples R China	Tianshui Normal University	Runke, W (corresponding author), Tianshui Normal Univ, Coll Resources & Environm Engn, Tianshui, Gansu, Peoples R China.	wrk0531@tsnu.edu.cn		Wang, Runke/0000-0003-1623-1834	Science and Technology Program of Gansu Province [21JR1RE293]; School-Level Scientific Research Project of Tianshui Normal University [ZDY2020-18]	Science and Technology Program of Gansu Province; School-Level Scientific Research Project of Tianshui Normal University	This research was supported by the Science and Technology Program of Gansu Province (21JR1RE293) and the School-Level Scientific Research Project of Tianshui Normal University (ZDY2020-18).	Bari SH, 2016, ATMOS RES, V176, P148, DOI 10.1016/j.atmosres.2016.02.008; Benali A, 2012, REMOTE SENS ENVIRON, V124, P108, DOI 10.1016/j.rse.2012.04.024; Bowman D. T., 2001, Journal of Cotton Science, V5, P137; Brown C.E., 1998, APPL MULTIVARIATE ST, P155, DOI DOI 10.1007/978-3-642-80328-4_13; Chen J, 2004, REMOTE SENS ENVIRON, V91, P332, DOI 10.1016/j.rse.2004.03.014; Chen SY, 2009, CHINESE J GEOPHYS-CH, V52, P2273, DOI 10.3969/j.issn.0001-5733.2009.09.011; Cristobal J, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009318; Emamifar S, 2013, INT J CLIMATOL, V33, P3174, DOI 10.1002/joc.3655; Firozjaei M, 2019, INT ARCH PHOTOGRAMM, V42, P395, DOI DOI 10.5194/ISPRS-ARCHIVES-XLII-4-W18-395-2019; Firozjaei MK, 2020, REMOTE SENS ENVIRON, V242, DOI 10.1016/j.rse.2020.111746; Fu P, 2018, ISPRS J PHOTOGRAMM, V146, P65, DOI 10.1016/j.isprsjprs.2018.09.003; Fushiki T, 2011, STAT COMPUT, V21, P137, DOI 10.1007/s11222-009-9153-8; Gardner AS, 2009, J CLIMATE, V22, P4281, DOI 10.1175/2009JCLI2845.1; Gong D, 1999, ACTA GEOGR SIN, V54, P132; [顾娟 GU Juan], 2006, [遥感技术与应用, Remote sensing Technology and Application], V21, P391; [韩秀珍 Han Xiuzhen], 2012, [气象学报, Acta Meteorologica Sinica], V70, P1107; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; Hartmann DL., 2015, GLOBAL PHYS CLIMATOL, P1; Hengl T, 2012, THEOR APPL CLIMATOL, V107, P265, DOI 10.1007/s00704-011-0464-2; Hou P, 2013, THEOR APPL CLIMATOL, V111, P109, DOI 10.1007/s00704-012-0629-7; [黄小燕 Huang Xiaoyan], 2011, [水科学进展, Advances in Water Science], V22, P151; Janatian N, 2017, INT J CLIMATOL, V37, P1181, DOI 10.1002/joc.4766; Jang JD, 2004, INT J REMOTE SENS, V25, P4541, DOI 10.1080/01431160310001657533; Jonsson P, 2002, IEEE T GEOSCI REMOTE, V40, P1824, DOI 10.1109/TGRS.2002.802519; Jung Y, 2018, J NONPARAMETR STAT, V30, P197, DOI 10.1080/10485252.2017.1404598; Kattel DB, 2018, THEOR APPL CLIMATOL, V132, P1129, DOI 10.1007/s00704-017-2153-2; Kawabata A, 2001, INT J REMOTE SENS, V22, P1377, DOI 10.1080/01431160119381; Khesali E, 2020, ADV SPACE RES, V65, P2339, DOI 10.1016/j.asr.2020.02.006; Kilibarda M, 2014, J GEOPHYS RES-ATMOS, V119, P2294, DOI 10.1002/2013JD020803; Lai YJ, 2012, INT J REMOTE SENS, V33, P7685, DOI 10.1080/01431161.2012.700422; Lehnert M, 2021, INT J BIOMETEOROL, V65, P1277, DOI 10.1007/s00484-020-02010-y; Li BF, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017953; [李军 LI Jun], 2006, [生态环境, Ecology and Environment], V15, P109; Li L, 2020, ECOL INDIC, V117, DOI 10.1016/j.ecolind.2020.106683; Li Y, 2011, PROCEDIA ENVIRON SCI, V10, P1953, DOI 10.1016/j.proenv.2011.09.306; [刘娜 Liu Na], 2019, [地球环境学报, Journal of Earth Environment], V10, P239; Liu Y, 2006, PROC SPIE, V6199, DOI 10.1117/12.673656; Metz M, 2014, REMOTE SENS-BASEL, V6, P3822, DOI 10.3390/rs6053822; Meyer H, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8090732; Mohsenzadeh Karimi Sahar, 2020, ISH Journal of Hydraulic Engineering, V26, P376, DOI 10.1080/09715010.2018.1495583; Monestiez P, 2001, ENVIRON ECOL STAT, V8, P297, DOI 10.1023/A:1012726317935; Nguyen OV, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4691-3; Nichol JE, 2012, ISPRS J PHOTOGRAMM, V74, P153, DOI 10.1016/j.isprsjprs.2012.09.007; Pede T, 2018, ISPRS J PHOTOGRAMM, V142, P137, DOI 10.1016/j.isprsjprs.2018.06.003; [彭彬 PENG Bin], 2011, [地球信息科学学报, Journal of Geo-Information Science], V13, P539; Peon J, 2014, INT J REMOTE SENS, V35, P5148, DOI 10.1080/01431161.2014.935831; Pfautsch S, 2010, FOREST ECOL MANAG, V259, P1190, DOI 10.1016/j.foreco.2010.01.006; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schatz J, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/9/094024; Shen HF, 2020, REMOTE SENS ENVIRON, V240, DOI 10.1016/j.rse.2020.111692; Shi C, 2018, ADV CLIM CHANG RES, V9, P120, DOI 10.1016/j.accre.2017.11.003; Shi Y, 2017, J METEOROL RES-PRC, V31, P448, DOI 10.1007/s13351-017-6073-y; Singh R, 2006, INT J REMOTE SENS, V27, P2831, DOI 10.1080/01431160500195234; Sonali P, 2013, J HYDROL, V476, P212, DOI 10.1016/j.jhydrol.2012.10.034; Stow D, 2007, INT J REMOTE SENS, V28, P4807, DOI 10.1080/01431160701264284; Sun T, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12081271; Vancutsem C, 2010, REMOTE SENS ENVIRON, V114, P449, DOI 10.1016/j.rse.2009.10.002; Vogt JV, 1997, INT J CLIMATOL, V17, P1559, DOI 10.1002/(SICI)1097-0088(19971130)17:14<1559::AID-JOC211>3.3.CO;2-X; Wan ZM, 2008, REMOTE SENS ENVIRON, V112, P59, DOI 10.1016/j.rse.2006.06.026; Wang MM, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9121278; WILLMOTT CJ, 1982, B AM METEOROL SOC, V63, P1309, DOI 10.1175/1520-0477(1982)063<1309:SCOTEO>2.0.CO;2; Wong TT, 2020, IEEE T KNOWL DATA EN, V32, P1586, DOI 10.1109/TKDE.2019.2912815; Xie F, 2021, INT J APPL EARTH OBS, V101, DOI 10.1016/j.jag.2021.102352; Yang YZ, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9050410; Yu WP, 2014, J APPL REMOTE SENS, V8, DOI 10.1117/1.JRS.8.083525; Yu YR, 2021, IEEE J-STARS, V14, P1783, DOI 10.1109/JSTARS.2020.3048823; [袁佰顺 Yuan Baishun], 2015, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V29, P185; Zaksek K, 2009, ISPRS J PHOTOGRAMM, V64, P414, DOI 10.1016/j.isprsjprs.2009.02.006; [赵冰 Zhao Bing], 2020, [国土资源遥感, Remote Sensing for Land & Resources], V32, P233	69	0	0	10	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2022	17	8							e0272946	10.1371/journal.pone.0272946	http://dx.doi.org/10.1371/journal.pone.0272946			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6J5SO	35972925	gold, Green Published			2022-12-26	WOS:000886882600001
J	Vigon, L; Galan, M; Torres, M; Mateos, E; Saez, AJ; Corona, M; Malo, R; Rodriguez-Mora, S; Murciano-Anton, MA; Garcia-Gutierrez, V; Martin-Galiano, AJ; Martinez-Laso, J; Lopez-Huertas, R; Coiras, M				Vigon, Lorena; Galan, Miguel; Torres, Monserrat; Mateos, Elena; Saez, Adolfo J.; Corona, Magdalena; Malo, Rosa; Rodriguez-Mora, Sara; Aranzazu Murciano-Anton, Maria; Garcia-Gutierrez, Valentin; Martin-Galiano, Antonio J.; Martinez-Laso, Jorge; Lopez-Huertas, Rosa; Coiras, Mayte			Association between HLA-C alleles and COVID-19 severity in a pilot study with a Spanish Mediterranean Caucasian Cohort	HLA			English	Meeting Abstract									[Vigon, Lorena; Galan, Miguel; Mateos, Elena; Lopez-Huertas, Rosa; Coiras, Mayte] Inst Salud Carlos III, Natl Ctr Microbiol, Immunopathol Unit, Madrid, Spain; [Torres, Monserrat; Rodriguez-Mora, Sara] Inst Salud Carlos III, Madrid, Spain; [Saez, Adolfo J.; Corona, Magdalena; Garcia-Gutierrez, Valentin] Hosp Univ Ramon & Cajal, Hematol Serv, Madrid, Spain; [Malo, Rosa] Hosp Univ Puerta Hierro, Neumol Serv, Madrid, Spain; [Aranzazu Murciano-Anton, Maria] Hosp El Escorial, Neumol Serv, Madrid, Spain; [Martin-Galiano, Antonio J.] Inst Salud Carlos III, Bioinformat Unit, Madrid, Spain; [Martinez-Laso, Jorge] Inst Salud Carlos III, Natl Ctr Microbiol, Immunogenet Unit, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Instituto de Salud Carlos III; Hospital Universitario Ramon y Cajal; Hospital Puerta de Hierro-Majadahonda; Instituto de Salud Carlos III; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)		jmlaso@isciii.es	Galán, Miguel/ABB-6215-2021	Galán, Miguel/0000-0002-6695-1509; Corona de Lapuerta, Magdalena/0000-0002-6553-0171					0	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2059-2302	2059-2310		HLA	HLA	MAY	2022	99	5			SI	P162	523	524						2	Cell Biology; Immunology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Immunology; Pathology	0U9YX	35960731	Green Published, gold			2022-12-26	WOS:000788004300236
J	Jiang, WS; Ruan, WF; Wang, ZQ				Jiang, Wangsheng; Ruan, Wenfeng; Wang, Zhengqiang			Dendrobium officinale polysaccharide inhibits vascular calcification via anti-inflammatory and anti-apoptotic effects in chronic kidney disease	FASEB JOURNAL			English	Article						apoptosis; cardiovascular disease; heme oxygenase-1; inflammation effect; rats; vascular smooth muscle cells	SMOOTH-MUSCLE-CELLS; OXIDATIVE STRESS; INFLAMMATION; ACTIVATION; CANDIDUM	Vascular calcification is very common in patients with chronic kidney disease (CKD), but so far, there is no effective treatment. Dendrobium officinale polysaccharide (DOP), a natural component of Chinese herbal medicine, has been shown to exert anti-inflammatory and anti-apoptotic activity. Inflammation and apoptosis play an essential role in the progression of vascular calcification. However, the exact role and molecular mechanisms of DOP in vascular calcification remain unclear. In this study, we investigated the effects of DOP on vascular calcification using vascular smooth muscle cells (VSMCs), arterial rings, and CKD rats. Alizarin red staining and gene expression analysis revealed that DOP inhibited calcification and osteogenic differentiation of rat VSMCs in a dose-dependent manner. Similarly, ex vivo studies revealed that DOP inhibited the calcification of rat arterial rings. Furthermore, the administration of DOP alleviated vascular calcification in CKD rats. Moreover, DOP treatment suppressed VSMC inflammation and apoptosis. Finally, DOP treatment upregulated mRNA and protein levels of heme oxygenase-1 (HMOX-1); both pharmacological inhibition of HMOX-1 by the HMOX-1 inhibitor zinc protoporphyrin-9ZnPP9 and knockdown of HMOX-1 by siRNA markedly abrogated the suppression of inflammation and osteogenic differentiation of VSMCs by DOP. Collectively, these results suggest that DOP alleviates vascular calcification in CKD by suppressing apoptosis and inflammation via HMOX-1 activation. These results may provide a promising treatment for vascular calcification in CKD.	[Jiang, Wangsheng] Taikang Ningbo Hosp Co Ltd, Ningbo 315000, Peoples R China; [Ruan, Wenfeng; Wang, Zhengqiang] Taikang Tongji Wuhan Hosp, Dept Orthoped, Wuhan, Peoples R China		Jiang, WS (corresponding author), Taikang Ningbo Hosp Co Ltd, Ningbo 315000, Peoples R China.; Wang, ZQ (corresponding author), Taikang Tongji Wuhan Hosp, Dept Orthoped Surg, Wuhan 430050, Peoples R China.	jiangwangsheng2441@163.com; 7726915@qq.com						Antonic DD, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9111589; Atta MG, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI156257; Buendia P, 2015, FASEB J, V29, P173, DOI 10.1096/fj.14-249706; Chang JZ, 2019, J CELL BIOCHEM, V120, P13924, DOI 10.1002/jcb.28666; Chen L, 2020, CELL MOL BIOL, V66, P66, DOI 10.14715/cmb/2020.66.7.11; Cui L, 2020, FREE RADICAL BIO MED, V161, P23, DOI 10.1016/j.freeradbiomed.2020.09.028; Ge JC, 2018, CARBOHYD POLYM, V189, P289, DOI 10.1016/j.carbpol.2018.02.054; Gong XY, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01542; Guo ZB, 2019, BIOMED PHARMACOTHER, V110, P371, DOI 10.1016/j.biopha.2018.11.149; Hruska KA, 2009, CIRC RES, V104, P710, DOI 10.1161/CIRCRESAHA.109.195487; Hu WX, 2021, FASEB J, V35, DOI 10.1096/fj.202001588RR; Jin DH, 2022, FASEB J, V36, DOI 10.1096/fj.202100625RR; Li MX, 2020, INT J BIOL MACROMOL, V149, P717, DOI 10.1016/j.ijbiomac.2020.01.305; Li WX, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI150051; Li XL, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00073; Liang YM, 2021, BIOMED PHARMACOTHER, V143, DOI 10.1016/j.biopha.2021.112101; Liu B, 2020, INT J BIOL MACROMOL, V143, P651, DOI 10.1016/j.ijbiomac.2019.12.041; Liu YG, 2020, J ETHNOPHARMACOL, V248, DOI 10.1016/j.jep.2019.112308; Marelli G, 2017, CANCER RES, V77, P4472, DOI 10.1158/0008-5472.CAN-16-2501; Nakano T, 2019, CIRCULATION, V139, P78, DOI 10.1161/CIRCULATIONAHA.118.034588; Peng H, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12624; Saito E, 2008, J ATHEROSCLER THROMB, V15, P130, DOI 10.5551/jat.E556; Sanchis P, 2019, KIDNEY INT, V95, P958, DOI 10.1016/j.kint.2018.12.014; Shi J, 2022, CELL DEATH DIS, V13, DOI 10.1038/s41419-022-04679-y; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Tziakas DN, 2019, CIRCULATION, V139, P2032, DOI 10.1161/CIRCULATIONAHA.118.037166; Wang C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09174-1; Wang MY, 2018, LIFE SCI, V200, P31, DOI 10.1016/j.lfs.2018.03.025; Wang SS, 2020, J CELL MOL MED, V24, P13564, DOI 10.1111/jcmm.16005; Wen YF, 2021, CHEM-BIOL INTERACT, V347, DOI 10.1016/j.cbi.2021.109615; Wu YY, 2018, BIOMED PHARMACOTHER, V101, P953, DOI 10.1016/j.biopha.2018.03.030; Yang K, 2020, CYTOKINE, V130, DOI 10.1016/j.cyto.2020.155058; Yang XL, 2021, FREE RADICAL BIO MED, V172, P530, DOI 10.1016/j.freeradbiomed.2021.06.020; Zeng Q, 2017, J ETHNOPHARMACOL, V208, P214, DOI 10.1016/j.jep.2017.07.006; Zhang K, 2021, CARBOHYD POLYM, V264, DOI 10.1016/j.carbpol.2021.118018; Zhang XL, 2020, ARTERIOSCL THROM VAS, V40, P751, DOI 10.1161/ATVBAHA.119.313414	36	0	0	14	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22504	10.1096/fj.202200353RRR	http://dx.doi.org/10.1096/fj.202200353RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3W3GW	35980507				2022-12-26	WOS:000842238500001
J	Green, R; Taggart, M; Pain, D; Smithson, K				Green, Rhys; Taggart, Mark; Pain, Deborah; Smithson, Keturah			Implications for food safety of the size and location of fragments of lead shotgun pellets embedded in hunted carcasses of small game animals intended for human consumption	PLOS ONE			English	Article							DEER; ABSORPTION; AMMUNITION; EXPOSURE	Carcasses of common pheasants (Phasianus colchicus) killed by hunters using shotguns are widely used or sold in the United Kingdom and elsewhere for human consumption. Almost all of the birds are shot using shotgun pellets composed principally of lead (Pb). Lead shotgun pellets often fragment on impact within the bodies of gamebirds, leaving small lead particles in the meat that are difficult for consumers to detect and remove and from which a greater proportion of lead is likely to be absorbed. Chronic exposure to even low levels of lead is associated with negative health effects in humans and especially in groups particularly vulnerable to the effects of lead, which include young children and pregnant women. Our study used a high-resolution computerised tomography X-ray scanner to locate, in three dimensions, metal fragments embedded within carcasses of eight pheasants sold for human consumption in the UK. Small radio-dense fragments (<2 mm diameter), assumed to be metallic lead, were present in all of the pheasant carcasses examined (mean number: 39 per carcass) and many were too small (<0.1 mm diameter) and too distant from the nearest large shotgun pellet for it to be practical for consumers to detect and remove them without discarding a large proportion of otherwise usable meat. Consumers of carcasses of pheasants killed using lead shotgun ammunition are likely to be exposed to elevated levels of dietary lead, even if careful food preparation is practiced to remove shotgun pellets and the most damaged tissue.	[Green, Rhys] RSPB, Ctr Conservat Sci, Sandy, Beds, England; [Green, Rhys; Pain, Deborah] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England; [Taggart, Mark] Univ Highlands & Islands, Environm Res Inst, Thurso, Scotland; [Pain, Deborah] Univ East Anglia, Sch Biol Sci, Norwich, England; [Smithson, Keturah] Univ Cambridge, Cambridge Biotomog Ctr, Museum Zool, Cambridge, England	Royal Society for Protection of Birds; University of Cambridge; UHI Millennium Institute; University of East Anglia; University of Cambridge	Green, R (corresponding author), RSPB, Ctr Conservat Sci, Sandy, Beds, England.; Green, R (corresponding author), Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England.	reg29@cam.ac.uk		Green, Rhys/0000-0001-8690-8914; Taggart, Mark/0000-0002-0649-8490	UK environmental charity the Royal Society for the Protection of Birds (RSPB)	UK environmental charity the Royal Society for the Protection of Birds (RSPB)	The only funding obtained for this study was to pay for time on the University Museum of Zoology's micro-CT facility. The UK environmental charity the Royal Society for the Protection of Birds (RSPB) provided funds for this purpose. There was no grant number. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1570; Andreotti A, 2016, ITAL J ANIM SCI, V15, P22, DOI 10.1080/1828051X.2016.1142360; Andreotti A, 2013, EUR J WILDLIFE RES, V59, P705, DOI 10.1007/s10344-013-0725-8; BARLTROP D, 1975, POSTGRAD MED J, V51, P805, DOI 10.1136/pgmj.51.601.805; BARLTROP D, 1979, ARCH ENVIRON HEALTH, V34, P280, DOI 10.1080/00039896.1979.10667414; Codex Alimentarius, 2004, CACRCP, P56; Codex Alimentarius, 2019, AD 1995 REV 1997 200; European Commission, 2006, EUROPEAN COMMISSION; Green R. E., 2021, Conservation Evidence, V18, P1, DOI 10.52201/CEJ18ROTZ8607; Green RE, 2012, FOOD CHEM TOXICOL, V50, P4180, DOI 10.1016/j.fct.2012.08.032; Green RE., 2015, OXFORD LEAD S LEAD A, P27; Green Rhys E., 2022, Conservation Evidence, V19, P8; Green RE, 2019, AMBIO, V48, P954, DOI 10.1007/s13280-019-01194-x; Grund Marrett D., 2010, Human-Wildlife Interactions, V4, P257; Hunt WG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005330; Knott J, 2010, SCI TOTAL ENVIRON, V409, P95, DOI 10.1016/j.scitotenv.2010.08.053; Kollander B, 2014, 18 FOOD AG SWED; Kuntz SH, 2021, EUR J VASC ENDOVASC, V61, P146, DOI 10.1016/j.ejvs.2020.08.037; PACEC, 2014, IND SURV REP PREP PA; Pain DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010315; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Thomas VG, 2020, AMBIO, V49, P2026, DOI 10.1007/s13280-020-01336-6	22	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0268089	10.1371/journal.pone.0268089	http://dx.doi.org/10.1371/journal.pone.0268089			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994440	Green Published, gold, Green Submitted			2022-12-26	WOS:000877093400002
J	Lewin, M; Price, C; Nester, C				Lewin, Max; Price, Carina; Nester, Christopher			Validation of the RunScribe inertial measurement unit for walking gait measurement	PLOS ONE			English	Article							GROUND REACTION FORCE; FOOTWEAR; INSOLES	Introduction The use of portable gait measurement systems in research is appealing to collect real-world data at low-cost, low participant burden, and without requirement for dedicated lab space. Most commercially available inertial measurement units (IMU's) designed for running only capture temporospatial data, the ability to capture biomechanics data such as shock and motion metrics with the RunScribe IMU makes it the closest to a lab alternative. The RunScribe system has been validated in running, however, is yet to be validated for walking. Method Qualisys motion capture, AMTI force plates, and Delsys Trigno accelerometers were used as gold standard lab measures for comparison against the RunScribe IMU. Twenty participants completed 10 footsteps per foot (20 total) measured by both systems simultaneously. Variables for validation included: Vertical Ground reaction force (GRF), instantaneous GRF rate, pronation excursion, pronation velocity, total shock, impact force, braking force. Interclass correlation (ICC) was used to determine agreement between the measurement systems, mean differences were used to evaluate group level accuracy. Results ICC results showed moderate agreement between measurement systems when both limbs were averaged. The greatest agreement was seen for GRF rate, pronation excursion, and pronation velocity (ICC = 0.627, 0.616, 0.539), low agreement was seen for GRF, total shock, impact shock, braking shock (ICC = 0.269, 0.351, 0.244, 0.180). However mean differences show the greatest level of accuracy for GRF, GRF rate, and impact shock. Discussion Results show mixed agreement between the RunScribe and gold standard lab measures, and varied agreement across left and right limbs. Kinematic variables showed the greatest agreement, however GRF had the lowest relative mean difference for group results. The results show acceptable levels of agreement for most variables, however further work must be done to assess the repeatability and sensitivity of the RunScribe to be applied within areas such as footwear testing and gait retraining protocols.	[Lewin, Max; Price, Carina; Nester, Christopher] Univ Salford, Sch Hlth & Soc, Manchester, Lancs, England	University of Salford	Lewin, M (corresponding author), Univ Salford, Sch Hlth & Soc, Manchester, Lancs, England.	m.lewin1@salford.ac.uk		Lewin, Max/0000-0001-9129-8735; Price, Carina/0000-0002-5633-1250	Innovate UK; Scholl's Wellness Company [KTP011560]	Innovate UK(UK Research & Innovation (UKRI)Innovate UK); Scholl's Wellness Company	This study comes from a project funded by Innovate UK (ukri.org/councils/innovate-uk/) and Scholl's Wellness Company (scholl.co.uk), project number KTP011560. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo LB, 2009, BRIT J SPORT MED, V43, P288, DOI 10.1136/bjsm.2008.053421; Benson LC, 2018, GAIT POSTURE, V63, P124, DOI 10.1016/j.gaitpost.2018.04.047; Bonanno DR, 2017, BRIT J SPORT MED, V51, P86, DOI 10.1136/bjsports-2016-096671; Cheung RTH, 2019, SCAND J MED SCI SPOR, V29, P835, DOI 10.1111/sms.13396; Cheung RTH, 2011, J SPORT SCI, V29, P1311, DOI 10.1080/02640414.2011.591420; Coates L, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20092631; Di Michele R, RELATIONSHIPS RUNNIN; Friesen KB, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73734-5; Lucas-Cuevas AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173179; Garcia-Pinillos F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222872; Garcia-Pinillos F, 2021, J STRENGTH COND RES, V35, P78, DOI 10.1519/JSC.0000000000002595; Goonetilleke RS, 1999, HUM FACTORS, V41, P241, DOI 10.1518/001872099779591231; Haque MR, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21030781; Hoitz F, 2020, FOOTWEAR SCI, V12, P193, DOI 10.1080/19424280.2020.1773936; Hollis CR, 2019, SPORT BIOMECH, DOI 10.1080/14763141.2019.1579366; Imbach F, 2020, SPORTS, V8, DOI 10.3390/sports8070103; Koldenhoven Rachel M, 2018, Digit Biomark, V2, P74, DOI 10.1159/000491645; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kosonen J, 2017, J BIOMECH, V54, P58, DOI 10.1016/j.jbiomech.2017.01.041; Kowalsky DB, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0228682; Lavender SA, 2019, APPL ERGON, V74, P118, DOI 10.1016/j.apergo.2018.08.006; Lempke AFD, 2021, J BIOMECH, V126, DOI 10.1016/j.jbiomech.2021.110646; Logan S, 2010, J SPORT SCI MED, V9, P147; Mitschke C, 2017, COMPUT METHOD BIOMEC, V20, P1502, DOI 10.1080/10255842.2017.1382482; Napier C., 2021, FRONT SPORTS ACT LIV, V3, P102; Napier C, 2020, J ATHL TRAINING, V55, P1285, DOI 10.4085/1062-6050-573-19; Okunuki T, 2019, J ORTHOP RES, V37, P927, DOI 10.1002/jor.24223; Silva RM, 2009, POLYM TEST, V28, P642, DOI 10.1016/j.polymertesting.2009.05.007; Sinclair J., 2017, MOV SPORT SCI SCI MO, P59, DOI [DOI 10.1051/SM/2016010, 10.3917/sm.095.0059, DOI 10.3917/SM.095.0059]; Sinclair J, 2013, FOOTWEAR SCI, V5, P45, DOI 10.1080/19424280.2012.693543; Soares D., 2018, ISBS P ARCHIVE, V36, P554; Viteckova S, 2020, PEERJ, V8, DOI 10.7717/peerj.8835; Yazici G., 2020, J EXERC THER REHABIL, V7, P159; Zadpoor AA, 2011, CLIN BIOMECH, V26, P23, DOI 10.1016/j.clinbiomech.2010.08.005	34	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0273308	10.1371/journal.pone.0273308	http://dx.doi.org/10.1371/journal.pone.0273308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994458	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000877093400043
J	Gjelsvik, EL; Fossen, M; Brunsvik, A; Tondel, K				Gjelsvik, Elise Lunde; Fossen, Martin; Brunsvik, Anders; Tondel, Kristin			Using machine learning-based variable selection to identify hydrate related components from FT-ICR MS spectra	PLOS ONE			English	Article							PARTIAL LEAST-SQUARES; ELECTROSPRAY-IONIZATION; HEAVY PETROLEUM; NAPHTHENIC ACIDS; CRUDE OILS; PART 2; FRACTIONATION; ASPHALTENES; IDENTIFICATION; DISSOCIATION	The blockages of pipelines caused by agglomeration of gas hydrates is a major flow assurance issue in the oil and gas industry. Some crude oils form gas hydrates that remain as transportable particles in a slurry. It is commonly believed that naturally occurring components in those crude oils alter the surface properties of gas hydrate particles when formed. The exact structure of the crude oil components responsible for this surface modification remains unknown. In this study, a successive accumulation and spiking of hydrate-active crude oil fractions was performed to increase the concentration of hydrate related compounds. Fourier Transform Ion Cyclotron Resonance Mass Spectrometry (FT-ICR MS) was then utilised to analyse extracted oil samples for each spiking generation. Machine learning-based variable selection was used on the FT-ICR MS spectra to identify the components related to hydrate formation. Among six different methods, Partial Least Squares Discriminant Analysis (PLS-DA) was selected as the best performing model and the 23 most important variables were determined. The FT-ICR MS mass spectra for each spiking level was compared to samples extracted before the successive accumulation, to identify changes in the composition. Principal Component Analysis (PCA) exhibited differences between the oils and spiking levels, indicating an accumulation of hydrate active components. Molecular formulas, double bond equivalents (DBE) and hydrogen-carbon (H/C) ratios were determined for each of the selected variables and evaluated. Some variables were identified as possibly asphaltenes and naphthenic acids which could be related to the positive wetting index (WI) for the oils.	[Gjelsvik, Elise Lunde; Tondel, Kristin] Norwegian Univ Life Sci, Fac Sci & Technol, As, Norway; [Fossen, Martin; Brunsvik, Anders] SINTEF AS, Trondheim, Norway	Norwegian University of Life Sciences; SINTEF	Gjelsvik, EL (corresponding author), Norwegian Univ Life Sci, Fac Sci & Technol, As, Norway.	elise.lunde.gjelsvik@nmbu.no		Gjelsvik, Elise Lunde/0000-0002-8212-0326; Brunsvik, Anders/0000-0002-3327-7060	Norwegian Research Council; Equinor ASA; OMV (Norge) AS; Wintershall DEA Norge AS; TotalEnergies; Knowledge-Building Project for Industry (PETROMAKS 2) [294636]	Norwegian Research Council(Research Council of NorwayEuropean Commission); Equinor ASA; OMV (Norge) AS; Wintershall DEA Norge AS; TotalEnergies; Knowledge-Building Project for Industry (PETROMAKS 2)	Funding from the Norwegian Research Council, Equinor ASA, OMV (Norge) AS, Wintershall DEA Norge AS and TotalEnergies. This work is a part of the Knowledge-Building Project for Industry (PETROMAKS 2), Project number: 294636 "New Hydrate Management: New understanding of hydrate phenomena in oil systems to enable safe operation within the hydrate zone".	Adams JJ, 2014, ENERG FUEL, V28, P2831, DOI 10.1021/ef500282p; Aman ZM, 2017, ENERG FUEL, V31, P5806, DOI 10.1021/acs.energyfuels.6b02943; Bancroft WD, 1913, J PHYS CHEM-US, V17, P501, DOI 10.1021/j150141a002; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Barrow MP, 2009, ENERG FUEL, V23, P2592, DOI 10.1021/ef800985z; Borgund AE, 2007, ENERG FUEL, V21, P2816, DOI 10.1021/ef070100r; Borgund AE, 2009, APPL GEOCHEM, V24, P777, DOI 10.1016/j.apgeochem.2009.01.004; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Breiman L, 1998, ANN STAT, V26, P801, DOI DOI 10.1214/AOS/1024691079; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Cho Y, 2015, MASS SPECTROM REV, V34, P248, DOI 10.1002/mas.21438; Clemente JS, 2005, CHEMOSPHERE, V60, P585, DOI 10.1016/j.chemosphere.2005.02.065; Emmett MR, 1998, J AM SOC MASS SPECTR, V9, P333, DOI 10.1016/S1044-0305(97)00287-0; Erstad K, 2009, ENERG FUEL, V23, P2213, DOI 10.1021/ef8009603; Fadnes FH, 1996, FLUID PHASE EQUILIBR, V117, P186, DOI 10.1016/0378-3812(95)02952-4; Fernandez-Lima FA, 2009, ANAL CHEM, V81, P9941, DOI 10.1021/ac901594f; Fink JK, 2011, PETROLEUM ENG GUIDE, V1st ed; Fossen M., 2021, 32 OIL FIELD CHEM S, P16; Fossen M, 2011, ENERG FUEL, V25, P3552, DOI 10.1021/ef200373v; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Headley JV, 2007, ANAL CHEM, V79, P6222, DOI 10.1021/ac070905w; Hemmingsen PV, 2007, J DISPER SCI TECHNOL, V28, P371, DOI 10.1080/01932690601107716; Hemmingsen PV, 2006, ENERG FUEL, V20, P1980, DOI 10.1021/ef0504321; Ho TK, 1998, IEEE T PATTERN ANAL, V20, P832, DOI 10.1109/34.709601; Hoiland S, 2005, J COLLOID INTERF SCI, V287, P217, DOI 10.1016/j.jcis.2005.01.080; Hoiland S, 2005, 5 INT C GAS HYDRATE, V4, P1151; Hoiland S, 2011, ICGH7; Hur M, 2010, ENERG FUEL, V24, P5524, DOI 10.1021/ef1007165; Kilpatrick PK, 2012, ENERG FUEL, V26, P4017, DOI 10.1021/ef3003262; Klein GC, 2006, ENERG FUEL, V20, P668, DOI 10.1021/ef050353p; Klein GC, 2006, ENERG FUEL, V20, P1973, DOI 10.1021/ef0600208; LINGELEM MN, 1994, ANN NY ACAD SCI, V715, P75, DOI 10.1111/j.1749-6632.1994.tb38825.x; Magnusson H, 2008, J DISPER SCI TECHNOL, V29, P464, DOI 10.1080/01932690701718966; Mullins O. C., 2007, ASPHALTENES HEAVY OI, DOI [10.1007/0-387-68903-6, DOI 10.1007/0-387-68903-6]; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Pinto FE, 2017, FUEL, V210, P790, DOI 10.1016/j.fuel.2017.09.028; Qian K, 2001, ENERG FUEL, V15, P492, DOI 10.1021/ef000255y; Qian KN, 2001, ENERG FUEL, V15, P1505, DOI 10.1021/ef010111z; Qiao PQ, 2017, ENERG FUEL, V31, P3330, DOI 10.1021/acs.energyfuels.6b02401; QUINLAN JR, 1987, INT J MAN MACH STUD, V27, P221, DOI 10.1016/S0020-7373(87)80053-6; Salmin DC, 2019, DOCTORAL THESIS; SCHAPIRE RE, 1990, MACH LEARN, V5, P197, DOI 10.1023/A:1022648800760; Schaub TM, 2007, ENERG FUEL, V21, P185, DOI 10.1021/ef0601115; Sloan ED., 2008, CHEM IND SERIES, V119; Smith DF, 2008, ENERG FUEL, V22, P3118, DOI 10.1021/ef8000357; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tran TN, 2014, CHEMOMETR INTELL LAB, V138, P153, DOI 10.1016/j.chemolab.2014.08.005; Utgoff P. E., 1989, Machine Learning, V4, P161, DOI 10.1023/A:1022699900025; WOLD S, 1983, LECT NOTES MATH, V973, P286; Yang F, 2015, ENERG FUEL, V29, P4783, DOI 10.1021/acs.energyfuels.5b00657; Zhang LZ, 2013, SCI CHINA CHEM, V56, P874, DOI 10.1007/s11426-013-4899-4; Zhang Q, 2022, FUEL, V315, DOI 10.1016/j.fuel.2022.123179	54	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0273084	10.1371/journal.pone.0273084	http://dx.doi.org/10.1371/journal.pone.0273084			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976915	Green Published, gold			2022-12-26	WOS:000847227000075
J	Saito, D; Nakagawa, Y; Sato, T; Fukunaka, A; Pereye, OB; Maruyama, N; Watada, H; Fujitani, Y				Saito, Daisuke; Nakagawa, Yuko; Sato, Takashi; Fukunaka, Ayako; Pereye, Ofejiro Blessing; Maruyama, Nobuhiro; Watada, Hirotaka; Fujitani, Yoshio			Establishment of an enzyme-linked immunosorbent assay for mouse pancreatic polypeptide clarifies the regulatory mechanism of its secretion from pancreatic gamma cells	PLOS ONE			English	Article							NEUROPEPTIDE-Y; INSULIN-SECRETION; FOOD-INTAKE; PEPTIDE-YY; GLUCAGON; IDENTIFICATION; DEGRADATION; HORMONE; MICE	Pancreatic polypeptide (PP), secreted from gamma cells of the islets of Langerhans, is a 36 amino-acid peptide encoded by the Ppy gene. Although previous studies have reported that PP causes a decrease in appetite, the molecular mechanism that regulates PP secretion has not been fully elucidated. Lack of understanding of the regulatory mechanism of PP secretion may be partially owing to the lack of assay systems that can specifically detect PP. We recently developed the mouse monoclonal antibody 23-2D3 that specifically recognizes PP. In the present study, we developed a sandwich enzyme-linked immunosorbent assay for the measurement of mouse PP, and directly monitored intracellular Ca2+ concentrations in Ppy-expressing cells from a newly developed reporter mouse. Using these systems, we identified agonists, such as carbachol and glucose-dependent insulinotropic polypeptide (GIP), which stimulate PP secretion. We further demonstrated that, unlike the case of GIP-induced insulin secretion from beta cells, there is a unique mechanism by which PP secretion is triggered by an increase in intracellular Ca2+ concentrations via voltage-dependent calcium channels even in low-glucose conditions.	[Saito, Daisuke; Nakagawa, Yuko; Sato, Takashi; Fukunaka, Ayako; Pereye, Ofejiro Blessing; Fujitani, Yoshio] Gunma Univ, Inst Mol & Cellular Regulat, Lab Dev Biol & Metab, Maebashi, Gunma, Japan; [Saito, Daisuke; Watada, Hirotaka] Juntendo Univ, Dept Metab & Endocrinol, Grad Sch Med, Tokyo, Japan; [Maruyama, Nobuhiro] Immunobiol Labs Co Ltd, Fujioka, Gunma, Japan; [Watada, Hirotaka] Juntendo Univ, Ctr Therapeut Innovat Diabet, Grad Sch Med, Tokyo, Japan; [Watada, Hirotaka] Juntendo Univ, Ctr Identificat Diabet Therapeut Targets, Grad Sch Med, Tokyo, Japan; [Watada, Hirotaka] Juntendo Univ, Sportol Ctr, Grad Sch Med, Tokyo, Japan	Gunma University; Juntendo University; Immuno-Biological Laboratories Co. Ltd.; Juntendo University; Juntendo University; Juntendo University	Fujitani, Y (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Lab Dev Biol & Metab, Maebashi, Gunma, Japan.	fujitani@gunma-u.ac.jp		Saito, Daisuke/0000-0003-4240-4911	Ministry of Education, Sports and Culture of Japan (JSPS KAKENHI) [20H0364, 19K06435]; Takeda Science Foundation	Ministry of Education, Sports and Culture of Japan (JSPS KAKENHI); Takeda Science Foundation(Takeda Science Foundation (TSF))	This study was supported by grants from the Ministry of Education, Sports and Culture of Japan (JSPS KAKENHI; 20H0364 to YF and 19K06435 to TS) and Takeda Science Foundation (to YF).	Adrian T E, 1978, J Clin Pathol Suppl (Assoc Clin Pathol), V8, P43, DOI 10.1136/jcp.s1-8.1.43; Aragon F, 2015, BBA-GEN SUBJECTS, V1850, P343, DOI 10.1016/j.bbagen.2014.11.005; Asakawa A, 1999, PEPTIDES, V20, P1445, DOI 10.1016/S0196-9781(99)00155-2; Asakawa A, 2003, GASTROENTEROLOGY, V124, P1325, DOI 10.1016/S0016-5085(03)00216-6; BERNTSON GG, 1993, PEPTIDES, V14, P497, DOI 10.1016/0196-9781(93)90138-7; Campbell RE, 2003, J NEUROSCI, V23, P1487, DOI 10.1523/JNEUROSCI.23-04-01487.2003; Chia CW, 2014, J CLIN ENDOCR METAB, V99, P2477, DOI 10.1210/jc.2013-3994; Cuenco J, 2017, ENDOCRINOLOGY, V158, P1755, DOI 10.1210/en.2016-1827; Ekblad E, 2002, PEPTIDES, V23, P251, DOI 10.1016/S0196-9781(01)00601-5; El K, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf1948; Fukaishi T, 2021, DIABETOLOGIA, V64, P2803, DOI 10.1007/s00125-021-05560-x; Gheni G, 2014, CELL REP, V9, P661, DOI 10.1016/j.celrep.2014.09.030; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; Hara A, 2019, ENDOCR J, V66, P459, DOI 10.1507/endocrj.EJ18-0441; Hasegawa Y, 2016, EXP ANIM TOKYO, V65, P319, DOI 10.1538/expanim.16-0016; Holst JJ, 2020, PEPTIDES, V125, DOI 10.1016/j.peptides.2019.170230; Holzer P, 2012, NEUROPEPTIDES, V46, P261, DOI 10.1016/j.npep.2012.08.005; Iyengar S, 1999, J PHARMACOL EXP THER, V289, P1031; Janson ET, 2016, ACS CHEM BIOL, V11, P2588, DOI 10.1021/acschembio.6b00602; KIMMEL JR, 1968, ENDOCRINOLOGY, V83, P1323, DOI 10.1210/endo-83-6-1323; LARSSON LI, 1976, DIABETOLOGIA, V12, P211, DOI 10.1007/BF00422088; LARSSON LI, 1975, CELL TISSUE RES, V156, P167; Li LC, 2018, EMBO REP, V19, DOI 10.15252/embr.201846148; Li LS, 2014, DIABETES, V63, P4100, DOI 10.2337/db13-1855; Lin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008488; LOETSCHER P, 1991, J BIOL CHEM, V266, P11213; Maeda Y, 2018, ENDOCRINOLOGY, V159, P1213, DOI 10.1210/en.2017-00636; Maruyama N, 2016, SCI REP-UK, V6, DOI 10.1038/srep39375; Miura Y, 2003, AM J PHYSIOL-ENDOC M, V285, pE1001, DOI 10.1152/ajpendo.00005.2003; MIYAZAKI K, 1988, GASTROENTEROLOGY, V94, P745, DOI 10.1016/0016-5085(88)90249-1; Nakagawa Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144053; Nakagawa Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005106; Pedragosa-Badia Xavier, 2013, Front Endocrinol (Lausanne), V4, P5, DOI 10.3389/fendo.2013.00005; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; Schirra J, 2000, GUT, V46, P622, DOI 10.1136/gut.46.5.622; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/NMETH.2413, 10.1038/nmeth.2413]; Shuai HY, 2016, PFLUG ARCH EUR J PHY, V468, P1765, DOI 10.1007/s00424-016-1864-z; Simonian HP, 2005, NEUROGASTROENT MOTIL, V17, P348, DOI 10.1111/j.1365-2982.2004.00634.x; TEITELMAN G, 1993, DEVELOPMENT, V118, P1031; Ueno N, 2002, DIABETOLOGIA, V45, P1048, DOI 10.1007/s00125-002-0866-x; Veedfald S, 2020, J CLIN ENDOCR METAB, V105, pE502, DOI 10.1210/clinem/dgz097; Wang XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055501; WEIR GC, 1979, DIABETES, V28, P35, DOI 10.2337/diabetes.28.1.35; Wortley KE, 2007, GASTROENTEROLOGY, V133, P1534, DOI 10.1053/j.gastro.2007.08.024; Yabe D, 2011, PROG BIOPHYS MOL BIO, V107, P248, DOI 10.1016/j.pbiomolbio.2011.07.010; Yulyaningsih E, 2014, CELL METAB, V19, P58, DOI 10.1016/j.cmet.2013.11.019; Zhao YF, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa157	47	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0269958	10.1371/journal.pone.0269958	http://dx.doi.org/10.1371/journal.pone.0269958			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976945	gold, Green Published			2022-12-26	WOS:000847227000007
J	Pederick, JL; Horsfall, AJ; Jovcevski, B; Klose, J; Abell, AD; Pukala, TL; Bruning, JB				Pederick, Jordan L.; Horsfall, Aimee J.; Jovcevski, Blagojce; Klose, Jack; Abell, Andrew D.; Pukala, Tara L.; Bruning, John B.			Discovery of an iota-amino acid ligase implicated in Staphylococcal sulfur amino acid metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROMOLECULAR CRYSTALLOGRAPHY COMMUNITIES; ENZYMATIC CHARACTERIZATION; AUREUS; ASPARTOKINASE; GENE; IDENTIFICATION; RESISTANCE; INHIBITORS; REGULATOR; ASPARTATE	Enzymes involved in Staphylococcus aureus amino acid metabolism have recently gained traction as promising targets for the development of new antibiotics, however, not all aspects of this process are understood. The ATP-grasp superfamily includes enzymes that predominantly catalyze the ATP -dependent ligation of various carboxylate and amine sub-strates. One subset, iota-amino acid ligases (LALs), primarily catalyze the formation of dipeptide products in Gram-positive bacteria, however, their involvement in S. aureus amino acid metabolism has not been investigated. Here, we present the characterization of the putative ATP-grasp enzyme (SAOUHSC_02373) from S. aureus NCTC 8325 and its iden-tification as a novel LAL. First, we interrogated the activity of SAOUHSC_02373 against a panel of iota-amino acid substrates. As a result, we identified SAOUHSC_02373 as an LAL with high selectivity for iota-aspartate and iota-methionine substrates, specifically forming an iota-aspartyl-iota-methionine dipeptide. Thus, we propose that SAOUHSC_02373 be assigned as iota-aspartate-iota-methionine ligase (LdmS). To further understand this unique activity, we investigated the mechanism of LdmS by X-ray crystallography, molecular modeling, and site-directed mutagenesis. Our results suggest that LdmS shares a similar mechanism to other ATP-grasp enzymes but possesses a distinctive active site architecture that confers selectivity for the iota-Asp and iota-Met substrates. Phylogenetic analysis revealed LdmS homologs are highly conserved in Staphylococcus and closely related Gram-positive Firmicutes. Subsequent genetic analysis upstream of the ldmS operon revealed several trans- acting regulatory elements associated with control of Met and Cys metabolism. Together, these findings support a role for LdmS in Staphylococcal sulfur amino acid metabolism.	[Horsfall, Aimee J.; Bruning, John B.] Univ Adelaide, Inst Photon & Adv Sensing IPAS, Sch Biol Sci, Adelaide, SA, Australia; [Horsfall, Aimee J.; Abell, Andrew D.] Univ Adelaide, Inst Photon & Adv Sensing IPAS, Sch Phys Sci, Adelaide, SA, Australia; [Jovcevski, Blagojce; Pukala, Tara L.] ARC Ctr Excellence Nanoscale BioPhoton CNBP, Adelaide, SA, Australia; [Jovcevski, Blagojce; Klose, Jack; Pukala, Tara L.] Univ Adelaide, Dept Chem, Adelaide, SA, Australia; [Jovcevski, Blagojce] Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA, Australia	University of Adelaide; University of Adelaide; University of Adelaide; University of Adelaide	Bruning, JB (corresponding author), Univ Adelaide, Inst Photon & Adv Sensing IPAS, Sch Biol Sci, Adelaide, SA, Australia.	john.bruning@adelaide.edu.au		Pederick, Jordan/0000-0003-4048-9771	Flinders Analytical (Flinders University)	Flinders Analytical (Flinders University)	This research was undertaken in part using theMX2 beamline at the Australian Synchrotron, part of ANSTO, and made use of the Australian Cancer Research Foundation (ACRF)detector. This work was performed in part at the Optofab node of the Australian National Fabrication Facility, a company established under the National Collaborative Research Infrastructure Strategy to provide nano and microfabrication facilities for Australia's re-searchers. We thank Flinders Analytical (Flinders University) for access and support to IM-MS instrumentation	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Alreshidi MM, 2019, MICROBIOLOGYOPEN, V8, DOI 10.1002/mbo3.772; Alreshidi MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159662; Annunziato G, 2021, ACS INFECT DIS, V7, P281, DOI 10.1021/acsinfecdis.0c00378; Aragao D, 2018, J SYNCHROTRON RADIAT, V25, P885, DOI 10.1107/S1600577518003120; Arai T, 2008, BIOSCI BIOTECH BIOCH, V72, P3048, DOI 10.1271/bbb.80439; Arai T, 2013, APPL ENVIRON MICROB, V79, P5023, DOI 10.1128/AEM.01003-13; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Chou CY, 2009, J BIOL CHEM, V284, P11690, DOI 10.1074/jbc.M805783200; Cowieson NP, 2015, J SYNCHROTRON RADIAT, V22, P187, DOI 10.1107/S1600577514021717; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Doherty N, 2006, J BACTERIOL, V188, P2885, DOI 10.1128/JB.188.8.2885-2897.2006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Epshtein V, 2003, P NATL ACAD SCI USA, V100, P5052, DOI 10.1073/pnas.0531307100; Fairhead Michael, 2015, Methods Mol Biol, V1266, P171, DOI 10.1007/978-1-4939-2272-7_12; FAN C, 1994, SCIENCE, V266, P439, DOI 10.1126/science.7939684; Fawaz MV, 2011, BIOORG CHEM, V39, P185, DOI 10.1016/j.bioorg.2011.08.004; Gagne OC, 2016, ACTA CRYSTALLOGR B, V72, P602, DOI 10.1107/S2052520616008507; Gao YN, 2019, RSC ADV, V9, P21344, DOI 10.1039/c9ra03293b; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GRAY BH, 1969, BIOCHIM BIOPHYS ACTA, V178, P248, DOI 10.1016/0005-2744(69)90394-5; Hiratake J, 2005, CHEM REC, V5, P209, DOI 10.1002/tcr.20045; Iyer LM, 2009, MOL BIOSYST, V5, P1636, DOI 10.1039/b917682a; Jakobsen OM, 2009, APPL ENVIRON MICROB, V75, P652, DOI 10.1128/AEM.01176-08; Jamdar SN, 2015, ARCH BIOCHEM BIOPHYS, V587, P18, DOI 10.1016/j.abb.2015.10.003; Jenkins HT, 2018, ACTA CRYSTALLOGR D, V74, P205, DOI 10.1107/S2059798318002292; Jochim A, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.00177-19; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kino K, 2008, J BIOSCI BIOENG, V106, P313, DOI 10.1263/jbb.106.313; Kino K, 2008, BIOCHEM BIOPH RES CO, V371, P536, DOI 10.1016/j.bbrc.2008.04.105; Kino K, 2010, J BIOSCI BIOENG, V110, P39, DOI 10.1016/j.jbiosc.2009.12.004; Kino K, 2009, BIOSCI BIOTECH BIOCH, V73, P901, DOI 10.1271/bbb.80842; Kobashi N, 2001, BIOSCI BIOTECH BIOCH, V65, P1391, DOI 10.1271/bbb.65.1391; Kondo N, 2001, ANTIMICROB AGENTS CH, V45, P815, DOI 10.1128/AAC.45.3.815-824.2001; Kourtis AP, 2019, MMWR-MORBID MORTAL W, V68, P214, DOI 10.15585/mmwr.mm6809e1; Krismer B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003862; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Mader U, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005962; Majerczyk CD, 2010, J BACTERIOL, V192, P2861, DOI 10.1128/JB.00220-10; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murphy GR, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00620; Murray CJL, 2022, LANCET, V399, P629, DOI [10.1016/S0140-6736(21)02724-0, 10.1016/j.eururo.2022.08.023]; Noike M, 2015, NAT CHEM BIOL, V11, P71, DOI 10.1038/nchembio.1697; Novichkov PS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-745; Patel C, 2018, FASEB J, V32; Pederick JL, 2021, ANAL BIOCHEM, V623, DOI 10.1016/j.ab.2021.114170; Pederick JL, 2020, J BIOL CHEM, V295, P7894, DOI 10.1074/jbc.RA120.012936; Pohl K, 2009, J BACTERIOL, V191, P2953, DOI 10.1128/JB.01492-08; Potterton L, 2018, ACTA CRYSTALLOGR D, V74, P68, DOI 10.1107/S2059798317016035; Rodionov DA, 2004, NUCLEIC ACIDS RES, V32, P3340, DOI 10.1093/nar/gkh659; Santiago M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1361-3; Schlippe YVG, 2005, ARCH BIOCHEM BIOPHYS, V433, P266, DOI 10.1016/j.abb.2004.09.018; Schoenfelder SMK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003606; Senoo A, 2010, BIOSCI BIOTECH BIOCH, V74, P415, DOI 10.1271/bbb.90644; Shatalin K, 2021, SCIENCE, V372, P1169, DOI 10.1126/science.abd8377; Shomura Y, 2012, PROTEIN SCI, V21, P707, DOI 10.1002/pro.2058; Soutourina O, 2009, MOL MICROBIOL, V73, P194, DOI 10.1111/j.1365-2958.2009.06760.x; SRITHARAN V, 1989, EUR J BIOCHEM, V180, P587, DOI 10.1111/j.1432-1033.1989.tb14685.x; Tabata K, 2005, J BACTERIOL, V187, P5195, DOI 10.1128/JB.187.15.5195-5202.2005; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	64	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102392	10.1016/j.jbc.2022.102392	http://dx.doi.org/10.1016/j.jbc.2022.102392			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5J0EG	35988643	gold, Green Published			2022-12-26	WOS:000868720100002
J	Munroe, SEM; McInerney, FA; Guerin, GR; Andrae, JW; Welti, N; Caddy-Retalic, S; Atkins, R; Sparrow, B				Munroe, Samantha E. M.; McInerney, Francesca A.; Guerin, Greg R.; Andrae, Jake W.; Welti, Nina; Caddy-Retalic, Stefan; Atkins, Rachel; Sparrow, Ben			Plant families exhibit unique geographic trends in C-4 richness and cover in Australia	PLOS ONE			English	Article							SEASONAL WATER AVAILABILITY; RELATIVE ABUNDANCE; ECOLOGICAL CHARACTERISTICS; PHOTOSYNTHETIC PATHWAYS; NATURAL OCCURRENCE; GROWTH-RESPONSES; FUNCTIONAL TYPES; ATMOSPHERIC CO2; ELEVATED CO2; CLIMATE	Numerous studies have analysed the relationship between C-4 plant cover and climate. However, few have examined how different C-4 taxa vary in their response to climate, or how environmental factors alter C-4:C-3 abundance. Here we investigate (a) how proportional C(4 )plant cover and richness (relative to C-3) responds to changes in climate and local environmental factors, and (b) if this response is consistent among families. Proportional cover and richness of C-4 species were determined at 541 one-hectare plots across Australia for 14 families. C-4 cover and richness of the most common and abundant families were regressed against climate and local parameters. C-4 richness and cover in the monocot families Poaceae and Cyperaceae increased with latitude and were strongly positively correlated with January temperatures, however C-4 Cyperaceae occupied a more restricted temperature range. Seasonal rainfall, soil pH, soil texture, and tree cover modified proportional C-4 cover in both families. Eudicot families displayed considerable variation in C-4 distribution patterns. Proportional C-4 Euphorbiaceae richness and cover were negatively correlated with increased moisture availability (i.e. high rainfall and low aridity), indicating they were more common in dry environments. Proportional C-4 Chenopodiaceae richness and cover were weakly correlated with climate and local environmental factors, including soil texture. However, the explanatory power of C-4 Chenopodiaceae models were poor, suggesting none of the factors considered in this study strongly influenced Chenopodiaceae distribution. Proportional C-4 richness and cover in Aizoaceae, Amaranthaceae, and Portulacaceae increased with latitude, suggesting C-4 cover and richness in these families increased with temperature and summer rainfall, but sample size was insufficient for regression analysis. Results demonstrate the unique relationships between different C-4 taxa and climate, and the significant modifying effects of environmental factors on C-4 distribution. Our work also revealed C-4 families will not exhibit similar responses to local perturbations or climate.	[Munroe, Samantha E. M.; Guerin, Greg R.; Caddy-Retalic, Stefan; Sparrow, Ben] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [Munroe, Samantha E. M.; Guerin, Greg R.; Sparrow, Ben] Univ Adelaide, TERN, Adelaide, SA, Australia; [McInerney, Francesca A.; Andrae, Jake W.; Atkins, Rachel] Univ Adelaide, Sch Phys Sci, Adelaide, SA, Australia; [McInerney, Francesca A.; Andrae, Jake W.; Atkins, Rachel] Univ Adelaide, Sprigg Geobiol Ctr, Adelaide, SA, Australia; [Welti, Nina] CSIRO Agr & Food, Urrbrae, SA, Australia; [Caddy-Retalic, Stefan] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia	University of Adelaide; University of Adelaide; University of Adelaide; University of Adelaide; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Sydney	Munroe, SEM (corresponding author), Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia.; Munroe, SEM (corresponding author), Univ Adelaide, TERN, Adelaide, SA, Australia.	samantha.munroe@adelaide.edu.au	Welti, Nina/S-2121-2016	Welti, Nina/0000-0001-9966-5915; McInerney, Francesca/0000-0002-2020-6650; Munroe, Samantha/0000-0001-7827-1028	Australian government; AMP Foundation; AMP Tomorrow Fund; Australian Research Council Future Fellowship [FT110100100793]; Australian Government Research Training Program; University of Adelaide Faculty of Sciences Divisional scholarships	Australian government(Australian GovernmentCGIAR); AMP Foundation; AMP Tomorrow Fund; Australian Research Council Future Fellowship(Australian Research Council); Australian Government Research Training Program(Australian Government); University of Adelaide Faculty of Sciences Divisional scholarships	TERN is funded by the Australian government through the National Collaborative Research Infrastructure Strategy(https://www.dese.gov.au/ncris).Additional financial support for this project was from the AMP Foundation and the AMP Tomorrow Fund (https://www.ampstomorrowfund.com.au) awarded to S.E.M.M, and Australian Research Council Future Fellowship FT110100100793) awarded to F.A.M. https://www.arc.gov.au/grants/discovery-program/futurefellowships), and Australian Government Research Training Program and University of Adelaide Faculty of Sciences Divisional scholarships (https://www.adelaide.edu.au/) awarded to J.W.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JT., 1987, BIOCH PLANTS COMPREH, P132; Angelo CL, 2015, BOTANY, V93, P9, DOI 10.1139/cjb-2014-0075; Awada T, 2003, CAN J PLANT SCI, V83, P533, DOI 10.4141/P02-129; BATANOUNY KH, 1991, OECOLOGIA, V87, P565, DOI 10.1007/BF00320421; Bivand RS, 2008, USE R, P1; Bond WJ, 2008, ANNU REV ECOL EVOL S, V39, P641, DOI 10.1146/annurev.ecolsys.39.110707.173411; Breheny P., 2020, R PACKAGE VISREG; Bromham L, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0642; Cabido M, 2008, J BIOGEOGR, V35, P131, DOI 10.1111/j.1365-2699.2007.01760.x; Collatz GJ, 1998, OECOLOGIA, V114, P441, DOI 10.1007/s004420050468; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Douma JC, 2019, METHODS ECOL EVOL, V10, P1412, DOI 10.1111/2041-210X.13234; Edwards EJ, 2008, ECOL LETT, V11, P266, DOI 10.1111/j.1461-0248.2007.01144.x; Edwards EJ, 2010, P NATL ACAD SCI USA, V107, P2532, DOI 10.1073/pnas.0909672107; EHLERINGER JR, 1978, OECOLOGIA, V31, P255, DOI 10.1007/BF00346246; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; Epstein HE, 2002, J BIOGEOGR, V29, P875, DOI 10.1046/j.1365-2699.2002.00701.x; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Feldman SR, 2008, GLOBAL ECOL BIOGEOGR, V17, P708, DOI 10.1111/j.1466-8238.2008.00403.x; Griffith DM, 2017, J BIOGEOGR, V44, P2564, DOI 10.1111/jbi.13061; Griffith DM, 2015, GLOBAL ECOL BIOGEOGR, V24, P304, DOI 10.1111/geb.12265; Griffith DM., 2019, GRASSMAPR R PACKAGE; Guerin GR., AUSPLOTSR TERN AUSPL; Harwood T., 9S CLIMATOLOGY CONTI; Hasegawa S, 2018, J ECOL, V106, P1483, DOI 10.1111/1365-2745.12943; Hattersley P. W., 1992, Desertified grasslands: their biology and management. Papers presented at an International Symposium, London, 27, 28 February and 1 March 1991., P181; HATTERSLEY PW, 1983, OECOLOGIA, V57, P113, DOI 10.1007/BF00379569; James JJ, 2005, J ECOL, V93, P113, DOI 10.1111/j.0022-0477.2004.00948.x; Kadereit G, 2012, P ROY SOC B-BIOL SCI, V279, P3304, DOI 10.1098/rspb.2012.0440; Kalapos T, 1997, PHOTOSYNTHETICA, V33, P227, DOI 10.1023/A:1022112329990; Kanai R., 1999, C4 PLANT BIOL, P49, DOI [10.5860/choice.36-6275, DOI 10.5860/CHOICE.36-6275, DOI 10.1016/B978-012614440-6/50004-5]; Kissel D. E., 1985, Fertilizer technology and use, P153; Lambers H., 2008, PLANTS PSYCHOL ECOLO; Matthews JL., 2019, MODERN STAT METHODS, P163, DOI DOI 10.1007/978-3-030-11431-2_9; McDougall KL, 2008, AUST J BOT, V56, P461, DOI 10.1071/BT08036; McFadden D., 1977, COWLES FDN RES EC, V474; Moore NA, 2019, NEW PHYTOL, V221, P1424, DOI 10.1111/nph.15480; Munroe S, 2021, J VEG SCI, V32, DOI 10.1111/jvs.13046; Munroe SEM, 2021, SCI DATA, V8, DOI 10.1038/s41597-021-00877-z; Murphy BP, 2007, GLOBAL ECOL BIOGEOGR, V16, P160, DOI 10.1111/j.1466-8238.2006.00285.x; Nippert JB, 2007, OIKOS, V116, P1017, DOI [10.1111/j.2007.0030-1299.15630.x, 10.1111/j.0030-1299.2007.15630.x]; Niu SL, 2008, J EXP BOT, V59, P1431, DOI 10.1093/jxb/ern051; OGREN WL, 1984, ANNU REV PLANT PHYS, V35, P415, DOI 10.1146/annurev.pp.35.060184.002215; Paruelo JM, 1996, ECOL APPL, V6, P1212, DOI 10.2307/2269602; Pau S, 2013, GLOBAL CHANGE BIOL, V19, P184, DOI 10.1111/gcb.12037; Peterson DW, 2007, J VEG SCI, V18, P3, DOI 10.1111/j.1654-1103.2007.tb02510.x; Pinto H, 2014, J EXP BOT, V65, P3669, DOI 10.1093/jxb/eru155; Powell RL, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00162.1; Pyankov VI, 2000, OECOLOGIA, V123, P15, DOI 10.1007/s004420050985; Pyankov VI, 2010, BOT J LINN SOC, V163, P283, DOI 10.1111/j.1095-8339.2010.01062.x; R Core Team, 2021, R LANGUAGE ENV STAT; Reich PB, 2018, SCIENCE, V360, P317, DOI 10.1126/science.aas9313; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; Sage RF, 2016, J EXP BOT, V67, P4039, DOI [10.1093/jxb/erx005, 10.1093/jxb/erw156]; Sage RF, 2014, PLANT CELL ENVIRON, V37, P1037, DOI 10.1111/pce.12246; Sage RF, 2012, ANNU REV PLANT BIOL, V63, P19, DOI 10.1146/annurev-arplant-042811-105511; Saslis-Lagoudakis CH, 2015, ANN BOT-LONDON, V115, P343, DOI 10.1093/aob/mcu248; Still CJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001807; Stock WD, 2004, AUSTRAL ECOL, V29, P313, DOI 10.1111/j.1442-9993.2004.01368.x; STOWE LG, 1978, AM NAT, V112, P609, DOI 10.1086/283301; TAKEDA T, 1985, BOT MAG TOKYO, V98, P393, DOI 10.1007/BF02488504; Taub DR, 2000, AM J BOT, V87, P1211, DOI 10.2307/2656659; Taylor SH, 2018, J EXP BOT, V69, P2731, DOI 10.1093/jxb/ery095; UENO O, 1992, OECOLOGIA, V89, P195, DOI 10.1007/BF00317218; Viscarra Rossel R, RELEASE 1 V3 ED2014; Vogel J., 1993, STABLE ISOTOPES PLAN, P26; von Fischer JC, 2008, GLOBAL CHANGE BIOL, V14, P1141, DOI 10.1111/j.1365-2486.2008.01552.x; Wan CSM, 2001, CAN J BOT, V79, P474, DOI 10.1139/cjb-79-4-474; Wang K, 2020, PLANT BIOLOGY, V22, P221, DOI 10.1111/plb.13064; Wang RZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep27977; White A., 2012, AUSPLOTS RANGELANDS; Winslow JC, 2003, ECOL MODEL, V163, P153, DOI 10.1016/S0304-3800(02)00415-5; Wittmer MHOM, 2010, GLOBAL CHANGE BIOL, V16, P605, DOI 10.1111/j.1365-2486.2009.02033.x; Xie QY, 2022, REMOTE SENS ENVIRON, V273, DOI 10.1016/j.rse.2022.112983	75	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0271603	10.1371/journal.pone.0271603	http://dx.doi.org/10.1371/journal.pone.0271603			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994485	gold, Green Published			2022-12-26	WOS:000877093400010
J	Bjoernsbo, KS; Joensen, AM; Joergensen, T; Lundbye-Christensen, S; Bysted, A; Christensen, T; Fagt, S; Capewell, S; O'Flaherty, M				Bjoernsbo, Kirsten Schroll; Joensen, Albert Marni; Joergensen, Torben; Lundbye-Christensen, Soeren; Bysted, Anette; Christensen, Tue; Fagt, Sisse; Capewell, Simon; O'Flaherty, Martin			Quantifying benefits of the Danish transfat ban for coronary heart disease mortality 1991-2007: Socioeconomic analysis using the IMPACTsec model	PLOS ONE			English	Article							FATTY-ACIDS; POLICIES; BURDEN	Denmark has experienced a remarkable reduction in CVD mortality over recent decades. The scale of the health contribution from the Danish regulation on industrially produced trans fatty acid (ITFA) has therefore long been of interest. Thus the objective was to determine health and equity benefits of the Danish regulation on ITFA content in Danish food, by quantifying the relative contributions of changes in ITFA intake, other risk factors and treatments on coronary heart disease (CHD) mortality decline from 1991 to 2007 in Denmark, stratified by socioeconomic group. To evaluate the effects of the ITFA ban (Danish Order no. 160 of March 2003) the Danish IMPACT sEc model was extended to quantify reductions in CHD deaths attributable to changes in ITFA (%E) intake between 1991-2007. Population counts were obtained from the Danish Central Office of Civil Registration, financial income from Statistics Denmark and ITFA intake from Dan-MONICA III (1991) and DANSDA (2005-2008). Participants were adults aged 25-84 years living in Denmark in 1991 and 2007, stratified by socioeconomic quintiles. The main outcome measure was CHD deaths prevented or postponed (DPP). Mean energy intake from ITFA was decimated between 1991 and 2007, falling from 1.1%E to 0.1%E in men and from 1.0%E to 0-1%E in women. Approximately 1,191 (95% CI 989-1,409) fewer CHD deaths were attributable to the ITFA reduction, representing some 11% of the overall 11,100 mortality fall observed in the period. The greatest attributable mortality falls were seen in the most deprived quintiles. Adding ITFA data to the original IMPACTsec model improved the overall model fit from 64% to 73%. In conclusion: Denmark's mandatory elimination of ITFA accounted for approximately 11% of the substantial reduction in CHD deaths observed between 1991 and 2007. The most deprived groups benefited the most, thus reducing inequalities. Adopting the Danish ITFA regulatory approach elsewhere could substantially reduce CHD mortality while improving health equity.	[Bjoernsbo, Kirsten Schroll; Joergensen, Torben] Bispebjerg & Frederiksberg Hosp, Ctr Clin Res & Prevent, Frederiksberg, Denmark; [Joensen, Albert Marni] North Denmark Reg Hosp, Dept Cardiol, Hjorring, Denmark; [Joergensen, Torben] Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, Copenhagen, Denmark; [Joergensen, Torben] Aalborg Univ, Fac Med, Aalborg, Denmark; [Lundbye-Christensen, Soeren] Aalborg Univ Hosp, Unit Clin Biostat, Aalborg, Denmark; [Bysted, Anette; Christensen, Tue; Fagt, Sisse] Tech Univ Denmark, Natl Food Inst, Lyngby, Denmark; [Capewell, Simon; O'Flaherty, Martin] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool, Merseyside, England	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Aalborg University; Aalborg University; Aalborg University Hospital; Technical University of Denmark; University of Liverpool	Bjoernsbo, KS (corresponding author), Bispebjerg & Frederiksberg Hosp, Ctr Clin Res & Prevent, Frederiksberg, Denmark.	Kirsten.Bjoernsbo@regionh.dk		Fagt, Sisse/0000-0003-0765-5555; Christensen, Tue/0000-0001-7693-7359; Bjoernsbo, Kirsten Schroll/0000-0001-7232-8310; Bysted, Anette/0000-0003-2500-8044	Danish Health Foundation "Helsefonden [18-B-0355]	Danish Health Foundation "Helsefonden	TJ Creation of the Transfat database was funded by the Danish Health Foundation "Helsefonden 18-B-0355" https://helsefonden.dk/Helsefonden had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen K, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4583; [Anonymous], 1985, WHO TECH REP SER, P1; [Anonymous], OFFICIAL J EUROPEAN; Bajekal M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001237; Bysted A, 2009, EUR J LIPID SCI TECH, V111, P574, DOI 10.1002/ejlt.200800293; Capewell S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000320; Downs SM, 2013, B WORLD HEALTH ORGAN, V91, P262, DOI 10.2471/BLT.12.111468; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Hotchkiss JW, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1088; Hyseni L, 2017, B WORLD HEALTH ORGAN, V95, P821, DOI [10.2471/BLT.16.189795, 10.2471/blt.16.189795]; Joensen AM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194793; Korsgaard Thomsen Kristian, 1995, Am J Geriatr Cardiol, V4, P31; Leth T, 2006, ATHEROSCLEROSIS SUPP, V7, P53, DOI 10.1016/j.atherosclerosissup.2006.04.019; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; O'Flaherty M, 2012, B WORLD HEALTH ORGAN, V90, P522, DOI 10.2471/BLT.11.092643; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Restrepo BJ, 2016, AM J PREV MED, V50, P69, DOI 10.1016/j.amepre.2015.06.018; Roth GA, 2020, J AM COLL CARDIOL, V76, P2982, DOI 10.1016/j.jacc.2020.11.010; Rubinstein A, 2015, B WORLD HEALTH ORGAN, V93, P614, DOI 10.2471/BLT.14.150516; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; WHO, WHOPRP181	22	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0272744	10.1371/journal.pone.0272744	http://dx.doi.org/10.1371/journal.pone.0272744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976852	Green Published, gold			2022-12-26	WOS:000847227000056
J	Consuegra, A; Lutz, K; Exadaktylos, AK; Z'Graggen, WJ; Hasler, RM				Consuegra, Alberto; Lutz, Katharina; Exadaktylos, Aristomenis K.; Z'Graggen, Werner J.; Hasler, Rebecca M.			Traumatic brain injury in the elderly after a skiing accident: A retrospective cohort study in a level 1 emergency department in Switzerland	PLOS ONE			English	Article							CHRONIC SUBDURAL-HEMATOMA; CLINICAL CHARACTERISTICS; OUTCOMES; IMPACT	Background Skiing is a very popular sport worldwide, with increasing trends over the past decades. This study aimed to evaluate the importance of traumatic brain injury (TBI), especially in the elderly, after a ski accident, and to describe its short-term repercussions. Methodology Patients were analyzed who were admitted to our neurotrauma center from 2012-2018 after a head trauma while skiing. Three different age groups were differentiated and analyzed for the severity of TBI depending on the initial Glasgow Coma Scale as the primary outcome and as secondary outcomes need and type of surgery, Glasgow Outcome Score, preexisting use of anticoagulant or antiplatelet drugs, time to presentation, and pattern of brain injury. TBI severity was adjusted to the time to initial medical consultation. Results No significant difference in TBI severity was found when comparing the middle (>29-54) and older (>= 54) age groups to the reference group <30 years (OR:0.45, p = 0.127; OR:0.46, p = 0.17). Acute subdural hemorrhage was present in 21.2% of the >= 55 group and 14.5% of the 30-54 age group, compared to 12.8% of the youngest group (p = <0.001). Overall, 39.4% of the patients in the >= 55 group and 8.1% of the 30-54 age group presented with chronic subdural hemorrhage, whereas none of the youngest patients did (p = <0.001). Conclusion No differences were observed in terms of TBI severity between age groups after acute trauma. Nonetheless, a different pattern of head injury after TBI in older patients was demonstrated. Accordingly, the management differs for these TBIs compared to those of younger patients.	[Consuegra, Alberto; Lutz, Katharina; Z'Graggen, Werner J.] Univ Bern, Bern Univ Hosp, Dept Neurosurg, Bern, Switzerland; [Exadaktylos, Aristomenis K.; Hasler, Rebecca M.] Univ Bern, Bern Univ Hosp, Dept Emergency Med, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Consuegra, A (corresponding author), Univ Bern, Bern Univ Hosp, Dept Neurosurg, Bern, Switzerland.	aconsuegralobato@gmail.com		Consuegra, Alberto/0000-0002-7904-5572				Acton P., 1988, J AM GERIATR SOC, V36; Amirjamshidi A, 2007, J CLIN NEUROSCI, V14, P1240, DOI 10.1016/j.jocn.2006.03.030; Andreotti F, 2015, EUR HEART J, V36, P3238, DOI 10.1093/eurheartj/ehv304; BASPO, 2008, SPORT SCHWEIZ 2008 F; Bobeff EJ, 2019, WORLD NEUROSURG, V128, pE129, DOI 10.1016/j.wneu.2019.04.060; Bundesamt fur Sport BASPO, 2014, SPORT SCHWEIZ 2014 O, P60; CAMEL M, 1986, J NEUROSURG, V65, P183, DOI 10.3171/jns.1986.65.2.0183; Cheng SY, 2014, INT J GERONTOL, V8, P37, DOI 10.1016/j.ijge.2014.01.001; Derrer P., 2018, BFU GRUNDLAGEN, V1, P12; Ernestus RI, 1997, SURG NEUROL, V48, P220, DOI 10.1016/S0090-3019(97)80031-6; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Gaist D, 2017, JAMA-J AM MED ASSOC, V317, P836, DOI 10.1001/jama.2017.0639; Garza N, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00112; Hunter RE., 2000, SPORTS MED, V27, P381; JENNETT B, 1975, LANCET, V1, P480; Karibe H, 2017, NEUROL MED-CHIR, V57, P418, DOI 10.2176/nmc.st.2017-0058; Kitya D, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.7.FOCUS18253; Kovarik J, 2013, PATHOBIOLOGY, V80, P275, DOI 10.1159/000346960; Leroy HA, 2015, J CLIN NEUROSCI, V22, P1895, DOI 10.1016/j.jocn.2015.03.064; Liu J, 2014, NEURAL REGEN RES, V9, P1222, DOI 10.4103/1673-5374.135330; Merzo A, 2016, ACTA NEUROCHIR, V158, P125, DOI 10.1007/s00701-015-2639-6; Poulsen FR, 2016, PHARMACOEPIDEM DR S, V25, P1253, DOI 10.1002/pds.4058; Rauhala M, 2020, J NEUROSURG, V132, P1147, DOI 10.3171/2018.12.JNS183035; Scotti P, 2020, J NEUROSURG, V133, P486, DOI 10.3171/2019.4.JNS19252; Sigurdsson S, 2012, NEUROIMAGE, V59, P3862, DOI 10.1016/j.neuroimage.2011.11.024; Sun H, 2017, WORLD NEUROSURG, V104, P909, DOI 10.1016/j.wneu.2017.05.108; SUVA, 2019, UNFALLSTATISTIK UVG, P1; Telgheder ZL, 2020, ORTHOP CLIN N AM, V51, P461, DOI 10.1016/j.ocl.2020.06.004; Toi H, 2018, J NEUROSURG, V128, P222, DOI 10.3171/2016.9.JNS16623; Wan XY, 2016, WORLD NEUROSURG, V89, P147, DOI 10.1016/j.wneu.2016.01.084; Wang JW, 2018, MED SCI MONITOR, V24, P3256, DOI 10.12659/MSM.908728	31	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0273168	10.1371/journal.pone.0273168	http://dx.doi.org/10.1371/journal.pone.0273168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976893	Green Published, gold			2022-12-26	WOS:000847227000082
J	Seomun, G; Ban, S; Park, J				Seomun, GyeongAe; Ban, Suyeon; Park, Jinkyung			Identifying the knowledge structure of electromagnetic fields and health research: Text network analysis and topic modeling	PLOS ONE			English	Article							RESIDENTIAL EXPOSURE; CHILDHOOD LEUKEMIA; RADIATION; PHONES; MOBILE; RISK; COIL; MRI	Background With technological and scientific advancement, people are being increasingly exposed to electromagnetic fields, particularly from portable devices such as mobile phones. However, there is currently no consensus regarding the health effects of electromagnetic field exposure, despite the large amount of research conducted on this topic. This study aimed to understand the knowledge structure and trend of electromagnetic field and health research through text network analysis and topic modeling. Methods PubMed, Embase, and Cochrane were searched, and 3,880 articles published before June 2021 were identified. We explored the main keywords and research topics regarding electromagnetic fields and human health by constructing a network of keywords. A social network analysis program was used to analyze the data, visualize the network, and perform topic modeling. Results Four keywords, "exposure," "effect," "cell," and "cancer," were highly correlated to other keywords and formed each colony in the knowledge structure of research on electromagnetic fields and health. Five topics were derived from topic modeling: cell research, research on the adaption of MRI, health effects of mobile phones, pain therapy, and exposure measurement. Cell research has been continuously performed, and many studies have been conducted on the health effects of mobile phones since 2000. Conclusions These findings will assist in gaining insights into and understanding changes in research on the health effects of electromagnetic fields, and suggest important areas and directions for future research.	[Seomun, GyeongAe; Ban, Suyeon] Korea Univ, Syst, Coll Nursing, BK21 FOUR R&E Ctr Learning Hlth, Seoul, South Korea; [Park, Jinkyung] Chonnam Natl Univ, Coll Nursing, Gwangju, South Korea	Korea University; Chonnam National University	Park, J (corresponding author), Chonnam Natl Univ, Coll Nursing, Gwangju, South Korea.	carpe@jnu.ac.kr		PARK, Jinkyung/0000-0001-8538-0476	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2018R1D1A1B07051103]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of KoreaNational Research Council for Economics, Humanities & Social Sciences, Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (grant number: 2018R1D1A1B07051103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelillo IF, 1999, B WORLD HEALTH ORGAN, V77, P906; Bartolucci AA, 2010, EVIDENCE-BASED PRACTICE: TOWARD OPTIMIZING CLINICAL OUTCOMES, P17, DOI 10.1007/978-3-642-05025-1_2; BASSETT CAL, 1984, ORTHOP CLIN N AM, V15, P61; Brainard GC, 1999, J PINEAL RES, V26, P65, DOI 10.1111/j.1600-079X.1999.tb00568.x; Calderon C, 2017, ENVIRON INT, V101, P59, DOI 10.1016/j.envint.2017.01.005; Chou C., 1995, BIOMEDICAL ENG HDB, V2nd; CRD, 2009, CRDS GUIDANCE UNDERT; Ding Y, 2001, INFORM PROCESS MANAG, V37, P817, DOI 10.1016/S0306-4573(00)00051-0; Drieger P, 2013, PROCD SOC BEHV, V79, P4, DOI 10.1016/j.sbspro.2013.05.053; Golestanirad L, 2017, NEUROIMAGE, V147, P577, DOI 10.1016/j.neuroimage.2016.12.056; Green AC, 2017, HEALTH PHYS, V112, P305, DOI 10.1097/HP.0000000000000654; Hardell L, 2017, INT J ONCOL, V51, P405, DOI 10.3892/ijo.2017.4046; He Q, 1999, LIBR TRENDS, V48, P133; IARC, 2011, IARC CLASS RAD EL FI; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2013, IARC Monogr Eval Carcinog Risks Hum, V102, P1; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2002, IARC MONOGRAPHS EVAL, VVolume 80, DOI DOI 10.1002/BEM.22228; Kheifets L, 2005, PEDIATRICS, V116, pE303, DOI 10.1542/peds.2004-2541; Khurana VG, 2009, SURG NEUROL, V72, P205, DOI 10.1016/j.surneu.2009.01.019; Lee Soosang, 2014, [Journal of the Korean Society for Information Management, 정보관리학회지], V31, P49, DOI 10.3743/KOSIM.2014.31.4.049; LERCH IA, 1983, INT J RADIAT ONCOL, V9, P939, DOI 10.1016/0360-3016(83)90022-6; Martens AL, 2016, SCI TOTAL ENVIRON, V550, P987, DOI 10.1016/j.scitotenv.2016.01.194; Mathur-De Vre R, 1987, Arch Belg, V45, P394; Park Jahyun, 2013, [Journal of the Korean Society for Information Management, 정보관리학회지], V30, P7, DOI 10.3743/KOSIM.2013.30.1.007; Peng LH, 2020, BIOELECTROMAGNETICS, V41, P323, DOI 10.1002/bem.22271; Schuz J, 2016, BIOELECTROMAGNETICS, V37, P183, DOI 10.1002/bem.21963; Seomun G, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251628; Sneed N V, 1990, J Gerontol Nurs, V16, P26; Tettamanti G, 2020, ENVIRON INT, V140, DOI 10.1016/j.envint.2020.105687; Turner MC, 2019, EPIDEMIOLOGY, V30, P145, DOI 10.1097/EDE.0000000000000932; Valdez D, 2021, HEALTH PROMOT PRACT, V22, P309, DOI 10.1177/1524839921999050; Vijayalaxmi, 2009, INT J RADIAT BIOL, V85, P196, DOI 10.1080/09553000902748575; Vila J., 2014, OCCUP ENVIRON MED, V71, DOI [10.1136/oemed-2014-102362.110, DOI 10.1136/OEMED-2014-102362.110]; Wang B, 2014, 2014 11TH INTERNATIONAL CONFERENCE ON FUZZY SYSTEMS AND KNOWLEDGE DISCOVERY (FSKD), P756, DOI 10.1109/FSKD.2014.6980931; WHO (World Health Organization), 2010, WHO RES AG RAD FIELD; Woo S, 2020, AM J ROENTGENOL, V214, P597, DOI 10.2214/AJR.19.21836; World Health Organization, 1997, INT EMF PROJECT HLTH; Yang XT, 2020, PHYS THER, V100, P1118, DOI 10.1093/ptj/pzaa054; Zhang JL, 2017, ADV INTEL SYS RES, V132, P300	38	0	0	7	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0273005	10.1371/journal.pone.0273005	http://dx.doi.org/10.1371/journal.pone.0273005			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976897	Green Published, gold			2022-12-26	WOS:000847227000069
J	White, TM; Stanfield, BA; Bonavita, CM; Rudd, JS; Cardin, RD				White, Timothy M.; Stanfield, Brent A.; Bonavita, Cassandra M.; Rudd, Jared S.; Cardin, Rhonda D.			Development of a mouse salivary gland- derived mesenchymal cell line for immunological studies of murine cytomegalovirus	PLOS ONE			English	Article							STROMAL CELLS; INFECTION; RECEPTOR; GROWTH	The salivary glands are a crucial site of replication for human cytomegalovirus (HCMV) and its murine counterpart, murine cytomegalovirus (MCMV). Studies of MCMV often involve the use of BALB/c strain mice, but most in vitro assays are carried out in the NIH 3T3 cell line, which is derived from Swiss Albino mice. This report describes a BALB/c-derived mouse salivary gland cell line immortalized using the SV40 large T antigen. Cells stained positive for PDGFR1 and negative for E-cadherin and PECAM-1, indicating mesenchymal origin. This cell line, which has been named murine salivary gland mesenchymal (mSGM), shows promise as a tool for ex vivo immunological assays due to its MHC haplotype match with the BALB/c mouse strain. In addition, plaque assays using mSGM rather than NIH 3T3 cells are significantly more sensitive for detecting low concentrations of MCMV particles. Finally, it is demonstrated that mSGM cells express all 3 BALB/c MHC class I isotypes and are susceptible to T cell-mediated ex vivo cytotoxicity assays, leading to many possible uses in immunological studies of MCMV.	[White, Timothy M.; Stanfield, Brent A.; Bonavita, Cassandra M.; Rudd, Jared S.; Cardin, Rhonda D.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA; [Bonavita, Cassandra M.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Rudd, Jared S.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; University of California System; University of California Davis; University of California System; University of California San Diego	Cardin, RD (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.	rhonda.cardin@pfizer.com		White, Timothy/0000-0003-1481-3013	NSTP Fellowship United States Department of Agriculture Animal and Plant Health Inspection Service [AP19VSNL00C037]; LSU School of Veterinary Medicine Startup Fund	NSTP Fellowship United States Department of Agriculture Animal and Plant Health Inspection Service; LSU School of Veterinary Medicine Startup Fund	TMW & RDC Grant AP19VSNL00C037 NSTP Fellowship United States Department of Agriculture Animal and Plant Health Inspection Service https://www.aphis.usda.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. RDC LSU School of Veterinary Medicine Startup Fund https://www.lsu.edu/vetmed/index.php The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bonavita CM, 2021, J VIROL METHODS, V297, DOI 10.1016/j.jviromet.2021.114270; Bonavita CM, 2020, VIRAL IMMUNOL, V33, P237, DOI 10.1089/vim.2020.0007; CARDIN RD, 1995, VIROLOGY, V209, P236, DOI 10.1006/viro.1995.1249; Cardin RD, 2009, J VIROL, V83, P7590, DOI 10.1128/JVI.00386-09; DELVAL M, 1989, CELL, V58, P305, DOI 10.1016/0092-8674(89)90845-3; HODGKIN PD, 1988, J VIROL METHODS, V22, P215, DOI 10.1016/0166-0934(88)90104-8; Holtappels R, 2002, J VIROL, V76, P151, DOI 10.1128/JVI.76.1.151-164.2002; JAINCHIL.JL, 1969, J VIROL, V4, P549, DOI 10.1128/JVI.4.5.549-553.1969; Lagenaur LA., 1994, STRUCTURE FUNCTION M, V68, P11; Leclercq G, 2021, J IMMUNOTHER CANCER, V9, DOI 10.1136/jitc-2021-002582; Lemmermann NAW, 2011, VIRUS RES, V157, P161, DOI 10.1016/j.virusres.2010.09.022; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Matuck BF, 2021, J PATHOL, V254, P239, DOI 10.1002/path.5679; Mocarski Jr E, 2013, FIELDS VIROLOGY, V2, P1960; Moraes MP, 2001, BIOTECHNIQUES, V31, P1050, DOI 10.2144/01315st05; POMEROY C, 1991, J VIROL, V65, P3330, DOI 10.1128/JVI.65.6.3330-3334.1991; REDDEHASE MJ, 1989, NATURE, V337, P651, DOI 10.1038/337651a0; ROSE SM, 1980, J IMMUNOL, V125, P2044; Scabini M, 2011, APOPTOSIS, V16, P198, DOI 10.1007/s10495-010-0553-1; Soland MA, 2014, AM J TRANSPLANT, V14, P820, DOI 10.1111/ajt.12642; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; STODDART CA, 1994, J VIROL, V68, P6243, DOI 10.1128/JVI.68.10.6243-6253.1994; Walton SM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002214; WISE TG, 1979, J GEN VIROL, V44, P551, DOI 10.1099/0022-1317-44-2-551; Yamamoto S, 2008, J BIOL CHEM, V283, P23139, DOI 10.1074/jbc.M710308200	26	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0265479	10.1371/journal.pone.0265479	http://dx.doi.org/10.1371/journal.pone.0265479			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976883	Green Published, Green Submitted, gold			2022-12-26	WOS:000847227000003
J	Vieira, JMF; Zamproni, LN; Wendt, CHC; de Miranda, KR; Lindoso, RS; Han, SW				Freitas Vieira, Juliana Maira; Zamproni, Laura Nicoleti; Wendt, Camila H. C.; de Miranda, Kildare Rocha; Lindoso, Rafael Soares; Han, Sang Won			Overexpression of mir-135b and mir-210 in mesenchymal stromal cells for the enrichment of extracellular vesicles with angiogenic factors	PLOS ONE			English	Article							EXOSOMES; DISEASE; THERAPY; IMPROVE; INJURY	Extracellular vesicles (EVs) are known as molecular carriers involved in cell communication and the regulation of (patho)physiological processes. miRNAs and growth factors are the main contents of EVs which make them a good candidate for the treatment of diseases caused by ischemia, but the low production of EVs by a cell producer and a significant variation of the molecular contents in EVs according to the cell source are the main limitations of their widespread use. Here, we show how to improve the therapeutic properties of mesenchymal stromal cell (MSC)-derived EVs (MSC-EVs) by modifying MSCs to enrich these EVs with specific angiomiRs (miR-135b or miR-210) using lentiviral vectors carrying miR-135b or miR-210. MSCs were obtained from the mouse bone marrow and transduced with a corresponding lentivector to overexpress miR-135b or miR-210. The EVs were then isolated by ultracentrifugation and characterized using a flow cytometer and a nanoparticle tracking analyzer. The levels of 20 genes in the MSCs and 12 microRNAs in both MSCs and EVs were assessed by RT-qPCR. The proangiogenic activity of EVs was subsequently assessed in human umbilical vein endothelial cells (HUVECs). The results confirmed the overexpression of the respective microRNA in modified MSCs. Moreover, miR-135b overexpression upregulated miR-210-5p and follistatin, whereas the overexpression of miR-210 downregulated miR-221 and upregulated miR-296. The tube formation assay showed that EVs from MSCs overexpressing miR-210-5p (EVmiR210) significantly promoted tubular structure formation in HUVECs. A significant increase in angiogenic proteins (PGF, endothelin 1, and artemin) and genes (VEGF, activin A, and IGFBP1) in HUVECs treated with VEmiR210 justifies the better tubular structure formation of these cells compared with that of EVmiR135b-treated HUVECs, which showed upregulated expression of only artemin. Collectively, our results show that the EV cargo can be modified by lentiviral vectors to enrich specific miRNAs to achieve a specific angiogenic potential.	[Freitas Vieira, Juliana Maira; Han, Sang Won] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil; [Zamproni, Laura Nicoleti] Univ Fed Sao Paulo, Dept Biochem, Sao Paulo, Brazil; [Wendt, Camila H. C.; de Miranda, Kildare Rocha; Lindoso, Rafael Soares] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil; [Wendt, Camila H. C.; de Miranda, Kildare Rocha] Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging CENABIO, Rio De Janeiro, Brazil; [Lindoso, Rafael Soares] Univ Fed Rio de Janeiro, Natl Inst Sci & Technol Regenerat Med REGENERA, Rio De Janeiro, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Han, SW (corresponding author), Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil.; Lindoso, RS (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.; Lindoso, RS (corresponding author), Univ Fed Rio de Janeiro, Natl Inst Sci & Technol Regenerat Med REGENERA, Rio De Janeiro, Brazil.	lindos@biof.ufrj.br; sang.han@unifesp.br		Soares Lindoso, Rafael/0000-0002-7297-0781	FAPESP [2015/20206-8, (2018/21072-3]; CNPQ [303646/2019-5]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	JMFV received a scholarship from FAPESP (2018/21072-3). This work was supported by FAPESP (2015/20206-8) and CNPQ (303646/2019-5).	Amend SR, 2016, JOVE-J VIS EXP, DOI 10.3791/53936; Aranda PS, 2012, ELECTROPHORESIS, V33, P366, DOI 10.1002/elps.201100335; Bai M, 2019, MOL THER, V27, P1772, DOI 10.1016/j.ymthe.2019.06.018; Bang OY, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00211; Barter MJ, 2015, STEM CELLS, V33, P3266, DOI 10.1002/stem.2093; Cabral Thiago, 2017, Int J Retina Vitreous, V3, P31, DOI 10.1186/s40942-017-0084-9; Carpentier G., 2012, ANGIOGENESIS ANAL IM; Collino Federica, 2019, Cell Physiol Biochem, V52, P1463, DOI 10.33594/000000102; Cunha FF, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt245; da Cunha FF, 2013, CYTOTHERAPY, V15, P820, DOI 10.1016/j.jcyt.2013.02.014; de Melo SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128922; Doeppner TR, 2015, STEM CELL TRANSL MED, V4, P1131, DOI 10.5966/sctm.2015-0078; Ferguson SW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19581-x; Guo L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/168358; Hui X, 2020, HUM HERED; Konoshenko MY, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8545347; Kordelas L, 2014, LEUKEMIA, V28, P970, DOI 10.1038/leu.2014.41; Kullo IJ, 2016, NEW ENGL J MED, V374, P861, DOI 10.1056/NEJMcp1507631; Landskroner-Eiger S, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006643; Leone P, 2019, J CLIN MED, V8, DOI 10.3390/jcm8122030; Mendt M, 2019, BONE MARROW TRANSPL, V54, P789, DOI 10.1038/s41409-019-0616-z; Moghiman T, 2021, HEART FAIL REV, V26, P205, DOI 10.1007/s10741-020-10001-9; Mori MA, 2019, CELL METAB, V30, P656, DOI 10.1016/j.cmet.2019.07.011; Mundra V, 2013, MOL PHARMACEUT, V10, P77, DOI 10.1021/mp3005148; Qadura M, 2018, STEM CELLS, V36, P161, DOI 10.1002/stem.2751; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rosca AM, 2018, ROMANIAN J MORPHOLOG, P59; Rose FF, 2009, HUM MOL GENET, V18, P997, DOI 10.1093/hmg/ddn426; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scholz D, 2003, MOL CELL BIOCHEM, V246, P57, DOI 10.1023/A:1023403928385; Sepporta MV, 2013, TARGET ONCOL, V8, P215, DOI 10.1007/s11523-013-0268-7; Tendera M, 2012, TURK KARDIYOLOJI DER, P5; Teng XM, 2015, CELL PHYSIOL BIOCHEM, V37, P2415, DOI 10.1159/000438594; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Umezu T, 2014, BLOOD, V124, P3748, DOI 10.1182/blood-2014-05-576116; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Wurdinger T, 2008, CANCER CELL, V14, P382, DOI 10.1016/j.ccr.2008.10.005; Zaccagnini G, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010129; Zhao AG, 2020, STEM CELLS INT, V2020, DOI 10.1155/2020/8825771; Zhu JH, 2011, AM J PATHOL, V179, P915, DOI 10.1016/j.ajpath.2011.04.008; Zou XY, 2016, AM J TRANSL RES, V8, P4289	41	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2022	17	8							e0272962	10.1371/journal.pone.0272962	http://dx.doi.org/10.1371/journal.pone.0272962			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4N3FI	35972944	gold, Green Published			2022-12-26	WOS:000853904500001
J	Ramasubramanian, B; Kim, J; Ke, YB; Li, Y; Zhang, CO; Promnares, K; Tanaka, KA; Birukov, KG; Karki, P; Birukova, AA				Ramasubramanian, Baalachandran; Kim, Junghyun; Ke, Yunbo; Li, Yue; Zhang, Chen-Ou; Promnares, Kamoltip; Tanaka, Kenichi A.; Birukov, Konstantin G.; Karki, Pratap; Birukova, Anna A.			Mechanisms of pulmonary endothelial permeability and inflammation caused by extracellular histone subunits H3 and H4	FASEB JOURNAL			English	Article						cytoskeleton; endothelial adhesion molecules; extracellular histones; inflammatory signaling; lung injury; pulmonary endothelial permeability	MULTIPLE ORGAN FAILURE; LUNG VASCULAR LEAK; BARRIER FUNCTION; THROMBIN GENERATION; CELL JUNCTIONS; MEDIATORS; TRAUMA; AFADIN; ENHANCEMENT; INVOLVEMENT	Extracellular DNA-binding proteins such as histones are danger-associated molecular pattern released by the injured tissues in trauma and sepsis settings, which trigger host immune response and vascular dysfunction. Molecular events leading to histone-induced endothelial cell (EC) dysfunction remain poorly understood. This study performed comparative analysis of H1, H2A, H2B, H3, and H4 histone subunits effects on human pulmonary EC permeability and inflammatory response. Analysis of transendothelial electrical resistance and EC monolayer permeability for macromolecues revealed that H3 and H4, but not H1, H2A, or H2B caused dose-dependent EC permeability accompanied by disassembly of adherens junctions. At higher doses, H3 and H4 activated nuclear factor kappa B inflammatory cascade leading to upregulation EC adhesion molecules ICAM1, VCAM1, E-selectin, and release of inflammatory cytokines. Inhibitory receptor analysis showed that toll-like receptor (TLR) 4 but not TLR1/2 or receptor for advanced glycation end inhibition significantly attenuated deleterious effects of H3 and H4 histones. Inhibitor of Rho-kinase was without effect, while inhibition of Src kinase caused partial preservation of cell-cell junctions, H3/H4-induced permeability and inflammation. Deleterious effects of H3/H4 were blocked by heparin. Activation of Epac-Rap1 signaling restored EC barrier properties after histone challenge. Intravenous injection of histones in mice caused elevation of inflammatory markers and increased vascular leak. Post-treatment with pharmacological Epac/Rap1 activator suppressed injurious effects of histones in vitro and in vivo. These results identify H3 and H4 as key histone subunits exhibiting deleterious effects on pulmonary vascular endothelium via TLR4-dependent mechanism. In conclusion, elevation of circulating histones may represent a serious risk of exacerbated acute lung injury (ALI) and multiple organ injury during severe trauma and infection.	[Ramasubramanian, Baalachandran; Li, Yue; Zhang, Chen-Ou; Karki, Pratap; Birukova, Anna A.] Univ Maryland, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21201 USA; [Kim, Junghyun; Ke, Yunbo; Promnares, Kamoltip; Tanaka, Kenichi A.; Birukov, Konstantin G.] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Birukova, AA (corresponding author), Univ Maryland, UMSOM Lung Biol Program, Dept Med, Sch Med, 20 Penn St,HSF 2,Room S143, Baltimore, MD 21201 USA.	abirukova@som.umaryland.edu			HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [HL152761, HL155051, HL076259, HL146829]; University of Maryland Baltimore, Institute for Clinical & Translational Research (ICTR)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI); University of Maryland Baltimore, Institute for Clinical & Translational Research (ICTR)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL152761, HL155051, HL076259 and HL146829; University of Maryland Baltimore, Institute for Clinical & Translational Research (ICTR), Grant/Award Number: pilot grant	Abrams ST, 2013, AM J RESP CRIT CARE, V187, P160, DOI 10.1164/rccm.201206-1037OC; Allam R, 2014, J MOL MED, V92, P465, DOI 10.1007/s00109-014-1148-z; Alsaffar H, 2018, AM J PHYSIOL-CELL PH, V314, pC589, DOI 10.1152/ajpcell.00235.2017; Ammollo CT, 2011, J THROMB HAEMOST, V9, P1795, DOI 10.1111/j.1538-7836.2011.04422.x; Ando K, 2013, J CELL BIOL, V202, P901, DOI 10.1083/jcb.201301115; Birukov KG, 2013, COMPR PHYSIOL, V3, P429, DOI 10.1002/cphy.c100066; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Birukova AA, 2013, TRANSL RES, V161, P495, DOI 10.1016/j.trsl.2012.12.008; Birukova AA, 2012, J CELL PHYSIOL, V227, P1883, DOI 10.1002/jcp.22916; Birukova AA, 2011, J CELL PHYSIOL, V226, P2052, DOI 10.1002/jcp.22543; Birukova AA, 2010, AM J PHYSIOL-LUNG C, V299, pL652, DOI 10.1152/ajplung.00202.2009; Birukova AA, 2010, TRANSL RES, V155, P44, DOI 10.1016/j.trsl.2009.09.002; Bosmann M, 2013, FASEB J, V27, P5010, DOI 10.1096/fj.13-236380; Burg N, 2018, ARTHRITIS RHEUMATOL, V70, P1879, DOI 10.1002/art.40558; CAMERINIOTERO RD, 1976, CELL, V8, P333, DOI 10.1016/0092-8674(76)90145-8; Chen R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.337; Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159; Durham RM, 2003, J TRAUMA, V55, P608, DOI 10.1097/01.TA.0000092378.10660.D1; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Han JL, 2013, THROMB RES, V132, pE42, DOI 10.1016/j.thromres.2013.03.010; Karki P, 2020, PULM CIRC, V10, DOI 10.1177/2045894020965357; Karki P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206251; Kasa A, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.974448; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Kierdorf K, 2013, J LEUKOCYTE BIOL, V94, P55, DOI 10.1189/jlb.1012519; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P1389, DOI 10.1097/TA.0b013e318270d595; Lv X, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0651-5; Meegan JE, 2018, BIOCHEM BIOPH RES CO, V503, P1498, DOI 10.1016/j.bbrc.2018.07.069; Mong PY, 2009, J IMMUNOL, V182, P2385, DOI 10.4049/jimmunol.0802811; Muller-Redetzky HC, 2014, CELL TISSUE RES, V355, P657, DOI 10.1007/s00441-014-1821-0; Ooshio T, 2010, J BIOL CHEM, V285, P5003, DOI 10.1074/jbc.M109.043760; Pannekoek WJ, 2014, CELL ADHES MIGR, V8, P100, DOI 10.4161/cam.27352; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Semeraro F, 2011, BLOOD, V118, P1952, DOI 10.1182/blood-2011-03-343061; Severson EA, 2009, ANN NY ACAD SCI, V1165, P10, DOI 10.1111/j.1749-6632.2009.04034.x; Shao Y, 2020, ARTERIOSCL THROM VAS, V40, pE138, DOI 10.1161/ATVBAHA.120.314330; Sharma SK, 2016, J THORAC DIS, V8, P1406, DOI 10.21037/jtd.2016.05.22; Silk E, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.52; Singleton PA, 2009, CIRC RES, V104, P978, DOI 10.1161/CIRCRESAHA.108.193367; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; Stevens TC, 2014, AM J PHYSIOL-LUNG C, V306, pL915, DOI 10.1152/ajplung.00135.2013; Surapisitchat J, 2011, HANDB EXP PHARMACOL, V204, P193, DOI 10.1007/978-3-642-17969-3_8; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Vouret-Craviari V, 1998, MOL BIOL CELL, V9, P2639, DOI 10.1091/mbc.9.9.2639; WAYDHAS C, 1992, ARCH SURG-CHICAGO, V127, P460; Wildhagen KCAA, 2014, BLOOD, V123, P1098, DOI 10.1182/blood-2013-07-514984; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Yao Lin, 2010, J Cardiovasc Dis Res, V1, P165, DOI 10.4103/0975-3583.74258; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhang YL, 2015, ANESTHESIOLOGY, V122, P127, DOI 10.1097/ALN.0000000000000429	52	2	2	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22470	10.1096/fj.202200303RR	http://dx.doi.org/10.1096/fj.202200303RR			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3T7MJ	35969180				2022-12-26	WOS:000840453200001
J	Zhang, H; Lu, JF; Shang, HP; Chen, J; Lin, ZX; Liu, YM; Wang, XW; Song, LP; Jiang, X; Jiang, HY; Shi, JD; Yan, DS; Wu, SZ				Zhang, He; Lu, Jinfang; Shang, Huiping; Chen, Juan; Lin, Zhengxiu; Liu, Yimei; Wang, Xianwei; Song, Liping; Jiang, Xue; Jiang, Haiyan; Shi, Jiandong; Yan, Dongsheng; Wu, Shengzhou			Alterations of serine racemase expression determine proliferation and differentiation of neuroblastoma cells	FASEB JOURNAL			English	Article						all-trans retinoic acid; cell cycle; differentiation; D-serine; neuroblastoma; proliferation; serine racemase; valproic acid	NEURONAL DIFFERENTIATION; NMDA RECEPTORS; MOUSE MODEL; CYCLE EXIT; PROTEIN; MIGRATION; LOCALIZATION; INHIBITION; ASTROCYTES; P27(KIP1)	Although the role of serine racemase (SR) in neuropsychiatric disorders has been extensively studied, its role in cell proliferation and differentiation remains unclear. Deletion of Srr, the encoding gene for SR, has been shown to reduce dendritic arborization and dendritic spine density in the brains of adult mice, whereas increased SR levels have been associated with differentiation in cell cultures. Previously, we demonstrated that valproic acid induces differentiation in the N2A neuroblastoma cell line, and that this differentiation is associated with increased SR expression. These observations suggest that SR may have a role in cell proliferation and differentiation. We herein found that both valproic acid and all-trans retinoic acid induced N2A differentiation. In contrast, knockdown of SR reduced levels of differentiation, increased N2A proliferation, promoted cell cycle entry, and modulated expression of cell cycle-related proteins. To further evaluate the effects of SR expression on cell proliferation and differentiation, we used an in vivo model of neuroblastoma in nude mice. N2A cells stably expressing scramble shRNA (Srr(wt)-N2A) or specific Srr shRNA (Srr(kd)-N2A) were subcutaneously injected into nude mice. The weights and volumes of Srr(wt)-N2A-derived tumors were lower than Srr(kd)-N2A-derived tumors. Furthermore, Srr(wt)-N2A-derived tumors were significantly mitigated by intraperitoneal injection of valproic acid, whereas Srr(kd)-N2A-derived tumors were unaffected. Taken together, our findings demonstrate for the first time that alterations in SR expression determine the transition between proliferation and differentiation in neural progenitor cells. Thus, in addition to its well-established roles in neuropsychiatric disorders, our study has highlighted a novel role for SR in cell proliferation and differentiation.	[Zhang, He] Wenzhou Univ, Coll Life & Environm Sci, Wenzhou, Peoples R China; [Zhang, He] Zhejiang Prov Key Lab Subtrop Water Environm & Ma, Wenzhou, Peoples R China; [Zhang, He; Shang, Huiping; Chen, Juan; Liu, Yimei; Wang, Xianwei; Song, Liping; Jiang, Xue; Jiang, Haiyan; Yan, Dongsheng; Wu, Shengzhou] Wenzhou Med Univ, Sch Optometry & Ophthalmol, Wenzhou 325003, Zhejiang, Peoples R China; [Zhang, He; Shang, Huiping; Chen, Juan; Liu, Yimei; Wang, Xianwei; Song, Liping; Jiang, Xue; Jiang, Haiyan; Yan, Dongsheng; Wu, Shengzhou] Wenzhou Med Univ, Eye Hosp, Wenzhou 325003, Zhejiang, Peoples R China; [Zhang, He; Shang, Huiping; Chen, Juan; Liu, Yimei; Wang, Xianwei; Song, Liping; Jiang, Xue; Jiang, Haiyan; Yan, Dongsheng; Wu, Shengzhou] Wenzhou Med Univ, State Key Lab Optometry Ophthalmol & Visual Sci, Wenzhou, Peoples R China; [Lu, Jinfang] Minist Educ, Key Lab Lab Med, Wenzhou Key Lab Sanit Microbiol, Wenzhou, Peoples R China; [Lu, Jinfang] Wenzhou Med Univ, Sch Lab Med & Life Sci, Wenzhou, Peoples R China; [Lin, Zhengxiu; Shi, Jiandong] Wenzhou Med Univ, Affiliated Hosp & Yuying Childrens Hosp 2, Wenzhou, Peoples R China	Wenzhou University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Wu, SZ (corresponding author), Wenzhou Med Univ, Sch Optometry & Ophthalmol, Wenzhou 325003, Zhejiang, Peoples R China.; Wu, SZ (corresponding author), Wenzhou Med Univ, Eye Hosp, Wenzhou 325003, Zhejiang, Peoples R China.	wszlab@wmu.edu.cn		wu, shengzhou/0000-0003-1154-2369	Integrated project of State Key Laboratory of Ophthalmology, Optometry, and Visual Science, Wenzhou Medical University [J02-20190204]; NSFC | NSFC-Zhejiang Joint Fund | Natural Science Foundation of Zhejiang Province (ZJNSF) [LY19H090011]; Start-up finding of Wenzhou Medical University [QTJ19019]	Integrated project of State Key Laboratory of Ophthalmology, Optometry, and Visual Science, Wenzhou Medical University; NSFC | NSFC-Zhejiang Joint Fund | Natural Science Foundation of Zhejiang Province (ZJNSF); Start-up finding of Wenzhou Medical University	Integrated project of State Key Laboratory of Ophthalmology, Optometry, and Visual Science, Wenzhou Medical University, Grant/ Award Number: J02-20190204; NSFC | NSFC-Zhejiang Joint Fund | Natural Science Foundation of Zhejiang Province (ZJNSF), Grant/Award Number: LY19H090011; Start-up finding of Wenzhou Medical University, Grant/Award Number: QTJ19019	Balu DT, 2019, NEUROBIOL DIS, V130, DOI 10.1016/j.nbd.2019.104511; Balu DT, 2013, P NATL ACAD SCI USA, V110, pE2400, DOI 10.1073/pnas.1304308110; Balu DT, 2012, NEUROSCI LETT, V517, P77, DOI 10.1016/j.neulet.2012.04.020; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bonnefont J, 2021, CURR OPIN NEUROBIOL, V66, P195, DOI 10.1016/j.conb.2020.12.006; Bosse KR, 2016, CANCER-AM CANCER SOC, V122, P20, DOI 10.1002/cncr.29706; Cai JJ, 2019, EXP CELL RES, V374, P231, DOI 10.1016/j.yexcr.2018.11.028; Carruthers S, 2003, MECH DEVELOP, V120, P607, DOI 10.1016/S0925-4773(03)00010-8; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Foltyn VN, 2005, J BIOL CHEM, V280, P1754, DOI 10.1074/jbc.M405726200; Fuchs SA, 2012, JIMD REP, V6, P47, DOI 10.1007/8904_2011_116; Gaviglio AL, 2017, FASEB J, V31, P1903, DOI 10.1096/fj.201600828R; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Hahn CK, 2008, P NATL ACAD SCI USA, V105, P9751, DOI 10.1073/pnas.0710413105; Inoue R, 2014, J INVEST DERMATOL, V134, P1618, DOI 10.1038/jid.2014.22; Jiang MR, 2011, CURR TOP DEV BIOL, V94, P77, DOI 10.1016/B978-0-12-380916-2.00004-8; Kim PM, 2005, P NATL ACAD SCI USA, V102, P2105, DOI 10.1073/pnas.0409723102; Koutmani Y, 2004, EUR J NEUROSCI, V20, P2509, DOI 10.1111/j.1460-9568.2004.03724.x; Kristiansen LV, 2007, CURR OPIN PHARMACOL, V7, P48, DOI 10.1016/j.coph.2006.08.013; Labrie V, 2009, HUM MOL GENET, V18, P3227, DOI 10.1093/hmg/ddp261; Lee MH, 1996, P NATL ACAD SCI USA, V93, P3259, DOI 10.1073/pnas.93.8.3259; Ma TM, 2013, MOL PSYCHIATR, V18, P557, DOI 10.1038/mp.2012.97; Madeira C, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.52; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; MATSUI T, 1995, J NEUROCHEM, V65, P454; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Muhlethaler-Mottet A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-55; Muth D, 2010, CANCER RES, V70, P3791, DOI 10.1158/0008-5472.CAN-09-1245; Namba T, 2011, J NEUROCHEM, V118, P34, DOI 10.1111/j.1471-4159.2011.07282.x; Nelson DL, 2017, J BIOL CHEM, V292, P13986, DOI 10.1074/jbc.M117.777904; Nguyen L, 2006, CELL CYCLE, V5, P2314, DOI 10.4161/cc.5.20.3381; Oehme I, 2009, CLIN CANCER RES, V15, P91, DOI 10.1158/1078-0432.CCR-08-0684; Ohshima K, 2020, NAT METAB, V2, P81, DOI 10.1038/s42255-019-0156-2; Ortiz-Sanz C, 2022, CELL DEATH DIS, V13, DOI 10.1038/s41419-022-04687-y; Pao PC, 2011, CELL DEATH DIFFER, V18, P1791, DOI 10.1038/cdd.2011.52; Piubelli L, 2021, TRANSL PSYCHIAT, V11, DOI 10.1038/s41398-021-01202-3; Resende RR, 2008, EXP CELL RES, V314, P1429, DOI 10.1016/j.yexcr.2008.01.003; Sasabe J, 2007, EMBO J, V26, P4149, DOI 10.1038/sj.emboj.7601840; Sasaki K, 2000, MOL BRAIN RES, V77, P209, DOI 10.1016/S0169-328X(00)00053-X; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Schmitt HP, 2005, PSYCHOPHARMACOLOGY, V179, P151, DOI 10.1007/s00213-004-2110-5; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Thompson M, 2012, J NEUROCHEM, V120, P598, DOI 10.1111/j.1471-4159.2011.07601.x; Waters AM, 2015, MOL CANCER THER, V14, P1559, DOI 10.1158/1535-7163.MCT-14-1103; Wu SZ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-2; Wu SZ, 2007, CURR ALZHEIMER RES, V4, P243; Xia M, 2016, J NEUROCHEM, V138, P518, DOI 10.1111/jnc.13663; Xiao YG, 2013, J BIOL CHEM, V288, P20034, DOI 10.1074/jbc.M113.458612; Yanaka N, 2007, FEBS LETT, V581, P712, DOI 10.1016/j.febslet.2007.01.035; Yasuda K, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.19; Zhang H, 2020, BBA-GENE REGUL MECH, V1863, DOI 10.1016/j.bbagrm.2020.194597; Zhang H, 2017, MOL CELL NEUROSCI, V85, P119, DOI 10.1016/j.mcn.2017.09.005	54	0	0	6	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22473	10.1096/fj.202200394RRR	http://dx.doi.org/10.1096/fj.202200394RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3V0NJ	35976172	Green Submitted			2022-12-26	WOS:000841359300001
J	Menon, JC; Bharti, OK; Dhaliwal, RS; John, D; Menon, GR; Grover, A; Chakma, JK				Menon, Jaideep C.; Bharti, Omesh K.; Dhaliwal, Rupinder S.; John, Denny; Menon, Geetha R.; Grover, Ashoo; Chakma, Joy K.			ICMR task force project- survey of the incidence, mortality, morbidity and socio- economic burden of snakebite in India: A study protocol	PLOS ONE			English	Article							DISTRICT; BITE	Background Snakebite is possibly the most neglected of the NTDs (Neglected Tropical Diseases). Half of the global deaths due to venomous snakebites, estimated at 100,000 per year, occur in India. The only representative data on snakebite available from India is the mortality data from the RGI-MDS study (Registrar General of India- 1 Million Death Study) and another study on mortality from the state of Bihar. Incidence data on snakebite is available for 2 districts of the state of West Bengal only. Hospital-based data on snakebite admissions and use of ASV are gross underestimates as most snakebite victims in rural India depend more on alternate treatment methods which do not get represented in National registries. The proposed study is a multi-centric study to determine the incidence, morbidity, mortality and economic burden of snakebites in India covering all 5 geographical zones of the country. Protocol A community level surveillance for snakebite covering 31 districts in 13 states of India in order to obtain annual incidence of snakebites from the community. Frontline health workers will be trained to gather information on new cases of snakebite over the study period of 1-year, from "wards "(smallest administrative subunit of a village or town) that they represent in the study districts. Dedicated field officers would collect data on snakebites, victim characteristics, outcomes, utilization of health facilities on a questionnaire sheet designed for this purpose. The study duration is for 18 months from April 2022 to October 2023. Discussion The study would be the first of its kind in India looking prospectively at the incidence of snakebite covering 13 states in 5 zones of India and a population of 84 million. Our study covers 6.12% of the total population of the country as compared to the incidence study conducted in Sri Lanka which covered 1% of the total population.	[Menon, Jaideep C.] Amrita Vishwa Vidyapeetham, Prevent Cardiol & Populat Hlth Sci, Amrita Inst Med Sci & Res Ctr, Kochi, Kerala, India; [Bharti, Omesh K.] Dept Hlth Family Welf, Shimla, Himachal Prades, India; [Dhaliwal, Rupinder S.] Indian Council Med Res ICMR, Non communicable Dis Div, New Delhi, India; [John, Denny] Amrita Vishwa Vidyapeetham, Amrita Inst Med Sci, Dept Publ Hlth, Kochi, Kerala, India; [Menon, Geetha R.] Indian Council Med Res, Natl Inst Med Stat ICMR, New Delhi, India; [Grover, Ashoo] Indian Council Med Res, Div, Res Methodol Cell, Non Communicable Dis, New Delhi, India; [Chakma, Joy K.] Indian Council Med Res, Non Communicable Dis Div, New Delhi, India	Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi; Indian Council of Medical Research (ICMR); National Centre for Disease Control (NCDC); Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi; Indian Council of Medical Research (ICMR); ICMR - National Institute of Medical Statistics (NIMS); Indian Council of Medical Research (ICMR); Indian Council of Medical Research (ICMR); National Centre for Disease Control (NCDC)	Menon, JC (corresponding author), Amrita Vishwa Vidyapeetham, Prevent Cardiol & Populat Hlth Sci, Amrita Inst Med Sci & Res Ctr, Kochi, Kerala, India.	menon7jc@gmail.com	John, Denny/J-7815-2017	John, Denny/0000-0002-4486-632X; Kumar Bharti, Omesh/0000-0001-5178-1503; Grover, Ashoo/0000-0001-8027-8608; MENON, JAIDEEP/0000-0002-0786-8123	National Task Force project of the Indian Council of Medical Research (ICMR), Government of India;  [NCD/NTF/16/2019-29]	National Task Force project of the Indian Council of Medical Research (ICMR), Government of India; 	The study is funded as a National Task Force project of the Indian Council of Medical Research (ICMR), Government of India. The PI for the study is the corresponding author. The Grant Number is RFC No. NCD/NTF/16/2019-29 dated 20.02.2020. The ICMR has no role other than for funding the project.	[Anonymous], FATALITIES VENOMOUS; Chippaux JP, 2015, J VENOM ANIM TOXINS, V21, DOI 10.1186/s40409-015-0011-1; Dandona R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198900; Ediriweera DS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004813; Majumder Dayalbandhu, 2014, Indian J Public Health, V58, P17, DOI 10.4103/0019-557X.128158; Menon Jaideep C, 2021, F1000Res, V10, P167, DOI 10.12688/f1000research.50970.1; Menon Jaideep C, 2017, J Assoc Physicians India, V65, P78; Mohapatra B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001018; Punde DP, 2005, NATL MED J INDIA, V18, P71; Roshnath Ramesh, 2018, Herpetological Bulletin, P26; Sarkhel S, 2017, TOXICOL REP, V4, P415, DOI 10.1016/j.toxrep.2017.07.007; Vaiyapuri S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080090; who, SNAKEBITE EPIDEMIOLO	13	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0270735	10.1371/journal.pone.0270735	http://dx.doi.org/10.1371/journal.pone.0270735			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994445	Green Published, gold			2022-12-26	WOS:000877093400007
J	Phulkerd, S; Thapsuwan, S; Chamratrithirong, A; Gray, RS; Pattaravanich, U; Ungchusak, C; Saonuam, P				Phulkerd, Sirinya; Thapsuwan, Sasinee; Chamratrithirong, Aphichat; Gray, Rossarin Soottipong; Pattaravanich, Umaporn; Ungchusak, Chantana; Saonuam, Pairoj			Implementing population-wide mass media campaigns: Key drivers to meet global recommendations on fruit and vegetable consumption	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; HEALTH; INTERVENTIONS; CONTEXT; POLICY	While the influence of implementation of mass media and community-based campaigns has been evident elsewhere, this information has been notably absent in Thailand. This study aimed to investigate the association between implementation of mass media campaigns (MMC) and community-based campaigns (CBC) for increased fruit and vegetable (FV) consumption to meet the global recommended level in the Thai population. The sample was obtained from a nationally-representative, longitudinal household survey of the Thai population, Round1 (2018) and Round2 (2019). The study applied a multi-stage sampling design to obtain a sample of persons age 15 years or older. Face-to-face interviews were conducted with 3,010 respondents who successfully participated in both Round1 and Round2 surveys. Information on FV consumption, exposure to Government MMC, ThaiHealth MMC including social marketing (MMSMC) and CBC, and sociodemographic characteristics were collected. Binary logistic regression analysis was used to investigate the association between implementation of those campaigns and increased FV consumption compared to the recommended level. Of the total respondents, only 11.3% had higher FV consumption and also met the minimum requirement. Respondents who lived in rural areas, were farmers, and grew FV at home had the highest probability of increased FV consumption. Exposure to the MMC and CBC was also associated with an increase in FV consumption. Above all, those who had exposure to the MMSMC, who reported either having high level of perception (OR = 1.832, 95% CI 1.259-2.666) or ever heard or seen (OR = 1.770, 95% CI 1.264-2.479) or heard and seen (OR = 1.698, 95% CI 1.131-2.550) campaign information were more likely to have a substantial increase in FV consumption and meeting/exceeding the recommended level than those who were not exposed to these campaigns. Other associated factors include education, occupation and physical activity. Implementation of MMSMC can help the population meet the global recommended level of FV consumption. This study presents its novelty since it was the first to highlight influence of mass media campaigns on increased FV consumption in Asian population. This was also the first study that used data from a population-based longitudinal study. The study suggested that MMC and CBC should also be promoted together with support systems to increase their intensity to a level that can increase population FV consumption to meet the recommended level. Sociodemographic characteristics should be taken into account, and targeted media is needed to effectively reach specific sub-groups of the population.	[Phulkerd, Sirinya; Thapsuwan, Sasinee; Chamratrithirong, Aphichat; Gray, Rossarin Soottipong; Pattaravanich, Umaporn] Mahidol Univ, Inst Populat & Social Res, Phutthamonthon Dist, Nakhon Pathom, Thailand; [Ungchusak, Chantana; Saonuam, Pairoj] Thai Hlth Promot Fdn, Hlth Lifestyle Promot Sect, Bangkok, Thailand	Mahidol University	Phulkerd, S (corresponding author), Mahidol Univ, Inst Populat & Social Res, Phutthamonthon Dist, Nakhon Pathom, Thailand.	sirinya.phu@mahidol.ac.th			Thai Health Promotion Foundation [61-00-0027, 62-00-0837]	Thai Health Promotion Foundation	This research was funded by Thai Health Promotion Foundation (grant numbers 61-00-0027 and 62-00-0837) -awarded to SP. The funders had no role in study design, data collection and analysis.	Atusingwize E, 2015, TOB CONTROL, V24, P320, DOI 10.1136/tobaccocontrol-2014-051579; Bleich SN, 2013, PEDIATRICS, V132, pE201, DOI 10.1542/peds.2013-0886; Brand T, 2014, INT J ENV RES PUB HE, V11, P5866, DOI 10.3390/ijerph110605866; Brownson RC, 2006, ANNU REV PUBL HEALTH, V27, P341, DOI 10.1146/annurev.publhealth.27.021405.102137; Burden of Disease Research Program Thailand, 2018, THIAL BURD DIS ATR R; Bureau of Nutrition, 2007, HLTH EAT GUID; Carter OBJ, 2011, PUBLIC HEALTH NUTR, V14, P982, DOI 10.1017/S1368980010003381; Commonwealth Department of Health and Ageing Assessing change in diet-intervention research, PRIOR ACT CANC CONTR; Department of Health, AN MED NONTH DEP HLT; Durkin S, 2012, TOB CONTROL, V21, P127, DOI 10.1136/tobaccocontrol-2011-050345; Englund TR, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11055-6; Grossman M, 2000, HANDB ECON, V17, P347; Grossman M., 1972, DEMAND HLTH THEORETI, DOI 10.7312/gros17900; Grossman M., 1975, HOUSEHOLD PRODUCTION, P142; Hartman JE, 2013, J PHYSIOTHER, V59, P117, DOI 10.1016/S1836-9553(13)70164-4; Hawe P, 2004, J EPIDEMIOL COMMUN H, V58, P788, DOI 10.1136/jech.2003.014415; Hofer R, 2021, SOC MARK Q, V27, P267, DOI 10.1177/15245004211042413; Li JH, 2015, SOC SCI MED, V127, P83, DOI 10.1016/j.socscimed.2014.07.021; Matson-Koffman DM, 2005, AM J HEALTH PROMOT, V19, P167, DOI 10.4278/0890-1171-19.3.167; Murukutla N, 2018, TOB CONTROL, V27, P547, DOI 10.1136/tobaccocontrol-2016-053564; Phulkerd S, 2021, ECOL FOOD NUTR, V60, P257, DOI 10.1080/03670244.2020.1850448; Phulkerd S, 2020, J HEALTH RES, V34, P419, DOI 10.1108/JHR-07-2019-0150; Pollard CM, 2008, PUBLIC HEALTH NUTR, V11, P314, DOI 10.1017/S1368980007000523; Pomerleau J, 2005, J NUTR, V135, P2486, DOI 10.1093/jn/135.10.2486; Poobalan AS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-640; Porteny Thalia, 2020, Implement Sci Commun, V1, P41, DOI 10.1186/s43058-020-00034-4; Ramanadhan S, 2012, HEALTH EDUC RES, V27, P717, DOI 10.1093/her/cyr088; Snyder LB, 2004, J HEALTH COMMUN, V9, P71, DOI 10.1080/10810730490271548; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Thai Health Promotion Foundation, FRUITS VEG; Van Ruler Betteke, 2018, INT J STRATEGIC COMM, V12, P367, DOI [10.1080/1553118X.2018.1452240, DOI 10.1080/1553118X.2018.1452240]; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4; WHO, 2004, JOINT FAO WHO WORKSH; World Health Organization, 2013, GLOB ACT PLAN PREV C; WORLD HEALTH ORGANIZATION (WHO), GLOB STRAT DIET PHYS	35	0	0	32	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0273232	10.1371/journal.pone.0273232	http://dx.doi.org/10.1371/journal.pone.0273232			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976961	Green Published, gold			2022-12-26	WOS:000847227000085
J	Haheim, LL; Thelle, DS; Ronningen, KS; Olsen, I; Schwarze, PE				Haheim, Lise Lund; Thelle, Dag S.; Ronningen, Kjersti S.; Olsen, Ingar; Schwarze, Per E.			Low level of antibodies to the oral bacterium Tannerella forsythia predicts bladder cancers and Treponema denticola predicts colon and bladder cancers: A prospective cohort study	PLOS ONE			English	Article							PANCREATIC-CANCER; PORPHYROMONAS-GINGIVALIS; PERIODONTAL-DISEASE; RISK	This study explores the risk for cancer by level of antibodies to the anaerobe oral bacteria of periodontitis Tannerella forsythia (TF), Porphyromonas gingivalis (PG), and Treponema denticola (TD) all three collectively termed the red complex, and the facultative anaerobe bacterium Aggregatibacter actinomycetemcomitans (AA). The prospective cohort, the Oslo I I-study from 2000, the second screening of the Oslo study of 1972/73, has been followed for 17 1/2 years with regard to cancer incidence and mortality. A random sample of 697 elderly men comprised the study cohort. The antibody results measured by enzyme linked immunosorbent assay (ELISA) were used in the Cox proportional hazards analyses, and quartile risk on cancer incidence in a 17 1/2 years follow-up. Among the 621 participants with no prior cancer diagnoses, 221 men developed cancer. The incidence trend was inverse, and the results are shown as 1st quartile of highest value and 4th as lowest of antibody levels. The results of the Cox proportional regression analyses showed that TF inversely predicts bladder cancer (n = 22) by Hazard Ratio (HR) = 1.71 (95% CI: 1.12, 2.61). TD inversely predicts colon cancer (n = 26) by HR = 1.52 (95% CI: 1.06, 2.19) and bladder cancer (n = 22) by HR = 1.60 (95% CI: 1.05, 2.43). Antibodies to two oral bacteria, TF and TD, showed an inverse risk relationship with incidence of specific cancers: TF bladder cancer, TD bladder and colon cancer. Lowered immunological response to the oral infection, periodontitis, is shown to be a risk factor in terms of cancer aetiology.	[Haheim, Lise Lund; Olsen, Ingar] Univ Oslo, Dept Oral Biol, Oslo, Norway; [Thelle, Dag S.] Univ Oslo, Inst Basic Med Sci, Oslo, Norway; [Thelle, Dag S.] Univ Gothenburg, Dept Community Med & Publ Hlth, Gothenburg, Sweden; [Ronningen, Kjersti S.] Oslo Univ Hosp, Dept Paediat Res, Oslo, Norway; [Schwarze, Per E.] Norwegian Inst Publ Hlth, Oslo, Norway	University of Oslo; University of Oslo; University of Gothenburg; University of Oslo; Norwegian Institute of Public Health (NIPH)	Haheim, LL (corresponding author), Univ Oslo, Dept Oral Biol, Oslo, Norway.	a.l.l.haheim@odont.uio.no		Lund Haheim, Lise/0000-0002-2012-6220	Norwegian Council for Cardiovascular Diseases of the Norwegian National Association for Public Health; "EXTRAStiftelsen for helse og rehabilitering" Research Health and Rehabilitation through the applicant organization National Organization for Heart and Lung Disease in Norway; National Organization for Heart and Lung Disease; University of Oslo; European Commission [306029]	Norwegian Council for Cardiovascular Diseases of the Norwegian National Association for Public Health; "EXTRAStiftelsen for helse og rehabilitering" Research Health and Rehabilitation through the applicant organization National Organization for Heart and Lung Disease in Norway; National Organization for Heart and Lung Disease; University of Oslo; European Commission(European CommissionEuropean Commission Joint Research Centre)	This study, including the second screening in 2000, Oslo II, was supported by the Norwegian Council for Cardiovascular Diseases of the Norwegian National Association for Public Health, "EXTRAStiftelsen for helse og rehabilitering" Research Health and Rehabilitation through the applicant organization National Organization for Heart and Lung Disease in Norway, the National Organization for Heart and Lung Disease, the University of Oslo in the form of a grant to LLH. Additional funding for these analyses were provided by the former EXTRA foundation for Health and Rehabilitation (EXTRAStiftelsen for helse og rehabilitering) through the applicant organization National Organization for Heart and Lung Disease in Norway in the form of a grant to LLH. This study was also supported by the European Commission in the form of a grant to IO (FP7-HEALTH-306029 `TRIGGER'). The National Organization for Heart and Lung Disease also provided additional financial support from their research fund. The University of Oslo also supported in part the hs-CRP analyses. The funders had no additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Al-Zalabani AH, 2016, EUR J EPIDEMIOL, V31, P811, DOI 10.1007/s10654-016-0138-6; Bracci PM, 2017, CANCER J, V23, P310, DOI 10.1097/PPO.0000000000000287; Corbella S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195683; D'Aiuto F, 2004, J DENT RES, V83, P156, DOI 10.1177/154405910408300214; Dahlen G., 2012, K BENHAVN MUNKSGAARD; Ferlazzo N, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040724; Gao SG, 2018, BMC CANCER, V18, DOI 10.1186/s12885-017-3905-1; Haheim LL, 2008, J CLIN PERIODONTOL, V35, P473, DOI 10.1111/j.1600-051X.2008.01229.x; Haheim LL, 2020, MED HYPOTHESES, V138, DOI 10.1016/j.mehy.2020.109575; Haheim LL, 2009, SCAND J PUBLIC HEALT, V37, P640, DOI 10.1177/1403494809104358; Helfand M, 1997, JAMA-J AM MED ASSOC, V277, P44, DOI 10.1001/jama.277.1.44; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Isola G, 2022, J PERIODONTOL, V93, P135, DOI 10.1002/JPER.21-0049; Leren P, 1975, Acta Med Scand Suppl, V588, P1; Haheim LL, 2006, QJM-INT J MED, V99, P665, DOI 10.1093/qjmed/hcl090; Maisonneuve P, 2017, ANN ONCOL, V28, P985, DOI 10.1093/annonc/mdx019; Michaud DS, 2017, EPIDEMIOL REV, V39, P49, DOI 10.1093/epirev/mxx006; Michaud DS, 2013, GUT, V62, P1764, DOI 10.1136/gutjnl-2012-303006; Mohanty R, 2019, J FAM MED PRIM CARE, V8, P3480, DOI 10.4103/jfmpc.jfmpc_759_19; Ogrendik M, 2015, INT J CLIN EXP PATHO, V8, P11835; Park DG, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112749; Progulske-Fox A, 2022, J ORAL MICROBIOL, V14, DOI 10.1080/20002297.2021.1952838; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sayehmiri F, 2015, INT J IMMUNOPATH PH, V28, P160, DOI 10.1177/0394632015586144; Sharp VJ, 2013, AM FAM PHYSICIAN, V88, P747; Shi TT, 2018, J CLIN PERIODONTOL, V45, P1025, DOI 10.1111/jcpe.12982; Socransky S S, 1994, Periodontol 2000, V5, P7, DOI 10.1111/j.1600-0757.1994.tb00016.x; Thorsson V, 2018, IMMUNITY, V48, P812, DOI [10.1016/j.immuni.2018.03.023, 10.1016/j.immuni.2019.08.004]; Wu YG, 2020, MED ORAL PATOL ORAL, V25, pE21, DOI 10.4317/medoral.23166; Xiao L, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000019698	31	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0272148	10.1371/journal.pone.0272148	http://dx.doi.org/10.1371/journal.pone.0272148			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994451	gold, Green Published			2022-12-26	WOS:000877093400017
J	Izydorczyk, B; Lipowska, M; Lizinczyk, S; Lipowski, M; Wojtas, J				Izydorczyk, Bernadetta; Lipowska, Malgorzata; Lizinczyk, Sebastian; Lipowski, Mariusz; Wojtas, Jakub			Media pressure and the process of Westernization in the context of body self-assessment among young heterosexual and gay Polish men	PLOS ONE			English	Article							TRIPARTITE INFLUENCE MODEL; SOCIOCULTURAL ATTITUDES; SEXUAL ORIENTATION; EATING-DISORDERS; MASCULINE NORMS; IMAGE; INTERNALIZATION; MUSCULARITY; APPEARANCE; GENDER	Mass media and social networks portray a unified image of the perfect male body. The intensity and universality of this influence is an important element of the process of Westernization, especially in traditional cultures such as that of Poland. The main aim of the present study was to investigate the differences between Polish gay and heterosexual men in terms of the role played by self-esteem and the level of internalization of sociocultural standards of body appearance as predictors of the development of their body images. The research study was conducted by reference to 19- to 29-year-old Polish heterosexual (n = 287) and gay (n = 97) men. The variables were measured using Polish versions of the Sociocultural Attitudes towards Appearance Scale-3, the Self-Esteem Scale, and the Multidimensional Body-Self Relations Questionnaire. Statistical analyses identified several variables as the main predictors of body image in both heterosexual and gay young men: self-esteem, information-seeking, perceived pressure and the internalization of sociocultural standards regarding an athletic body image drawn from mass media. The only significant difference between the two groups was the fact that self-esteem, perceived pressure and the internalization of sociocultural standards from mass media did not play a predictive role with respect to Appearance Orientation among the group of gay men.	[Izydorczyk, Bernadetta; Lipowska, Malgorzata] Jagiellonian Univ, Inst Psychol, Krakow, Poland; [Lipowska, Malgorzata] Univ Gdansk, Inst Psychol, Gdansk, Poland; [Lipowska, Malgorzata; Lizinczyk, Sebastian; Wojtas, Jakub] Jagiellonian Univ, Inst Appl Psychol, Krakow, Poland; [Lipowski, Mariusz] Gdansk Univ Phys Educ & Sport, Dept Psychol, Gdansk, Poland	Jagiellonian University; Fahrenheit Universities; University of Gdansk; Jagiellonian University; Gdansk University of Physical Education & Sport	Lipowska, M (corresponding author), Univ Gdansk, Inst Psychol, Gdansk, Poland.; Lipowska, M (corresponding author), Jagiellonian Univ, Inst Appl Psychol, Krakow, Poland.	malgorzata.lipowska@ug.edu.pl		Lipowska, Malgorzata/0000-0002-7422-159X; Lipowski, Mariusz/0000-0002-8389-7006; Wojtas, Jakub/0000-0001-8941-8937	Priority Research Area Society of the Future under the Strategic Program Excellence Initiative at Jagiellonian University	Priority Research Area Society of the Future under the Strategic Program Excellence Initiative at Jagiellonian University	BI work has been supported by a grant from the Priority Research Area Society of the Future under the Strategic Program Excellence Initiative at Jagiellonian University. The funder provided support in the form of salaries for authors BI, MLa, SL, JW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Ahmadpanah M, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16214236; Anderson JR, 2018, EUR J SOC PSYCHOL, V48, P600, DOI 10.1002/ejsp.2350; [Anonymous], 2004, BICEPS BODY IMAGE RE; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Basabas MC, 2019, J SEX RES, V56, P1091, DOI 10.1080/00224499.2019.1667947; Blashill AJ, 2016, ARCH SEX BEHAV, V45, P1241, DOI 10.1007/s10508-015-0683-1; Blashill AJ, 2011, BODY IMAGE, V8, P1, DOI 10.1016/j.bodyim.2010.09.002; Blashill AJ, 2010, BODY IMAGE, V7, P310, DOI 10.1016/j.bodyim.2010.07.006; Branstrom R, 2016, SOC PSYCH PSYCH EPID, V51, P289, DOI 10.1007/s00127-015-1116-0; Brytek-Matera A, 2015, EAT WEIGHT DISORD-ST, V20, P109, DOI 10.1007/s40519-014-0156-x; Calogero RM, 2010, HANDBOOK OF GENDER RESEARCH IN PSYCHOLOGY, VOL 2, P153, DOI 10.1007/978-1-4419-1467-5_8; Cash T. F, 2015, ENCY FEEDING EATING; Cash TF, MULTIDIMENSIONAL BOD, V3; Cella S, 2013, EAT WEIGHT DISORD-ST, V18, P115, DOI 10.1007/s40519-013-0017-z; Czepczor-Bernat K, 2017, ARCH PSYCHIATR PSYCH, V19, P57, DOI 10.12740/APP/78172; Dakanalis A., 2013, HDB BODY IMAGE GENDE, P195; Daniel S, 2010, BODY IMAGE, V7, P32, DOI 10.1016/j.bodyim.2009.08.003; de Vries DA, 2014, SEX ROLES, V71, P283, DOI 10.1007/s11199-014-0412-6; Dixson AF, 2003, ARCH SEX BEHAV, V32, P29, DOI 10.1023/A:1021889228469; Doyle D.M., 2014, PSYCHOL SEX ORIENTAT, V1, P279, DOI [10.1037/sgd0000049, DOI 10.1037/sgd0000049, https://doi.org/10.1037/sgd0000049, DOI 10.1037/SGD0000049]; Duggan SJ, 2004, J HOMOSEXUAL, V47, P45, DOI 10.1300/J082v47n03_03; Filice E, 2020, SEX ROLES, V82, P387, DOI 10.1007/s11199-019-01063-7; Franko DL, 2015, BODY IMAGE, V15, P54, DOI 10.1016/j.bodyim.2015.05.002; Frederick D. A., 2007, PSYCHOL MEN MASCULIN, V8, P103, DOI [10.1037/1524-9220.8.2.103, DOI 10.1037/1524-9220.8.2.103]; Frederick DA, 2016, PSYCHOL MEN MASCULIN, V17, P336, DOI 10.1037/men0000031; Fredrickson BL, 1997, PSYCHOL WOMEN QUART, V21, P173, DOI 10.1111/j.1471-6402.1997.tb00108.x; Gallup AC, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00439; Garza R, 2021, EVOL PSYCHOL-US, V19, DOI 10.1177/14747049211032351; Gattario KH, 2015, PSYCHOL MEN MASCULIN, V16, P337, DOI 10.1037/a0038494; Grogan S., 2008, BODY IMAGE UNDERSTAN, V14, P250; Gultzow T, 2020, CYBERPSYCH BEH SOC N, V23, P281, DOI 10.1089/cyber.2019.0368; He JB, 2020, CLIN PSYCHOL REV, V81, DOI 10.1016/j.cpr.2020.101896; HEINBERG LJ, 1995, INT J EAT DISORDER, V17, P81, DOI 10.1002/1098-108X(199501)17:1<81::AID-EAT2260170111>3.0.CO;2-Y; Hobza C.L., 2007, PSYCHOL MEN MASCULIN, V8, P161, DOI [https://doi.org/10.1037/1524-9220.8.3.161, DOI 10.1037/1524-9220.8.3.161, 10.1037/1524-9220.8.3.161]; Hoffmann S, 2019, BODY IMAGE, V28, P159, DOI 10.1016/j.bodyim.2019.01.011; Hughes SM, 2003, EVOL HUM BEHAV, V24, P173, DOI 10.1016/S1090-5138(02)00149-6; Hunt CJ, 2013, BODY IMAGE, V10, P290, DOI 10.1016/j.bodyim.2013.02.007; Huxley CJ, 2015, PSYCHOL WOMEN QUART, V39, P337, DOI 10.1177/0361684314554917; Izydorczyk B, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00506; Izydorczyk B, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030666; Izydorczyk B, 2020, HEALTH PSYCHOL REP, V8, P68, DOI 10.5114/hpr.2020.91443; Kahalon R, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01268; Keery Helene, 2004, Body Image, V1, P237, DOI 10.1016/j.bodyim.2004.03.001; Klimek P, 2018, INT J EAT DISORDER, V51, P352, DOI 10.1002/eat.22844; Klonkowska AM, 2018, MEN MASC, V21, P210, DOI 10.1177/1097184X16658760; Kosakowska-Berezecka N., 2018, J MENS STUDIES, V26, P143, DOI [10.1177/1060826517734379, DOI 10.1177/1060826517734379]; Kosakowska-Berezecka N, 2016, HEALTH PSYCHOL REP, V4, P189, DOI 10.5114/hpr.2016.62232; Laguna M., 2007, PSYCHOL SPOLECZNA, V2, P164; Lee MS, 2020, SEX ROLES, V82, P743, DOI 10.1007/s11199-019-01082-4; Levine MP, 2009, J SOC CLIN PSYCHOL, V28, P9, DOI 10.1521/jscp.2009.28.1.9; Liao KYH, 2020, PSYCHOL MEN MASCULIN, V21, P333, DOI 10.1037/men0000234; Lipowska K, 2021, CHILDREN-BASEL, V8, DOI 10.3390/children8090744; Lipowska M, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16162814; Lipowski M., 2015, POLSKIE FORUM PSYCHO, V20, P31, DOI [10.14656/PFP20150103, DOI 10.14656/PFP20150103]; Losiak J, 2009, PSYCHIATR POL, V43, P99; Lovering ME, 2018, BODY IMAGE, V24, P44, DOI 10.1016/j.bodyim.2017.12.001; Manago AM, 2015, SEX ROLES, V72, P1, DOI 10.1007/s11199-014-0441-1; Mandal E., 2012, MASCULINITY FEMININI, P11; Mandal E, 2012, MASCULINITY FEMININI, P45; Matera C, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01843; Monks H, 2021, SEX ROLES, V84, P221, DOI 10.1007/s11199-020-01162-w; Morgan JF, 2009, EUR EAT DISORD REV, V17, P435, DOI 10.1002/erv.955; Morrison Melanie A, 2004, Body Image, V1, P127, DOI 10.1016/j.bodyim.2004.01.002; Nerini A, 2016, PSYCHOL MEN MASCULIN, V17, P137, DOI 10.1037/a0039675; Olejniczak E., 2018, HUMANISTYKA PRZYRODO, V24, P105, DOI [10.31648/hip.2599, DOI 10.31648/HIP.2599]; Pan Wenjing, 2020, Health Commun, V35, P731, DOI 10.1080/10410236.2019.1584780; Peplau LA, 2009, ARCH SEX BEHAV, V38, P713, DOI 10.1007/s10508-008-9378-1; Pike KM, 2014, CURR OPIN PSYCHIATR, V27, P436, DOI 10.1097/YCO.0000000000000100; Platek SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009042; Pope H.G., 2000, ADONIS COMPLEX SECRE; Quittkat HL, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00864; Rollero C, 2013, REV PSICOL SOC, V28, P373, DOI 10.1174/021347413807719166; Sanchez FJ, 2009, PSYCHOL MEN MASCULIN, V10, P73, DOI 10.1037/a0013513; Sandfort TGM, 2005, ARCH SEX BEHAV, V34, P595, DOI 10.1007/s10508-005-7907-8; Sani SHZ, 2016, NEUROPSYCH DIS TREAT, V12, DOI 10.2147/NDT.S116811; Singh D, 2007, PERS INDIV DIFFER, V43, P329, DOI 10.1016/j.paid.2006.12.003; Slater A, 2006, J HEALTH PSYCHOL, V11, P553, DOI 10.1177/1359105306065016; Soh NL, 2006, EUR EAT DISORD REV, V14, P54, DOI 10.1002/erv.678; Stojcic I, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00731; Swami V, 2018, BODY IMAGE, V24, P82, DOI 10.1016/j.bodyim.2017.12.006; Swami V, 2016, BODY IMAGE, V16, P41, DOI 10.1016/j.bodyim.2015.11.001; Teng F, 2019, SEX ROLES, V81, P97, DOI 10.1007/s11199-018-0977-6; Thompson J.K., 1999, EXACTING BEAUTY THEO, DOI [10.1037/10312-000, DOI 10.1037/10312-000]; Thompson JK, 2018, INT J EAT DISORDER, V51, P363, DOI 10.1002/eat.22839; Thompson JK, 2004, INT J EAT DISORDER, V35, P293, DOI 10.1002/eat.10257; Thornborrow T, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00495; Tiggemann M., 2007, PSYCHOL MEN MASCULIN, V8, P15, DOI [10.1037/1524-9220.8.1.15, DOI 10.1037/1524-9220.8.1.15]; Toczyski P., 2015, STUDIES GLOBAL ETHIC, V3, P74, DOI [10.5604/23920890.1159700, DOI 10.5604/23920890.1159700]; Tortora C, 2020, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02864; Tylka TL, 2012, BODY IMAGE, V9, P57, DOI 10.1016/j.bodyim.2011.09.006; Tylka TL, 2011, BODY IMAGE, V8, P199, DOI 10.1016/j.bodyim.2011.04.008; Ward LM, 2016, J SEX RES, V53, P560, DOI 10.1080/00224499.2016.1142496; WINCH RF, 1965, SOC FORCES, V44, P255; Witcomb Gemma L, 2013, Shanghai Arch Psychiatry, V25, P332, DOI 10.3969/j.issn.1002-0829.2013.06.002; Yaan C, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00887; Sani SHZ, 2021, PSYCHOL REP, V124, P1515, DOI 10.1177/0033294120948226; Zurbriggen EL, 2011, SEX ROLES, V64, P449, DOI 10.1007/s11199-011-9933-4	97	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0272907	10.1371/journal.pone.0272907	http://dx.doi.org/10.1371/journal.pone.0272907			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994493	gold, Green Published			2022-12-26	WOS:000877093400029
J	Koehn, LE; Nelson, LK; Samhouri, JF; Norman, KC; Jacox, MG; Cullen, AC; Fiechter, J; BuiI, MP; Levin, PS				Koehn, Laura E.; Nelson, Laura K.; Samhouri, Jameal F.; Norman, Karma C.; Jacox, Michael G.; Cullen, Alison C.; Fiechter, Jerome; BuiI, Mercedes Pozo; Levin, Phillip S.			Social-ecological vulnerability of fishing communities to climate change: A US West Coast case study	PLOS ONE			English	Article							ADAPTIVE CAPACITY; CHANGE IMPACTS; ADAPTATION; OCEAN; CONSERVATION; FORMULATION; RESILIENCE; INDICATORS; SUPPORT; RISK	Climate change is already impacting coastal communities, and ongoing and future shifts in fisheries species productivity from climate change have implications for the livelihoods and cultures of coastal communities. Harvested marine species in the California Current Large Marine Ecosystem support U.S. West Coast communities economically, socially, and culturally. Ecological vulnerability assessments exist for individual species in the California Current but ecological and human vulnerability are linked and vulnerability is expected to vary by community. Here, we present automatable, reproducible methods for assessing the vulnerability of U.S. West Coast fishing dependent communities to climate change within a social-ecological vulnerability framework. We first assessed the ecological risk of marine resources, on which fishing communities rely, to 50 years of climate change projections. We then combined this with the adaptive capacity of fishing communities, based on social indicators, to assess the potential ability of communities to cope with future changes. Specific communities (particularly in Washington state) were determined to be at risk to climate change mainly due to economic reliance on at risk marine fisheries species, like salmon, hake, or sea urchins. But, due to higher social adaptive capacity, these communities were often not found to be the most vulnerable overall. Conversely, certain communities that were not the most at risk, ecologically and economically, ranked in the category of highly vulnerable communities due to low adaptive capacity based on social indicators (particularly in Southern California). Certain communities were both ecologically at risk due to catch composition and socially vulnerable (low adaptive capacity) leading to the highest tier of vulnerability. The integration of climatic, ecological, economic, and societal data reveals that factors underlying vulnerability are variable across fishing communities on the U.S West Coast, and suggests the need to develop a variety of well-aligned strategies to adapt to the ecological impacts of climate change.	[Koehn, Laura E.; Nelson, Laura K.; Levin, Phillip S.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Samhouri, Jameal F.; Norman, Karma C.] NOAA, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA; [Jacox, Michael G.; BuiI, Mercedes Pozo] NOAA, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA; [Cullen, Alison C.] Univ Washington, Evans Sch Publ Policy & Governance, Seattle, WA 98195 USA; [Fiechter, Jerome] Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; [BuiI, Mercedes Pozo] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Levin, Phillip S.] Nat Conservancy Washington, Seattle, WA USA; [Koehn, Laura E.] NOAA, West Coast Reg Off, Natl Marine Fisheries Serv, Seattle, WA 98115 USA	University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Nature Conservancy; National Oceanic Atmospheric Admin (NOAA) - USA	Koehn, LE (corresponding author), Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA.; Koehn, LE (corresponding author), NOAA, West Coast Reg Off, Natl Marine Fisheries Serv, Seattle, WA 98115 USA.	laura.koehn216@gmail.com	Nelson, Laura/HGT-9729-2022	Nelson, Laura/0000-0002-0085-7675; samhouri, jameal/0000-0002-8239-3519	Lenfest Ocean Program - Packard Foundation [2019-69817]	Lenfest Ocean Program - Packard Foundation	1. L.E.K., L.K.N., P.S.L, and A.C.C. were funded by the Lenfest Ocean Program. URL: https://www.lenfestocean.org/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 2. J.F.S. was funded by the Packard Foundation [grant numbers 2019-69817]. URL: https://www.packard.org/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SC, 2017, P NATL ACAD SCI USA, V114, P10797, DOI 10.1073/pnas.1702506114; Badjeck MC, 2010, MAR POLICY, V34, P375, DOI 10.1016/j.marpol.2009.08.007; Barange M, 2014, NAT CLIM CHANGE, V4, P211, DOI [10.1038/NCLIMATE2119, 10.1038/nclimate2119]; Barange M., 2009, CLIMATE CHANGE IMPLI, P7; Barnes ML, 2020, NAT CLIM CHANGE, V10, P823, DOI 10.1038/s41558-020-0871-4; Bastille K, 2020, COAST MANAGE, V49, P72, DOI 10.1080/08920753.2021.1846155; Bell RJ, 2020, MAR COAST FISH, V12, P166, DOI 10.1002/mcf2.10112; Bhattachan A, 2018, ENVIRON SCI POLICY, V90, P122, DOI 10.1016/j.envsci.2018.10.006; Boko M, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P433; Bond NA, 2015, GEOPHYS RES LETT, V42, P3414, DOI 10.1002/2015GL063306; Breslow SJ, 2016, ENVIRON SCI POLICY, V66, P250, DOI 10.1016/j.envsci.2016.06.023; Buil MP, 2021, FRONT MAR SCI, V8, DOI 10.3389/fmars.2021.612874; Burgman M., 2005, RISKS DECISIONS CONS; Centers for Disease Control [CDC] and Prevention/ Agency for Toxic Substances and Disease Registry/ Geospatial Research Analysis and SP, 2020, CDCATSDR SOCIAL VULN; Checkley DM, 2009, PROG OCEANOGR, V83, P49, DOI 10.1016/j.pocean.2009.07.028; Cheung WWL, 2015, PROG OCEANOGR, V130, P19, DOI 10.1016/j.pocean.2014.09.003; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Cinner JE, 2009, CONSERV BIOL, V23, P124, DOI 10.1111/j.1523-1739.2008.01041.x; Cinner JE, 2018, NAT CLIM CHANGE, V8, P117, DOI 10.1038/s41558-017-0065-x; Cinner JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074321; Cisneros-Montemayor AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166681; Clark WC, 2016, P NATL ACAD SCI USA, V113, P4615, DOI 10.1073/pnas.0900231108; Colburn LL, 2016, MAR POLICY, V74, P323, DOI 10.1016/j.marpol.2016.04.030; Collins WJ, 2011, GEOSCI MODEL DEV, V4, P1051, DOI 10.5194/gmd-4-1051-2011; Columbia River Inter-Tribal Fish Commission, 2021, SALMON CULTURE PACIF; Crozier LG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217711; Cutter SL, 2008, P NATL ACAD SCI USA, V105, P2301, DOI 10.1073/pnas.0710375105; Davies IP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205825; Dawson C, 2019, MAR POLICY, V100, P58, DOI 10.1016/j.marpol.2018.11.005; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Dickinson MG, 2014, SCI REP-UK, V4, DOI 10.1038/srep06898; Dittmer K, 2013, CLIMATIC CHANGE, V120, P627, DOI 10.1007/s10584-013-0745-0; Donatuto J, 2020, CLIMATIC CHANGE, V158, P161, DOI 10.1007/s10584-019-02596-2; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Dufresne JL, 2013, CLIM DYNAM, V40, P2123, DOI 10.1007/s00382-012-1636-1; Dunne JP, 2013, J CLIMATE, V26, P2247, DOI 10.1175/JCLI-D-12-00150.1; Dunne JP, 2012, J CLIMATE, V25, P6646, DOI 10.1175/JCLI-D-11-00560.1; Ekstrom JA, 2015, NAT CLIM CHANGE, V5, P207, DOI 10.1038/NCLIMATE2508; Fiechter J, 2021, FRONT MAR SCI, V8, DOI 10.3389/fmars.2021.685241; Fisher MC, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2014379117; Flanagan BE, 2011, J HOMEL SECUR EMERG, V8, DOI 10.2202/1547-7355.1792; Fogarty HE, 2019, REV FISH BIOL FISHER, V29, P877, DOI 10.1007/s11160-019-09579-7; Folke C, 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI 10.1016/j.gloenvcha.2006.04.002; Garibaldi A, 2004, ECOL SOC, V9; Gaston KJ, 2009, J APPL ECOL, V46, P1, DOI 10.1111/j.1365-2664.2008.01596.x; Glenn EH., 2019, **DATA OBJECT**; Grothmann T, 2005, GLOBAL ENVIRON CHANG, V15, P199, DOI 10.1016/j.gloenvcha.2005.01.002; Hare JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146756; Harvey C., 2020, ECOSYSTEM STATUS REP, DOI [10.25923/E5RB-9F55, DOI 10.25923/E5RB-9F55]; Heisenberg W., 1958, PHYS PHILOS REVOLUTI; Himes-Cornell A, 2015, FISH RES, V162, P1, DOI 10.1016/j.fishres.2014.09.010; Hodgson EE, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00609; Hodgson EE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158917; Holland DS, 2020, HARMFUL ALGAE, V98, DOI 10.1016/j.hal.2020.101904; Holland DS, 2020, AMBIO, V49, P628, DOI 10.1007/s13280-019-01206-w; Holsman K, 2017, ECOSYST HEALTH SUST, V3, DOI 10.1002/ehs2.1256; Holsman KK, 2019, ICES J MAR SCI, V76, P1368, DOI 10.1093/icesjms/fsz031; Jepson M., 2013, US DEP COMMERCE NOAA, P64; Jones MC, 2018, GLOBAL CHANGE BIOL, V24, pE719, DOI 10.1111/gcb.13869; Kaschner K., 2019, AQUAMAPS PREDICTED R; Kaschner K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019653; Kirtman B, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P953; Koehn JZ, 2017, CONSERVATION FOR THE ANTHROPOCENE OCEAN: INTERDISCIPLINARY SCIENCE IN SUPPORT OF NATURE AND PEOPLE, P65, DOI 10.1016/B978-0-12-805375-1.00004-0; Kunz M, 2013, NAT HAZARD EARTH SYS, V13, P2579, DOI 10.5194/nhess-13-2579-2013; Malone EL, 2011, WIRES CLIM CHANGE, V2, P462, DOI 10.1002/wcc.116; Marshall KN, 2017, GLOBAL CHANGE BIOL, V23, P1525, DOI 10.1111/gcb.13594; Marshall N, 2013, ECOSYSTEMS, V16, P797, DOI 10.1007/s10021-013-9651-6; Masson-Delmotte V., 2021, CLIMATE CHANGE 2021, DOI DOI 10.1080/03736245.2010.480842; Mathews DL, 2017, CONSERVATION FOR THE ANTHROPOCENE OCEAN: INTERDISCIPLINARY SCIENCE IN SUPPORT OF NATURE AND PEOPLE, P169, DOI 10.1016/B978-0-12-805375-1.00009-X; McHenry J, 2019, GLOBAL CHANGE BIOL, V25, P4208, DOI 10.1111/gcb.14828; Messager ML, 2021, APPL GEOGR, V133, DOI 10.1016/j.apgeog.2021.102492; Miller JJ, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2883-1; Moore SK, 2019, MAR POLICY, V110, DOI 10.1016/j.marpol.2019.103543; Morley JW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196127; National Marine Fisheries Service, 2017, NOAA TECH MEMO NMFS; National Marine Fisheries Service, 2018, NOAA TECH MEMO NMFS; Norman K, 2022, OCEAN COAST MANAGE, V224, DOI 10.1016/j.ocecoaman.2022.106191; O'Hara CC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175739; Ojea E, 2017, AMBIO, V46, P399, DOI 10.1007/s13280-016-0850-1; Okamoto DK, 2020, FISH FISH, V21, P1, DOI 10.1111/faf.12409; Otto IM, 2017, REG ENVIRON CHANGE, V17, P1651, DOI 10.1007/s10113-017-1105-9; Pacific Fishery Management Council, 2020, 2040 SCENARIOS W COA; Padgett J, 2008, J BRIDGE ENG, V13, P6, DOI 10.1061/(ASCE)1084-0702(2008)13:1(6); Palacios-Abrantes J, 2020, ECOL SOC, V25, DOI 10.5751/ES-11743-250441; Papaioannou EA, 2021, FRONT MAR SCI, V8, DOI 10.3389/fmars.2021.669094; Payne MR, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2018086118; Pebesma E, 2018, R J, V10, P439; Poe MR, 2015, ECOL ECON, V116, P241, DOI 10.1016/j.ecolecon.2015.05.003; Poe MR, 2014, CONSERV LETT, V7, P166, DOI 10.1111/conl.12068; Poloczanska E., 2019, IPCC SPECIAL REPORT; R Core Team, 2021, R LANG ENV STAT; Ralston S, 2018, FISH RES, V199, P12, DOI 10.1016/j.fishres.2017.11.009; Reidmiller D., 2018, IMPACTS RISKS ADAPTA, DOI 10.7930/NCA4.2018; Rogers LA, 2019, NAT CLIM CHANGE, V9, P512, DOI 10.1038/s41558-019-0503-z; RStudio Team, 2020, RSTUDIO INT DEV ENV; Samhouri JF, 2012, BIOL CONSERV, V145, P118, DOI 10.1016/j.biocon.2011.10.021; Samhouri JF., 2013, CALIFORNIA CURRENT I; Santora JA, 2017, MAR ECOL PROG SER, V580, P205, DOI 10.3354/meps12278; Selig ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082898; Selig ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060284; Sepez J., 2001, POLITICAL SOCIAL ECO; Siegel KJ, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2018.2365; Smit B, 2006, GLOBAL ENVIRON CHANG, V16, P282, DOI 10.1016/j.gloenvcha.2006.03.008; Smith JA, 2021, FISH OCEANOGR, V30, P437, DOI 10.1111/fog.12529; Spencers PD, 2019, GLOBAL CHANGE BIOL, V25, P3954, DOI 10.1111/gcb.14763; Sumaila UR, 2011, NAT CLIM CHANGE, V1, P449, DOI 10.1038/NCLIMATE1301; Tallis H, 2010, MAR POLICY, V34, P340, DOI 10.1016/j.marpol.2009.08.003; Thiault L, 2021, ECOL SOC, V26, DOI 10.5751/ES-12167-260201; Thiault L, 2020, CONSERV LETT, V13, DOI 10.1111/conl.12677; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; Walker K., 2021, TIDYCENSUS LOAD US C; Walker K, 2020, TIGRIS LOAD CENSUS T; Wang XM, 2020, ADV CLIM CHANG RES, V11, P317, DOI 10.1016/j.accre.2020.11.010; Wells ML, 2015, HARMFUL ALGAE, V49, P68, DOI 10.1016/j.hal.2015.07.009; Wilson TJB, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226544; Yohe G, 2002, GLOBAL ENVIRON CHANG, V12, P25, DOI 10.1016/S0959-3780(01)00026-7	116	0	0	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0272120	10.1371/journal.pone.0272120	http://dx.doi.org/10.1371/journal.pone.0272120			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976855	Green Published, gold			2022-12-26	WOS:000847227000022
J	Yenilmez, B; Kelly, M; Zhang, GF; Wetoska, N; Ilkayeva, OR; Min, K; Rowland, L; DiMarzio, C; He, WT; Raymond, N; Lifshitz, L; Pan, MX; Han, XL; Xie, J; Friedline, RH; Kim, JK; Gao, GP; Herman, MA; Newgard, CB; Czech, MP				Yenilmez, Batuhan; Kelly, Mark; Zhang, Guo-Fang; Wetoska, Nicole; Ilkayeva, Olga R.; Min, Kyounghee; Rowland, Leslie; DiMarzio, Chloe; He, Wentao; Raymond, Naideline; Lifshitz, Lawrence; Pan, Meixia; Han, Xianlin; Xie, Jun; Friedline, Randall H.; Kim, Jason K.; Gao, Guangping; Herman, Mark A.; Newgard, Christopher B.; Czech, Michael P.			Paradoxical activation of transcription factor SREBP1c and de novo lipogenesis by hepatocyte-selective ATP-citrate lyase depletion in obese mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPROVES HEPATIC STEATOSIS; FATTY LIVER-DISEASE; MULTIDIMENSIONAL MASS-SPECTROMETRY; ELEMENT-BINDING PROTEIN; AMINO-ACID RESTRICTION; ACETYL-COA; NONALCOHOLIC STEATOHEPATITIS; INSULIN-RESISTANCE; INHIBITION; CHOLESTEROL	Hepatic steatosis associated with high-fat diet, obesity, and type 2 diabetes is thought to be the major driver of severe liver inflammation, fibrosis, and cirrhosis. Cytosolic acetyl CoA (AcCoA), a central metabolite and substrate for de novo lipo-genesis (DNL), is produced from citrate by ATP-citrate lyase (ACLY) and from acetate through AcCoA synthase short chain family member 2 (ACSS2). However, the relative contributions of these two enzymes to hepatic AcCoA pools and DNL rates in response to high-fat feeding are unknown. We report here that hepatocyte-selective depletion of either ACSS2 or ACLY caused similar 50% decreases in liver AcCoA levels in obese mice, showing that both pathways contribute to the generation of this DNL substrate. Unexpectedly however, the hepatocyte ACLY depletion in obese mice paradoxically increased total DNL flux measured by D2O incorporation into palmitate, whereas in contrast, ACSS2 depletion had no effect. The in-crease in liver DNL upon ACLY depletion was associated with increased expression of nuclear sterol regulatory element- binding protein 1c and of its target DNL enzymes. This upre-gulated DNL enzyme expression explains the increased rate of palmitate synthesis in ACLY-depleted livers. Furthermore, this increased flux through DNL may also contribute to the observed depletion of AcCoA levels because of its increased conversion to malonyl CoA and palmitate. Together, these data indicate that in fat diet-fed obese mice, hepatic DNL is not limited by its immediate substrates AcCoA or malonyl CoA but rather by activities of DNL enzymes.	[Yenilmez, Batuhan; Kelly, Mark; Wetoska, Nicole; Min, Kyounghee; Rowland, Leslie; DiMarzio, Chloe; Raymond, Naideline; Lifshitz, Lawrence; Friedline, Randall H.; Kim, Jason K.; Czech, Michael P.] Univ Massachusetts, Chan Med Sch, Program Mol Med, Worcester, MA 01003 USA; [Zhang, Guo-Fang; Ilkayeva, Olga R.; He, Wentao; Herman, Mark A.; Newgard, Christopher B.] Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27705 USA; [Zhang, Guo-Fang; Ilkayeva, Olga R.; He, Wentao; Herman, Mark A.; Newgard, Christopher B.] Duke Mol Physiol Inst, Durham, NC 27701 USA; [Zhang, Guo-Fang; Ilkayeva, Olga R.; He, Wentao; Herman, Mark A.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Zhang, Guo-Fang; Ilkayeva, Olga R.; He, Wentao; Herman, Mark A.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Med, Endocrinol & Metab Div, Durham, NC 27708 USA; [Pan, Meixia; Han, Xianlin] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX USA; [Xie, Jun; Gao, Guangping] Univ Massachusetts, Med Sch, Viral Vector Core, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; Duke University; Duke University; University of Texas System; University of Texas Health San Antonio; University of Massachusetts System; University of Massachusetts Worcester	Czech, MP (corresponding author), Univ Massachusetts, Chan Med Sch, Program Mol Med, Worcester, MA 01003 USA.; Newgard, CB (corresponding author), Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27705 USA.; Newgard, CB (corresponding author), Duke Mol Physiol Inst, Durham, NC 27701 USA.; Newgard, CB (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.; Newgard, CB (corresponding author), Duke Univ, Med Ctr, Dept Med, Endocrinol & Metab Div, Durham, NC 27708 USA.	Chris.Newgard@duke.edu; Michael.Czech@umassmed.edu		Min, Kyounghee/0000-0002-2546-0236; Wetoska, Nicole/0000-0003-3400-5873; kelly, mark/0000-0001-9018-594X	National Institutes of Health [DK103047, DK121710, DK124723]; Isadore and Fannie Foxman Chair in Medical Science; American Heart Association [19PRE34460013]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Isadore and Fannie Foxman Chair in Medical Science; American Heart Association(American Heart Association)	This work was supported by the National Institutes of Health grants DK103047 (to M. P. C.), DK121710 (to C. B. N. and M. A. H.), and DK124723 (to C. B. N.). We also gratefully acknowledge generous funding through the Isadore and Fannie Foxman Chair in Medical Science (to M. P. C.), and predoctoral fellowship support to B. Y. by the American Heart Association (award no.: 19PRE34460013). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdul-Wahed A, 2017, CELL METAB, V26, P324, DOI 10.1016/j.cmet.2017.07.004; Alexander M, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1321-x; Aljohani A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52339-7; Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Amin NB, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav9701; Ballantyne CM, 2018, ATHEROSCLEROSIS, V277, P195, DOI 10.1016/j.atherosclerosis.2018.06.002; Ballantyne CM, 2016, AM J CARDIOL, V117, P1928, DOI 10.1016/j.amjcard.2016.03.043; Ballantyne CM, 2013, J AM COLL CARDIOL, V62, P1154, DOI 10.1016/j.jacc.2013.05.050; BasuRay S, 2019, P NATL ACAD SCI USA, V116, P9521, DOI 10.1073/pnas.1901974116; Bence KK, 2020, MOL METAB, V50, DOI 10.1016/j.molmet.2020.101143; Calle RA, 2021, NAT MED, V27, P1836, DOI 10.1038/s41591-021-01489-1; Chamoun Z, 2013, BIOL CELL, V105, P219, DOI 10.1111/boc.201200036; Chen Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042475; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Dei Cas M, 2020, J CHROMATOGR B, V1154, DOI 10.1016/j.jchromb.2020.121982; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Drenth JPH, 2020, EXPERT OPIN INV DRUG, V29, P1365, DOI 10.1080/13543784.2020.1839888; Engelking LJ, 2004, J CLIN INVEST, V113, P1168, DOI 10.1172/JCI200420978; Erion DM, 2013, ENDOCRINOLOGY, V154, P36, DOI 10.1210/en.2012-1725; Esler WP, 2019, CELL MOL GASTROENTER, V8, P247, DOI 10.1016/j.jcmgh.2019.04.007; Estes C, 2018, HEPATOLOGY, V67, P123, DOI 10.1002/hep.29466; Feng XJ, 2020, PROG LIPID RES, V77, DOI 10.1016/j.plipres.2019.101006; Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9; Gao L, 2007, J CHROMATOGR B, V853, P303, DOI 10.1016/j.jchromb.2007.03.029; Goedeke L, 2018, HEPATOLOGY, V68, P2197, DOI 10.1002/hep.30097; Han XL, 2008, RAPID COMMUN MASS SP, V22, P2115, DOI 10.1002/rcm.3595; Han XL, 2016, WIL SER MASS SPECTR, P21; Han YM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08585-4; Harris RA, 2005, J NUTR, V135, p1527S, DOI 10.1093/jn/135.6.1527S; He AY, 2020, MOL CELL, V79, P30, DOI 10.1016/j.molcel.2020.05.007; He WT, 2021, MOL GENET METAB, V134, P257, DOI 10.1016/j.ymgme.2021.09.009; Herman MA, 2021, CELL METAB, V33, P2329, DOI 10.1016/j.cmet.2021.09.010; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Jang C, 2020, NAT METAB, V2, P586, DOI 10.1038/s42255-020-0222-9; Jonas W, 2020, MOL METAB, V50, DOI 10.1016/j.molmet.2020.101111; Karlsson M, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abh2169; Kim CW, 2017, CELL METAB, V26, P576, DOI 10.1016/j.cmet.2017.08.011; Klett EL, 2013, J BIOL CHEM, V288, P21618, DOI 10.1074/jbc.M113.481077; Kunze M, 2006, BBA-MOL CELL RES, V1763, P1441, DOI 10.1016/j.bbamcr.2006.09.009; Lambert JE, 2014, GASTROENTEROLOGY, V146, P726, DOI 10.1053/j.gastro.2013.11.049; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lomonaco R, 2012, HEPATOLOGY, V55, P1389, DOI 10.1002/hep.25539; Loomba R, 2020, LANCET GASTROENTEROL, V5, P829, DOI 10.1016/S2468-1253(20)30186-2; Lounis MA, 2017, AM J PHYSIOL-ENDOC M, V313, pE710, DOI 10.1152/ajpendo.00151.2017; Madiraju P, 2009, EPIGENETICS-US, V4, P296; Mahady SE, 2011, J HEPATOL, V55, P1383, DOI 10.1016/j.jhep.2011.03.016; McGarrah RW, 2020, AM J PHYSIOL-ENDOC M, V318, pE216, DOI 10.1152/ajpendo.00334.2019; Morrow MR, 2022, CELL METAB, V34, P919, DOI 10.1016/j.cmet.2022.05.004; Muoio DM, 2012, CELL METAB, V15, P764, DOI 10.1016/j.cmet.2012.04.005; Musso G, 2012, DIABETOLOGIA, V55, P885, DOI 10.1007/s00125-011-2446-4; Muthiah MD, 2020, LIVER INT, V40, P89, DOI 10.1111/liv.14355; Noureddin Mazen, 2018, Curr Hepatol Rep, V17, P350, DOI 10.1007/s11901-018-0425-7; Owen JL, 2012, P NATL ACAD SCI USA, V109, P16184, DOI 10.1073/pnas.1213343109; Patel MS, 2014, J BIOL CHEM, V289, P16615, DOI 10.1074/jbc.R114.563148; Perry RJ, 2016, NATURE, V534, P213, DOI 10.1038/nature18309; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Pinkosky SL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13457; Ray KK, 2019, NEW ENGL J MED, V380, P1022, DOI 10.1056/NEJMoa1803917; Schug ZT, 2015, CANCER CELL, V27, P57, DOI 10.1016/j.ccell.2014.12.002; Schuster S, 2018, NAT REV GASTRO HEPAT, V15, P349, DOI 10.1038/s41575-018-0009-6; Sena-Esteves Miguel, 2020, Cold Spring Harb Protoc, V2020, P095513, DOI 10.1101/pdb.top095513; Shi L, 2015, CURR OPIN CELL BIOL, V33, P125, DOI 10.1016/j.ceb.2015.02.003; Singh S, 2015, HEPATOLOGY, V62, P1417, DOI 10.1002/hep.27999; Sjostedt E, 2020, SCIENCE, V367, P1090, DOI 10.1126/science.aay5947; Strittmatter L, 2014, HUM MOL GENET, V23, P2313, DOI 10.1093/hmg/ddt624; Tian J, 2016, P NATL ACAD SCI USA, V113, P8182, DOI 10.1073/pnas.1608987113; Tomcik K, 2011, ANAL BIOCHEM, V410, P110, DOI 10.1016/j.ab.2010.11.030; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Violante S, 2013, BBA-MOL BASIS DIS, V1832, P773, DOI 10.1016/j.bbadis.2013.02.012; Wang Miao, 2014, Methods Mol Biol, V1198, P203, DOI 10.1007/978-1-4939-1258-2_13; Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774; Wang Y, 2019, HEPATOLOGY, V69, P2427, DOI 10.1002/hep.30583; Wei J, 2019, NATURE, V568, P566, DOI 10.1038/s41586-019-1094-6; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; White PJ, 2018, CELL METAB, V27, P1281, DOI 10.1016/j.cmet.2018.04.015; White PJ, 2016, MOL METAB, V5, P538, DOI 10.1016/j.molmet.2016.04.006; Xie J, 2020, MOL THER, V28, P422, DOI 10.1016/j.ymthe.2019.11.018; Xie J, 2012, NAT METHODS, V9, P403, DOI [10.1038/NMETH.1903, 10.1038/nmeth.1903]; Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655; Yang CD, 2006, J BIOL CHEM, V281, P27816, DOI 10.1074/jbc.M603781200; Yang K, 2009, ANAL CHEM, V81, P4356, DOI 10.1021/ac900241u; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Yellaturu CR, 2009, J BIOL CHEM, V284, P31726, DOI 10.1074/jbc.M109.050914; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Yenilmez B, 2022, MOL THER, V30, P1329, DOI 10.1016/j.ymthe.2021.11.007; Yennawar NH, 2006, J BIOL CHEM, V281, P39660, DOI 10.1074/jbc.M607552200; Younossi ZM, 2016, HEPATOLOGY, V64, P1577, DOI 10.1002/hep.28785; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Yu XX, 2005, HEPATOLOGY, V42, P362, DOI 10.1002/hep.20783; Zammit VA, 2013, BIOCHEM J, V451, P1, DOI 10.1042/BJ20121689; Zhao S, 2020, NATURE, V579, P586, DOI 10.1038/s41586-020-2101-7; Zhao S, 2016, CELL REP, V17, P1037, DOI 10.1016/j.celrep.2016.09.069	98	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	298	10							102401	10.1016/j.jbc.2022.102401	http://dx.doi.org/10.1016/j.jbc.2022.102401			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5K6GU	35988648	gold, Green Published			2022-12-26	WOS:000869823800008
J	Liu, P; Lin, CX; Liu, LL; Lu, ZW; Tu, ZG; Liu, HQ				Liu, Peng; Lin, Chunxiu; Liu, Lanlan; Lu, Ziwen; Tu, Zhigang; Liu, Hanqing			RAD54B mutations enhance the sensitivity of ovarian cancer cells to poly(ADP-ribose) polymerase (PARP) inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOLOGY-DIRECTED REPAIR; DNA-REPAIR; FANCONI-ANEMIA; HISTONE H2AX; OPEN-LABEL; RECOMBINATION; BRCA; OLAPARIB; DAMAGE; STIMULATION	Synthetic lethal targeting of homologous recombination (HR)-deficient ovarian cancers (OvCas) with poly(ADP-ribose) polymerase inhibitors (PARPis) has attracted considerable attention. Olaparib was the first PARPi approved by the Food and Drug Administration, offering significant clinical benefits in BRCA1/2-deficient OvCas. However, only approximately 20% of OvCa patients harbor BRCA1/2 mutations. Given the shared roles that BRCA1/2 have with other HR regulators, alterations in HR genes may also contribute to "BRCAness profiles" in OvCas. RAD54B has been considered a key player in HR repair, although its roles and therapeutic potential in cancers need further investigation. Here, we identified 22 frequently mutated HR genes by whole-exome sequencing of OvCa tissues from 82 patients. To our surprise, 7.3% of patients were found to harbor mutations of RAD54B, the third-highest mutated gene among patients. We determined that RAD54B-mutated tumor tissues harbored more DNA double-strand breaks than normal tissues. Additionally, we found that RAD54B knockdown inhibited HR repair, enhanced sensitivities of OvCa cells with increased DNA double-strand breaks to olaparib, and induced apoptosis. Enhanced inhibitory effects of olaparib on the growth of ES2 xenograft tumors were further demonstrated by RAD54B knockdown. Finally, we show that restoration with wildtype RAD54B rather than RAD54B(N593S) and RAD54B(H219Y), identified in patients, abolished the effects of RAD54B knockdown, indicating these RAD54B mutants probably malfunctioned in HR repair. Our investigations may offer insight into the contributions of RAD54B mutations to synthetic lethality with olaparib treatment in OvCas, enrich the gene list for "HR deficiency scoring," and expand the applications of PARPis.	[Liu, Peng; Lin, Chunxiu; Liu, Lanlan; Tu, Zhigang] Jiangsu Univ, Sch Life Sci, Zhenjiang, Jiangsu, Peoples R China; [Lu, Ziwen; Liu, Hanqing] Jiangsu Univ, Sch Pharm, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University	Tu, ZG (corresponding author), Jiangsu Univ, Sch Life Sci, Zhenjiang, Jiangsu, Peoples R China.; Liu, HQ (corresponding author), Jiangsu Univ, Sch Pharm, Zhenjiang, Jiangsu, Peoples R China.	zhigangtu@ujs.edu.cn; hanqing@ujs.edu.cn		LIU, Peng/0000-0002-8580-3763	National Natural Science Foundation [81672582, 31771521]; Top Talent of Innovative Research Team of Jiangsu Province; Innovation and Entrepreneurial PhD Fund of Jiangsu Province; Senior Talent Start-up Funds of Jiangsu University [17JDG011]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Top Talent of Innovative Research Team of Jiangsu Province; Innovation and Entrepreneurial PhD Fund of Jiangsu Province; Senior Talent Start-up Funds of Jiangsu University	This work was supported by the National Natural Science Foundation (grant nos.: 81672582; to H. L. and 31771521; to Z. T.; Top Talent of Innovative Research Team of Jiangsu Province (to H. L. and Z. T.); Innovation and Entrepreneurial PhD Fund of Jiangsu Province (to P. L.); Senior Talent Start-up Funds of Jiangsu University (grant no.: 17JDG011; to P. L.).	Arora S, 2021, ONCOLOGIST, V26, pE164, DOI 10.1002/onco.13551; Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bohl SR, 2021, BLOOD ADV, V5, P2391, DOI 10.1182/bloodadvances.2020003541; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Chirnomas D, 2006, MOL CANCER THER, V5, P952, DOI 10.1158/1535-7163.MCT-05-0493; da Costa A, 2020, NEW ENGL J MED, V382, P1572, DOI 10.1056/NEJMc2000644; Evans T, 2017, THER ADV MED ONCOL, V9, P253, DOI 10.1177/1758834016687254; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Feng J, 2019, ONCOL LETT, V18, P5350, DOI 10.3892/ol.2019.10854; Feng SW, 2021, TRANSL ONCOL, V14, DOI 10.1016/j.tranon.2021.101124; Fong PC, 2010, J CLIN ONCOL, V28, P2512, DOI 10.1200/JCO.2009.26.9589; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Garcia-de-Teresa B, 2020, GENES-BASEL, V11, DOI 10.3390/genes11121528; Gelmon KA, 2011, LANCET ONCOL, V12, P852, DOI 10.1016/S1470-2045(11)70214-5; Gilardini Montani MS, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-95; Gralewska P, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249715; Grelletyy T, 2020, ANN ONCOL, V31, P822, DOI 10.1016/j.annonc.2020.03.283; Grunewald T, 2017, BEST PRACT RES CL OB, V41, P139, DOI 10.1016/j.bpobgyn.2016.12.001; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Hiramoto T, 1999, ONCOGENE, V18, P3422, DOI 10.1038/sj.onc.1202691; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Kaye SB, 2012, J CLIN ONCOL, V30, P372, DOI 10.1200/JCO.2011.36.9215; Kim G, 2015, CLIN CANCER RES, V21, P4257, DOI 10.1158/1078-0432.CCR-15-0887; Kulkarni AS, 2011, J VIROL, V85, P6049, DOI 10.1128/JVI.02514-10; Ledermann JA, 2016, EUR J CANCER, V60, P49, DOI 10.1016/j.ejca.2016.03.005; Lheureux S, 2019, CA-CANCER J CLIN, V69, P280, DOI 10.3322/caac.21559; Lheureux S, 2017, CLIN CANCER RES, V23, P4086, DOI 10.1158/1078-0432.CCR-16-2615; Li LK, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aam7479; Liu HQ, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100996; Lord CJ, 2017, SCIENCE, V355, P1152, DOI 10.1126/science.aam7344; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Martin SA, 2008, CURR OPIN GENET DEV, V18, P80, DOI 10.1016/j.gde.2008.01.016; McAndrew EN, 2017, GENE CHROMOSOME CANC, V56, P513, DOI 10.1002/gcc.22458; McAndrew EN, 2016, ONCOTARGET, V7, P87417, DOI 10.18632/oncotarget.13654; McManus KJ, 2009, P NATL ACAD SCI USA, V106, P3276, DOI 10.1073/pnas.0813414106; Mirza MR, 2020, ANN ONCOL, V31, P1148, DOI 10.1016/j.annonc.2020.06.004; Miyagawa K, 2002, EMBO J, V21, P175, DOI 10.1093/emboj/21.1.175; Murai J, 2017, INT J CLIN ONCOL, V22, P619, DOI 10.1007/s10147-017-1145-7; Nikkila J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3578; Norquist BM, 2016, JAMA ONCOL, V2, P482, DOI 10.1001/jamaoncol.2015.5495; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Patch AM, 2015, NATURE, V521, P489, DOI 10.1038/nature14410; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pothuri B, 2020, GYNECOL ONCOL, V159, P8, DOI 10.1016/j.ygyno.2020.07.097; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sajesh Babu V, 2013, Cancers (Basel), V5, P739, DOI 10.3390/cancers5030739; Sajesh BV, 2013, GENETICS, V195, P757, DOI 10.1534/genetics.113.156836; Sarai N, 2008, NUCLEIC ACIDS RES, V36, P5441, DOI 10.1093/nar/gkn516; Sarai N, 2006, NUCLEIC ACIDS RES, V34, P4429, DOI 10.1093/nar/gkl562; Sehorn MG, 2004, NATURE, V429, P433, DOI 10.1038/nature02563; Seluanov Andrei, 2010, J Vis Exp, DOI 10.3791/2002; Shang DS, 2020, AGING CELL, V19, DOI 10.1111/acel.13145; Shen YT, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0163-9; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Stover EH, 2020, GYNECOL ONCOL, V159, P887, DOI 10.1016/j.ygyno.2020.09.029; Su RJ, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.762741; Tan DSP, 2008, J CLIN ONCOL, V26, P5530, DOI 10.1200/JCO.2008.16.1703; Tanaka K, 2000, J BIOL CHEM, V275, P26316, DOI 10.1074/jbc.M910306199; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240; Torre LA, 2018, CA-CANCER J CLIN, V68, P284, DOI 10.3322/caac.21456; Tu ZG, 2011, DEV CELL, V21, P1077, DOI 10.1016/j.devcel.2011.10.010; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Venkitaraman AR, 2004, NAT REV CANCER, V4, P266, DOI 10.1038/nrc1321; Vergote I, 2022, ANN ONCOL, V33, P276, DOI 10.1016/j.annonc.2021.11.013; Wagener-Ryczek S, 2021, J PERS MED, V11, DOI 10.3390/jpm11070612; Wang R, 2018, ONCOL REP, V40, P1233, DOI 10.3892/or.2018.6522; Wang YM, 2012, CANCER RES, V72, P4037, DOI 10.1158/0008-5472.CAN-12-0103; Wesoly J, 2006, MOL CELL BIOL, V26, P976, DOI 10.1128/MCB.26.3.976-989.2006; Wessman S., 2021, CANCERS, V20, P13; Xu C, 2019, J INT MED RES, V47, P5650, DOI 10.1177/0300060519869423; Zhang YL, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-79694-0; Zhang ZY, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109341; Zhao QY, 2017, J GYNECOL ONCOL, V28, DOI 10.3802/jgo.2017.28.e39	76	0	0	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102354	10.1016/j.jbc.2022.102354	http://dx.doi.org/10.1016/j.jbc.2022.102354			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6F7ME	35952757	gold, Green Published			2022-12-26	WOS:000884241800012
J	Tang, BQ; Lee, HO; Gupta, S; Wang, LQ; Kurimchak, AM; Duncan, JS; Kruger, WD				Tang, Baiqing; Lee, Hyung-Ok; Gupta, Sapna; Wang, Liqun; Kurimchak, Alison M.; Duncan, James S.; Kruger, Warren D.			Extracellular 5'-methylthioadenosine inhibits intracellular symmetric dimethylarginine protein methylation of FUSE-binding proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLTHIOADENOSINE PHOSPHORYLASE; DOWN-REGULATION; HOMOZYGOUS DELETION; CANCER-CELLS; DNA; METABOLISM; EXPRESSION; CARCINOMA	Methylthioadenosine phosphorylase (MTAP) is a key enzyme in the methionine salvage pathway that converts the polyamine synthesis byproduct 5'-deoxy-5'-methyl-thioadenosine (MTA) into methionine. Inactivation of MTAP, often by homozygous deletion, is found in both solid and he-matologic malignancies and is one of the most frequently observed genetic alterations in human cancer. Previous work established that MTAP-deleted cells accumulate MTA and contain decreased amounts of proteins with symmetric dime-thylarginine (sDMA). These findings led to the hypothesis that accumulation of intracellular MTA inhibits the protein argi-nine methylase (PRMT5) responsible for bulk protein sDMAylation. Here, we confirm that MTAP-deleted cells have increased MTA accumulation and reduced protein sDMAyla-tion. However, we also show that addition of extracellular MTA can cause a dramatic reduction of the steady-state levels of sDMA-containing proteins in MTAP+ cells, even though no sustained increase in intracellular MTA is found because of catabolism of MTA by MTAP. We determined that inhibition of protein sDMAylation by MTA occurs within 48 h, is reversible, and is specific. In addition, we have identified two enhancer-binding proteins, FUBP1 and FUBP3, that are differentially sDMAylated in response to MTAP and MTA. These proteins work via the far upstream element site located upstream of Myc and other promoters. Using a transcription reporter construct containing the far upstream element site, we demonstrate that MTA addition can reduce transcription, suggesting that the reduction in FUBP1 and FUBP3 sDMAy-lation has functional consequences. Overall, our findings show that extracellular MTA can inhibit protein sDMAylation and that this inhibition can affect FUBP function.	[Tang, Baiqing; Lee, Hyung-Ok; Gupta, Sapna; Wang, Liqun; Kruger, Warren D.] Fox Chase Canc Ctr, Mol Therapeut Program, Philadelphia, PA 19111 USA; [Kurimchak, Alison M.; Duncan, James S.] Fox Chase Canc Ctr, Canc Signaling & Epigenet Program, Philadelphia, PA USA	Fox Chase Cancer Center; Fox Chase Cancer Center	Kruger, WD (corresponding author), Fox Chase Canc Ctr, Mol Therapeut Program, Philadelphia, PA 19111 USA.	Warren.kruger@fccc.edu			National Cancer Institute [CA245871, CA006927]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Cynthia Myers and the FCCC Organic Chemistry Facility for help with the protein hydrolysis and James Oesterling and the FCCC Cell Sorting Facility. We also thank Dr Fedor Kouzine and Dr David Levens for sending the FUSE-reporter plasmid. This work was funded in part by grants from the National Cancer Institute CA245871 and CA006927.	Amano Y, 2022, PATHOLOGY, V54, P294, DOI 10.1016/j.pathol.2021.05.101; Barekatain Y, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24240-3; Benjamin LR, 2008, P NATL ACAD SCI USA, V105, P18296, DOI 10.1073/pnas.0803279105; CAIRNS P, 1995, NAT GENET, V11, P210, DOI 10.1038/ng1095-210; Chen JF, 2013, NAT REV DRUG DISCOV, V12, P265, DOI 10.1038/nrd3955; Cheng XY, 2017, ONCOTARGETS THER, V10, P5855, DOI 10.2147/OTT.S151953; Christopher SA, 2002, CANCER RES, V62, P6639; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Debaize L, 2019, CELL MOL LIFE SCI, V76, P259, DOI 10.1007/s00018-018-2933-6; Guan R, 2011, BIOCHEMISTRY-US, V50, P1247, DOI 10.1021/bi101642d; Hartel NG, 2019, MOL CELL PROTEOMICS, V18, P2149, DOI 10.1074/mcp.RA119.001625; Hellerbrand C, 2006, CARCINOGENESIS, V27, P64, DOI 10.1093/carcin/bgi201; Hormann Alexandra, 2018, Oncotarget, V9, P28625, DOI 10.18632/oncotarget.25586; Kalev P, 2021, CANCER CELL, V39, P209, DOI 10.1016/j.ccell.2020.12.010; KAMATANI N, 1980, CANCER RES, V40, P4178; Kim J, 2011, GENE CHROMOSOME CANC, V50, P421, DOI 10.1002/gcc.20867; Kirovski G, 2011, AM J PATHOL, V178, P1145, DOI 10.1016/j.ajpath.2010.11.059; Kouzine F, 2008, NAT STRUCT MOL BIOL, V15, P146, DOI 10.1038/nsmb.1372; Kryukov GV, 2016, SCIENCE, V351, P1214, DOI 10.1126/science.aad5214; Lee HO, 2017, J INHERIT METAB DIS, V40, P113, DOI 10.1007/s10545-016-9958-5; Lim Y, 2020, PROTEOMICS, V20, DOI 10.1002/pmic.201900367; Limm K, 2014, EUR J CANCER, V50, P2714, DOI 10.1016/j.ejca.2014.07.005; Marjon K, 2016, CELL REP, V15, P574, DOI 10.1016/j.celrep.2016.03.043; Mavrakis KJ, 2016, SCIENCE, V351, P1208, DOI 10.1126/science.aad5944; Musiani D, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aat8388; Pei JM, 2006, CANCER GENET CYTOGEN, V170, P65, DOI 10.1016/j.cancergencyto.2006.05.002; Quinn LM, 2017, TRANSCR-AUSTIN, V8, P185, DOI 10.1080/21541264.2017.1293595; Smith CR, 2022, J MED CHEM, V65, P1749, DOI 10.1021/acs.jmedchem.1c01900; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Tang BQ, 2018, CANCER RES, V78, P4386, DOI 10.1158/0008-5472.CAN-18-0814; Tang BQ, 2015, G3-GENES GENOM GENET, V5, P35, DOI 10.1534/g3.114.014555; TOOHEY JI, 1978, BIOCHEM BIOPH RES CO, V83, P27, DOI 10.1016/0006-291X(78)90393-5; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Wang LQ, 2005, HUM MOL GENET, V14, P2201, DOI 10.1093/hmg/ddi224; WILLIAMSASHMAN HG, 1982, BIOCHEM PHARMACOL, V31, P277, DOI 10.1016/0006-2952(82)90171-X; Zheng Y, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01264-x	36	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102367	10.1016/j.jbc.2022.102367	http://dx.doi.org/10.1016/j.jbc.2022.102367			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5A9IM	35963436	Green Published, gold			2022-12-26	WOS:000863192700007
J	Arslan, M; Anwar, SM; Lone, SA; Rasheed, Z; Khan, M; Abbasi, SA				Arslan, Muhammad; Anwar, Syed Masroor; Lone, Showkat Ahmad; Rasheed, Zahid; Khan, Majid; Abbasi, Saddam Akbar			Improved adaptive EWMA control chart for process location with applications in groundwater physicochemical parameters and glass manufacturing industry	PLOS ONE			English	Article							AUXILIARY INFORMATION; CUSUM; SCHEME	The adaptive exponentially weighted moving average (AEWMA) control charts are the advanced form of classical memory control charts used for efficiently monitoring small-to-large shifts in the process parameters (location and/or dispersion). These AEWMA control charts estimate the unknown shifts using exponentially weighted moving average (EWMA) or cumulative sum (CUSUM) control charts statistics. The hybrid EWMA (HEWMA) control chart is preferred over classical memory control charts to detect early shifts in process parameters. So, this study presents a new auxiliary information-based (AIB) AEWMA (IAEWMA(AIB)) control chart for process location that estimates the unknown location shift using HEWMA statistic. The objective is to develop an unbiased location shift estimator using HEWMA statistic and then adaptively update the smoothing constant. The shift estimation using HEWMA statistic instead of EWMA or CUSUM statistics boosts the performance of the proposed IAEWMA(AIB) control chart. The Monte Carlo simulation technique is used to get the numerical results. Famous performance evaluation measures like average run length, extra quadratic loss, relative average run length, and performance comparison index are used to evaluate the performance of the proposed chart with existing counterparts. The comparison reveals the superiority of the proposed control chart. Finally, two real-life applications from the glass manufacturing industry and physicochemical parameters of groundwater are considered to show the proposed control chart's implementation procedure and dominance.	[Arslan, Muhammad] Air Univ Pakistan, Dept Math, Islamabad, Pakistan; [Anwar, Syed Masroor] Univ Azad Jammu & Kashmir, Dept Stat, Muzaffarabad, Pakistan; [Lone, Showkat Ahmad] Saudi Elect Univ, Jeddah Branch, Dept Basic Sci, Coll Sci & Theoret Studies, Riyadh, Saudi Arabia; [Rasheed, Zahid] Women Univ Azad Jammu & Kashmir, Dept Math, Muzaffarabad, Pakistan; [Khan, Majid] Riphah Int Univ, Dept Math & Stat, Islamabad, Pakistan; [Abbasi, Saddam Akbar] Qatar Univ, Dept Math Stat & Phys, Doha, Qatar	Air University Islamabad; University of Azad Jammu & Kashmir; Saudi Electronic University; Qatar University	Anwar, SM (corresponding author), Univ Azad Jammu & Kashmir, Dept Stat, Muzaffarabad, Pakistan.	masroorstatistics@gmail.com	Anwar, Syed Masroor/ABB-2626-2021	Anwar, Syed Masroor/0000-0001-7184-9579; Abbasi, Saddam Akber/0000-0003-1843-8863; Rasheed, Zahid/0000-0002-9542-6762				Abbas N, 2012, MEMORY TYPE CONTROL; Abbas N, 2014, COMMUN STAT-THEOR M, V43, P3485, DOI 10.1080/03610926.2012.700368; Abbasi S, 2019, J STAT COMPUT SIM, V89, P337, DOI 10.1080/00949655.2018.1548619; Abid M, 2021, QUAL RELIAB ENG INT, V37, P618, DOI 10.1002/qre.2752; Adegoke NA, 2017, COMPUT IND ENG, V114, P114, DOI 10.1016/j.cie.2017.10.013; Anwar SM, 2022, QUAL RELIAB ENG INT, V38, P174, DOI 10.1002/qre.2966; Anwar SM, 2021, COMPUT IND ENG, V156, DOI 10.1016/j.cie.2021.107284; Anwar SM, 2020, QUAL RELIAB ENG INT, V36, P1949, DOI 10.1002/qre.2667; Anwar SM, 2020, QUAL TECHNOL QUANT M, V17, P561, DOI 10.1080/16843703.2019.1696011; Asadzadeh S, 2017, QUAL RELIAB ENG INT, V33, P2551, DOI 10.1002/qre.2217; Aslam M., 2018, COMMUN STAT-THEOR M, V47, P2018; Aslam M., 2022, MATH PROBL ENG, V2022, P1265204, DOI [10.1155/2022/1265204, DOI 10.1155/2022/1265204]; Aslam M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229422; Aslam M, 2018, T I MEAS CONTROL, V40, P456, DOI 10.1177/0142331216659920; Azam M, 2015, INT J ADV MANUF TECH, V77, P1927, DOI 10.1007/s00170-014-6585-x; Capizzi G, 2003, TECHNOMETRICS, V45, P199, DOI 10.1198/004017003000000023; Haq A, 2021, QUAL RELIAB ENG INT, V37, P47, DOI 10.1002/qre.2719; Haq A, 2020, COMMUN STAT-THEOR M, V49, P1232, DOI 10.1080/03610926.2018.1554140; Haq A, 2020, QUAL TECHNOL QUANT M, V17, P16, DOI 10.1080/16843703.2018.1530181; Haq A, 2019, COMPUT IND ENG, V127, P549, DOI 10.1016/j.cie.2018.10.040; Haq A, 2018, COMMUN STAT-THEOR M, V47, P4840, DOI 10.1080/03610926.2018.1448417; Haq A, 2018, QUAL RELIAB ENG INT, V34, P563, DOI 10.1002/qre.2272; Haq A, 2016, J STAT COMPUT SIM, V86, P3068, DOI 10.1080/00949655.2016.1150477; Haq A, 2013, QUAL RELIAB ENG INT, V29, P1015, DOI 10.1002/qre.1453; Mehmood R, 2017, T I MEAS CONTROL, V39, P883, DOI 10.1177/0142331215622248; Montgomery DC, 2009, STAT QUALITY CONTROL, V7th; Noor-ul-Amin M, 2019, QUAL RELIAB ENG INT, V35, P2639, DOI 10.1002/qre.2546; Noor-ul-Amin M, 2019, IRAN J SCI TECHNOL A, V43, P891, DOI 10.1007/s40995-018-0585-x; Ou YJ, 2012, INT J PROD ECON, V135, P479, DOI 10.1016/j.ijpe.2011.08.026; Rasheed Z, 2021, MATH PROBL ENG, V2021, DOI 10.1155/2021/2570198; Rasheed Z, 2021, MATH PROBL ENG, V2021, DOI 10.1155/2021/2582210; Roberts SW., 1959, TECHNOMETRICS, V1, P239, DOI [10.1080/00401706.1959.10489860, DOI 10.1080/00401706.1959.10489860]; Van Nostrand D., 1931, EC CONTROL QUALITY M; Wu Z, 2009, IIE TRANS, V41, P642, DOI 10.1080/07408170802712582; Zaman B, 2017, QUAL RELIAB ENG INT, V33, P2463, DOI 10.1002/qre.2203	35	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0272584	10.1371/journal.pone.0272584	http://dx.doi.org/10.1371/journal.pone.0272584			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994483	Green Published, gold			2022-12-26	WOS:000877093400023
J	Huang, DL; Zong, ZL; Tang, AP				Huang, Delong; Zong, Zhongling; Tang, Aiping			Study on connectivity of buried pipeline network considering nodes reliability under seismic action	PLOS ONE			English	Article								Currently, the connectivity calculation of complex pipeline networks is mostly simplified or ignores the influence of nodes such as elbows and tees on the connectivity reliability of the entire network. Historical earthquake damage shows that the seismic performance of municipal buried pipelines depends on the ability of nodes and interfaces to resist deformation. The influence of node reliability on network connectivity under reciprocal loading is a key issue to be addressed. Therefore, based on the general connectivity probabilistic analysis algorithm, this paper embeds the reliability of nodes into the reliability of edges, and derives a more detailed and comprehensive on-intersecting minimum path recursive decomposition algorithm considering elbows, tees, and other nodes; then, based on the reliability calculation theory of various pipeline components, the reliability of various nodes in different soil is calculated using finite element numerical simulation; finally, the reliability of a small simple pipeline network and a large complex pipeline network are used as examples to reveal the importance of considering nodes in the connectivity calculation of pipeline network. The reliability of the network system decreases significantly after considering the nodes such as elbows and tees. The damage of one node usually causes the failure of the whole pipes of the path. The damage probability is greater in the area with dense elbow and tee nodes. In this study, all types of nodes that are more prone to damage are considered in detail in the calculation. As a result, the proposed algorithm has been improved in computational accuracy, which lays the foundation for further accurate calculation of pipeline network connectivity.	[Huang, Delong; Zong, Zhongling] Jiangsu Ocean Univ, Sch Civil & Ocean Engn, Lianyungang, Jiangsu, Peoples R China; [Tang, Aiping] Harbin Inst Technol, Sch Civil Engn, Harbin, Heilongjiang, Peoples R China	Jiangsu Ocean University; Harbin Institute of Technology	Huang, DL (corresponding author), Jiangsu Ocean Univ, Sch Civil & Ocean Engn, Lianyungang, Jiangsu, Peoples R China.	2022000018@jou.edu.cn	Huang, Delong/HGB-8118-2022	Huang, Delong/0000-0003-2399-7221	Hainan Province Key R&D Program (Social Development) Project of China [ZDYF2022SHFZ089]; Jiangsu Province Key R&D Program (Social Development) Project of China [BE2021681]	Hainan Province Key R&D Program (Social Development) Project of China; Jiangsu Province Key R&D Program (Social Development) Project of China	This research was supported by the Hainan Province Key R&D Program (Social Development) Project of China (No. ZDYF2022SHFZ089), and the Jiangsu Province Key R&D Program (Social Development) Project of China (No. BE2021681).	AHMAD SH, 1982, IEEE T RELIAB, V31, P41, DOI 10.1109/TR.1982.5221220; Ba ZN, 2021, J PIPELINE SYST ENG, V12, DOI 10.1061/(ASCE)PS.1949-1204.0000543; [巴振宁 Ba Zhenning], 2018, [安全与环境学报, Journal of Safety and Environment], V18, P2103; Bakalis K, 2018, J STRUCT ENG, V144, DOI 10.1061/(ASCE)ST.1943-541X.0002141; Berezin Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08934; Bouziou D, 2017, SOIL DYN EARTHQ ENG, V97, P14, DOI 10.1016/j.soildyn.2017.01.035; [陈玲俐 Chen Lingli], 2004, [工程力学, Engineering Mechanics], V21, P45; Cornell CA., 2000, PEER CENT NEWS, V3, P1; Eguchi R., 1991, EARLY POSTEARTHQUAKE; Eskandari M, 2017, ISPRS INT GEO-INF, V6, DOI 10.3390/ijgi6060169; Hall W., 1977, CURRENT STATE KNOWLE, P18; He J, 2002, THESIS TONGJI U SHAN; [胡群芳 Hu Qunfang], 2020, [同济大学学报. 自然科学版, Journal of Tongji University. Natural Science], V48, P972; Huang DL, 2020, J PIPELINE SYST ENG, V11, DOI 10.1061/(ASCE)PS.1949-1204.0000457; Huang DL, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247677; Ilozumba E, 2022, J PIPELINE SYST ENG, V13, DOI 10.1061/(ASCE)PS.1949-1204.0000634; Li J., 2005, EARTHQUAKE RESISTANC; [李杰 Li Jie], 2006, [地震工程与工程振动, Earthquake Engineering and Engineering Vibration], V26, P172; [李倩 Li Qian], 2019, [灾害学, Journal of Catastrophology], V34, P83; Liang JW., 2013, J DISASTER PREVENTIO, V33, P51, DOI [10.13409/j.cnki.jdpme.2013.s1.018, DOI 10.13409/J.CNKI.JDPME.2013.S1.018]; Liao JS., 1982, J ASTRONAUTICS, P51; [柳春光 Liu Chunguang], 2010, [世界地震工程, World Earthquake Engineering], V26, P25; Liu Q, 2021, NAT HAZARDS, V108, P1047, DOI 10.1007/s11069-021-04719-4; Liu W, 2007, THESIS TONGJI U SHAN; [刘威 Liu Wei], 2021, [安全与环境学报, Journal of Safety and Environment], V21, P949; Liu W, 2020, RELIAB ENG SYST SAFE, V203, DOI 10.1016/j.ress.2020.107088; Liu W, 2020, EARTHQ ENG ENG VIB, V19, P791, DOI 10.1007/s11803-020-0596-4; Liu W, 2017, SOIL DYN EARTHQ ENG, V100, P113, DOI 10.1016/j.soildyn.2017.05.024; Liu W, 2012, SCI CHINA TECHNOL SC, V55, P3047, DOI 10.1007/s11431-012-4965-8; Mazumder RK, 2020, J PIPELINE SYST ENG, V11, DOI 10.1061/(ASCE)PS.1949-1204.0000487; Miao HQ, 2016, SOIL DYN EARTHQ ENG, V90, P510, DOI 10.1016/j.soildyn.2016.09.022; O'Rourke TD., 2008, GEOTECHNICAL EARTHQU, P1; Piratla KR, 2011, J PIPELINE SYST ENG, V2, P91, DOI 10.1061/(ASCE)PS.1949-1204.0000077; Psyrras N, 2019, SOIL DYN EARTHQ ENG, V116, P511, DOI 10.1016/j.soildyn.2018.10.027; Psyrras NK, 2018, SOIL DYN EARTHQ ENG, V106, P254, DOI 10.1016/j.soildyn.2017.12.020; Romero N, 2010, J EARTHQ ENG, V14, P1022, DOI 10.1080/13632460903527989; Soleimani F, 2017, ENG STRUCT, V153, P460, DOI 10.1016/j.engstruct.2017.10.036; Stefanidou SP, 2017, EARTHQ ENG STRUCT D, V46, P73, DOI 10.1002/eqe.2774; Taylor CE., 1991, SEISMIC LOSS ESTIMAT, P180; Tsinidis G, 2020, SOIL DYN EARTHQ ENG, V131, DOI 10.1016/j.soildyn.2019.106030; Wu BC, 2016, RELIAB ENG SYST SAFE, V147, P1, DOI 10.1016/j.ress.2015.10.019; [于天洋 Yu Tianyang], 2021, [地震工程与工程振动, Journal of Earthquake Engineering and Engineering Vibration], V41, P100; [邹日青 Zou Riqing], 2018, [土木建筑与环境工程, Journal of Civil, Architectural & Environmental Engineering], V40, P83	43	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0271533	10.1371/journal.pone.0271533	http://dx.doi.org/10.1371/journal.pone.0271533			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994478	gold, Green Published			2022-12-26	WOS:000877093400009
J	Hymel, E; Vlock, E; Fisher, KW; Farazi, PA				Hymel, Emma; Vlock, Elizabeth; Fisher, Kurt W.; Farazi, Paraskevi A.			Differential progression of unhealthy diet-induced hepatocellular carcinoma in obese and non-obese mice	PLOS ONE			English	Article							FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; CHOLINE-DEFICIENT; CANCER; METABOLISM; SIGNATURES; REDUCTION; CELLS; MODEL	Background Non-alcoholic fatty liver disease (NAFLD) ranks first among liver diseases in Western countries. NAFLD is typically associated with obesity and diabetes, however it also develops in lean individuals without metabolic syndrome. The prevalence of lean NAFLD is 7 percent in the U.S. and 25-30 percent in some Asian countries. NAFLD starts with excess liver fat accumulation (NAFL), progresses to nonalcoholic steatohepatitis (NASH), cirrhosis and hepatocellular carcinoma (HCC). The pathogenesis of lean NASH-HCC and how it differs from obese NASH-HCC is not well understood. Methods In this work, we generated a mouse model of lean and obese NASH-HCC using a choline deficient/high trans-fat/fructose/cholesterol diet and a choline supplemented/high trans-fat/ fructose/cholesterol diet, respectively, to compare progression to NASH-HCC in lean versus obese mice. Comparisons were made at the organismal, histological, and molecular level by investigating fatty acid metabolism in the plasma of these mice. Results Obese mice showed more pronounced glucose intolerance and insulin resistance, higher levels of plasma cholesterol and triglycerides, and higher penetrance of NASH compared to lean mice. Despite the abnormal metabolic profile of obese mice, male obese and lean mice developed HCC with similar penetrance (53.3% and 53.8%, respectively), albeit lean mice showed faster tumor progression as evidenced by the larger tumor size and lower HCC-free survival. None of the female lean mice developed HCC, while 50% of female obese mice developed HCC. Both groups of mice showed a reduction in plasma polyunsaturated fatty acids (PUFAs), however, the levels were higher towards the endpoint in obese mice compared to lean mice. Conclusions Unhealthy diet composition appears to drive progression to NASH-HCC rather than the organismal effects of obesity. PUFA levels may increase due to systemic inflammation in obese mice and act as suppressors of tumor progression, thus delaying HCC progression in obese mice compared to lean mice. These models could be used to further dissect the molecular pathogenesis of lean and obese NASH-HCC and address the mechanisms whereby PUFAs may be implicated in hepatocarcinogenesis.	[Hymel, Emma; Vlock, Elizabeth; Farazi, Paraskevi A.] Univ Nebraska Med Ctr, Coll Publ Hlth, Dept Epidemiol, Omaha, NE 68198 USA; [Vlock, Elizabeth; Farazi, Paraskevi A.] Univ Nebraska, Nebraska Ctr Prevent Obes Dis Dietary Mol, Coll Educ & Human Sci, Lincoln, NE 68588 USA; [Fisher, Kurt W.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Coll Med, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Medical Center	Farazi, PA (corresponding author), Univ Nebraska Med Ctr, Coll Publ Hlth, Dept Epidemiol, Omaha, NE 68198 USA.; Farazi, PA (corresponding author), Univ Nebraska, Nebraska Ctr Prevent Obes Dis Dietary Mol, Coll Educ & Human Sci, Lincoln, NE 68588 USA.	evi.farazi@unmc.edu		Hymel, Emma/0000-0003-1229-6307; Fisher, Kurt/0000-0002-8391-390X; Farazi, Paraskevi/0000-0002-4375-5812	University of Nebraska Medical Center College of Public Health Innovation Fund; NIH [1P20GM104320-04]	University of Nebraska Medical Center College of Public Health Innovation Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the University of Nebraska Medical Center College of Public Health Innovation Fund, who provided support for the execution of the experiments and awarded a grant to PAF. The Nebraska Center for Prevention of Obesity Diseases also supported the researchers and experiments through NIH grant awarded to PAF (1P20GM104320-04). The funders had no role in study design, data collection and analysis,	Albracht-Schulte K, 2018, J NUTR BIOCHEM, V58, P1, DOI 10.1016/j.jnutbio.2018.02.012; Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Barr J, 2012, J PROTEOME RES, V11, P2521, DOI 10.1021/pr201223p; Bedossa P, 2012, HEPATOLOGY, V56, P1751, DOI 10.1002/hep.25889; Besse-Patin A, 2017, GASTROENTEROLOGY, V152, P243, DOI 10.1053/j.gastro.2016.09.017; Brown AL, 2020, J NUTR, V150, P775, DOI 10.1093/jn/nxz315; Dowman JK, 2014, AM J PATHOL, V184, P1550, DOI 10.1016/j.ajpath.2014.01.034; Dyson J, 2014, J HEPATOL, V60, P110, DOI 10.1016/j.jhep.2013.08.011; El-Serag Hashem B, 2011, Therap Adv Gastroenterol, V4, P5, DOI 10.1177/1756283X10385964; Feldman A, 2017, AM J GASTROENTEROL, V112, P102, DOI 10.1038/ajg.2016.318; Fingas Christian Dominik, 2016, Clin Liver Dis (Hoboken), V8, P119, DOI 10.1002/cld.585; Ganz M, 2014, WORLD J GASTROENTERO, V20, P8525, DOI 10.3748/wjg.v20.i26.8525; Ikawa-Yoshida A, 2017, INT J EXP PATHOL, V98, P221, DOI 10.1111/iep.12240; Kinoshita Y, 2014, ONCOL REP, V32, P1385, DOI 10.3892/or.2014.3390; Krautbauer S, 2016, BBA-MOL CELL BIOL L, V1861, P1767, DOI 10.1016/j.bbalip.2016.08.014; Kumar R, 2017, J CLIN TRANSL HEPATO, V5, P216, DOI 10.14218/JCTH.2016.00068; Laitinen Alli, 2018, Tumour Biol, V40, p1010428318799266, DOI 10.1177/1010428318799266; LOMBARDI B, 1968, J LIPID RES, V9, P437; Muir K, 2013, CANCER RES, V73, P4722, DOI 10.1158/0008-5472.CAN-12-3797; Safaei Akram, 2016, Gastroenterol Hepatol Bed Bench, V9, P158; Sanyal A, 2010, CURR MED RES OPIN, V26, P2183, DOI 10.1185/03007995.2010.506375; Shaker M, 2014, WORLD J GASTROENTERO, V20, P5320, DOI 10.3748/wjg.v20.i18.5320; Suzuki A, 2017, ANNU REV MED, V68, P85, DOI 10.1146/annurev-med-051215-031109; Tu LN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05040-6; Vlock EM, 2020, J CANCER, V11, P5536, DOI 10.7150/jca.48495; Wolf MJ, 2014, CANCER CELL, V26, P549, DOI 10.1016/j.ccell.2014.09.003; YAO Z, 1990, BIOCHEM CELL BIOL, V68, P552, DOI 10.1139/o90-079; YOSHIDA LS, 1993, FREE RADICAL BIO MED, V14, P191, DOI 10.1016/0891-5849(93)90010-R; Younossi Zobair M, 2018, Clin Liver Dis (Hoboken), V11, P92, DOI 10.1002/cld.710	31	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0272623	10.1371/journal.pone.0272623	http://dx.doi.org/10.1371/journal.pone.0272623			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994501	gold, Green Published			2022-12-26	WOS:000877093400026
J	Nantongo, JS; Odoi, JB; Agaba, H; Gwali, S				Nantongo, Judith Ssali; Odoi, Juventine Boaz; Agaba, Hillary; Gwali, Samson			SilicoDArT and SNP markers for genetic diversity and population structure analysis of Trema orientalis; a fodder species	PLOS ONE			English	Article							MOLECULAR MARKERS; PACKAGE; DART; L.	Establishing the genetic diversity and population structure of a species can guide the selection of appropriate conservation and sustainable utilization strategies. Next-generation sequencing (NGS) approaches are increasingly being used to generate multi-locus data for genetic structure determination. This study presents the genetic structure of a fodder species -Trema orientalis based on two genome-wide high-throughput diversity array technology (DArT) markers; silicoDArT and single nucleotide polymorphisms (SNPs). Genotyping of 119 individuals generated 40,650 silicoDArT and 4767 SNP markers. Both marker types had a high average scoring reproducibility (> 99%). Genetic relationships explored by principal coordinates analysis (PCoA) showed that the first principal coordinate axis explained most of the variation in both the SilicoDArT (34.2%) and SNP (89.6%) marker data. The average polymorphic information content did not highly differ between silicoDArT (0.22) and SNPs (0.17) suggesting minimal differences in informativeness in the two groups of markers. The, mean observed (Ho) and expected (He) heterozygosity were low and differed between the silicoDArT and SNPs respectively, estimated at H-o = 0.08 and H-e = 0.05 for silicoDArT and H-o = 0.23 and H-e = 0.19 for SNPs. The population of T. orientalis was moderately differentiated (FST = 0.20-0.53) and formed 2 distinct clusters based on maximum likelihood and principal coordinates analysis. Analysis of molecular variance revealed that clusters contributed more to the variation (46.3-60.8%) than individuals (32.9-31.2%). Overall, the results suggest a high relatedness of the individuals sampled and a threatened genetic potential of T. orientalis in the wild. Therefore, genetic management activities such as ex-situ germplasm management are required for the sustainability of the species. Ex-situ conservation efforts should involve core collection of individuals from different populations to capture efficient diversity. This study demonstrates the importance of silicoDArT and SNP makers in population structure and genetic diversity analysis of Trema orientalis, useful for future genome wide studies in the species.	[Nantongo, Judith Ssali; Odoi, Juventine Boaz; Agaba, Hillary; Gwali, Samson] Natl Forestry Resources Res Inst, Kifu, Mukono, Uganda		Nantongo, JS (corresponding author), Natl Forestry Resources Res Inst, Kifu, Mukono, Uganda.	jsnantongo@yahoo.com		Nantongo, Judith/0000-0001-7914-9139; GWALI, SAMSON/0000-0003-0231-4292	National Agricultural Research Organisation/National Forestry Resources research institute Agricultural Technology and Agribusiness Advisory Services (ATAAS) Project	National Agricultural Research Organisation/National Forestry Resources research institute Agricultural Technology and Agribusiness Advisory Services (ATAAS) Project	Funds were received through the National Agricultural Research Organisation/National Forestry Resources research institute Agricultural Technology and Agribusiness Advisory Services (ATAAS) Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2006, ANN BOT-LONDON, V98, P317, DOI 10.1093/aob/mcl117; Adinortey Michael Buenor, 2013, Pharmacogn Rev, V7, P67, DOI 10.4103/0973-7847.112852; Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Alam M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203465; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Brinez B, 2012, MOL BREEDING, V30, P181, DOI 10.1007/s11032-011-9609-3; Coates DJ, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00165; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Farahani S, 2019, GENES-BASEL, V10, DOI 10.3390/genes10090676; Frankham R., 2002, INTRO CONSERVATION G, DOI 10.1017/CBO9780511808999; Franzel S, 2014, CURR OPIN ENV SUST, V6, P98, DOI 10.1016/j.cosust.2013.11.008; Goodale UM, 2014, BIOTROPICA, V46, P183, DOI 10.1111/btp.12088; Gopaulchan D, 2019, PHYSIOL MOL BIOL PLA, V25, P361, DOI 10.1007/s12298-018-0632-2; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Gruber B, 2018, MOL ECOL RESOUR, V18, P691, DOI 10.1111/1755-0998.12745; Gwali S., 2015, Forests, Trees and Livelihoods, V24, P163, DOI 10.1080/14728028.2014.956808; Hassani SMR, 2020, MOL BIOL REP, V47, P2123, DOI 10.1007/s11033-020-05312-x; Huang YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102448; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kabirizi J, 2006, FARMERS HDB; Kilian A, 2003, P INT C WAKE DOUBLE; Kilian Andrzej, 2012, Methods Mol Biol, V888, P67, DOI 10.1007/978-1-61779-870-2_5; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Serrote CML, 2020, GENE, V726, DOI 10.1016/j.gene.2019.144175; Macko-Podgorni A, 2014, ACTA BIOCHIM POL, V61, P19; Mosango Mbokuyo, 2008, Polish Botanical Journal, V53, P125; Muktar MS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43406-0; Nantongo JS, 2020, FORESTS, V11, DOI 10.3390/f11121356; Nantongo JS, 2018, AFR J ECOL, V56, P136, DOI 10.1111/aje.12423; Nantongo JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155638; Nantongo JS, 2010, AFR J ECOL, V48, P841, DOI 10.1111/j.1365-2028.2009.01164.x; Orwa C, 2009, AGROFORESTRY TREE DA; Otieno A, 2013, LOCAL COMMUNITIES CO; Pritchard JK., 2010, DOCUMENTATION STRUCT; Schippmann U, 2002, BIODIVERISTY ECOSYST; Schulman AH, 2007, EUPHYTICA, V158, P313, DOI 10.1007/s10681-006-9282-5; Sekaatuba J, 2004, UGANDA J AGR SCI, V9, P372; Stoeckel S, 2006, MOL ECOL, V15, P2109, DOI 10.1111/j.1365-294X.2006.02926.x; Tabangin Meredith E, 2009, BMC Proc, V3 Suppl 7, pS41, DOI 10.1186/1753-6561-3-S7-S41; Valdisser PAMR, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3805-4; Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI [10.1186/1297-9686-34-3-275, 10.1051/gse:2002009]; Vinson CC, 2018, BRAZ J BOT, V41, P481, DOI 10.1007/s40415-018-0472-x; WRIGHT S, 1978, P580; Xia L, 2005, THEOR APPL GENET, V110, P1092, DOI 10.1007/s00122-005-1937-4; Zalapa JE, 2010, EVOL APPL, V3, P157, DOI 10.1111/j.1752-4571.2009.00106.x; Zhang HL, 2018, PLANT DIVERSITY, V40, P127, DOI 10.1016/j.pld.2018.04.003	47	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0267464	10.1371/journal.pone.0267464	http://dx.doi.org/10.1371/journal.pone.0267464			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VW	35994436	Green Published, gold			2022-12-26	WOS:000877093700003
J	Yi, RL; Chen, E; Roberts, EW; Krummel, MF; Serwas, NK				Yi, Rulan; Chen, Emily; Roberts, Edward W.; Krummel, Matthew F.; Serwas, Nina Kathrin			Impact of protein identity on tumor- associated antigen uptake into infiltrating immune cells: A comparison of different fluorescent proteins as model antigens	PLOS ONE			English	Article							MONOMERIC RED; VACCINATION	Effective immune responses depend on efficient antigen uptake in the periphery, transport of those antigens to, and presentation in draining lymph nodes (LNs). These processes have been studied intensively using stable fluorescent proteins (FPs) as model antigens. To date, ZsGreen is the only FP that can be tracked efficiently towards LNs, hence, it is difficult to compare studies using alternated tracking proteins. Here, we systematically compared six different FPs. We included ZsGreen, ZsYellow, DsRed, AsRed, mCherry, and mRFP based on sequence homology and/or origin species, and generated FP-expressing tumor cell lines. Stability of fluorescent signal was assessed in vitro over time, across different pH environments, and in vivo through FP antigen uptake and transfer to immune cells isolated from tumors and tumor-draining LNs. ZsGreen could be detected in high percentages of all analyzed tumor-infiltrating immune cells, with highest amounts in tumor-associated macrophages (TAMs) and type 2 conventional dendritic cells (cDC2s). ZsYellow, AsRed, and DsRed followed a similar pattern, but percentages of FP-containing immune cells in the tumor were lower than for ZsGreen. Strikingly, mRFP and mCherry demonstrated a 'non-canonical' antigen uptake pattern where percentages of FP-positive tumor-infiltrating immune cells were highest for cDC1s not TAMs and cDC2s despite comparable stabilities and localization of all FPs. Analysis of antigen-containing cells in the LN was hindered by intracellular degradation of FPs. Only ZsGreen could be efficiently tracked to the LN, though some signal was measurable for ZsYellow and DsRed. In summary, we find that detection of antigen uptake and distribution is subject to variabilities related to fluorophore nature. Future experiments need to consider that these processes might be impacted by protein expression, stability, or other unknown factors. Thus, our data sheds light on potential under-appreciated mechanisms regulating antigen transfer and highlights potential uses and necessary caveats to interpretation based on FP use.	[Yi, Rulan] Univ Calif Berkeley, MCB Undergrad Program, Berkeley, CA 94720 USA; [Chen, Emily; Krummel, Matthew F.; Serwas, Nina Kathrin] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Roberts, Edward W.] Canc Res UK Beatson Inst, Glasgow, Lanark, Scotland	University of California System; University of California Berkeley; University of California System; University of California San Francisco; Beatson Institute	Krummel, MF; Serwas, NK (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA.	matthew.krummel@ucsf.edu; nina.serwas@ucsf.edu		Serwas, Nina/0000-0003-2243-5446; Krummel, Matthew/0000-0001-7915-3533; Roberts, Edward/0000-0002-8229-1715	Human Frontier Science Program [LT000061/2018-L]; National Institutes of Health [5U01CA217864]	Human Frontier Science Program(Human Frontier Science Program); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Human Frontier Science Program in the form of a fellowship (LT000061/2018-L) to NKS. This work was also supported by National Institutes of Health in the form of a grant (5U01CA217864) to MFK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Babala N, 2018, CANCER IMMUNOL RES, V6, P835, DOI 10.1158/2326-6066.CIR-17-0408; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Dersh D, 2021, NAT REV IMMUNOL, V21, P116, DOI 10.1038/s41577-020-0390-6; Lambert TJ, 2019, NAT METHODS, V16, P277, DOI 10.1038/s41592-019-0352-8; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Ozcan A, 2022, SCI IMMUNOL, V7, DOI 10.1126/sciimmunol.abi9126; Roberts EW, 2016, CANCER CELL, V30, P324, DOI 10.1016/j.ccell.2016.06.003; Ruhland MK, 2020, CANCER CELL, V37, P786, DOI 10.1016/j.ccell.2020.05.002; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shinoda H, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061548; Wang YY, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00939-6	15	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0272857	10.1371/journal.pone.0272857	http://dx.doi.org/10.1371/journal.pone.0272857			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976946	Green Published, Green Submitted, gold			2022-12-26	WOS:000847227000062
J	Lee, SL; Lee, MHH; Wu, KJ; Chiang, CW; Chang, YX; Fang, JD; Tung, HH; Kuo, LW; Wang, Y				Lee, Sheau-Ling; Lee, Michelle Hui-Hsin; Wu, Kuo-Jen; Chiang, Chia-Wen; Chang, Yun-Xuan; Fang, Jung-Da; Tung, Hsiu-Hui; Kuo, Li-Wei; Wang, Yun			Post-ischemic protection of hepatocyte growth factor requires the type II transmembrane serine protease matriptase-A reciprocal regulation of the two for neuroprotection in stroke brain	FASEB JOURNAL			English	Article						astrogliosis; glia reactivation; inflammatory response; microgliosis; neurotrophic factor	NEURAL STEM/PROGENITOR CELLS; CEREBRAL-ARTERY OCCLUSION; ACTIVATION; MICROGLIA; ISCHEMIA; DIFFERENTIATION; PRECURSOR; SURFACE; FORM	In a rat middle cerebral artery occlusion (MACo) model of ischemic stroke, intracerebroventricular administration of human recombinant hepatocyte growth factor (HGF) mitigated motor impairment and cortical infarction. Recombinant HGF reduced MCAo-induced TNF alpha and IL1 beta expression, and alleviated perilesional reactivation of microglia and astrocyte. All of the aforementioned beneficial effects of HGF were antagonized by an inhibitor to the type II transmembrane serine protease matriptase (MTP). MCAo upregulated MTP mRNA and protein in the lesioned cortex. MTP protein, not the mRNA, was increased further by recombinant HGF but reduced when MTP inhibitor (MTPi) was added to the treatment. Changes of the endogenous active HGF by MCAo, HGF or MTPi paralleled with the changes of MTP protein under the same conditions whilst neither HGF mRNA nor the total endogenous HGF protein were altered. These data showed that the therapeutic effects of HGF in stroke brain is attributed to its proteolytic activation and that MTP is a main protease of the event. MCAo enhanced MTP mRNA and thus protein expression; the initial use of the recombinant active HGF stabilized MCAo-induced MTP protein and subsequent activation of endogenous latent HGF which in turn stabilized further MTP protein. A reciprocal regulation between MTP and HGF appears to be present where MTP promotes HGF activation and the active HGF prevents MTP protein turnover. This study, for the first time, shows that MTP can participate in neural protection in stroke brain through activation of HGF. The cycles of HGF-MTP regulation achieved preservation of the neurological activity.	[Lee, Sheau-Ling; Lee, Michelle Hui-Hsin; Chang, Yun-Xuan; Fang, Jung-Da; Tung, Hsiu-Hui] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Lee, Sheau-Ling] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Lee, Sheau-Ling] Natl Chung Hsing Univ, Biotechnol Ctr, Taichung, Taiwan; [Wu, Kuo-Jen; Wang, Yun] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Zhunan, Taiwan; [Chiang, Chia-Wen; Kuo, Li-Wei] Natl Hlth Res Inst, Inst Biomed Engn & Nanomed, Zhunan, Taiwan	National Health Research Institutes - Taiwan; China Medical University Taiwan; National Chung Hsing University; National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan	Lee, SL (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, 35 Keyan Rd, Zhunan Town 35053, Miaoli County, Taiwan.	sllee@nhri.edu.tw			Central Government ST Grant [06A1-NPSP06-034]; National Health Research Institutes (NHRI) [06A1-CSPP10-014, 07A1-CSPP10-014]	Central Government ST Grant; National Health Research Institutes (NHRI)(National Health Research Institutes - Taiwan)	Central Government S&T Grant, Grant/Award Number: 06A1-NPSP06-034; National Health Research Institutes (NHRI), Grant/Award Number: 06A1-CSPP10-014 and 07A1-CSPP10-014	Aarum J, 2003, P NATL ACAD SCI USA, V100, P15983, DOI 10.1073/pnas.2237050100; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Benaud CM, 2002, CLIN EXP METASTAS, V19, P639, DOI 10.1023/A:1020985632550; Borlongan CV, 1998, NEUROREPORT, V9, P3615, DOI 10.1097/00001756-199811160-00012; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Chen LM, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-018-4040-z; Darragh MR, 2008, FRONT BIOSCI-LANDMRK, V13, P528, DOI 10.2741/2698; Date I, 2004, BIOCHEM BIOPH RES CO, V319, P1152, DOI 10.1016/j.bbrc.2004.05.100; Date I, 2006, NEUROSCI LETT, V407, P141, DOI 10.1016/j.neulet.2006.08.050; Doeppner TR, 2011, J CEREBR BLOOD F MET, V31, P1251, DOI 10.1038/jcbfm.2010.211; Enyedy IJ, 2001, J MED CHEM, V44, P1349, DOI 10.1021/jm000395x; Fang JD, 2019, FASEB J, V33, P4327, DOI 10.1096/fj.201801307R; Fang JD, 2014, BBA-MOL CELL RES, V1843, P1285, DOI 10.1016/j.bbamcr.2014.03.020; Fang JD, 2011, J BIOL CHEM, V286, P5667, DOI 10.1074/jbc.M110.153866; Fontainhas AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015973; Haage V, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0665-y; Hayashi T, 1998, BRAIN RES, V799, P311, DOI 10.1016/S0006-8993(98)00391-6; Hung YW, 2020, FASEB J, V34, P6950, DOI 10.1096/fj.201902818R; Ito Y, 2006, GLYCOBIOLOGY, V16, P368, DOI 10.1093/glycob/cwj084; Jin XL, 2005, J CELL BIOCHEM, V95, P632, DOI 10.1002/jcb.20418; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Lee SL, 2010, MECH DEVELOP, V127, P82, DOI 10.1016/j.mod.2009.10.004; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; Luo Y, 2013, J CEREBR BLOOD F MET, V33, P300, DOI 10.1038/jcbfm.2012.172; Luo Y, 2009, ANN NEUROL, V65, P520, DOI 10.1002/ana.21592; MIYAZAWA K, 1993, J BIOL CHEM, V268, P10024; MIYAZAWA K, 1994, J BIOL CHEM, V269, P8966; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; NAKA D, 1992, J BIOL CHEM, V267, P20114; Nakajima K, 2001, J BIOCHEM-TOKYO, V130, P169, DOI 10.1093/oxfordjournals.jbchem.a002969; Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Sanders Andrew J, 2006, J Exp Ther Oncol, V6, P39; Seitz I, 2007, ARTERIOSCL THROM VAS, V27, P769, DOI 10.1161/01.ATV.0000258862.61067.14; Shang JW, 2011, J NEUROSCI RES, V89, P86, DOI 10.1002/jnr.22524; Shang JW, 2010, J NEUROSCI RES, V88, P2197, DOI 10.1002/jnr.22373; Shimada IS, 2012, J NEUROSCI, V32, P7926, DOI 10.1523/JNEUROSCI.4303-11.2012; Shimamura M, 2004, CIRCULATION, V109, P424, DOI 10.1161/01.CIR.0000109496.82683.49; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Tung HH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05131-4; Tung HH, 2012, J BIOL CHEM, V287, P22497, DOI 10.1074/jbc.M111.330589; Yin ZR, 2017, NEUROBIOL AGING, V55, P115, DOI 10.1016/j.neurobiolaging.2017.03.021; Yoon JS, 2018, EXP NEUROBIOL, V27, P287, DOI 10.5607/en.2018.27.4.287; Zhang LL, 2000, J NEUROSCI RES, V62, P389, DOI 10.1002/1097-4547(20001101)62:3<389::AID-JNR9>3.0.CO;2-M	50	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22494	10.1096/fj.202200414R	http://dx.doi.org/10.1096/fj.202200414R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3V0FZ	35976173				2022-12-26	WOS:000841340100001
J	Converso, TR; Goulart, C; Rodriguez, D; Guerra, MES; Darrieux, M; Leite, LCC				Converso, Thiago Rojas; Goulart, Cibelly; Rodriguez, Dunia; Souza Guerra, Maria Eduarda; Darrieux, Michelle; Leite, Luciana C. C.			Immune response induced in mice by a hybrid rPotD-PdT pneumococcal protein	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL COLONIZATION; POLYAMINE TRANSPORT; INTRANASAL IMMUNIZATION; CONJUGATE VACCINE; PNEUMOLYSIN; PSPA; INFECTION; POTD; PROTECTION	Streptococcus pneumoniae is a human pathogen that colonizes the naso and/or oropharynx and can cause otitis, pneumonia, bacteremia and meningitis. To broaden the protection against pneumococcus, several pneumococcal proteins have been investigated as vaccine candidates. In this study we analyzed the immunological response induced by mouse subcutaneous immunization with a fusion of the Polyamine transport protein D (PotD) and a pneumolysin derivative (PdT), resulting in a hybrid rPotD-PdT protein. Immunization of mice with rPotD-PdT induced increased production of nitric oxide, indicating a higher innate immune response. In agreement, immunization of mice with the hybrid protein was more immunogenic than the individual proteins or their combination, eliciting higher antibody levels. The anti-rPotD-PdT IgG displayed increased binding onto the pneumococcal surface. Furthermore, the anti-rPotD-PdT antisera promoted superior opsonophagocytosis as compared with the other tested formulations. However, despite that the encouraging results in vitro, immunization with the hybrid was not sufficient to induce protection against sepsis with a highly virulent pneumococcal strain. taken together, the results suggest that hybrid proteins are an interesting strategy, able to promote improved immune responses, but the inclusion of other antigens may be necessary to promote protection against invasive infections caused by this bacterium.	[Converso, Thiago Rojas] Univ Sao Paulo, IPT, IB, Programa Pos Grad Interunidade, Sao Paulo, Brazil; [Converso, Thiago Rojas; Goulart, Cibelly; Rodriguez, Dunia; Leite, Luciana C. C.] Inst Butantan, Lab Dev Vacinas, Sao Paulo, Brazil; [Converso, Thiago Rojas; Souza Guerra, Maria Eduarda; Darrieux, Michelle] Univ Sao Francisco, Lab Biol Mol Microrganismos, Braganca Paulista, SP, Brazil	Universidade de Sao Paulo; Instituto Butantan; Universidade Sao Francisco	Converso, TR (corresponding author), Univ Sao Paulo, IPT, IB, Programa Pos Grad Interunidade, Sao Paulo, Brazil.; Converso, TR (corresponding author), Inst Butantan, Lab Dev Vacinas, Sao Paulo, Brazil.; Converso, TR (corresponding author), Univ Sao Francisco, Lab Biol Mol Microrganismos, Braganca Paulista, SP, Brazil.	trconverso@hotmail.com	Converso, Thiago Rojas/AAZ-8433-2020	Converso, Thiago Rojas/0000-0001-5631-4541; Rodriguez, Dunia/0000-0001-9779-1280	FAPESP [2012/04286-3, 2017/24832-6, 2019/23566-6]; Fundacao Butantan	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao Butantan	This project was supported by FAPESP (Grant numbers: 2012/04286-3, 2017/24832-6 and 2019/23566-6) and Fundacao Butantan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basavanna S, 2009, INFECT IMMUN, V77, P3412, DOI 10.1128/IAI.01543-08; Benton KA, 1998, INFECT IMMUN, V66, P839, DOI 10.1128/IAI.66.2.839-842.1998; BERRY AM, 1995, INFECT IMMUN, V63, P1969, DOI 10.1128/IAI.63.5.1969-1974.1995; BHAKDI S, 1988, PROG ALLERGY, V40, P1; Nguyen CT, 2011, VACCINE, V29, P5731, DOI 10.1016/j.vaccine.2011.05.095; Converso TR, 2020, EXPERT REV VACCINES, V19, P57, DOI 10.1080/14760584.2020.1711055; Converso TR, 2017, VACCINE, V35, P5140, DOI 10.1016/j.vaccine.2017.08.010; Converso TR, 2017, MICROB PATHOGENESIS, V109, P233, DOI 10.1016/j.micpath.2017.06.004; Converso TR, 2017, VACCINE, V35, P149, DOI 10.1016/j.vaccine.2016.11.027; Darrieux M, 2015, CRIT REV MICROBIOL, V41, P190, DOI 10.3109/1040841X.2013.813902; Dawson C TE., 2004, PNEUMOCOCCUS, V2; Ferreira DM, 2009, CLIN VACCINE IMMUNOL, V16, P636, DOI 10.1128/CVI.00395-08; Ghaffar F, 2004, CLIN INFECT DIS, V39, P930, DOI 10.1086/423379; Ghaffar Faryal, 2005, Expert Opin Drug Saf, V4, P631, DOI 10.1517/14740338.4.4.631; Goulart C, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00133-17; Goulart C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059605; Goulart C, 2011, VACCINE, V29, P1634, DOI 10.1016/j.vaccine.2010.12.074; Hansen J, 2006, PEDIATR INFECT DIS J, V25, P779, DOI 10.1097/01.inf.0000232706.35674.2f; Henriques-Normark B, 2010, EXP CELL RES, V316, P1408, DOI 10.1016/j.yexcr.2010.03.003; Hollingshead SK, 2000, INFECT IMMUN, V68, P5889, DOI 10.1128/IAI.68.10.5889-5900.2000; Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0; Lu YJ, 2009, INFECT IMMUN, V77, P2076, DOI 10.1128/IAI.01554-08; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Malley R, 2001, INFECT IMMUN, V69, P4870, DOI 10.1128/IAI.69.8.4870-4873.2001; Mehr S, 2012, PAEDIATR RESPIR REV, V13, P258, DOI 10.1016/j.prrv.2011.12.001; Min X, 2012, VACCINE, V30, P3624, DOI 10.1016/j.vaccine.2012.03.042; MITCHELL TJ, 1991, MOL MICROBIOL, V5, P1883, DOI 10.1111/j.1365-2958.1991.tb00812.x; OBrien KL, 1996, PEDIATR INFECT DIS J, V15, P425, DOI 10.1097/00006454-199605000-00009; Pneumococcal conjugate vaccine for childhood immunization-WHO position paper, 2007, WKLY EPIDEMIOL REC; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; RODRIGUEZ D, 1992, BRAZ J MED BIOL RES, V25, P823; RUBINS JB, 1992, INFECT IMMUN, V60, P1740, DOI 10.1128/IAI.60.5.1740-1746.1992; Shah P, 2006, FEMS MICROBIOL LETT, V261, P235, DOI 10.1111/j.1574-6968.2006.00352.x; Shah P, 2011, MICROBIOL-SGM, V157, P504, DOI 10.1099/mic.0.042564-0; Shah P, 2008, MICROB PATHOGENESIS, V45, P167, DOI 10.1016/j.micpath.2008.05.001; Shah P, 2009, EXP BIOL MED, V234, P403, DOI 10.3181/0809-RM-269; Skinner J, 2010, J IMMUNOL, V184; Su YF, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00686; Yother J., 2004, CAPSULES PNEUMOCOCCU	39	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0273017	10.1371/journal.pone.0273017	http://dx.doi.org/10.1371/journal.pone.0273017			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994444	Green Published, gold			2022-12-26	WOS:000877093400034
J	Mwau, M; Schaffer, S; Kimani, H; Kasiano, P; Ogolla, F; Ajema, E; Adoyo, S; Nyairo, E; Saleri, N; Nair, SV				Mwau, Matilu; Schaffer, Sven; Kimani, Humphrey; Kasiano, Purity; Ogolla, Francis; Ajema, Elizabeth; Adoyo, Scriven; Nyairo, Ednah; Saleri, Norah; Nair, Sangeetha Vijaysri			Comparison of the performance of Aptima HIV-1 Quant Dx Assay with Abbott RealTime HIV Assay for viral load monitoring using plasma and Dried Blood Spots collected in Kenya	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RNA QUANTITATION; V2.0 ASSAY; QUANTIFICATION; AMPLIFICATION; SYSTEM	Introduction HIV-1 viral Load (VL) testing is recommended for the monitoring of antiretroviral treatment. Dried Blood Spots (DBS) are an effective sample type in resource limited settings, where safe phlebotomy and reliable shipping are hard to guarantee. In HIV high burden countries, high throughput assays can improve access to testing services. The Hologic Aptima HIV-1 Quant Dx Assay (Aptima Assay) is a high throughput assay that runs on the CE-IVD approved Panther platform. The objectives of this study were to assess the performance characteristics of Aptima for VL monitoring using plasma and venous DBS specimens and to determine the stability of HIV-1 RNA in DBS. Materials and methods This was a cross-sectional study of 2227 HIV infected adults visiting health facilities in Nairobi and Busia, Kenya. Each provided a venous blood sample; plasma was prepared from 1312 samples while paired DBS samples and plasma were prepared from the remaining 915 samples. The agreement between the Aptima assay and the Abbott RealTime HIV-1 Assay (Abbott RT) was analysed by comparing the HIV-1 VL in both assays at the medical decision point of 1000 copies/mL. To assess stability of HIV-1 RNA in DBS, VL in DBS spotted on day 0 were compared with that from the same DBS card after 21 days of storage at room temperature. Results Overall, 436 plasma samples had quantifiable results in both Aptima and Abbott RT. The agreement between the two assays at 1000 copies/mL was 97.48% with a Pearson' correlation coefficient (r) of 0.9589 and gave a mean bias of 0.33 log copies/mL on Bland-Altman analysis. For fresh DBS, the agreement in both assays was 94.64% at 1000 copies/mL, with an r of 0.8692 and a mean bias of 0.35 log copies/mL. The overall agreement between DBS tested in Aptima on day 0 versus day 21 was 95.71%, with a mean bias of -0.154. Conclusion The Aptima HIV-1 Quant Dx assay is an accurate test for VL monitoring of HIV-1 using DBS and plasma sample types in Kenya.	[Mwau, Matilu; Kimani, Humphrey; Kasiano, Purity; Ogolla, Francis; Ajema, Elizabeth; Adoyo, Scriven; Nyairo, Ednah; Saleri, Norah] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Schaffer, Sven] Hologic Deutschland GmbH, Wiesbaden, Germany; [Nair, Sangeetha Vijaysri] Hologic Inc, San Diego, CA USA	Kenya Medical Research Institute	Mwau, M (corresponding author), Kenya Govt Med Res Ctr, Nairobi, Kenya.	mmwau@kemri.go.ke			Hologic, Inc	Hologic, Inc	Hologic, Inc provided the funds and materials for the study.	Amendola A, 2016, J MED VIROL, V88, P1535, DOI 10.1002/jmv.24493; [Anonymous], ABBOTT REALTIME HIV; [Anonymous], AW11853001REV3; [Anonymous], 2019, PACKAGE INSERT DRIED; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bbosa N, 2019, CURR OPIN HIV AIDS, V14, P153, DOI 10.1097/COH.0000000000000534; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Carrera A, 2015, PERFORMANCE EVALUATI, V91, pA1; Gounder K, 2017, AIDS RES HUM RETROV, V33, P500, DOI [10.1089/AID.2016.0321, 10.1089/aid.2016.0321]; Hatzakis A, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0627-y; HIV/AIDS,, 2014, 90 90 90 AMB TREATM; Hopkins M, 2015, J CLIN VIROL, V69, P56, DOI 10.1016/j.jcv.2015.05.020; Manak MM, 2016, J CLIN MICROBIOL, V54, P2575, DOI 10.1128/JCM.01350-16; Ministry of Health, GUIDELINES USE ANTIR; Monleau M, 2010, J ANTIMICROB CHEMOTH, V65, P1562, DOI 10.1093/jac/dkq205; Mor O, 2015, J CLIN MICROBIOL, V53, P3458, DOI 10.1128/JCM.01806-15; Mwau M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249376; Nair SV, 2016, J CLIN VIROL, V77, P46, DOI 10.1016/j.jcv.2016.02.002; Rutherford GW, 2014, AIDS, V28, pS161, DOI 10.1097/QAD.0000000000000236; Sahoo MK, 2016, J CLIN MICROBIOL, V54, P2597, DOI 10.1128/JCM.01569-16; Sam SS, 2016, J CLIN MICROBIOL, V54, P1036, DOI 10.1128/JCM.03289-15; Saune K, 2016, J CLIN VIROL, V84, P70, DOI 10.1016/j.jcv.2016.09.002; Schalasta G, 2016, CLIN CHEM LAB MED, V54, P493, DOI 10.1515/cclm-2015-0522; Schonning K, 2017, J CLIN VIROL, V92, P14, DOI 10.1016/j.jcv.2017.05.006; Sloma CR, 2009, J CLIN MICROBIOL, V47, P889, DOI 10.1128/JCM.02231-08; UNAIDS,, 2021, HIV AIDS STAT; Wiesmann F, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.00292-18; World Health Organization, 2013, CONSOLIDATED GUIDELI; World Health Organization, 2014, TECHN OP CONS IMPL H; Yek C, 2017, J CLIN MICROBIOL, V55, P2544, DOI 10.1128/JCM.00425-17	30	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2022	17	8							e0269838	10.1371/journal.pone.0269838	http://dx.doi.org/10.1371/journal.pone.0269838			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2VT	35994447	Green Published, gold			2022-12-26	WOS:000877093400004
J	Du, QY; Huo, FC; Du, WQ; Sun, XL; Jiang, X; Zhang, LS; Pei, DS				Du, Qiu-Ying; Huo, Fu-Chun; Du, Wen-Qi; Sun, Xiao-Lin; Jiang, Xin; Zhang, Lan-Sheng; Pei, Dong-Sheng			METTL3 potentiates progression of cervical cancer by suppressing ER stress via regulating m6A modification of TXNDC5 mRNA	ONCOGENE			English	Article							ENDOPLASMIC-RETICULUM; DISULFIDE-ISOMERASE; LUNG-CANCER; EXPRESSION; APOPTOSIS; PROTEIN; CARCINOMA; ETS-1; TRANSCRIPTION; INVOLVEMENT	N6-methyladenosine (m6A) is the most abundant chemical modification on mRNA and plays significant roles in many bioprocesses. However, the functions of m6A on cervical cancer (CC) tumorigenesis remain unclear. Here we found methyltransferase-like 3 (METTL3), a core member of the m6A methyltransferase family, was greatly upregulated as an independent prognostic factor in CC. Mechanistically, the transcription factor ETS1 recruited P300 and WDR5 which separately mediated H3K27ac and H3K4me3 histone modification in the promoter of METTL3 and induced METTL3 transcription activation. Furthermore, we identified TXNDC5 as a target of METTL3-mediated m6A modification through MeRIP-seq, and revealed that METTL3-mediated TXNDC5 expression relied on the m6A reader-dependent manner. Functionally, we verified that METTL3 promoted proliferation and metastasis of CC cells by regulating of TXNDC5 expression through in vitro and in vivo experiments. In addition, our study verified the effect of METTL3/TXNDC5 axis on ER stress. Taken together, METTL3 facilitates the malignant progression of CC, suggesting that METTL3 might be a potential prognostic biomarker and therapeutic target for CC.	[Du, Qiu-Ying; Huo, Fu-Chun; Du, Wen-Qi; Sun, Xiao-Lin; Jiang, Xin; Pei, Dong-Sheng] Xuzhou Med Univ, Dept Pathol, 209 Tong Shan Rd, Xuzhou 221004, Jiangsu, Peoples R China; [Zhang, Lan-Sheng] Xuzhou Med Univ, Affiliated Hosp 2, Dept Oncol Radiotherapy, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University	Pei, DS (corresponding author), Xuzhou Med Univ, Dept Pathol, 209 Tong Shan Rd, Xuzhou 221004, Jiangsu, Peoples R China.; Zhang, LS (corresponding author), Xuzhou Med Univ, Affiliated Hosp 2, Dept Oncol Radiotherapy, Xuzhou, Jiangsu, Peoples R China.	lanshengyan@163.com; dspei@xzhmu.edu.cn			National Natural Science Foundation of China [81872080]; Jiangsu Provincial Medical Talent [ZDRCA2016055]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Medical Talent	This work was supported by the National Natural Science Foundation of China (No.81872080), Jiangsu Provincial Medical Talent (ZDRCA2016055).	Beacon TH, 2021, CLIN EPIGENETICS, V13, DOI 10.1186/s13148-021-01126-1; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Biancotto C, 2010, ADV GENET, V70, P341, DOI [10.1016/B978-0-12-380866-0.60013-7, 10.1016/S0065-2660(10)70013-4]; Chawsheen HA, 2019, J BIOL CHEM, V294, P8991, DOI 10.1074/jbc.RA118.005804; Chen X, 2021, INT IMMUNOPHARMACOL, V95, DOI 10.1016/j.intimp.2021.107519; Datan E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.409; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Du QY, 2021, INVEST NEW DRUG, V39, P1682, DOI 10.1007/s10637-021-01148-9; Froimchuk E, 2017, GENE, V627, P337, DOI 10.1016/j.gene.2017.06.056; Funkner A, 2013, J MOL BIOL, V425, P1340, DOI 10.1016/j.jmb.2013.01.029; Hasanain M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.219; Horna-Terron E, 2014, INT J MOL SCI, V15, P23501, DOI 10.3390/ijms151223501; Jorgensen MM, 2003, APMIS, V111, P86; Kojima R, 2014, STRUCTURE, V22, P431, DOI 10.1016/j.str.2013.12.013; Kumar P, 2009, HYPERTENSION, V54, P172, DOI 10.1161/HYPERTENSIONAHA.109.133033; Lee CG, 2012, J IMMUNOL, V188, P2244, DOI 10.4049/jimmunol.1101614; Li Jian, 2017, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V34, P448, DOI 10.3760/cma.j.issn.1003-9406.2017.03.031; Li T, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1038-7; Li X, 2017, ONCOTARGET, V8, P96103, DOI 10.18632/oncotarget.21726; Lin Y, 2020, CANCER MED-US, V9, P2859, DOI 10.1002/cam4.2918; Liu JY, 2020, ONCOTARGETS THER, V13, P11957, DOI 10.2147/OTT.S276559; Liu K, 2016, CURR PROTEIN PEPT SC, V17, P306, DOI 10.2174/1389203716666150901113553; Liu SP, 2020, AM J CANCER RES, V10, P1631; Liu SP, 2020, AM J CANCER RES, V10, P1068; Lu MJ, 2020, NAT MICROBIOL, V5, P584, DOI 10.1038/s41564-019-0653-9; Luo GY, 2020, J CELL PHYSIOL, V235, P7107, DOI 10.1002/jcp.29608; Lopez AM, 2021, GENES-BASEL, V12, DOI 10.3390/genes12071019; Matsusaki M, 2020, BBA-GEN SUBJECTS, V1864, DOI 10.1016/j.bbagen.2019.04.003; Park MS, 2013, ANTICANCER RES, V33, P3983; Pecoraro A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197334; Peng FS, 2018, MOL MED REP, V17, P4767, DOI 10.3892/mmr.2018.8376; Ren Tao-wen, 2009, Zhonghua Zhong Liu Za Zhi, V31, P674; Senft D, 2015, TRENDS BIOCHEM SCI, V40, P141, DOI 10.1016/j.tibs.2015.01.002; Shen CQ, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01190-w; Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15; Song SL, 2017, J CELL PHYSIOL, V232, P2977, DOI 10.1002/jcp.25785; Sullivan DC, 2003, J BIOL CHEM, V278, P47079, DOI 10.1074/jbc.M308124200; Sun T, 2019, BIOMED PHARMACOTHER, V112, DOI 10.1016/j.biopha.2019.108613; Tan FB, 2018, INT J MOL MED, V42, P935, DOI 10.3892/ijmm.2018.3664; Teruyama K, 2001, J CELL PHYSIOL, V188, P243, DOI 10.1002/jcp.1112; Tong JY, 2018, FRONT MED-PRC, V12, P481, DOI 10.1007/s11684-018-0654-8; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang L, 2015, ONCOGENE, V34, P4735, DOI 10.1038/onc.2014.401; Wang Q, 2020, GUT, V69, P1193, DOI 10.1136/gutjnl-2019-319639; Wang QQ, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03071-y; Wang TY, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01204-7; Wang XL, 2017, ONCOTARGET, V8, P98918, DOI 10.18632/oncotarget.22041; Wei WW, 2019, CANCER MANAG RES, V11, P1177, DOI 10.2147/CMAR.S181058; Xu B, 2017, ONCOTARGET, V8, P91009, DOI 10.18632/oncotarget.18857; Xu J, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009530; Xu Y, 2015, MOL MED REP, V11, P189, DOI 10.3892/mmr.2014.2683; Yan JJ, 2020, BIOCHEM BIOPH RES CO, V521, P887, DOI 10.1016/j.bbrc.2019.11.016; Yang YX, 2020, J CELL MOL MED, V24, P2772, DOI 10.1111/jcmm.15030; Yue B, 2021, MOL THER-NUCL ACIDS, V26, P458, DOI 10.1016/j.omtn.2021.08.019; Zeng CW, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00951-w; Zhao W, 2020, MOL THER-NUCL ACIDS, V20, P1, DOI 10.1016/j.omtn.2020.01.033; Zhu LY, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1585-2; Zou DL, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-1045-1	58	1	1	13	13	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 23	2022	41	39					4420	4432		10.1038/s41388-022-02435-2	http://dx.doi.org/10.1038/s41388-022-02435-2		AUG 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	4S3XC	35987795				2022-12-26	WOS:000843263800001
J	Yi, YM; Li, P; Huang, YF; Chen, DY; Fan, SW; Wang, J; Yang, MQ; Zeng, SS; Deng, J; Lv, XW; Luo, K; He, ZW; Liu, H				Yi, Yanmei; Li, Pan; Huang, Yuanfeng; Chen, Danyang; Fan, Siwen; Wang, Jun; Yang, Minqiang; Zeng, Shanshan; Deng, Jin; Lv, Xinwu; Luo, Kai; He, Zhiwei; Liu, Hao			P21-activated kinase 2-mediated beta-catenin signaling promotes cancer stemness and osimertinib resistance in EGFR-mutant non-small-cell lung cancer	ONCOGENE			English	Article							ACQUIRED-RESISTANCE; 1ST-LINE TREATMENT; UP-REGULATION; OPEN-LABEL; INHIBITORS; MUTATION; TKI; CHEMOTHERAPY; CONTRIBUTES; ACTIVATION	Osimertinib (AZD9291) is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), used for treating patients with advanced non-small-cell lung cancer (NSCLC) harboring EGFR-activating mutations or the resistant T790M mutation. However, acquired resistance to osimertinib is inevitable in EGFR-mutant NSCLC. By employing a global mass spectrometry-based phosphoproteomics approach, we identified that the activated p21-activated kinase 2 (PAK2)/beta-catenin axis acts as a driver of osimertinib resistance. We found that PAK2 directly phosphorylates beta-catenin and increases the nuclear localization of beta-catenin, leading to the increased expression and transcriptional activity of beta-catenin, which in turn enhances cancer stem-like properties and osimertinib resistance. Moreover, we revealed that HER3 as an upstream regulator of PAK2, drives the activation of PAK2/beta-catenin pathways in osimertinib-resistant cells. The clinical relevance of these findings was further confirmed by examining tissue specimens from patients with EGFR-mutant NSCLC. The results demonstrated that the levels of HER3, phospho-PAK2 (p-PAK2) and beta-catenin in the tissues from patients with EGFR-mutant NSCLC, that had relapsed after treatment with osimertinib, were elevated compared to those of the corresponding untreated tissues. Additionally, the high levels of HER3, p-PAK2 and beta-catenin correlated with shorter progression-free survival (PFS) in patients with EGFR-TKI-treated NSCLC. We additionally observed that the suppression of PAK2 via knockdown or pharmacological targeting with PAK inhibitors markedly restored the response of osimertinib-resistant NSCLC cells to osimertinib both in vitro and in vivo. In conclusion, these results indicated that the PAK2-mediated activation of beta-catenin is important for osimertinib resistance and targeting the HER3/PAK2/beta-catenin pathway has potential therapeutic value in NSCLCs with acquired resistance to osimertinib.	[Yi, Yanmei; Fan, Siwen; Lv, Xinwu; He, Zhiwei] Guangdong Med Univ, Sch Basic Med Sci, Zhanjiang, Guangdong, Peoples R China; [Li, Pan; Huang, Yuanfeng; Chen, Danyang; Wang, Jun; Yang, Minqiang; Zeng, Shanshan; Deng, Jin; Luo, Kai; Liu, Hao] Guangzhou Med Univ, Guangzhou Key Lab Translat Med Malignant Tumor Tr, Affiliated Canc Hosp & Inst, Guangzhou, Guangdong, Peoples R China; [He, Zhiwei] Guangdong Med Univ, China Amer Canc Res Inst, Guangzhou, Guangdong, Peoples R China	Guangdong Medical University; Guangzhou Medical University; Guangdong Medical University	He, ZW (corresponding author), Guangdong Med Univ, Sch Basic Med Sci, Zhanjiang, Guangdong, Peoples R China.; Luo, K; Liu, H (corresponding author), Guangzhou Med Univ, Guangzhou Key Lab Translat Med Malignant Tumor Tr, Affiliated Canc Hosp & Inst, Guangzhou, Guangdong, Peoples R China.; He, ZW (corresponding author), Guangdong Med Univ, China Amer Canc Res Inst, Guangzhou, Guangdong, Peoples R China.	luokainan@126.com; 467853605@qq.com; liuhao@gzhmu.edu.cn		Chen, Danyang/0000-0002-7894-9457	National Natural Science Foundation of China [81972194, 82172810, 81772825]; Guangdong Natural Science Funds [2019A1515010113]; Science and Technology Program of Guangzhou [202201010839]; Medical Scientific Research Foundation of Guangdong [B2020165]; Discipline construction project of Guangdong Medical University [4SG22005G]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Funds; Science and Technology Program of Guangzhou; Medical Scientific Research Foundation of Guangdong; Discipline construction project of Guangdong Medical University	This work was supported by the National Natural Science Foundation of China (81972194, 82172810, 81772825); Guangdong Natural Science Funds (2019A1515010113); The Science and Technology Program of Guangzhou (202201010839); Medical Scientific Research Foundation of Guangdong (B2020165); Discipline construction project of Guangdong Medical University (4SG22005G).	Araiza-Olivera D, 2018, ONCOGENE, V37, P944, DOI 10.1038/onc.2017.400; Arasada RR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05626-2; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; CARRAWAY KL, 1994, J BIOL CHEM, V269, P14303; Chiu CF, 2016, P NATL ACAD SCI USA, V113, pE2526, DOI 10.1073/pnas.1522612113; Coniglio SJ, 2008, MOL CELL BIOL, V28, P4162, DOI 10.1128/MCB.01532-07; Cross DAE, 2014, CANCER DISCOV, V4, P1046, DOI 10.1158/2159-8290.CD-14-0337; Del Re M, 2018, STEM CELLS, V36, P633, DOI 10.1002/stem.2787; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Eberlein CA, 2015, CANCER RES, V75, P2489, DOI 10.1158/0008-5472.CAN-14-3167; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Gupta A, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0887-0; Holland JD, 2013, CURR OPIN CELL BIOL, V25, P254, DOI 10.1016/j.ceb.2013.01.004; Huynh N, 2016, CANCER BIOL THER, V17, P813, DOI 10.1080/15384047.2016.1195045; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kumar R, 2016, ADV CANCER RES, V130, P137, DOI 10.1016/bs.acr.2016.01.002; Kumar R, 2017, GENE, V605, P20, DOI 10.1016/j.gene.2016.12.014; Kuo MH, 2020, CANCER RES, V80, P4426, DOI 10.1158/0008-5472.CAN-19-3228; Leonetti A, 2019, BRIT J CANCER, V121, P725, DOI 10.1038/s41416-019-0573-8; Licciulli S, 2013, J BIOL CHEM, V288, P29105, DOI 10.1074/jbc.M113.510933; Lopez-Haber C, 2016, MOL CELL BIOL, V36, P2011, DOI 10.1128/MCB.00180-16; Lu HZ, 2017, NATURE, V550, P133, DOI 10.1038/nature24040; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mok Tony S, 2017, N Engl J Med, V376, P629, DOI 10.1056/NEJMoa1612674; Nakayama S, 2014, CANCER RES, V74, P5891, DOI 10.1158/0008-5472.CAN-14-0184; Ortiz-Cuaran S, 2016, CLIN CANCER RES, V22, P4837, DOI 10.1158/1078-0432.CCR-15-1915; Papadimitrakopoulou VA, 2020, ANN ONCOL, V31, P1536, DOI 10.1016/j.annonc.2020.08.2100; Park K, 2016, LANCET ONCOL, V17, P577, DOI 10.1016/S1470-2045(16)30033-X; Radu M, 2014, NAT REV CANCER, V14, P13, DOI 10.1038/nrc3645; Ramalingam SS, 2020, NEW ENGL J MED, V382, P41, DOI 10.1056/NEJMoa1913662; Ramalingam SS, 2018, J CLIN ONCOL, V36, P841, DOI 10.1200/JCO.2017.74.7576; Rane CK, 2019, SEMIN CANCER BIOL, V54, P40, DOI 10.1016/j.semcancer.2018.01.006; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Rudolph J, 2016, J MED CHEM, V59, P5520, DOI 10.1021/acs.jmedchem.6b00638; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shah KN, 2019, NAT MED, V25, P111, DOI 10.1038/s41591-018-0264-7; Shien K, 2013, CANCER RES, V73, P3051, DOI 10.1158/0008-5472.CAN-12-4136; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Soria JC, 2018, NEW ENGL J MED, V378, P113, DOI 10.1056/NEJMoa1713137; Stewart DJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt356; Sun J, 2009, ONCOGENE, V28, P3132, DOI 10.1038/onc.2009.167; Taniguchi H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08074-0; Togashi Y, 2015, J THORAC ONCOL, V10, P93, DOI 10.1097/JTO.0000000000000353; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Wang K, 2019, AM J TRANSL RES, V11, P3353; Yeo D, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2057-z; Yonesaka K, 2022, CLIN CANCER RES, V28, P390, DOI 10.1158/1078-0432.CCR-21-3359; Yu HA, 2015, JAMA ONCOL, V1, P981, DOI 10.1001/jamaoncol.2015.1066; Zeng Y, 2022, CURR OPIN ONCOL, V34, P54, DOI 10.1097/CCO.0000000000000805; Zhang F, 2021, ONCOGENE, V40, P5854, DOI 10.1038/s41388-021-01986-0; Zhang X, 2021, CANCER RES, V81, P3051, DOI 10.1158/0008-5472.CAN-20-2435; Zhang Y, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00990-3; Zhou L, 2011, NEOPLASIA, V13, P1101, DOI 10.1593/neo.111060	53	0	0	6	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 9	2022	41	37					4318	4329		10.1038/s41388-022-02438-z	http://dx.doi.org/10.1038/s41388-022-02438-z		AUG 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	4L2AN	35986102				2022-12-26	WOS:000843252700002
J	Kaggiah, A; Wilson, K; Richardson, BA; Kinuthia, J; Farquhar, C; McClelland, RS				Kaggiah, Anne; Wilson, Katherine; Richardson, Barbra A.; Kinuthia, John; Farquhar, Carey; McClelland, R. Scott			Prevalence and correlates of intimate partner violence among women with HIV in serodifferent relationships in Nairobi, Kenya	PLOS ONE			English	Article							DOMESTIC VIOLENCE; TRANSACTIONAL SEX; RISK-FACTORS; VICTIMIZATION; INTERVENTION; PREDICTORS; PREGNANCY; PROJECT; MOMBASA	Background Intimate partner violence (IPV) is a major public health problem and is the most common form of violence against women. Women with HIV in serodifferent relationships may be at an increased risk of IPV compared to women without HIV, hindering their ability to adhere to antiretroviral therapy, clinic appointments, and condom use during sex. This study assessed the prevalence and correlates of IPV in the past year among women with HIV in serodifferent relationships in Nairobi, Kenya. Methods This cross-sectional study included women with HIV in serodifferent relationships who were at least 18 years old and provided written informed consent. Their experience of physical, sexual, or emotional violence in the past year by the current partner was assessed using 13 questions adapted from the World Health Organization survey on violence against women. Standardized instruments were used to assess sociodemographic and behavioral factors. Associations between intimate partner violence and other variables were evaluated using log binomial regression models. Results Of the 159 women enrolled, 47 (29.6%, 95% CI 22.9-37.2%) reported IPV in the past year. Of these, 32 (68.1%) reported emotional, 27 (57.4%) physical, and 27 (57.4%) sexual violence. In the multivariate model, pregnancy (adjusted prevalence ratio [aPR] 2.14, 95% CI 1.09-4.20), alcohol use (minimal drinking aPR 1.91, 95% CI 1.10-3.33; moderate/severe drinking aPR 1.17, 95% CI 0.53-2.59), male partner controlling behavior (aPR 2.09, 95% CI 1.24-3.51), and past physical violence (aPR 1.93, 95% CI 1.22-3.05) remained significantly associated with a higher prevalence of IPV in the past year. Conclusion This study identified a high prevalence of IPV in the past year among women with HIV in serodifferent relationships. Pregnant women and women who had experienced prior violence had a higher prevalence of IPV. These data highlight the need to screen for IPV during clinic visits, and to offer evidence based interventions to support women in serodifferent relationships who have experienced IPV.	[Kaggiah, Anne; Kinuthia, John] Kenyatta Natl Hosp, Res & Programs Dept, Nairobi, Kenya; [Wilson, Katherine; Richardson, Barbra A.; Farquhar, Carey; McClelland, R. Scott] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Richardson, Barbra A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Farquhar, Carey; McClelland, R. Scott] Univ Washington, Dept Med, Seattle, WA USA; [Farquhar, Carey; McClelland, R. Scott] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [McClelland, R. Scott] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya	Kenyatta National Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Nairobi	Kaggiah, A (corresponding author), Kenyatta Natl Hosp, Res & Programs Dept, Nairobi, Kenya.	akaggiah@gmail.com		McClelland, Raymond Scott/0000-0003-2574-4201	National Institutes of Health [R01 HD072617, D43 TW009580-06, K24-HD88229]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by a grant from the National Institutes of Health (R01 HD072617). AK received research mentorship support through D43 TW009580-06. RSM and CF receive support for mentoring through K24-HD88229 and D43 TW009580-06, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsky T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-109; Adjiwanou V, 2015, STUD FAMILY PLANN, V46, P127, DOI 10.1111/j.1728-4465.2015.00020.x; Antai D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-511; Bailey BA, 2010, INT J WOMENS HEALTH, V2, P183, DOI 10.2147/ijwh.s8632; Bello Folasade Adenike, 2011, ISRN Obstet Gynecol, V2011, P856586, DOI 10.5402/2011/856586; Bello O., 2018, TROP J OBS GYNAECOL, V35, P292; Capaldi DM, 2012, PARTN ABUSE, V3, P231, DOI 10.1891/1946-6560.3.2.231; Costa BM, 2015, AGGRESS VIOLENT BEH, V24, P261, DOI 10.1016/j.avb.2015.06.001; Devries KM, 2014, ADDICTION, V109, P379, DOI 10.1111/add.12393; Ehrensaft MK, 2003, J CONSULT CLIN PSYCH, V71, P741, DOI 10.1037/0022-006X.71.4.741; Emusu D, 2009, AIDS CARE, V21, P1363, DOI 10.1080/09540120902883077; Gazmararian JA, 1996, JAMA-J AM MED ASSOC, V275, P1915, DOI 10.1001/jama.275.24.1915; Hardesty JL, 2006, FAM RELAT, V55, P200, DOI 10.1111/j.1741-3729.2006.00370.x; Heise L L, 1998, Violence Against Women, V4, P262, DOI 10.1177/1077801298004003002; Heise L, 2019, SSM-POPUL HLTH, V9, DOI 10.1016/j.ssmph.2019.100377; Jasinski Jana L, 2004, Trauma Violence Abuse, V5, P47, DOI 10.1177/1524838003259322; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Kazaura MR, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3161-3; Kelmendi K., 2013, PSYCHOL INTERNET, V4, P559; Kenya National Bureau of Statistics Ministry of Health/Kenya National AIDS Control Council Kenya Medical Research Institute National Council for Population Development ICF International, 2014, KENYA DEMOGRAPHIC HL; Kevany S, 2013, J PUBLIC HEALTH AFR, V4, P1, DOI 10.4081/jphia.2013.e1; Kouyoumdjian FG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081044; Kouyoumdjian FG, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-566; London School of Hygiene and Tropical Medicine, 2013, GLOBAL REGIONAL ESTI; Marshall KJ, 2018, AIDS BEHAV, V22, P3244, DOI 10.1007/s10461-017-2020-2; Monahan PO, 2009, J GEN INTERN MED, V24, P189, DOI 10.1007/s11606-008-0846-z; Mulrenan C, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006907; Osinde MO, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-50; Ruiz-Perez I, 2007, J EPIDEMIOL COMMUN H, V61, P26, DOI 10.1136/jech.2007.059907; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schraiber LB, 2010, REV SAUDE PUBL, V44, P658, DOI 10.1590/S0034-89102010000400009; Shamu S, 2013, TROP MED INT HEALTH, V18, P696, DOI 10.1111/tmi.12078; Shamu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017591; Shi CF, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-512; Siemieniuk RAC, 2013, CURR HIV-AIDS REP, V10, P380, DOI 10.1007/s11904-013-0173-9; Wechsberg WM, 2011, J DRUG ISSUES, V41, P233, DOI 10.1177/002204261104100205; Were E, 2011, AIDS, V25, P2009, DOI 10.1097/QAD.0b013e32834b005d; Wilson KS, 2016, INT J STD AIDS, V27, P1194, DOI 10.1177/0956462415611514; Wilson KS, 2016, AIDS BEHAV, V20, P2065, DOI 10.1007/s10461-016-1420-z; World Health Organization, 2012, INTIMATE PARTNER VIO; World Health Organization, 2002, WORLD REPORT VIOLENC; Young CR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202992	43	0	0	11	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0272640	10.1371/journal.pone.0272640	http://dx.doi.org/10.1371/journal.pone.0272640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976905	Green Published, gold			2022-12-26	WOS:000847227000052
J	Nishi, K; Fu, WQ; Kiyama, R				Nishi, Kentaro; Fu, Wenqiang; Kiyama, Ryoiti			Novel estrogen-responsive genes (ERGs) for the evaluation of estrogenic activity	PLOS ONE			English	Article							BREAST-CANCER CELLS; RNA-SEQ; DNA MICROARRAY; EXPRESSION; IDENTIFICATION; TRANSCRIPTION; BINDING; PROTEIN; PROLIFERATION; ALPHA	Estrogen action is mediated by various genes, including estrogen-responsive genes (ERGs). ERGs have been used as reporter-genes and markers for gene expression. Gene expression profiling using a set of ERGs has been used to examine statistically reliable transcriptomic assays such as DNA microarray assays and RNA sequencing (RNA-seq). However, the quality of ERGs has not been extensively examined. Here, we obtained a set of 300 ERGs that were newly identified by six sets of RNA-seq data from estrogen-treated and control human breast cancer MCF-7 cells. The ERGs exhibited statistical stability, which was based on the coefficient of variation (CV) analysis, correlation analysis, and examination of the functional association with estrogen action using database searches. A set of the top 30 genes based on CV ranking were further evaluated quantitatively by RT-PCR and qualitatively by a functional analysis using the GO and KEGG databases and by a mechanistic analysis to classify ER alpha/beta-dependent or ER-independent types of transcriptional regulation. The 30 ERGs were characterized according to (1) the enzymes, such as metabolic enzymes, proteases, and protein kinases, (2) the genes with specific cell functions, such as cell-signaling mediators, tumor-suppressors, and the roles in breast cancer, (3) the association with transcriptional regulation, and (4) estrogen-responsiveness. Therefore, the ERGs identified here represent various cell functions and cell signaling pathways, including estrogen signaling, and thus, may be useful to evaluate estrogenic activity.	[Nishi, Kentaro; Fu, Wenqiang; Kiyama, Ryoiti] Kyushu Sangyo Univ Matsukadai, Fac Life Sci, Dept Life Sci, Higashi Ku, Fukuoka, Japan		Kiyama, R (corresponding author), Kyushu Sangyo Univ Matsukadai, Fac Life Sci, Dept Life Sci, Higashi Ku, Fukuoka, Japan.	kiyama.r@ip.kyusan-u.ac.jp			Kyushu Sangyo University for promoting basic technologies; Ministry of Education, Culture, Sports, Science and Technology of Japan [Kakenhi 20H04343]	Kyushu Sangyo University for promoting basic technologies; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported partly by a grant from Kyushu Sangyo University for promoting basic technologies, and a Grant-in-Aid for Basic Areas (Kakenhi 20H04343) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Alcaraz LB, 2021, THERANOSTICS, V11, P6173, DOI 10.7150/thno.58254; Antony J, 2015, BBA-GENE REGUL MECH, V1849, P257, DOI 10.1016/j.bbagrm.2014.12.011; Ashraf Y, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0498-z; Asperger H, 2020, BREAST CANCER RES, V22, DOI 10.1186/s13058-020-01312-8; Aushev VN, 2018, CLIN CANCER RES, V24, P581, DOI 10.1158/1078-0432.CCR-17-0996; Avino S, 2016, ONCOTARGET, V7, P52710, DOI 10.18632/oncotarget.10348; Barutcu AR, 2016, BBA-GENE REGUL MECH, V1859, P1389, DOI 10.1016/j.bbagrm.2016.08.003; Benes P, 2008, CRIT REV ONCOL HEMAT, V68, P12, DOI 10.1016/j.critrevonc.2008.02.008; Bernard DJ, 2020, TRENDS ENDOCRIN MET, V31, P37, DOI 10.1016/j.tem.2019.08.014; Bockers M, 2020, TOXICOL APPL PHARM, V396, DOI 10.1016/j.taap.2020.114995; Bojcsuk D, 2017, NUCLEIC ACIDS RES, V45, P3693, DOI 10.1093/nar/gkw1283; Bond HM, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00255; Bouju S, 1999, NEUROMUSCULAR DISORD, V9, P3, DOI 10.1016/S0960-8966(98)00087-X; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chen J, 2018, J LEUKOCYTE BIOL, V104, P953, DOI 10.1002/JLB.MR1117-471R; Chen X, 2018, BIOINFORMATICS, V34, P1733, DOI 10.1093/bioinformatics/btx827; Chiarella E, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22168461; Choi HJ, 2012, BIOCHEM BIOPH RES CO, V426, P620, DOI 10.1016/j.bbrc.2012.08.140; Chung S, 2009, ONCOGENE, V28, P2849, DOI 10.1038/onc.2009.144; Cicatiello L, 2004, J MOL ENDOCRINOL, V32, P719, DOI 10.1677/jme.0.0320719; Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8; Coscujuela Tarrero Lucia, 2018, Oncotarget, V9, P14580, DOI 10.18632/oncotarget.24522; Deak F, 1999, MATRIX BIOL, V18, P55, DOI 10.1016/S0945-053X(98)00006-7; Flach KD, 2016, J ENDOCRINOL, V229, pR43, DOI 10.1530/JOE-16-0003; de la Guardia-Bolivar ED, 2022, INT J CANCER, V151, P255, DOI 10.1002/ijc.33988; Ding M, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/568950; Doherty JA, 2010, CANCER EPIDEM BIOMAR, V19, P245, DOI 10.1158/1055-9965.EPI-09-0729; Dong S, 2011, ENVIRON POLLUT, V159, P212, DOI 10.1016/j.envpol.2010.09.004; Dong S, 2013, J AGR FOOD CHEM, V61, P128, DOI 10.1021/jf304546a; Dou PH, 2016, EXP BIOL MED, V241, P1911, DOI 10.1177/1535370216655908; Drabovich AP, 2016, MOL CELL PROTEOMICS, V15, P2093, DOI 10.1074/mcp.M115.057257; Fachal L, 2020, NAT GENET, V52, P56, DOI 10.1038/s41588-019-0537-1; Faucz FR, 2015, ENDOCR-RELAT CANCER, V22, P47, DOI 10.1530/ERC-14-0465; Fei LF, 2020, IUBMB LIFE, V72, P1468, DOI 10.1002/iub.2270; Ferraro L, 2012, HORM CANCER-US, V3, P65, DOI 10.1007/s12672-012-0102-1; Ferreira S, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10020312; Ferrero G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08754-9; Finsterer J, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1025-5; Fujimoto N, 2009, J STEROID BIOCHEM, V115, P75, DOI [10.1016/j.jsbmb.2004.12.016, 10.1016/j.jsbmb.2004.02.006]; Giovannelli P, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00492; Guemes M, 2014, J BONE MINER RES, V29, P2676, DOI 10.1002/jbmr.2296; Ha NT, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9112352; Hah N, 2014, MOL CELL ENDOCRINOL, V382, P652, DOI 10.1016/j.mce.2013.06.021; Hah N, 2013, GENOME RES, V23, P1210, DOI 10.1101/gr.152306.112; Hahm ER, 2021, J CANCER PREV, V26, P128, DOI 10.15430/JCP.2021.26.2.128; Hellebrekers DMEI, 2009, CLIN CANCER RES, V15, P3990, DOI 10.1158/1078-0432.CCR-09-0055; Helzer KT, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00417-18; Herbst R, 2020, NEUROSCI LETT, V716, DOI 10.1016/j.neulet.2019.134676; Ikeda K, 2015, ACTA PHARMACOL SIN, V36, P24, DOI 10.1038/aps.2014.123; Indukuri R, 2021, INT J CANCER, V149, P692, DOI 10.1002/ijc.33573; Inoue A, 2004, J MOL ENDOCRINOL, V32, P649, DOI 10.1677/jme.0.0320649; Inoue A, 2002, J MOL ENDOCRINOL, V29, P175, DOI 10.1677/jme.0.0290175; Inoue Akio, 2006, Current Pharmacogenomics, V4, P245, DOI 10.2174/157016006778195070; Irie K, 2020, J BIOL CHEM, V295, P3017, DOI 10.1074/jbc.RA119.010783; Jones FS, 1997, P NATL ACAD SCI USA, V94, P2632, DOI 10.1073/pnas.94.6.2632; Joustra SD, 2020, J CLIN ENDOCR METAB, V105, pE70, DOI 10.1210/clinem/dgz093; Keppler D, 2006, CANCER LETT, V235, P159, DOI 10.1016/j.canlet.2005.04.001; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kiyama R, 2020, J NUTR BIOCHEM, V86, DOI 10.1016/j.jnutbio.2020.108486; Kiyama R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34415-6; Kiyama R, 2014, ENVIRON TECHNOL INNO, V1-2, P16, DOI 10.1016/j.eti.2014.09.001; Kiyama R, 2015, ENVIRON INT, V83, P11, DOI 10.1016/j.envint.2015.05.012; Kiyama R, 2014, CELL MOL LIFE SCI, V71, P2065, DOI 10.1007/s00018-013-1544-5; Kulasekaran G, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202004229; Lahoz A, 2013, ONCOGENE, V32, P4854, DOI 10.1038/onc.2012.489; Lamas A, 2019, FOOD RES INT, V125, DOI 10.1016/j.foodres.2019.108543; Lee JY, 2017, ONCOTARGET, V8, P42752, DOI 10.18632/oncotarget.17459; Lee-Sundlov MM, 2020, J THROMB HAEMOST, V18, P1535, DOI 10.1111/jth.14874; Lentjes MHFM, 2016, EXPERT REV MOL MED, V18, DOI 10.1017/erm.2016.2; Li H, 2021, ONCOL LETT, V21, DOI 10.3892/ol.2020.12365; Li MX, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.619517; Liang JQ, 2018, MOL MED REP, V17, P3218, DOI 10.3892/mmr.2017.8263; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; Lin KH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21065-x; Liu CF, 2021, REPROD SCI, V28, P178, DOI 10.1007/s43032-020-00258-8; Liu DJ, 2020, ONCOTARGETS THER, V13, P351, DOI 10.2147/OTT.S200317; Liu M, 2013, BMC COMPLEM ALTERN M, V13, DOI [10.1186/1472-6882-13-141, 10.1186/1472-6882-13-11]; Liu Y, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01279; Lobenhofer EK, 2002, MOL ENDOCRINOL, V16, P1215, DOI 10.1210/me.16.6.1215; Luo P, 2017, ONCOL REP, V37, P2057, DOI 10.3892/or.2017.5449; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mary DJSJ, 2017, J GENET GENOMICS, V44, P593, DOI 10.1016/j.jgg.2017.10.001; Men X, 2018, ONCOTARGET, V9, P4074, DOI 10.18632/oncotarget.23694; Mescher M, 2018, PHARMACOL THERAPEUT, V187, P71, DOI 10.1016/j.pharmthera.2018.02.012; Migliaccio A, 2005, CANCER RES, V65, P10585, DOI 10.1158/0008-5472.CAN-05-0912; Miranda-Carboni GA, 2011, MOL ENDOCRINOL, V25, P1126, DOI 10.1210/me.2010-0463; Montero JA, 2007, BIOESSAYS, V29, P725, DOI 10.1002/bies.20607; Moon HJ, 2013, J BIOL CHEM, V288, P30000, DOI 10.1074/jbc.C113.502310; Morita K, 2016, RHEUMATOLOGY, V55, P76, DOI 10.1093/rheumatology/kew342; Moy I, 2015, ONCOGENE, V34, P362, DOI 10.1038/onc.2013.553; Nagai T, 2014, J BIOCHEM, V155, P137, DOI 10.1093/jb/mvu001; Duong NT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094380; Niazian M, 2019, PLANTA, V249, pCP5, DOI 10.1007/s00425-019-03099-1; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; O'Mara TA, 2015, ENDOCR-RELAT CANCER, V22, P851, DOI 10.1530/ERC-15-0319; Oki S, 2018, EMBO REP, V19, DOI 10.15252/embr.201846255; Pathak BR, 2018, J STEROID BIOCHEM, V181, P20, DOI 10.1016/j.jsbmb.2018.02.012; Pfisterer P, 1996, MOL CELL BIOL, V16, P6160; Radulovich N, 2015, ONCOGENE, V34, P4238, DOI 10.1038/onc.2014.357; Rebhun JF, 2000, J BIOL CHEM, V275, P34901, DOI 10.1074/jbc.M005327200; Rui X, 2015, INT J CLIN EXP PATHO, V8, P5435; Santes-Palacios R, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5341081; Sapkota Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15539; Schoenmakers N, 2015, J ENDOCRINOL, V227, pR51, DOI 10.1530/JOE-15-0341; Schuurs-Hoeijmakers JHM, 2013, J MED GENET, V50, P802, DOI 10.1136/jmedgenet-2013-101644; SCHWIDETZKY U, 1995, BIOCHEM J, V309, P831, DOI 10.1042/bj3090831; Seki N, 2000, J HUM GENET, V45, P309, DOI 10.1007/s100380070023; Severson TM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02856-2; Shah S, 2019, SEMIN CANCER BIOL, V54, P29, DOI 10.1016/j.semcancer.2018.03.005; SHECHTER I, 1994, GENOMICS, V20, P116, DOI 10.1006/geno.1994.1135; Shen W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163962; Smid M, 2019, GENOME RES, V29, P356, DOI 10.1101/gr.238121.118; Sridhar J, 2017, MOLECULES, V22, DOI 10.3390/molecules22071143; Stevens TA, 2006, ONCOGENE, V25, P5426, DOI 10.1038/sj.onc.1209529; Su CH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166090; Susa T, 2015, J CELL PHYSIOL, V230, P1594, DOI 10.1002/jcp.24906; Tang HR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14909; Tanji Masao, 2004, Current Pharmacogenomics, V2, P255, DOI 10.2174/1570160043377529; Terasaka S, 2006, TOXICOL LETT, V163, P130, DOI 10.1016/j.toxlet.2005.10.005; Terasaka S, 2004, ENVIRON HEALTH PERSP, V112, P773, DOI 10.1289/ehp.6753; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trokovic N, 2012, AM J PHYSIOL-ENDOC M, V303, pE1015, DOI 10.1152/ajpendo.00139.2012; Uezu A, 2016, SCIENCE, V353, P1123, DOI 10.1126/science.aag0821; Valimaki MJ, 2020, IUBMB LIFE, V72, P68, DOI 10.1002/iub.2150; van der Heijden AG, 2016, EUR J CANCER, V64, P127, DOI 10.1016/j.ejca.2016.06.003; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vendrell JA, 2004, J MOL ENDOCRINOL, V32, P397, DOI 10.1677/jme.0.0320397; Vilarinho S, 2016, P NATL ACAD SCI USA, V113, P11289, DOI 10.1073/pnas.1613228113; Wakana K, 2006, CANCER LETT, V241, P281, DOI 10.1016/j.canlet.2005.10.039; Wang C, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.668743; Wang DY, 2004, MOL ENDOCRINOL, V18, P402, DOI 10.1210/me.2003-0202; Wang J, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2019.12.141; Wang SN, 2018, MOLECULES, V23, DOI 10.3390/molecules23102543; Wardell SE, 2012, MOL ENDOCRINOL, V26, P1235, DOI 10.1210/me.2012-1031; Wei HX, 2019, ADV EXP MED BIOL, V1172, P79, DOI 10.1007/978-981-13-9367-9_4; Weidenfeld K, 2016, ONCOTARGET, V7, P71362, DOI 10.18632/oncotarget.12109; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Wen B, 2020, BBA-REV CANCER, V1874, DOI 10.1016/j.bbcan.2020.188435; Wu HY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S6-S6; Wu LH, 2015, INT J MOL MED, V36, P1200, DOI 10.3892/ijmm.2015.2337; Xia HH, 1997, J CELL BIOL, V139, P507, DOI 10.1083/jcb.139.2.507; Xu JS, 2016, PHARMACEUTICS, V8, DOI 10.3390/pharmaceutics8010008; Yamaga R, 2013, HORM CANCER-US, V4, P222, DOI 10.1007/s12672-013-0140-3; Yu ZH, 2015, CELL BIOCHEM BIOPHYS, V72, P321, DOI 10.1007/s12013-014-0480-9; Yue CL, 2021, J ONCOL, V2021, DOI 10.1155/2021/4035257; Zhang JB, 2017, EUR REV MED PHARMACO, V21, P1264; Zhao Shuang, 2015, Asian Pac J Cancer Prev, V16, P8633; Zhu Y, 2017, ENVIRON TECHNOL INNO, V7, P182, DOI 10.1016/j.eti.2017.02.006; Zhu Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171390; Zwart W, 2011, EMBO J, V30, P4764, DOI 10.1038/emboj.2011.368	152	0	0	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0273164	10.1371/journal.pone.0273164	http://dx.doi.org/10.1371/journal.pone.0273164			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976950	Green Published, gold			2022-12-26	WOS:000847227000081
J	Mouillet-Richard, S; Martin-Lanneree, S; Le Corre, D; Hirsch, TZ; Ghazi, A; Sroussi, M; Pilati, C; de Reynies, A; Djouadi, F; Vodovar, N; Launay, JM; Laurent-Puig, P				Mouillet-Richard, Sophie; Martin-Lanneree, Severine; Le Corre, Delphine; Hirsch, Theo Z.; Ghazi, Alexandre; Sroussi, Marine; Pilati, Camilla; de Reynies, Aurelien; Djouadi, Fatima; Vodovar, Nicolas; Launay, Jean-Marie; Laurent-Puig, Pierre			A proof of concept for targeting the PrPC-Amyloid beta peptide interaction in basal prostate cancer and mesenchymal colon cancer	ONCOGENE			English	Article							CELLULAR PRION PROTEIN; CLEAVAGE	The cellular prion protein PrPC partners with caveolin-1 (CAV1) in neurodegenerative diseases but whether this interplay occurs in cancer has never been investigated. By leveraging patient and cell line datasets, we uncover a molecular link between PrPC and CAV1 across cancer. Using cell-based assays, we show that PrPC regulates the expression of and interacts with CAV1. PrPC additionally controls the expression of the amyloid precursor protein APP and of the A beta generating enzyme BACE1, and regulates the levels of A beta, whose accumulation is a central event in Alzheimer's disease. We further identify DKK1 and DKK3, involved in both Alzheimer's disease and cancer progression, as targets of the PrPC-dependent axis. Finally, we establish that antibody-mediated blocking of the A beta-PrPC interaction delays the growth of prostate cancer cell line-derived xenografts and prevents the development of metastases. Our data additionally support an enrichment of the A beta-PrPC-dependent pathway in the basal subtype of prostate cancer, associated with anti-hormonal therapy resistance, and in mesenchymal colon cancer, associated with poor prognosis. Thus, based on a parallel with neurodegenerative diseases, our results bring to light an A beta-PrPC axis and support the potential of targeting this pathway in patients with selected subtypes of prostate and colon cancer.	[Mouillet-Richard, Sophie; Martin-Lanneree, Severine; Le Corre, Delphine; Hirsch, Theo Z.; Ghazi, Alexandre; Sroussi, Marine; Pilati, Camilla; de Reynies, Aurelien; Djouadi, Fatima; Laurent-Puig, Pierre] Univ Paris, Sorbonne Univ, INSERM, Ctr Rech Cordeliers, F-75006 Paris, France; [Sroussi, Marine] Ecole Super Phys & Chim Ind Ville Paris, Lab Biochim, F-75005 Paris, France; [Vodovar, Nicolas; Launay, Jean-Marie] Univ Paris Cite, Paris, France; [Vodovar, Nicolas; Launay, Jean-Marie] Inserm UMR S942 MASCOT, Paris, France; [Launay, Jean-Marie] F Hoffmann La Roche Ltd, Pharma Res Dept, CH-4070 Basel, Switzerland; [Laurent-Puig, Pierre] Hop Europeen Georges Pompidou, AP HP, Inst Canc Paris CARPEM, Dept Biol, F-75015 Paris, France; [Martin-Lanneree, Severine] IntegraGen SA, Genopole Campus 1,Rue Henri Desbrueres, F-91000 Evry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Roche Holding; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Genopole	Mouillet-Richard, S (corresponding author), Univ Paris, Sorbonne Univ, INSERM, Ctr Rech Cordeliers, F-75006 Paris, France.	sophie.mouillet-richard@parisdescartes.fr	Mouillet, Sophie/E-4960-2017; laurent-puig, pierre/B-2226-2013	Mouillet, Sophie/0000-0002-8950-1949; laurent-puig, pierre/0000-0001-8475-5459; Hirsch, Theo/0000-0003-4428-2997	Canceropole Ile de France [2016-1-EMERG-36-UP 5-1]; Association pour la Recherche sur le Cancer [PJA 20171206220]; SIRIC CARPEM (CAncer Research for PErsonalized Medicine) [INCaDGOS Inserm_12561]; Labex Immuno-oncology, SATT Ile de France [415]; INSERM; Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC); Fondation pour la Recherche Medicale [FDM202006011237]	Canceropole Ile de France(Region Ile-de-France); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); SIRIC CARPEM (CAncer Research for PErsonalized Medicine); Labex Immuno-oncology, SATT Ile de France; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	Grant support was provided by the following: Canceropole Ile de France (grant number 2016-1-EMERG-36-UP 5-1), Association pour la Recherche sur le Cancer (grant number PJA 20171206220), SIRIC CARPEM (CAncer Research for PErsonalized Medicine, INCaDGOS Inserm_12561), Labex Immuno-oncology, SATT Ile de France (grant number 415) as well as INSERM and Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC). M. Sroussi was supported by a fellowship from Fondation pour la Recherche Medicale (FRM grant FDM202006011237). The authors acknowledge N. Pierron and F. d'Agostini for expert methodological assistance.	Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bruggink KA, 2015, J NEUROCHEM, V134, P1152, DOI 10.1111/jnc.13216; D'Amico L, 2016, J EXP MED, V213, P827, DOI 10.1084/jem.20150950; Ferrari N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07987-0; Ghazi A, 2021, ONCOIMMUNOLOGY, V10, DOI 10.1080/2162402X.2021.1940674; Griffiths HH, 2011, J BIOL CHEM, V286, P33489, DOI 10.1074/jbc.M111.278556; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Hampel H, 2021, BIOL PSYCHIAT, V89, P745, DOI 10.1016/j.biopsych.2020.02.001; Hirsch TZ, 2017, PROG MOL BIOL TRANSL, V150, P1, DOI 10.1016/bs.pmbts.2017.06.001; Kamoun A, 2018, ANN ONCOL, V29, P1814, DOI 10.1093/annonc/mdy224; Karran E, 2022, NAT REV DRUG DISCOV, V21, P306, DOI 10.1038/s41573-022-00391-w; Killick R, 2014, MOL PSYCHIATR, V19, P88, DOI 10.1038/mp.2012.163; Kleffman K, 2022, CANCER DISCOV, V12, P1314, DOI 10.1158/2159-8290.CD-21-1006; Kralovicova S, 2009, MOL CELL NEUROSCI, V41, P135, DOI 10.1016/j.mcn.2009.02.002; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Le Corre D, 2019, EBIOMEDICINE, V46, P94, DOI 10.1016/j.ebiom.2019.07.036; Li J, 2017, CANCER CELL, V31, P225, DOI 10.1016/j.ccell.2017.01.005; Linsenmeier L, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abj1826; McHugh PC, 2012, NEUROCHEM INT, V61, P672, DOI 10.1016/j.neuint.2012.07.002; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Mouillet-Richard S, 2021, CANCERS, V13, DOI 10.3390/cancers13195032; Pankiewicz JE, 2019, MOL NEUROBIOL, V56, P2073, DOI 10.1007/s12035-018-1208-4; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Qin KF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44317-w; Rajan P, 2014, EUR UROL, P66; Rajan P, 2014, EUR UROL, V66, P32, DOI 10.1016/j.eururo.2013.08.011; Smith BA, 2015, P NATL ACAD SCI USA, V112, pE6544, DOI 10.1073/pnas.1518007112; Whitehouse IJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159119; Whitehouse IJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059554; Zhang DX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10798; Zhao SG, 2017, JAMA ONCOL, V3, P1663, DOI 10.1001/jamaoncol.2017.0751	32	0	0	3	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 16	2022	41	38					4397	4404		10.1038/s41388-022-02430-7	http://dx.doi.org/10.1038/s41388-022-02430-7		AUG 2022	8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	4O3TC	35962130	hybrid, Green Published			2022-12-26	WOS:000840000600002
J	Jahan, S; Awaja, N; Hess, B; Hajjar, S; Sad, S; Lohnes, D				Jahan, Sanzida; Awaja, Nidaa; Hess, Bradley; Hajjar, Stephanie; Sad, Subash; Lohnes, David			The transcription factor Cdx2 regulates inflammasome activity through expression of the NLRP3 suppressor TRIM31 to maintain intestinal homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; GENE-EXPRESSION; BOWEL-DISEASE; HOMEOBOX GENE; EPITHELIAL-CELLS; STEM-CELLS; TNF-ALPHA; ACTIVATION; CHROMATIN	The intestine-specific transcription factor Cdx2 is essential for intestinal homeostasis and has been implicated in the pathogenesis of disorders including inflammatory bowel disease. However, the mechanism by which Cdx2 influences intestinal disease is not clear. Here, we present evidence sup-porting a novel Cdx2-TRIM31-NLRP3 (NLR family, pyrin domain containing 3) signaling pathway, which may represent a mechanistic means by which Cdx2 impacts intestinal inflammation. We found that conditional loss of Cdx function resulted in an increase in proinflammatory cytokines, including tumor necrosis factor alpha, interleukin (IL)-1 beta, and IL-6, in the mouse colon. We further show that TRIM31, which en-codes a suppressor of NLRP3 (a central component of the NLRP3 inflammasome complex) is a novel Cdx2 target gene and is attenuated in the colon of Cdx conditional mutants. Consistent with this, we found that attenuation of TRIM31 in Cdx mutant intestine occurs concomitant with elevated levels of NLRP3 and an increase in inflammasome products. We demonstrate that specific inhibition of NLRP3 activity signifi- cantly reduced IL-1 beta and IL-6 levels and extended the life span of Cdx conditional mutants, reflecting the therapeutic potential of targeting NLRP3. Tumor necrosis factor-alpha levels were also induced independent of NLRP3, potentially via elevated activity of the proinflammatory NF -KB signaling pathway in Cdx mutants. Finally, in silico analysis of ulcerative colitis pa-tients revealed attenuation of CDX2 and TRIM31 expression coincident with enhanced expression of proinflammatory cytokines. We conclude that the novel Cdx2-TRIM31-NLRP3 signaling pathway promotes proinflammatory cytokine expression, and its inhibition may have therapeutic potential in human intestinal diseases.	[Jahan, Sanzida; Awaja, Nidaa; Hess, Bradley; Lohnes, David] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Hajjar, Stephanie; Sad, Subash] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa; University of Ottawa	Lohnes, D (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada.	dlohnes@uottawa.ca		Jahan, Sanzida/0000-0002-0765-1581	Canadian Institutes of Health Research [146014]; Canadian Institutes of Health Research postdoctoral fellowship [154639]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research postdoctoral fellowship(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research (grant no.: 146014) to D. L. and a Canadian Institutes of Health Research postdoctoral fellowship to S. J. (reference number: 154639).	Amin S, 2016, CELL REP, V17, P3165, DOI 10.1016/j.celrep.2016.11.069; Banerjee S, 2009, MUCOSAL IMMUNOL, V2, P220, DOI 10.1038/mi.2009.3; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Bonhomme C, 2003, GUT, V52, P1465, DOI 10.1136/gut.52.10.1465; Boyd M, 2010, J BIOL CHEM, V285, P25115, DOI 10.1074/jbc.M109.089516; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Calon A, 2007, GUT, V56, P1688, DOI 10.1136/gut.2007.125542; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Chen QL, 2021, BIOMED PHARMACOTHER, V138, DOI 10.1016/j.biopha.2021.111442; Coskun M, 2017, J CELL BIOCHEM, V118, P298, DOI 10.1002/jcb.25636; Coskun M, 2014, DAN MED J, V61; Coskun M, 2014, CARCINOGENESIS, V35, P1185, DOI 10.1093/carcin/bgu037; Coskun M, 2011, BBA-MOL BASIS DIS, V1812, P283, DOI 10.1016/j.bbadis.2010.11.008; Coskun M, 2012, BBA-MOL BASIS DIS, V1822, P843, DOI 10.1016/j.bbadis.2012.01.012; Davidson AJ, 2006, DEV BIOL, V292, P506, DOI 10.1016/j.ydbio.2006.01.003; De Cesaris P, 1998, J BIOL CHEM, V273, P7566, DOI 10.1074/jbc.273.13.7566; Ellinghaus D, 2016, NAT GENET, V48, P510, DOI 10.1038/ng.3528; Fielding CA, 2008, J IMMUNOL, V181, P2189, DOI 10.4049/jimmunol.181.3.2189; Foley TE, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.170498; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Graham DB, 2020, NATURE, V578, P527, DOI 10.1038/s41586-020-2025-2; Grainger S, 2010, DEV BIOL, V339, P155, DOI 10.1016/j.ydbio.2009.12.025; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Hazel K, 2020, THER ADV CHRONIC DIS, V11, DOI 10.1177/2040622319899297; Hryniuk A, 2014, J BIOL CHEM, V289, P33343, DOI 10.1074/jbc.M114.583823; Hryniuk A, 2012, DEV BIOL, V363, P426, DOI 10.1016/j.ydbio.2012.01.010; Huang DS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16009-w; Jahan S, 2020, BIOCHEM CELL BIOL, V98, P171, DOI 10.1139/bcb-2019-0107; Jahan S, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0068-2; Jiang H, 2017, J EXP MED, V214, P3219, DOI 10.1084/jem.20171419; Khatri V, 2021, FASEB J, V35, DOI 10.1096/fj.202002622R; Koslowski MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004496; Kumar N, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.172189; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Saiz ML, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01854; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lichtenstein GR, 2013, THER ADV GASTROENTER, V6, P269, DOI 10.1177/1756283X13479826; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maier EA, 2005, J BIOL CHEM, V280, P13195, DOI 10.1074/jbc.M413158200; McGeough MD, 2012, J IMMUNOL, V189, P2707, DOI 10.4049/jimmunol.1101737; Meldrum DR, 1998, AM J PHYSIOL-REG I, V274, pR577, DOI 10.1152/ajpregu.1998.274.3.R577; Morosi LG, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf8630; Nguyen TT, 2017, J BIOL CHEM, V292, P3389, DOI 10.1074/jbc.M116.752774; Nielsen OH, 2013, NEW ENGL J MED, V369, P754, DOI 10.1056/NEJMct1209614; O'Rourke Kevin P, 2016, Bio Protoc, V6; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Poudel B, 2018, J LEUKOCYTE BIOL, V103, P1165, DOI 10.1002/JLB.3MIR0917-350R; Ra EA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11726; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; San Roman AK, 2015, STEM CELL REP, V5, P673, DOI 10.1016/j.stemcr.2015.09.006; Savory JGA, 2009, DEVELOPMENT, V136, P4099, DOI 10.1242/dev.041582; Savory JGA, 2009, DEV BIOL, V330, P114, DOI 10.1016/j.ydbio.2009.03.016; Saxena M, 2017, GENE DEV, V31, P2391, DOI 10.1101/gad.308536.117; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shao BZ, 2019, INFLAMMATION, V42, P1147, DOI 10.1007/s10753-019-01008-y; Soneson Charlotte, 2015, F1000Res, V4, P1521, DOI 10.12688/f1000research.7563.1; Song H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13727; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; SUBRAMANIAN V, 1995, CELL, V83, P641, DOI 10.1016/0092-8674(95)90104-3; SUH E, 1994, MOL CELL BIOL, V14, P7340, DOI 10.1128/MCB.14.11.7340; Swanson KV, 2019, NAT REV IMMUNOL, V19, P477, DOI 10.1038/s41577-019-0165-0; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Tanaka T, 2014, CANCER IMMUNOL RES, V2, P288, DOI 10.1158/2326-6066.CIR-14-0022; Taylor JK, 1997, NUCLEIC ACIDS RES, V25, P2293, DOI 10.1093/nar/25.12.2293; Tourkochristou E, 2019, WORLD J GASTROENTERO, V25, P4796, DOI 10.3748/wjg.v25.i33.4796; Tsuchiya K, 2017, J GASTROEN HEPATOL, V32, P1032, DOI 10.1111/jgh.13645; van den Akker E, 2002, DEVELOPMENT, V129, P2181; Verzi MP, 2013, MOL CELL BIOL, V33, P281, DOI 10.1128/MCB.01185-12; Verzi MP, 2010, P NATL ACAD SCI USA, V107, P15157, DOI 10.1073/pnas.1003822107; Watts DA, 2002, GUT, V50, P31; Wright G, 2002, AM J PHYSIOL-HEART C, V282, pH872, DOI 10.1152/ajpheart.00256.2001; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zaki MH, 2011, TRENDS IMMUNOL, V32, P171, DOI 10.1016/j.it.2011.02.002; Zhen Y, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00276; Zhu AQ, 2019, BIOINFORMATICS, V35, P2084, DOI 10.1093/bioinformatics/bty895	81	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	298	10							102386	10.1016/j.jbc.2022.102386	http://dx.doi.org/10.1016/j.jbc.2022.102386			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5K6GU	35985421	Green Published, gold			2022-12-26	WOS:000869823800003
J	Volonte, D; Sedorovitz, M; Galbiati, F				Volonte, Daniela; Sedorovitz, Morgan; Galbiati, Ferruccio			Impaired Cdc20 signaling promotes senescence in normal cells and apoptosis in non-small cell lung cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-TRANSFORMING GENE; DNA-DAMAGE; PREMATURE SENESCENCE; POOR-PROGNOSIS; FIBROBLASTS; EXPRESSION; OVEREXPRESSION; SECURIN; SUPPRESSION; CAVEOLIN-1	Cellular senescence is a form of irreversible growth arrest that cancer cells evade. The cell division cycle protein 20 homolog (Cdc20) is a positive regulator of cell division, but how its dys-regulation may relate to senescence is unclear. Here, we find that Cdc20 mRNA and protein expression are downregulated in stress-induced premature senescent lung fibroblasts in a p53-dependent manner. Either Cdc20 downregulation or inhibition of anaphase-promoting complex/cyclosome (APC/C) is suffi- cient to induce premature senescence in lung fibroblasts, while APC/C activation inhibits stress-induced premature senescence. Mechanistically, we show both Cdc20 downregulation and APC/ C inhibition induce premature senescence through glycogen synthase kinase (GSK)-3 beta-mediated phosphorylation and downregulation of securin expression. Interestingly, we deter-mined Cdc20 expression is upregulated in human lung adeno-carcinoma. We find that downregulation of Cdc20 in non-small cell lung cancer (NSCLC) cells is sufficient to inhibit cell prolif-eration and growth in soft agar and to promote apoptosis, but not senescence, in a manner dependent on downregulation of securin following GSK-3 beta-mediated securin phosphorylation. Similarly, we demonstrate securin expression is downregulated and cell viability is inhibited in NSCLC cells following inhibition of APC/C. Furthermore, we show chemotherapeutic drugs downregulate both Cdc20 and securin protein expression in NSCLC cells. Either Cdc20 downregulation by siRNA or APC/C inhibition sensitize, while securin overexpression inhibits, chemotherapeutic drug-induced NSCLC cell death. Together, our findings provide evidence that Cdc20/APC/C/securin-dependent signaling is a key regulator of cell survival, and its disruption promotes premature senescence in normal lung cells and induces apoptosis in lung cancer cells that have bypassed the senescence barrier.	[Volonte, Daniela; Sedorovitz, Morgan; Galbiati, Ferruccio] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Galbiati, F (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA.	feg5@pitt.edu			National Cancer Institute [R01-CA205165]; Aging Institute and Hillman Cancer Center Seed Grant Program; National Institute on Aging [R21-AG061614]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Aging Institute and Hillman Cancer Center Seed Grant Program; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	- F. G. was supported by grants from the National Cancer Institute (R01-CA205165) and the Aging Institute and Hillman Cancer Center Seed Grant Program; D. V. was supported by a grant from the National Institute on Aging (R21-AG061614) .	Agarwal R, 2002, GENE DEV, V16, P1371, DOI 10.1101/gad.971402; Baek KH, 2013, J CLIN INVEST, V123, P4375, DOI 10.1172/JCI67465; Banerjee T, 2009, NUCLEIC ACIDS RES, V37, P2688, DOI 10.1093/nar/gkp110; Bartholomew JN, 2009, CANCER RES, V69, P2878, DOI 10.1158/0008-5472.CAN-08-2857; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Campisi J, 1997, EUR J CANCER, V33, P703, DOI 10.1016/S0959-8049(96)00058-5; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Coppe JP, 2008, MOL CANCER RES, V6, P1085, DOI 10.1158/1541-7786.MCR-08-0062; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9; Delgado-Esteban M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3879; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dumont P, 2000, FREE RADICAL BIO MED, V28, P361, DOI 10.1016/S0891-5849(99)00249-X; Engelbert D, 2008, ONCOGENE, V27, P907, DOI 10.1038/sj.onc.1210703; Eytan E, 2006, P NATL ACAD SCI USA, V103, P2081, DOI 10.1073/pnas.0510695103; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Frippiat C, 2001, J BIOL CHEM, V276, P2531, DOI 10.1074/jbc.M006809200; Fujii T, 2006, HEPATOLOGY, V43, P1267, DOI 10.1002/hep.21181; Fujita H, 2020, AGING CELL, V19, DOI 10.1111/acel.13251; Fujita K, 2009, NAT CELL BIOL, V11, P1135, DOI 10.1038/ncb1928; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; Gayyed MF, 2016, TUMOR BIOL, V37, P749, DOI 10.1007/s13277-015-3808-1; Genkai N, 2006, ONCOL REP, V15, P1569; Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283; Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Kapanidou M, 2017, TRENDS BIOCHEM SCI, V42, P193, DOI 10.1016/j.tibs.2016.12.001; Karra H, 2014, BRIT J CANCER, V110, P2905, DOI 10.1038/bjc.2014.252; Kato T, 2012, J SURG ONCOL, V106, P423, DOI 10.1002/jso.23109; Kidokoro T, 2008, ONCOGENE, V27, P1562, DOI 10.1038/sj.onc.1210799; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Lafranchi L, 2014, EMBO J, V33, P2860, DOI 10.15252/embj.201489017; Lawrence Katherine S, 2015, Trends Cell Mol Biol, V10, P141; Lawrence KS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005150; Li J, 2014, INT J ONCOL, V45, P1547, DOI 10.3892/ijo.2014.2559; Limon-Mortes MC, 2008, J CELL SCI, V121, P1825, DOI 10.1242/jcs.020552; Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; Manchado E, 2010, CANCER CELL, V18, P641, DOI 10.1016/j.ccr.2010.10.028; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mocciaro A, 2010, J CELL BIOL, V189, P631, DOI 10.1083/jcb.200910057; Mora-Santos M, 2011, J BIOL CHEM, V286, P30047, DOI 10.1074/jbc.M111.232330; Musacchio A, 2015, CURR BIOL, V25, pR1002, DOI 10.1016/j.cub.2015.08.051; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Place RF, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-37; Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862; Romero F, 2004, MOL CELL BIOL, V24, P2720, DOI 10.1128/MCB.24.7.2720-2733.2004; Saez C, 2006, J CLIN ENDOCR METAB, V91, P1404, DOI 10.1210/jc.2005-2532; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Shibata Y, 2002, JPN J CLIN ONCOL, V32, P233, DOI 10.1093/jjco/hyf058; Sivakumar S, 2015, NAT REV MOL CELL BIO, V16, P82, DOI 10.1038/nrm3934; Talvinen K, 2006, ANTICANCER RES, V26, P4745; Tran PT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002650; Volonte D, 2002, MOL BIOL CELL, V13, P2502, DOI 10.1091/mbc.01-11-0529; Volonte D, 2015, J BIOL CHEM, V290, P4202, DOI 10.1074/jbc.M114.598268; Volonte D, 2009, J BIOL CHEM, V284, P5462, DOI 10.1074/jbc.C800225200; Wiebusch L, 2010, ONCOGENE, V29, P3477, DOI 10.1038/onc.2010.99; Winnepenninckx V, 2006, MODERN PATHOL, V19, P1170, DOI 10.1038/modpathol.3800627; Wynford-Thomas D, 1999, J PATHOL, V187, P100; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	68	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	298	10							102405	10.1016/j.jbc.2022.102405	http://dx.doi.org/10.1016/j.jbc.2022.102405			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5K6GU	35988650	Green Published, gold			2022-12-26	WOS:000869823800004
J	Han, JX; Wen, CX; Sun, R; Tang, MY; Li, XM; Lian, H				Han, Jia-Xuan; Wen, Chen-Xi; Sun, Rui; Tang, Meng-Yu; Li, Xiao-Ming; Lian, Hong			The dorsal hippocampal CA3 regulates spatial reference memory through the CtBP2/GluR2 pathway	FASEB JOURNAL			English	Article						CtBP2; dorsal hippocampal CA3; GluR2; spatial reference memory	PERMEABLE AMPA RECEPTORS; TERMINAL BINDING-PROTEIN; TRANSCRIPTIONAL COREPRESSOR; VENTRAL HIPPOCAMPUS; SYNAPTIC PLASTICITY; SUBUNIT; CTBP2; RECONSOLIDATION; EXPRESSION; RIBBONS	The dorsal hippocampus plays a pivotal role in spatial memory. However, the role of subregion-specific molecular pathways in spatial cognition remains unclear. We observed that the transcriptional coregulator C-terminal binding protein 2 (CtBP2) presented CA3-specific enrichment in expression. RNAi interference of CtBP2 in the dorsal CA3 (dCA3) neurons, but not the ventral CA3 (vCA3), specifically impaired spatial reference memory and reduced the expression of GluR2, the calcium permeability determinant subunit of AMPA receptors. Application of an antagonist for GluR2-absent calcium permeable AMPA receptors rescued spatial memory deficits in dCA3 CtBP2 knockdown animals. Transcriptomic analysis suggest that CtBP2 may regulate GluR2 protein level through post-translational mechanisms, especially by the endocytosis pathway which regulates AMPA receptor sorting. Consistently, CtBP2 deficiency altered the mRNA expression of multiple endocytosis-regulatory genes, and CtBP2 knockdown in primary hippocampal neurons enhanced GluR2-containing AMPA receptor endocytosis. Together, our results provide evidence that the dCA3 regulates spatial reference memory by the CtBP2/GluR2 pathway through the modulation of calcium permeable AMPA receptors.	[Han, Jia-Xuan; Sun, Rui; Tang, Meng-Yu; Li, Xiao-Ming; Lian, Hong] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurol, Res Bldg A505,866 Yuhangtang Rd, Hangzhou 310058, Peoples R China; [Han, Jia-Xuan; Wen, Chen-Xi; Sun, Rui; Tang, Meng-Yu; Li, Xiao-Ming] Zhejiang Univ, Sch Brain Sci & Brain Med, Sch Med,NHC & CAMS Key Lab Med Neurobiol, MOE Frontier Ctr Brain Sci & Brain Machine Integr, Hangzhou, Peoples R China	Zhejiang University; Zhejiang University	Li, XM; Lian, H (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurol, Res Bldg A505,866 Yuhangtang Rd, Hangzhou 310058, Peoples R China.	lixm@zju.edu.cn; honglian@zju.edu.cn			National Natural Science Foundation of China [32000718, U20A6005]; National Key Research and Development Program of China [SQ2021YFA1100045]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	National Natural Science Foundation of China, Grant/Award Number: 32000718 and U20A6005; National Key Research and Development Program of China, Grant/Award Number: SQ2021YFA1100045	Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Artinian J, 2007, HIPPOCAMPUS, V17, P181, DOI 10.1002/hipo.20256; Bagot RC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8062; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Bast T, 2003, HIPPOCAMPUS, V13, P657, DOI 10.1002/hipo.10115; Bellet MM, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03086-5; Bliss T.V.P., 2018, E NEUROFORUM, V24, pA103, DOI [10.1515/nf-2017-A059, DOI 10.1515/NF-2017-A059]; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Cembrowski MS, 2016, ELIFE, V5, DOI 10.7554/eLife.14997; Chawla MK, 2018, HIPPOCAMPUS, V28, P178, DOI 10.1002/hipo.22820; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Coughlan G, 2018, NAT REV NEUROL, V14, P496, DOI 10.1038/s41582-018-0031-x; Da Silva WC, 2008, HIPPOCAMPUS, V18, P29, DOI 10.1002/hipo.20362; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Feldmeyer D, 1999, NAT NEUROSCI, V2, P57, DOI 10.1038/4561; Fellini L, 2009, LEARN MEMORY, V16, P387, DOI 10.1101/lm.1433209; Gilbert PE, 2009, PROG NEURO-PSYCHOPH, V33, P774, DOI 10.1016/j.pnpbp.2009.03.037; Glikmann-Johnston Y, 2019, NEUROSCI BIOBEHAV R, V98, P194, DOI 10.1016/j.neubiorev.2019.01.015; Glikmann-Johnston Y, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00289; Graham J, 2021, FRONT BEHAV NEUROSCI, V15, DOI 10.3389/fnbeh.2021.595049; Gusev PA, 2005, J NEUROSCI, V25, P9384, DOI 10.1523/JNEUROSCI.0832-05.2005; Hauser J, 2020, HIPPOCAMPUS, V30, P938, DOI 10.1002/hipo.23207; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hong I, 2013, P NATL ACAD SCI USA, V110, P8218, DOI 10.1073/pnas.1305235110; Hubler D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039710; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Jin JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08388; Karaca E, 2020, MOL CELL NEUROSCI, V104, DOI 10.1016/j.mcn.2020.103481; Kegel KB, 2002, J BIOL CHEM, V277, P7466, DOI 10.1074/jbc.M103946200; Kim R, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-9; Konen LM, 2020, MOL BRAIN, V13, DOI 10.1186/s13041-020-0545-1; Krestel HE, 2004, J NEUROSCI, V24, P10568, DOI 10.1523/JNEUROSCI.4579-03.2004; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; Lee S, 2011, BBA-MOL CELL RES, V1813, P713, DOI 10.1016/j.bbamcr.2011.01.035; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lester AW, 2017, NEURON, V95, P1019, DOI 10.1016/j.neuron.2017.06.037; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lin DT, 2007, J NEUROSCI, V27, P13903, DOI 10.1523/JNEUROSCI.1750-07.2007; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lussier MP, 2011, J NEUROSCI, V31, P3077, DOI 10.1523/JNEUROSCI.5944-10.2011; Lv CX, 2016, CELL REP, V15, P2784, DOI 10.1016/j.celrep.2016.05.045; Maxeiner S, 2016, EMBO J, V35, P1098, DOI 10.15252/embj.201592701; Monfort P, 2015, ACS CHEM NEUROSCI, V6, P1420, DOI 10.1021/acschemneuro.5b00096; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; Murk K, 2013, J CELL SCI, V126, P3873, DOI 10.1242/jcs.125146; Oguro K, 1999, J NEUROSCI, V19, P9218; Paliwal S, 2006, MOL CELL BIOL, V26, P2360, DOI 10.1128/MCB.26.6.2360-2372.2006; Park P, 2018, FRONT SYNAPTIC NEURO, V10, DOI 10.3389/fnsyn.2018.00042; Park P, 2016, J NEUROSCI, V36, P622, DOI 10.1523/JNEUROSCI.3625-15.2016; Ramos JMJ, 2022, BEHAV BRAIN RES, V417, DOI 10.1016/j.bbr.2021.113620; Rebola N, 2017, NAT REV NEUROSCI, V18, P209, DOI 10.1038/nrn.2017.10; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Shen YG, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00707-0; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shepherd JD, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00049; Shimshek DR, 2006, J NEUROSCI, V26, P8428, DOI 10.1523/JNEUROSCI.5410-05.2006; Stankiewicz Trisha R., 2014, BioMolecular Concepts, V5, P489, DOI 10.1515/bmc-2014-0027; Strange BA, 2014, NAT REV NEUROSCI, V15, P655, DOI 10.1038/nrn3785; Thio SSC, 2004, NUCLEIC ACIDS RES, V32, P1836, DOI 10.1093/nar/gkh344; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; Torquatto KI, 2019, NEUROPHARMACOLOGY, V144, P312, DOI 10.1016/j.neuropharm.2018.10.030; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Wang HH, 2019, CELL REP, V27, P2335, DOI 10.1016/j.celrep.2019.04.081; Yang HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002809; Zhang GW, 2012, J MOL HISTOL, V43, P327, DOI 10.1007/s10735-012-9399-x; Zou FH, 2013, J MOL NEUROSCI, V49, P395, DOI 10.1007/s12031-012-9906-2	70	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22456	10.1096/fj.202101609RR	http://dx.doi.org/10.1096/fj.202101609RR			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3T7LE	35969153				2022-12-26	WOS:000840450100001
J	Yan, FZ; Qian, H; Liu, F; Ding, CH; Liu, SQ; Xiao, MC; Chen, SJ; Zhang, X; Luo, C; Xie, WF				Yan, Fang-Zhi; Qian, Hui; Liu, Fang; Ding, Chen-Hong; Liu, Shu-Qing; Xiao, Meng-Chao; Chen, Shi-Jie; Zhang, Xin; Luo, Cheng; Xie, Wei-Fen			Inhibition of protein arginine methyltransferase 1 alleviates liver fibrosis by attenuating the activation of hepatic stellate cells in mice	FASEB JOURNAL			English	Article						hepatic stellate cell; inflammation; inhibitor; liver fibrosis; protein arginine methyltransferase 1	METHYLATION; INFLAMMATION; EXPRESSION; MECHANISMS; PRMT1	Protein arginine methyltransferase 1 (PRMT1) has been reported to be involved in various diseases. The expression of PRMT1 was increased in cirrhotic livers from human patients. However, the role of PRMT1 in hepatic fibrogenesis remains largely unexplored. In this study, we investigated the effect of PRMT1 on hepatic fibrogenesis and its underlying mechanism. We found that PRMT1 expression was significantly higher in fibrotic livers of the mice treated with thioacetamide (TAA) or 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) diet. Immunofluorescence staining revealed that PRMT1 expression was augmented in both hepatocytes and hepatic stellate cells (HSCs) in the fibrotic livers. Applying a selective inhibitor of PRMT1, PT1001B, significantly suppressed PRMT1 activity and mitigated liver fibrosis in mice. Hepatocyte-specific Prmt1 knockout did not affect liver fibrosis in mice. PRMT1 overexpression promoted the expression of fibrotic genes in the LX-2 cells, whereas knockdown of PRMT1 or treatment with PT1001B exhibited reversal effects, suggesting that PRMT1 plays an important role in HSC activation. Additionally, HSC-specific Prmt1 knockout attenuated HSC activation and liver fibrosis in TAA-induced fibrotic model. RNA-seq analysis revealed that Prmt1 knockout in HSCs significantly suppressed pro-inflammatory NF-kappa B and pro-fibrotic TGF-beta signals, and also downregulated the expression of pro-fibrotic mediators in mouse livers. Moreover, treatment with PT1001B consistently inhibited hepatic inflammatory response in fibrotic model. In conclusion, PRMT1 plays a vital role in HSC activation. Inhibition of PRMT1 mitigates hepatic fibrosis by attenuating HSC activation in mice. Therefore, targeting PRMT1 could be a feasible therapeutic strategy for liver fibrosis.	[Yan, Fang-Zhi; Qian, Hui; Liu, Fang; Ding, Chen-Hong; Liu, Shu-Qing; Zhang, Xin; Xie, Wei-Fen] Naval Med Univ, Changzheng Hosp, Dept Gastroenterol, 415 Fengyang Rd, Shanghai 200003, Peoples R China; [Xiao, Meng-Chao] Tongji Univ, Shanghai East Hosp, Dept Gastroenterol, Sch Med, Shanghai, Peoples R China; [Chen, Shi-Jie; Luo, Cheng] Chinese Acad Sci, State Key Lab Drug Res, Shanghai Inst Mat Med, Ctr Chem Biol,Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China	Naval Medical University; Tongji University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Xie, WF (corresponding author), Naval Med Univ, Changzheng Hosp, Dept Gastroenterol, 415 Fengyang Rd, Shanghai 200003, Peoples R China.; Luo, C (corresponding author), Chinese Acad Sci, State Key Lab Drug Res, Shanghai Inst Mat Med, Ctr Chem Biol,Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China.	cluo@simm.ac.cn; weifenxie@medmail.com.cn			National Natural Science Foundation of China (NSFC) [82030021, 82072641, 81802324, 81870419]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 82030021, 82072641, 81802324 and 81870419	Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Blanc RS, 2017, MOL CELL, V65, P8, DOI 10.1016/j.molcel.2016.11.003; Cheng DH, 2004, J BIOL CHEM, V279, P23892, DOI 10.1074/jbc.M401853200; Choi D, 2012, HEPATOLOGY, V56, P1546, DOI 10.1002/hep.25809; El Sabeh R, 2021, J INFLAMM RES, V14, P2149, DOI 10.2147/JIR.S306805; Ellis EL, 2012, J HEPATOL, V56, P1171, DOI 10.1016/j.jhep.2011.09.024; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Goulet I, 2007, J BIOL CHEM, V282, P33009, DOI 10.1074/jbc.M704349200; Hashimoto M, 2021, BBA-GEN SUBJECTS, V1865, DOI 10.1016/j.bbagen.2020.129776; Hassa PO, 2008, J MOL BIOL, V377, P668, DOI 10.1016/j.jmb.2008.01.044; Hellerbrand C, 1999, J HEPATOL, V30, P77, DOI 10.1016/S0168-8278(99)80010-5; Hu GH, 2020, EXP CELL RES, V394, DOI 10.1016/j.yexcr.2020.112152; Koyama Y, 2017, J CLIN INVEST, V127, P55, DOI 10.1172/JCI88881; Ma YX, 2020, FASEB J, V34, P14863, DOI 10.1096/fj.202001061R; Mookerjee RP, 2007, HEPATOLOGY, V45, P62, DOI 10.1002/hep.21491; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; Park MJ, 2014, J HEPATOL, V61, P1151, DOI 10.1016/j.jhep.2014.06.032; Sanchez PS, 2021, CANCERS, V13, DOI 10.3390/cancers13205045; Seki E, 2015, HEPATOLOGY, V61, P1066, DOI 10.1002/hep.27332; Sun QZ, 2019, J IMMUNOL, V202, P37, DOI 10.4049/jimmunol.1800782; Sun QZ, 2016, CELL SIGNAL, V28, P307, DOI 10.1016/j.cellsig.2016.01.004; Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38; Wang C, 2017, J MED CHEM, V60, P8888, DOI 10.1021/acs.jmedchem.7b01134; Wei H, 2019, NEOPLASMA, V66, P918, DOI 10.4149/neo_2018_181226N999; Weiskirchen S, 2017, METHODS MOL BIOL, V1627, P165, DOI 10.1007/978-1-4939-7113-8_11; Wu M, 2019, FASEB J, V33, P6948, DOI 10.1096/fj.201802585RR; Xie YQ, 2014, ORG BIOMOL CHEM, V12, P9665, DOI 10.1039/c4ob01591f; Xu J, 2013, MOL CELL, V51, P5, DOI 10.1016/j.molcel.2013.05.004; Yang L, 2010, TRENDS IMMUNOL, V31, P220, DOI 10.1016/j.it.2010.04.002; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yang YY, 2012, LIVER INT, V32, P48, DOI 10.1111/j.1478-3231.2011.02651.x; Zakrzewicz D, 2015, BBA-MOL BASIS DIS, V1852, P2678, DOI 10.1016/j.bbadis.2015.09.008; Zhang XP, 2018, CELL PHYSIOL BIOCHEM, V47, P1643, DOI 10.1159/000490983; Zhao J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45585-2; Zhao J, 2018, HEPATOLOGY, V67, P1109, DOI 10.1002/hep.29587; Zhong YG, 2015, BIOCHEM BIOPH RES CO, V468, P906, DOI 10.1016/j.bbrc.2015.11.055; Zhu Y, 2020, AM J PHYSIOL-RENAL, V318, pF375, DOI 10.1152/ajprenal.00487.2019	37	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22489	10.1096/fj.202200238R	http://dx.doi.org/10.1096/fj.202200238R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3S4EK	35959865				2022-12-26	WOS:000839550800001
J	Zhang, JY; Ding, YG; Yang, XR; Zhong, JP; Qiu, XX; Zou, ZS; Xu, YJ; Jin, XN; Wu, XM; Huang, JX; Zheng, YX				Zhang, Junyi; Ding, Yigang; Yang, Xinru; Zhong, Jinping; Qiu, XinXin; Zou, Zhishan; Xu, Yujie; Jin, Xiunan; Wu, Xiaomin; Huang, Jingxiu; Zheng, Yunxiang			COVID-19's impacts on the scope, effectiveness, and interaction characteristics of online learning: A social network analysis	PLOS ONE			English	Article							DISCIPLINARY DIFFERENCES; STUDENT SATISFACTION; PERFORMANCE; COMMUNITIES; CENTRALITY; TEAM	The COVID-19 outbreak brought online learning to the forefront of education. Scholars have conducted many studies on online learning during the pandemic, but only a few have performed quantitative comparative analyses of students' online learning behavior before and after the outbreak. We collected review data from China's massive open online course platform called icourse.163 and performed social network analysis on 15 courses to explore courses' interaction characteristics before, during, and after the COVID-19 pan-demic. Specifically, we focused on the following aspects: (1) variations in the scale of online learning amid COVID-19; (2a) the characteristics of online learning interaction during the pandemic; (2b) the characteristics of online learning interaction after the pandemic; and (3) differences in the interaction characteristics of social science courses and natural science courses. Results revealed that only a small number of courses witnessed an uptick in online interaction, suggesting that the pandemic's role in promoting the scale of courses was not significant. During the pandemic, online learning interaction became more frequent among course network members whose interaction scale increased. After the pandemic, although the scale of interaction declined, online learning interaction became more effective. The scale and level of interaction in Electrodynamics (a natural science course) and Economics (a social science course) both rose during the pan-demic. However, long after the pandemic, the Economics course sustained online interaction whereas interaction in the Electrodynamics course steadily declined. This discrepancy could be due to the unique characteristics of natural science courses and social science courses.	[Zhang, Junyi; Ding, Yigang; Yang, Xinru; Zhong, Jinping; Qiu, XinXin; Xu, Yujie; Jin, Xiunan; Wu, Xiaomin; Huang, Jingxiu; Zheng, Yunxiang] South China Normal Univ, Sch Educ Informat Technol, Guangzhou, Guangdong, Peoples R China; [Ding, Yigang] Hangzhou Zhongce Vocat Sch Qiantang, Hangzhou, Zhejiang, Peoples R China; [Zou, Zhishan] Shenzhen Univ, Fac Educ, Shenzhen, Guangdong, Peoples R China	South China Normal University; Shenzhen University	Huang, JX; Zheng, YX (corresponding author), South China Normal Univ, Sch Educ Informat Technol, Guangzhou, Guangdong, Peoples R China.	jimsow@163.com; dr.zheng.scnu@hotmail.com		Zhong, Jinping/0000-0001-5144-4662				Alawamleh M, 2022, ASIAN EDUC DEV STUD, V11, P380, DOI 10.1108/AEDS-06-2020-0131; Aliyyah R.R., 2020, J ETHN CULT STUD, V7, P90, DOI [10.29333/ejecs/388, DOI 10.29333/EJECS/388]; Alqurashi E, 2019, DISTANCE EDUC, V40, P133, DOI 10.1080/01587919.2018.1553562; Amir LR, 2020, BMC MED EDUC, V20, DOI 10.1186/s12909-020-02312-0; Baber H., 2020, J ED E LEARN RES, V7, P285, DOI [10.20448/journal.509.2020.73.285.292, DOI 10.20448/JOURNAL.509.2020.73.285.292]; Banna Jinan, 2015, J Online Learn Teach, V11, P249; Bao W, 2020, HUM BEHAV EMERG TECH, V2, P113, DOI 10.1002/hbe2.191; Bhatnagar Amit, CHEMOSPHERE, V157, P277, DOI [10.1016/j.cej.2010.01.007, DOI 10.1016/J.CHEMOSPHERE.2003.10.039, 10.1016/j.neubiorev.2012.11.002, DOI 10.1016/J.NEUBIOREV.2012.11.002]; Boys C, 1988, HIGHER ED PREPARATIO, DOI [10.1080/03075079612331381467, DOI 10.1080/03075079612331381467]; Brint S, 2012, RES HIGH EDUC, V53, P1, DOI 10.1007/s11162-011-9227-2; Bydzovska H, 2016, P 9 INT C ED DATA MI, P306; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Chiu TKF, 2018, AUSTRALAS J EDUC TEC, V34, P16, DOI 10.14742/ajet.3240; Cole MT, 2014, INT REV RES OPEN DIS, V15, P111; De Gagne JC, 2009, MERLOT J ONLINE LEAR, V5, P577; Ding Y, 2021, INT C BLENDED LEARNI; DONALD JG, 1983, J HIGH EDUC, V54, P31, DOI 10.2307/1981643; Doran Rice P, 2011, J SYSTEMICS CYBERNET, V9; Duncan-Howell J, 2010, BRIT J EDUC TECHNOL, V41, P324, DOI 10.1111/j.1467-8535.2009.00953.x; Fang-fang G, 2014, HIGHER ED RES, V35, P63; Fung YYH, 2004, OPEN LEARN, V19, P135, DOI [10.1080/, DOI 10.1080/0268051042000224743]; Garrison DR, 2005, AM J DISTANCE EDUC, V19, P133, DOI 10.1207/s15389286ajde1903_2; Gasevic D, 2014, INT REV RES OPEN DIS, V15, P134; Golbeck J, 2013, ANAL SOCIAL WEB, P25, DOI [10.1016/B978-0-12-405531-5.00003-1, DOI 10.1016/B978-0-12-405531-5.00003-1]; Grunspan DZ, 2014, CBE-LIFE SCI EDUC, V13, P167, DOI 10.1187/cbe.13-08-0162; Hodges C., 2020, ED REV, DOI DOI 10.5688/AJPE8142; Hrastinski S., 2006, Internet and Higher Education, V9, P117, DOI 10.1016/j.iheduc.2006.03.006; Hu X, 2013, INT C SOCIAL MEDIA S; Huang Q, 2019, COMPUT ASSIST LANG L, V32, P190, DOI 10.1080/09588221.2018.1540434; Jan SK, 2019, TECHNOL KNOWL LEARN, V24, P621, DOI 10.1007/s10758-018-9375-y; Kavanagh SS, 2019, TEACH TEACH EDUC, V86, DOI 10.1016/j.tate.2019.06.017; Knowlton D. S., 2000, NEW DIRECTIONS TEACH, V84, P5, DOI DOI 10.1002/(ISSN)1536-0768; Lapitan LDS, 2020, EDUC CHEM ENG, V35, P116, DOI 10.1016/j.ece.2021.01.012; Lear J.L., 2010, J ONLINE LEARN TEACH, V6, P71; Lederman D., 2020, INSIDE HIGHER ED, V18; Lee J, 2016, INTERNET HIGH EDUC, V28, P35, DOI 10.1016/j.iheduc.2015.09.001; Lin MH, 2017, EURASIA J MATH SCI T, V13, P3553, DOI 10.12973/eurasia.2017.00744a; Liu Z, 2022, J EDUC COMPUT RES, V60, P132, DOI 10.1177/07356331211027300; M'Chirgui Z, 2005, ECON INNOV NEW TECH, V14, P455, DOI 10.1080/1043859042000304070; Mahmood S, 2021, HUM BEHAV EMERG TECH, V3, P199, DOI 10.1002/hbe2.218; Maroulis S, 2008, TEACH COLL REC, V110, P1901; Moore M.G., 1989, AM J DISTANCE EDUC, V3, P1, DOI [10.1080/08923648909526659, DOI 10.1080/08923648909526659]; Neumann R, 2001, STUD HIGH EDUC, V26, P135, DOI 10.1080/03075070124813; Okamoto K, 2008, LECT NOTES COMPUT SC, V5059, P186; Olivares D, 2019, IEEE INT CONF ADV LE, P145, DOI 10.1109/ICALT.2019.00044; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Partlow K. M., 2003, Journal of Computing in Higher Education, V14, P68, DOI 10.1007/BF02940939; Patricia Aguilera-Hermida A, 2020, Int J Educ Res Open, V1, P100011, DOI 10.1016/j.ijedro.2020.100011; Putnik G, 2016, INT J TECHNOL DES ED, V26, P413, DOI 10.1007/s10798-015-9318-z; Rajab MH, 2020, CUREUS, V12, DOI 10.7759/cureus.8966; Rong YH, 2017, I C SERV SYST SERV M; SCOTT J, 1988, SOCIOLOGY, V22, P109, DOI 10.1177/0038038588022001007; Serrat O., 2017, KNOWLEDGE SOLUTIONS, DOI [10.1007/978-981-10-0983-9_9, DOI 10.1007/978-981-10-0983-9_9]; Smeby JC, 1996, STUD HIGH EDUC, V21, P69, DOI 10.1080/03075079612331381467; TRAVERS J, 1969, SOCIOMETRY, V32, P425, DOI 10.2307/2786545; Vo M.H., 2020, INT J RES EDUC SCI, V6, P250, DOI DOI 10.46328/IJRES.V6I2.868; Wang, 2020, NEW YORK TIMES; Wang CY, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01168; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wellman B, 1988, SOCIAL STRUCTURES NE, V4, DOI [10.2307/1961708, DOI 10.2307/1961708]; Wise S, 2014, EUR MANAG J, V32, P703, DOI 10.1016/j.emj.2013.12.005; Woo Y., 2007, Internet and Higher Education, V10, P15, DOI 10.1016/j.iheduc.2006.10.005; Wu B, 2021, EDUC INF TECHNOL, V26, P3483, DOI 10.1007/s10639-020-10412-z; Yang HL, 2004, INFORM MANAGE-AMSTER, V41, P335, DOI 10.1016/S0378-7206(03)00078-8; Yau JC, 2018, 1 MONDAY, V23, DOI [10.5210/fm.v22i5.8195, DOI 10.5210/FM.V22I5.8195]; Zhou L., 2020, BEST EVID CHIN ED, V4, P501, DOI [10.15354/bece.20.ar023, DOI 10.15354/BECE.20.AR023]; Zulfikar AF, 2019, PROCEDIA COMPUT SCI, V161, P32, DOI 10.1016/j.procs.2019.11.096	68	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2022	17	8							e0273016	10.1371/journal.pone.0273016	http://dx.doi.org/10.1371/journal.pone.0273016			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6F7BA	35998175	gold, Green Published			2022-12-26	WOS:000884210600001
J	Giaretta, A; Petrucci, G; Rocca, B; Toffolo, GM				Giaretta, Alberto; Petrucci, Giovanna; Rocca, Bianca; Toffolo, Gianna Maria			Physiologically based modelling of the antiplatelet effect of aspirin: A tool to characterize drug responsiveness and inform precision dosing	PLOS ONE			English	Article							LOW-DOSE ASPIRIN; THROMBOXANE BIOSYNTHESIS; CLINICAL-PHARMACOLOGY; PHARMACOKINETICS; ACETYLATION; INHIBITION; PREVENTION; OBESITY; STROKE; PBPK	A computational approach involving mathematical modeling and in silico experiments was used to characterize the determinants of extent and duration of platelet cyclooxygenase (COX)-1 inhibition by aspirin and design precision dosing in patients with accelerated platelet turnover or reduced drug bioavailability. To this purpose, a recently developed physiologically-based pharmacokinetics (PK) and pharmacodynamics (PD) model of low-dose aspirin in regenerating platelets and megakaryocytes, was used to predict the main features and determinants of platelet COX-1 inhibition. The response to different aspirin regimens in healthy subjects and in pathological conditions associated with alterations in aspirin PK (i.e., severely obese subjects) or PD (i.e., essential thrombocytemya patients), were simulated. A model sensitivity analysis was performed to identify the main processes influencing COX-1 dynamics. In silico experiments and sensitivity analyses indicated a major role for megakaryocytes and platelet turnover in determining the extent and duration of COX-1 inhibition by once-daily, low-dose aspirin. They also showed the superiority of reducing the dosing interval vs increasing the once-daily dose in conditions of increased platelet turnover, while suggested specific dose adjustments in conditions of possible reduction in drug bioavailability. In conclusion, the consistency of our model-based findings with experimental data from studies in healthy subjects and patients with essential thrombocythemia supports the potential of our approach for describing the determinants of platelet inhibition by aspirin and informing precision dosing which may guide personalized antithrombotic therapy in different patient populations, especially in those under-represented in clinical trials or in those associated with poor feasibility.	[Giaretta, Alberto; Toffolo, Gianna Maria] Univ Padua, Dept Informat Engn, Padua, Italy; [Giaretta, Alberto] Univ Cambridge, Dept Pathol, Cambridge, England; [Petrucci, Giovanna; Rocca, Bianca] Catholic Univ, Dept Pharmacol, Sch Med, Rome, Italy	University of Padua; University of Cambridge; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Giaretta, A (corresponding author), Univ Padua, Dept Informat Engn, Padua, Italy.; Giaretta, A (corresponding author), Univ Cambridge, Dept Pathol, Cambridge, England.	ag2242@cam.ac.uk			MIUR (Italian Minister for Education) under the initiative "Departments of Excellence" [Law 232/2016]	MIUR (Italian Minister for Education) under the initiative "Departments of Excellence"(Ministry of Education, Universities and Research (MIUR))	This work was supported by MIUR (Italian Minister for Education) under the initiative "Departments of Excellence" (Law 232/2016).	Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Darwich AS, 2017, CLIN PHARMACOL THER, V101, P646, DOI 10.1002/cpt.659; De Stefano V, 2018, BLOOD CANCER J, V8, DOI 10.1038/s41408-018-0078-3; Diener HC, 1996, J NEUROL SCI, V143, P1, DOI 10.1016/S0022-510X(96)00308-5; European Medicines Agency, 2002, REGULATORY REQUIREME, P2; Giaretta A, 2017, CLIN PHARMACOL THER, V102, P823, DOI 10.1002/cpt.694; Jones HM, 2015, CLIN PHARMACOL THER, V97, P247, DOI 10.1002/cpt.37; Loisios-Konstantinidis I, 2019, J PHARM PHARMACOL, V71, P699, DOI 10.1111/jphp.13070; Machlus KR, 2014, BRIT J HAEMATOL, V165, P227, DOI 10.1111/bjh.12758; Maree AO, 2005, J AM COLL CARDIOL, V46, P1258, DOI 10.1016/j.jacc.2005.06.058; Marsousi N, 2017, J PHARM SCI-US, V106, P2380, DOI 10.1016/j.xphs.2017.04.035; Mourikis P, 2020, VASC PHARMACOL, V125, DOI 10.1016/j.vph.2019.106635; NEEDS CJ, 1985, CLIN PHARMACOKINET, V10, P164, DOI 10.2165/00003088-198510020-00004; Norgard NB, 2018, CLIN PHARMACOKINET, V57, P663, DOI 10.1007/s40262-017-0611-8; Parker WAE, 2019, PLATELETS, V30, P148, DOI 10.1080/09537104.2019.1572880; Pascale S, 2012, BLOOD, V119, P3595, DOI 10.1182/blood-2011-06-359224; Patrignani P, 2014, J THROMB HAEMOST, V12, P1320, DOI 10.1111/jth.12637; PATRONO C, 1980, THROMB RES, V17, P317, DOI 10.1016/0049-3848(80)90066-3; PATRONO C, 1985, CIRCULATION, V72, P1177, DOI 10.1161/01.CIR.72.6.1177; Patrono C, 2021, RES PRACT THROMB HAE, V5, DOI 10.1002/rth2.12516; Patrono C, 2017, J AM COLL CARDIOL, V69, P613, DOI 10.1016/j.jacc.2016.11.049; Patrono C, 2013, BLOOD, V121, P1701, DOI 10.1182/blood-2012-10-429134; Peace A, 2010, J THROMB HAEMOST, V8, P2323, DOI 10.1111/j.1538-7836.2010.03997.x; PEDERSEN AK, 1984, NEW ENGL J MED, V311, P1206, DOI 10.1056/NEJM198411083111902; Perumal TM, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-41; Petrucci G, 2019, J THROMB HAEMOST, V17, P885, DOI 10.1111/jth.14445; Rocca B, 2012, J THROMB HAEMOST, V10, P1220, DOI 10.1111/j.1538-7836.2012.04723.x; ROCCA B, 1995, THROMB HAEMOSTASIS, V74, P1225; Rocca B, 2020, BLOOD, V136, P171, DOI 10.1182/blood.2019004596; Rocca B, 2018, EUR HEART J, V39, P1672, DOI 10.1093/eurheartj/ehy066; Rocca B, 2015, EUR HEART J, V36, P3211, DOI 10.1093/eurheartj/ehv366; ROTH GJ, 1975, J CLIN INVEST, V56, P624, DOI 10.1172/JCI108132; ROTH GJ, 1975, P NATL ACAD SCI USA, V72, P3073, DOI 10.1073/pnas.72.8.3073; Rowland M, 2015, CPT-PHARMACOMET SYST, V4, P313, DOI 10.1002/psp4.52; Rowland M, 2011, ANNU REV PHARMACOL, V51, P45, DOI 10.1146/annurev-pharmtox-010510-100540; Saltelli A., 2008, GLOBAL SENSITIVITY A; Santilli F, 2009, J AM COLL CARDIOL, V53, P667, DOI 10.1016/j.jacc.2008.10.047; Tosetto A, 2022, CLIN PHARMACOL THER, V111, P939, DOI 10.1002/cpt.2485; Wagner C, 2015, CPT-PHARMACOMET SYST, V4, P226, DOI 10.1002/psp4.33; Zi Z, 2011, IET SYST BIOL, V5, P336, DOI 10.1049/iet-syb.2011.0015	40	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0268905	10.1371/journal.pone.0268905	http://dx.doi.org/10.1371/journal.pone.0268905			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976924	Green Published, gold			2022-12-26	WOS:000847227000006
J	Schmucker, S; Preisler, V; Marr, I; Kruger, K; Stefanski, V				Schmucker, Sonja; Preisler, Vanessa; Marr, Isabell; Kruger, Konstanze; Stefanski, Volker			Single housing but not changes in group composition causes stress-related immunomodulations in horses	PLOS ONE			English	Article							SOCIAL STRESS; YOUNG HORSES; RESPONSES; BEHAVIOR; PREVALENCE; MANAGEMENT; IMMUNITY; WELFARE; OWNERS; DIFFER	Domestic horses are currently often subject to management practices that can entail social stressors, which in turn can negatively influence immunocompetence and disease susceptibility. The present study therefore aimed to characterize the number of various blood leukocyte subsets in horses, focusing on two potentially stressful housing environments: changes in group composition and relocation to individual stabling. Immune measurements were conducted before as well as one and eight days after changes were made. They were complemented by an assessment of plasma cortisol concentrations as well as behavioral observations. One and eight days after relocation to single housing, the mean numbers of eosinophils, T helper cells and cytotoxic T cells decreased by up to 31%, 20% and 22% respectively, whereas the mean numbers of neutrophils increased by 25%. In contrast, one and eight days after changes in group composition not only the mean number of neutrophils, but also of monocytes, T helper cells and cytotoxic T cells increased by up to 24%, 17%, 9%, and 15% respectively. In consequence, an increase in the neutrophil-to-lymphocyte ratio indicating stress-induced immune modulation was found after relocation to single housing, but not after changes in group composition. The changes in leukocyte numbers after relocation to single housing were accompanied by a transient increase in cortisol concentrations after one day and the occurrence of disturbed behavior patterns one week after change in housing condition. In contrast, changes in group composition did not result in an increase of cortisol concentrations or in an increase of aggressive interactions. The results strongly indicate that individual stabling is an intense stressor leading to acute and lasting alterations in blood counts of various leukocyte types. The study highlights a probable negative impact of single housing on welfare and health of horses and an advantage of group housing systems in view of immunocompetence.	[Schmucker, Sonja; Preisler, Vanessa; Stefanski, Volker] Univ Hohenheim, Inst Anim Sci, Behav Physiol Livestock, Stuttgart, Germany; [Marr, Isabell; Kruger, Konstanze] Nuertingen Geislingen Univ, Fac Agr Econ & Management, Equine Econ, Nuertingen, Germany	University Hohenheim; Nuertingen-Geislingen University (NGU)	Schmucker, S (corresponding author), Univ Hohenheim, Inst Anim Sci, Behav Physiol Livestock, Stuttgart, Germany.	sonja.schmucker@uni-hohenheim.de			Ministry of Food, Rural Affairs and Consumer Protection of the State of Baden-Wurttemberg, Germany	Ministry of Food, Rural Affairs and Consumer Protection of the State of Baden-Wurttemberg, Germany	The study was funded by the Ministry of Food, Rural Affairs and Consumer Protection of the State of Baden-Wurttemberg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGSHAW CS, 1994, APPL ANIM BEHAV SCI, V40, P1, DOI 10.1016/0168-1591(94)90083-3; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bourjade M, 2008, DEV PSYCHOBIOL, V50, P408, DOI 10.1002/dev.20301; Christensen JW, 2011, APPL ANIM BEHAV SCI, V133, P199, DOI 10.1016/j.applanim.2011.05.013; Christensen JW, 2002, APPL ANIM BEHAV SCI, V75, P233, DOI 10.1016/S0168-1591(01)00196-4; Clegg HA, 2008, APPL ANIM BEHAV SCI, V109, P68, DOI 10.1016/j.applanim.2007.02.001; Costa H., 2019, PET BEHAV SCI, P11; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; Dhabhar FS, 2006, NEURAL AND NEUROENDOCRINE MECHANISMS IN HOST DEFENSE AND AUTOIMMUNITY, P7, DOI 10.1007/978-0-387-48334-4_2; Dhabhar FS, 2012, PSYCHONEUROENDOCRINO, V37, P1345, DOI 10.1016/j.psyneuen.2012.05.008; Dhabhar FS, 2009, NEUROIMMUNOMODULAT, V16, P300, DOI 10.1159/000216188; Engert LC, 2017, DOMEST ANIM ENDOCRIN, V61, P11, DOI 10.1016/j.domaniend.2017.04.004; Engert LC, 2018, DEV COMP IMMUNOL, V79, P11, DOI 10.1016/j.dci.2017.10.003; Fureix C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039280; Granquist SM, 2012, APPL ANIM BEHAV SCI, V141, P49, DOI 10.1016/j.applanim.2012.07.001; Hartmann E, 2015, J ANIM SCI, V93, P4564, DOI 10.2527/jas.2015-9233; Hartmann E, 2012, APPL ANIM BEHAV SCI, V136, P77, DOI 10.1016/j.applanim.2011.10.004; Hemelrijk CK, 2005, BEHAVIOUR, V142, P1037, DOI 10.1163/156853905774405290; Hines MT, 1996, J VET INTERN MED, V10, P280, DOI 10.1111/j.1939-1676.1996.tb02063.x; Hockenhull J, 2015, ANIM WELFARE, V24, P29, DOI 10.7120/09627286.24.1.029; Hotchkiss JW, 2007, EQUINE VET J, V39, P294, DOI 10.2746/042516407X177538; Keeling LJ, 2016, APPL ANIM BEHAV SCI, V185, P59, DOI 10.1016/j.applanim.2016.10.006; Kozak M, 2018, J AGRON CROP SCI, V204, P86, DOI 10.1111/jac.12220; Krueger K, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11061798; Krueger Koustanze, 2008, P195, DOI 10.1007/978-3-540-75957-7_9; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Lesimple C, 2020, APPL ANIM BEHAV SCI, V225, DOI 10.1016/j.applanim.2020.104972; Lesimple C, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10020294; Marr I, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.191994; Martin P., 2007, MEASURING BEHAV INTR, V3; McDonnell S.M, 2003, EQUID ETHOGRAM PRACT; MCDONNELL SM, 1995, APPL ANIM BEHAV SCI, V43, P147, DOI 10.1016/0168-1591(94)00550-X; MCGREEVY PD, 1995, VET REC, V137, P36, DOI 10.1136/vr.137.2.36; Nieman DC, 2019, J SPORT HEALTH SCI, V8, P201, DOI 10.1016/j.jshs.2018.09.009; Nieman DC, 2005, MED SCI SPORT EXER, V37, P57, DOI 10.1249/01.MSS.0000149808.38194.21; Padalino B, 2017, RES VET SCI, V115, P78, DOI 10.1016/j.rvsc.2017.01.024; Passantino L., 2010, BIOMED RES-TOKYO, V21; Pawluski J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182257; Pierard M, 2019, J VET BEHAV, V29, P61, DOI 10.1016/j.jveb.2018.03.008; Popescu S, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9030081; Popescu S, 2017, RES VET SCI, V115, P442, DOI 10.1016/j.rvsc.2017.07.028; Proudfoot K, 2015, VET J, V206, P15, DOI 10.1016/j.tvjl.2015.05.024; Rizzo M, 2017, J VET BEHAV, V18, P56, DOI 10.1016/j.jveb.2016.12.006; Roberts K, 2017, J VET BEHAV, V20, P37, DOI 10.1016/j.jveb.2017.05.003; Ruet A, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9090621; Sarrafchi A, 2013, J VET BEHAV, V8, P386, DOI 10.1016/j.jveb.2013.04.068; Stefanski V, 2000, PSYCHONEUROENDOCRINO, V25, P389, DOI 10.1016/S0306-4530(99)00066-9; Stefanski V, 1998, PHYSIOL BEHAV, V64, P733, DOI 10.1016/S0031-9384(98)00127-9; Stull CL, 2004, EQUINE VET J, V36, P583, DOI 10.2746/0425164044864589; Valle E, 2015, J ANIM PHYSIOL AN N, V99, P856, DOI 10.1111/jpn.12289; Visser EK, 2008, APPL ANIM BEHAV SCI, V114, P521, DOI 10.1016/j.applanim.2008.03.003; von Holst D, 1998, ADV STUD BEHAV, V27, P1; WEIL GJ, 1981, BLOOD, V57, P1099; Wolter R, 2018, ANIMALS-BASEL, V8, DOI 10.3390/ani8110191; Yarnell K, 2015, PHYSIOL BEHAV, V143, P51, DOI 10.1016/j.physbeh.2015.02.040	56	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0272445	10.1371/journal.pone.0272445	http://dx.doi.org/10.1371/journal.pone.0272445			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976860	gold, Green Published			2022-12-26	WOS:000847227000037
J	Vettese, D; Borel, A; Blasco, R; Chevillard, L; Stavrova, T; Hohenstein, UT; Arzarello, M; Moncel, MH; Daujeard, C				Vettese, Delphine; Borel, Antony; Blasco, Ruth; Chevillard, Louis; Stavrova, Trajanka; Hohenstein, Ursula Thun; Arzarello, Marta; Moncel, Marie-Helene; Daujeard, Camille			New evidence of Neandertal butchery traditions through the marrow extraction in southwestern Europe (MIS 5-3)	PLOS ONE			English	Article							MIDDLE RHONE VALLEY; BONE RETOUCHERS; HAMMERSTONE PERCUSSION; SOUTHEASTERN FRANCE; PALEOLITHIC SITES; ISOTOPIC EVIDENCE; RIPARO TAGLIENTE; PLEISTOCENE SITE; QESEM CAVE; EL-SIDRON	Long bone breakage for bone marrow recovery is a commonly observed practice in Middle Palaeolithic contexts, regardless of the climatic conditions. While lithic technology is largely used to define cultural patterns in human groups, despite dedicating research by zooarchaeologists, for now butchering techniques rarely allowed the identification of clear traditions, notably for ancient Palaeolithic periods. In this paper, we test the hypothesis of butchery traditions among Neandertal groupsusing the bone assemblages from three sites in southwestern Europe. These sites are located in southeastern France and northern Italy and are dated to the Late Middle Palaeolithic: Abri du Maras (Marine Isotopic Stages (MIS) 4-3, Ardeche), Saint-Marcel (MIS 3, Ardeche), and Riparo Tagliente (MIS 4-3, Verona). The detection of culturally-induced patterns of bone breakage involves differentiating them from intuitively generated patterns. To tackle this issue, we used a zooarchaeological approach focusing on the percussion marks produced during the bone breakage process. Statistical analyses as the chi-square test of independence were employed to verify if percussion mark locations were randomly distributed, and if these distributions were different from the intuitive ones. For femurs and humeri, our results demonstrate that Neandertal groups occupying the Abri du Maras (levels 4.1 and 4.2) and the Saint-Marcel Cave (levels g and h) sites in France applied butchery traditions to recover yellow marrow. However, the traditions developed at each site were different. On the contrary, in Riparo Tagliente, in Italy, several groups or individuals of a same group did not share the same butchery traditions over time. Regarding the Abri du Maras and Saint Marcel Cave assemblages, our research demonstrates that Neandertal groups applied intense standardized bone breakage, far from the intuitive practice observed experimentally and related to bone density and/or skeletal morphology. These standardized patterns, which are systematic and counter-intuitive, can be interpreted as culturally induced for the Abri du Maras and Saint Marcel Cave. The diversity of Neandertal traditions should be considered by taking into account the butchery, in particular the practice of bone marrow extraction, and not only technological behaviours and types of tool kits.	[Vettese, Delphine; Borel, Antony; Chevillard, Louis; Stavrova, Trajanka; Moncel, Marie-Helene; Daujeard, Camille] Univ Perpignan, Hist Nat Homme Prehist HNHP, UMR 7194, Museum Natl Hist Nat MNHN,CNRS,Inst Paleontol Hum, Via Domitia, Paris, France; [Vettese, Delphine; Hohenstein, Ursula Thun; Arzarello, Marta] Univ Ferrara, Dipartimento Studi Umanist, Ferrara, Italy; [Vettese, Delphine] Univ Cantabria, Dept Ciencias Hist, Grp I D I EVOADAPTA Evoluc Humana & Adaptac Econ, Santander, Spain; [Borel, Antony] Eotvos Lorand Univ, Inst Archeol Sci, Budapest, Hungary; [Blasco, Ruth] Inst Catala Paleoecol Humana & Evolucio Social IP, CERCA, Campus Sescelades URV Edifici W3, Tarragona, Spain; [Blasco, Ruth] Univ Rovira & Virgili, Dept Hist Hist Art, Tarragona, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Universite Perpignan Via Domitia; University of Ferrara; Universidad de Cantabria; Eotvos Lorand University; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Universitat Rovira i Virgili	Vettese, D (corresponding author), Univ Perpignan, Hist Nat Homme Prehist HNHP, UMR 7194, Museum Natl Hist Nat MNHN,CNRS,Inst Paleontol Hum, Via Domitia, Paris, France.	delphinevettese@aol.com	Blasco, Ruth/AAG-8200-2019; Arzarello, Marta/F-1464-2015	Blasco, Ruth/0000-0001-9804-739X; Vettese, Delphine/0000-0001-6441-6054; Arzarello, Marta/0000-0003-3379-1112; Moncel, Marie-helene/0000-0002-0398-2316	Ministry of Economy and Competitiveness [RYC2019-026386-I]; AEI/FEDER; EUproject [PID2019-104949GB-I00]; Generalitat de Catalunya [2017 SGR 836, CLT009/18/00055]; Fondation Nestle France [SJ 671-16]; Centre d'Information des Viandes -Viande, sciences et societe [SJ 334-17]; Museum national d'Histoire naturelle	Ministry of Economy and Competitiveness; AEI/FEDER; EUproject(European Commission); Generalitat de Catalunya(Generalitat de Catalunya); Fondation Nestle France(Nestle SA); Centre d'Information des Viandes -Viande, sciences et societe; Museum national d'Histoire naturelle	RB:Ramon y Cajal research contract by the Ministry of Economy and Competitiveness (RYC2019-026386-I) and AEI/FEDER, EUproject PID2019-104949GB-I00, and the Generalitat de Catalunya projects 2017 SGR 836 and CLT009/18/00055; CD, DV, TS and LC was supported by the Fondation Nestle France (SJ 671-16) (https://fondation.nestle.fr/); DV is supported by the Centre d'Information des Viandes -Viande, sciences et societe (SJ 334-17); AB, CD, DV, LC, MHM and TS are supported by the Museum national d'Histoire naturelle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A.Borel, 2020, bioRxiv, DOI 10.1101/2020.03.31.011320; Abe Y., 2005, HUNTING BUTCHERY PAT; Alhaique F, 2004, COLLEGIUM ANTROPOL, V28, P23; Arnaud J, 2016, QUATERN INT, V425, P437, DOI 10.1016/j.quaint.2016.09.009; Arzarello M., 2005, DONN ES R CENTES MOD, V1364, P281; Auguste P., 1994, ARTEFACTS, V9, P11; Bardo A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75694-2; Barone R., 1976, ANATOMIE COMPAREE MA, V1; Bartolomei G., 1974, RIV SCI PREIST, V29, P101; Bartolomei G., 1982, ANN DELLUNIVERSIT FE, V15, P31; Bartolomei G., 1984, PREIST PROTOSTORIA, V2, P167; Bartram LE, 1999, J ARCHAEOL SCI, V26, P9; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Berruti GLF, 2020, QUATERN INT, V554, P45, DOI 10.1016/j.quaint.2020.07.016; Berto C, 2013, THESIS; Binford L.R., 1981, BONES ANCIENT MEN MO; Binford L. R., 1978, NUNAMIUT ETHNOARCHAE; Blasco R, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav9822; Blasco R, 2016, QUATERNARY SCI REV, V133, P165, DOI 10.1016/j.quascirev.2015.12.006; Blasco R, 2014, J ANTHROPOL ARCHAEOL, V35, P248, DOI 10.1016/j.jaa.2014.06.005; Blasco R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055863; Blasco R, 2012, QUATERN INT, V252, P16, DOI 10.1016/j.quaint.2011.03.019; Blasco R, 2010, CR PALEVOL, V9, P171, DOI 10.1016/j.crpv.2010.05.004; Blumenschine RJ, 1996, J ARCHAEOL SCI, V23, P493, DOI 10.1006/jasc.1996.0047; Bocherens H, 2005, J HUM EVOL, V49, P71, DOI 10.1016/j.jhevol.2005.03.003; Bocherens H, 2016, QUATERNARY SCI REV, V154, P226, DOI 10.1016/j.quascirev.2016.11.004; Bocherens Herve, 2003, BAR International Series, V1105, P1; Boeda E., 1994, CONCEPT LEVALLOIS VA; Boulestin B., 1998, APPROCHE TAPHONOMIQU, P435; Brugal JP., 1994, OUTILLAGE PEU ELABOR, V9, P143; BUNN HT, 1988, J ANTHROPOL ARCHAEOL, V7, P412, DOI 10.1016/0278-4165(88)90004-9; BURCH ES, 1972, AM ANTIQUITY, V37, P339, DOI 10.2307/278435; CAPALDO SD, 1994, AM ANTIQUITY, V59, P724, DOI 10.2307/282345; Castel JC, 2017, QUATERN INT, V433, P140, DOI 10.1016/j.quaint.2015.12.033; Chevillard L., 2018, MUS UM NATL DHISTOIR; Combier J., 1967, MEMOIRE U BORDEAU; Conard NJ, 2015, J HUM EVOL, V89, P1, DOI 10.1016/j.jhevol.2015.10.003; Costamagno S., 2013, HIST LALIMENTATION H, P134; Costamagno S, 2006, J ANTHROPOL ARCHAEOL, V25, P466, DOI 10.1016/j.jaa.2006.03.008; Costamagno S, 2009, ARCHAEOFAUNA, V18, P9; Cregut-Bonnoure E., 2002, OVIBOVINI CAPRINI MA; Cregut-Bonnoure E, 2010, QUATERNAIRE, V21, P227, DOI 10.4000/quaternaire.5592; Daujeard C, 2019, ARCHAEOL ANTHROP SCI, V11, P985, DOI 10.1007/s12520-017-0580-8; Daujeard C., 2004, PALEO, V16, P49; Daujeard C., 2008, THESIS; Daujeard C., 2004, C S CENTENAIRE SI CL, P481; Daujeard C, 2016, QUATERN INT, V411, P179, DOI 10.1016/j.quaint.2016.02.009; Daujeard C, 2014, QUATERN INT, V326, P492, DOI 10.1016/j.quaint.2013.12.022; Daujeard C, 2012, QUATERN INT, V252, P32, DOI 10.1016/j.quaint.2011.01.047; Daujeard C, 2010, J ANTHROPOL ARCHAEOL, V29, P368, DOI 10.1016/j.jaa.2010.05.002; Debard E., 1988, QUATERNAIRE BAS VIVA; Defleur A., 2001, ANTHROPOLOGIE, V105, P69; Delagnes A, 2011, J ARCHAEOL SCI, V38, P1771, DOI 10.1016/j.jas.2011.04.007; Denys C., 2004, MANUEL DE TAPHONOMIE; Dominguez-Rodrigo M., 1999, COMPLUTUM, V10, P15; Duveau J, 2019, P NATL ACAD SCI USA, V116, P19409, DOI 10.1073/pnas.1901789116; Estalrrich A, 2017, J HUM EVOL, V104, P13, DOI 10.1016/j.jhevol.2016.12.003; EVIN J, 1985, RADIOCARBON, V27, P386, DOI 10.1017/S003382220000713X; FernandezJalvo Y, 2016, VERTEBR PALEOBIOL PA, P1, DOI 10.1007/978-94-017-7432-1; Fiore I, 2016, QUATERN INT, V421, P134, DOI 10.1016/j.quaint.2015.11.142; Forestier H., 1993, PALEO, V5, P53, DOI [DOI 10.3406/PAL.1993.1104, 10.3406/pal.1993.1104]; Forte V, 2019, J ANTHROPOL ARCHAEOL, V55, DOI 10.1016/j.jaa.2019.101072; Gaudzinski-Windheuser S, 2012, QUATERN INT, V247, P59, DOI 10.1016/j.quaint.2010.11.029; Gaudzinski-Windheuser S, 2009, VERTEBR PALEOBIOL PA, P99, DOI 10.1007/978-1-4020-9699-0_7; Gifford-Gonzalez DP., 1977, OBSERVATIONS MODERN; Gilles R., 1950, B SOC PREHIST FR, V47, P202; Gomez-Olivencia A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28377-y; Guadelli JL, 2008, ANN PALEONTOL, V94, P121, DOI 10.1016/j.annpal.2008.05.002; Guerreschi A., 2002, MEMORIE MUSEO CIVICO, P15; Guillaud E, 2021, QUATERNARY SCI REV, V252, DOI 10.1016/j.quascirev.2020.106731; Hardy BL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61839-w; Hardy BL, 2013, QUATERNARY SCI REV, V82, P23, DOI 10.1016/j.quascirev.2013.09.028; Hardy BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023768; Hardy K, 2012, NATURWISSENSCHAFTEN, V99, P617, DOI 10.1007/s00114-012-0942-0; Henry AG, 2017, CURR ANTHROPOL, V58, pS329, DOI 10.1086/692095; Henry AG, 2011, P NATL ACAD SCI USA, V108, P486, DOI 10.1073/pnas.1016868108; Hutson JM., 2018, ORIGINS BONE TOOL TE; Jaouen K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23249-x; Jin JJH, 2011, J ARCHAEOL SCI, V38, P1798, DOI 10.1016/j.jas.2011.03.013; JONES KT, 1988, J ARCHAEOL SCI, V15, P415, DOI 10.1016/0305-4403(88)90039-8; Lalueza-Fox C, 2011, P NATL ACAD SCI USA, V108, P250, DOI 10.1073/pnas.1011553108; Lam YM, 1999, AM ANTIQUITY, V64, P343, DOI 10.2307/2694283; Lavocat R., 1966, ATLAS PREHISTOIRE FA; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lloveras L, 2020, QUATERN INT, V543, P25, DOI 10.1016/j.quaint.2020.03.010; Lyman L.D., 1994, VERTEBRATE TAPHONOMY, DOI DOI 10.1017/CBO9781139878302; Lyman RL, 2008, CAMB MAN ARCHAEOL, P1, DOI 10.1017/CBO9780511813863; Mallye JB, 2012, J ARCHAEOL SCI, V39, P1131, DOI 10.1016/j.jas.2011.12.018; Masset C, 2016, BULL SOC PREHIST FR, V113, P691; Mezzana F., 1964, RIV SCI PREIST, V19, P175; Miras Y, 2020, J ARCHAEOL SCI-REP, V33, DOI 10.1016/j.jasrep.2020.102569; Moclan A, 2018, J ARCHAEOL SCI, V96, P1, DOI 10.1016/j.jas.2018.05.007; Moigne AM, 2016, QUATERN INT, V409, P195, DOI 10.1016/j.quaint.2015.06.059; Moncel M.-H., 2000, B SOC PREHISTORIQUE, V97, P371, DOI [10.3406/bspf.2000.11127, DOI 10.3406/BSPF.2000.11127]; Moncel M.-H., 2004, B SOC PREHISTORIQUE, P257, DOI [DOI 10.3406/bspf.2004.12993, 10.3406/bspf.2004.12993, DOI 10.3406/BSPF.2004.12993]; Moncel M-H., 1998, B SOCI T PR HISTORIQ, V95, P141; Moncel M-H., 1994, B SOCI T PR HISTORIQ, V91, P363, DOI [10.3406/bspf.1994.9786, DOI 10.3406/BSPF.1994.9786]; Moncel M-H., 2003, BR ARCHAEOL REPORTS, P1184; Moncel MH, 2021, ARCHAEOL ANTHROP SCI, V13, DOI 10.1007/s12520-021-01285-5; Moncel MH, 2015, QUATERN INT, V378, P22, DOI 10.1016/j.quaint.2013.12.009; Moncel MH, 2014, QUATERN INT, V350, P180, DOI 10.1016/j.quaint.2014.05.013; Moncel MH, 2010, QUATERNAIRE, V21, P385; Moncel MH, 2012, QUATERN INT, V247, P103, DOI 10.1016/j.quaint.2010.10.030; Morin E, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav9106; Morin E, 2017, AM ANTIQUITY, V82, P96, DOI 10.1017/aaq.2016.16; Niven L, 2012, J HUM EVOL, V63, P624, DOI 10.1016/j.jhevol.2012.07.002; OCONNELL JF, 1988, J ANTHROPOL RES, V44, P113, DOI 10.1086/jar.44.2.3630053; OCONNELL JF, 1990, J ARCHAEOL SCI, V17, P301, DOI 10.1016/0305-4403(90)90025-Z; Outram AK, 2001, J ARCHAEOL SCI, V28, P401, DOI 10.1006/jasc.2000.0619; Pales L., 1971, ATLAS OSTEOLOGIQUE S; Pasa A., 1964, RIV SCI PREIST, V19, P295; Patou-Mathis M, 2000, INT J OSTEOARCHAEOL, V10, P379, DOI 10.1002/1099-1212(200009/10)10:5<379::AID-OA558>3.0.CO;2-4; Patou-Mathis M., 2002, RETOUCHOIRS COMPRESS; Patou-Mathis Marylene, 1997, Anthropozoologica, V25-26, P363; Pelletier M, 2019, QUATERNARY SCI REV, V224, DOI 10.1016/j.quascirev.2019.105972; Pickering TR, 2006, J ARCHAEOL SCI, V33, P459, DOI 10.1016/j.jas.2005.09.001; Pizarro-Monzo M, 2021, J R SOC INTERFACE, V18, DOI 10.1098/rsif.2020.0958; Power RC, 2018, J HUM EVOL, V119, P27, DOI 10.1016/j.jhevol.2018.02.009; R Core Team, 2021, R LANG ENV STAT; Rendu W, 2010, J ARCHAEOL SCI, V37, P1798, DOI 10.1016/j.jas.2010.01.037; Richard M, 2015, QUAT GEOCHRONOL, V30, P529, DOI 10.1016/j.quageo.2015.06.002; Richards MP, 2008, ANTIQUITY, V82, P553, DOI 10.1017/S0003598X00097210; Romandini M, 2020, QUATERN INT, V551, P188, DOI 10.1016/j.quaint.2019.11.008; Romandini M, 2018, QUATERNAIRE, V29, P61; Romandini M, 2014, QUATERN INT, V337, P11, DOI 10.1016/j.quaint.2014.03.027; Rosas A, 2006, P NATL ACAD SCI USA, V103, P19266, DOI 10.1073/pnas.0609662104; Rosell J, 2012, QUATERN INT, V247, P69, DOI 10.1016/j.quaint.2011.01.020; Saladie P, 2011, J HUM EVOL, V61, P425, DOI 10.1016/j.jhevol.2011.05.012; Shea JJ, 2007, J ANTHROPOL RES, V63, P449, DOI 10.3998/jar.0521004.0063.401; Soulier MC, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245213; Soulier MC, 2017, J ARCHAEOL SCI-REP, V11, P782, DOI 10.1016/j.jasrep.2016.12.033; Speth JD, 2010, INTERD CONTRIB ARCH, P1, DOI 10.1007/978-1-4419-6733-6; Stapert D, 2007, PALARCHS J ARCHAEOLO, V1, P16; Stavrova T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216733; Stiner MC, 2011, J HUM EVOL, V60, P213, DOI 10.1016/j.jhevol.2010.10.006; STINER MC, 1995, J ARCHAEOL SCI, V22, P223, DOI 10.1006/jasc.1995.0024; Szmidt CC, 2010, CR PALEVOL, V9, P185, DOI 10.1016/j.crpv.2010.05.002; Thery-Parisot I., 2005, GALL PREHISTOIRE, V47, P235, DOI [10.3406/galip.2005.2051, DOI 10.3406/GALIP.2005.2051]; Thun Hohenstein U., 2006, ARCHAEOZOOLOGICAL ST, P31; Thun Hohenstein U., 2005, PREMIERS PEUPLEMENTS, V35, P261; Thun Hohenstein U., 2001, ANALISI ARCHEOZOOLOG; Vettese D, 2017, J ARCHAEOL SCI-REP, V13, P151, DOI 10.1016/j.jasrep.2017.03.029; Vettese D., 2020, ARCHAEOLOGICAL EXPT, DOI [10.1371/journal.pone.0216733.KEYWORDS, DOI 10.1371/JOURNAL.PONE.0216733.KEYWORDS]; Vettese D, 2020, ARCHAEOL ANTHROP SCI, V12, DOI 10.1007/s12520-019-00972-8; Villa G., 2001, ROMA, P45; VILLA P, 1991, J HUM EVOL, V21, P27, DOI 10.1016/0047-2484(91)90034-S; Weyrich LS, 2017, NATURE, V544, P357, DOI 10.1038/nature21674; Yellen J. E., 1977, EXPT ARCHAEOLOGY, V271, P1; Zilhao J, 2020, SCIENCE, V367, P1443, DOI 10.1126/science.aaz7943; Zorzi F., 1962, GREZZANA, V17, P284; Zorzi F., 1963, GREZZANA RIV SCI PRE, V18, P307	151	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0271816	10.1371/journal.pone.0271816	http://dx.doi.org/10.1371/journal.pone.0271816			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976853	gold, Green Published			2022-12-26	WOS:000847227000016
J	Bircher, JE; Corcoran, EE; Lam, TT; Trnka, MJ; Koleske, AJ				Bircher, Josie E.; Corcoran, Ellen E.; Lam, TuKiet T.; Trnka, Michael J.; Koleske, Anthony J.			Autoinhibition of the GEF activity of cytoskeletal regulatory protein Trio is disrupted in neurodevelopmental disorder-related genetic variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; RHO-GTPASES; FACTOR DOMAINS; RAC GTPASE; MUTATIONS; KALIRIN; DISTINCT; GROWTH; BINDS; CELL	TRIO encodes a cytoskeletal regulatory protein with three catalytic domains-two guanine exchange factor (GEF) domains, GEF1 and GEF2, and a kinase domain-as well as several accessory domains that have not been extensively studied. Function-damaging variants in the TRIO gene are known to be enriched in individuals with neurodevelopmental disorders (NDDs). Disease variants in the GEF1 domain or the nine adjacent spectrin repeats (SRs) are enriched in NDDs, suggesting that dysregulated GEF1 activity is linked to these disorders. We provide evidence here that the Trio SRs interact intramolecularly with the GEF1 domain to inhibit its enzymatic activity. We demonstrate that SRs 6-9 decrease GEF1 catalytic activity both in vitro and in cells and show that NDD-associated variants in the SR8 and GEF1 domains relieve this autoinhibitory constraint. Our results from chemical cross-linking and bio-layer interferometry indicate that the SRs primarily contact the pleckstrin homology region of the GEF1 domain, reducing GEF1 binding to the small GTPase Rac1. Together, our findings reveal a key regulatory mechanism that is commonly disrupted in multiple NDDs and may offer a new target for therapeutic intervention for TRIO-associated NDDs.	[Bircher, Josie E.; Corcoran, Ellen E.; Lam, TuKiet T.; Koleske, Anthony J.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Lam, TuKiet T.] Yale Univ, Keck MS & Prote Resource, New Haven, CT USA; [Trnka, Michael J.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Koleske, Anthony J.] Yale Univ, Dept Neurosci, New Haven, CT 06520 USA	Yale University; Yale University; University of California System; University of California San Francisco; Yale University	Koleske, AJ (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.; Koleske, AJ (corresponding author), Yale Univ, Dept Neurosci, New Haven, CT 06520 USA.	anthony.koleske@yale.edu		Corcoran, Ellen/0000-0002-5752-3094	National Institute of Health (NIH) [R56MH122449, R01 MH115939, R01 NS105640, F31MH127891-01, F31 NS113511-03]	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-This work was supported by the National Institute of Health (NIH) grants R56MH122449, R01 MH115939, and R01 NS105640 to A. J. K., F31MH127891-01 to E. E. C., and F31 NS113511-03 to J. E. B. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barbosa S, 2020, AM J HUM GENET, V106, P338, DOI 10.1016/j.ajhg.2020.01.018; Bellanger JM, 2003, BIOL CELL, V95, P625, DOI 10.1016/j.biolcel.2003.10.002; Bellanger JM, 1998, ONCOGENE, V16, P147, DOI 10.1038/sj.onc.1201532; Bircher JE, 2021, J CELL SCI, V134, DOI 10.1242/jcs.248393; Blaise AM, 2022, BIOL METHODS PROTOC, V7, DOI 10.1093/biomethods/bpab024; Chhatriwala MK, 2007, J MOL BIOL, V368, P1307, DOI 10.1016/j.jmb.2007.02.060; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Debreceni B, 2004, J BIOL CHEM, V279, P3777, DOI 10.1074/jbc.M308282200; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Katrancha SM, 2017, HUM MOL GENET, V26, P4728, DOI 10.1093/hmg/ddx355; Kubiseski TJ, 2003, MOL CELL BIOL, V23, P6823, DOI 10.1128/MCB.23.19.6823-6835.2003; Lim C, 2020, P NATL ACAD SCI USA, V117, P30380, DOI 10.1073/pnas.2018163117; McPherson CE, 2005, GENE, V347, P125, DOI 10.1016/j.gene.2004.12.028; McQuin C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005970; Neubrand VE, 2010, J CELL SCI, V123, P2110, DOI 10.1242/jcs.064055; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Paskus JD, 2020, TRENDS NEUROSCI, V43, P505, DOI 10.1016/j.tins.2020.05.002; Pengelly RJ, 2016, J MED GENET, V53, P735, DOI 10.1136/jmedgenet-2016-103942; Penzes P, 2001, J NEUROSCI, V21, P8426, DOI 10.1523/JNEUROSCI.21-21-08426.2001; Perez-Riverol Y, 2022, NUCLEIC ACIDS RES, V50, pD543, DOI 10.1093/nar/gkab1038; Rabiner CA, 2005, NEUROSCIENTIST, V11, P148, DOI 10.1177/1073858404271250; Sadybekov A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00472-0; Saito K, 2007, BBA-MOL CELL BIOL L, V1771, P719, DOI 10.1016/j.bbalip.2007.02.010; Sanchez NA, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101276; Schiller MR, 2008, EXP CELL RES, V314, P2674, DOI 10.1016/j.yexcr.2008.05.011; Schiller MR, 2006, J BIOL CHEM, V281, P18774, DOI 10.1074/jbc.M512482200; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schnirch L, 2020, ANAL CHEM, V92, P10495, DOI 10.1021/acs.analchem.0c01273; Son K, 2015, CYTOSKELETON, V72, P47, DOI 10.1002/cm.21210; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Tao T, 2019, J BIOL CHEM, V294, P10954, DOI 10.1074/jbc.RA118.007318; Terry-Lorenzo RT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167535; Tian C, 2021, J NEUROSCI, V41, P7768, DOI 10.1523/JNEUROSCI.3148-20.2021; Timmerman I, 2015, J CELL SCI, V128, P3514, DOI 10.1242/jcs.179424; Trnka MJ, 2014, MOL CELL PROTEOMICS, V13, P420, DOI 10.1074/mcp.M113.034009; van Rijssel J, 2012, MOL BIOL CELL, V23, P2831, DOI 10.1091/mbc.E11-11-0907; van Rijssel J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029912; Varadi M, 2022, NUCLEIC ACIDS RES, V50, pD439, DOI 10.1093/nar/gkab1061; Vishwanatha KS, 2012, BIOCHEMISTRY-US, V51, P5663, DOI 10.1021/bi300583s; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Wells CM, 2004, J CELL SCI, V117, P1259, DOI 10.1242/jcs.00997; Xu Z, 2017, J BIOL CHEM, V292, P17777, DOI 10.1074/jbc.M117.799114	46	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102361	10.1016/j.jbc.2022.102361	http://dx.doi.org/10.1016/j.jbc.2022.102361			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5A7IQ	35963430	Green Published, gold			2022-12-26	WOS:000863057500002
J	Pasiana, AD; Miyata, H; Chida, J; Hara, H; Imamura, M; Atarashi, R; Sakaguchi, S				Pasiana, Agriani Dini; Miyata, Hironori; Chida, Junji; Hara, Hideyuki; Imamura, Morikazu; Atarashi, Ryuichiro; Sakaguchi, Suehiro			Central residues in prion protein PrPC are crucial for its conversion into the pathogenic isoform	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; MONOCLONAL-ANTIBODIES; MICE; SCRAPIE; ACCUMULATION; REPLICATION; GENE; RESISTANT; TERMINUS; STRAINS	Conformational conversion of the cellular prion protein, PrPC, into the amyloidogenic isoform, PrPSc, is a key pathogenic event in prion diseases. However, the conversion mechanism remains to be elucidated. Here, we generated Tg(PrP.91-106)-8545/Prnp(0/0) mice, which overexpress mouse PrP lacking residues 91-106. We showed that none of the mice became sick after intracerebral inoculation with RML, 22L, and FK-1 prion strains nor accumulated PrPSc Delta 91-106 in their brains except for a small amount of PrP(Sc.)91-106 detected in one 22L-inoculated mouse. However, they developed disease around 85 days after inoculation with bovine spongiform encephalopathy (BSE) prions with PrPSc Delta 91-106 in their brains. These results suggest that residues 91-106 are important for PrPC conversion into PrPSc in infection with RML, 22L, and FK-1 prions but not BSE prions. We then narrowed down the residues 91-106 by transducing various PrP deletional mutants into RML- and 22L-infected cells and identified that PrP mutants lacking residues 97-99 failed to convert into PrPSc in these cells. Our in vitro conversion assay also showed that RML, 22L, and FK-1 prions did not convert PrP Delta 97-99 into PrPSc Delta 97-99, but BSE prions did. We further found that PrP mutants with proline residues at positions 97 to 99 or charged residues at positions 97 and 99 completely or almost completely lost their converting activity into PrPSc in RMLand 22L-infected cells. These results suggest that the structurally flexible and noncharged residues 97-99 could be important for PrPC conversion into PrPSc following infection with RML, 22L, and FK-1 prions but not BSE prions.	[Pasiana, Agriani Dini; Chida, Junji; Hara, Hideyuki; Sakaguchi, Suehiro] Tokushima Univ, Inst Enzyme Res KOSOKEN, Div Mol Neurobiol, Tokushima, Japan; [Miyata, Hironori] Univ Occupat & Environm Hlth, Anim Res Ctr, Sch Med, Kitakyushu, Fukuoka, Japan; [Imamura, Morikazu; Atarashi, Ryuichiro] Univ Miyazaki, Fac Med, Dept Infect Dis, Div Microbiol, Kiyotake, Miyazaki, Japan	Tokushima University; University of Occupational & Environmental Health - Japan; University of Miyazaki	Sakaguchi, S (corresponding author), Tokushima Univ, Inst Enzyme Res KOSOKEN, Div Mol Neurobiol, Tokushima, Japan.	sakaguchi@tokushima-u.ac.jp			JSPS KAKENHI [19H03548]; OTSUKA Toshimi Scholarship Foundation [20-66, 21-8]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); OTSUKA Toshimi Scholarship Foundation(Otsuka Pharmaceutical)	This research was supported in part by JSPS KAKENHI (grand number 19H03548) to S. S. A. D. P. was supported by the OTSUKA Toshimi Scholarship Foundation (No. 20-66, No. 21-8).	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Bosque PJ, 2000, J VIROL, V74, P4377, DOI 10.1128/JVI.74.9.4377-4386.2000; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Cali I, 2009, BRAIN, V132, P2643, DOI 10.1093/brain/awp196; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Fang C, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005623; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Fujita K, 2011, CELL MOL NEUROBIOL, V31, P999, DOI 10.1007/s10571-011-9696-z; Hara H, 2018, J VIROL, V92, DOI [10.1128/jvi.01368-17, 10.1128/JVI.01368-17]; Hayashi H, 2004, J VET MED SCI, V66, P515, DOI 10.1292/jvms.66.515; Hayashi HK, 2005, BIOCHEM BIOPH RES CO, V328, P1024, DOI 10.1016/j.bbrc.2005.01.065; Imamura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082538; Kraus A, 2021, MOL CELL, V81, P4540, DOI 10.1016/j.molcel.2021.08.011; Lund C, 2007, J NEUROSCI METH, V165, P183, DOI 10.1016/j.jneumeth.2007.06.005; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; MANSON JC, 1994, NEURODEGENERATION, V3, P331; Nishida N, 1999, LAB INVEST, V79, P689; Nishida N, 2000, J VIROL, V74, P320, DOI 10.1128/JVI.74.1.320-325.2000; Notari S, 2008, J BIOL CHEM, V283, P30557, DOI 10.1074/jbc.M801877200; Pankiewicz J, 2006, EUR J NEUROSCI, V23, P2635, DOI 10.1111/j.1460-9568.2006.04805.x; Pankiewicz JE, 2019, MOL NEUROBIOL, V56, P2073, DOI 10.1007/s12035-018-1208-4; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; Prusiner SB, 1998, BRAIN PATHOL, V8, P499; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Manka SW, 2021, bioRxiv, DOI 10.1101/2021.12.13.472424; Sadowski MJ, 2009, NEUROBIOL DIS, V34, P267, DOI 10.1016/j.nbd.2009.01.013; Saijo E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003692; SAKAGUCHI S, 1995, J VIROL, V69, P7586, DOI 10.1128/JVI.69.12.7586-7592.1995; SAKAGUCHI S, 1993, J GEN VIROL, V74, P2117, DOI 10.1099/0022-1317-74-10-2117; Striebel JF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002275; Uchiyama K, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197260; Uchiyama K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109737; Uchiyama K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2873; Wadsworth JDF, 2010, NEUROPATH APPL NEURO, V36, P576, DOI 10.1111/j.1365-2990.2010.01129.x; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; WILMUT I, 1991, J REPROD FERTIL, V92, P245, DOI 10.1530/jrf.0.0920245; Yamaguchi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043540	43	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102381	10.1016/j.jbc.2022.102381	http://dx.doi.org/10.1016/j.jbc.2022.102381			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5B1GH	35973512	gold, Green Published			2022-12-26	WOS:000863323200013
J	Ling, H; Cao, CH; Han, K; Lv, YR; Ma, XD; Cao, JH; Chen, JW; Li, S; Lin, JL; Fang, YJ; Pan, ZZ; Xie, D; Wang, FW				Ling, Han; Cao, Chen-Hui; Han, Kai; Lv, Yong-Rui; Ma, Xiao-Dan; Cao, Jing-Hua; Chen, Jie-Wei; Li, Si; Lin, Jin-Long; Fang, Yu-Jing; Pan, Zhi-Zhong; Xie, Dan; Wang, Feng-Wei			CEP63 upregulates YAP1 to promote colorectal cancer progression through stabilizing RNA binding protein FXR1	ONCOGENE			English	Article							MESSENGER-RNA; CHROMOSOME SEGREGATION; CENTROSOME; TRANSLATION; COMPLEX	Abnormal regulation of centrosome components can induce chromosome instability and tumorigenesis. Centrosomal protein 63 (CEP63) is a vital member for assembling centrosome. Yet, the involvement of CEP63 in cancer pathogenesis remains unclear. Here we identify CEP63 as an important mediator for RNA-binding proteins (RBPs) to facilitate regulation on their RNA targets in colorectal cancer (CRC). We demonstrate that CEP63 protein is upregulated in a large cohort of colorectal cancer tissues and predicts poor prognosis, and USP36 is identified for stabilizing CEP63 by enhancing its K48-dependent deubiquitination. CEP63 overexpression promotes the proliferation and tumor growth of CRC cells in vitro and in vivo. Furthermore, we find that CEP63 can promote cancer stem-like cell properties by enhancing YAP1 expression through binding with and inhibiting the K63-ubiquitylation degradation of RBP FXR1 in CRC cells. Importantly, we further verify that the KH domain of FXR1 is necessary for the interaction between CEP63 and FXR1. Moreover, microtube motor proteins can form a complex with CEP63 and FXR1 to mediate the regulation of FXR1 on RNA targets. Additionally, we also confirm that CEP63 can bind and regulate multiple RBPs. In conclusion, our findings unveil an unrecognized CEP63/RBPs/RNA axis that CEP63 may perform as an adapter facilitating the formation of RBPs complex to regulate RNA progression and discover the role of CEP63 involved in signal transduction and RNA regulation, providing potential therapeutic target for CRC patients.	[Ling, Han; Cao, Chen-Hui; Han, Kai; Lv, Yong-Rui; Ma, Xiao-Dan; Cao, Jing-Hua; Chen, Jie-Wei; Li, Si; Lin, Jin-Long; Fang, Yu-Jing; Pan, Zhi-Zhong; Xie, Dan; Wang, Feng-Wei] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510060, Peoples R China; [Cao, Chen-Hui] Univ Elect Sci & Technol China, Sch Med, Sichuan Canc Ctr, Sichuan Canc Hosp & Inst,Integrat Canc Ctr, Chengdu 610041, Peoples R China; [Cao, Chen-Hui] Univ Elect Sci & Technol China, Sch Med, Sichuan Canc Ctr, Sichuan Canc Hosp & Inst,Canc Clin Res Ctr, Chengdu 610041, Peoples R China; [Han, Kai; Fang, Yu-Jing; Pan, Zhi-Zhong] Sun Yat Sen Univ, Canc Ctr, Dept Colorectal Surg, Guangzhou 510060, Peoples R China; [Chen, Jie-Wei; Xie, Dan] Sun Yat Sen Univ, Canc Ctr, Dept Pathol, Guangzhou 510060, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; University of Electronic Science & Technology of China; University of Electronic Science & Technology of China; Sun Yat Sen University; Sun Yat Sen University	Xie, D; Wang, FW (corresponding author), Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510060, Peoples R China.; Xie, D (corresponding author), Sun Yat Sen Univ, Canc Ctr, Dept Pathol, Guangzhou 510060, Peoples R China.	xiedan@sysucc.org.cn; wangfengw@sysucc.org.cn			National Key R&D Program of China [2021YFA1300201]; National Natural Science Foundation of China [81972227, 81730072, 82072608, 81872001, 81903007, 82002467]; Guangzhou Science and Technology Plan Projects [201904020044]; China Postdoctoral Science Foundation [2020M672999]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Science and Technology Plan Projects; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants from the National Key R&D Program of China (grant number 2021YFA1300201); the National Natural Science Foundation of China (grant numbers 81972227, 81730072, 82072608, 81872001, 81903007 and 82002467); the Guangzhou Science and Technology Plan Projects (grant number 201904020044) and the China Postdoctoral Science Foundation (2020M672999).	Agote-Aran A, 2020, EMBO J, V39, DOI 10.15252/embj.2020104467; Auslander D, 2018, NAT METHODS, V15, P57, DOI [10.1038/NMETH.4505, 10.1038/nmeth.4505]; Boo SH, 2020, EXP MOL MED, V52, P400, DOI 10.1038/s12276-020-0407-z; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brown NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069986; Cai Z, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.674933; Conduit PT, 2015, NAT REV MOL CELL BIO, V16, P611, DOI 10.1038/nrm4062; De Simone A, 2016, CELL REP, V14, P2250, DOI 10.1016/j.celrep.2016.01.077; Denes LT, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26383-9; Dockendorff TC, 2019, MOL NEUROBIOL, V56, P711, DOI 10.1007/s12035-018-1122-9; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Dumont J, 2012, TRENDS CELL BIOL, V22, P241, DOI 10.1016/j.tcb.2012.02.007; Eliscovich C, 2013, J BIOL CHEM, V288, P20361, DOI 10.1074/jbc.R113.452094; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fallmann J, 2016, NUCLEIC ACIDS RES, V44, pD90, DOI 10.1093/nar/gkv1238; Farina F, 2016, NAT CELL BIOL, V18, P65, DOI 10.1038/ncb3285; Frederick MI, 2021, BIOL CHEM, V402, P425, DOI 10.1515/hsz-2020-0325; Giampetruzzi A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11837-y; Gurkaslar HK, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107630; Hanahan D, 2022, CANCER DISCOV, V12, P31, DOI 10.1158/2159-8290.CD-21-1059; Herman AB, 2018, CELL REP, V24, P1176, DOI 10.1016/j.celrep.2018.07.002; Hirokawa N, 2006, J NEUROSCI, V26, P7139, DOI 10.1523/JNEUROSCI.1821-06.2006; Honda S, 2017, ONCOTARGET, V8, P14277, DOI 10.18632/oncotarget.15362; Hong AW, 2016, NAT REV GASTRO HEPAT, V13, P324, DOI 10.1038/nrgastro.2016.59; Jayaraman D, 2016, NEURON, V92, P813, DOI 10.1016/j.neuron.2016.09.056; Ke WL, 2022, BIOENGINEERED, V13, P5443, DOI 10.1080/21655979.2022.2030572; Kim TS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08838-2; Kwon YT, 2017, TRENDS BIOCHEM SCI, V42, P873, DOI 10.1016/j.tibs.2017.09.002; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Liu Q, 2019, BIOCHEM BIOPH RES CO, V513, P502, DOI 10.1016/j.bbrc.2019.03.043; Loffler H, 2011, CANCER RES, V71, P2129, DOI 10.1158/0008-5472.CAN-10-2684; Lukinaviclus G, 2013, CURR BIOL, V23, P265, DOI 10.1016/j.cub.2012.12.030; Madiraju C, 2022, TRENDS IMMUNOL, V43, P148, DOI 10.1016/j.it.2021.12.005; Marjanovic M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8676; Mondal T, 2018, CANCER CELL, V33, P417, DOI 10.1016/j.ccell.2018.01.020; Ohtake F, 2018, P NATL ACAD SCI USA, V115, pE1401, DOI 10.1073/pnas.1716673115; Peng F, 2021, CELL RES, V31, P345, DOI 10.1038/s41422-020-00397-2; Richards J, 2021, MOL MICROBIOL, V116, P361, DOI 10.1111/mmi.14723; Rowinsky EK, 2020, INVEST NEW DRUG, V38, P1448, DOI 10.1007/s10637-020-00915-4; SANTIAGO TC, 1987, NUCLEIC ACIDS RES, V15, P2417, DOI 10.1093/nar/15.6.2417; Say E, 2010, MOL CELL, V38, P236, DOI 10.1016/j.molcel.2010.04.004; Schaeffer C, 2003, BIOL CELL, V95, P221, DOI 10.1016/S0248-4900(03)00037-6; Sir JH, 2011, NAT GENET, V43, P1147, DOI 10.1038/ng.971; Turner-Bridger B, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.200177; Uchida Y, 2019, J BIOCHEM, V166, P375, DOI 10.1093/jb/mvz067; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Watanabe Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13508; Wei Z, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00535-19; Xia WL, 2018, J CELL BIOL, V217, P3464, DOI 10.1083/jcb.201801143; Xu N, 2020, CIRC RES, V126, P907, DOI 10.1161/CIRCRESAHA.119.316444; Yan YL, 2020, NUCLEIC ACIDS RES, V48, P12711, DOI 10.1093/nar/gkaa1090; Zhang JY, 2019, CANCER LETT, V440, P106, DOI 10.1016/j.canlet.2018.10.010	53	0	0	1	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 23	2022	41	39					4433	4445		10.1038/s41388-022-02439-y	http://dx.doi.org/10.1038/s41388-022-02439-y		AUG 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	4S3XC	35989368				2022-12-26	WOS:000842428900001
J	Furar, E; Wang, F; Durocher, JS; Ahn, YA; Memis, I; Cavalcante, L; Klahr, L; Samson, AC; Van Herwegen, J; Dukes, D; Alessandri, M; Mittal, R; Eshraghi, AA				Furar, Emily; Wang, Florence; Durocher, Jennifer S.; Ahn, Yeojin A.; Memis, Idil; Cavalcante, Leylane; Klahr, Lorena; Samson, Andrea C.; Van Herwegen, Jo; Dukes, Daniel; Alessandri, Michael; Mittal, Rahul; Eshraghi, Adrien A.			The impact of COVID-19 on individuals with ASD in the US: Parent perspectives on social and support concerns	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDER; CHILDREN; MOTHERS; TODDLERS; STRESS	The COVID-19 pandemic's disruptions to daily routines and services have proven especially challenging for children with autism spectrum disorder (ASD) and their families. The current retrospective study aimed to determine the impact of the COVID-19 pandemic's social environmental changes on parental ratings of personal and child concerns about family conflict, opportunities for social interaction, and loss of institutional support (school and therapy services). Analyses of responses from families with ASD in the US determined differences in concerns across three time points which were measured simultaneously: prior to COVID19, at the start of COVID-19, and at the time of survey completion. From our sample of 246 school-aged children, parents retrospectively reported significantly increasing levels of concern for both themselves and their children over time, with parents' personal concern levels rated consistently higher than their ratings of their child's level of concern. Concerns about loss of institutional support were higher for parents of children reported as having cooccurring intellectual disability. Further, parents of younger children also reported more concerns about loss of services, as well as more social concerns. For parent ratings of child concerns, children who were reportedly aware of COVID-19 were determined to have higher levels of social concerns and concerns about loss of institutional support. Meanwhile, the child's age and gender did not impact their parent ratings of child concerns. The increased level of parental and child-perceived concerns over the course of the pandemic suggests a need for improved service delivery and support for these families. The high levels of concerns observed in the current study provide support for the need to assess families' priorities and tailor services to best meet families' needs. This will potentially increase the quality of life of family members, and improve ASD services across the lifespan, and improve outcomes.	[Furar, Emily; Wang, Florence; Memis, Idil; Cavalcante, Leylane; Klahr, Lorena; Mittal, Rahul; Eshraghi, Adrien A.] Univ Miami, Miller Sch Med, Hearing Res & Commun Disorders Lab, Dept Otolaryngol, Miami, FL 33136 USA; [Durocher, Jennifer S.; Ahn, Yeojin A.; Alessandri, Michael] Univ Miami, Dept Psychol, POB 248185, Coral Gables, FL 33124 USA; [Samson, Andrea C.; Dukes, Daniel] Univ Fribourg, Inst Special Educ, Fribourg, Switzerland; [Samson, Andrea C.] Unidistance Suisse, Fac Psychol, Brig, Switzerland; [Van Herwegen, Jo] UCL, Inst Educ, Dept Psychol & Human Dev, UCL, London, England; [Dukes, Daniel] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland; [Eshraghi, Adrien A.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Eshraghi, Adrien A.] Univ Miami, Miller Sch Med, Dept Pediat, Miami, FL 33136 USA	University of Miami; University of Miami; University of Fribourg; University of London; University College London; UCL Institute of Education; University of Geneva; University of Miami; University of Miami	Eshraghi, AA (corresponding author), Univ Miami, Miller Sch Med, Hearing Res & Commun Disorders Lab, Dept Otolaryngol, Miami, FL 33136 USA.; Eshraghi, AA (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA.; Eshraghi, AA (corresponding author), Univ Miami, Miller Sch Med, Dept Pediat, Miami, FL 33136 USA.	aeshraghi@med.miami.edu	; Samson, Andrea/K-3928-2017	Furar, Emily/0000-0002-1035-9178; Van Herwegen, Jo/0000-0001-5316-1818; Samson, Andrea/0000-0001-6807-3132; Ahn, Yeo Jin/0000-0003-3504-6909	Research Funds of Unidistance Suisse; Swiss National Science Foundation [PP00P1_176722]	Research Funds of Unidistance Suisse; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research project was supported by Research Funds of Unidistance Suisse and the Swiss National Science Foundation (PP00P1_176722 for Andrea Samson).	Al Khateeb JM, 2019, AUTISM, V23, P1645, DOI 10.1177/1362361319833929; Ameis SH, 2020, MOL AUTISM, V11, DOI 10.1186/s13229-020-00365-y; Asbury K, 2021, J AUTISM DEV DISORD, V51, P1772, DOI 10.1007/s10803-020-04577-2; Baweja R, 2022, J AUTISM DEV DISORD, V52, P473, DOI 10.1007/s10803-021-04950-9; Behar-Zusman V, 2020, FAM PROCESS, V59, P1045, DOI 10.1111/famp.12579; Behr SK., 1993, COGNITIVE COPING FAM, P151; Bhat A, 2021, AUTISM RES, V14, P2454, DOI 10.1002/aur.2618; Bottini S, 2018, RES AUTISM SPECT DIS, V45, P9, DOI 10.1016/j.rasd.2017.10.001; Bromley J, 2004, AUTISM, V8, P409, DOI 10.1177/1362361304047224; Brown HK, 2011, J AUTISM DEV DISORD, V41, P1291, DOI 10.1007/s10803-010-1148-y; Chafouleas SM, 2021, SCHOOL PSYCHOL, V36, P358, DOI 10.1037/spq0000426; Chan RCH, 2022, J AUTISM DEV DISORD, V52, P1314, DOI 10.1007/s10803-021-05004-w; Chavez JV, 2021, COUPLE FAM PSYCHOL, V10, P233, DOI 10.1037/cfp0000166; Chung EYH, 2019, J DEV PHYS DISABIL, V31, P419, DOI 10.1007/s10882-018-9651-8; Chung GR, 2022, J FAM VIOLENCE, V37, P801, DOI 10.1007/s10896-020-00200-1; Clements CC, 2018, JAMA PSYCHIAT, V75, P797, DOI 10.1001/jamapsychiatry.2018.1100; CNN Editorial Research, 2022, COVID 19 PANDEMIC TI; Colizzi M, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10060341; Davis NO, 2008, J AUTISM DEV DISORD, V38, P1278, DOI 10.1007/s10803-007-0512-z; Doenyas C, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.566809; Donohue JM, 2020, JAMA-J AM MED ASSOC, V324, P845, DOI 10.1001/jama.2020.13092; Education Week, 2020, CORONAVIRUS SPRING H; Eshraghi AA, 2020, LANCET PSYCHIAT, V7, P481, DOI 10.1016/S2215-0366(20)30197-8; Estes A, 2013, BRAIN DEV-JPN, V35, P133, DOI 10.1016/j.braindev.2012.10.004; Hartley SL, 2015, J AUTISM DEV DISORD, V45, P1636, DOI 10.1007/s10803-014-2318-0; Jaspers M, 2010, J CLIN EPIDEMIOL, V63, P185, DOI 10.1016/j.jclinepi.2009.05.003; Jeste S, 2020, J INTELL DISABIL RES, V64, P825, DOI 10.1111/jir.12776; Kalb LG, 2021, AUTISM RES, V14, P2183, DOI 10.1002/aur.2589; Kawaoka N, 2022, J AUTISM DEV DISORD, V52, P2149, DOI 10.1007/s10803-021-05119-0; Lee S.J., 2020, RES BRIEF STRESS PAR; Lim TSH, 2022, J AUTISM DEV DISORD, V52, P3015, DOI 10.1007/s10803-021-05180-9; Lugo-Marin J, 2021, RES AUTISM SPECT DIS, V83, DOI 10.1016/j.rasd.2021.101757; Macchiarola L, 2022, KNEE SURG SPORT TR A, V30, P3361, DOI 10.1007/s00167-022-06922-7; Manning J, 2021, J AUTISM DEV DISORD, V51, P2920, DOI 10.1007/s10803-020-04760-5; McGinn D., 2021, GLOBE MAIL; Meral BF, 2022, J AUTISM DEV DISORD, V52, P1712, DOI 10.1007/s10803-021-05070-0; Mosquera ML, 2021, RES DEV DISABIL, V117, DOI 10.1016/j.ridd.2021.104057; Mumbardo-Adam C, 2021, RES DEV DISABIL, V110, DOI 10.1016/j.ridd.2021.103860; MUNDY P, 1995, DEV PSYCHOPATHOL, V7, P63, DOI 10.1017/S0954579400006349; Mutluer T, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.561882; Papoudi D, 2021, REV J AUTISM DEV DIS, V8, P195, DOI 10.1007/s40489-020-00210-1; Parenteau C, 2020, EXPERIENCE PARENTS C, DOI [10.21203/rs.3.rs-46426/v1, DOI 10.21203/RS.3.RS-46426/V1]; Pavlopoulou G, 2020, UCL DISCOVERY; Pellicano L, 2020, EVERYDAY EXPERIENCES; Russell BS, 2020, CHILD PSYCHIAT HUM D, V51, P671, DOI 10.1007/s10578-020-01037-x; Schieve LA, 2007, PEDIATRICS, V119, pS114, DOI 10.1542/peds.2006-2089Q; Sideropoulos V, 2022, J AUTISM DEV DISORD, V52, P2656, DOI 10.1007/s10803-021-05168-5; Smile SC, 2020, CAN MED ASSOC J, V192, pE587, DOI 10.1503/cmaj.75399; Stankovic M, 2020, SSRN ELECT J, DOI [10.2139/ssrn.3582788, DOI 10.2139/SSRN.3582788]; Stedman A, 2019, J AUTISM DEV DISORD, V49, P1378, DOI 10.1007/s10803-018-3844-y; Su XY, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.708465; Taylor D. B., 2020, NEW YORK TIMES, P15; Thomas KC, 2007, J AUTISM DEV DISORD, V37, P1902, DOI 10.1007/s10803-006-0323-7; Latzer IT, 2021, AUTISM, V25, P1047, DOI 10.1177/1362361320984317; Van Herwegen J., 2020, IMPACT COVID 19 ED C; Vasa RA, 2021, AUTISM RES, V14, P2113, DOI 10.1002/aur.2574; White LC, 2021, J AUTISM DEV DISORD, V51, P3766, DOI 10.1007/s10803-020-04816-6	57	1	1	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0270845	10.1371/journal.pone.0270845	http://dx.doi.org/10.1371/journal.pone.0270845			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976958	gold, Green Published			2022-12-26	WOS:000847227000009
J	Sepulveda, PBP; Mayordomo, AC; Sala, C; Sosa, EJ; Zaiat, JJ; Cuello, M; Schwab, M; Golpe, DR; Aquilano, E; Santos, MR; Dipierri, JE; Gomez, ELA; Bravi, CM; Muzzio, M; Bailliet, G				Paz Sepulveda, Paula B.; Constanza Mayordomo, Andrea; Sala, Camila; Jorge Sosa, Ezequiel; Javier Zaiat, Jonathan; Cuello, Mariela; Schwab, Marisol; Rodriguez Golpe, Daniela; Aquilano, Eliana; Rita Santos, Maria; Edgardo Dipierri, Jose; Alfaro Gomez, Emma L.; Bravi, Claudio M.; Muzzio, Marina; Bailliet, Graciela			Human Y chromosome sequences from Q Haplogroup reveal a South American settlement pre-18,000 years ago and a profound genomic impact during the Younger Dryas	PLOS ONE			English	Article							LENGTH POLYMORPHISM ANALYSIS; BIOMASS-BURNING EPISODE; COSMIC IMPACT; EXTRATERRESTRIAL IMPACT; ARCHAEOLOGICAL SEQUENCE; HUMAN OCCUPATION; C-14 DATES; SITE; DNA; MITOCHONDRIAL	The settlement of the Americas has been the focus of incessant debate for more than 100 years, and open questions regarding the timing and spatial patterns of colonization still remain today. Phylogenetic studies with complete human Y chromosome sequences are used as a highly informative tool to investigate the history of human populations in a given time frame. To study the phylogenetic relationships of Native American lineages and infer the settlement history of the Americas, we analyzed Y chromosome Q Haplogroup, which is a Pan-American haplogroup and represents practically all Native American lineages in Mesoamerica and South America. We built a phylogenetic tree for Q Haplogroup based on 102 whole Y chromosome sequences, of which 13 new Argentine sequences were provided by our group. Moreover, 1,072 new single nucleotide polymorphisms (SNPs) that contribute to its resolution and diversity were identified. Q-M848 is known to be the most frequent autochthonous sub-haplogroup of the Americas. The present is the first genomic study of Q Haplogroup in which current knowledge on Q-M848 sub-lineages is contrasted with the historical, archaeological and linguistic data available. The divergence times, spatial structure and the SNPs found here as novel for Q-Z780, a less frequent sub-haplogroup autochthonous of the Americas, provide genetic support for a South American settlement before 18,000 years ago. We analyzed how environmental events that occurred during the Younger Dryas period may have affected Native American lineages, and found that this event may have caused a substantial loss of lineages. This could explain the current low frequency of Q-Z780 (also perhaps of Q-F4674, a third possible sub-haplogroup autochthonous of the Americas). These environmental events could have acted as a driving force for expansion and diversification of the Q-M848 sub-lineages, which show a spatial structure that developed during the Younger Dryas period.	[Paz Sepulveda, Paula B.; Constanza Mayordomo, Andrea; Sala, Camila; Cuello, Mariela; Schwab, Marisol; Rodriguez Golpe, Daniela; Aquilano, Eliana; Rita Santos, Maria; Bravi, Claudio M.; Muzzio, Marina; Bailliet, Graciela] Univ Nacl La Plata, Inst Multidisciplinario Biol Celular, Consejo Nacl Invest Cient & Tecn, Comis Invest Cient, La Plata, Buenos Aires, Argentina; [Constanza Mayordomo, Andrea] Hosp Italiano Buenos Aires, Programa Canc Hereditario, Buenos Aires, DF, Argentina; [Jorge Sosa, Ezequiel; Javier Zaiat, Jonathan] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Consejo Nacl Invest Cient & Tecn, Inst Quim Biol, Buenos Aires, DF, Argentina; [Edgardo Dipierri, Jose; Alfaro Gomez, Emma L.] Univ Nacl Jujuy, Fac Humanidades & Ciencias Sociales, Inst Biol La Altura, San Salvador De Jujuy, Jujuy, Argentina; [Alfaro Gomez, Emma L.] Univ Nacl Jujuy, Inst Ecorreg Andinas, San Salvador De Jujuy, Jujuy, Argentina; [Bravi, Claudio M.; Muzzio, Marina] Univ Nacl La Plata, Fac Ciencias Nat & Museo, La Plata, Buenos Aires, Argentina	Comision de Investigaciones Cientificas; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Hospital Italiano de Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; National University of La Plata; Museo La Plata	Muzzio, M; Bailliet, G (corresponding author), Univ Nacl La Plata, Inst Multidisciplinario Biol Celular, Consejo Nacl Invest Cient & Tecn, Comis Invest Cient, La Plata, Buenos Aires, Argentina.; Muzzio, M (corresponding author), Univ Nacl La Plata, Fac Ciencias Nat & Museo, La Plata, Buenos Aires, Argentina.	paulabeatrizpaz@gmail.com; marinamuzzio@gmail.com; graciela.bailliet@gmail.com		paz, paula/0000-0001-5244-7419; Rodriguez Golpe, Daniela/0000-0002-6667-146X; Aquilano, Eliana Anahi/0000-0002-6940-3823; Sosa, Ezequiel Jorge/0000-0002-7925-8973	Consejo Nacional de Investigacion Cientifica y Tecnologica (CONICET) [0396, 325, 1]; Agencia Nacional de Promocion Cientifica y Tecnologica [424, 16-32450, 715, 1611, 2167, 27]; Fundacion Bunge y Born; Comision de Investigaciones Cientificas de la Provincia de Buenos Aires; Universidad Nacional de Jujuy, Argentina	Consejo Nacional de Investigacion Cientifica y Tecnologica (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Fundacion Bunge y Born; Comision de Investigaciones Cientificas de la Provincia de Buenos Aires; Universidad Nacional de Jujuy, Argentina	MM was supported by funding from the Consejo Nacional de Investigacion Cientifica y Tecnologica (CONICET; http://www.conicet.gov.ar/?lan=en); the PICT2014 #0396, Agencia Nacional de Promocion Cientifica y Tecnologica (http://www.agencia.mincyt.gob.ar/); and the Fundacion Bunge y Born (https://www.fundacionbyb.org/), Argentina. GB was supported by funding from the PIP2013-2015 #325 of the Consejo Nacional de Investigacion Cientifica y Tecnologica (CONICET; http://www.conicet.gov.ar/?lan=en); and the PICT 2013-2015 #424 of the Agencia Nacional de Promocion Cientifica y Tecnologica (http://www.agencia.mincyt.gob.ar/), Argentina. CMB was supported by funding from the PIP CONICET 2010 N degrees 1 of the Consejo Nacional de Investigacion Cienti ' fica y Tecnolo ' gica (CONICET; http://www.conicet.gov.ar/?lan=en); the PICT 2005 #16-32450; PICT 2008 #715; PICT 2013 #1611; PICT 2015 #2167; and PICT 2017 #27 of the Agencia Nacional de Promocion Cientifica y Tecnologica (http://www.agencia.mincyt.gob.ar/), Argentina. PBPS, ACM, EJS, JJZ, MC, MS, DRG, EA and ELAG was supported by funding from the Consejo Nacional de Investigacion Cientifica y Tecnologica (CONICET; http://www.conicet.gov.ar/?lan=en); PBPS, DRG, and EA was supported by funding from the Agencia Nacional de Promocion Cientifica y Tecnologica (http://www.agencia.mincyt.gob.ar/), Argentina. CS and MRS was supported by funding from the Comisio ' n de Investigaciones Cientificas de la Provincia de Buenos Aires (www.cic.gba.gob.ar), Argentina. JED was supported by funding from the Universidad Nacional de Jujuy, Argentina (www.unju.edu.ar).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Adler R, 2006, NEW SCI, V190, P42; AlbersCornelis A, 2011, VARIANT CALL FORMAT; Alley RB, 2000, P NATL ACAD SCI USA, V97, P1331, DOI 10.1073/pnas.97.4.1331; Alves ND, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11024-3; Ameghino F., 1880, ANTIGUEDAD HOMBRE PL; Anderson DG, 2011, QUATERN INT, V242, P570, DOI 10.1016/j.quaint.2011.04.020; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2016, UPDATING NATIVE AM Q; [Anonymous], 2020, CARLOS EFRAIN PORTO; Ardelean CF, 2020, NATURE, V584, P87, DOI 10.1038/s41586-020-2509-0; Arnaiz-Villena A, 2009, INT J IMMUNOGENET, V36, P159, DOI 10.1111/j.1744-313X.2009.00841.x; Avena S.A., 2009, REV ARGENTINA ANTROP, V11, P25; Bailliet G, 2009, AM J PHYS ANTHROPOL, V140, P578, DOI 10.1002/ajpa.21133; Bakke J, 2009, NAT GEOSCI, V2, P202, DOI 10.1038/NGEO439; Balanovsky O, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-016-0870-2; Bar-Yosef O, 2002, STUDIES EARLY NEAR E; Battaglia V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071390; Bellwood P., 1997, ARCHAEOLOGY LINGUIST, P123; Bellwood P, 1999, U ARIZONA DEP ANTHR, P27; Bisso-Machado R, 2011, AM J HUM BIOL, V23, P563, DOI 10.1002/ajhb.21173; Blockley SPE, 2011, QUATERNARY SCI REV, V30, P98, DOI 10.1016/j.quascirev.2010.09.021; Boeda E, 2013, PALEOAMERICAN ODYSSE; Boeda E., 2016, PALEOAMERICA, V2, P286; Boeda E, 2014, ANTIQUITY, V88, P927, DOI 10.1017/S0003598X00050845; Borrero LA, 1999, J WORLD PREHIST, V13, P321, DOI 10.1023/A:1022341730119; Bortolini MC, 2003, AM J HUM GENET, V73, P524, DOI 10.1086/377588; Bouysse-Cassagne T, 1991, POBLACIONES HUMANAS; Braunstein J, HIST GLOBAL PERSPECT; Broecker WS, 2010, QUATERNARY SCI REV, V29, P1078, DOI 10.1016/j.quascirev.2010.02.019; Calandra HA, 2006, REGISTRO ARQUEOLOGIC; Carabias D., 2014, PREHISTORIC ARCHAEOL, P131, DOI DOI 10.1007/978-1-4614-9635-9_8; Carlson AE, 2007, P NATL ACAD SCI USA, V104, P6556, DOI 10.1073/pnas.0611313104; Carlson J, 2020, CURR OPIN GENET DEV, V62, P50, DOI 10.1016/j.gde.2020.05.024; Cerron-Palomino R, 2007, LEXIS, V31, P47; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; cme.h-its.org, RAXML 8 2 MANUAL; Consortium G, US; Cook DE, 2017, BIOINFORMATICS, V33, P1581, DOI 10.1093/bioinformatics/btx011; Danecek P, 2021, GIGASCIENCE, V10, DOI 10.1093/gigascience/giab008; Demarchi DA, 2008, INT J HUM GENET, V8, P131, DOI 10.1080/09723757.2008.11886025; Di Cristofaro J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076748; Dillehay T., 2000, SETTLEMENT AM NEW PR; Dillehay TD, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602778; docs.google.com, ISOGG INDEX SNP 2019; Dulik Matthew C, 2012, Proc Natl Acad Sci U S A, V109, P8471, DOI 10.1073/pnas.1118760109; Epps P, 2009, LANG LINGUIST COMPAS, V3, P581, DOI 10.1111/j.1749-818x.2009.00126.x; Farina RA, 2015, AM ANTIQUITY, V80, P193, DOI 10.7183/0002-7316.79.4.193; Firestone RB, 2007, P NATL ACAD SCI USA, V104, P16016, DOI 10.1073/pnas.0706977104; Flannery KV, 2003, P NATL ACAD SCI USA, V100, P11801, DOI 10.1073/pnas.1934526100; Flegontov P, 2016, BIORXIV; Forster P, 1996, AM J HUM GENET, V59, P935; Freitas FO., 2013, TIPIT J SOC ANTHR LO, V11, P60; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Full Genomes Corporation, US; Garcia A, 2018, J HUM GENET, V63, P493, DOI 10.1038/s10038-017-0406-7; Geppert M, 2015, FORENSIC SCI INT-GEN, V15, P111, DOI 10.1016/j.fsigen.2014.09.014; Gonzalez S, 2006, QUATERNARY SCI REV, V25, P201, DOI 10.1016/j.quascirev.2005.10.004; Gonzalez S, 2008, MEMORIA S INT FUMDHA; Grugni V, 2012, ANCIENT MIGRATORY EV; Grugni V, 2019, BMC BIOL, V17, DOI 10.1186/s12915-018-0622-4; GUIDON N, 1986, NATURE, V321, P769, DOI 10.1038/321769a0; Holen SR, 2017, NATURE, V544, P479, DOI 10.1038/nature22065; Hrdlicka A, 1912, EARLY MAN S AM; Ibanez G, 2008, COLLAS; ISOGG, 2019 2020 HAPL Q; Jennings AE, 2006, QUATERNARY SCI REV, V25, P282, DOI 10.1016/j.quascirev.2005.04.006; Jobling MA, 2017, NAT REV GENET, V18, P485, DOI 10.1038/nrg.2017.36; Jota Marilza S, 2016, J Hum Genet, V61, P593, DOI 10.1038/jhg.2016.26; Medina LSJ, 2014, ELECTROPHORESIS, V35, P2524, DOI 10.1002/elps.201400020; Jurado Medina LS, 2015, THESIS U NACL PLATA; Jurado Medina LS, CONTINENTAL ORIGIN Q; KARASIK G, 2016, PUEBLO MUCHOS PUEBLO, P6; Karmin M, 2015, GENOME RES, V25, P459, DOI 10.1101/gr.186684.114; Kennett JP, 2018, FLA MUS NAT HIST-RIP, P175; Kinzie CR, 2014, J GEOL, V122, P475, DOI 10.1086/677046; Knutti R, 2004, NATURE, V430, P851, DOI 10.1038/nature02786; Lahaye C, 2019, QUAT GEOCHRONOL, V49, P223, DOI 10.1016/j.quageo.2018.03.006; Lahaye C, 2013, J ARCHAEOL SCI, V40, P2840, DOI 10.1016/j.jas.2013.02.019; Leon E., 2007, ORIGENES HUMANOS AND; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lippold Sebastian, 2014, Investig Genet, V5, P13, DOI 10.1186/2041-2223-5-13; Mahaney WC, 2018, J GEOL, V126, P285, DOI 10.1086/697248; Mahaney WC, 2010, GEOMORPHOLOGY, V116, P48, DOI 10.1016/j.geomorph.2009.10.007; Mahaney WC, 2010, SEDIMENT GEOL, V231, P31, DOI 10.1016/j.sedgeo.2010.08.004; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; Malyarchuk B, 2011, J HUM GENET, V56, P583, DOI 10.1038/jhg.2011.64; Manelis de Klein HE., 1973, ESTUDIOS ANDINOS, V3, P129; Mark A., 2014, HUMAN EVOLUTIONARY G, VSecond; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Muysken P., 2002, INTERJ MULTICULT SOC, V4, P235; Norstedt J., 2016, Q NORDIC PROJECT; Park CG, 2018, TOX RESEARCH, V34, P163, DOI 10.5487/TR.2018.34.2.163; Paz Sepulveda PB, 2020, THESIS U NACL PLATA; Pereyra Carlos, 1930, BREVE HIST AM; Pino M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38089-y; Pino M, 2013, QUATERN INT, V299, P3, DOI 10.1016/j.quaint.2012.05.001; Pinotti T, 2019, CURR BIOL, V29, P149, DOI 10.1016/j.cub.2018.11.029; Politis G, 2015, MOBILITY ANCIENT SOC, P89; Poznik GD, 2016, NAT GENET, V48, P593, DOI 10.1038/ng.3559; Poznik GD, 2013, SCIENCE, V341, P562, DOI 10.1126/science.1237619; Prates L, 2013, QUATERN INT, V301, P104, DOI 10.1016/j.quaint.2013.03.011; Prates L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236023; project FTDg, PROJECT FTDG; Ramallo V, 2011, NATIVE MALE FOUNDER; Rambaut A., 2009, FIGTREE; Rasmussen M, 2015, NATURE, V523, P455, DOI 10.1038/nature14625; Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; Renne PR, 2005, NATURE, V438, pE7, DOI 10.1038/nature04425; Rodrigues AD, 1983, ANN M BERKELEY LINGU; Saenz V, 2003, REV TEXTOS ANTROPOL, V14, P55; Sandoval JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073006; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Seidemann RM., 2003, W VA L REV, V106, P149; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Susnik B., 1972, DIMENSIONES MIGRATOR; Taylor KC, 1997, SCIENCE, V278, P825, DOI 10.1126/science.278.5339.825; Umetsu K, 2001, ELECTROPHORESIS, V22, P3533, DOI 10.1002/1522-2683(200109)22:16<3533::AID-ELPS3533>3.0.CO;2-S; Umetsu K, 2005, ELECTROPHORESIS, V26, P91, DOI 10.1002/elps.200406129; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; vcf-kit.readthedocs.io, VCK KIT; Velasquez Garcia E., 2010, NUEVA HIST GEN MEXIC, P17; Vialou D, 2017, ANTIQUITY, V91, P865, DOI 10.15184/aqy.2017.101; Viegas Barros JP, 2005, ALGUNAS SEMEJANZAS G; Wachtel N., 1986, MEN WATER URU PROBLE; Weeks NT, 2017, CLUSTER COMPUT, V20, P1869, DOI 10.1007/s10586-017-0874-8; Wei LH, 2018, EUR J HUM GENET, V26, P1687, DOI 10.1038/s41431-018-0211-6; Wolbach WS, 2018, J GEOL, V126, P185, DOI 10.1086/695704; Wolbach WS, 2018, J GEOL, V126, P165, DOI 10.1086/695703; www.yfull.com, Q Y4276; Ye KX, 2011, ADV NUTR, V2, P486, DOI 10.3945/an.111.001024; YFull, Q Z5906; YFull, Q Y27993; YFull, Q BZ4012; YFull, Q Z35840; YFull, Q Y26467; YFull, Q Z5908 Q B48; YFull, Q F4674; Yfull, Q CTS11357 Q M925; YFull, Q CTS2731; YFull, Q SK1974 Q Y26547; YFull, Q MPB096; YFull, Q Y2816; Yfull, Q Z5915; YFull, Q Y780; YFull, 2018, Q MPB122; Zhong H, 2011, MOL BIOL EVOL, V28, P717, DOI 10.1093/molbev/msq247	150	0	0	32	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2022	17	8							e0271971	10.1371/journal.pone.0271971	http://dx.doi.org/10.1371/journal.pone.0271971			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4D6CO	35976870	Green Published, gold			2022-12-26	WOS:000847227000020
